Citrus Sinensis ID: 047569
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 832 | 2.2.26 [Sep-21-2011] | |||||||
| Q9T020 | 878 | Probable receptor-like pr | yes | no | 0.960 | 0.910 | 0.706 | 0.0 | |
| Q9SJT0 | 871 | Probable receptor-like pr | no | no | 0.967 | 0.924 | 0.695 | 0.0 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.895 | 0.884 | 0.574 | 0.0 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.957 | 0.932 | 0.491 | 0.0 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.933 | 0.936 | 0.505 | 0.0 | |
| Q9FN92 | 829 | Probable receptor-like pr | no | no | 0.901 | 0.904 | 0.503 | 0.0 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.872 | 0.881 | 0.488 | 0.0 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.908 | 0.890 | 0.433 | 1e-180 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.881 | 0.818 | 0.449 | 1e-176 | |
| Q9SR05 | 850 | Receptor-like protein kin | no | no | 0.870 | 0.851 | 0.429 | 1e-165 |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1228 bits (3177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 587/831 (70%), Positives = 672/831 (80%), Gaps = 32/831 (3%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSAD-VPSPIYLSAR 88
F P D+ LIDCG KSS+ PDGR FKSD+E + +++ KEDIQVS P +D V SPIYL+AR
Sbjct: 52 FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPSDKVASPIYLTAR 111
Query: 89 VFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNCC------------- 135
+F+EE+TY F L +PGWHWVRLHF A P + DLQ+A+F V T+
Sbjct: 112 IFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNND 171
Query: 136 ------EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEG 189
+E+++N+T++ F+++F PMK+S AFINAIEVVSAPD LISD G++LFPV + G
Sbjct: 172 SQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGFSG 231
Query: 190 LSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVT 249
LS ++YQ VYR+N+GGP I PQND+LGRTW+PD FLK++NLA +A++YP VT
Sbjct: 232 LSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPEVT 291
Query: 250 PLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNV 309
PLIAP TVY++A MA+S T+ PNFNV+W F + +F+YL+RLHFCDIVSKSLNDLYFNV
Sbjct: 292 PLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFNV 351
Query: 310 YVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGL 369
Y+NGKTAIS LDLSTVA LA PYY+DIVVNA+LM L VQIGP E+TGT+NAILNG+
Sbjct: 352 YINGKTAISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAILNGV 411
Query: 370 EVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKWHKRPQDW 429
EV+KMSNSVNSLDGEFGVDG G V GF +MFGAF+GLGAMV KW KRPQDW
Sbjct: 412 EVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKWKKRPQDW 471
Query: 430 QRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAI 489
Q+RNSFSSWLLP+H GD++FMTSK GS KS F NSTLGLGRYFS ELQEATKNF++S I
Sbjct: 472 QKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNFEASQI 531
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
IGVGGFGNVY+G +DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE
Sbjct: 532 IGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 591
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
NSEMILVYE+MSNGPFRDHLYGKNL PL+WKQRLEI IGSARGLHYLHTGTAQGIIHRDV
Sbjct: 592 NSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDV 651
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
KSTNILLD+ VAKV+DFGLSKD GQ HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYS
Sbjct: 652 KSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYS 711
Query: 670 FGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFA 729
FGVVLLE LCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL GTINPES+KKFA
Sbjct: 712 FGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFA 771
Query: 730 EAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQS---AATAAASPAAVA 786
EAAEKCL D+GVDRPTMGDVLWNLEYALQLQEAFTQGKAEE + T + P +
Sbjct: 772 EAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETENAKPDVVTPGSVPVSDP 831
Query: 787 APAATSASDDRPVSAPKENVGPAEVH-----AIDEHSGTAMFAQFSGLNGR 832
+P S + + + P PA+V A+DEHSGTAMF QF+ LNGR
Sbjct: 832 SPITPSVTTNEAATVPV----PAKVEENSGTAVDEHSGTAMFTQFANLNGR 878
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 1214 bits (3141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 579/832 (69%), Positives = 671/832 (80%), Gaps = 27/832 (3%)
Query: 23 GPPTAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSAD-VPS 81
G PTA F P D+ LIDCG KSS P+GR FKSD E + +++ K+DIQVS P +D +PS
Sbjct: 45 GSPTAG-FKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPS 103
Query: 82 PIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNCC------ 135
PIYL+A++F+EE+ Y F L +PGWHWVRLHFFA P + DLQ+A+F V T+
Sbjct: 104 PIYLTAKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFK 163
Query: 136 -------------EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLF 182
+E++LN+T++ F+++F PMK S AFIN IE+VSAPD LISD G+SLF
Sbjct: 164 LSNDNNDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLF 223
Query: 183 PVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAV 242
PV+ + GLS ++YQ VYR+N+GGP ITPQND+LGRTW PD +LK++NLA A+
Sbjct: 224 PVNGFSGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAI 283
Query: 243 QYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSL 302
YP GVTPLIAP TVY++ + MADS T+ PNFNVTW F + +F Y +RLHFCDI+SKSL
Sbjct: 284 IYPPGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSL 343
Query: 303 NDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTR 362
NDLYFNVY+NGKTAIS LDLSTVA L+ PYY+DIVVN++LM + L VQIGP E+TG +
Sbjct: 344 NDLYFNVYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKK 403
Query: 363 NAILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKW 422
NAILNG+EV+KMSNSVNSLDGEFGVDG +A+ +G V GF +MFGAFVGLGAMV KW
Sbjct: 404 NAILNGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMVYKW 463
Query: 423 HKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATK 482
KRPQDWQ+RNSFSSWLLP+H GD++FMTSK GSHKS NS LGLGRYFS ELQE TK
Sbjct: 464 KKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNSALGLGRYFSLSELQEVTK 523
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
NFD+S IIGVGGFGNVY+G IDDGT+VA+KRGNPQSEQGITEF TEIQMLSKLRHRHLVS
Sbjct: 524 NFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVS 583
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
LIGYCDEN+EMILVYEYMSNGPFRDHLYGKNL PL+WKQRLEI IG+ARGLHYLHTGTAQ
Sbjct: 584 LIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQ 643
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
GIIHRDVKSTNILLD+ VAKV+DFGLSKD GQ HVSTAVKGSFGYLDPEYFRRQQLT
Sbjct: 644 GIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYLDPEYFRRQQLT 703
Query: 663 EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722
+KSDVYSFGVVLLE LCARPAINPQLPREQVNLAEWAM WK+KGLLEKIIDPHLVG +NP
Sbjct: 704 DKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVNP 763
Query: 723 ESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQSA--ATAAA 780
ES+KKFAEAAEKCLAD+GVDRPTMGDVLWNLEYALQLQEAF+QGKAE E A
Sbjct: 764 ESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQGKAEAEEVETPKPVAVP 823
Query: 781 SPAAVAAPAATSASDDRPVSAPKENVGPAEVHAIDEHSGTAMFAQFSGLNGR 832
+ A + A T+A+ +RPVS +E + +D+HSGT MF QF+ LNGR
Sbjct: 824 AAAPTSPAATTAAASERPVSQTEEK----DDSTVDQHSGTTMFTQFASLNGR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 918 bits (2372), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/796 (57%), Positives = 570/796 (71%), Gaps = 51/796 (6%)
Query: 26 TAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPS---- 81
++++F+P DN+LIDCG L DGR FKSD++++ FLQT EDI+ SV S +
Sbjct: 24 SSSSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNAS 83
Query: 82 --PIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNCC---- 135
P+YL+AR+F +STY+F +++PG HW+RLHF+ L +L + F V TD
Sbjct: 84 TLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLLHD 143
Query: 136 -----------EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPV 184
+E+++ E S+ F P K S AFINA+E+VS PD L+ D SS+
Sbjct: 144 FSAGDTSSIVFKEYLIYAAEK-LSLYFKPHKGSTAFINAVEIVSVPDELVPDSASSVPQA 202
Query: 185 DSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQY 244
++GLS FS + ++R+N+GG I+P+ D L RTW+ D + + +V+ + + Y
Sbjct: 203 PDFKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNVTVDPSTITY 262
Query: 245 PDG-VTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLN 303
PDG T LIAP VY++A MAD+ T QPNFN++W VD Y +RLHFCDIVSKSLN
Sbjct: 263 PDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVSKSLN 322
Query: 304 DLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNG-LNVQIGPNKE-NTGT 361
DL FNV++N +AISALDLS++ L T YY D V+NAS + NG + VQ+GP +G
Sbjct: 323 DLIFNVFINKLSAISALDLSSLTSALGTAYYADFVLNASTITNGSILVQVGPTPNLQSGK 382
Query: 362 RNAILNGLEVIKMSNSVNSLDGEFGVDGSKAN-----SSSRGPVVAVGFAVMFGAFVGLG 416
NAILNGLE++K++N+ SLDG FGVDG SS + + +GF + AF+G+
Sbjct: 383 PNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLAIAGIGFVMALTAFLGVV 442
Query: 417 AMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGS-------------HKSGFTN 463
++++W +RP+DWQ++NSFSSWLLPLH +S+++SK GS +GF++
Sbjct: 443 VLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIFGSKKSKSNGFSS 502
Query: 464 --STLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQG 521
S GLGRYF F ELQ AT+NFD +A+ GVGGFG VY+GEID GT+VA+KRG+ SEQG
Sbjct: 503 FFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQSSEQG 562
Query: 522 ITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKN------LP 575
I EFQTEIQMLSKLRHRHLVSLIG+CDEN EMILVYEYMSNGP RDHLYG +P
Sbjct: 563 INEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDPNPIP 622
Query: 576 PLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635
LSWKQRLEI IGSARGLHYLHTG AQGIIHRDVK+TNILLD+N VAKVSDFGLSKDAP+
Sbjct: 623 TLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSKDAPM 682
Query: 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695
+GHVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVL EVLCARP INPQLPREQVNL
Sbjct: 683 DEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPREQVNL 742
Query: 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755
AE+AM RKG+LEKIIDP +VGTI+ SL+KF EAAEKCLA++GVDRP MGDVLWNLEY
Sbjct: 743 AEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLWNLEY 802
Query: 756 ALQLQEAFTQGKAEEE 771
ALQLQEA Q E+
Sbjct: 803 ALQLQEASAQVDLSED 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 776 bits (2005), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/844 (49%), Positives = 535/844 (63%), Gaps = 47/844 (5%)
Query: 26 TAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDK--EALPFLQTKEDIQVSVPSADVPSPI 83
++A F+P DN+LI CG S N R F D +L + S S + + I
Sbjct: 22 SSALFNPPDNYLISCG-SSQNITFQNRIFVPDSLHSSLVLKIGNSSVATSTTSNNSTNSI 80
Query: 84 YLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNCC-------- 135
Y +ARVF ++Y F++ G HW+RLHF + +L AS V T++
Sbjct: 81 YQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLNNFSFN 140
Query: 136 --------EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSY 187
+E+ +N+T ++ F P NSV F+NAIEVVS PD LI D+ +L P +
Sbjct: 141 NFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPDQALALNPSTPF 200
Query: 188 EGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDG 247
GLS +++ VYRLNMGGP +T QND+LGR W D+ +L + + ++++Y
Sbjct: 201 SGLSLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVLVVTANPSSIKYSPS 260
Query: 248 VTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYF 307
VT AP VY++A M D++ P+FNVTW VD F Y +R+HFCDIVS++LN L F
Sbjct: 261 VTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQALNTLVF 320
Query: 308 NVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNG-LNVQIGPNKENTGTRNAIL 366
N+YVN A+ +LDLST+ GL PY++D + N S+ +G L V +GP+ + T NA +
Sbjct: 321 NLYVNDDLALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSVGPDSQADIT-NATM 379
Query: 367 NGLEVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVG------------ 414
NGLEV+K+SN SL G V K+ + AV+ G+ VG
Sbjct: 380 NGLEVLKISNEAKSLSG---VSSVKSLLPGGSGSKSKKKAVIIGSLVGAVTLILLIAVCC 436
Query: 415 LGAMVIKWHKRPQDWQRRNSFSSWL-LPLHTGDTSFMTSKCGSHKSG----FTNSTLGLG 469
+V +R Q + WL LPL+ G + +T SHKS + ++ LG
Sbjct: 437 YCCLVASRKQRSTSPQEGGNGHPWLPLPLY-GLSQTLTKSTASHKSATASCISLASTHLG 495
Query: 470 RYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEI 529
R F FQE+ +AT FD S+++GVGGFG VY G ++DGTKVAVKRGNP+SEQG+ EF+TEI
Sbjct: 496 RCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEI 555
Query: 530 QMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS 589
+MLSKLRHRHLVSLIGYCDE SEMILVYEYM+NGP R HLYG +LPPLSWKQRLEI IG+
Sbjct: 556 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGA 615
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSF 648
ARGLHYLHTG +Q IIHRDVK+TNILLD+N VAKV+DFGLSK P + Q HVSTAVKGSF
Sbjct: 616 ARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSF 675
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708
GYLDPEYFRRQQLTEKSDVYSFGVVL+EVLC RPA+NP LPREQVN+AEWAM W++KGLL
Sbjct: 676 GYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLL 735
Query: 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKA 768
++I+D +L G +NP SLKKF E AEKCLA++GVDRP+MGDVLWNLEYALQL+E +
Sbjct: 736 DQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEET-SSALM 794
Query: 769 EEESQSAATAAASPAAVAAPAATSASDDRPVSAPKENVGPAEVHAIDEHSGTAMFAQFSG 828
E + S P A P S S + N G ++ + +A+F+Q
Sbjct: 795 EPDDNSTNHIPGIPMAPMEPFDNSMS---IIDRGGVNSGTGTDDDAEDATTSAVFSQLVH 851
Query: 829 LNGR 832
GR
Sbjct: 852 PRGR 855
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/823 (50%), Positives = 524/823 (63%), Gaps = 46/823 (5%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPSPIYLSARV 89
F+P DN+LI+CG ++ L GR F SDK + L + ++I SV + S IY +ARV
Sbjct: 25 FTPVDNYLINCGSPTNGTLM-GRIFLSDKLSSKLLTSSKEILASV-GGNSGSDIYHTARV 82
Query: 90 FKEESTYTFQLNQPGWHWVRLHF--------------FALPAKEADLQKASFHVATDNCC 135
F E S+Y F + + G HWVRL+F FA+ + ++ + + F V +
Sbjct: 83 FTEVSSYKFSVTR-GRHWVRLYFNPFDYQNFKMGSAKFAV-SSQSHVLLSDFTVTSSKVV 140
Query: 136 EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDE-----GSSLFPVDSYEGL 190
+E+ LN+T + + FTP S AF+NAIEV+S PDTLI+ + FP S +GL
Sbjct: 141 KEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLITGSPRFVGNPAQFPDMSMQGL 200
Query: 191 SKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTP 250
+ ++R+NMGGP + ND+L RTWVPDS FL EKNLA + S S P T
Sbjct: 201 -----ETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKSMSKFSTVNFVPGYATE 255
Query: 251 LIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVY 310
AP TVY S + M + FNVTW FDVD F Y R HFCDIVS SLN LYFN+Y
Sbjct: 256 DSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSLNQLYFNLY 315
Query: 311 VNGKTAISALDLST-VAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGL 369
V+ A + +DLST V LA Y D V N + V IGP+ +T NAI+NGL
Sbjct: 316 VDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKVRVSIGPSTVHTDYPNAIVNGL 375
Query: 370 EVIKMSNSVNSLD-GEFGVDGSKANSSSRGPVVAVGFAVMFGA-FVGLGAMVIKWHKRPQ 427
E++KM+NS L G F S ++ S+ G +V + F+G ++ K KR Q
Sbjct: 376 EIMKMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKRGQ 435
Query: 428 DWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSS 487
D + +W+ P TS M SK S+ + T+ T F +++AT NFD S
Sbjct: 436 DGHSK----TWM-PFSINGTS-MGSKY-SNGTTLTSITTNANYRIPFAAVKDATNNFDES 488
Query: 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IGVGGFG VY GE++DGTKVAVKRGNP+S+QG+ EF+TEI+MLS+ RHRHLVSLIGYC
Sbjct: 489 RNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
DEN+EMIL+YEYM NG + HLYG LP L+WKQRLEI IG+ARGLHYLHTG ++ +IHR
Sbjct: 549 DENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHR 608
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
DVKS NILLD+N++AKV+DFGLSK P + Q HVSTAVKGSFGYLDPEYFRRQQLT+KSD
Sbjct: 609 DVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSD 668
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLK 726
VYSFGVVL EVLCARP I+P LPRE VNLAEWAM+W++KG L++IID L G I P+SL+
Sbjct: 669 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLR 728
Query: 727 KFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQSAATAAASPAAVA 786
KFAE EKCLAD+GVDRP+MGDVLWNLEYALQLQEA G E E S P +
Sbjct: 729 KFAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDG--EPEDNSTNMIGELPPQIN 786
Query: 787 APAATSASDDRPVSAPKENVGPAEVHAIDEHSGTAMFAQFSGL 829
+ S + P +A G E +ID+ SG +M FS L
Sbjct: 787 NFSQGDTSVNVPGTA-----GRFEESSIDDLSGVSMSKVFSQL 824
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/784 (50%), Positives = 504/784 (64%), Gaps = 34/784 (4%)
Query: 5 LALLYALVSGPTIAFSQNGPPTAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFL 64
L ++S P + F G + P DN+LI+CG S+N R F SD A FL
Sbjct: 6 FGFLIWILSIPCLIFLCYG------YVPVDNYLINCG-SSTNVTVTSRVFISDNLASNFL 58
Query: 65 QTKEDIQVSVPSADVPSPIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQK 124
+ +I ++ + + S IY +AR+F S Y F + + G HW+RLHF + +
Sbjct: 59 TSPNEI-LAASNRNSNSDIYQTARIFTGISKYRFSVAR-GRHWIRLHFNPFQYQNFQMVS 116
Query: 125 ASFHVATD------------NCCEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDT 172
A F V+++ +E+ LN+ + FTP +S AF+NA+EVVS PDT
Sbjct: 117 AKFSVSSETHVLLSDFTVSSRVMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDT 176
Query: 173 LISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLA 232
L S + S ++GLS + + VYR+NMGGP +TP ND+L R W PDS FL EKNL
Sbjct: 177 LFSGDPSFAGSPGKFQGLSWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLV 236
Query: 233 TTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRL 292
+ S ++ P T AP TVY + + M + NFNVTW FDVD F Y LR
Sbjct: 237 KSVSKIASVDYVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRF 296
Query: 293 HFCDIVSKSLNDLYFNVYVNGKTAISALDLST-VAQGLATPYYRDIVVNASLMHNGLNVQ 351
HFCDIVSK+LN LYFN+YV+ + LDLS+ ++ L+ Y D V ++ + + V
Sbjct: 297 HFCDIVSKALNQLYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVS 356
Query: 352 IGPNKENTGTRNAILNGLEVIKMSNSVNSLD-GEFGVDGSKANSSSR-GPVVAVGFAVMF 409
IG + +T AILNGLE++KM+NS + L G F GS + + G ++ + +
Sbjct: 357 IGRSSVHTDYPTAILNGLEIMKMNNSKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGSLL 416
Query: 410 GAFVGLGAMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLG 469
A V LG + + KR +D Q NS +W+ PL + T+ +S + S +NS+ +
Sbjct: 417 -ALVVLGGFFVLYKKRGRD-QDGNS-KTWI-PLSSNGTT-SSSNGTTLASIASNSSYRI- 470
Query: 470 RYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEI 529
++EAT +FD + IGVGGFG VY GE+ DGTKVAVKR NP+S+QG+ EF+TEI
Sbjct: 471 ---PLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEI 527
Query: 530 QMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS 589
+MLS+ RHRHLVSLIGYCDEN+EMILVYEYM NG + HLYG L LSWKQRLEI IGS
Sbjct: 528 EMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGS 587
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSF 648
ARGLHYLHTG A+ +IHRDVKS NILLD+N +AKV+DFGLSK P I Q HVSTAVKGSF
Sbjct: 588 ARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSF 647
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708
GYLDPEYFRRQQLTEKSDVYSFGVV+ EVLCARP I+P L RE VNLAEWAM+W++KG L
Sbjct: 648 GYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQL 707
Query: 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKA 768
E IIDP L G I P+SL+KF E EKCLAD+GVDRP+MGDVLWNLEYALQLQEA G
Sbjct: 708 EHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDP 767
Query: 769 EEES 772
E+ +
Sbjct: 768 EDST 771
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 667 bits (1722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/772 (48%), Positives = 491/772 (63%), Gaps = 46/772 (5%)
Query: 28 ATFSPRDNFLIDCGGKSSNPLPDGRTFKSD--KEALPFLQTKEDIQVS--VPSADVPSPI 83
A F+P DN+LI+ G ++ R+F SD + FL T I +S PS D P +
Sbjct: 24 AAFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISISDTNPSPDSPV-L 82
Query: 84 YLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDN---------- 133
Y +ARVF +Y FQ+ G H++RLHF A +L+ A F V +
Sbjct: 83 YNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFSTS 142
Query: 134 --CCEEFMLNLTESTFSIKFTPMKNS-VAFINAIEVVSAPDTLISDEGSSLFPVDSYEGL 190
+EF+L + + I F P K S F+NA+EV SAP I D+G+ L +S +
Sbjct: 143 SVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQIF 202
Query: 191 SKFSYQY---VYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDG 247
S S Q V+R+N+GG +TP ND+L RTWV D N+L + A A + G
Sbjct: 203 SNLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGG 262
Query: 248 VTPLIAPATVYSSASMM-ADSHTVQPNFNVTWTFDVDST-FSYLLRLHFCDIVSKSLNDL 305
T IAP VY +A M D+ +Q FN++W F VD +L+RLHFCDIVS SLN L
Sbjct: 263 ATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQL 322
Query: 306 YFNVYVNGKTAISALDLSTVA-QGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTR-N 363
YFNV++N A +DLST+ LA+P Y D V + L + +GP+ + R N
Sbjct: 323 YFNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESD-RSGMLRISVGPSDLSNPARVN 381
Query: 364 AILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFG-AFVGLGAMVIKW 422
A+LNG+E++++ + V+S + S R V V +V+ G F+ L + +
Sbjct: 382 ALLNGVEIMRILSPVSS----------EVVSGKRNVVWIVVGSVLGGFVFLSLFFLSVLC 431
Query: 423 HKRPQDWQRRNSFSSWLLPLHT--GDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEA 480
R ++ + R+S S+ PL G ++ T++ SG+ TL + SF ELQ
Sbjct: 432 LCRRKNNKTRSSESTGWTPLRRFRGSSNSRTTERTVSSSGY--HTLRI----SFAELQSG 485
Query: 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL 540
T NFD S +IGVGGFG V+ G + D TKVAVKRG+P S QG+ EF +EI +LSK+RHRHL
Sbjct: 486 TNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHL 545
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
VSL+GYC+E SEMILVYEYM GP + HLYG PPLSWKQRLE+ IG+ARGLHYLHTG+
Sbjct: 546 VSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGS 605
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQ 659
+QGIIHRD+KSTNILLD+NYVAKV+DFGLS+ P I + HVST VKGSFGYLDPEYFRRQ
Sbjct: 606 SQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQ 665
Query: 660 QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719
QLT+KSDVYSFGVVL EVLCARPA++P L REQVNLAEWA++W+RKG+L++I+DP++
Sbjct: 666 QLTDKSDVYSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADE 725
Query: 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEE 771
I P SLKKFAE AEKC AD+GVDRPT+GDVLWNLE+ LQLQE+ EE+
Sbjct: 726 IKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEED 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 633 bits (1633), Expect = e-180, Method: Compositional matrix adjust.
Identities = 347/801 (43%), Positives = 484/801 (60%), Gaps = 45/801 (5%)
Query: 35 NFLIDCGGKSSNPLPDGRTFKSD--KEALPFLQTKEDIQVSV-PSADVPSPIYLSARVFK 91
+FL+DCG ++ + DGRT+ D LQ + I S + V + IY +ARVF
Sbjct: 32 SFLVDCGSNATTEV-DGRTWVGDLSPNKSVTLQGFDAITASTSKGSSVYAEIYKTARVFD 90
Query: 92 EESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATD------------------- 132
YTF+ G ++VRLHF + ++ ++SF V D
Sbjct: 91 AVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIAGEIAHKNL 150
Query: 133 ------------NCCEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSS 180
+ +EF+L + F P K S F+NAIE+VS D L + +
Sbjct: 151 ILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDDKLFKESVTK 210
Query: 181 LFPVDSYEGLSKFSYQYVYRLNMGGPSITPQND-SLGRTWVPDSNFLKEKNLATTASVES 239
+ + GL + +YRLN+GGP + P D L RTW D +++ +N S
Sbjct: 211 VGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEVKNSS 270
Query: 240 NAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVS 299
N + Y +AP VY +A MM+++ ++ FN++W F+VD F YL+RLHFC+++
Sbjct: 271 N-ITYALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCELLV 329
Query: 300 KSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENT 359
N F +Y+N +TA D+ A G Y+D + S ++ L +Q+GP+
Sbjct: 330 DKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSSKNDVLWIQLGPDSSVG 389
Query: 360 GTRNAILNGLEVIKMSNSVNSLDG-EFGVDG-SKANSSSRGPVVAVGFA---VMFGAFVG 414
+ +A+L+GLE+ K+S + N F G S ++S R ++VG ++F F+G
Sbjct: 390 ASGDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSDSKMRIIWISVGAGIAIIIFFVFLG 449
Query: 415 LGAMVIKWHKRPQDWQRRNSFSSWL-LPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFS 473
+ + + +R + + +N+ W L LH +++ G T + +GR F+
Sbjct: 450 ILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLRLNTLAASTMGRKFT 509
Query: 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLS 533
E++ ATKNFD IGVGGFG VY GE++DGT +A+KR P S+QG+ EF+TEI MLS
Sbjct: 510 LAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEIVMLS 569
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGL 593
+LRHRHLVSLIG+CDE++EMILVYEYM+NG R HL+G NLPPLSWKQRLE IGSARGL
Sbjct: 570 RLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSARGL 629
Query: 594 HYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLD 652
HYLHTG+ +GIIHRDVK+TNILLD+N+VAK+SDFGLSK P + HVSTAVKGSFGYLD
Sbjct: 630 HYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFGYLD 689
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712
PEYFRRQQLTEKSDVYSFGVVL E +CAR INP LP++Q+NLAEWA+ W+++ LE II
Sbjct: 690 PEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLESII 749
Query: 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEES 772
D +L G +PESL+K+ E AEKCLAD G +RP MG+VLW+LEY LQ+ EA+ + + E S
Sbjct: 750 DSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHEAWLRKQNGENS 809
Query: 773 QSAATAA-ASPAAVAAPAATS 792
S++ A +P + PA ++
Sbjct: 810 FSSSQAVEEAPESFTLPACSN 830
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1592), Expect = e-176, Method: Compositional matrix adjust.
Identities = 357/795 (44%), Positives = 480/795 (60%), Gaps = 62/795 (7%)
Query: 26 TAATFSPRDNFLIDCGGKSSNPL-PDGRTFKSDKEALPFLQTKEDIQVSVPS----ADVP 80
+AA +SP + L++CGG +SN D R + SD ++ FL + + + P+ VP
Sbjct: 26 SAADYSPTEKILLNCGGGASNLTDTDNRIWISDVKS-KFLSSSSEDSKTSPALTQDPSVP 84
Query: 81 SPIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDN------- 133
Y++ARVF+ TYTF + G +VRL+F+ + + F V+
Sbjct: 85 EVPYMTARVFRSPFTYTFPVAS-GRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNF 143
Query: 134 -------------CCEEFMLNLTESTFSIKFTPMK---NSVAFINAIEVVSAPDTLISDE 177
+EF++N+ T ++ FTP N+ AF+N IEV S PD S +
Sbjct: 144 SASQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDMYSSTD 203
Query: 178 GSSLFPVDSYEGLS---KFSYQYVYRLNMGGPSITPQNDS-LGRTWVPDSNFLKEKNLAT 233
G+ L V S ++ + + VYRLN+GG I+P D+ L R+W D ++ L
Sbjct: 204 GT-LTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGAGLGI 262
Query: 234 TASVESN-AVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRL 292
+ + N ++YP G +AP VYS+A M + + N+N+TW F +DS F+YL+RL
Sbjct: 263 PETADPNMTIKYPTGTPTYVAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRL 322
Query: 293 HFCDIVSK--SLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNG--- 347
HFC++ S +N F +Y+N +TA D+ P+++D VVN NG
Sbjct: 323 HFCEVSSNITKINQRVFTIYLNNQTAEPEADVIAWTSSNGVPFHKDYVVNPP-EGNGQQD 381
Query: 348 LNVQIGPNKENTGTR-NAILNGLEVIKMSNSVNSLDGEFGVDG---------------SK 391
L + + PN N +++LNG+E+ KM+ S +L G + G K
Sbjct: 382 LWLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRK 441
Query: 392 ANSSSRGPVVAVGFAVMFGAFVGLGAMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMT 451
+ S++ A AV+ +G ++ D+Q + +S LPL S
Sbjct: 442 SKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYGNSHSA 501
Query: 452 SKCGSHKSGFTNSTL--GLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGT-K 508
++ +G S+L L R+FSF E++ ATKNFD S ++GVGGFG VY GEID GT K
Sbjct: 502 GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTK 561
Query: 509 VAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDH 568
VA+KRGNP SEQG+ EFQTEI+MLSKLRHRHLVSLIGYC+EN EMILVY+YM++G R+H
Sbjct: 562 VAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREH 621
Query: 569 LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628
LY P L WKQRLEI IG+ARGLHYLHTG IIHRDVK+TNILLD+ +VAKVSDFG
Sbjct: 622 LYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG 681
Query: 629 LSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQ 687
LSK P + HVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL E LCARPA+NP
Sbjct: 682 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPT 741
Query: 688 LPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMG 747
L +EQV+LAEWA +KG+L++I+DP+L G I PE KKFAE A KC+ D G++RP+MG
Sbjct: 742 LAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMG 801
Query: 748 DVLWNLEYALQLQEA 762
DVLWNLE+ALQLQE+
Sbjct: 802 DVLWNLEFALQLQES 816
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 581 bits (1498), Expect = e-165, Method: Compositional matrix adjust.
Identities = 336/783 (42%), Positives = 454/783 (57%), Gaps = 59/783 (7%)
Query: 29 TFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPSPI----Y 84
T S + + CG ++ D + ++ D + FL+T I + D PS + Y
Sbjct: 22 TRSNGQDLALSCGTSEASADQDKKKWEPDTK---FLKTGNSIHATATYQD-PSLLSTVPY 77
Query: 85 LSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNC---------- 134
++AR+F +TY + H +RL+F+ ++ + F V ++
Sbjct: 78 MTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAAI 137
Query: 135 -CE---------EFMLNLTES-TFSIKFTP---MKNSVAFINAIEVVSAPDTLISDEGSS 180
C+ E+ L T+ SIKFTP +++ AFIN IEV+ P+ + D +
Sbjct: 138 TCQALTQAYLVKEYSLAPTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPE--LFDTAAL 195
Query: 181 LFPVDSYEGLSKFSYQYVYRLNMGGPSITPQNDS--LGRTWVPDSNFLKEKNLATTASVE 238
+ D + Q ++RLN+GG I DS L RTW D+ ++ L T
Sbjct: 196 VGFTDQTMDAKTANLQSMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFSAGLGVTLQAS 255
Query: 239 SNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIV 298
+N + IAPA +Y +A + + N+TW F +D F+Y+LRLHFC+
Sbjct: 256 NNFRINYQNMPVSIAPADIYKTARSQGPNGDINLKSNLTWMFQIDKNFTYILRLHFCEFQ 315
Query: 299 SKSLNDLYFNVYVNGKTA---ISALDLSTVAQGLATPYYRD--IVVNASLMHNGLNVQIG 353
+N FN+Y+N +TA + D+ P Y+D I V+A+ + +Q+
Sbjct: 316 LSKINQKVFNIYINNRTAQADTTPADIIGWTGEKGIPMYKDYAIYVDANNGGEEITLQMT 375
Query: 354 PNK-ENTGTRNAILNGLEVIKMSNSVN---------SLDGEFGVDGSKANSSSRGPVVAV 403
P+ ++ LNGLE+ KM N + E V N ++
Sbjct: 376 PSTFGQPEYYDSSLNGLEIFKMDTMKNLAGPNPEPSPMQAEEEVKKEFKNEKRHAFIIGS 435
Query: 404 GFAVMFGAFVGLGAMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSG--- 460
V+ V +GA+ +K+ Q +Q +S +S LP++ T+ T S KS
Sbjct: 436 AGGVLA---VLIGALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSGTKSTISGKSNNGS 492
Query: 461 -FTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE 519
+N GL R FS E++ T+NFD S +IGVGGFG VY G ID TKVAVK+ NP SE
Sbjct: 493 HLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSNPNSE 552
Query: 520 QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSW 579
QG+ EF+TEI++LS+LRH+HLVSLIGYCDE EM LVY+YM+ G R+HLY P L+W
Sbjct: 553 QGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTW 612
Query: 580 KQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQG 638
K+RLEI+IG+ARGLHYLHTG IIHRDVK+TNIL+D+N+VAKVSDFGLSK P + G
Sbjct: 613 KRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGG 672
Query: 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW 698
HV+T VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL E+LCARPA+NP LP+EQV+L +W
Sbjct: 673 HVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVSLGDW 732
Query: 699 AMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
AM KRKG LE IIDP+L G IN E LKKFA+ AEKCL D G++RPTMGDVLWNLE+ALQ
Sbjct: 733 AMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQ 792
Query: 759 LQE 761
LQE
Sbjct: 793 LQE 795
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 832 | ||||||
| 359474779 | 846 | PREDICTED: probable receptor-like protei | 0.990 | 0.973 | 0.72 | 0.0 | |
| 255543779 | 863 | kinase, putative [Ricinus communis] gi|2 | 0.987 | 0.952 | 0.732 | 0.0 | |
| 297802004 | 882 | kinase family protein [Arabidopsis lyrat | 0.965 | 0.910 | 0.712 | 0.0 | |
| 15234944 | 878 | putative receptor-like protein kinase [A | 0.960 | 0.910 | 0.706 | 0.0 | |
| 15226565 | 871 | Malectin/receptor-like protein kinase [A | 0.967 | 0.924 | 0.695 | 0.0 | |
| 356542359 | 878 | PREDICTED: probable receptor-like protei | 0.990 | 0.938 | 0.697 | 0.0 | |
| 224077872 | 814 | predicted protein [Populus trichocarpa] | 0.929 | 0.949 | 0.709 | 0.0 | |
| 356546380 | 869 | PREDICTED: probable receptor-like protei | 0.981 | 0.940 | 0.689 | 0.0 | |
| 224103371 | 783 | predicted protein [Populus trichocarpa] | 0.911 | 0.968 | 0.710 | 0.0 | |
| 357514905 | 848 | Kinase-like protein [Medicago truncatula | 0.965 | 0.946 | 0.693 | 0.0 |
| >gi|359474779|ref|XP_002280183.2| PREDICTED: probable receptor-like protein kinase At4g39110-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1283 bits (3319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 612/850 (72%), Positives = 712/850 (83%), Gaps = 26/850 (3%)
Query: 2 AILLALLYALVSGPTIAFSQNGPPTAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEAL 61
+ +L L+ + T + P A+T++P+D++LIDCGG +S+PLPDGR FK+D++A
Sbjct: 4 STVLLGLFCVFFASTFTITSAAP--ASTYTPQDSYLIDCGGTTSSPLPDGRVFKTDQQAA 61
Query: 62 PFLQTKEDIQVSVPSADVPSPIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEAD 121
P++ +++DIQ+SVPSADVPSPIYL+AR+F E++TY+F++++PGWHWVRLHFF + E D
Sbjct: 62 PYISSEDDIQISVPSADVPSPIYLTARIFVEDTTYSFRMSRPGWHWVRLHFFPMNNTEFD 121
Query: 122 LQKASFHVATDNCC---------------EEFMLNLTESTFSIKFTPMKNSVAFINAIEV 166
LQ A F V+TD +E+++N+T F++KF+PM+NSVAF+NAIEV
Sbjct: 122 LQHAVFSVSTDQVVLLHSFNLDNSTEWVLKEYLVNVTNERFTLKFSPMRNSVAFVNAIEV 181
Query: 167 VSAPDTLISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFL 226
VSAPD LI+D GS+LFPV + GLS +SYQ VYRLNMGGP I QND+LGRTWV D +L
Sbjct: 182 VSAPDILITDTGSALFPVGDFSGLSSYSYQVVYRLNMGGPLINSQNDTLGRTWVSDHPYL 241
Query: 227 KEKNLATTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTF 286
K LA + SV + + YP+G +PLIAP VY+SA MAD+ PNFNVTW F++D +F
Sbjct: 242 KSDVLAKSVSVSPSVITYPEGESPLIAPQLVYASAIQMADARVTNPNFNVTWNFNIDPSF 301
Query: 287 SYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHN 346
YL+R+HFCDIVSKSLNDLYFNVY+NG+ AIS LDLST+ LATPYY+DIVVN SL+ +
Sbjct: 302 GYLIRMHFCDIVSKSLNDLYFNVYINGRMAISGLDLSTITSALATPYYKDIVVNTSLLSD 361
Query: 347 GLNVQIGPNKENTGTRNAILNGLEVIKMSNSVNSLDGEFGVDGSKANSSS-RGPVVAVGF 405
L VQIGP ++TG+ NAI+NGLE++KMSNSVNSLDGEFGVDGSKA +SS R V AVGF
Sbjct: 362 QLTVQIGPMNQDTGSVNAIINGLEILKMSNSVNSLDGEFGVDGSKAETSSNRNAVAAVGF 421
Query: 406 AVMFGAFVGLGAMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSK--CGSHKSGFTN 463
A+MFGAFVGLGAMVIKW +RP DW++RNSFSSWLLPLH GDTSFMTSK GSHKSGF +
Sbjct: 422 AMMFGAFVGLGAMVIKWQRRPHDWEKRNSFSSWLLPLHAGDTSFMTSKNSLGSHKSGFYS 481
Query: 464 STLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGIT 523
STLGLGRYFSF ELQEATKNFDS+AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGIT
Sbjct: 482 STLGLGRYFSFTELQEATKNFDSNAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGIT 541
Query: 524 EFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL 583
EFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNL LSWKQRL
Sbjct: 542 EFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLASLSWKQRL 601
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVST 642
EI IG+ARGLHYLHTG AQGIIHRDVK+TNILLDDN++AKV+DFGLSK+AP + QGHVST
Sbjct: 602 EICIGAARGLHYLHTGAAQGIIHRDVKTTNILLDDNFIAKVADFGLSKNAPTMEQGHVST 661
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702
AVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLLE LCARPAINPQLPREQVNLAEWAMQW
Sbjct: 662 AVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQW 721
Query: 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEA 762
KRKGLL+KIIDP L GTINPES+KKFAEAAEKCLADHGVDRP+MGDVLWNLEYALQLQEA
Sbjct: 722 KRKGLLDKIIDPLLAGTINPESMKKFAEAAEKCLADHGVDRPSMGDVLWNLEYALQLQEA 781
Query: 763 FTQGKAEEESQSAATAAASPAAVAAPAATSASDDRPVSAPKENVGPAEVHAIDEHSGTAM 822
QGKAEEES+ +A A A TS +D+RP+S+P+E+ PAEV IDEHSGTAM
Sbjct: 782 SLQGKAEEESKLSAAPAP-----AVVPPTSTADNRPLSSPEESNNPAEVQVIDEHSGTAM 836
Query: 823 FAQFSGLNGR 832
FAQFSGL+GR
Sbjct: 837 FAQFSGLSGR 846
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255543779|ref|XP_002512952.1| kinase, putative [Ricinus communis] gi|223547963|gb|EEF49455.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1280 bits (3311), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/851 (73%), Positives = 707/851 (83%), Gaps = 29/851 (3%)
Query: 1 MAILLALLYALVSGPTIAFSQNGPPTAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEA 60
MAILL LLY+ V ++F+P D LI CG KS + +PDGR FK+D EA
Sbjct: 23 MAILLVLLYSFVFA--------SAADTSSFAPADQILISCGSKSLSAIPDGRVFKTDHEA 74
Query: 61 LPFLQTKEDIQVSVPSADVPSPIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEA 120
L+T+EDI VS PSADVPSPIYLSAR+F +ESTY F + PGWHW RLHFF
Sbjct: 75 QSLLKTEEDILVSAPSADVPSPIYLSARIFVQESTYAFTMKSPGWHWFRLHFFPFNNTRF 134
Query: 121 DLQKASFHVATDNCC---------------EEFMLNLTESTFSIKFTPMKNSVAFINAIE 165
DLQ A+F V+TD +E+++N+T+ ++KF PMKNS AFINAIE
Sbjct: 135 DLQSATFSVSTDKYVLLHNFNVNNQTKPFLKEYLVNVTDPKVTLKFQPMKNSAAFINAIE 194
Query: 166 VVSAPDTLISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNF 225
VVSAPD LISDEGS LFPV S+ GL+ + YQ VYRLN+GGP IT +ND+L RTW D F
Sbjct: 195 VVSAPDILISDEGSGLFPVSSFSGLTNYGYQVVYRLNVGGPLITSKNDTLWRTWENDKPF 254
Query: 226 LKEKNLATTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDST 285
LK+++LA + S+ +++++Y G +PLIAPATVY+SA MA+S T+ PNFNVTW F+VD+
Sbjct: 255 LKDQSLAQSVSIPTSSIKYGTGTSPLIAPATVYASAQEMAESKTMLPNFNVTWKFEVDTA 314
Query: 286 FSYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMH 345
F+YL+RLHF DIVSKSLNDLYFNVY+NGKTAIS LDLS++ LA PYY+DIVVN++LM
Sbjct: 315 FNYLVRLHFADIVSKSLNDLYFNVYINGKTAISGLDLSSITNQLAAPYYKDIVVNSTLMS 374
Query: 346 NGLNVQIGPNKENTGTRNAILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGF 405
NGLNVQIGP E+TG+ NAILNGLE++KMSNSV+SLDGEFGVDG A +SR V AVGF
Sbjct: 375 NGLNVQIGPMNEDTGSTNAILNGLEILKMSNSVDSLDGEFGVDGRMA-IASRSTVAAVGF 433
Query: 406 AVMFGAFVGLGAMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKC--GSHKSGFTN 463
A+MFGAFVGLGAMVIKWHKRPQDWQ+RNSFSSWLLP+H GDTSFMTSK GSHK+ +
Sbjct: 434 AMMFGAFVGLGAMVIKWHKRPQDWQKRNSFSSWLLPIHAGDTSFMTSKTSLGSHKTNMYS 493
Query: 464 STLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGIT 523
STLGLGRYFSF ELQEATKNFD SAIIGVGGFGNVYLG IDD T+VAVKRGNPQSEQGIT
Sbjct: 494 STLGLGRYFSFSELQEATKNFDQSAIIGVGGFGNVYLGVIDDATQVAVKRGNPQSEQGIT 553
Query: 524 EFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL 583
EFQTEIQMLSKLRHRHLVSLIGYCDEN EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL
Sbjct: 554 EFQTEIQMLSKLRHRHLVSLIGYCDENDEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL 613
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA 643
EISIG+ARGLHYLHTGTAQGIIHRDVK+TNILLDD +VAKV+DFGLSKDAP+GQGHVSTA
Sbjct: 614 EISIGAARGLHYLHTGTAQGIIHRDVKTTNILLDDAFVAKVADFGLSKDAPMGQGHVSTA 673
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703
VKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK
Sbjct: 674 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 733
Query: 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAF 763
RKGLLEKIIDP LVGTINPES+KKFAEAAEKCLA+HGVDRP+MGDVLWNLEYALQLQEAF
Sbjct: 734 RKGLLEKIIDPILVGTINPESMKKFAEAAEKCLAEHGVDRPSMGDVLWNLEYALQLQEAF 793
Query: 764 TQGKAEEESQ--SAATAAASPAAVAAPAATSASDDRPVSAPKENVGPAEVHAIDEHSGTA 821
+QGKAE+E++ ++ A+ + A A AT SD+RPVS P+EN PAEV AIDEHSGTA
Sbjct: 794 SQGKAEDETKSSASVAASPAVVAAAPAPATPTSDNRPVSIPEENKSPAEVQAIDEHSGTA 853
Query: 822 MFAQFSGLNGR 832
MFAQ+ GLNGR
Sbjct: 854 MFAQY-GLNGR 863
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297802004|ref|XP_002868886.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297314722|gb|EFH45145.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1244 bits (3219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/831 (71%), Positives = 680/831 (81%), Gaps = 28/831 (3%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSAD-VPSPIYLSAR 88
F P D+ LIDCG KSS+ PDGR FKSD+E + +++ KEDIQVS P +D V SPIYL+AR
Sbjct: 52 FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPSDKVASPIYLTAR 111
Query: 89 VFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNCC------------- 135
+F+EE+TY F L +PGWHWVRLHF A P + DLQ+A+F V T+
Sbjct: 112 IFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNND 171
Query: 136 ------EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEG 189
+E+++N+T++ F+++F PMK+S AFINAIEVVSAPD LISD G++LFPV+ + G
Sbjct: 172 SQAVVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVNGFSG 231
Query: 190 LSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVT 249
LS ++YQ VYR+N+GGP I PQND+LGRTW+PD FLK++NLA +A++YP VT
Sbjct: 232 LSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPEVT 291
Query: 250 PLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNV 309
PLIAP TVY++A MA+S T+ PNFNV+W F + +F+YL+RLHFCDIVSKSLNDLYFNV
Sbjct: 292 PLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFNV 351
Query: 310 YVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGL 369
Y+NGKTAIS LDLSTVA LA PYY+DIVVNA+LM L VQIGP E+TGT+NAILNG+
Sbjct: 352 YINGKTAISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAILNGV 411
Query: 370 EVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKWHKRPQDW 429
EV+KMSNSVNSLDGEFGVDG G V GF +MFGAF+GLGAMV +W KRPQDW
Sbjct: 412 EVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYRWKKRPQDW 471
Query: 430 QRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAI 489
Q+RNSFSSWLLP+H GD++FMTSK GS KS F NSTLGLGRYFS ELQEATKNF++S I
Sbjct: 472 QKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNFEASQI 531
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
IGVGGFGNVY+G +DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE
Sbjct: 532 IGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 591
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
NSEMILVYE+MSNGPFRDHLYGKNL PL+WKQRLEI IGSARGLHYLHTGTAQGIIHRDV
Sbjct: 592 NSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDV 651
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
KSTNILLDD VAKV+DFGLSKD GQ HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYS
Sbjct: 652 KSTNILLDDALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYS 711
Query: 670 FGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFA 729
FGVVLLE LCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL GTINPES+KKFA
Sbjct: 712 FGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFA 771
Query: 730 EAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQS-------AATAAASP 782
EAAEKCL D+GVDRPTMGDVLWNLEYALQLQEAFTQGKAEE + + ++P
Sbjct: 772 EAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETENAKPGVGTPGSVPVSAP 831
Query: 783 AAVAAPAATSASDDRPVSAP-KENVGPAEVHAIDEHSGTAMFAQFSGLNGR 832
+ +A A T+A+ PVS+ +EN G AE A+DEHSGTAMF QF+ LNGR
Sbjct: 832 SPIAPSATTNAAATVPVSSKVEENNGTAEGQAVDEHSGTAMFTQFANLNGR 882
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15234944|ref|NP_195622.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|75337933|sp|Q9T020.1|Y4391_ARATH RecName: Full=Probable receptor-like protein kinase At4g39110; Flags: Precursor gi|4914423|emb|CAB43626.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|7270894|emb|CAB80574.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|332661620|gb|AEE87020.1| putative receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1228 bits (3177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 587/831 (70%), Positives = 672/831 (80%), Gaps = 32/831 (3%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSAD-VPSPIYLSAR 88
F P D+ LIDCG KSS+ PDGR FKSD+E + +++ KEDIQVS P +D V SPIYL+AR
Sbjct: 52 FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPSDKVASPIYLTAR 111
Query: 89 VFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNCC------------- 135
+F+EE+TY F L +PGWHWVRLHF A P + DLQ+A+F V T+
Sbjct: 112 IFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNND 171
Query: 136 ------EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEG 189
+E+++N+T++ F+++F PMK+S AFINAIEVVSAPD LISD G++LFPV + G
Sbjct: 172 SQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGFSG 231
Query: 190 LSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVT 249
LS ++YQ VYR+N+GGP I PQND+LGRTW+PD FLK++NLA +A++YP VT
Sbjct: 232 LSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPEVT 291
Query: 250 PLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNV 309
PLIAP TVY++A MA+S T+ PNFNV+W F + +F+YL+RLHFCDIVSKSLNDLYFNV
Sbjct: 292 PLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFNV 351
Query: 310 YVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGL 369
Y+NGKTAIS LDLSTVA LA PYY+DIVVNA+LM L VQIGP E+TGT+NAILNG+
Sbjct: 352 YINGKTAISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAILNGV 411
Query: 370 EVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKWHKRPQDW 429
EV+KMSNSVNSLDGEFGVDG G V GF +MFGAF+GLGAMV KW KRPQDW
Sbjct: 412 EVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKWKKRPQDW 471
Query: 430 QRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAI 489
Q+RNSFSSWLLP+H GD++FMTSK GS KS F NSTLGLGRYFS ELQEATKNF++S I
Sbjct: 472 QKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNFEASQI 531
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
IGVGGFGNVY+G +DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE
Sbjct: 532 IGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 591
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
NSEMILVYE+MSNGPFRDHLYGKNL PL+WKQRLEI IGSARGLHYLHTGTAQGIIHRDV
Sbjct: 592 NSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDV 651
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
KSTNILLD+ VAKV+DFGLSKD GQ HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYS
Sbjct: 652 KSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYS 711
Query: 670 FGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFA 729
FGVVLLE LCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL GTINPES+KKFA
Sbjct: 712 FGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFA 771
Query: 730 EAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQS---AATAAASPAAVA 786
EAAEKCL D+GVDRPTMGDVLWNLEYALQLQEAFTQGKAEE + T + P +
Sbjct: 772 EAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETENAKPDVVTPGSVPVSDP 831
Query: 787 APAATSASDDRPVSAPKENVGPAEVH-----AIDEHSGTAMFAQFSGLNGR 832
+P S + + + P PA+V A+DEHSGTAMF QF+ LNGR
Sbjct: 832 SPITPSVTTNEAATVPV----PAKVEENSGTAVDEHSGTAMFTQFANLNGR 878
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15226565|ref|NP_179743.1| Malectin/receptor-like protein kinase [Arabidopsis thaliana] gi|75337322|sp|Q9SJT0.1|Y2214_ARATH RecName: Full=Probable receptor-like protein kinase At2g21480; Flags: Precursor gi|4567279|gb|AAD23692.1| putative protein kinase [Arabidopsis thaliana] gi|330252090|gb|AEC07184.1| Malectin/receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1214 bits (3141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 579/832 (69%), Positives = 671/832 (80%), Gaps = 27/832 (3%)
Query: 23 GPPTAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSAD-VPS 81
G PTA F P D+ LIDCG KSS P+GR FKSD E + +++ K+DIQVS P +D +PS
Sbjct: 45 GSPTAG-FKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPS 103
Query: 82 PIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDNCC------ 135
PIYL+A++F+EE+ Y F L +PGWHWVRLHFFA P + DLQ+A+F V T+
Sbjct: 104 PIYLTAKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFK 163
Query: 136 -------------EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLF 182
+E++LN+T++ F+++F PMK S AFIN IE+VSAPD LISD G+SLF
Sbjct: 164 LSNDNNDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLF 223
Query: 183 PVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAV 242
PV+ + GLS ++YQ VYR+N+GGP ITPQND+LGRTW PD +LK++NLA A+
Sbjct: 224 PVNGFSGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAI 283
Query: 243 QYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSL 302
YP GVTPLIAP TVY++ + MADS T+ PNFNVTW F + +F Y +RLHFCDI+SKSL
Sbjct: 284 IYPPGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSL 343
Query: 303 NDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTR 362
NDLYFNVY+NGKTAIS LDLSTVA L+ PYY+DIVVN++LM + L VQIGP E+TG +
Sbjct: 344 NDLYFNVYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKK 403
Query: 363 NAILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKW 422
NAILNG+EV+KMSNSVNSLDGEFGVDG +A+ +G V GF +MFGAFVGLGAMV KW
Sbjct: 404 NAILNGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMVYKW 463
Query: 423 HKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATK 482
KRPQDWQ+RNSFSSWLLP+H GD++FMTSK GSHKS NS LGLGRYFS ELQE TK
Sbjct: 464 KKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNSALGLGRYFSLSELQEVTK 523
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
NFD+S IIGVGGFGNVY+G IDDGT+VA+KRGNPQSEQGITEF TEIQMLSKLRHRHLVS
Sbjct: 524 NFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVS 583
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
LIGYCDEN+EMILVYEYMSNGPFRDHLYGKNL PL+WKQRLEI IG+ARGLHYLHTGTAQ
Sbjct: 584 LIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQ 643
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
GIIHRDVKSTNILLD+ VAKV+DFGLSKD GQ HVSTAVKGSFGYLDPEYFRRQQLT
Sbjct: 644 GIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYLDPEYFRRQQLT 703
Query: 663 EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722
+KSDVYSFGVVLLE LCARPAINPQLPREQVNLAEWAM WK+KGLLEKIIDPHLVG +NP
Sbjct: 704 DKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVNP 763
Query: 723 ESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQSA--ATAAA 780
ES+KKFAEAAEKCLAD+GVDRPTMGDVLWNLEYALQLQEAF+QGKAE E A
Sbjct: 764 ESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQGKAEAEEVETPKPVAVP 823
Query: 781 SPAAVAAPAATSASDDRPVSAPKENVGPAEVHAIDEHSGTAMFAQFSGLNGR 832
+ A + A T+A+ +RPVS +E + +D+HSGT MF QF+ LNGR
Sbjct: 824 AAAPTSPAATTAAASERPVSQTEEK----DDSTVDQHSGTTMFTQFASLNGR 871
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542359|ref|XP_003539634.1| PREDICTED: probable receptor-like protein kinase At4g39110-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1208 bits (3126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/855 (69%), Positives = 687/855 (80%), Gaps = 31/855 (3%)
Query: 1 MAILLALLYALVSGPTIAFSQNGPPTAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEA 60
MA LL +L AL S P++ G P A +F P+DNFLIDCG +++ LPDGR FKSD +A
Sbjct: 32 MATLLVILLALFS-PSL-----GLPLA-SFQPKDNFLIDCGAENTVTLPDGRQFKSDPQA 84
Query: 61 LPFLQTKEDIQVSVPSADVPSPIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEA 120
FLQ ++ +VS + PSPIY +AR+F +E+ Y+F L QPG+HW+RL+F+ +
Sbjct: 85 RSFLQANDEYKVSANDVNFPSPIYSNARIFIQEAKYSFHLVQPGFHWIRLYFYPIKNNIF 144
Query: 121 DLQKASFHVATDNCC---------------EEFMLNLTESTFSIKFTPMKNSVAFINAIE 165
DLQKASF V TD +E+++N TE F++ F P+KNS AFINAIE
Sbjct: 145 DLQKASFSVYTDTYVLLHSFNVNNTDKPIFKEYLINATEPQFTMSFIPLKNSAAFINAIE 204
Query: 166 VVSAPDTLISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNF 225
VVSAPD LI D G+ LFPV + GL+ + +Q VYR+N GGP IT ND+LGRTW D +
Sbjct: 205 VVSAPDNLIFDTGAGLFPVGEFSGLTTYGFQPVYRVNNGGPLITSSNDTLGRTWETDEPY 264
Query: 226 LKEKNLATTASVESNAVQYPD---GVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDV 282
L KNLA +ASV ++AV++P ++P+IAP TVY+SA+ M D+ QPNFNV+W FDV
Sbjct: 265 LTNKNLAKSASVATSAVKFPQDNPSISPMIAPQTVYASATEMGDAGVNQPNFNVSWKFDV 324
Query: 283 DSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNAS 342
D++FSYL+RLHFCDIVSK LN+LYFNVYVNGK AI+ LDLS + L+TPYY+DIVVNA+
Sbjct: 325 DTSFSYLVRLHFCDIVSKGLNELYFNVYVNGKVAINNLDLSAITGALSTPYYKDIVVNAT 384
Query: 343 LMHNGLNVQIGPNKENTGTRNAILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVA 402
LM GL VQ+GP + G NAI+NG+EV+KMS+SVNSLDGEFGVDG N S+RG V A
Sbjct: 385 LMSEGLTVQVGPANADGGNANAIVNGIEVLKMSSSVNSLDGEFGVDGRSVNGSNRGTVAA 444
Query: 403 VGFAVMFGAFVGLGAMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFT 462
VGFA+MFGAFVGLGAMVIKWHKRPQDWQ+RNSFSSWLLPLH GDTSFM SK KS F
Sbjct: 445 VGFAMMFGAFVGLGAMVIKWHKRPQDWQKRNSFSSWLLPLHAGDTSFM-SKNSMGKSNFF 503
Query: 463 NSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGI 522
+S++GLGRYFSF ELQEATKNFDS IIGVGGFGNVYLG ID+GT+VAVKRGNPQSEQGI
Sbjct: 504 SSSMGLGRYFSFAELQEATKNFDSKNIIGVGGFGNVYLGVIDEGTQVAVKRGNPQSEQGI 563
Query: 523 TEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQR 582
TEFQTEIQMLSKLRHRHLVSLIGYCDEN EMILVYEYM NG FRDHLYGKNLP LSWKQR
Sbjct: 564 TEFQTEIQMLSKLRHRHLVSLIGYCDENDEMILVYEYMPNGHFRDHLYGKNLPALSWKQR 623
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
L+I IGSARGLHYLHTGTAQGIIHRDVK+TNILLD+N+ AKVSDFGLSKDAP+GQGHVST
Sbjct: 624 LDICIGSARGLHYLHTGTAQGIIHRDVKTTNILLDENFTAKVSDFGLSKDAPMGQGHVST 683
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702
AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLE LCARPAINPQLPREQVNLA+WAMQW
Sbjct: 684 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEALCARPAINPQLPREQVNLADWAMQW 743
Query: 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEA 762
KRKGLL+KIIDP LVG INPES+KKFAEAAEKCLADHGVDRP+MGDVLWNLEYALQLQEA
Sbjct: 744 KRKGLLDKIIDPLLVGCINPESMKKFAEAAEKCLADHGVDRPSMGDVLWNLEYALQLQEA 803
Query: 763 FTQGKAEEE--SQSAATAAASPAAVAAPAATSASDDRPVSAPKENVG---PAEVHAIDEH 817
FTQGKAE+E S SA AA P + A P +SDDRP + + V ++VH+ID+H
Sbjct: 804 FTQGKAEDETKSSSAVPTAAVPTSPAPPTPPISSDDRPAAPARPEVNNNTSSDVHSIDDH 863
Query: 818 SGTAMFAQFSGLNGR 832
SGTAMFAQFS LNGR
Sbjct: 864 SGTAMFAQFSNLNGR 878
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224077872|ref|XP_002305446.1| predicted protein [Populus trichocarpa] gi|222848410|gb|EEE85957.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1206 bits (3120), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 582/820 (70%), Positives = 665/820 (81%), Gaps = 47/820 (5%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPSPIYLSARV 89
F P D FLI+CG K+ PDGR FK+DKEA +LQTK+DI VS+PSA+V SP+YLSAR+
Sbjct: 25 FKPADEFLINCGAKNLASFPDGRIFKTDKEAQGYLQTKQDILVSIPSANVSSPLYLSARI 84
Query: 90 FKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDN---------------C 134
FKE++TY F L GWHWVRLH F + E DL+ A+F V TD
Sbjct: 85 FKEDATYAFTLKSAGWHWVRLHLFPMNNTEFDLRTATFSVNTDKYALLHNFNTNNDTQAV 144
Query: 135 CEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLSKFS 194
+E+++N+T+ FSI F P+KNS AFINAIEVVSAPD LISD+ ++LFPV+++ GL+ F
Sbjct: 145 LKEYLINMTDPNFSIHFIPLKNSAAFINAIEVVSAPDILISDQATNLFPVNNFAGLNNFG 204
Query: 195 YQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAP 254
Y+ VYRLNMGGP IT +ND+L R WVPD +LK + LA +ASV +++++Y G++ LIAP
Sbjct: 205 YEVVYRLNMGGPLITSENDTLWRRWVPDKPYLKHEALAKSASVPTSSIKYGPGISSLIAP 264
Query: 255 ATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGK 314
ATVY+SA MADS T NFN+TW F D+TFSY++RLHFCDIVSKSLNDLYFNVY+NGK
Sbjct: 265 ATVYASAEQMADSETRIQNFNLTWNFVADATFSYVVRLHFCDIVSKSLNDLYFNVYLNGK 324
Query: 315 TAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGLEVIKM 374
AIS LDLS++ LA Y++D VV+ASLM NGL V++GP + TGTRNAILNGLEV KM
Sbjct: 325 MAISGLDLSSIKDELAVSYFKDFVVDASLMSNGLAVEVGPMGDETGTRNAILNGLEVFKM 384
Query: 375 SNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKWHKRPQDWQRRNS 434
S+ VNSLDG FGVDG + VV VGF +MFGAFVGLGAM++KWHKRPQDWQ+RNS
Sbjct: 385 SSKVNSLDGVFGVDGKML--ENHKAVVYVGFGLMFGAFVGLGAMLLKWHKRPQDWQKRNS 442
Query: 435 FSSWLLPLHTGDTSFMTSKC--GSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGV 492
FSSWLLP+H GD SFM+SK GSHK+ F +STLGLGR+FS ELQEATKNFDSS IIGV
Sbjct: 443 FSSWLLPVHAGDHSFMSSKTSLGSHKTNFYSSTLGLGRFFSLSELQEATKNFDSSEIIGV 502
Query: 493 GGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552
GGFGNVY+G IDD TKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN E
Sbjct: 503 GGFGNVYIGMIDDSTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENDE 562
Query: 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKST 612
MILVYEYMSNGPFRDHLYGKNLP LSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVK+T
Sbjct: 563 MILVYEYMSNGPFRDHLYGKNLPTLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKTT 622
Query: 613 NILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 672
NILLDD +VAKV+DFGLSKDAP+GQG+VSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGV
Sbjct: 623 NILLDDAFVAKVADFGLSKDAPMGQGYVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGV 682
Query: 673 VLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAA 732
VLLEVLCARPA+NPQLPREQVNLAEWAMQWKRKGLLEKIIDP LVGTINPESL KFAEAA
Sbjct: 683 VLLEVLCARPALNPQLPREQVNLAEWAMQWKRKGLLEKIIDPCLVGTINPESLMKFAEAA 742
Query: 733 EKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQSAATAAASPAAVAAPAATS 792
EKCLA+HGVDRPTMGDVLWNLEYALQLQEAF++GKAE+ES+ +A A SP AV
Sbjct: 743 EKCLAEHGVDRPTMGDVLWNLEYALQLQEAFSKGKAEDESKLSAAVADSPVAV------- 795
Query: 793 ASDDRPVSAPKENVGPAEVHAIDEHSGTAMFAQFSGLNGR 832
ID+HSGTAMF+QF+GLNGR
Sbjct: 796 ---------------------IDDHSGTAMFSQFAGLNGR 814
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546380|ref|XP_003541604.1| PREDICTED: probable receptor-like protein kinase At4g39110-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1194 bits (3089), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 589/854 (68%), Positives = 681/854 (79%), Gaps = 37/854 (4%)
Query: 3 ILLALLYALVSGPTIAFSQNGPPTAATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALP 62
ILL +L AL S P++ G P A +F P+DNFLIDCG +++ LPDGR FKSD ++
Sbjct: 29 ILLVILLALFS-PSL-----GLPLA-SFQPKDNFLIDCGAENTATLPDGRHFKSDPQSRS 81
Query: 63 FLQTKEDIQVSVPSADVPSPIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADL 122
FLQ ++ +VS ++PSP+Y +AR+F +E+ Y+F L QPG+HW+RLHF+ + DL
Sbjct: 82 FLQANDEYKVSANDVNLPSPVYSNARIFIQEAKYSFHLVQPGFHWIRLHFYPIKNNIFDL 141
Query: 123 QKASFHVATDN---------------CCEEFMLNLTESTFSIKFTPMKNSVAFINAIEVV 167
QKA+F V TD +E+++N TE ++ F P+KNS AFINAIEVV
Sbjct: 142 QKATFSVYTDTYVLLHSFNVNNTDKPIMKEYLINATEPQLTMSFIPLKNSAAFINAIEVV 201
Query: 168 SAPDTLISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLK 227
SAPD LI D G+ LFPV GL+ + +Q VYR+N GGP IT ND+LGRTW D +FL
Sbjct: 202 SAPDNLIFDTGAGLFPVGEIGGLTTYGFQPVYRVNNGGPLITSSNDTLGRTWESDEHFLT 261
Query: 228 EKNLATTASVESNAVQYPD---GVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDS 284
KNLA +ASV ++AV++P ++P+IAP TVY+SA+ M D+ QPNFNV+W FDVD+
Sbjct: 262 NKNLAKSASVATSAVKFPQDNPSISPMIAPQTVYASATEMGDAGVNQPNFNVSWKFDVDT 321
Query: 285 TFSYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLM 344
+F YL+RLHFCDIVSK LN+LYFNVYVNGK AI+ LDLS + L+TPYY+DIVVNA+LM
Sbjct: 322 SFGYLVRLHFCDIVSKGLNELYFNVYVNGKVAINNLDLSAITGALSTPYYKDIVVNATLM 381
Query: 345 HNGLNVQIGPNKENTGTRNAILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVG 404
GL VQ+GP + G NAI+NG+EV+KMSNSVNSLDGEFGVDG + S+RG V AVG
Sbjct: 382 SEGLTVQVGPANADGGNANAIMNGIEVLKMSNSVNSLDGEFGVDGRSVSGSNRGTVAAVG 441
Query: 405 FAVMFGAFVGLGAMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNS 464
FA+MFGAFVGLGAMVIKWHKRPQDWQ+RNSFSSWLLPLH GDTSFM SK KS F +S
Sbjct: 442 FAMMFGAFVGLGAMVIKWHKRPQDWQKRNSFSSWLLPLHAGDTSFM-SKNSMGKSNFFSS 500
Query: 465 TLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITE 524
++GLGRYFSF ELQEATKNFDS IIGVGGFGNVYLG ID+GT+VAVKRGNPQSEQGITE
Sbjct: 501 SMGLGRYFSFAELQEATKNFDSKNIIGVGGFGNVYLGVIDEGTQVAVKRGNPQSEQGITE 560
Query: 525 FQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE 584
FQTEIQMLSKLRHRHLVSLIGYCDEN EMILVYEYM NG FRDHLYGKNLP LSWKQRL+
Sbjct: 561 FQTEIQMLSKLRHRHLVSLIGYCDENDEMILVYEYMPNGHFRDHLYGKNLPALSWKQRLD 620
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
I IGSARGLHYLHTGTAQGIIHRDVK+TNILLD+N+ AKVSDFGLSKDAP+GQGHVSTAV
Sbjct: 621 ICIGSARGLHYLHTGTAQGIIHRDVKTTNILLDENFTAKVSDFGLSKDAPMGQGHVSTAV 680
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704
KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLE LCARPAINPQLPREQVNLA+WAMQWKR
Sbjct: 681 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEALCARPAINPQLPREQVNLADWAMQWKR 740
Query: 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFT 764
KGLL+KIIDP LVG INPES+KKFAEAAEKCLADHGVDRP+MGDVLWNLEYALQLQEAFT
Sbjct: 741 KGLLDKIIDPLLVGCINPESMKKFAEAAEKCLADHGVDRPSMGDVLWNLEYALQLQEAFT 800
Query: 765 QGKAEEESQSAATAAASPAAVAAPAATSASDDR------PVSAPKENVGPAEVHAIDEHS 818
QGK E+ES+S AS A +P + SDDR P N +EV++ID+HS
Sbjct: 801 QGKPEDESKS-----ASAAVPTSPTPPTPSDDRPAAPAVPARPEAANNASSEVNSIDDHS 855
Query: 819 GTAMFAQFSGLNGR 832
GTAMFAQFS LNGR
Sbjct: 856 GTAMFAQFSNLNGR 869
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103371|ref|XP_002313029.1| predicted protein [Populus trichocarpa] gi|222849437|gb|EEE86984.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1188 bits (3073), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 578/814 (71%), Positives = 658/814 (80%), Gaps = 56/814 (6%)
Query: 43 KSSNPLPDG-RTF------KSDKEALPFLQTKEDIQVSVPSADVPSPIYLSARVFKEEST 95
K +NP+ G +TF +D EA +LQTK+DI VSVPSADVPSPIYLSAR+FKE++T
Sbjct: 2 KLTNPITGGLKTFLFDILLSTDHEAQGYLQTKQDILVSVPSADVPSPIYLSARIFKEDAT 61
Query: 96 YTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDN---------------CCEEFML 140
Y F L GWHWVRLHFF + E DL+ A+F V TD +E+++
Sbjct: 62 YAFTLKSAGWHWVRLHFFPIKNTEFDLRTATFSVNTDKYALLHNFNINNNTEAVLKEYLI 121
Query: 141 NLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLSKFSYQYVYR 200
N+T+ FSI+F P+KNS AFINAIEVVSAPD LISD+ ++LFPV+ + GL+ F Y+ VYR
Sbjct: 122 NMTDPNFSIQFKPLKNSAAFINAIEVVSAPDILISDQATNLFPVNDFAGLNDFGYEVVYR 181
Query: 201 LNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPATVYSS 260
LNMGGP IT +ND+L R WVPD +LK + LA +ASV +++++Y G +PLIAPATVY+S
Sbjct: 182 LNMGGPLITSENDTLSRRWVPDKPYLKHEALAKSASVPTSSIKYGPGTSPLIAPATVYAS 241
Query: 261 ASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISAL 320
A MADS T NFN+TW F D+TFSY++RLHFCDIVSK+LNDLYFNVY+NGK AIS L
Sbjct: 242 AKQMADSETRIQNFNITWNFVADATFSYVVRLHFCDIVSKTLNDLYFNVYLNGKKAISGL 301
Query: 321 DLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGLEVIKMSNSVNS 380
DLS++ LA PY++DIVV+ASLM NGL V++GP + TGTRNAILNGLEV KMS+ VNS
Sbjct: 302 DLSSIEDELAVPYFKDIVVDASLMSNGLAVEVGPMDDETGTRNAILNGLEVFKMSSKVNS 361
Query: 381 LDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKWHKRPQDWQRRNSFSSWLL 440
LDG FGVDG V VGF +MFGAF+GLGAMV+KWHKRPQDWQ+RNSFSSWLL
Sbjct: 362 LDGVFGVDGEVLEKHKV--VTYVGFGLMFGAFIGLGAMVLKWHKRPQDWQKRNSFSSWLL 419
Query: 441 PLHTGDTSFMTSKC--GSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNV 498
P+H GD SFMTSK GSHK+ F +STLGLGR+FS ELQEAT NFDSSAIIGVGGFGNV
Sbjct: 420 PVHAGDHSFMTSKTSMGSHKTNFYSSTLGLGRFFSLSELQEATNNFDSSAIIGVGGFGNV 479
Query: 499 YLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558
YLG IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN EMILVYE
Sbjct: 480 YLGTIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENDEMILVYE 539
Query: 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618
YMSNGP+RDHLYGKNLPPLSWK+RLEISIG+ARGLHYLHTGTAQGIIHRDVK+TNILLDD
Sbjct: 540 YMSNGPYRDHLYGKNLPPLSWKKRLEISIGAARGLHYLHTGTAQGIIHRDVKTTNILLDD 599
Query: 619 NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++VAKV+DFGLSKDAP+GQGHVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLLEVL
Sbjct: 600 SFVAKVADFGLSKDAPMGQGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEVL 659
Query: 679 CARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLAD 738
CARPA+NPQLPREQVNLAEWAMQWKRKGL+EKIIDP LVGTINPESLKK+AEAAEKCLA+
Sbjct: 660 CARPALNPQLPREQVNLAEWAMQWKRKGLIEKIIDPLLVGTINPESLKKYAEAAEKCLAE 719
Query: 739 HGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQSAATAAASPAAVAAPAATSASDDRP 798
HGVDRPTMGDVLWNLEYALQLQE+F++GK E+ES+ AA A SPA VA P
Sbjct: 720 HGVDRPTMGDVLWNLEYALQLQESFSKGKDEDESKIAAAVADSPAVVATP---------- 769
Query: 799 VSAPKENVGPAEVHAIDEHSGTAMFAQFSGLNGR 832
GTAMFAQFSGLNGR
Sbjct: 770 --------------------GTAMFAQFSGLNGR 783
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357514905|ref|XP_003627741.1| Kinase-like protein [Medicago truncatula] gi|355521763|gb|AET02217.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1186 bits (3067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/823 (69%), Positives = 661/823 (80%), Gaps = 20/823 (2%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPSPIYLSARV 89
F P+D+FLIDCG ++ LPDGR FKSD +A FLQ K+D +VS ADVPSPIY +AR+
Sbjct: 26 FVPKDSFLIDCGSENVVTLPDGRQFKSDPQANSFLQAKDDYKVSATDADVPSPIYSTARI 85
Query: 90 FKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDN---------------C 134
F +E+ Y+F L QPG+HW+RLHF+ + DLQKA+F V T+
Sbjct: 86 FIQEAKYSFHLVQPGFHWIRLHFYPIKNSVFDLQKATFSVNTNTFVLLHSFNVNNTDKAI 145
Query: 135 CEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLSKFS 194
+E+++N TE + F P+KNS AFINAIEVV+APD+LI D GS LFPV GL+ ++
Sbjct: 146 LKEYLINATEPQLMLSFIPLKNSAAFINAIEVVTAPDSLIVDTGSGLFPVAPVNGLTAYA 205
Query: 195 YQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDG---VTPL 251
+Q V+RLN GGP IT ND+LGR W D +L KNL + +V +N V++P ++PL
Sbjct: 206 FQPVFRLNNGGPLITSANDTLGRIWESDEPYLTNKNLGKSVTVATNVVKFPQDNPDISPL 265
Query: 252 IAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYV 311
IAP TVYSSA+ M ++ PNFNV+W FDVD++FSYL+RLHFCDIVSK LN LYFNVYV
Sbjct: 266 IAPQTVYSSATEMGNADVSLPNFNVSWKFDVDTSFSYLVRLHFCDIVSKGLNQLYFNVYV 325
Query: 312 NGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGLEV 371
NGKTAI+ LDLS + LATPYY+D VVNA+LM GL+VQIGP N G NAI+NG+EV
Sbjct: 326 NGKTAIANLDLSAINGALATPYYKDFVVNATLMTQGLSVQIGPADANGGNANAIMNGIEV 385
Query: 372 IKMSNSVNSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVGLGAMVIKWHKRPQDWQR 431
+K+SN+VNSLDGEFGVDG + S+RG V AVGFA+MFGAFVGLGAMVIKWHKRPQDWQ+
Sbjct: 386 LKISNTVNSLDGEFGVDGRRVGGSNRGTVAAVGFAMMFGAFVGLGAMVIKWHKRPQDWQK 445
Query: 432 RNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIG 491
RNSFSSWLLPLH GDTSFM+SK KS +S++GLGR FSF E+QEATKNFDS IIG
Sbjct: 446 RNSFSSWLLPLHAGDTSFMSSKNSIGKSNIFSSSMGLGRIFSFSEIQEATKNFDSKNIIG 505
Query: 492 VGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS 551
VGGFGNVYLG ID+G +VAVKRGNPQSEQGI EFQTEIQMLSKLRHRHLVS+IGYCDEN
Sbjct: 506 VGGFGNVYLGVIDEGVQVAVKRGNPQSEQGINEFQTEIQMLSKLRHRHLVSMIGYCDENE 565
Query: 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKS 611
EMILVYEYM NG RDHLYGKN+P LSWKQRL+I IGSARGLHYLHTGTAQGIIHRDVK+
Sbjct: 566 EMILVYEYMPNGHLRDHLYGKNMPALSWKQRLDICIGSARGLHYLHTGTAQGIIHRDVKT 625
Query: 612 TNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 671
TNILLD+N+ AKVSDFGLSKDAP+GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG
Sbjct: 626 TNILLDENFTAKVSDFGLSKDAPMGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 685
Query: 672 VVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEA 731
VVLLE LCARPAINPQLPREQVNLA+WAMQWKRKGLL+KIIDP LVG+INPES+KKFAEA
Sbjct: 686 VVLLEALCARPAINPQLPREQVNLADWAMQWKRKGLLDKIIDPLLVGSINPESMKKFAEA 745
Query: 732 AEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEESQSAATAAASPAAVAAPAAT 791
AEKCLADHGVDRP+MGDVLWNLEYALQLQEAFTQGK E+E+++ + A P + A P
Sbjct: 746 AEKCLADHGVDRPSMGDVLWNLEYALQLQEAFTQGKVEDENEAKSAAVVVPTSPAPPTTP 805
Query: 792 SASDDRPVSAPKENVG--PAEVHAIDEHSGTAMFAQFSGLNGR 832
+ D P + P++ V PAEV AID HSGTAMFAQFS LNGR
Sbjct: 806 PSVTDCPPTPPQQEVNNSPAEVQAIDGHSGTAMFAQFSNLNGR 848
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 832 | ||||||
| TAIR|locus:2136338 | 878 | AT4G39110 [Arabidopsis thalian | 0.836 | 0.792 | 0.719 | 2.6e-310 | |
| TAIR|locus:2050080 | 871 | AT2G21480 [Arabidopsis thalian | 0.858 | 0.819 | 0.689 | 4.4e-308 | |
| TAIR|locus:2163158 | 842 | AT5G61350 [Arabidopsis thalian | 0.385 | 0.381 | 0.777 | 1.4e-220 | |
| TAIR|locus:2075346 | 830 | HERK1 "hercules receptor kinas | 0.939 | 0.942 | 0.5 | 2.3e-190 | |
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.75 | 0.729 | 0.562 | 6.9e-189 | |
| TAIR|locus:2174249 | 829 | AT5G59700 [Arabidopsis thalian | 0.871 | 0.874 | 0.509 | 1.2e-186 | |
| TAIR|locus:2178707 | 824 | AT5G24010 [Arabidopsis thalian | 0.862 | 0.871 | 0.488 | 4.3e-173 | |
| TAIR|locus:2081895 | 895 | FER "FERONIA" [Arabidopsis tha | 0.408 | 0.379 | 0.655 | 2e-167 | |
| TAIR|locus:2204564 | 849 | HERK2 "hercules receptor kinas | 0.775 | 0.759 | 0.463 | 4.6e-163 | |
| TAIR|locus:2039717 | 815 | AT2G39360 [Arabidopsis thalian | 0.854 | 0.872 | 0.437 | 1.5e-152 |
| TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2615 (925.6 bits), Expect = 2.6e-310, Sum P(2) = 2.6e-310
Identities = 505/702 (71%), Positives = 564/702 (80%)
Query: 136 EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLSKFSY 195
+E+++N+T++ F+++F PMK+S AFINAIEVVSAPD LISD G++LFPV + GLS ++Y
Sbjct: 178 KEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGFSGLSDYAY 237
Query: 196 QYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPA 255
Q VYR+N+GGP I PQND+LGRTW+PD FLK++NLA +A++YP VTPLIAP
Sbjct: 238 QSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPEVTPLIAPQ 297
Query: 256 TVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKT 315
TVY++A MA+S T+ PNFNV+W F + +F+YL+RLHFCDIVSKSLNDLYFNVY+NGKT
Sbjct: 298 TVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFNVYINGKT 357
Query: 316 AISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGLEVIKMS 375
AIS LDLSTVA LA PYY+DIVVNA+LM L VQIGP E+TGT+NAILNG+EV+KMS
Sbjct: 358 AISGLDLSTVAGNLAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAILNGVEVLKMS 417
Query: 376 NSVNSLDGEFGVDGSKANSSSRXXXXXXXXXXXXXXXXXXXXMVIKWHKRPQDWQRRNSF 435
NSVNSLDGEFGVDG MV KW KRPQDWQ+RNSF
Sbjct: 418 NSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKWKKRPQDWQKRNSF 477
Query: 436 SSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGF 495
SSWLLP+H GD++FMTSK GS KS F NSTLGLGRYFS ELQEATKNF++S IIGVGGF
Sbjct: 478 SSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNFEASQIIGVGGF 537
Query: 496 GNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555
GNVY+G +DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL
Sbjct: 538 GNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 597
Query: 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNIL 615
VYE+MSNGPFRDHLYGKNL PL+WKQRLEI IGSARGLHYLHTGTAQGIIHRDVKSTNIL
Sbjct: 598 VYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNIL 657
Query: 616 LDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLL 675
LD+ VAKV+DFGLSKD GQ HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLL
Sbjct: 658 LDEALVAKVADFGLSKDVAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLL 717
Query: 676 EVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKC 735
E LCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL GTINPES+KKFAEAAEKC
Sbjct: 718 EALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKC 777
Query: 736 LADHGVDRPTMGDVLWNLEYALQLQEAFTQGKXXXXXXXXXXXXXXXXXXXXXXXXXXXD 795
L D+GVDRPTMGDVLWNLEYALQLQEAFTQGK
Sbjct: 778 LEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETENAKPDVVTPGSVPVSDPSPITPS 837
Query: 796 DRPVSAPKENVGPAEVH-----AIDEHSGTAMFAQFSGLNGR 832
A V PA+V A+DEHSGTAMF QF+ LNGR
Sbjct: 838 VTTNEAATVPV-PAKVEENSGTAVDEHSGTAMFTQFANLNGR 878
|
|
| TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2615 (925.6 bits), Expect = 4.4e-308, Sum P(2) = 4.4e-308
Identities = 502/728 (68%), Positives = 571/728 (78%)
Query: 107 WVRLHFFALPAKEADLQKASFHVATDNCCEEFMLNLTESTFSIKFTPMKNSVAFINAIEV 166
+V LH F L D Q AT +E++LN+T++ F+++F PMK S AFIN IE+
Sbjct: 156 YVLLHNFKLSNDNNDSQ------ATVQ--KEYLLNMTDAQFALRFKPMKGSAAFINGIEL 207
Query: 167 VSAPDTLISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPSITPQNDSLGRTWVPDSNFL 226
VSAPD LISD G+SLFPV+ + GLS ++YQ VYR+N+GGP ITPQND+LGRTW PD +L
Sbjct: 208 VSAPDELISDAGTSLFPVNGFSGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYL 267
Query: 227 KEKNLATTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTF 286
K++NLA A+ YP GVTPLIAP TVY++ + MADS T+ PNFNVTW F + +F
Sbjct: 268 KDENLAKDVKTNPTAIIYPPGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSF 327
Query: 287 SYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHN 346
Y +RLHFCDI+SKSLNDLYFNVY+NGKTAIS LDLSTVA L+ PYY+DIVVN++LM +
Sbjct: 328 HYFIRLHFCDIISKSLNDLYFNVYINGKTAISGLDLSTVAGDLSAPYYKDIVVNSTLMTS 387
Query: 347 GLNVQIGPNKENTGTRNAILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRXXXXXXXXX 406
L VQIGP E+TG +NAILNG+EV+KMSNSVNSLDGEFGVDG +A+ +
Sbjct: 388 ELQVQIGPMGEDTGKKNAILNGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFV 447
Query: 407 XXXXXXXXXXXMVIKWHKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTL 466
MV KW KRPQDWQ+RNSFSSWLLP+H GD++FMTSK GSHKS NS L
Sbjct: 448 MMFGAFVGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNSAL 507
Query: 467 GLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQ 526
GLGRYFS ELQE TKNFD+S IIGVGGFGNVY+G IDDGT+VA+KRGNPQSEQGITEF
Sbjct: 508 GLGRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFH 567
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEIS 586
TEIQMLSKLRHRHLVSLIGYCDEN+EMILVYEYMSNGPFRDHLYGKNL PL+WKQRLEI
Sbjct: 568 TEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEIC 627
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646
IG+ARGLHYLHTGTAQGIIHRDVKSTNILLD+ VAKV+DFGLSKD GQ HVSTAVKG
Sbjct: 628 IGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKG 687
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706
SFGYLDPEYFRRQQLT+KSDVYSFGVVLLE LCARPAINPQLPREQVNLAEWAM WK+KG
Sbjct: 688 SFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKG 747
Query: 707 LLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQG 766
LLEKIIDPHLVG +NPES+KKFAEAAEKCLAD+GVDRPTMGDVLWNLEYALQLQEAF+QG
Sbjct: 748 LLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQG 807
Query: 767 KXXXXXXXXXXXXX--XXXXXXXXXXXXXXDDRPVSAPKENVGPAEVHAIDEHSGTAMFA 824
K +RPVS +E + +D+HSGT MF
Sbjct: 808 KAEAEEVETPKPVAVPAAAPTSPAATTAAASERPVSQTEEK----DDSTVDQHSGTTMFT 863
Query: 825 QFSGLNGR 832
QF+ LNGR
Sbjct: 864 QFASLNGR 871
|
|
| TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1303 (463.7 bits), Expect = 1.4e-220, Sum P(2) = 1.4e-220
Identities = 258/332 (77%), Positives = 281/332 (84%)
Query: 445 GDTSFMTSKCGSHKS---GFTN--STLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVY 499
G TS S GS KS GF++ S GLGRYF F ELQ AT+NFD +A+ GVGGFG VY
Sbjct: 481 GSTSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVY 540
Query: 500 LGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559
+GEID GT+VA+KRG+ SEQGI EFQTEIQMLSKLRHRHLVSLIG+CDEN EMILVYEY
Sbjct: 541 IGEIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEY 600
Query: 560 MSNGPFRDHLYGKN------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTN 613
MSNGP RDHLYG +P LSWKQRLEI IGSARGLHYLHTG AQGIIHRDVK+TN
Sbjct: 601 MSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTN 660
Query: 614 ILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 673
ILLD+N VAKVSDFGLSKDAP+ +GHVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVV
Sbjct: 661 ILLDENLVAKVSDFGLSKDAPMDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVV 720
Query: 674 LLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAE 733
L EVLCARP INPQLPREQVNLAE+AM RKG+LEKIIDP +VGTI+ SL+KF EAAE
Sbjct: 721 LFEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAE 780
Query: 734 KCLADHGVDRPTMGDVLWNLEYALQLQEAFTQ 765
KCLA++GVDRP MGDVLWNLEYALQLQEA Q
Sbjct: 781 KCLAEYGVDRPGMGDVLWNLEYALQLQEASAQ 812
|
|
| TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1845 (654.5 bits), Expect = 2.3e-190, P = 2.3e-190
Identities = 409/818 (50%), Positives = 513/818 (62%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPSPIYLSARV 89
F+P DN+LI+CG ++ L GR F SDK + L + ++I SV + S IY +ARV
Sbjct: 25 FTPVDNYLINCGSPTNGTLM-GRIFLSDKLSSKLLTSSKEILASV-GGNSGSDIYHTARV 82
Query: 90 FKEESTYTFQLNQPGWHWVRLHF-------FAL-PAK-----EADLQKASFHVATDNCCE 136
F E S+Y F + + G HWVRL+F F + AK ++ + + F V + +
Sbjct: 83 FTEVSSYKFSVTR-GRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFTVTSSKVVK 141
Query: 137 EFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVD--SYEGLSKFS 194
E+ LN+T + + FTP S AF+NAIEV+S PDTLI+ GS F + + +S
Sbjct: 142 EYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLIT--GSPRFVGNPAQFPDMSMQG 199
Query: 195 YQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAP 254
+ ++R+NMGGP + ND+L RTWVPDS FL EKNLA + S S P T AP
Sbjct: 200 LETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKSMSKFSTVNFVPGYATEDSAP 259
Query: 255 ATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGK 314
TVY S + M + FNVTW FDVD F Y R HFCDIVS SLN LYFN+YV+
Sbjct: 260 RTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSLNQLYFNLYVDSM 319
Query: 315 TAISALDLSTVAQG-LATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGLEVIK 373
A + +DLST+ LA Y D V N + V IGP+ +T NAI+NGLE++K
Sbjct: 320 VAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKVRVSIGPSTVHTDYPNAIVNGLEIMK 379
Query: 374 MSNSVNSLD-GEFGVDGSKANSSSRXXXXXXXXXXXXXXXXXXXXMVIKWHKRPQDWQRR 432
M+NS L G F V GS ++S S + + KR + Q
Sbjct: 380 MNNSKGQLSTGTF-VPGSSSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKRG-QDG 437
Query: 433 NSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGV 492
+S +W+ P TS M SK S+ + T+ T F +++AT NFD S IGV
Sbjct: 438 HS-KTWM-PFSINGTS-MGSKY-SNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGV 493
Query: 493 GGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552
GGFG VY GE++DGTKVAVKRGNP+S+QG+ EF+TEI+MLS+ RHRHLVSLIGYCDEN+E
Sbjct: 494 GGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNE 553
Query: 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKST 612
MIL+YEYM NG + HLYG LP L+WKQRLEI IG+ARGLHYLHTG ++ +IHRDVKS
Sbjct: 554 MILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSA 613
Query: 613 NILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 671
NILLD+N++AKV+DFGLSK P + Q HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFG
Sbjct: 614 NILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFG 673
Query: 672 VVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEA 731
VVL EVLCARP I+P LPRE VNLAEWAM+W++KG L++IID L G I P+SL+KFAE
Sbjct: 674 VVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAET 733
Query: 732 AEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKXXXXXXXXXXXXXXXXXXXXXXXX 791
EKCLAD+GVDRP+MGDVLWNLEYALQLQEA G+
Sbjct: 734 GEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNSTNMIGELPPQINNFSQG-- 791
Query: 792 XXXDDRPVSAPKENVGPAEVHAIDEHSGTAMFAQFSGL 829
D V+ P G E +ID+ SG +M FS L
Sbjct: 792 ----DTSVNVPG-TAGRFEESSIDDLSGVSMSKVFSQL 824
|
|
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1831 (649.6 bits), Expect = 6.9e-189, P = 6.9e-189
Identities = 361/642 (56%), Positives = 452/642 (70%)
Query: 136 EEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLSKFSY 195
+E+ +N+T ++ F P NSV F+NAIEVVS PD LI D+ +L P + GLS ++
Sbjct: 149 KEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPDQALALNPSTPFSGLSLLAF 208
Query: 196 QYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPA 255
+ VYRLNMGGP +T QND+LGR W D+ +L + + ++++Y VT AP
Sbjct: 209 ETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVLVVTANPSSIKYSPSVTQETAPN 268
Query: 256 TVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKT 315
VY++A M D++ P+FNVTW VD F Y +R+HFCDIVS++LN L FN+YVN
Sbjct: 269 MVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQALNTLVFNLYVNDDL 328
Query: 316 AISALDLSTVAQGLATPYYRDIVVNASLMHNG-LNVQIGPNKENTGTRNAILNGLEVIKM 374
A+ +LDLST+ GL PY++D + N S+ +G L V +GP+ + T NA +NGLEV+K+
Sbjct: 329 ALGSLDLSTLTNGLKVPYFKDFISNGSVESSGVLTVSVGPDSQADIT-NATMNGLEVLKI 387
Query: 375 SNSVNSLDGEFGVD-----GSKANSSSRXXXXXXXXXXXXXXXXXXXX----MVIKWHKR 425
SN SL G V GS + S + +V +R
Sbjct: 388 SNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAVTLILLIAVCCYCCLVASRKQR 447
Query: 426 PQDWQRRNSFSSWL-LPLHTGDTSFMTSKCGSHKSGFTN----STLGLGRYFSFQELQEA 480
Q + WL LPL+ G + +T SHKS + ++ LGR F FQE+ +A
Sbjct: 448 STSPQEGGNGHPWLPLPLY-GLSQTLTKSTASHKSATASCISLASTHLGRCFMFQEIMDA 506
Query: 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL 540
T FD S+++GVGGFG VY G ++DGTKVAVKRGNP+SEQG+ EF+TEI+MLSKLRHRHL
Sbjct: 507 TNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHL 566
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
VSLIGYCDE SEMILVYEYM+NGP R HLYG +LPPLSWKQRLEI IG+ARGLHYLHTG
Sbjct: 567 VSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGA 626
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQ 659
+Q IIHRDVK+TNILLD+N VAKV+DFGLSK P + Q HVSTAVKGSFGYLDPEYFRRQ
Sbjct: 627 SQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQ 686
Query: 660 QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719
QLTEKSDVYSFGVVL+EVLC RPA+NP LPREQVN+AEWAM W++KGLL++I+D +L G
Sbjct: 687 QLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGK 746
Query: 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761
+NP SLKKF E AEKCLA++GVDRP+MGDVLWNLEYALQL+E
Sbjct: 747 VNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEE 788
|
|
| TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1810 (642.2 bits), Expect = 1.2e-186, P = 1.2e-186
Identities = 384/753 (50%), Positives = 485/753 (64%)
Query: 30 FSPRDNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPSPIYLSARV 89
+ P DN+LI+CG S+N R F SD A FL + +I ++ + + S IY +AR+
Sbjct: 25 YVPVDNYLINCGS-STNVTVTSRVFISDNLASNFLTSPNEI-LAASNRNSNSDIYQTARI 82
Query: 90 FKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDN------------CCEE 137
F S Y F + + G HW+RLHF + + A F V+++ +E
Sbjct: 83 FTGISKYRFSVAR-GRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTVSSRVMKE 141
Query: 138 FMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLSKFSYQY 197
+ LN+ + FTP +S AF+NA+EVVS PDTL S + S ++GLS + +
Sbjct: 142 YSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSGDPSFAGSPGKFQGLSWQALET 201
Query: 198 VYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPATV 257
VYR+NMGGP +TP ND+L R W PDS FL EKNL + S ++ P T AP TV
Sbjct: 202 VYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSVSKIASVDYVPGFATEETAPRTV 261
Query: 258 YSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKTAI 317
Y + + M + NFNVTW FDVD F Y LR HFCDIVSK+LN LYFN+YV+ +
Sbjct: 262 YGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKALNQLYFNLYVDSMDVV 321
Query: 318 SALDLST-VAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGLEVIKMSN 376
LDLS+ ++ L+ Y D V ++ + + V IG + +T AILNGLE++KM+N
Sbjct: 322 ENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGRSSVHTDYPTAILNGLEIMKMNN 381
Query: 377 SVNSLD-GEFGVDGSKANSSSRXXXXXXXXXXXXXXXXXXXXMVIKWHKRPQDWQRRNSF 435
S + L G F GS + + + + KR +D Q NS
Sbjct: 382 SKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALVVLGGFFVLYKKRGRD-QDGNS- 439
Query: 436 SSWLLPLHTGDTSFMTSKCGSHKSGF-TNSTLGLGRYFSFQELQEATKNFDSSAIIGVGG 494
+W+ PL + T+ +S G+ + +NS+ + ++EAT +FD + IGVGG
Sbjct: 440 KTWI-PLSSNGTT--SSSNGTTLASIASNSSYRI----PLVAVKEATNSFDENRAIGVGG 492
Query: 495 FGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554
FG VY GE+ DGTKVAVKR NP+S+QG+ EF+TEI+MLS+ RHRHLVSLIGYCDEN+EMI
Sbjct: 493 FGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMI 552
Query: 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNI 614
LVYEYM NG + HLYG L LSWKQRLEI IGSARGLHYLHTG A+ +IHRDVKS NI
Sbjct: 553 LVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANI 612
Query: 615 LLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 673
LLD+N +AKV+DFGLSK P I Q HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV
Sbjct: 613 LLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 672
Query: 674 LLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAE 733
+ EVLCARP I+P L RE VNLAEWAM+W++KG LE IIDP L G I P+SL+KF E E
Sbjct: 673 MFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGE 732
Query: 734 KCLADHGVDRPTMGDVLWNLEYALQLQEAFTQG 766
KCLAD+GVDRP+MGDVLWNLEYALQLQEA G
Sbjct: 733 KCLADYGVDRPSMGDVLWNLEYALQLQEAVVDG 765
|
|
| TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1682 (597.2 bits), Expect = 4.3e-173, P = 4.3e-173
Identities = 372/762 (48%), Positives = 481/762 (63%)
Query: 28 ATFSPRDNFLIDCGGKSSNPLPDGRTFKSDKE--ALPFLQTKEDIQVSVPSADVPSPI-Y 84
A F+P DN+LI+ G ++ R+F SD FL T I +S + SP+ Y
Sbjct: 24 AAFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISISDTNPSPDSPVLY 83
Query: 85 LSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHV-----------ATDN 133
+ARVF +Y FQ+ G H++RLHF A +L+ A F V +T +
Sbjct: 84 NTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFSTSS 143
Query: 134 CC-EEFMLNLTESTFSIKFTPMKNS-VAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLS 191
+EF+L + + I F P K S F+NA+EV SAP I D+G+ L +S + S
Sbjct: 144 VVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQIFS 203
Query: 192 KFSYQY---VYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGV 248
S Q V+R+N+GG +TP ND+L RTWV D N+L + A A + G
Sbjct: 204 NLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGGA 263
Query: 249 TPLIAPATVYSSASMM-ADSHTVQPNFNVTWTFDVDST-FSYLLRLHFCDIVSKSLNDLY 306
T IAP VY +A M D+ +Q FN++W F VD +L+RLHFCDIVS SLN LY
Sbjct: 264 TREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQLY 323
Query: 307 FNVYVNGKTAISALDLSTVA-QGLATPYYRDIVVNASLMHNG-LNVQIGPNKENTGTR-N 363
FNV++N A +DLST+ LA+P Y D V + +G L + +GP+ + R N
Sbjct: 324 FNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESD--RSGMLRISVGPSDLSNPARVN 381
Query: 364 AILNGLEVIKMSNSVNSLDGEFGVDGSKANSSSRXXXXXXXXXXXXXXXXXXXXMVIKWH 423
A+LNG+E++++ + V+S E V G K N V+
Sbjct: 382 ALLNGVEIMRILSPVSS---EV-VSG-KRNV---VWIVVGSVLGGFVFLSLFFLSVLCLC 433
Query: 424 KRPQDWQRRNSFSSWLLPLHT--GDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEAT 481
+R + R + + W PL G ++ T++ SG+ TL + SF ELQ T
Sbjct: 434 RRKNNKTRSSESTGWT-PLRRFRGSSNSRTTERTVSSSGY--HTLRI----SFAELQSGT 486
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
NFD S +IGVGGFG V+ G + D TKVAVKRG+P S QG+ EF +EI +LSK+RHRHLV
Sbjct: 487 NNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLV 546
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
SL+GYC+E SEMILVYEYM GP + HLYG PPLSWKQRLE+ IG+ARGLHYLHTG++
Sbjct: 547 SLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSS 606
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQ 660
QGIIHRD+KSTNILLD+NYVAKV+DFGLS+ P I + HVST VKGSFGYLDPEYFRRQQ
Sbjct: 607 QGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQ 666
Query: 661 LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720
LT+KSDVYSFGVVL EVLCARPA++P L REQVNLAEWA++W+RKG+L++I+DP++ I
Sbjct: 667 LTDKSDVYSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEI 726
Query: 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEA 762
P SLKKFAE AEKC AD+GVDRPT+GDVLWNLE+ LQLQE+
Sbjct: 727 KPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQES 768
|
|
| TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 2.0e-167, Sum P(3) = 2.0e-167
Identities = 226/345 (65%), Positives = 267/345 (77%)
Query: 428 DWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTL--GLGRYFSFQELQEATKNFD 485
D+Q + +S LPL S ++ +G S+L L R+FSF E++ ATKNFD
Sbjct: 478 DYQPASDATSGWLPLSLYGNSHSAGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFD 537
Query: 486 SSAIIGVGGFGNVYLGEIDDGT-KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
S ++GVGGFG VY GEID GT KVA+KRGNP SEQG+ EFQTEI+MLSKLRHRHLVSLI
Sbjct: 538 ESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLI 597
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
GYC+EN EMILVY+YM++G R+HLY P L WKQRLEI IG+ARGLHYLHTG I
Sbjct: 598 GYCEENCEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTI 657
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
IHRDVK+TNILLD+ +VAKVSDFGLSK P + HVST VKGSFGYLDPEYFRRQQLTE
Sbjct: 658 IHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTE 717
Query: 664 KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723
KSDVYSFGVVL E LCARPA+NP L +EQV+LAEWA +KG+L++I+DP+L G I PE
Sbjct: 718 KSDVYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPE 777
Query: 724 SLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQ-GK 767
KKFAE A KC+ D G++RP+MGDVLWNLE+ALQLQE+ + GK
Sbjct: 778 CFKKFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQESAEENGK 822
|
|
| TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 4.6e-163, Sum P(2) = 4.6e-163
Identities = 303/654 (46%), Positives = 411/654 (62%)
Query: 118 KEADLQKASFHVATDNCCEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDE 177
K L+ + + +EF+L + F P K S F+NAIE+VS D L +
Sbjct: 148 KNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDDKLFKES 207
Query: 178 GSSLFPVDSYEGLSKFSYQYVYRLNMGGPSITPQND-SLGRTWVPDSNFLKEKNLATTAS 236
+ + + GL + +YRLN+GGP + P D L RTW D +++ +N
Sbjct: 208 VTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEVK 267
Query: 237 VESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCD 296
SN + Y +AP VY +A MM+++ ++ FN++W F+VD F YL+RLHFC+
Sbjct: 268 NSSN-ITYALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCE 326
Query: 297 IVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNK 356
++ N F +Y+N +TA D+ A G Y+D + S ++ L +Q+GP+
Sbjct: 327 LLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSSKNDVLWIQLGPDS 386
Query: 357 ENTGTRNAILNGLEVIKMSNSVNSLDG-EFGVDG-SKANSSSRXXXXXXXXXXXXXXXXX 414
+ +A+L+GLE+ K+S + N F G S ++S R
Sbjct: 387 SVGASGDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSDSKMRIIWISVGAGIAIIIFFV 446
Query: 415 XXXMVIKW---HKRPQDWQRRNSFSSWL-LPLHTGDTSFMTSKCGSHKSGFTNSTLGLGR 470
+++ +R + + +N+ W L LH +++ G T + +GR
Sbjct: 447 FLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLRLNTLAASTMGR 506
Query: 471 YFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQ 530
F+ E++ ATKNFD IGVGGFG VY GE++DGT +A+KR P S+QG+ EF+TEI
Sbjct: 507 KFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEIV 566
Query: 531 MLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA 590
MLS+LRHRHLVSLIG+CDE++EMILVYEYM+NG R HL+G NLPPLSWKQRLE IGSA
Sbjct: 567 MLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSA 626
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFG 649
RGLHYLHTG+ +GIIHRDVK+TNILLD+N+VAK+SDFGLSK P + HVSTAVKGSFG
Sbjct: 627 RGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFG 686
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709
YLDPEYFRRQQLTEKSDVYSFGVVL E +CAR INP LP++Q+NLAEWA+ W+++ LE
Sbjct: 687 YLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLE 746
Query: 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAF 763
IID +L G +PESL+K+ E AEKCLAD G +RP MG+VLW+LEY LQ+ EA+
Sbjct: 747 SIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHEAW 800
|
|
| TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1488 (528.9 bits), Expect = 1.5e-152, P = 1.5e-152
Identities = 332/759 (43%), Positives = 451/759 (59%)
Query: 31 SPRDNFLIDCGGKSSNPLPDGRTFKSDKEALP-FLQTKEDIQVSVPSADVPSPIYLSARV 89
S D F I+CG + N + RTF SD + F D S D S ++ +ARV
Sbjct: 26 SVSDTFFINCGSPT-NVTVNNRTFVSDNNLVQGFSVGTTDSN----SGD-ESTLFQTARV 79
Query: 90 FKEES--TYTFQLNQPGWHWVRLHFFALPAKEADLQKASFHVATDN-------------C 134
F +ES TY F + + GW +R++F L + DL A F V+ N
Sbjct: 80 FSDESSSTYRFPIEEHGWFLIRIYFLPLVSASQDLTTARFSVSAQNFTLIREYKPSTTSV 139
Query: 135 CEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEGLSKFS 194
E++LN+T + ++F P SV+FINA+EV+ P+TLI ++ + L LS +
Sbjct: 140 VREYILNVTTDSLLLQFLPRTGSVSFINALEVLRLPETLIPED-AKLIGTQKDLKLSSHA 198
Query: 195 YQYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYP-DGVTPLIA 253
+ V R+NMG S++ D L R W DS + K T + AV + G+T IA
Sbjct: 199 METVSRVNMGNLSVSRDQDKLWRQWDSDSAY---KAHFGTPVMNLKAVNFSAGGITDDIA 255
Query: 254 PATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLN---DLYFNVY 310
P VY +A+ + N N+TWTF V+ F Y +R HFC+I+ + F+++
Sbjct: 256 PVYVYGTATRLNSDLDPNTNANLTWTFKVEPGFDYFVRFHFCNIIVDPFGFERQIRFDIF 315
Query: 311 VNGKTAISALDLSTVAQG-LATPYYRDIVVNASLMHNG-LNVQIGPNKENTGTRNAILNG 368
VN + + +D++ V G P++ D V+ + G LN+ IG + + + +NG
Sbjct: 316 VNSEK-VRTIDMTEVLNGTFGAPFFVDAVMRKAKSREGFLNLSIGLVMDVSSYPVSFING 374
Query: 369 LEVIKMSNSVNSLDGEFGV--DGSKANSSSRXXXXXXXXXXXXXXXXXXXXMVIKWHKRP 426
E+ K+SN SLD + DGS +N SS +V+ W
Sbjct: 375 FEISKLSNDKRSLDAFDAILPDGSSSNKSSNTSVGLIAGLSAALCVALVFGVVVSW---- 430
Query: 427 QDW--QRRNSFSSWLLPLHT-GDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKN 483
W ++R + + +H+ GD + F++S +G RY ++EAT +
Sbjct: 431 --WCIRKRRRRNRQMQTVHSRGDDHQIKKNETGESLIFSSSKIGY-RY-PLALIKEATDD 486
Query: 484 FDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
FD S +IGVGGFG VY G + D T+VAVKRG PQS QG+ EF+TE++ML++ RHRHLVSL
Sbjct: 487 FDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFRHRHLVSL 546
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYG-KNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
IGYCDENSEMI+VYEYM G +DHLY + P LSW+QRLEI +G+ARGLHYLHTG+ +
Sbjct: 547 IGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHYLHTGSTR 606
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQL 661
IIHRDVKS NILLDDN++AKV+DFGLSK P + Q HVSTAVKGSFGYLDPEY RQQL
Sbjct: 607 AIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVSTAVKGSFGYLDPEYLTRQQL 666
Query: 662 TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721
TEKSDVYSFGVV+LEV+C RP I+P LPRE+VNL EWAM+ +KG LE IIDP LVG +
Sbjct: 667 TEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKKGKLEDIIDPFLVGKVK 726
Query: 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760
E +KK+ E EKCL+ +G++RP MGD+LWNLE+ LQ+Q
Sbjct: 727 LEEVKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQVQ 765
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9T020 | Y4391_ARATH | 2, ., 7, ., 1, 1, ., - | 0.7063 | 0.9603 | 0.9100 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | scaffold_700110.1 | annotation not avaliable (882 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 832 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-40 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-30 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 1e-54
Identities = 90/369 (24%), Positives = 142/369 (38%), Gaps = 66/369 (17%)
Query: 38 IDCGGKSSNPLPD---GRTFKSDKEALPFLQTKEDIQVS-VPSADVPSPIYLSARVFKE- 92
IDCG S+ D G T+ SD F+ T + +S S+ S Y + R F +
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDA---GFIDTGKSGNISKENSSSFLSKPYKTLRSFPDG 57
Query: 93 -ESTYTFQLNQPG--WHWVRLHF----------------FAL-----PAKEADLQKASFH 128
+ YT + + +R F F L +L S
Sbjct: 58 KRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGD 117
Query: 129 VATDNCCEEFMLNLTES-TFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSY 187
+E+++++T+S T S+ FI+A+E+ PD+L G S
Sbjct: 118 SVV----KEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS------- 166
Query: 188 EGLSKFSYQYVYRLNMG--GPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYP 245
+ + V RLN G +I +D R W P + ++T+ SV+ ++
Sbjct: 167 -----QALKLVARLNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNN-- 219
Query: 246 DGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDL 305
P I P+ V +A ++ N TW D F Y + LHF +I SL
Sbjct: 220 ---APYIPPSAVLQTAVTPTNASA---PLNFTWDLV-DPNFEYYVYLHFAEIQ--SLETR 270
Query: 306 YFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAI 365
F++Y+NGKT + Y D VN S LN+ + P + T +
Sbjct: 271 EFDIYINGKTVYGDVS-PKYLGTDTGALYLDFPVNVSG-GGLLNISLVPT--SGSTLPPL 326
Query: 366 LNGLEVIKM 374
LN LE+ K+
Sbjct: 327 LNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 74/191 (38%), Positives = 103/191 (53%), Gaps = 9/191 (4%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSLIGYC 547
+G GGFG VYL G KVA+K + + E EI++L KL H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
++ + + LV EY G +D L +N LS + L I + GL YLH + GIIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 608 DVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ-LTEKS 665
D+K NILLD DN K++DFGLSK + + G+ Y+ PE + +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 666 DVYSFGVVLLE 676
D++S GV+L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 88/270 (32%), Positives = 132/270 (48%), Gaps = 29/270 (10%)
Query: 489 IIGVGGFGNVYLGEIDD-----GTKVAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG VY G++ +VAVK SEQ I EF E +++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L+G C E + +V EYM G +L KN P LS L ++ ARG+ YL ++
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE---SK 121
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
IHRD+ + N L+ +N V K+SDFGLS+D + K ++ PE + + T
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 663 EKSDVYSFGVVLLEV--LCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720
KSDV+SFGV+L E+ L +P P + E+V +++ + G P
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEV------LEYLKNGYRLPQ--PPNC--- 228
Query: 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
P L +C A+ DRPT +++
Sbjct: 229 -PPELYDL---MLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 6e-51
Identities = 87/284 (30%), Positives = 133/284 (46%), Gaps = 49/284 (17%)
Query: 489 IIGVGGFGNVYLGEIDDG----TKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG VY G++ T+VAVK + + E+ +F E +++ KL H ++V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVVR 60
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL-------YGKNLPPLSWKQRLEISIGSARGLHY 595
L+G C E + LV EYM G D+L LS K L +I A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA-----VKGSFGY 650
L ++ +HRD+ + N L+ ++ V K+SDFGLS+D + ++ +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 651 LDPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQVNLAEWAMQWKRKGL- 707
+ PE + T KSDV+SFGV+L E+ L A P P L E+V +++ RKG
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV------LEYLRKGYR 225
Query: 708 LEKIIDPHLVGTINPESL-KKFAEAAEKCLADHGVDRPTMGDVL 750
L K PE + E C DRPT +++
Sbjct: 226 LPK-----------PEYCPDELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 489 IIGVGGFGNVYLGEIDDG-----TKVAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG VY G + +VAVK SEQ I EF E +++ KL H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L+G C E +++V EYM G D+L LS L ++ ARG+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
IHRD+ + N L+ +N V K+SDFGLS+D + K ++ PE + + T
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 663 EKSDVYSFGVVLLEV--LCARP 682
KSDV+SFGV+L E+ L P
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 87/266 (32%), Positives = 129/266 (48%), Gaps = 20/266 (7%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITE--FQTEIQMLSKLRHRHLVSLIG 545
+G G FG VY G VAVK +SE+ + + EI++L +L H ++V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
++ + LV EY G D+L PLS + +I++ RGL YLH + GII
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE-YFRRQQLTEK 664
HRD+K NILLD+N V K++DFGL+K ++T V G+ Y+ PE K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 665 SDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724
DV+S GV+L E+L +P + + +Q +Q R+ L + + E
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQ-------LQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 725 LKKFAEAAEKCLADHGVDRPTMGDVL 750
K +KCL RPT ++L
Sbjct: 233 AKDL---IKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 69/197 (35%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 490 IGVGGFGNVYLGEIDD-----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG VY G + TKVAVK SE+ EF E ++ KL H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+G C + + +V EYM G D L K+ L+ K L++++ A+G+ YL ++
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKD-APIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
+HRD+ + N L+ +N V K+SDFGLS+D K ++ PE + + T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 663 EKSDVYSFGVVLLEVLC 679
KSDV+SFGV+L E+
Sbjct: 183 SKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSLIGY 546
+G G FG VYL + G VA+K + + E EI++L KL+H ++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
++ ++ LV EY G D L K LS + L YLH ++GI+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+K NILLD++ K++DFGL++ + G T G+ Y+ PE + + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 667 VYSFGVVLLEVLCARP 682
++S GV+L E+L +P
Sbjct: 179 IWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 45/273 (16%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
++G G FG+VYL + D G +AVK + SE+ + + EI++LS L+H ++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 546 -YCDENSEMILVY-EYMSNGPFRDHLYGKNLPPLS-------WKQRLEISIGSARGLHYL 596
DE + ++ EY+S G L K L +Q LE GL YL
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILE-------GLAYL 117
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD-APIGQGHVSTAVKGSFGYLDPEY 655
H + GI+HRD+K NIL+D + V K++DFG +K I G + +V+G+ ++ PE
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI--ID 713
R ++ +D++S G ++E+ +P P ++ A+ + G + I
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP------PWSELGNPMAAL--YKIGSSGEPPEIP 226
Query: 714 PHLVGTINPESLKKFAEAAEKCLA-DHGVDRPT 745
HL E K F KCL D RPT
Sbjct: 227 EHL-----SEEAKDF---LRKCLRRDPK-KRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 73/212 (34%), Positives = 114/212 (53%), Gaps = 9/212 (4%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
K A IG G FG+V LG+ G KVAVK S F E +++ LRH +LV
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLV 63
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L+G + + + +V EYM+ G D+L + ++ Q+L ++ G+ YL
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---E 120
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+ +HRD+ + N+L+ ++ VAKVSDFGL+K+A GQ VK + PE R ++
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK----WTAPEALREKKF 176
Query: 662 TEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
+ KSDV+SFG++L E+ P++P + V
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 61/188 (32%), Positives = 95/188 (50%), Gaps = 7/188 (3%)
Query: 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG GGFG VY G +VA+K +S++ + EIQ+L K +H ++V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
+ E+ +V E+ S G +D L N L+ Q + +GL YLH + GIIHRD
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLH---SNGIIHRD 123
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 668
+K+ NILL + K+ DFGLS + + G+ ++ PE + K+D++
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKADIW 181
Query: 669 SFGVVLLE 676
S G+ +E
Sbjct: 182 SLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 69/200 (34%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 490 IGVGGFGNVYLGEID---DGT--KVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG V L D D T +VAVK N EQ ++F+ EI++L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 544 IGYCDENSEMI--LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
G C++ L+ EY+ +G RD+L ++ ++ K+ L S +G+ YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGS--- 127
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS---FGYLDPEYFRR 658
Q IHRD+ + NIL++ + K+SDFGL+K P + + G F Y PE R
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 659 QQLTEKSDVYSFGVVLLEVL 678
+ + SDV+SFGV L E+
Sbjct: 187 SKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 5e-32
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG VYL DG +K + SE+ + E+++L KL H +++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 547 CDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+E ++ +V EY G + K P +Q L+ + L YLH+ + I
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKI 124
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA--VKGSFGYLDPEYFRRQQLT 662
+HRD+K NI L N + K+ DFG+SK + V A V G+ YL PE + +
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISK---VLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181
Query: 663 EKSDVYSFGVVLLEVLCARPA 683
KSD++S G VL E+ +
Sbjct: 182 YKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 489 IIGVGGFGNVYLGE-IDDGTKVAVKR----GNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+IG G FG VY G ++ G VA+K+ + + EI +L L+H ++V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA--LKSIMQEIDLLKNLKHPNIVKY 64
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHL--YGK---NLPPLSWKQRLEISIGSARGLHYLHT 598
IG + + + ++ EY NG R + +G +L + Q L+ GL YLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLHE 117
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
QG+IHRD+K+ NIL + V K++DFG++ +V G+ ++ PE
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEM 173
Query: 659 QQLTEKSDVYSFGVVLLEVLCARP 682
+ SD++S G ++E+L P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 71/190 (37%), Positives = 103/190 (54%), Gaps = 9/190 (4%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G FG V+LG + KVA+K R SE+ +F E Q++ KL H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E S + LV+E+M +G D+L + S + L + + G+ YL + +IHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 667
D+ + N L+ +N V KVSDFG+++ Q ST K + PE F + + KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 668 YSFGVVLLEV 677
+SFGV++ EV
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 12/211 (5%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G FG+VY G + T+VAVK R + +F E ++L + H ++V LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
+ + +V E + G L K L+ K+ L++S+ +A G+ YL ++ IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG-SFGYLDPEYFRRQQLTEKSD 666
D+ + N L+ +N V K+SDFG+S++ G VS +K + PE + T +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 667 VYSFGVVLLEVL----CARPAINPQLPREQV 693
V+S+G++L E P ++ Q RE++
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 33/213 (15%)
Query: 490 IGVGGFGNVYLGEI------DDGTKVAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG V+LGE +D VAVK S +F+ E ++L+ +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 543 LIGYCDENSEMILVYEYM----------SNGPFRDHLYGKNLP--PLSWKQRLEISIGSA 590
G C E I+V+EYM S+GP L + P L+ Q L+I++ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA------PIGQGHVSTAV 644
G+ YL +Q +HRD+ + N L+ + V K+ DFG+S+D +G GH +
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG-GHTMLPI 188
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEV 677
+ ++ PE ++ T +SDV+SFGVVL E+
Sbjct: 189 R----WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 16/194 (8%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V+ G + +VA+K +FQ E+Q L +LRH+HL+SL C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 550 NSEMILVYEYMSNGPFRDHLY---GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ ++ E M G L G+ LP S ++++ A G+ YL Q IH
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASL---IDMACQVAEGMAYLE---EQNSIH 127
Query: 607 RDVKSTNILLDDNYVAKVSDFGLS---KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
RD+ + NIL+ ++ V KV+DFGL+ K+ + ++S+ K + + PE +
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKE-DV---YLSSDKKIPYKWTAPEAASHGTFST 183
Query: 664 KSDVYSFGVVLLEV 677
KSDV+SFG++L E+
Sbjct: 184 KSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 82/282 (29%), Positives = 121/282 (42%), Gaps = 23/282 (8%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITE---FQTEIQMLSKLRH-R 538
++ +G G FG VYL D VA+K + E E F EIQ+L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHL-YGKNLPPLSWKQRLEISIGSARGLHYLH 597
++V L + + + LV EY+ G D L PLS + L I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 598 TGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVS-----TAVKGSFGYL 651
+ +GIIHRD+K NILLD D V K+ DFGL+K P S + G+ GY+
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 652 DPEYFRRQQL---TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708
PE L + SD++S G+ L E+L P P + + ++ +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP---PFEGEKNSSATSQTLKIILELPT 232
Query: 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ L + K ++ +K LA +R + L
Sbjct: 233 PSLA-SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 73/207 (35%), Positives = 111/207 (53%), Gaps = 13/207 (6%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVK-RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY- 546
IG G FG+V LG+ G KVAVK N + Q F E ++++LRH +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+E + +V EYM+ G D+L + L L+ S+ + YL A +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+ + N+L+ ++ VAKVSDFGL+K+A Q VK + PE R ++ + KSD
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSD 181
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQV 693
V+SFG++L E+ P++P + V
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 73/206 (35%), Positives = 114/206 (55%), Gaps = 11/206 (5%)
Query: 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IIG G FG V GE G KVAVK N + + F E +++KL H++LV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
N + +V E MS G + L + +S Q L+ S+ A G+ YL + + ++HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 667
D+ + NIL+ ++ VAKVSDFGL++ +G + VK + PE + ++ + KSDV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFSSKSDV 180
Query: 668 YSFGVVLLEVLCARPAINPQLPREQV 693
+S+GV+L EV A P++ ++V
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/191 (32%), Positives = 98/191 (51%), Gaps = 8/191 (4%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V+ G ++ T VAVK P + +F E Q++ KLRH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ +V E M G ++L G L Q ++++ A G+ YL AQ IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 610 KSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 667
+ N+L+ +N + KV+DFGL++ I + K + PE + + KSDV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGA--KFPIKWTAPEAALYNRFSIKSDV 187
Query: 668 YSFGVVLLEVL 678
+SFG++L E++
Sbjct: 188 WSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGIT-EFQTEIQMLSKLRHRHLVSLIGYC 547
++G G FG V+ G + D T VAVK Q + +F +E ++L + H ++V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
+ + +V E + G F L K L KQ ++ ++ +A G+ YL + + IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 667
D+ + N L+ +N V K+SDFG+S+ G S + + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 668 YSFGVVLLEV----LCARPAINPQLPREQV 693
+S+G++L E +C P + Q REQV
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 71/194 (36%), Positives = 103/194 (53%), Gaps = 16/194 (8%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++G + TKVAVK P + F E Q++ KLRH LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 550 NSEMILVYEYMSNGPFRDHLY---GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ +V EYMS G D L GK L Q ++++ A G+ YL ++ IH
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLR---LPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS---FGYLDPEYFRRQQLTE 663
RD+ + NIL+ +N V K++DFGL A + + TA +G+ + PE + T
Sbjct: 127 RDLAARNILVGENLVCKIADFGL---ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 664 KSDVYSFGVVLLEV 677
KSDV+SFG++L E+
Sbjct: 184 KSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 71/236 (30%), Positives = 113/236 (47%), Gaps = 34/236 (14%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-----GNPQSEQGITEFQTEIQMLSKLR 536
N+ ++G G FG VYL ++D G ++AVK+ +P++++ + + EIQ+L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLH 594
H +V G ++ + + EYM G +D L YG ++ K +I G+
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI----LEGVE 118
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGYLD 652
YLH+ I+HRD+K NIL D K+ DFG SK G +V G+ ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARP---------AI--------NPQLPRE 691
PE + K+DV+S G ++E+L +P AI NPQLP
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 490 IGVGGFGNVYLGEI------DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG V+L E D VAVK S+ +F E ++L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 544 IGYCDENSEMILVYEYMSNGP----FRDH-----LYGKNLPP--LSWKQRLEISIGSARG 592
G C E +I+V+EYM +G R H L + P L+ Q L I+ A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA------PIGQGHVSTAVKG 646
+ YL +Q +HRD+ + N L+ +N + K+ DFG+S+D +G GH ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG-GHTMLPIR- 187
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++ PE ++ T +SDV+S GVVL E+
Sbjct: 188 ---WMPPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 65/190 (34%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
+G G FG V+LG+ VA+K R SE +F E +++ KL H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
+ + +V EYM+NG ++L + L + L++ + YL + G IHR
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHR 124
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 667
D+ + N L+ ++ V KVSDFGL++ Q S K + PE F + + KSDV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 668 YSFGVVLLEV 677
+SFGV++ EV
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 84/283 (29%), Positives = 124/283 (43%), Gaps = 59/283 (20%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKR-----GNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG+VY G +DDG AVK ++ + + + EI +LSKL+H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPP---LSWKQRLEISIGSARGLHYLHT 598
+G E + + E + G L YG P L +Q L GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH- 119
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST-----AVKGSFGYLDP 653
+ +HRD+K NIL+D N V K++DFG++K V + KGS ++ P
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAP 170
Query: 654 EYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK--RKGLLEK 710
E +Q +D++S G +LE+ +P P E V A +K R L
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKP---PWSQLEGV-----AAVFKIGRSKELPP 222
Query: 711 IIDPHLVGTINPESLKKFAEAAE---KCLADHGVDRPTMGDVL 750
I P+ L EA + KCL RPT ++L
Sbjct: 223 I----------PDHLS--DEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 474 FQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQ 530
+ + + + IG G G VY + G +VA+K R Q+++ I EI
Sbjct: 11 IVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEIL 67
Query: 531 MLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA 590
++ +H ++V E+ +V EYM G D + + ++ Q +
Sbjct: 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVL 126
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKG 646
+GL YLH +Q +IHRD+KS NILL + K++DFG L+K + ++ V G
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK----EKSKRNSVV-G 178
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLE 676
+ ++ PE +R+ K D++S G++ +E
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 78/293 (26%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQSEQGI-TE 524
F LQE T +G G FG V+L + T V VK ++ + +E
Sbjct: 2 FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54
Query: 525 FQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL-------YGKNLPPL 577
F+ E+ M KL H+++V L+G C E ++ EY G + L PPL
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 578 SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637
S KQ++ + A G+ +L +HRD+ + N L+ KVS LSKD +
Sbjct: 115 STKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
Query: 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE 697
+ +L PE + + KSDV+SFGV++ EV +LP ++ E
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----QGELPFYGLSDEE 226
Query: 698 WAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ + L + + G P L K +C A + DRP+ +++
Sbjct: 227 VLNRLQAGKLELPVPE----GC--PSRLYKL---MTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 490 IGVGGFGNVYL-GEIDDGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G G FG V L + D G A+K + + + TE +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLH 597
++ LV EY G HL + S AR L YLH
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS----------KEGRFSEERARFYAAEIVLALEYLH 110
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
+ GII+RD+K NILLD + K++DFGL+K+ +T G+ YL PE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLL 166
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
+ + D +S GV+L E+L +P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 490 IGVGGFGNVYLGEI------DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG V+L E D VAVK SE +FQ E ++L+ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLY-----------GKNLP--PLSWKQRLEISIGSA 590
G C E +++V+EYM +G L G+++ L+ Q L I+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA-PIGQGHVSTAVKGSFG 649
G+ YL + +HRD+ + N L+ V K+ DFG+S+D V
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++ PE ++ T +SD++SFGVVL E+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQG--ITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG VY +D G +AVK Q I E E+++L L+H +LV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
++ + EY S G + L + + + + GL YLH+ GI+H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHS---HGIVH 122
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSK-----DAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
RD+K NI LD N V K+ DFG + +G+ S A G+ Y+ PE +
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPEVITGGKG 180
Query: 662 TEK---SDVYSFGVVLLEVLCARP 682
+D++S G V+LE+ +
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 71/203 (34%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 490 IGVGGFGNVYLGEID---DGTK--VAVK---RGN-PQSEQGITEFQTEIQMLSKLRHRHL 540
+G G FG V L D DGT VAVK R Q+ G ++ EI +L L H ++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG---WKKEINILKTLYHENI 68
Query: 541 VSLIGYCDENSEMI--LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
V G C E L+ EY+ G RD+L L + Q L + G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL---NLAQLLLFAQQICEGMAYLH- 124
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS---FGYLDPEY 655
+Q IHRD+ + N+LLD++ + K+ DFGL+K P G + G F Y E
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181
Query: 656 FRRQQLTEKSDVYSFGVVLLEVL 678
+ + + SDV+SFGV L E+L
Sbjct: 182 LKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 489 IIGVGGFGNVYLG--------EIDDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRH 539
+IG G FG V G EID VA+K S++ +F TE ++ + H +
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEID----VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
++ L G ++ ++++ EYM NG D +N + Q + + G A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL--- 122
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV-KGSFGYLDPEYFRR 658
+ +HRD+ + NIL++ N V KVSDFGLS+ + +T K + PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 659 QQLTEKSDVYSFGVVLLEVL 678
++ T SDV+SFG+V+ EV+
Sbjct: 183 RKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-R 536
+F IIG G F V L E + + A+K + + E+ + + E ++L++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ-RLEIS-IGSARGLH 594
H ++ L + + V EY NG ++ + L K R + I A L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA--LE 116
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP---------------IGQGH 639
YLH ++GIIHRD+K NILLD + K++DFG +K Q
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 640 VSTAVKGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ SF G Y+ PE + + SD+++ G ++ ++L +P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 68/192 (35%), Positives = 97/192 (50%), Gaps = 13/192 (6%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
+G G FG V G+ VA+K + SE EF E +++ KL H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 548 DENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
+ + +V EYMSNG ++L +GK P Q LE+ G+ YL + + I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLES---KQFI 122
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS 665
HRD+ + N L+DD KVSDFGLS+ + S K + PE + + KS
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 666 DVYSFGVVLLEV 677
DV++FGV++ EV
Sbjct: 183 DVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 490 IGVGGFGNVYLGE------IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG V+L E D VAVK + +FQ E ++L+ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLY-----------GKNLPP---LSWKQRLEISIGS 589
G C + +I+V+EYM +G L G+ L Q L I+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA------PIGQGHVSTA 643
A G+ YL +Q +HRD+ + N L+ N + K+ DFG+S+D +G GH
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG-GHTMLP 188
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++ ++ PE ++ T +SDV+SFGV+L E+
Sbjct: 189 IR----WMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 29/212 (13%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGN-PQSEQG---------ITEFQTEIQMLSKLRH 537
+IG G +G VYL + G +AVK+ P + G + ++EI+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLS---WKQRLEISIGSARG 592
++V +G+ + + EY+ G L YG+ L +Q LE G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------G 120
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS-TAVKGSFGYL 651
L YLH+ +GI+HRD+K+ N+L+D + + K+SDFG+SK + + +++GS ++
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 652 DPE--YFRRQQLTEKSDVYSFGVVLLEVLCAR 681
PE + Q + K D++S G V+LE+ R
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 490 IGVGGFGNVYLG--------EIDDGTKVAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHL 540
+G G FG+V G E++ VAVK G EF E ++++L H +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE----VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
V LIG C ++LV E GP +L K + E++ A G+ YL +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLES-- 113
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG----HVSTAVKGSFGYLDPEYF 656
+ +HRD+ + N+LL + + AK+SDFG+S+ +G G +TA + + PE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSR--ALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 657 RRQQLTEKSDVYSFGVVLLEVL 678
+ + KSDV+S+GV L E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 63/188 (33%), Positives = 97/188 (51%), Gaps = 5/188 (2%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++G + T+VA+K P + F E Q++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ +V EYMS G D L G+ L Q ++++ A G+ Y+ +HRD+
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
++ NIL+ +N V KV+DFGL++ + K + PE + T KSDV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 670 FGVVLLEV 677
FG++L E+
Sbjct: 189 FGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 63/229 (27%), Positives = 122/229 (53%), Gaps = 28/229 (12%)
Query: 490 IGVGGFGNVYLGE---ID-----DGTKVAVKR-GNPQSEQGITEFQTEIQMLSKL-RHRH 539
+G G FG V + E ID + VAVK + +E+ +++ +E++M+ + +H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLP--------------PLSWKQRLEI 585
+++L+G C ++ + ++ EY S G R++L + P +++K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA-PIGQGHVSTAV 644
+ ARG+ YL +Q IHRD+ + N+L+ +N V K++DFGL++D I +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
+ ++ PE + T +SDV+SFGV++ E+ + P +P E++
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 15/200 (7%)
Query: 489 IIGVGGFGNVYLGEIDDG----TKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSL 543
+IG G FG VY G + D AVK N ++ + + +F E ++ H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 544 IGYC--DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+G C E S ++ V YM +G R+ + + P + K + + A+G+ YL +
Sbjct: 62 LGICLPSEGSPLV-VLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA---PIGQGHVSTAVKGSFGYLDPEYFRR 658
+ +HRD+ + N +LD+++ KV+DFGL++D H T K ++ E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 659 QQLTEKSDVYSFGVVLLEVL 678
Q+ T KSDV+SFGV+L E++
Sbjct: 177 QKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 490 IGVGGFGNVYLGEIDDGTK--VAVKRGN-PQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG VY ID T VA+K + ++E I + Q EIQ LS+ R ++ G
Sbjct: 9 IGKGSFGEVYKA-IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA-----RGLHYLHTGTA 601
+ S++ ++ EY G D L L E I GL YLH
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLD--------ETYIAFILREVLLGLEYLH---E 116
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK------GSFGYLDPEY 655
+G IHRD+K+ NILL + K++DFG+S G +++ + G+ ++ PE
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARP 682
++ EK+D++S G+ +E+ P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 33/265 (12%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKR----GNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
+G G G VY G A+K+ G+ + + + E++ L ++V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVKCY 65
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
G + E+ +V EYM G D L K + + I+ +GL YLHT + I
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHT--KRHI 121
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
IHRD+K +N+L++ K++DFG+SK +T V G+ Y+ PE + + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 665 SDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID---PHLV-GTI 720
+D++S G+ LLE + P LP Q + E L++ I D P L
Sbjct: 181 ADIWSLGLTLLECALGK---FPFLPPGQPSFFE---------LMQAICDGPPPSLPAEEF 228
Query: 721 NPESLKKFAEAAEKCLADHGVDRPT 745
+PE F + CL RP+
Sbjct: 229 SPE----FRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 489 IIGVGGFGNVYLGEIDDGTKV-AVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSL- 543
+IG G FG V + + D K+ A+K N Q + + E ++L +L H LV+L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEIS-IGSARGLHYLHTGTAQ 602
+ DE M LV + + G R HL + + + + I I A L YLH+ +
Sbjct: 67 YSFQDEE-NMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA--LEYLHS---K 119
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
GIIHRD+K NILLD+ ++DF ++ ST+ G+ GY+ PE RQ +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQGYS 177
Query: 663 EKSDVYSFGVVLLEVLCAR 681
D +S GV E L +
Sbjct: 178 VAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 65/193 (33%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
+G G FG V+LG+ KVA+K SE+ +F E +++ KL H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 548 DENSEMILVYEYMSNGPFRDHL---YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ + +V E+M NG ++L GK LS L + G+ YL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLER---NSF 121
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
IHRD+ + N L+ V KVSDFG+++ + S+ K + PE F + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 665 SDVYSFGVVLLEV 677
SDV+SFGV++ EV
Sbjct: 182 SDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
FD +G G +G+VY + G VA+K E+ + E EI +L + ++V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 543 LIGYCDENSEMILVYEYMSNGPFRD--HLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
G +N+++ +V EY G D + K L+ ++ I + +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+ IHRD+K+ NILL++ AK++DFG+S +T V G+ ++ PE +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 661 LTEKSDVYSFGVVLLEVLCARP 682
K+D++S G+ +E+ +P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-22
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 9/208 (4%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++G + TKVAVK P + F E Q++ KLRH LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ +V EYMS G D L L ++++ A G+ Y+ IHRD+
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
+S NIL+ D V K++DFGL++ + K + PE + T KSDV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 670 FGVVLLEVLCA----RPAINPQLPREQV 693
FG++L E++ P +N + EQV
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 41/218 (18%)
Query: 490 IGVGGFGNVYLGEI------DDGTKVAVK----RGNPQSEQGITEFQTEIQMLSKLRHRH 539
+G G FG VY GE+ T VA+K P+ +Q EF+ E +++S L+H +
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLP---------------PLSWKQRLE 584
+V L+G C + +++EY+++G + L +N P L L
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLV-RNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-----QGH 639
I+I A G+ YL ++ +HRD+ + N L+ + K+SDFGLS+D Q
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEV 677
V+ ++ PE + T +SD++SFGVVL E+
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 4/189 (2%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++G ++ TKVAVK P + + F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ ++ EYM+ G D L + + ++ S A G+ Y+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
++ N+L+ ++ + K++DFGL++ + K + PE T KSDV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 670 FGVVLLEVL 678
FG++L E++
Sbjct: 190 FGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 66/234 (28%), Positives = 124/234 (52%), Gaps = 38/234 (16%)
Query: 490 IGVGGFGNVYLGEI--------DDGTKVAVKR-GNPQSEQGITEFQTEIQMLSKL-RHRH 539
+G G FG V + E + TKVAVK + +E+ +++ +E++M+ + +H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPP---------------LSWKQRLE 584
+++L+G C ++ + ++ EY S G R++L + PP LS+K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
+ ARG+ YL ++ IHRD+ + N+L+ ++ V K++DFGL++D H+
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYK 197
Query: 645 KGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
K + G ++ PE + T +SDV+SFGV+L E+ + P +P E++
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 490 IGVGGFGNVYLGEID-----DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
+G G FG+V L D G VAVK+ + + + +F+ EI++L L+H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 545 GYCDE--NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
G C + LV EY+ G RD+L K+ L ++ L + +G+ YL ++
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYL---GSK 127
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS---FGYLDPEYFRRQ 659
+HRD+ + NIL++ K+ DFGL+K P + + G F Y PE
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTES 186
Query: 660 QLTEKSDVYSFGVVLLEV 677
+ + SDV+SFGVVL E+
Sbjct: 187 KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 11/195 (5%)
Query: 490 IGVGGFGNVYLGEIDDGT----KVAVKRGNPQSEQGI-TEFQTEIQMLSKLRHRHLVSLI 544
+G G FG V GE VAVK I +F E ++ L H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
G + +++V E G D L L + ++ A G+ YL + +
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA--VKGSFGYLDPEYFRRQQLT 662
IHRD+ + NILL + K+ DFGL + P + H +K F + PE R + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 663 EKSDVYSFGVVLLEV 677
SDV+ FGV L E+
Sbjct: 179 HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 63/234 (26%), Positives = 121/234 (51%), Gaps = 40/234 (17%)
Query: 489 IIGVGGFGNVYLGE---IDDGTK---VAVK--RGNPQSEQGITEFQTEIQMLSKL-RHRH 539
+G G FG V E +D+ + VAVK + + +E+ +++ +E++M+ + +H++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHL---------YGKNLP-----PLSWKQRLEI 585
+++L+G C + + +V EY ++G RD L + P L+ K +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA-------PIGQG 638
+ ARG+ +L ++ IHRD+ + N+L+ +++V K++DFGL++D G
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ 692
+ VK ++ PE + T +SDV+SFGV+L E+ + P +P E+
Sbjct: 195 RLP--VK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 54/296 (18%)
Query: 490 IGVGGFGNVYLGEIDDGTK-----------------VAVKRGNP-QSEQGITEFQTEIQM 531
+G G FG V+L E D VAVK P S+ +F E+++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 532 LSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLY---------GKNLPPLSWKQR 582
LS+L ++ L+G C + + ++ EYM NG L N LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-----Q 637
L ++ A G+ YL + +HRD+ + N L+ NY K++DFG+S++ Q
Sbjct: 133 LYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQV-- 693
G ++ ++ E + T KSDV++FGV L E+ LC L +QV
Sbjct: 190 GRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQVIE 244
Query: 694 NLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDV 749
N + R+ L + P P+ + E +C DRPT ++
Sbjct: 245 NAGHFFRDDGRQIYLPR---PPNC----PKDI---YELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 62/189 (32%), Positives = 96/189 (50%), Gaps = 5/189 (2%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++G + TKVA+K P + F E Q++ KLRH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ +V E+M G D L + L Q ++++ A G+ Y+ IHRD+
Sbjct: 73 EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
++ NIL+ DN V K++DFGL++ + K + PE + T KSDV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 670 FGVVLLEVL 678
FG++L E++
Sbjct: 189 FGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 489 IIGVGGFGNVYL-GEIDDGTKVAVK-----RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
IG G FG V DG + K + +Q + +E+ +L +L+H ++V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV- 62
Query: 543 LIGYCD-----ENSEMILVYEYMSNGPF--------RDHLYGKNLP-PLSWKQRLEISIG 588
Y D N + +V EY G ++ Y + W+ ++ +
Sbjct: 63 --RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---IEEEFIWRILTQLLLA 117
Query: 589 SARGLHYLHTGTAQG--IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646
L+ H + G ++HRD+K NI LD N K+ DFGL+K T V G
Sbjct: 118 ----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-G 172
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA 680
+ Y+ PE EKSD++S G ++ E LCA
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYE-LCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 24/156 (15%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEF-QT---EIQMLSKLRHRHLVS 542
A IG G +G VY G VA+K+ ++E+ F T EI++L KLRH ++V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 543 LIGYC--DENSEMILVYEYMS---NGPFRDHLYGKNLPPL-SW-KQRLEISIGSARGLHY 595
L + +V+EYM G + + KQ LE GL Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQY 115
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
LH+ GI+HRD+K +NIL++++ V K++DFGL++
Sbjct: 116 LHS---NGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 36/236 (15%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-----GNPQSEQGITEFQTEIQMLSKLR 536
N+ ++G G FG VYL ++D G ++A K+ +P++ + ++ + EIQ+L L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 537 HRHLVSLIGYCDENSE--MILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARG 592
H +V G + +E + + EYM G +D L YG ++ K +I G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI----LEG 118
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGY 650
+ YLH+ I+HRD+K NIL D K+ DFG SK G +V G+ +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 651 LDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP-----------------AINPQLP 689
+ PE + K+DV+S G ++E+L +P NPQLP
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-20
Identities = 63/229 (27%), Positives = 121/229 (52%), Gaps = 28/229 (12%)
Query: 490 IGVGGFGNVYLGE---IDD-----GTKVAVKR-GNPQSEQGITEFQTEIQMLSKL-RHRH 539
+G G FG V + E ID VAVK + +++ +++ +E++M+ + +H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLP--------------PLSWKQRLEI 585
+++L+G C ++ + ++ EY S G R++L + P L++K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA-PIGQGHVSTAV 644
+ ARG+ YL +Q IHRD+ + N+L+ ++ V K++DFGL++D I +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
+ ++ PE + T +SDV+SFGV+L E+ + P +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 72/238 (30%), Positives = 109/238 (45%), Gaps = 40/238 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-----GNPQSEQGITEFQTEIQMLSKLR 536
N+ ++G G FG VYL + D G ++AVK+ +P++ + + + EIQ+L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 537 HRHLVSLIGYCDENSEMIL--VYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARG 592
H +V G + E L E+M G +D L YG ++ K +I G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI----LEG 118
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI----GQGHVSTAVKGSF 648
+ YLH+ I+HRD+K NIL D K+ DFG SK G G S V G+
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTP 173
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP---------AI--------NPQLP 689
++ PE + K+D++S G ++E+L +P AI NP LP
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 489 IIGVGGFGNVYLG----EIDDGT---KVAVK---RGNPQSEQGITEFQTEIQMLSKLRHR 538
+G G FG VY G + G+ +VAVK +G E+ EF E ++S H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHP 59
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNL-----PPLSWKQRLEISIGSARGL 593
++V L+G C N ++ E M G +L + P L+ K+ L+I + A+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 594 HYLHTGTAQGIIHRDVKSTNILL-----DDNYVAKVSDFGLSKD-------APIGQGHVS 641
YL IHRD+ + N L+ D + V K+ DFGL++D G+G +
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++ PE + T +SDV+SFGV++ E+L
Sbjct: 177 VR------WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 32/212 (15%)
Query: 488 AIIGVGGFGNVYLG-EIDDGTKVAVKR---------GNPQSEQGITEFQTEIQMLSKLRH 537
A+IG G FG+VYLG G +AVK+ + + EI +L +L+H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 538 RHLVSLIGYCDENSEMILVY-EYMSNGPFRDHL--YGKNLPPLSW---KQRLEISIGSAR 591
++V +G +++ + ++ EY+ G L YG L +Q L +
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------K 117
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI-----GQGHVSTAVKG 646
GL+YLH +GIIHRD+K NIL+D+ K+SDFG+SK +++G
Sbjct: 118 GLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
S ++ PE ++ T K+D++S G +++E+L
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR----GNPQSEQGIT--EFQTEIQMLSKL 535
+ +G G F + Y ++ GT +AVK+ N SEQ + EI+++++L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 536 RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGL 593
H H++ ++G E+S L E+M+ G L YG + ++ RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL----LRGL 116
Query: 594 HYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFG----LSKDAPIGQGHVSTAVKGSF 648
YLH IIHRDVK N+L+D +++DFG L+ G G + G+
Sbjct: 117 SYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-TGAGEFQGQLLGTI 172
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAIN 685
++ PE R +Q DV+S G V++E+ A+P N
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTK----VAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLV 541
++G G FG VY G I +G K VA+K S + E E +++ + H H+V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L+G C +S++ L+ + M G D++ + + + L + A+G+ YL
Sbjct: 73 RLLGIC-LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLEE--- 127
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-STAVKGSFGYLDPEYFRRQQ 660
+ ++HRD+ + N+L+ K++DFGL+K + + + K ++ E +
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 661 LTEKSDVYSFGVVLLEVLC--ARP 682
T KSDV+S+GV + E++ A+P
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 489 IIGVGGFGNVYLGEIDDGTK----VAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVSL 543
+IG G FG V+ G + + VA+K P +E+ +F +E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
G + +++ EYM NG +L + S Q + + G A G+ YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSK---DAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+HRD+ + NIL++ N KVSDFGLS+ D P G + ++ K + PE ++
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPEAIAYRK 186
Query: 661 LTEKSDVYSFGVVLLEVL 678
T SDV+SFG+V+ EV+
Sbjct: 187 FTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 489 IIGVGGFGNVYLGEI--DDGT--KVAVKR----GNPQSEQGITEFQTEIQMLSKLRHRHL 540
I+G G FG+V G++ DDG+ KVAVK + SE I EF +E + H ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE--IEEFLSEAACMKDFDHPNV 63
Query: 541 VSLIGYCDENSEM------ILVYEYMSNGPFRDHLYGKNLPPLSWK---QRL-EISIGSA 590
+ LIG C E S + +++ +M +G L L L K Q L + + A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG----QGHVSTAVKG 646
G+ YL + IHRD+ + N +L ++ V+DFGLSK G QG ++ K
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KM 177
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++ E + T KSDV++FGV + E+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 490 IGVGGFGNVY------LGEIDDGTKVAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
IG G FG V+ L + T VAVK S +FQ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL--------------------YGKNLPPLSWKQR 582
L+G C M L++EYM+ G + L G N PLS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD---APIGQGH 639
L I+ A G+ YL + + +HRD+ + N L+ +N V K++DFGLS++ A +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEV 677
+ A+ ++ PE + T +SDV+++GVVL E+
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 61/199 (30%), Positives = 107/199 (53%), Gaps = 14/199 (7%)
Query: 490 IGVGGFGNVYLGEID-----DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG V L D G +VAVK P+S I + + EI++L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 544 IGYCDEN--SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
G C E+ + + L+ E++ +G +++L +N ++ KQ+L+ ++ +G+ YL G+
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH--VSTAVKGSFGYLDPEYFRRQ 659
Q +HRD+ + N+L++ + K+ DFGL+K + + V + + PE +
Sbjct: 129 Q-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 660 QLTEKSDVYSFGVVLLEVL 678
+ SDV+SFGV L E+L
Sbjct: 188 KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 35/228 (15%)
Query: 490 IGVGGFGNVYLGEIDD------GTKVAVKRGNPQSEQG-ITEFQTEIQMLSKLRHRHLVS 542
+G G FG VY G T+VA+K N + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGK--------NLPPLSWKQRLEISIGSARGLH 594
L+G ++V E M+ G + +L + L P + ++ ++++ A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA-------PIGQGHVSTAVKGS 647
YL A+ +HRD+ + N ++ ++ K+ DFG+++D G+G + V+
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP--VR-- 186
Query: 648 FGYLDPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQV 693
++ PE + T KSDV+SFGVVL E+ L +P L E+V
Sbjct: 187 --WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--QGLSNEEV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 34/214 (15%)
Query: 489 IIGVGGFGNVYLGEI-DDGTKV--AVKR-GNPQSEQGITEFQTEIQMLSKL-RHRHLVSL 543
+IG G FG V I DG ++ A+KR S+ +F E+++L KL H ++++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNL--------------PPLSWKQRLEISIGS 589
+G C+ + L EY +G D L + LS +Q L +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
ARG+ YL + + IHRD+ + NIL+ +NYVAK++DFGLS+ GQ VK + G
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQ---EVYVKKTMG 183
Query: 650 YLDPEYFRRQQL-----TEKSDVYSFGVVLLEVL 678
L + + L T SDV+S+GV+L E++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 490 IGVGGFGNVYLGEI----DDGTK--VAVK-RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG VY G D + VAVK SEQ ++F E ++SK H+++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL-YGKNLP----PLSWKQRLEISIGSARGLHYLH 597
LIG E ++ E M+ G + L + P L+ K L + A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 598 TGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLSKDA------PIGQGHVSTAVKGSF 648
IHRD+ + N LL VAK++DFG+++D G G +K
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-GRAMLPIK--- 186
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEV 677
++ PE F T K+DV+SFGV+L E+
Sbjct: 187 -WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 7/190 (3%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++G + TKVA+K S F E ++ +L+H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRL--YAVV 70
Query: 550 NSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
E I ++ EYM NG D L L+ + ++++ A G+ ++ + IHRD
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 668
+++ NIL+ + K++DFGL++ + K + PE T KSDV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 669 SFGVVLLEVL 678
SFG++L E++
Sbjct: 188 SFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 490 IGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G +G VY G VAVK + + + EF E ++ +++H +LV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
++ E+M+ G D+L N ++ L ++ + + YL + IHRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS---FGYLDPEYFRRQQLTEKS 665
+ + N L+ +N++ KV+DFGLS+ + G TA G+ + PE + + KS
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 666 DVYSFGVVLLEV 677
DV++FGV+L E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 3e-19
Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKR-GNPQSEQGITEFQT---EIQMLSKLRHRHLVSL 543
+G G +G VY + G VA+K+ E+GI T EI +L +L+H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63
Query: 544 IGYCDENSEMILVYEYMSNGPFRD--HLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+ ++ LV+EY D K PLS I RGL Y H +
Sbjct: 64 LDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
I+HRD+K NIL++ + V K++DFGL++
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 34/214 (15%)
Query: 489 IIGVGGFGNVYLGEID-DGTKV--AVKRGNP-QSEQGITEFQTEIQMLSKL-RHRHLVSL 543
+IG G FG V I DG K+ A+K SE +F E+++L KL H ++++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNL--------------PPLSWKQRLEISIGS 589
+G C+ + + EY G D L + L+ +Q L+ +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
A G+ YL + + IHRD+ + N+L+ +N +K++DFGLS+ + VK + G
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV-------YVKKTMG 178
Query: 650 YLDPEYFRRQQL-----TEKSDVYSFGVVLLEVL 678
L + + L T KSDV+SFGV+L E++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-----GNPQSEQGITEFQTEIQMLSKLR 536
N+ ++G G FG VYL + D G ++AVK+ + ++ + + + EIQ+L LR
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 537 HRHLVSLIGYCDENSE--MILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARG 592
H +V G + E + + EYM G +D L YG ++ + +I +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI----LQG 118
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGY 650
+ YLH+ I+HRD+K NIL D K+ DFG SK G +V G+ +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 651 LDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ PE + K+DV+S ++E+L +P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG G +G+VY +I G VA+K + Q EI ML + RH ++V+ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
++ +V EY G +D +Y PLS Q + + +GL YLH G IHRD
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRD 126
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF-G---YLDPEYF---RRQQL 661
+K NILL ++ K++DFG+S A + + A + SF G ++ PE R+
Sbjct: 127 IKGANILLTEDGDVKLADFGVS--AQLTA---TIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 662 TEKSDVYSFGVVLLE 676
K D+++ G+ +E
Sbjct: 182 DGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI- 544
I G +G V+L + G A+K + + + + + TE +LS+ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 545 GYCDENSEMILVYEYMSNGPFRD--HLYGKNLPPLSWKQRL-EISIGSARGLHYLHTGTA 601
+ + + + LV EY+ G G +L + + EI + L YLH +
Sbjct: 61 SFQGKKN-LYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLA----LEYLH---S 111
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSK----DAPIGQGHVSTAVKGSFG---YLDPE 654
GIIHRD+K NIL+D N K++DFGLSK I K G Y+ PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE 691
Q ++ D +S G +L E L P + + P E
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 490 IGVGGFGNVYLGEIDDGTKV-AVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G GGFG V ++ K+ A K+ + + +G E ++L K+ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
+ ++ LV M+ G + H+Y P + + + GL +LH + I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIV 117
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS 665
+RD+K N+LLDD+ ++SD GL+ + G+ G+ GY+ PE + +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 666 DVYSFGVVLLEVLCAR 681
D ++ G L E++ R
Sbjct: 176 DWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-19
Identities = 82/287 (28%), Positives = 129/287 (44%), Gaps = 31/287 (10%)
Query: 489 IIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
+I G G Y G+ I +G + VK N I +EI + KL+H ++V LIG C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEIN--DVNSIPS--SEIADMGKLQHPNIVKLIGLC 752
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPP----LSWKQRLEISIGSARGLHYLHTGTAQG 603
L++EY+ GKNL LSW++R +I+IG A+ L +LH +
Sbjct: 753 RSEKGAYLIHEYIE---------GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
++ ++ I++D + LS + T S Y+ PE + +TE
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC---TDTKCFISSAYVAPETRETKDITE 857
Query: 664 KSDVYSFGVVLLEVLCARPAINPQLPREQVN--LAEWAMQWKRKGLLEKIIDPHLVG--T 719
KSD+Y FG++L+E+L + +P V+ + EWA L+ IDP + G +
Sbjct: 858 KSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQG 766
+N + + A C A RP DVL LE A + + G
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 483 NFDSSAIIGVGGFGNVY-LGEIDDGTKVAVKRGNPQSEQGI--TEFQTEIQMLSKLRHRH 539
+F+ IG G FG V+ + D A+K+ + E E ++L+KL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
++ + ++ +V EY NG L + PL Q I GL +LH+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
+ I+HRD+KS N+ LD K+ D G++K +T V G+ YL PE +
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDK 176
Query: 660 QLTEKSDVYSFGVVLLEVLC 679
EKSDV++ GVVL E C
Sbjct: 177 PYNEKSDVWALGVVLYE-CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 487 SAIIGVGGFGNVYLG----EIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLV 541
IG G FG+VY G ++ VAVK + + E F E ++ + H H+V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
LIG EN + +V E G R +L N L + S + L YL +
Sbjct: 71 KLIGVITENP-VWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+ +HRD+ + N+L+ K+ DFGLS+ + ++ K ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 662 TEKSDVYSFGVVLLEVL 678
T SDV+ FGV + E+L
Sbjct: 186 TSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 11/211 (5%)
Query: 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGI-TEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G FG V+ G + D T VAVK + +F E ++L + H ++V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
+ + +V E + G F L + P L K+ +++ +A G+ YL + + IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHR 118
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG-SFGYLDPEYFRRQQLTEKSD 666
D+ + N L+ + V K+SDFG+S++ G + +K + PE + + +SD
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 667 VYSFGVVLLEVL----CARPAINPQLPREQV 693
V+SFG++L E ++ Q RE +
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 489 IIGVGGFGNVYLGEIDDGTK----VAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVSL 543
+IG G FG V G + K VA+K +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
G ++ +++V EYM NG D K+ + Q + + G A G+ YL + G
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSK---DAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+HRD+ + NIL++ N V KVSDFGLS+ D P + + K + PE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 661 LTEKSDVYSFGVVLLEVL 678
T SDV+S+G+V+ EV+
Sbjct: 186 FTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRHRH 539
+F +G G +G+VY + + D A+K + S++ + EI++L+ + H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 540 LVSLI-GYCDENSEMILVYEYMSNGPFRDHL----YGKNLPP--LSWKQRLEISIGSARG 592
++S + D N + +V EY G + + L P W+ +++ RG
Sbjct: 61 IISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRG 115
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
L LH Q I+HRD+KS NILL N + K+ D G+SK + + +++ G+ Y+
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQIGTPHYMA 169
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARPAIN 685
PE ++ + + KSD++S G +L E+ P
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 40/223 (17%)
Query: 490 IGVGGFGNVYLGEIDDGTK---------------VAVKRGNPQ-SEQGITEFQTEIQMLS 533
+G G FG V+L E + + VAVK ++ +F EI+++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL----------YGKNLPPLSWKQRL 583
+L++ +++ L+G C + + ++ EYM NG L + N+P +S L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-----QG 638
+++ A G+ YL + +HRD+ + N L+ ++Y K++DFG+S++ G QG
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEV--LC 679
++ ++ E + T SDV++FGV L E+ LC
Sbjct: 190 RAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 489 IIGVGGFGNVY------LGEIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKL-RHRHL 540
+G G FG V L + D KVAVK P + E +E++++S L H ++
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
V+L+G C ++++ EY G + L K L+ + L S A+G+ +L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---A 158
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS----FGYLDPEYF 656
++ IHRD+ + N+LL + K+ DFGL++D +V VKG+ ++ PE
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESI 215
Query: 657 RRQQLTEKSDVYSFGVVLLEV 677
T +SDV+S+G++L E+
Sbjct: 216 FNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 59/233 (25%), Positives = 116/233 (49%), Gaps = 36/233 (15%)
Query: 490 IGVGGFGNVYLGEI--------DDGTKVAVKR-GNPQSEQGITEFQTEIQMLSKL-RHRH 539
+G G FG V E D VAVK + +++ + + +E++++ + +H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLP--------------PLSWKQRLEI 585
+++L+G C + + ++ EY + G R+ L + P LS+K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
+ ARG+ YL + + IHRD+ + N+L+ ++ V K++DFGL++ G + K
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192
Query: 646 GSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
S G ++ PE + T +SDV+SFG+++ E+ + P +P E++
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITE-----FQTEIQMLSKLR 536
++ ++G G FG V+L D V +K+ + +T+ Q E Q+L L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE---QMTKDERLAAQNECQVLKLLS 57
Query: 537 HRHLVSLIGYCD---ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGL 593
H ++I Y + E+ +++V EY G +++ + L L + L
Sbjct: 58 HP---NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 594 HYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
H++HT + I+HRD+K+ NILLD + V K+ DFG+SK + + V G+ Y+
Sbjct: 115 HHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYTVVGTPCYIS 169
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVL 678
PE + +KSD+++ G VL E+
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 490 IGVGGFGNVYL---GEIDDGTKVAVKRGNPQSEQGITEF---QTEIQMLSKLRHRHLVSL 543
+G G FG VYL + ++ V + P E E E Q+LSKL H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
E ++ EY L LS Q E I G+HY+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--- 124
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+ I+HRD+K+ NI L +N + K+ DFG+S+ +G ++T G+ Y+ PE + Q
Sbjct: 125 RRILHRDLKAKNIFLKNNLL-KIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 662 TEKSDVYSFGVVLLEVLC 679
KSD++S G +L E+ C
Sbjct: 183 DSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKR------GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
++G G +G VY G + G +AVK+ +E+ + Q E+ +L L+H ++V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
+G C +++ + + E++ G L +G P+ K +I G+ YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNNC 122
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS-----TAVKGSFGYLDPEY 655
++HRD+K N++L N + K+ DFG ++ H + ++ G+ ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARP 682
KSD++S G + E+ +P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHLVSLIGY 546
IG G +G VY + G VA+K+ + E EI++L +L H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
++ LV+E+M + L L +GL + H + GI+H
Sbjct: 67 FRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG----HVSTAVKGSFGYLDPE-YFRRQQL 661
RD+K N+L++ V K++DFGL++ +V T Y PE +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176
Query: 662 TEKSDVYSFGVVLLEVLCARP 682
+ D++S G + E+L RP
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 9/202 (4%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITE---FQTEIQMLSKLRHRH 539
++ IG G FG +YL + ++ V + ++ + E + E+ +L+K++H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V+ EN + +V EY G + + S Q L + + GL ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD- 119
Query: 600 TAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
+ I+HRD+KS NI L N VAK+ DFG+++ T V G+ YL PE +
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQN 176
Query: 659 QQLTEKSDVYSFGVVLLEVLCA 680
+ K+D++S G VL E LC
Sbjct: 177 RPYNNKTDIWSLGCVLYE-LCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 5/189 (2%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++ + TKVAVK P S + F E ++ L+H LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ ++ E+M+ G D L + ++ S A G+ ++ + IHRD+
Sbjct: 73 EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 128
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
++ NIL+ + V K++DFGL++ + K + PE T KSDV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 670 FGVVLLEVL 678
FG++L+E++
Sbjct: 189 FGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 70/248 (28%), Positives = 105/248 (42%), Gaps = 20/248 (8%)
Query: 508 KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG-YCDENSEMI-LVYEYMSNGPF 565
K NP ++ I E+++ + ++V G + DE+S I + EY G
Sbjct: 32 KTITTDPNPDLQKQILR---ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL 88
Query: 566 RDHLYGKNLPP---LSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622
D +Y K + K +I+ +GL YLH+ + IIHRD+K +NILL
Sbjct: 89 -DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQV 144
Query: 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
K+ DFG+S + T SF Y+ PE + + + SDV+S G+ LLEV R
Sbjct: 145 KLCDFGVSGEL--VNSLAGTFTGTSF-YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF 201
Query: 683 AINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVD 742
P+ + E E +P G E K F ++CL
Sbjct: 202 PFPPEGE-PPLGPIELLSYIVNMPNPELKDEPG-NGIKWSEEFKDF---IKQCLEKDPTR 256
Query: 743 RPTMGDVL 750
RPT D+L
Sbjct: 257 RPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGN-PQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IGVG VY + + KVA+KR + + + + E + E+Q +S+ H ++V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 548 DENSEMILVYEYMSNGPFRD---HLYGKNLPPLSWKQRLEISI-----GSARGLHYLHTG 599
E+ LV Y+S G D Y + E I +GL YLH+
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-------EAIIATVLKEVLKGLEYLHS- 120
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK---DAPIGQGHVSTAVKGSFGYLDPEYF 656
G IHRD+K+ NILL ++ K++DFG+S D V G+ ++ PE
Sbjct: 121 --NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 657 RRQQ-LTEKSDVYSFGVVLLE 676
+ K+D++SFG+ +E
Sbjct: 179 EQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 490 IGVGGFGNVYLG-------EIDDGTKVAVKRGNPQSEQGIT-EFQTEIQMLSKLRHRHLV 541
+G G FG V G +ID VA+K ++E+ + E E +++ +L + ++V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID----VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+IG C+ + M LV E S GP L GK ++ +E+ + G+ YL
Sbjct: 59 RMIGVCEAEALM-LVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---G 113
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH--VSTAVKGSFGYLDPEYFRRQ 659
+ +HRD+ + N+LL + + AK+SDFGLSK + +A K + PE +
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 660 QLTEKSDVYSFGVVLLEVL 678
+ + +SDV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 7/196 (3%)
Query: 489 IIGVGGFGNVYL-GEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIG 545
++G G FG L +D + V K N SE+ + EI +LS L+H ++++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
+ +++ +++ EY + G D + + + L + Y+H GI+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGIL 123
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS 665
HRD+K+ NI L + K+ DFG+SK T V G+ Y+ PE + + KS
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFKS 182
Query: 666 DVYSFGVVLLEVLCAR 681
D+++ G VL E+L +
Sbjct: 183 DIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
++G G +G VY ++ ++A+K + + + EI + S L+HR++V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 548 DENSEMILVYEYMSNGPFRDHLYGK------NLPPLSW--KQRLEISIGSARGLHYLHTG 599
EN + E + G L K N + + KQ LE GL YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-------GLKYLHD- 126
Query: 600 TAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
I+HRD+K N+L++ + V K+SDFG SK G + G+ Y+ PE +
Sbjct: 127 --NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDK 183
Query: 659 QQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716
+D++S G ++E+ +P P ++ + AM + G+ + I P +
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKP------PFIELGEPQAAM--FKVGMFK--IHPEI 233
Query: 717 VGTINPESLKKFAEA-AEKCLADHGVDRPTMGDVL 750
PESL A+ +C R + D+L
Sbjct: 234 -----PESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 48/245 (19%)
Query: 490 IGVGGFGNVYLGEIDDGTKVA-------VKRGNP-----------QSEQGITEFQTEIQM 531
+G G FG V+L E+ + + V++G P ++ +F E+++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 532 LSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNL----------------- 574
LS+L+ +++ L+G C + + ++ EYM NG L +L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 575 PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634
P +S+ L +++ A G+ YL + +HRD+ + N L+ +N K++DFG+S++
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 635 IG-----QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL-CARPAINPQL 688
G QG ++ ++ E + T SDV++FGV L E+L + +L
Sbjct: 190 AGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 689 PREQV 693
EQV
Sbjct: 246 TDEQV 250
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 36/243 (14%)
Query: 490 IGVGGFGNVYLG------EIDDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG VY G + + T+VA+K N S + EF E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLY----------GKNLPPLSWKQRLEISIGSARG 592
L+G + +++ E M+ G + +L + P L K+ ++++ A G
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL--KKMIQMAGEIADG 131
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG--- 649
+ YL+ A +HRD+ + N ++ +++ K+ DFG+++D KG G
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYRKGGKGLLP 184
Query: 650 --YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707
++ PE + T SDV+SFGVVL E+ + EQV + M+ GL
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV--LRFVME---GGL 239
Query: 708 LEK 710
L+K
Sbjct: 240 LDK 242
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 489 IIGVGGFGNVYLGEIDDGTK----VAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+IG G FG V G + K VA+K + +E+ +F +E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
G ++ ++++ E+M NG D +N + Q + + G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSK---DAPIGQGHVST-AVKGSFGYLDPEYFRRQ 659
+HRD+ + NIL++ N V KVSDFGLS+ D + S+ K + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 660 QLTEKSDVYSFGVVLLEVL 678
+ T SDV+S+G+V+ EV+
Sbjct: 187 KFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 34/214 (15%)
Query: 489 IIGVGGFGNVYLGEID-DGTKV--AVKR-GNPQSEQGITEFQTEIQMLSKL-RHRHLVSL 543
+IG G FG V I DG ++ A+KR S+ +F E+++L KL H ++++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNL--------------PPLSWKQRLEISIGS 589
+G C+ + L EY +G D L + LS +Q L +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
ARG+ YL + + IHRD+ + NIL+ +NYVAK++DFGLS+ + VK + G
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 171
Query: 650 YLDPEYFRRQQL-----TEKSDVYSFGVVLLEVL 678
L + + L T SDV+S+GV+L E++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 80/286 (27%), Positives = 123/286 (43%), Gaps = 52/286 (18%)
Query: 490 IGVGGFGNVYLG---------EIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRH 539
+G G F N+Y G + G +V+V S+ + F ++S+L H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 540 LVSLIGYC--DENSEMILVYEYMSNGPFRDHLY-GKNLPPLSWKQRLEISIGSARGLHYL 596
LV L G C DEN I+V EY+ GP L+ KN L WK L+++ A LHYL
Sbjct: 63 LVKLYGVCVRDEN---IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYL 117
Query: 597 HTGTAQGIIHRDVKSTNILL-----DDNYV--AKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
+ ++H +V NIL+ ++ YV K+SD G+ PI V+
Sbjct: 118 ED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVERI-P 169
Query: 650 YLDPEYFRRQQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707
++ PE R Q LT +D +SFG LLE+ N + P ++ +E ++ +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEPLSTLSSSEKERFYQDQHR 224
Query: 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753
L L IN +C RP+ +L +L
Sbjct: 225 LPMPDCAELANLIN------------QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 490 IGVGGFGNVYLGEIDD------GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG VY G D T+VAVK N S + EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYG--------KNLPPLSWKQRLEISIGSARGLH 594
L+G + ++V E M++G + +L PP + ++ ++++ A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG----- 649
YL+ A+ +HRD+ + N ++ ++ K+ DFG+++D KG G
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY----ETDYYRKGGKGLLPVR 186
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
++ PE + T SD++SFGVVL E+ L EQV
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 490 IGVGGFGNVYLGEIDDGTK--VAVKRGN-PQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG V+ G ID+ T+ VA+K + ++E I + Q EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ +++ ++ EY+ G D L P Q + +GL YLH+ + IH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS---EKKIH 124
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+K+ N+LL + K++DFG++ Q +T V F ++ PE ++ K+D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKAD 183
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLK 726
++S G+ +E+ P + P + L+ K P L G E K
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLF------------LIPKNNPPTLTG----EFSK 227
Query: 727 KFAEAAEKCLADHGVDRPTMGDVL 750
F E + CL RPT ++L
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 64/253 (25%), Positives = 117/253 (46%), Gaps = 27/253 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
D+ IG G G V + + G +VAVK+ + + +Q E+ ++ +H ++V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+ E+ +V E++ G D + + + +Q + + + L +LH A
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRM---NEEQIATVCLAVLKALSFLH---A 133
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
QG+IHRD+KS +ILL + K+SDFG +SK+ P + V T ++ PE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-----WMAPEVIS 188
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717
R + D++S G++++E++ P + P + AM+ R L K+ + H V
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDNLPPKLKNLHKV 241
Query: 718 GTINPESLKKFAE 730
L+ F +
Sbjct: 242 SPR----LRSFLD 250
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-16
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 20/195 (10%)
Query: 504 DDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI--GYCDENSEMILVYE 558
G +VA+K P+ E F+ E + ++L H ++V+L+ G + V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL-- 616
Y+ R+ L P RL + + L L QGI+HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQV-----LDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 617 -DDNYVAKVSDFGLS------KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
AKV DFG+ +DA + +T V G+ Y PE R + +T SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 670 FGVVLLEVLCARPAI 684
+G++ LE L + +
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 490 IGVGGFGNVYL-GEIDDGTKVAVKR-GNPQSEQGI-TEFQTEIQMLSKLRHRHLVSLIGY 546
IG G G V+ + + G VA+K+ + E GI + EI+ L +H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 547 CDENSEMILVYEYMSNGPFRDHLYG--KNLP-PLSWKQRLEISIGSARGLHYLHTGTAQG 603
S +LV EYM + L ++ PL Q +G+ Y+H A G
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANG 119
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE-YFRRQQLT 662
I+HRD+K N+L+ + V K++DFGL++ + + + + Y PE + ++
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 663 EKSDVYSFGVVLLEVLCARP 682
D+++ G + E+L P
Sbjct: 180 PGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 49/239 (20%)
Query: 489 IIGVGGFGNV------YLGEIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRH 539
+G G FG V L T VAVK SE + + +E +L ++ H H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPH 64
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHL----------------------YGKNLPPL 577
++ L G C ++ ++L+ EY G R L + L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 578 SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK-----D 632
+ + + +RG+ YL ++HRD+ + N+L+ + K+SDFGLS+ D
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC----ARPAINPQ 687
+ + + VK ++ E T +SDV+SFGV+L E++ P I P+
Sbjct: 182 SYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 27/264 (10%)
Query: 490 IGVGGFGNVYLGEIDDGTK--VAVKRGN-PQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG V+ G ID+ T+ VA+K + ++E I + Q EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+++++ ++ EY+ G D L PL Q I +GL YLH+ + IH
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS---EKKIH 124
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+K+ N+LL ++ K++DFG++ Q +T V F ++ PE ++ K+D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKAD 183
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLK 726
++S G+ +E+ P P +++ K L+ K P L G + + LK
Sbjct: 184 IWSLGITAIELAKGEP------PHSELH------PMKVLFLIPKNNPPTLEGNYS-KPLK 230
Query: 727 KFAEAAEKCLADHGVDRPTMGDVL 750
+F EA CL RPT ++L
Sbjct: 231 EFVEA---CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 76/236 (32%), Positives = 107/236 (45%), Gaps = 26/236 (11%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQ---TEIQMLSKLRH 537
K+F +G GG+G V+L + D G VA+KR + E + TE +L+ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ-RLEIS--IGSARGLH 594
LV L+ ++ + L EY+ G FR L NL LS R ++ + LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA--VKGSFGYLD 652
L G IHRD+K N L+D + K++DFGLSK G V+ A V GS Y+
Sbjct: 119 EL------GYIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPDYMA 166
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ-VNLAEW--AMQWKRK 705
PE R + D +S G +L E LC P + P E NL W +Q
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKR---GNPQSEQGITEFQTEIQMLSKLRHRH 539
F ++G GGFG V ++ G A KR + +G + E Q+L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V+L + + LV M+ G + H+Y P ++ L + GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR- 120
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
+ ++RD+K NILLDD ++SD GL+ P +G G+ GY+ PE Q
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRVGTVGYMAPEVLNNQ 176
Query: 660 QLTEKSDVYSFGVVLLEVL 678
+ T D + G ++ E++
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 76/264 (28%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 490 IGVGGFGNVYLGEIDDGTK--VAVKRGN-PQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG VY G ID+ TK VA+K + ++E I + Q EI +LS+ ++ G
Sbjct: 12 IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ +++ ++ EY+ G D L PL I +GL YLH+ + IH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHS---ERKIH 124
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+K+ N+LL + K++DFG++ Q +T V F ++ PE ++ K+D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDFKAD 183
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLK 726
++S G+ +E+ P + P + L+ K P L G + K
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLF------------LIPKNSPPTLEG----QYSK 227
Query: 727 KFAEAAEKCLADHGVDRPTMGDVL 750
F E E CL RPT ++L
Sbjct: 228 PFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 490 IGVGGFGNVYLGEIDDGTKV-AVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G GGFG V ++ K+ A K+ N + +G E ++L+K+ R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+++ LV M+ G R H+Y + P + + GL +LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
II+RD+K N+LLD++ ++SD GL+ + GQ + G+ G++ PE + ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDF 176
Query: 664 KSDVYSFGVVLLEVLCAR 681
D ++ GV L E++ AR
Sbjct: 177 SVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI-GYC 547
+G G FG VY + + G A K +SE+ + +F EI +LS+ +H ++V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
EN IL+ E+ G D + + L+ Q + L++LH + +IHR
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127
Query: 608 DVKSTNILLDDNYVAKVSDFGLS-KDAPIGQGHVSTAVKGSFGYLDPEY-----FRRQQL 661
D+K+ NILL + K++DFG+S K+ Q T + G+ ++ PE F+
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 662 TEKSDVYSFGVVLLEVLCARP---AINP 686
K+D++S G+ L+E+ P +NP
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKR----GNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
+G G G V G +AVK N ++ I E+ +L K ++V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSPYIVGFY 65
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
G N ++ + EYM G D + + + + +I++ +GL YLH I
Sbjct: 66 GAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKD--APIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
IHRDVK +NIL++ K+ DFG+S + + V T+ Y+ PE + +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS-----YMAPERIQGNDYS 177
Query: 663 EKSDVYSFGVVLLEV 677
KSD++S G+ L+E+
Sbjct: 178 VKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 470 RYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTK----VAVK----RGNPQSEQ 520
R EL++ ++G G FG V+ G I +G VA+K R Q+ Q
Sbjct: 2 RILKETELRKLK-------LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54
Query: 521 GITEFQTEIQMLS--KLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS 578
IT+ ML+ L H ++V L+G C + + LV + G DH+ ++ L
Sbjct: 55 EITD-----HMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLD 107
Query: 579 WKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA-PIGQ 637
++ L + A+G++YL ++HR++ + NILL + + +++DFG++ P +
Sbjct: 108 PQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
+ + K ++ E + T +SDV+S+GV + E++
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 528 EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISI 587
E+Q++ + R ++VS G + + + E+M G D +Y K P+ + +I++
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIY-KKGGPIPVEILGKIAV 110
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA--PIGQGHVSTAVK 645
GL YL+ I+HRD+K +NIL++ K+ DFG+S + I V T+
Sbjct: 111 AVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST- 167
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR-P-AINPQLPREQVNLAEWAMQWK 703
Y+ PE + + T KSDV+S G+ ++E+ + P A + Q +
Sbjct: 168 ----YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD------PMG 217
Query: 704 RKGLLEKIID---PHLVGTINPESLKKFAEAAEKCLADHGVDRPT 745
LL++I+ P L + PE L+ F + CL +RPT
Sbjct: 218 ILDLLQQIVQEPPPRLPSSDFPEDLRDF---VDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 23/242 (9%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
DS IG G G V + E G +VAVK+ + + +Q E+ ++ H ++V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
+ E+ +V E++ G D + + + +Q + + R L YLH Q
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRM---NEEQIATVCLSVLRALSYLHN---Q 137
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
G+IHRD+KS +ILL + K+SDFG +SK+ P + V T ++ PE R
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY-----WMAPEVISR 192
Query: 659 QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718
+ D++S G++++E++ P + P + AM+ R L ++ D H V
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIRDNLPPRVKDSHKVS 245
Query: 719 TI 720
++
Sbjct: 246 SV 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 76/307 (24%), Positives = 132/307 (42%), Gaps = 58/307 (18%)
Query: 490 IGVGGFGNVYLGEI-----------------DDGTKVAVKRGNPQSEQGI-TEFQTEIQM 531
+G G FG V+L E + VAVK + + +F EI++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 532 LSKLRHRHLVSLIGYCDENSEMILVYEYMSNG---------PFRDHLYGKNLPPLSWKQR 582
+S+L+ +++ L+ C + + ++ EYM NG ++ ++ +S+
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-----Q 637
+ ++ A G+ YL ++ +HRD+ + N L+ NY K++DFG+S++ G Q
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQV--N 694
G ++ ++ E + T SDV++FGV L E+L + QL EQV N
Sbjct: 190 GRAVLPIR----WMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245
Query: 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
E+ R+ L K P L P+SL K + C + +RP+ E
Sbjct: 246 TGEFFRDQGRQVYLPK---PALC----PDSLYKLMLS---CWRRNAKERPSF------QE 289
Query: 755 YALQLQE 761
L E
Sbjct: 290 IHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 68/257 (26%), Positives = 114/257 (44%), Gaps = 32/257 (12%)
Query: 484 FDSSAIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
F ++G GGFG V ++ K+ +++ + +G + E Q+L K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+VSL + + LV M+ G + H+Y + + + GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ- 120
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ---GHVSTAVKGSFGYLDPEYF 656
+ I++RD+K NILLDD+ ++SD GL+ P GQ G V G+ GY+ PE
Sbjct: 121 --ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMAPEVV 173
Query: 657 RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716
+ ++ T D ++ G +L E+ I Q P +Q RK +++ L
Sbjct: 174 KNERYTFSPDWWALGCLLYEM------IAGQSPFQQ-----------RKKKIKREEVERL 216
Query: 717 VGTINPESLKKFAEAAE 733
V + E +KF+ A
Sbjct: 217 VKEVQEEYSEKFSPDAR 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 477 LQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL 535
L + T F+ +IG G +G VY G VA+K + ++ E + E +L K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 536 -RHRHLVSLIG------YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE---- 584
H ++ + G + ++ LV E G D + K L +RL+
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV--KGL--RKKGKRLKEEWI 115
Query: 585 --ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHV 640
I + RGL YLH +IHRD+K NILL N K+ DFG+S D+ +G+ +
Sbjct: 116 AYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 641 STAVKGSFGYLDPE-----YFRRQQLTEKSDVYSFGVVLLE 676
G+ ++ PE +SDV+S G+ +E
Sbjct: 173 FI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL 540
++F+ IG G +G+VY ++ G A+K + + Q EI M+ +H ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRD--HLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
V+ G ++ + E+ G +D H+ G PLS Q +S + +GL+YLH+
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS 124
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF----GYLDPE 654
+G +HRD+K NILL DN K++DFG+S Q + A + SF ++ PE
Sbjct: 125 ---KGKMHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFIGTPYWMAPE 176
Query: 655 YF---RRQQLTEKSDVYSFGVVLLEVLCARPAI 684
R+ + D+++ G+ +E+ +P +
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 54/262 (20%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNP----QSEQGITEFQTEIQMLSKLR 536
+F+ +IG G FG V+L + D G A+K + Q I + E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
+V L + + LV EYM G + L K++ P + + A L +
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA--LDSV 117
Query: 597 HTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVK---------- 645
H G IHRD+K NIL+D D ++ K++DFGL K + +
Sbjct: 118 HK---LGFIHRDIKPDNILIDADGHI-KLADFGLCKK--MNKAKDREYYLNDSHNLLFRD 171
Query: 646 --------------------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP--- 682
G+ Y+ PE R + D +S GV+L E+L P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231
Query: 683 AINPQLPREQVNLAEWAMQWKR 704
+ Q ++ + WK
Sbjct: 232 SDTLQETYNKI------INWKE 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 489 IIGVGGFGNVYLGEIDDGTK----VAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
I+G G FG + G + +K VA+ R +Q F E L + H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L G + M++V EYMSNG D K+ L Q + + G A G+ YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
G +H+ + + +L++ + V K+S F ++ + + + K + PE + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 663 EKSDVYSFGVVLLEVL 678
SDV+SFG+V+ EV+
Sbjct: 187 SASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 488 AIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVS 542
++G G FG V L E+ ++ +K+ + + TE ++L+ +H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
L + V EY++ G H+ G+ P + EI +G L +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHE-- 114
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+GII+RD+K N+LLD K++DFG+ K+ I G ++ G+ Y+ PE Q
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG-ILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 661 LTEKSDVYSFGVVLLEVLCARP 682
D ++ GV+L E+L +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 56/242 (23%), Positives = 107/242 (44%), Gaps = 35/242 (14%)
Query: 522 ITEFQTEIQMLSKLRHRHLVSLIGY----CDENSEMILVYEYMSNGPFRDHLYGKNLPPL 577
I + EI+ L ++ +++ + G+ D+ + L+ EY + G R+ L L
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDL 119
Query: 578 SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637
S+K +L+++I +GL+ L+ T ++++ S + L+ +NY K+ GL K
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177
Query: 638 -GHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVN 694
+V+ V Y + + T K D+YS GVVL E+ + +P E +
Sbjct: 178 FKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK------IPFENLT 226
Query: 695 LAE-WAMQWKRKGLLEKIID-PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752
E + + + L+ +D P + I E C + + RP + ++L+N
Sbjct: 227 TKEIYDLIINKNNSLKLPLDCPLEIKCI-----------VEACTSHDSIKRPNIKEILYN 275
Query: 753 LE 754
L
Sbjct: 276 LS 277
|
Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-14
Identities = 51/174 (29%), Positives = 76/174 (43%), Gaps = 60/174 (34%)
Query: 489 IIGVGGFGNVYLGEID--DGTKVAVKR-GNPQSEQGITEFQT---------EIQMLSKLR 536
IG G +G V +D G KVA+K+ N F EI++L LR
Sbjct: 7 PIGSGAYGVVCSA-VDKRTGRKVAIKKISNV--------FDDLIDAKRILREIKLLRHLR 57
Query: 537 HRHLVSLI-----GYCDENSEMILVYEYM---------SNGPFR-DH----LYGKNLPPL 577
H +++ L+ ++ +++ +V E M S P DH LY
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY------- 110
Query: 578 SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
Q L RGL YLH+ +IHRD+K +NIL++ N K+ DFGL++
Sbjct: 111 ---QIL-------RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKR---GNPQSEQ-GI--TEFQTEIQMLSKLRHRHLVS 542
+G G + VY + G VA+K+ G + + GI T + EI++L +L+H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 543 LIGYCDENSEMILVYEYMSN---GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
L+ S + LV+E+M +D K++ L+ + + RGL YLH
Sbjct: 67 LLDVFGHKSNINLVFEFMETDLEKVIKD----KSIV-LTPADIKSYMLMTLRGLEYLH-- 119
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE-YFRR 658
+ I+HRD+K N+L+ + V K++DFGL++ ++ V + Y PE F
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-YRAPELLFGA 177
Query: 659 QQLTEKSDVYSFGVVLLEVLCARP 682
+ D++S G + E+L P
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 48/216 (22%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT--------EIQMLSKL-RHRH 539
+G G FG+VYL + G VA+K+ +F + E++ L KL H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYG----KNLPPLSWKQRLEISIGS-----A 590
+V L EN E+ V+EYM +LY + P S E I S
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG-----NLYQLMKDRKGKPFS-----ESVIRSIIYQIL 109
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK---DAPIGQGHVSTAVKGS 647
+GL ++H G HRD+K N+L+ V K++DFGL++ P +VST
Sbjct: 110 QGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR---- 162
Query: 648 FGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARP 682
Y PE R + D+++ G ++ E+ RP
Sbjct: 163 -WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 73/271 (26%), Positives = 109/271 (40%), Gaps = 72/271 (26%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQG---ITEFQTEIQMLSKLRHRHLVSLIG 545
+G G FG VY +I G VA+K+ +E+ IT + EI++L KL+H ++V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLI- 73
Query: 546 YCDENSEMILVYE----------YMSNGPFRDH-LYGK------NLPP----LSWKQRLE 584
+M + YM P+ DH L G L Q LE
Sbjct: 74 ------DMAVERPDKSKRKRGSVYMVT-PYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL----------SKDAP 634
G++YLH I+HRD+K+ NIL+D+ + K++DFGL K
Sbjct: 127 -------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 635 IGQGHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
G T + + Y PE ++ T D++ G V E+ RP + + +Q
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ- 235
Query: 694 NLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724
L I L GT E+
Sbjct: 236 --------------LHLIFK--LCGTPTEET 250
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 496 GNVYLGEIDDGTKVAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554
G++YL +D VA+K + + Q EFQ E ++++L H ++V L+G + +
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 555 LVYEYMSNGPFRDHLY---------------GKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+++EY++ G + L G L L I+I A G+ YL
Sbjct: 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL--- 140
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRR 658
++ +H+D+ + NIL+ + K+SD GLS++ + V ++ PE
Sbjct: 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200
Query: 659 QQLTEKSDVYSFGVVLLEVL 678
+ + SD++SFGVVL E+
Sbjct: 201 GKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 476 ELQEATKN-FDSSAIIGVGGFGNVYLGE-IDDGTKVAVKR----GNPQSEQGITEFQTEI 529
+ A N ++ IG G G VY G +AVK+ GN + + I ++
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL-MDLDV 66
Query: 530 QMLSKLRHR--HLVSLIGYCDENSEMILVYEYMS----------NGPFRDHLYGKNLPPL 577
+ S H ++V GY +S++ + E MS GP + + GK
Sbjct: 67 VLKS---HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK----- 118
Query: 578 SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637
+ ++I A LHYL G+IHRDVK +NILLD + K+ DFG+S +
Sbjct: 119 -----MTVAIVKA--LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169
Query: 638 GHVSTAVKGSFGYLDPEYFRRQQLTEK----SDVYSFGVVLLE 676
+A G Y+ PE K +DV+S G+ L+E
Sbjct: 170 AKTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 490 IGVGGFGNVYLGEI---DDGTKVAVKRGN----PQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG+V G++ D KVAVK +SE + +F +E + + H +++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMR 64
Query: 543 LIGYCDENSEM------ILVYEYMSNGPFRDHLYGKNL--PPLSWKQRLEISIGS--ARG 592
LIG C + E +++ +M +G L L P ++ + + A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG----QGHVSTAVKGSF 648
+ YL + + IHRD+ + N +L++N V+DFGLSK G QG ++ K
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA---KMPV 178
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708
++ E + T KSDV+SFGV + E+ A Q P V +E + R+G
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEI-----ATRGQTPYPGVENSE-IYDYLRQG-- 230
Query: 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757
++ P P+ L C + DRP+ + LE AL
Sbjct: 231 NRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 490 IGVGGFGNVYL-GEIDDGTKVAVKRGNPQS--EQGITE-FQTEIQMLSKLRHRHLVSLIG 545
+GVGGFG V L A+K + E G E +E ++L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEI-SIGSARGLHYLHTGTAQGI 604
+ + ++ EY G L + L + R I + A YLH +GI
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIACVVLA--FEYLH---NRGI 114
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
I+RD+K N+LLD N K+ DFG +K + G + G+ Y+ PE +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKK--LKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 665 SDVYSFGVVLLEVLCARP 682
D +S G++L E+L RP
Sbjct: 173 VDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG G G VY ++ G +VA+K+ N Q + EI ++ + +H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA-----RGLHYLHTGTAQG 603
E+ +V EY++ G D ++ E I + + L +LH +
Sbjct: 87 VGDELWVVMEYLAGGSLTD--------VVTETCMDEGQIAAVCRECLQALEFLH---SNQ 135
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
+IHRD+KS NILL + K++DFG Q ST V G+ ++ PE R+
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 664 KSDVYSFGVVLLEVLCARP 682
K D++S G++ +E++ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-14
Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 64/246 (26%)
Query: 475 QELQEATKNFDSSAIIGVGGFGNV-YLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQM 531
+E K + S ++G G G V + DG AVK + + SE Q E+
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 532 L------SKLR-HRHLVSLIGYCDENSE-----MILVYEYMSNG--------------PF 565
L S ++ H D + + LV +Y + G F
Sbjct: 85 LLNCDFFSIVKCHEDFA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF 140
Query: 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625
R+H G L + Q L +H++H+ + +IHRD+KS NILL N + K+
Sbjct: 141 REHEAG-----LLFIQVL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185
Query: 626 DFGLSKDAPIGQGHVSTAVKGSFG--------YLDPEYFRRQQLTEKSDVYSFGVVLLEV 677
DFG SK + V G Y+ PE +RR+ ++K+D++S GV+L E+
Sbjct: 186 DFGFSK-------MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYEL 238
Query: 678 LC-ARP 682
L RP
Sbjct: 239 LTLKRP 244
|
Length = 496 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 474 FQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQ---TEI 529
F +L+E IG G FG VY ++ VA+K+ + +Q ++Q E+
Sbjct: 17 FTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 530 QMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISI 587
+ L +LRH + + G LV EY G D L + K L Q +EI+
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPL------QEVEIAA 119
Query: 588 ---GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
G+ +GL YLH+ IHRD+K+ NILL + K++DFG + V T
Sbjct: 120 ICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPY 176
Query: 645 KGSFGYLDPEY---FRRQQLTEKSDVYSFGVVLLEVLCARP 682
++ PE Q K DV+S G+ +E+ +P
Sbjct: 177 -----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKV-AVKRGNP-------QSEQGITEFQTEIQMLS 533
+F+ +G G FG V L K A+K + Q E + E ++L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE----KRILQ 56
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGL 593
+RH LV+L G ++S + LV EY+ G HL P + + A L
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA--L 114
Query: 594 HYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
YLH+ I++RD+K N+LLD D Y+ K++DFG +K G T G+ YL
Sbjct: 115 EYLHS---LDIVYRDLKPENLLLDSDGYI-KITDFGFAKRVK---GRTYTLC-GTPEYLA 166
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
PE + + D ++ G+++ E+L P
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 483 NFDSSAIIGVGGFGNVYL----GEIDDGT----KVAVKRGNPQSEQGITEFQTEIQMLSK 534
NF+ ++G G +G V+L G D G KV K Q + +TE Q+L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 535 LRHR-HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS-ARG 592
+R LV+L ++++ L+ +Y++ G HLY + S + + I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLA 117
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
L +LH GII+RD+K NILLD ++DFGLSK+ + + + G+ Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 653 PEYFRRQQLTEKS--DVYSFGVVLLEVL 678
PE R D +S GV+ E+L
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 49/162 (30%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGN-PQSEQGITEFQT-EIQMLSKLR---H 537
++ A IG G +G VY +++ G VA+K+ P SE+GI EI +L +L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 538 RHLVSLIGYC-----DENSEMILVYEYMSNGPFRD-HLYGKNLPP--LSWKQRLEISIGS 589
++V L+ C D ++ LV+E++ +D Y P L + ++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
RG+ +LH+ I+HRD+K NIL+ + K++DFGL++
Sbjct: 117 LRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 490 IGVGGFGNVYLG--EIDDGTK-VAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
+G G FG V G ++ K VAVK + + E E ++ +L + ++V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
G C+ S M LV E GP L KN ++ K E+ + G+ YL
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFL-QKN-KHVTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRRQQLT 662
+HRD+ + N+LL + AK+SDFGLSK + + G + + PE + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 663 EKSDVYSFGVVLLE 676
KSDV+SFGV++ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
++ IG G G V + E G +VAVK + + +Q E+ ++ +H+++V
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
+ E+ ++ E++ G D + L + +Q + + L YLH +Q
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQTRL---NEEQIATVCESVLQALCYLH---SQ 136
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
G+IHRD+KS +ILL + K+SDFG +SKD P + V T ++ PE R
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-----WMAPEVISR 191
Query: 659 QQLTEKSDVYSFGVVLLEVLCARP 682
+ D++S G++++E++ P
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 490 IGVGGFGNV------YLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G GGFG V G++ K+ KR +S + + + EI L K+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+ + + LV M+ G + H+Y L ++ + S G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
I++RD+K N+LLDD ++SD GL+ + G T G+ GY+ PE + + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 664 KSDVYSFGVVLLEVLCAR 681
D ++ G + E++ R
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 484 FDSSAIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
F ++G GGFG V ++ K+ +++ + +G E ++L K+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 540 LVSLIGYCDENSE-MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
+VSL Y E + + LV M+ G + H+Y P ++ + + GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ---GHVSTAVKGSFGYLDPEY 655
+ I++RD+K NILLDD ++SD GL+ P G+ G V G+ GY+ PE
Sbjct: 121 ---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-----GTVGYMAPEV 172
Query: 656 FRRQQLTEKSDVYSFGVVLLEVL 678
++ T D + G ++ E++
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 488 AIIGVGGFGNVYLGEIDDGTKV-AVKRGNPQSEQGITEFQTEIQMLSK------LRHRHL 540
++G G FG V L E+ + A+K + + + + E M+ + H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIK--ALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 541 VSLIGYC--DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR------- 591
L +C + V EY++ G H+ + AR
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGGDLMFHI----------QSSGRFDEARARFYAAEII 106
Query: 592 -GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY 650
GL +LH +GII+RD+K N+LLD + K++DFG+ K+ G+G ST G+ Y
Sbjct: 107 CGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDY 162
Query: 651 LDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
+ PE + Q+ E D +SFGV+L E+L
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 82/289 (28%), Positives = 128/289 (44%), Gaps = 65/289 (22%)
Query: 490 IGVGGFGNVY-LGEIDDGTKVAVKRGNPQSEQGITEFQT---EIQMLSKLRHRHLVSLI- 544
IG G FG V+ + + DG +VA+K+ P Q + + E++ML +H +++S +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 545 ----GYCDENSEMILVYEYM---------SNGPFR-DH----LYGKNLPPLSWKQRLEIS 586
+ D E+ +V E M S P DH LY Q L
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLY----------QIL--- 113
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS-KDAPIGQGHVSTAVK 645
RGL YLH+ GI+HRD+K N+L++ N V K+ DFGL+ + P H++ V
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 646 GSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704
+ Y PE + T D++S G + E+L R Q P +Q++L
Sbjct: 167 TQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL--------- 216
Query: 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753
I D L+GT + E+++ E A + G +P VL+ L
Sbjct: 217 ------ITD--LLGTPSLEAMRSACEGARAHIL-RGPHKPPSLPVLYTL 256
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 490 IGVGGFGNVY-------------LGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSK-L 535
+G G FG VY L EI+ A + + ++ I + +E+ ++ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEIN-VHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 536 RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLY-----GKNLPPLS-WKQRLEISIGS 589
RH ++V EN + +V + + P +H + W +++ +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
L YLH + I+HRD+ NI+L ++ ++DFGL+K T+V G+
Sbjct: 126 ---LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK--QPESKLTSVVGTIL 178
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Y PE + + EK+DV++FG +L ++ +P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 489 IIGVGGFGNVYLGEID-DGTKVAVKR---GNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
++G GGFG V ++ G A K+ + +G E Q+L K+ R +VSL
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ + LV M+ G + H+Y P ++ + + GL LH + I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERI 123
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ---GHVSTAVKGSFGYLDPEYFRRQQL 661
++RD+K NILLDD ++SD GL+ + P G+ G V G+ GY+ PE + ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-----GTVGYMAPEVVKNERY 178
Query: 662 TEKSDVYSFGVVLLEVL 678
T D + G ++ E++
Sbjct: 179 TFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 7/197 (3%)
Query: 490 IGVGGFGNVYL-GEIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG L +DG + +K N S + E + E+ +LS ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+EN + +V +Y G + + Q L+ + L ++H + I+H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILH 124
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+KS NI L + K+ DFG+++ T + G+ YL PE + KSD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSD 183
Query: 667 VYSFGVVLLEVLCARPA 683
+++ G VL E+ + A
Sbjct: 184 IWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 8/205 (3%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH 537
+ K + IG G G V+ ++ G +VA+K+ N Q + EI ++ +L++
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN 75
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
++V+ + E+ +V EY++ G D + + Q + + L +LH
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE---AQIAAVCRECLQALEFLH 132
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
A +IHRD+KS N+LL + K++DFG Q ST V G+ ++ PE
Sbjct: 133 ---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
R+ K D++S G++ +E++ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 69/268 (25%), Positives = 118/268 (44%), Gaps = 28/268 (10%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQG-ITEFQTEIQMLSKLRHRHLVSLIGY 546
+IG G +G VY G + G VA+K N + +++ Q E+ +LS+LR ++ Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 547 CD---ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+ + ++ EY G R + P++ K I L Y+H G
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VG 121
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLT 662
+IHRD+K+ NIL+ + K+ DFG++ ST V G+ ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 663 EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722
K+D++S G+ + E+ P P V+ AM L+ K P L
Sbjct: 181 TKADIWSLGITIYEMATGNP------PYSDVDAFR-AMM-----LIPKSKPPRLEDNGYS 228
Query: 723 ESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ L++F A CL + +R + ++L
Sbjct: 229 KLLREFVAA---CLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 34/227 (14%)
Query: 490 IGVGGFGNVYLGEIDDGTKVA---VKR----GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
IG G FG V LGE G A VK P EQ F E+Q +L H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-EQ--LLFLQEVQPYRELNHPNVLQ 59
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYG-----KNLPPLSWKQRLEISIGSARGLHYLH 597
+G C E+ +LV E+ G +++L + QR+ + A GL +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLH 117
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG--YLDPEY 655
IH D+ N L + K+ D+GL+ + + + T + +L PE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ-YPEDYYITKDCHAVPLRWLAPEL 173
Query: 656 F--RRQQL-----TEKSDVYSFGVVLLEV--LCARPAINPQLPREQV 693
R Q L T+KS+++S GV + E+ +P P L EQV
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 489 IIGVGGFGNVYLGEIDDGT--------KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL 540
++G GG+G V+ G KV K ++++ + E +L ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLY--GKNLPPLSWKQRLEISIGSARGLHYLHT 598
V LI ++ L+ EY+S G HL G + + EIS+ L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLHQ 118
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
QGII+RD+K NILLD K++DFGL K++ I +G V+ G+ Y+ PE R
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKES-IHEGTVTHTFCGTIEYMAPEILMR 174
Query: 659 QQLTEKSDVYSFGVVLLEVLCARP 682
+ D +S G ++ ++L P
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 43/238 (18%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQG---ITEFQTEIQMLSKLRHRH 539
FD IG G +G VY + D G VA+K+ +E+ IT + EI++L +L HR+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 540 LVSL----------IGYCDENSEMILVYEYMSNGPFRDH-LYG---KNLPPLS------- 578
+V+L + + + LV+EYM DH L G L S
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSEDHIKSF 121
Query: 579 WKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638
KQ LE GL+Y H + +HRD+K +NILL++ K++DFGL++ +
Sbjct: 122 MKQLLE-------GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 639 HVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695
T + Y PE ++ DV+S G +L E+ +P Q+ L
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 8/203 (3%)
Query: 489 IIGVGGFGNVYL-GEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLI- 544
++G G +G V L DG + +K+ N + S + + E Q+LS+L+H ++V+
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ E+ + +V + G L + L Q +E + A L YLH + I
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
+HRD+K+ N+ L + KV D G+++ Q +++ + G+ Y+ PE F + K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 665 SDVYSFGVVLLEVLCARPAINPQ 687
SDV++ G + E+ + A N +
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAK 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 489 IIGVGGFGNVYLGEI--DDGT--KVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
++G G FG+V ++ +DG+ KVAVK + + S I EF E + + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 543 LIGYCDENSEM------ILVYEYMSNGPFRDHLY----GKNLPPLSWKQRLEISIGSARG 592
LIG + +++ +M +G L G+ L + + I A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG----QGHVSTAVKGSF 648
+ YL +++ IHRD+ + N +L++N V+DFGLSK G QG S K
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS---KLPV 179
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
+L E T SDV++FGV + E++
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 11/170 (6%)
Query: 528 EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISI 587
E+++L + ++V G + E+ + E+M G L K + +ISI
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENILGKISI 106
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA--VK 645
RGL YL I+HRDVK +NIL++ K+ DFG+S GQ S A
Sbjct: 107 AVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV 159
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695
G+ Y+ PE + T +SD++S G+ L+E+ R I P +E +
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-GNPQSEQGITEFQT--EIQMLSK 534
E T + +G+G FG V + G VA+K+ P S + + +T E+++L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK-RTYRELKLLKH 65
Query: 535 LRHRHLVSLIGYCDENSEMILVYEYMSNGPFRD-----HLYGKNLPPLSWKQRLEISIGS 589
LRH +++SL D I + P D L G +L L + LE
Sbjct: 66 LRHENIISL---SD-----IFI------SPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQ 111
Query: 590 ------ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK-DAPIGQGHVST 642
RGL Y+H+ G++HRD+K +NIL+++N K+ DFGL++ P G+VST
Sbjct: 112 YFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVST 168
Query: 643 AVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Y PE Q+ + D++S G + E+L +P
Sbjct: 169 RY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 489 IIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLS-KLRHRHLVSL 543
++G G FG V+L E+ + A+K+ + + E ++LS H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHL---YGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
+ V EY++ G H+ + +LP ++ EI G L +LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAA-EIICG----LQFLHS-- 114
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+GI++RD+K NILLD + K++DFG+ K+ +G T G+ Y+ PE Q+
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQK 172
Query: 661 LTEKSDVYSFGVVLLEVL 678
D +SFGV+L E+L
Sbjct: 173 YNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 23/233 (9%)
Query: 490 IGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG G G V + + G VAVK+ + + +Q E+ ++ +H ++V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
E+ +V E++ G D + + + +Q + + + L LH AQG+IHRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRM---NEEQIAAVCLAVLKALSVLH---AQGVIHRD 141
Query: 609 VKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
+KS +ILL + K+SDFG +SK+ P + V T ++ PE R +
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-----WMAPELISRLPYGPE 196
Query: 665 SDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717
D++S G++++E++ P + P + AM+ R L K+ + H V
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPKLKNLHKV 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 40/234 (17%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQG---ITEFQTEIQMLSKLRH 537
F+ IG G +G VY + G VA+K+ +E+ I+ + EI +L LRH
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRH 65
Query: 538 RHLVSL---------------IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQR 582
++V L + YC+++ +L + M P S Q
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT-------------PFSESQV 110
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
+ + RGL YLH IIHRD+K +N+LL D K++DFGL++ + ++
Sbjct: 111 KCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167
Query: 643 AVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695
V + Y PE T D+++ G +L E+L +P + + EQ++L
Sbjct: 168 KVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG G G VY +I G +VA+K+ N Q + EI ++ + ++ ++V+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
E+ +V EY++ G D + + Q + + L +LH+ +IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALDFLHSNQ---VIHRD 140
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 668
+KS NILL + K++DFG Q ST V G+ ++ PE R+ K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 669 SFGVVLLEVLCARP 682
S G++ +E++ P
Sbjct: 200 SLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKR------GNPQSEQGITEFQTEIQMLS 533
NF IG G F VY + DG VA+K+ + ++ Q + EI +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNGP-------FRDHLYGKNLP-PLSWKQRLEI 585
+L H +++ + EN+E+ +V E G F+ + +P WK +++
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQL 115
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL----SKDAPIGQGHVS 641
L ++H+ + I+HRD+K N+ + V K+ D GL S V
Sbjct: 116 ----CSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR 681
T Y+ PE KSD++S G +L E+ +
Sbjct: 169 TPY-----YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 489 IIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSL 543
+IG G + V L + ++ VK+ ++ I QTE + + + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
S + LV EY++ G H+ + P + I A L++LH +G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHE---RG 116
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
II+RD+K N+LLD + K++D+G+ K+ +G G ++ G+ Y+ PE R ++
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEG-LGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 664 KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701
D ++ GV++ E++ R + +N ++ Q
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
I G FG+VYL + G A+K + + ++ +T + E ++ V+ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 546 YCDENSE-MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
Y ++ + + LV EY++ G + P W ++ + G+ LH +GI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV--VLGVEDLH---QRGI 118
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
IHRD+K N+L+D K++DFGLS+ G + G+ YL PE +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGDDKM 173
Query: 665 SDVYSFGVVLLEVLCARPAINPQLPRE 691
SD +S G V+ E L P + + P
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 493 GGFGNVYLGEIDDGT-----KVAVKR-GNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
G FG ++ G + D +V VK + SE +T E +L L H++++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 547 CDENSEMILV-YEYMSNGPFRDHLY------GKNLPPLSWKQRLEISIGSARGLHYLHTG 599
C E+ E V Y YM+ G + L N LS +Q + ++I A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-----STAVKGSFGYLDPE 654
+G+IH+D+ + N ++D+ K++D LS+D H + VK ++ E
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----WMALE 189
Query: 655 YFRRQQLTEKSDVYSFGVVLLE 676
++ + SDV+SFGV+L E
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 490 IGVGGFGNVYLG---EIDDG-----TKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
+G G F ++ G E+ D T+V +K + F M+S+L H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHL-YGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
G C E I+V EY+ G +L KNL +SWK LE++ A LH+L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD------PE 654
+G+ H +V + N+LL K + K + G +S V L+ PE
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG---ISITVLPKEILLERIPWVPPE 174
Query: 655 YFRR-QQLTEKSDVYSFGVVLLEVLC 679
Q L+ +D +SFG L E+
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 490 IGVGGFGNVY------LGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
+G G +G V GEI VA+K + + E E+++L +LRH ++V
Sbjct: 9 VGEGAYGVVLKCRNKATGEI-----VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRD-HLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
+L + LV+EY+ LPP + + + + Y H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS---YIWQLLQAIAYCH--- 117
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+ IIHRD+K NIL+ ++ V K+ DFG ++ T Y+ ++R +
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD------YVATRWYRAPE 171
Query: 661 LTEKS-------DVYSFGVVLLEVLCARP 682
L DV++ G ++ E+L P
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 65/201 (32%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 489 IIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQ-----MLSKLRHRHLVS 542
+IG G FG V L + DG AVK ++ E Q I +L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60
Query: 543 LIGYCDENSE-MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L Y + ++ + V +Y++ G HL + P + I SA G YLH+
Sbjct: 61 L-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS--- 114
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
II+RD+K NILLD ++DFGL K+ ST G+ YL PE R+Q
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQPY 173
Query: 662 TEKSDVYSFGVVLLEVLCARP 682
D + G VL E+L P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 36/89 (40%), Positives = 56/89 (62%), Gaps = 4/89 (4%)
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
A L +LH+ GII+RD+K NILLD+ K++DFGLSK++ I + + G+
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVE 163
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
Y+ PE R+ T+ +D +SFGV++ E+L
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 46/144 (31%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G +G+VY + G AVK + + Q EI M+ + +H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 549 ENSEMILVYEYMSNGPFRD--HLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
++ + EY G +D H+ G PLS Q + + +GL YLH+ +G +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMH 129
Query: 607 RDVKSTNILLDDNYVAKVSDFGLS 630
RD+K NILL DN K++DFG++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQ---TEIQMLSKLRHRHLVSLIG 545
IG G FG VY ++ + VA+K+ + +Q ++Q E++ L KLRH + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 546 -YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
Y E++ LV EY G D L + PL + ++ G+ +GL YLH+ +
Sbjct: 83 CYLREHTAW-LVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNM 136
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY---FRRQQL 661
IHRDVK+ NILL + + K+ DFG + V T ++ PE Q
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY-----WMAPEVILAMDEGQY 191
Query: 662 TEKSDVYSFGVVLLEVLCARPAI 684
K DV+S G+ +E+ +P +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 489 IIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSL 543
+IG G + V L E+ ++ +K+ ++ I QTE + H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ--RLEISIGSARGLHYLHTGTA 601
S + V E++S G H+ + P + EIS+ L++LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHER-- 115
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
GII+RD+K N+LLD K++D+G+ K+ I G ++ G+ Y+ PE R +
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-IRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 662 TEKSDVYSFGVVLLEVLCAR 681
D ++ GV++ E++ R
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 483 NFDSSAIIGVGGFGNVYL----GEIDDG----TKVAVKRGNPQSEQGITEFQTEIQMLSK 534
NF+ ++G G +G V+L D G KV K Q + + +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 535 LRHR-HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR-- 591
+R LV+L +++ L+ +Y+S G HLY QR S R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRFY 110
Query: 592 ------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
L +LH GI++RD+K NILLD ++DFGLSK+ + + +
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 646 GSFGYLDPEYFRRQQLTEKS-DVYSFGVVLLEVL 678
G+ Y+ PE R + K+ D +S G+++ E+L
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 57/231 (24%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEID--DGTKVAVKRGNPQSEQGITEFQT-------EIQML 532
+ + + IG G +G V G KVA+K+ +P E QT EI++L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSA-THKPTGVKVAIKKISP------FEHQTFCQRTLREIKIL 57
Query: 533 SKLRHRHLVSLI-----GYCDENSEMILVYEYMSNGPFR---------DH----LYGKNL 574
+ +H +++ ++ + +++ +V E M ++ DH LY
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY---- 113
Query: 575 PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634
Q L RGL Y+H + ++HRD+K +N+LL+ N K+ DFGL++ A
Sbjct: 114 ------QIL-------RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157
Query: 635 IGQGHVS--TAVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLLEVLCARP 682
H T + Y PE + K+ D++S G +L E+L RP
Sbjct: 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 489 IIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSL 543
+IG G + V L + ++ VK+ ++ I QTE + + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
S + V EY++ G H+ + P + I A L+YLH +G
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHE---RG 116
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
II+RD+K N+LLD K++D+G+ K+ + G ++ G+ Y+ PE R +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 664 KSDVYSFGVVLLEVLCAR 681
D ++ GV++ E++ R
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 484 FDSSAIIGVGGFGNVY-LGEIDDGTKVAVKRGNPQSEQGITE--FQTEIQMLSKLRHRHL 540
+++ ++G G +G V + G VA+K+ + + + EI+ML +LRH +L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRD-HLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
V+LI + LV+E++ + D Y L ++ L + RG+ + H+
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL---RGIEFCHS- 118
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGYLDPEYFR 657
IIHRD+K NIL+ + V K+ DFG ++ AP G V T + Y PE
Sbjct: 119 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---GEVYTDYVATRWYRAPELLV 173
Query: 658 RQQLTEKS-DVYSFGVVLLEVLCARP 682
++ D+++ G ++ E+L P
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 488 AIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQML---SKLRHRHL 540
A++G G FG V L E ++ A+K+G+ + + E ++ + RH L
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
V+L + V EY + G H++ S + + + GL YLH
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVFYAACVVLGLQYLHE-- 119
Query: 601 AQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
I++RD+K N+LLD + +V K++DFGL K+ +G G ++ G+ +L PE
Sbjct: 120 -NKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEG-MGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 660 QLTEKSDVYSFGVVLLEVL 678
T D + GV++ E+L
Sbjct: 177 SYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 489 IIGVGGFGNVYL-GEIDDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLI 544
++G G FG V L E G A+K + ++ + TE ++L RH L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ V EY++ G HL + + + I SA L YLH+G I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSGK---I 116
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
++RD+K N++LD + K++DFGL K+ + T G+ YL PE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 665 SDVYSFGVVLLEVLCAR 681
D + GVV+ E++C R
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 490 IGVGGFGNVY-LGEIDDGTKVAVKRGNPQSEQG--ITEFQT-EIQMLSKLRHRHLVSLIG 545
IG G +G V+ + G VA+K+ +SE I + EI+ML +L+H +LV+LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 546 YCDENSEMILVYEYMSNGPFRDHL-------YGKNLPPLSWKQRLEISIGSARGLHYLHT 598
++ LV+EY DH + +P K+ I + + +++ H
Sbjct: 68 VFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCH- 117
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYF-R 657
IHRDVK NIL+ K+ DFG ++ G G T + Y PE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
Q DV++ G V E+L +P
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 62/237 (26%)
Query: 484 FDSSAIIGVGGFGNVYLG---EIDDGTKVAVK--RGNPQSEQGITEFQT---EIQMLSKL 535
++ IG G +G VY DG + A+K +G+ + GI+ Q+ EI +L +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLREL 59
Query: 536 RHRHLVSLIGYCDENSEMI--LVYEYMSNG----------PFRDHLYGKNLPPLSWKQRL 583
+H ++VSL+ E+++ L+++Y + R + + L W Q L
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QIL 118
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSK--DAPI-- 635
G+HYLH + ++HRD+K NIL+ + V K+ D GL++ +AP+
Sbjct: 119 N-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 636 ---GQGHVSTAVKGSFGYLDPE-------YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
V T Y PE Y T+ D+++ G + E+L P
Sbjct: 169 LADLDPVVVT-----IWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 65/204 (31%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQ-----MLSKLRHRHLV 541
+IG G FG V L + DG+ AVK ++ E Q I +L L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLV 59
Query: 542 SLIGYCDENSE-MILVYEYMSNGPFRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHT 598
L Y + +E + V +Y++ G HL + L P + E+ A + YLH+
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV----ASAIGYLHS 114
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
II+RD+K NILLD ++DFGL K+ + ST G+ YL PE R+
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRK 170
Query: 659 QQLTEKSDVYSFGVVLLEVLCARP 682
+ D + G VL E+L P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 489 IIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSK------LRHRHLV 541
++G G FG V L E+ G AVK + + + + E M+ K + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L + V E+++ G H+ K L I GL +LH+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFLHS--- 114
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+GII+RD+K N++LD + K++DFG+ K+ G ST G+ Y+ PE + +
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKY 173
Query: 662 TEKSDVYSFGVVLLEVL 678
T D +SFGV+L E+L
Sbjct: 174 TFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 8/194 (4%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG G G VY ++ G +VA+++ N Q + EI ++ + ++ ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
E+ +V EY++ G D + + Q + + L +LH+ +IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLHSNQ---VIHRD 141
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 668
+KS NILL + K++DFG Q ST V G+ ++ PE R+ K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 669 SFGVVLLEVLCARP 682
S G++ +E++ P
Sbjct: 201 SLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 34/170 (20%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR---GNPQSEQGITEFQTEIQMLSKLRH 537
++ A IG G FG V+ VA+K+ N + IT + EI++L L+H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKH 70
Query: 538 RHLVSLIGYCDENSEM--------ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS 589
++V+LI C + LV+E F +H +L L + ++ ++
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFE------FCEH----DLAGLLSNKNVKFTLSE 120
Query: 590 AR--------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
+ GL+Y+H I+HRD+K+ NIL+ + + K++DFGL++
Sbjct: 121 IKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 489 IIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-----SEQGITEFQTEIQMLSKLRHRHLVS 542
+IG G FG V L + DG AVK + EQ + + +L ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L ++ V ++++ G HL + P + I SA G YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---I 115
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
I++RD+K NILLD ++DFGL K+ I Q +T G+ YL PE R+Q
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEG-IAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 663 EKSDVYSFGVVLLEVLCARP 682
D + G VL E+L P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 489 IIGVGGFGNVYLGEI-DDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
++G G FG V L + + G AVK + + + TE ++LS R+ ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 545 GYCDENSE-MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
C + + + V E+++ G H+ + + I SA L +LH +G
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHD---KG 116
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
II+RD+K N+LLD K++DFG+ K+ I G ++ G+ Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 664 KSDVYSFGVVLLEVLC 679
D ++ GV+L E+LC
Sbjct: 176 SVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLR---H 537
++ A IGVG +G VY + G VA+K Q+ + T E+ +L +L H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 538 RHLVSLIGYC-----DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARG 592
++V L+ C D +++ LV+E++ R +L P L + ++ RG
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS-TAVKGSFGYL 651
L +LH I+HRD+K NIL+ K++DFGL++ I ++ T V + Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYR 174
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
PE + D++S G + E+ +P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 477 LQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL 535
L++ F+ ++G G +G VY G + G A+K + +E E + EI ML K
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKY 69
Query: 536 -RHRHLVSLIGYCDENS------EMILVYEYMSNGPFRDHLYGKNLPPLSWKQR--LEIS 586
HR++ + G + S ++ LV E+ G D + KN + K+ I
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYIC 127
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646
RGL +LH A +IHRD+K N+LL +N K+ DFG+S G +T + G
Sbjct: 128 REILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 183
Query: 647 SFGYLDPEYFRRQQLTE-----KSDVYSFGVVLLEVLCARPAI 684
+ ++ PE + + +SD++S G+ +E+ P +
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDG--------TKVAVKRGNPQSEQGITEFQTEIQMLSK 534
NF+ ++G G +G V+L G KV K Q + +TE Q+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 535 LRHR-HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS-ARG 592
+R LV+L ++++ L+ +Y++ G HL + +Q ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
L +LH GII+RD+K NILLD N ++DFGLSK+ + + + G+ Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 653 PEYFRRQQLTEKS--DVYSFGVVLLEVL 678
P+ R D +S GV++ E+L
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSE-QGITEFQT-EIQMLSKLRHRHLVSLIGY 546
IG G +G VY G G VA+K+ +SE +G+ EI +L +L+H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 547 CDENSEMILVYEYMSNGPFRDHL----YGKNLPPLSWKQRL-EISIGSARGLHYLHTGTA 601
+ S + L++E++S + +L G+ + K L +I +G+ + H +
Sbjct: 68 LMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQI----LQGILFCH---S 119
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGYLDPEYFR-R 658
+ ++HRD+K N+L+D+ V K++DFGL++ P+ V T + Y PE
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLGS 176
Query: 659 QQLTEKSDVYSFGVVLLEVLCARP 682
+ + D++S G + E+ +P
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTK--VAVKRGNPQSEQGITEFQTEIQMLSKL----- 535
+F+ ++G G FG V L E GT A+K + + I + E M+ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALP 57
Query: 536 -RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARG 592
+ L L + V EY++ G H+ GK P + EI+IG
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG---- 113
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
L +LH+ +GII+RD+K N++LD K++DFG+ K+ I G + G+ Y+
Sbjct: 114 LFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN-IFGGKTTRTFCGTPDYIA 169
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
PE Q + D ++FGV+L E+L +P
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 53/200 (26%), Positives = 104/200 (52%), Gaps = 18/200 (9%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKV----AVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVS 542
++G G FG VY G + +G V A+K N + + EF E +++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L+G C + + LV + M +G D+++ ++ + + L + A+G+ YL +
Sbjct: 74 LLGVC-LSPTIQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEE---R 128
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG----HVSTAVKGSFGYLDPEYFRR 658
++HRD+ + N+L+ K++DFGL++ + +G + + K ++ E
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLAR---LLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 659 QQLTEKSDVYSFGVVLLEVL 678
++ T +SDV+S+GV + E++
Sbjct: 186 RKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKLRHR 538
+F+ ++G G FG V L E ++ +K+ + + E ++L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 539 HLVSLIGYCDENSE-MILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHY 595
++ + C + + + V EY++ G H+ GK P + EIS+G L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY 655
LH +GII+RD+K N++LD K++DFG+ K+ + G + G+ Y+ PE
Sbjct: 117 LHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-DGVTTRTFCGTPDYIAPEI 172
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARP 682
Q + D +++GV+L E+L +P
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 6/155 (3%)
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEIS 586
TE ++L RH L +L + + V EY + G HL + + +
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646
I SA L YLH+ +++RD+K N++LD + K++DFGL K+ I G G
Sbjct: 104 IVSA--LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCG 157
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR 681
+ YL PE D + GVV+ E++C R
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 528 EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLY-GKNLPPLSWKQRL-EI 585
E+Q+L + ++V G + E+ + E+M G L K +P ++ L ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP----EEILGKV 108
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ--GHVSTA 643
SI RGL YL I+HRDVK +NIL++ K+ DFG+S GQ ++ +
Sbjct: 109 SIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANS 161
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703
G+ Y+ PE + + +SD++S G+ L+E+ R I P +E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE------------ 209
Query: 704 RKGLLEKIIDPHLV--GTINPESLKKFAEAAEKCLADHGVD-RPTMG 747
LE I +V P S+ + ++ HG+D RP M
Sbjct: 210 ----LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMA 252
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG VY + + G A K +SE+ + ++ EI++L+ H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 549 ENSEMILVYEYMSNGPFRDHLY----GKNLPPLS--WKQRLEISIGSARGLHYLHTGTAQ 602
+ ++ ++ E+ G + G P + +Q LE L YLH+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE-------ALQYLHS---M 129
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLS-KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
IIHRD+K+ N+LL + K++DFG+S K+ Q S G+ ++ PE + +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETM 187
Query: 662 TE-----KSDVYSFGVVLLEVLCARPA---INP 686
+ K+D++S G+ L+E+ P +NP
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 33/235 (14%)
Query: 461 FTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVY-LGEIDDGTKVAVKRGNPQSE 519
+ +S LGL + L + T ++ IG G +G VY + DG+ AVK +P S+
Sbjct: 7 YNSSMLGL------ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 520 QGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMI-----LVYEYMSNGPFRDHLYGKN 573
E + E +L L H ++V G + +++ LV E + G + + G
Sbjct: 61 VD-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL- 118
Query: 574 LPPLSWKQRLE------ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627
L QRL+ I G+ GL +LH IIHRDVK NILL K+ DF
Sbjct: 119 ---LICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDF 172
Query: 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLLEV 677
G+S + +T+V F ++ PE +Q + S DV+S G+ +E+
Sbjct: 173 GVSAQLTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 39/147 (26%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSE-QGITEFQT-EIQMLSKLRHRHLVSLIGY 546
IG G +G V+ + VA+KR + +G+ EI +L +L+H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 547 CDENSEMILVYEYMSNG--PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ ++ LV+EY + D G P + ++ +GL + H + +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL----LKGLAFCH---SHNV 120
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSK 631
+HRD+K N+L++ N K++DFGL++
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 489 IIGVGGFGNVYL-GEIDDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLI 544
++G G FG V L E G A+K + ++ + TE ++L RH L +L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ + V EY + G HL + + + I SA L YLH+ + +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHS---RDV 116
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
++RD+K N++LD + K++DFGL K+ I G G+ YL PE
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 665 SDVYSFGVVLLEVLCAR 681
D + GVV+ E++C R
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 17/101 (16%)
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
I++ + + L+YL IIHRDVK +NILLD N K+ DFG+S G + ++
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDSI 162
Query: 645 K-----GSFGYLDPEY---FRRQQLTEKSDVYSFGVVLLEV 677
G Y+ PE R +SDV+S G+ L EV
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 67/292 (22%), Positives = 115/292 (39%), Gaps = 57/292 (19%)
Query: 493 GGFGNVYLGEIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN 550
++ + T VAVK+ N S++ + Q EI +L+H +++ + +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 551 SEMILVYEYMSNGPFRDHL---YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
SE+ +V M+ G D L + + LP L+ L+ L Y+H+ +G IHR
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DVLNALDYIHS---KGFIHR 125
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAP-IGQGHVSTAVKGS-------FGYLDPEYFRRQ 659
VK+++ILL + +S GL I G V +L PE +Q
Sbjct: 126 SVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL-QQ 182
Query: 660 QL---TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID--- 713
L EKSD+YS G+ E+ N +P + + + ++ K +G + ++D
Sbjct: 183 NLQGYNEKSDIYSVGITACEL------ANGHVPFKDMPATQMLLE-KVRGTVPCLLDKST 235
Query: 714 ---------------PHLVGTINPE--SLKKFAEA----AEKCLADHGVDRP 744
H + + + F+E E CL RP
Sbjct: 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 490 IGVGGFGNV---YLGEIDDGTKVAVKR-GNP-QSEQGITEFQTEIQMLSKLRHRHLVSLI 544
+G G +G V + + G KVA+K+ P QS E+++L + H +++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKT--GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 545 G-YC-DENSEMILVYEYMSNGPFRD-----HLYGKNLPPLSWKQRL---EISI---GSAR 591
+ + E F+D HL G +L + Q+L I R
Sbjct: 81 DVFTPASSLE-----------DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-GHVSTAVKGSFGY 650
GL Y+H+ GIIHRD+K +NI ++++ K+ DFGL++ G+V+T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 181
Query: 651 LDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
PE + D++S G ++ E+L +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 54/183 (29%), Positives = 72/183 (39%), Gaps = 22/183 (12%)
Query: 505 DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564
KV VK G EI +L + HR +++LI S + +V
Sbjct: 118 QRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172
Query: 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV 624
F Y PL +Q + I L YLH +GIIHRDVK+ NI LD+ A +
Sbjct: 173 FT---YVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVL 226
Query: 625 SDFG------LSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
DFG D P G T S PE K+D++S G+VL E+
Sbjct: 227 GDFGAACKLDAHPDTPQCYGWSGTLETNS-----PELLALDPYCAKTDIWSAGLVLFEMS 281
Query: 679 CAR 681
Sbjct: 282 VKN 284
|
Length = 392 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 44/124 (35%), Positives = 66/124 (53%), Gaps = 12/124 (9%)
Query: 574 LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633
PL+ + + S ARG+ +L ++ IHRD+ + NILL +N V K+ DFGL++D
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 634 PIGQGHVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQ 687
+V KGS ++ PE + T +SDV+SFGV+L E+ L A P Q
Sbjct: 225 YKDPDYVR---KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281
Query: 688 LPRE 691
+ E
Sbjct: 282 INEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 489 IIGVGGFGNVYL-GEIDDGTKVAVKRGN-PQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
++G G FG L ++ K A+K P+S + + + E +L+K++H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 547 CDENSEMILVYEYMSNGPFRDHL---YGKNLPP---LSWKQRLEISIGSARGLHYLHTGT 600
+ + + +V EY G + GK P L W ++ + G+ ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE-- 118
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+ ++HRD+KS NI L N K+ DFG ++ + T V G+ Y+ PE +
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 661 LTEKSDVYSFGVVLLEVLC 679
KSD++S G +L E LC
Sbjct: 177 YNNKSDIWSLGCILYE-LC 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 38/126 (30%)
Query: 576 PLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635
PL+ + + S ARG+ +L ++ IHRD+ + NILL +N V K+ DFGL++D
Sbjct: 169 PLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI-- 223
Query: 636 GQGHVSTAVKGSFGYLDPEYFRR-----------------QQLTEKSDVYSFGVVLLEV- 677
Y DP+Y R+ + T +SDV+SFGV+L E+
Sbjct: 224 --------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 269
Query: 678 -LCARP 682
L A P
Sbjct: 270 SLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQ---TEIQMLSKLRHRHLVSLIG 545
IG G FG VY ++ VA+K+ + +Q ++Q E++ L +++H + + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 546 -YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
Y E++ LV EY G D L + PL + I+ G+ +GL YLH+ +
Sbjct: 93 CYLREHTAW-LVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 146
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY---FRRQQL 661
IHRD+K+ NILL + K++DFG + A V T ++ PE Q
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY-----WMAPEVILAMDEGQY 201
Query: 662 TEKSDVYSFGVVLLEVLCARPAI 684
K DV+S G+ +E+ +P +
Sbjct: 202 DGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 490 IGVGGFGNVYLGEIDDGTK-VAVKRGNPQSEQGITEFQ---TEIQMLSKLRHRHLVSLIG 545
IG G FG VY + VAVK+ + +Q ++Q E++ L +L+H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
+ LV EY G D L + PL + I+ G+ +GL YLH+ +I
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 143
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY---FRRQQLT 662
HRD+K+ NILL + K++DFG + + V T ++ PE Q
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-----WMAPEVILAMDEGQYD 198
Query: 663 EKSDVYSFGVVLLEVLCARPAI 684
K DV+S G+ +E+ +P +
Sbjct: 199 GKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 33/281 (11%)
Query: 477 LQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL 535
L++ F+ ++G G +G VY G + G A+K + ++ E + EI ML K
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59
Query: 536 -RHRHLVSLIG-YCDEN-----SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIG 588
HR++ + G + +N ++ LV E+ G D + L + I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF 648
RGL +LH +IHRD+K N+LL +N K+ DFG+S G +T + G+
Sbjct: 120 ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 175
Query: 649 GYLDPEYFRRQQLTE-----KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703
++ PE + + KSD++S G+ +E+ P + P +
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--------- 226
Query: 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRP 744
L+ + P L + + KKF E CL + RP
Sbjct: 227 ---LIPRNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRP 261
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 29/246 (11%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI-GYC 547
+G G FG VY + + G A K + +SE+ + ++ EI +L+ H ++V L+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
EN+ IL+ E+ + G D + + PL+ Q + + L+YLH IIHR
Sbjct: 73 YENNLWILI-EFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHR 127
Query: 608 DVKSTNILLDDNYVAKVSDFGLS-KDAPIGQGHVSTAVKGSFGYLDPEYF-----RRQQL 661
D+K+ NIL + K++DFG+S K+ Q S G+ ++ PE + +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 185
Query: 662 TEKSDVYSFGVVLLEVLCARPA---INPQL---------PREQVNLAEWAMQWKR--KGL 707
K+DV+S G+ L+E+ P +NP P + W+ ++K K
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245
Query: 708 LEKIID 713
LEK +D
Sbjct: 246 LEKNVD 251
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 42/120 (35%), Positives = 56/120 (46%), Gaps = 14/120 (11%)
Query: 565 FRDHLYG---KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621
+ LY K PL Q L I GL YLH AQ IIHRDVK+ NI ++D
Sbjct: 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQ 195
Query: 622 AKVSDFGLSK---DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
+ D G ++ AP G T + PE R + K+D++S G+VL E+L
Sbjct: 196 VCIGDLGAAQFPVVAPAFLGLAGTVETNA-----PEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTK----VAVKR----GNPQSEQGITEFQTEIQMLSK 534
F ++G G FG VY G I +G K VA+K +P++ + I + E +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVMAS 65
Query: 535 LRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLH 594
+ + H+ L+G C S + L+ + M G D++ ++ + + L + A+G++
Sbjct: 66 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMN 123
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGYLD 652
YL + ++HRD+ + N+L+ K++DFGL+K A + H K ++
Sbjct: 124 YLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKWMA 179
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVL 678
E + T +SDV+S+GV + E++
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 490 IGVGGFGNVYLGEIDDG---TKVAVKR----GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
IG G FG V LGE++ G +V VK + Q + +F E Q L+H +L+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM---KFLEEAQPYRSLQHSNLLQ 59
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNL-----PPLSWKQRLEISIGSARGLHYLH 597
+G C E + +LV E+ G + +L P + QR+ I A GL +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLH 117
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630
IH D+ N LL + K+ D+GLS
Sbjct: 118 K---NNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 9/197 (4%)
Query: 489 IIGVGGFGNVYL-GEIDDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLI 544
++G G FG V L E G A+K + ++ + TE ++L RH L +L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ + V EY + G HL + + + I SA L YLH+ + +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHS--EKNV 117
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
++RD+K N++LD + K++DFGL K+ I G G+ YL PE
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 665 SDVYSFGVVLLEVLCAR 681
D + GVV+ E++C R
Sbjct: 177 VDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 490 IGVGGFGNVYLGEI------DDGTKVAVKRGNPQSEQGI-TEFQTEIQMLSKLRHRHLVS 542
+G FG VY G + + VA+K ++E + EF+ E M S+L+H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL--------YGKNLPPLSWKQRLE------ISIG 588
L+G + + +++ Y S+ + L G + K LE I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL-----SKDAPIGQGHVSTA 643
A G+ +L ++ ++H+D+ + N+L+ D K+SD GL + D G+
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++ ++ PE + + SD++S+GVVL EV
Sbjct: 190 IR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 528 EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL-EIS 586
E+Q+L + ++V G + E+ + E+M G L P +Q L ++S
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 109
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ--GHVSTAV 644
I +GL YL I+HRDVK +NIL++ K+ DFG+S GQ ++ +
Sbjct: 110 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSF 162
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE 691
G+ Y+ PE + + +SD++S G+ L+E+ R I P +E
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTK-VAVKRGNPQSEQGITEFQT--EIQMLSKLR- 536
+ ++ A IG G +G V+ ++ +G + VA+KR Q+ + T E+ +L L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 537 --HRHLVSLIGYC-----DENSEMILVYEYMSNG--PFRDHLYGKNLPPLSWKQRLEISI 587
H ++V L C D +++ LV+E++ + D + +P + K ++
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMF 117
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS 647
RGL +LH+ ++HRD+K NIL+ + K++DFGL++ T+V +
Sbjct: 118 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVT 172
Query: 648 FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Y PE + D++S G + E+ +P
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 489 IIGVGGFGNVY-LGEIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRH---RHLV 541
IIG GGFG VY + D G A+K + + +QG T E MLS + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+ ++ + + M+ G HL + S K+ + GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHN--- 115
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+ +++RD+K NILLD++ ++SD GL+ D + H S G+ GY+ PE ++
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTA 172
Query: 662 TEKS-DVYSFGVVLLEVL 678
+ S D +S G +L ++L
Sbjct: 173 YDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 60/201 (29%), Positives = 86/201 (42%), Gaps = 15/201 (7%)
Query: 489 IIGVGGFGNVYLG-----EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+IG G FG V L E KV K+ + ++ +L ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHTGTA 601
++ V +Y++ G HL + L P + EI A L YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS--- 114
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
I++RD+K NILLD ++DFGL K+ G ST G+ YL PE +Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 662 TEKSDVYSFGVVLLEVLCARP 682
D + G VL E+L P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 19/120 (15%)
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH-VST 642
+I++ + L YLH+ + +IHRDVK +N+L++ N K+ DFG+S G+ V +
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157
Query: 643 AVK----GSFGYLDPEYF----RRQQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQV 693
K G Y+ PE ++ KSDV+S G+ ++E+ R P + + P +Q+
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 489 IIGVGGFGNVY-LGEIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
IIG GGFG VY + D G A+K + + +QG T E MLS LVS
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS-T 53
Query: 545 GYC----------DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLH 594
G C ++ + + M+ G HL + S + + GL
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLE 111
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
++H + +++RD+K NILLD++ ++SD GL+ D + H S G+ GY+ PE
Sbjct: 112 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 655 YFRRQQLTEKS-DVYSFGVVLLEVL 678
++ + S D +S G +L ++L
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL------R 536
+F+ ++G G FG V L E GT + + I + E M+ K +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLH 594
L L + V EY++ G + G+ P + EI+IG L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LF 115
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
+LH+ +GII+RD+K N++LD K++DFG+ K+ + G + G+ Y+ PE
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-MWDGVTTKTFCGTPDYIAPE 171
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Q + D ++FGV+L E+L +
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 10/106 (9%)
Query: 576 PLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635
PL L S A+G+ +L ++ IHRDV + N+LL D VAK+ DFGL++D
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 636 GQGHVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLLEV 677
+V VKG+ ++ PE T +SDV+S+G++L E+
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 489 IIGVGGFGNVYLG-EIDDGTK----VAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
++G G FG VY G I DG VA+K R N S + E E +++ + ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVC 72
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L+G C S + LV + M G D++ +N + + L + A+G+ YL
Sbjct: 73 RLLGIC-LTSTVQLVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEEVR- 129
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-STAVKGSFGYLDPEYFRRQQ 660
++HRD+ + N+L+ K++DFGL++ I + + K ++ E ++
Sbjct: 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 661 LTEKSDVYSFGVVLLEVL 678
T +SDV+S+GV + E++
Sbjct: 188 FTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 504 DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563
D KV K E+ ++E+ L+ H +V + +++L+ EY S G
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHY-----LHTGTAQGIIHRDVKSTNILLDD 618
+ + K+ L L Y L ++ ++HRD+KS NI L
Sbjct: 151 DLNKQIKQR------LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204
Query: 619 NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG----YLDPEYFRRQQLTEKSDVYSFGVVL 674
+ K+ DFG SK VS V SF YL PE + R++ ++K+D++S GV+L
Sbjct: 205 TGIIKLGDFGFSKQY---SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 675 LEVLCA-RPAINP 686
E+L RP P
Sbjct: 262 YELLTLHRPFKGP 274
|
Length = 478 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 13/148 (8%)
Query: 490 IGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
I G FG VYLG + +K+ VK+ + ++ + + Q E L+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 546 YCDENSEMILVYEYMSNGPFRD--HLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+ + LV EY+ G + H+YG ++ K E+ A L YLH G
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEV----ALALDYLHR---HG 124
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSK 631
IIHRD+K N+L+ + K++DFGLSK
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 6/110 (5%)
Query: 576 PLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635
L+ + + S A+G+ +L ++ IHRD+ + NILL +N V K+ DFGL++D
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 636 GQGHVSTA-VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEV--LCARP 682
+V + ++ PE + T +SDV+SFGV+L E+ L A P
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 475 QELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE----QGITEFQTEIQ 530
++LQ +++D +IG G FG V L KV + + E F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 531 MLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA 590
+++ +V L ++ + +V EYM G + + ++P W + + A
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLA 154
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS-KDAPIGQGHVSTAVKGSFG 649
L +H+ G+IHRDVK N+LLD + K++DFG K G TAV G+
Sbjct: 155 --LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPD 208
Query: 650 YLDPEYFRRQ----QLTEKSDVYSFGVVLLEVL 678
Y+ PE + Q + D +S GV L E+L
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQS-EQGI--TEFQTEIQMLSKLRHR 538
++ IG G +G VY + + G VA+K+ + E+GI T + EI +L L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSES 60
Query: 539 -HLVSLIGYCDENSE-------MILVYEYMSNG--PFRDHLYGKNLPPLSWKQRLEISIG 588
++V L+ E+ E + LV+EY+ + F D PL K
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKD--------------- 632
+G+ + H G++HRD+K N+L+D + K++D GL +
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175
Query: 633 ---AP---IGQGHVSTAVK-GSFGYLDPEYFRRQQL 661
AP +G H ST V S G + E R+Q L
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 13/148 (8%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSE-QGI--TEFQTEIQMLSKLRHRHLVSLIG 545
IG G +G VY + G VA+K+ ++E +G+ T + EI +L +L H ++V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65
Query: 546 YCDENSEMILVYEY--MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+++ LV+E+ + + D L P K L + +G+ Y H+
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL---QGIAYCHS---HR 119
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSK 631
++HRD+K N+L+D K++DFGL++
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 483 NFDSSAIIGVGGFGNVYL-GEIDDGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHR 538
+F++ +I G +G VYL + + A+K+ N Q+ I + E +L+ +
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
+VS+ + + +V EY+ G L KN+ L + L YLH
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHN 119
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG---------QGHVSTAVK---- 645
GI+HRD+K N+L+ K++DFGLSK IG +GH+ +
Sbjct: 120 ---YGIVHRDLKPDNLLITSMGHIKLTDFGLSK---IGLMSLTTNLYEGHIEKDTREFLD 173
Query: 646 ----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
G+ Y+ PE RQ + D ++ G++L E L
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 490 IGVGGFGNV-YLGEIDDGTKVAVKR-GNP-QSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
+G G +G V + G KVA+K+ P QSE E+++L ++H +++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 547 ------CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE------ISIGSARGLH 594
D + LV +M G +L L ++L + +GL
Sbjct: 83 FTPDLSLDRFHDFYLVMPFM----------GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-GHVSTAVKGSFGYLDP 653
Y+H A GIIHRD+K N+ ++++ K+ DFGL++ G+V T Y P
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAP 184
Query: 654 EY-FRRQQLTEKSDVYSFGVVLLEVLCARP 682
E T+ D++S G ++ E+L +P
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS-ARGLHYLHTGTAQGIIHRDV 609
S++ LV +YMS G HL + + R + I L +LH I++RD+
Sbjct: 69 SDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHK---YDIVYRDL 122
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVY 668
K NILLD + DFGLSK A + + G+ YL PE ++ T+ D +
Sbjct: 123 KPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181
Query: 669 SFGVVLLEVLCA-RPAINPQLPREQVNLAEWAMQWKR-----------KGLLEKIIDPHL 716
S GV++ E+ C P + N+A +++ + KGLL +
Sbjct: 182 SLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR------ 235
Query: 717 VGTINPES-LKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAF 763
NP+ L +A E L +H P D+ W+L Q+ F
Sbjct: 236 ----NPQHRLGAHRDAVE--LKEH----PFFADIDWDLLSKKQITPPF 273
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 60/224 (26%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHLVSLIGY 546
IG G +G V + KVA+K+ + I +T EI++L L H +++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 547 C-----DENSEMILVYEYM---------SNGPF-RDH----LYGKNLPPLSWKQRLEISI 587
+ +++ +VYE M S+ DH LY Q L
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY----------QLL---- 118
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS 647
RGL Y+H+ ++HRD+K +N+LL+ N K+ DFGL++ +T+ KG
Sbjct: 119 ---RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR---------TTSEKGD 163
Query: 648 F--GYLDPEYFRRQQL-------TEKSDVYSFGVVLLEVLCARP 682
F Y+ ++R +L T DV+S G + E+L +P
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 47/220 (21%)
Query: 489 IIGVGGFGNVYLGEIDDGT--KVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHLVSLI 544
IG G +G V ID + KVA+K+ + +T E+++L +H +++++
Sbjct: 12 NIGSGAYG-VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 545 G-YCDENSEMILVYEYM------------SNGPFRDH-----LYGKNLPPLSWKQRLEIS 586
++ VY M S+ P + LY Q L
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY----------QLL--- 117
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK---DAPIGQGHVSTA 643
RGL Y+H + +IHRD+K +N+L++++ ++ DFG+++ +P + T
Sbjct: 118 ----RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 644 VKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ Y PE + T D++S G + E+L R
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 67/269 (24%), Positives = 106/269 (39%), Gaps = 79/269 (29%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNP--QSEQGITEFQTEIQMLSKLR-HRHLVSLIG 545
IG G F V G A+K +S + + + EIQ L +L H +++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 546 --YCDENSEMILV--------YEYMSNGPFRDHLYGKNLPPLSWK----QRLEISIGSAR 591
+ + + LV YE + R LP K Q L +
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKG---RKRP----LPEKRVKSYMYQLL-------K 111
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG-Y 650
L ++H GI HRD+K NIL+ D+ + K++DFG + K + Y
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR---------GIYSKPPYTEY 158
Query: 651 LDPEYFRRQQ--LTE-----KSDVYSFGVVLLEVLCARPAINPQLPRE----QVNLAEWA 699
+ ++R + LT+ K D+++ G V E+L ++ P P Q+
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL----SLFPLFPGTNELDQIA----- 209
Query: 700 MQWKRKGLLEKIIDPHLVGTINPESLKKF 728
KI D ++GT + E LKKF
Sbjct: 210 ----------KIHD--VLGTPDAEVLKKF 226
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 489 IIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLS-KLRHRHLVSL 543
++G G FG V L E+ +V +K+ + + TE ++L+ +H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 544 IGYCDENSEMILVYEYMSNGP--FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+ V EY++ G F+ K P S E+++ L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA----LMFLHR--- 114
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
G+I+RD+K NILLD K++DFG+ K+ I G +T G+ Y+ PE + +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG-ILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 662 TEKSDVYSFGVVLLEVLCARP 682
D ++ GV++ E++ +P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKV-AVKRGNP-----QSEQGITEFQ 526
+L+ ++FD +IG G FG V L +V A+K + +S+ F
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FW 91
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEIS 586
E +++ +V L ++ + +V EYM G + + ++P W +
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAE 150
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVST 642
+ A L +H+ G IHRDVK N+LLD + K++DFG + + G T
Sbjct: 151 VVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN---GMVRCDT 202
Query: 643 AVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLLEVL 678
AV G+ Y+ PE + Q + D +S GV L E+L
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 43/239 (17%)
Query: 478 QEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKR--GNPQSEQGITEFQTEIQMLSK 534
+ K++ IIG G FG VY ID KVA+K+ +PQ + E+ ++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKN 115
Query: 535 LRHRHLVSLIGY-----CDENSEMILVYEYMSNGPFRDHLYGK-------NLPPLSWKQR 582
L H +++ L Y +N + I + M P H Y K LP K
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL- 174
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDAPIGQGHVS 641
S R L Y+H+ + I HRD+K N+L+D N + K+ DFG +K+ GQ VS
Sbjct: 175 --YSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 642 TAVKGSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
Y+ ++R +L T D++S G ++ E++ P + Q +Q+
Sbjct: 230 --------YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 528 EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISI 587
EI++L + H ++V D N E+ ++ E+M G L+ R +S
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE-QFLADVARQILS- 179
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS 647
G+ YLH + I+HRD+K +N+L++ K++DFG+S+ +++V G+
Sbjct: 180 ----GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GT 231
Query: 648 FGYLDPEYFRRQQLTE------KSDVYSFGVVLLEVLCAR 681
Y+ PE L D++S GV +LE R
Sbjct: 232 IAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-08
Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 51/229 (22%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKR------GNPQSEQGITEFQTEIQMLSKLRHRHLV 541
+IG GG G VYL + +VA+K+ NP ++ F E ++ + L H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLREAKIAADLIHPGIV 65
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQR-----LEI--SIGS----- 589
+ C + VY M P+ + K+L W++ L S+G+
Sbjct: 66 PVYSICSDGD---PVYYTM---PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 590 ---ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK------------DAP 634
+ Y+H+ +G++HRD+K NILL + D+G + D
Sbjct: 120 HKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 635 IGQGHVSTAVK-----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
S+ G+ Y+ PE +E +D+Y+ GV+L ++L
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKR---GNPQSEQGITEFQTEIQMLSKLRHR 538
NF IG G F VY + DG VA+K+ + + + EI +L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPF----RDHLYGKNLPP--LSWKQRLEISIGSARG 592
+++ E++E+ +V E G + K L P WK +++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL----CSA 118
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGY 650
L ++H+ + ++HRD+K N+ + V K+ D GL + + H ++ G+ Y
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYY 172
Query: 651 LDPEYFRRQQLTEKSDVYSFGVVLLEV 677
+ PE KSD++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 36/119 (30%), Positives = 61/119 (51%), Gaps = 10/119 (8%)
Query: 575 PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634
P LS+ + S A G+ +L ++ +HRD+ + N+L+ + + K+ DFGL++D
Sbjct: 234 PALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 635 IGQGHVSTAVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLP 689
++S KGS ++ PE T SDV+SFG++L E+ P+LP
Sbjct: 291 RDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQ---TEIQMLSKLRHR 538
+F+ +G G FG V + + G A+K + + + Q E +L +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 539 HLVSLI-GYCDENSEMILVYEYMSNGPFRDHLY--GKNLPPLSWKQRLEISIGSARGLHY 595
+V+++ + DEN + + E++ G HL G+ ++ E+ + Y
Sbjct: 79 FIVNMMCSFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEY 133
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY 655
LH+ + II+RD+K N+LLD+ KV+DFG +K P + + G+ YL PE
Sbjct: 134 LHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----DRTFTLCGTPEYLAPEV 186
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ + + D ++ GV+L E + P
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 17/157 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRH 539
NF IG G +G VY G VA+K R + ++E + EI +L +L H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 540 LVSLIGYCDENSEMILVYEYMSNG--PFRDHLYGKNLP-PL--SWKQRLEISIGSARGLH 594
+V L+ +++ LV+E++ F D +P PL S+ +L +GL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL------LQGLA 114
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
+ H + ++HRD+K N+L++ K++DFGL++
Sbjct: 115 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 490 IGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQT-EIQMLSKLRHRHLVSLIGYC 547
+G G + VY G G VA+K + +E+G EI ++ +L+H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 548 DENSEMILVYEYMSNGPFR---DHLYGKNLPPLSWK----QRLEISIGSARGLHYLHTGT 600
++++LV+EYM + H L P + K Q L +G+ + H
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL-------KGIAFCHE-- 118
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
++HRD+K N+L++ K++DFGL++ I S V + Y P+ +
Sbjct: 119 -NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 661 LTEKS-DVYSFGVVLLEVLCARP 682
S D++S G ++ E++ RP
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
L S A+G+ +L ++ IHRD+ + NILL + K+ DFGL++D +V
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-- 271
Query: 643 AVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLP 689
VKG+ ++ PE T +SDV+S+G++L E+ + P +P
Sbjct: 272 -VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 34/156 (21%)
Query: 493 GGFGNVYLG-EIDDGTKVAVKRGNPQSE-QG--ITEFQTEIQMLSKLRHRHLVSLIGYCD 548
G +G VY + G VA+K+ + E +G IT + EI +L KL+H ++V++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTV----- 69
Query: 549 ENSEMI---------LVYEYMSNGPFRDH----LYGKNLPPLSWKQRLEISIGSARGLHY 595
E++ +V EY+ +H L P + + + G+ +
Sbjct: 70 --KEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
LH I+HRD+K++N+LL++ + K+ DFGL++
Sbjct: 122 LH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEIS 586
+E+++L K +++ G + + + E+M G +Y K + + I+
Sbjct: 48 SELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL--DVYRKIPEHVLGR----IA 101
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646
+ +GL YL + I+HRDVK +N+L++ K+ DFG+S ++ G
Sbjct: 102 VAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVG 155
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQVNLAEWAMQWKRK 705
+ Y+ PE +Q SDV+S G+ +E+ R P PQ+ + Q +L +Q
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY--PQIQKNQGSLM--PLQ---- 207
Query: 706 GLLEKIID---PHL-VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
LL+ I+D P L VG + KF +C+ +RP +++
Sbjct: 208 -LLQCIVDEDPPVLPVGQFSE----KFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQG--ITEFQTEIQMLSKLRHRHLVSLIGY 546
+G G + V+ G VA+K + E+G T + E+ +L L+H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA-RGLHYLHTGTAQGII 605
+ LV+EY+ + + Y N L ++I + RGL Y H + I+
Sbjct: 72 IHTERCLTLVFEYLDSDLKQ---YLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKIL 125
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS 665
HRD+K N+L+++ K++DFGL++ + S V + Y P+ TE S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS--TEYS 182
Query: 666 ---DVYSFGVVLLEVLCARPAINPQLPREQVNL 695
D++ G +L E+ RP +E+++L
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 27/156 (17%)
Query: 490 IGVGGFGNVYLGEIDDGTKV-AVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G G G V+L + K+ A+K + + TE ++L+ L H L +L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL-- 66
Query: 546 YCDENSEM--ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHY 595
Y +E LV +Y G L + + L + AR L Y
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQP------GKCLSEEV--ARFYAAEVLLALEY 118
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
LH GI++RD+K NILL ++ +SDF LSK
Sbjct: 119 LH---LLGIVYRDLKPENILLHESGHIMLSDFDLSK 151
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHR 538
+ + +G G FG V+L + A+K + E ++L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
++ L + + ++ EY+ G +L +N S L + L YLH+
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST-AVKGSFGYLDPEYFR 657
+ I++RD+K NILLD K++DFG +K T + G+ YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPEVIQ 171
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
+ + D ++ G+++ E+L P
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 54/230 (23%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 472 FSFQELQ----EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQ 526
F QEL E + + + + +G G +G+V + G +VAVK+ + + I +
Sbjct: 3 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 62
Query: 527 T--EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE 584
T E+++L ++H +++ L+ + E ++ HL G +L + Q+L
Sbjct: 63 TYRELRLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 585 ------ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638
+ RGL Y+H+ IIHRD+K +N+ ++++ K+ DFGL++
Sbjct: 119 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR------- 168
Query: 639 HVSTAVKGSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLLEVLCAR 681
H + GY+ ++R ++ + D++S G ++ E+L R
Sbjct: 169 HTDDEMT---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 44/293 (15%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKR------GNPQSEQGITEFQTEIQMLSKL 535
NF IG G F VY + D VA+K+ + ++ Q + EI +L +L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59
Query: 536 RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLY----GKNLPP--LSWKQRLEISIGS 589
H +++ + E++E+ +V E G + K L P WK +++
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL---- 115
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGS 647
+ ++H+ + ++HRD+K N+ + V K+ D GL + + H ++ G+
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGT 169
Query: 648 FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707
Y+ PE KSD++S G +L E+ A+ +++NL +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQK------ 219
Query: 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760
+E+ P L E K E C+ RP +G V + A Q+
Sbjct: 220 IEQCDYPPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYV---HQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGT--KVAVKRGNPQS---EQGITEFQTEIQMLSKLR 536
++F+ +G G FG V L + VA+KR ++ + +E ++L+ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIG---SARGL 593
H V+L G + S + LV E++ G F L +R +G +A+ +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEF--------FTFLRRNKRFPNDVGCFYAAQIV 141
Query: 594 HYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDP 653
+ I++RD+K N+LLD + K++DFG +K + T + G+ Y+ P
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---VVDTRTYT-LCGTPEYIAP 197
Query: 654 EYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLP 689
E + +D ++ G+ + E+L P P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 44/219 (20%)
Query: 489 IIGVGGFGNVYLGEIDD--GTKVAVKRGNPQSEQ--GITEFQTEIQMLSKLRHRHLVS-- 542
+IG G +G V ID G KVA+K+ N E T EI++L LRH +V
Sbjct: 7 VIGKGSYG-VVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 543 ---LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWK----QRLEISIGSARGLHY 595
L E ++ +V+E M + + +L P + Q L R L Y
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL-------RALKY 118
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK----DAPIGQGHVSTAVKGSFGYL 651
+HT + HRD+K NIL + + K+ DFGL++ D P TA+ + Y+
Sbjct: 119 IHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-------TAIFWT-DYV 167
Query: 652 DPEYFRRQQL--------TEKSDVYSFGVVLLEVLCARP 682
++R +L T D++S G + EVL +P
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 27/227 (11%)
Query: 469 GRYFSFQELQEATKNFDSSAIIGVGGFGNVY-LGEIDDGTKVAVKRGNPQSEQGITEFQT 527
G+ F + + ++ IG G +G V+ + +G+K AVK +P + E +
Sbjct: 5 GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEA 63
Query: 528 EIQMLSKLR-HRHLVSLIGY-----CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ 581
E +L L H ++V G ++ LV E + G D + G L +
Sbjct: 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF----LKRGE 119
Query: 582 RLEISI------GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635
R+E I + GL +LH IHRDVK NILL K+ DFG+S
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 636 GQGHVSTAVKGSFGYLDPEYFR-RQQL----TEKSDVYSFGVVLLEV 677
+ +T+V F ++ PE QQL + DV+S G+ +E+
Sbjct: 177 TRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 484 FDSSAIIGVGGFGNVYLGEIDDGTK-VAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHL 540
F+ ++G G +G V + + VA+K+ E + T E++ML L+ ++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFR---DHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
V L ++ LV+EY+ + G +PP + + I + +H+ H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLI---KAIHWCH 117
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
I+HRD+K N+L+ N V K+ DFG +++ G T + Y PE
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
+ D++S G +L E+ +P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 472 FSFQELQ----EATKNFDSSAIIGVGGFGNVYLGEIDD--GTKVAVKR-GNP-QSEQGIT 523
F +E+ E + + S +G G +G+V ID G KVA+K+ P QSE
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSV-CSAIDKRTGEKVAIKKLSRPFQSEIFAK 59
Query: 524 EFQTEIQMLSKLRHRHLVSLIGY------CDENSEMILVYEYMSNGPFRDHLYGKNLPPL 577
E+ +L ++H +++ L+ DE + LV YM + L PL
Sbjct: 60 RAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPL 114
Query: 578 SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK--DAPI 635
S + + GL Y+H + GIIHRD+K N+ ++++ K+ DFGL++ DA +
Sbjct: 115 SEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171
Query: 636 GQGHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLLEVL 678
G+V T Y PE + D++S G ++ E+L
Sbjct: 172 -TGYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 39/224 (17%)
Query: 490 IGVGGFGNVYLG--EIDDGTKVAVKRGNPQSEQG--ITEFQTEIQMLSKLRHRHLVSLIG 545
+G G + VY G ++ D VA+K + E+G T + E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE-----ISIGSA--------RG 592
+ LV+EY+ K+L KQ L+ I++ + RG
Sbjct: 72 IIHTEKSLTLVFEYLD----------KDL-----KQYLDDCGNSINMHNVKLFLFQLLRG 116
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
L+Y H + ++HRD+K N+L+++ K++DFGL++ I S V + Y
Sbjct: 117 LNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRP 172
Query: 653 PE-YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695
P+ + + D++ G + E+ RP EQ++
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 482 KNFDSSAIIGVGGFGNVYL------GEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL 535
K+FD +++G G FG V + G+I KV +K+ +++ ++ F+ E +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDI-YAMKV-MKKSVLLAQETVSFFEEERDILSIS 58
Query: 536 RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHY 595
+ L + + LV EY G LS R E Y
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQFY 107
Query: 596 L-------HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF 648
L H+ G +HRD+K N+L+D K++DFG + + S G+
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 649 GYLDPEYFRRQQLTEKS------DVYSFGVVLLEVLCAR 681
Y+ PE K D +S GV+ E++ R
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 4e-07
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 66/228 (28%)
Query: 490 IGVGGFGNVYLGEIDDGTK--VAVKR-----GNPQSEQGITEFQT--EIQMLSKLR-HRH 539
+G G +G V+ ID TK VA+K+ N Q +T EI L +L H +
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQ-----RTFREIMFLQELGDHPN 68
Query: 540 LVSLIGY--CDENSEMILVYEYM---------SNGPFRDH----LYGKNLPPLSWKQRLE 584
+V L+ + + ++ LV+EYM +N H +Y Q L
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY----------QLL- 117
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL---------SKDAPI 635
+ L Y+H+G +IHRD+K +NILL+ + K++DFGL + + P+
Sbjct: 118 ------KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 636 GQGHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+V+T Y PE + T+ D++S G +L E+L +P
Sbjct: 169 LTDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 74/285 (25%), Positives = 131/285 (45%), Gaps = 57/285 (20%)
Query: 472 FSFQELQ----EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQ 526
F QEL E + + + +G G +G+V + KVAVK+ + + I +
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR 60
Query: 527 T--EIQMLSKLRHRHLVSLIGY------CDENSEMILVYEYMSNGPFRDHLYGKNLPPLS 578
T E+++L ++H +++ L+ + +E+ LV M G +L +
Sbjct: 61 TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM----------GADLNNIV 110
Query: 579 WKQRLE------ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632
Q+L + RGL Y+H+ GIIHRD+K +N+ ++++ ++ DFGL++
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ 167
Query: 633 APIGQ-GHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPR 690
A G+V+T Y PE + D++S G ++ E+L + A+ P
Sbjct: 168 ADDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK-ALFPG--- 218
Query: 691 EQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKF-AEAAEK 734
++ Q KR ++E +VGT +PE LKK +E A K
Sbjct: 219 -----NDYIDQLKR--IME------VVGTPSPEVLKKISSEHARK 250
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHLVSLIGY 546
+G G + VY G+ +G VA+K Q E+G T F E +L L+H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71
Query: 547 CDENSEMILVYEYMSNG--PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
+ LV+EY+ + D G L P + K L RGL Y+H + I
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPG-GLHPENVKLFL---FQLLRGLSYIHQ---RYI 124
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
+HRD+K N+L+ D K++DFGL++ + S V + Y P+ TE
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGS--TEY 181
Query: 665 S---DVYSFGVVLLEVL 678
S D++ G + +E++
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS-- 647
ARG+ +L ++ +HRD+ + N+LL + K+ DFGL++D +VS KGS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 648 --FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
++ PE T SDV+S+G++L E+
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/261 (21%), Positives = 104/261 (39%), Gaps = 48/261 (18%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKLRH 537
++F+S +IG G FG V L + D V +++ + ++ + + E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYL 596
+V + + + L+ E++ G L K+ L + + ++ + +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL--------------------------- 629
G IHRD+K N+LLD K+SDFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 630 -------SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
++ + ++ + G+ Y+ PE F + + D +S GV++ E+L P
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 683 AINPQLPREQVNLAEWAMQWK 703
+ P+E + M WK
Sbjct: 235 PFCSETPQETY---KKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 50/261 (19%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDD-----GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH 537
+F+S +IG G FG V L + D K+ K + EQ + + E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQ-VAHIRAERDILVEADG 60
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYL 596
+V + + + L+ E++ G L K+ L + + + ++ + +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG----------------LSKDAPI----- 635
G IHRD+K N+LLD K+SDFG L+ + P
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 636 -------------GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ ++ + G+ Y+ PE F + + D +S GV++ E+L P
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 683 AINPQLPREQVNLAEWAMQWK 703
+ P+E M WK
Sbjct: 235 PFCSETPQETYRK---VMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 528 EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISI 587
E+ +L K ++V G + + EYM G D LY + + + I
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRI 107
Query: 588 GSA--RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
A +GL +L IIHRDVK TN+L++ N K+ DFG+S + V++ K
Sbjct: 108 TYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAK 159
Query: 646 GSFG---YLDPEYFR------RQQLTEKSDVYSFGVVLLE 676
+ G Y+ PE + T +SDV+S G+ +LE
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 65/256 (25%), Positives = 111/256 (43%), Gaps = 38/256 (14%)
Query: 508 KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRD 567
+V +K +P F ++S++ H HL + G C SE I+V E++ +GP
Sbjct: 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105
Query: 568 HLYGKNLP-PLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA---- 622
L + P++WK + + SA L YL + ++H +V + NILL +A
Sbjct: 106 CLRKEKGRVPVAWKITVAQQLASA--LSYLED---KNLVHGNVCAKNILLARLGLAEGTS 160
Query: 623 ---KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVL 678
K+SD G+S A + V ++ PE L+ +D +SFG LLE+
Sbjct: 161 PFIKLSDPGVSFTALSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI- 214
Query: 679 CARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE-SLKKFAEAAEKCLA 737
+ ++P ++ +E +++K L PE S K+ A +CL
Sbjct: 215 ----CFDGEVPLKERTPSEKERFYEKKHRL-------------PEPSCKELATLISQCLT 257
Query: 738 DHGVDRPTMGDVLWNL 753
RP+ +L +L
Sbjct: 258 YEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 24/143 (16%)
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG---S 647
GL Y+H+ ++HRD+K N+L++ + K+ DFGL++ G + + +
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 648 FGYLDPEYFRRQQLTEKS-DVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706
Y PE Q K+ DV+S G +L E+L +P + +Q+N
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ----------- 221
Query: 707 LLEKIIDPHLVGTINPESLKKFA 729
I+ ++GT + E+L +
Sbjct: 222 ----IL--QVLGTPDEETLSRIG 238
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 494 GFGN---VYLGE-IDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
GF N VYL GT V V+ + + +E+ + Q E+ + RH ++++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL--EISIGSARGLHYLHTGTAQGII 605
S + ++ +M+ G L K P + L I G+ RGL+YLH G I
Sbjct: 69 TTGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYI 123
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPI---GQGH--------VSTAVKGSFGYLDPE 654
HR++K+++IL+ + + +S GLS + GQ ST+V +L PE
Sbjct: 124 HRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPE 178
Query: 655 YFRRQQL---TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695
RQ L KSD+YS G+ E+ R + R Q+ L
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVPFQ-DMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 475 QELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE----QGITEFQTEIQ 530
++L+ ++++ +IG G FG V L KV + + E F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 531 MLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA 590
+++ +V L ++ + +V EYM G + + ++P W + + A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA 154
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKG 646
L +H+ G IHRDVK N+LLD + K++DFG ++K+ G TAV G
Sbjct: 155 --LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE---GMVRCDTAV-G 205
Query: 647 SFGYLDPEYFRRQ----QLTEKSDVYSFGVVLLEVL 678
+ Y+ PE + Q + D +S GV L E+L
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 37/161 (22%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTKVAVKR--------GNPQSEQGITE----FQT--EIQML 532
A +G G +G V G VA+K+ + Q + F T E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 533 SKLRHRHLVSLIG-YCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA 590
++++H +++ L+ Y + + I LV + M+ + + K S + + + I
Sbjct: 75 NEIKHENIMGLVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQI--L 129
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
GL+ LH +HRD+ NI ++ + K++DFGL++
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 76/311 (24%), Positives = 128/311 (41%), Gaps = 70/311 (22%)
Query: 482 KNFDSSAIIGVGGFGNVYL-GEIDDGTKVAVK--RGNPQSEQGITE-FQTEIQMLSKLRH 537
+F+S +IG G FG V L + D G A+K R + E+ + E +L++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 538 RHLVSLIGYC---DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ-RLEISIGSARGL 593
+V L Y DEN + L+ EY+ G L K+ + ++ R I+ + +
Sbjct: 61 PWVVKL--YYSFQDENY-LYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIA-ETILAI 114
Query: 594 HYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST----------- 642
+H G IHRD+K N+LLD K+SDFGL + + H +
Sbjct: 115 DSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPS 169
Query: 643 ----------------------------AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 674
+ G+ Y+ PE F + ++ D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 675 LEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES---LKKFAEA 731
E+L P P+E + WK E + P V ++PE+ +K+
Sbjct: 230 YEMLVGYPPFCSDNPQETY---RKIINWK-----ETLQFPDEVP-LSPEAKDLIKRLCCE 280
Query: 732 AEKCLADHGVD 742
AE+ L ++GV+
Sbjct: 281 AERRLGNNGVN 291
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 490 IGVGGFGNVYLGEIDD--GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV------ 541
+G G G V +D +VAVK+ Q + EI+++ +L H ++V
Sbjct: 13 LGCGSNGLV-FSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 542 --------SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGL 593
+G E + + +V EYM D PLS + RGL
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 594 HYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSK--DAPIG-QGHVSTAVKGSFG 649
Y+H+ ++HRD+K N+ ++ ++ V K+ DFGL++ D +G++S + +
Sbjct: 128 KYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 650 YLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695
Y P T+ D+++ G + E+L +P EQ+ L
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 490 IGVGGFGNVYLGEIDDGTK--VAVKRGN-PQSEQGITEFQT-EIQMLSKLRHRHLVSLIG 545
IG G +G VY D T +A+K+ Q ++G+ EI +L +++H ++V L
Sbjct: 10 IGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISI--GSARGLHYLHTGTAQG 603
+ LV+EY+ + + H+ + P + RL + RG+ Y H+
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCHS---HR 122
Query: 604 IIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE-YFRRQQL 661
++HRD+K N+L+D K++DFGL++ I + V + Y PE +
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHY 181
Query: 662 TEKSDVYSFGVVLLEVLCARP 682
+ D++S G + E++ +P
Sbjct: 182 STPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++ A G + T + Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLA--EWAMQWKRKGLLE 709
PE E D++S G ++ E++ R ++ ++ QW + ++E
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV-----------RHKILFPGRDYIDQWNK--VIE 232
Query: 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAE 769
++ GT PE +KK + + ++ +RP + + + L A ++
Sbjct: 233 QL------GTPCPEFMKKL----QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282
Query: 770 EESQSAATAAASPAAVAAPAATSASDDRPVSAPKENV--GPAEVHA 813
+ SQ A S V PA + D+ + P NV PAEV A
Sbjct: 283 KASQ--ARDLLSKMLVIDPAKRISVDE-ALQHPYINVWYDPAEVEA 325
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++ A G + T + Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLC 679
PE E D++S G ++ E++
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 23/146 (15%)
Query: 197 YVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAP-- 254
V +N GGP T DS G T+ D+ F T V +G + +
Sbjct: 1 VVLAINCGGPEHT---DSDGITYEADTYF--------TGGSADYYVSDTNGSSSIAGTTD 49
Query: 255 ATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIV--SKSLNDLYFNVYVN 312
+Y + +F ++ +Y + LHF +I L F+VYV
Sbjct: 50 PELYQTE------RYSPSSF--SYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQ 101
Query: 313 GKTAISALDLSTVAQGLATPYYRDIV 338
GK + D+ A G +++ +
Sbjct: 102 GKLVLKDFDIVAEAGGKGKTAHKEYI 127
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 23/160 (14%)
Query: 217 RTWVPDSNFLKEKNLA-TTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFN 275
R W F + A +T +V A P P ++Y SA + D+ QP+
Sbjct: 218 RFWNRMQTFGSGSDQAISTENVIKKA-----SNAPNFYPESLYQSALVSTDT---QPD-- 267
Query: 276 VTWTFDVDSTFSYLLRLHFCDIVS--KSLNDLYFNVYVNGKTAISALDLSTVAQGLATPY 333
+++T DVD +Y + LHF +I + + F+V +NG TA +D+ ++
Sbjct: 268 LSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGER---- 323
Query: 334 YRDIVVNASLMHNGLNVQIG--PNKENTGTRNAILNGLEV 371
Y +V+N ++ +G + I P K GT AI+N +EV
Sbjct: 324 YTALVLNKTVAVSGRTLTIVLQPKK---GTH-AIINAIEV 359
|
Length = 623 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 490 IGVGGFGNVYLG--EIDDGTKVAVKRGNPQSEQG--ITEFQTEIQMLSKLRHRHLVSLIG 545
+G G + V+ G ++ + VA+K + E+G T + E+ +L L+H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA-RGLHYLHTGTAQGI 604
+ + LV+EY+ + Y + + ++I + RGL Y H + +
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQ---YMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR-RQQLTE 663
+HRD+K N+L+++ K++DFGL++ + S V + Y P+ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 664 KSDVYSFGVVLLEVLCARP 682
+ D++ G + E+ RP
Sbjct: 185 QIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 508 KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRD 567
KV +K +P F M+ ++ H+H+V L G C + E I+V E++ GP D
Sbjct: 34 KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-D 92
Query: 568 HLYGKNLPPLS--WKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL-----DDNY 620
+ L+ WK ++ + SA L YL + ++H +V + NILL D
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASA--LSYLED---KDLVHGNVCTKNILLAREGIDGEC 147
Query: 621 --VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEV 677
K+SD G+ PI V+ ++ PE + L+ +D +SFG L E+
Sbjct: 148 GPFIKLSDPGI----PITVLSRQECVE-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 678 LCARPAINPQLPREQVNLAE 697
N ++P + LAE
Sbjct: 203 -----CYNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKV-AVKRGNPQSEQGITE---FQTEIQMLSKLRH 537
++F+ +IG G FG V + ++ + KV A+K N E F+ E +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLP---PLSWKQRLEISIGSARG 592
+ + +L + + + LV +Y G L + LP + + I+I S
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKGSF 648
LHY +HRD+K NIL+D N +++DFG L +D + S+ G+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ----SSVAVGTP 167
Query: 649 GYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVL 678
Y+ PE + + + + D +S GV + E+L
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 49/211 (23%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQT-EIQMLSKLRHRHLVSL--IGY 546
+G G +G+VY + DG GI+ EI +L +L+H +++SL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLHT 598
+ ++ L+++Y + + H+ + + K+ +++ G + G+HYLH
Sbjct: 69 SHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH- 125
Query: 599 GTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSK--DAPIGQGHVSTAVKGSFGYLD 652
A ++HRD+K NIL+ + K++D G ++ ++P+ V +F Y
Sbjct: 126 --ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 653 PEYFR-RQQLTEKSDVYSFGVVLLEVLCARP 682
PE + T+ D+++ G + E+L + P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
G+ +LH + GIIHRD+K +NI++ + K+ DFGL++ A G + T + Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCAR 681
PE E D++S G ++ E++
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGI--TEFQTEIQMLSKLRHRHLVSL--I 544
+G G + VY G +G VA+K + ++E+G+ T + E +L L+H ++V L I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 545 GYCDENSEMILVY------EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
+ E + Y +YM P H Y L Q L RGL Y+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMF---QLL-------RGLAYIH- 120
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR- 657
Q I+HRD+K N+L+ K++DFGL++ I S+ V + Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLG 177
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARPA 683
+ D++ G + +E+L +PA
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 50/217 (23%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQ---------TEIQMLSKLRHRHL 540
+G G +G+VY K K G + E + + + EI +L +L+H ++
Sbjct: 9 VGRGTYGHVY--------KAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 541 VSL--IGYCDENSEMILVYEYMSNGPF---RDHLYGK-NLPPLSWKQRLEISI--GSARG 592
++L + + ++ L+++Y + + + H K N P+ + + S+ G
Sbjct: 61 IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 593 LHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSK--DAPIGQGHVSTAVKG 646
+HYLH A ++HRD+K NIL+ + K++D G ++ ++P+ V
Sbjct: 121 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 647 SFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVLCARP 682
+F Y PE + T+ D+++ G + E+L + P
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 37/213 (17%)
Query: 490 IGVGGFGNVYLGEIDDGTKVA------VKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
IG G FG V L EI T VA +K EQ EF + L+H +++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWK---------QRLEISIGSARGLH 594
+G C E +LV+EY G + +L + W QR+ I A G+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACEI--AAGVT 113
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG--YLD 652
++H +H D+ N L + KV D+G+ + + ++ T +L
Sbjct: 114 HMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGP-SRYKEDYIETEDDKCVPLRWLA 169
Query: 653 PEYFRRQQ-------LTEKSDVYSFGVVLLEVL 678
PE T+ S+V++ GV L E+
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-05
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 27/169 (15%)
Query: 523 TEFQTEIQMLSKLRHRHLVSL--IGYCDENSEMIL------VYEYMSNGPFRDHLYGKNL 574
+ + EI L +L H +++ + I + N+ MI +Y +M + F K+
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDR 263
Query: 575 PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL----- 629
P L + + + A + Y+H + +IHRD+K NI L+ + + DFG
Sbjct: 264 PLLKQTRAIMKQLLCA--VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
+ G V T S PE E +D++S G++LL++L
Sbjct: 319 KEREAFDYGWVGTVATNS-----PEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 58/267 (21%), Positives = 100/267 (37%), Gaps = 58/267 (21%)
Query: 484 FDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRH 539
F +G+G FG V L ++D A+K + + + + E +L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA-RGLHYLHT 598
+V L + + V +Y+ G L + P + + A +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM-- 120
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGL--------------SKDAP---------- 634
G IHRD+K NIL+D + K++DFGL S D
Sbjct: 121 ----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 635 -------------------IGQGH---VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 672
+ H ++ ++ G+ Y+ PE R T+ D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 673 VLLEVLCARPAINPQLPRE-QVNLAEW 698
+L E+L +P Q P E Q+ + W
Sbjct: 237 ILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 57/264 (21%), Positives = 101/264 (38%), Gaps = 64/264 (24%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G+G FG V L ++D A+K + + + + + E +L++ + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS----WKQRLEISIGSARGLHYLHTGTA 601
+ + V +Y+ G L + P + L ++I S +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM-------- 120
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGL-------------SKDAPIGQGH--------- 639
G IHRD+K NIL+D + K++DFGL K + I Q
Sbjct: 121 -GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 640 ------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLL 675
++ ++ G+ Y+ PE R+ T+ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 676 EVLCARPAINPQLPRE-QVNLAEW 698
E+L +P P E Q+ + W
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
G+ +LH+ GIIHRD+K +NI++ + K+ DFGL++ A + T + Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVL 678
PE E D++S G ++ E++
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHLVSLIGY 546
+G G + VY G G VA+K + E+G F E +L L+H ++V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDI 71
Query: 547 CDENSEMILVYEYMSN--GPFRDHLYGKNLPPLSWK----QRLEISIGSARGLHYLHTGT 600
+ LV+EY+ + D G L + + Q L RGL Y H
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDD-CGGGLSMHNVRLFLFQLL-------RGLAYCHQ-- 121
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
+ ++HRD+K N+L+ + K++DFGL++
Sbjct: 122 -RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 9e-05
Identities = 37/152 (24%), Positives = 58/152 (38%), Gaps = 27/152 (17%)
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
+ + + L +L+ +Y+ +G D L K LS + +I L+ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 597 HTGTAQGIIHRDVKSTNILLDDN----YVAKVSDFGLSKDAPIGQ-----GHVSTAVKGS 647
H IIH D+K N+L D Y+ D+GL K IG G +
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLC---DYGLCK--IIGTPSCYDGTLD------ 171
Query: 648 FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC 679
Y PE + D ++ GV+ E+L
Sbjct: 172 --YFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKV-AVKRGNPQSEQGITE---FQTEIQMLSKLRHR 538
+F+ +IG G FG V + ++ + +V A+K N E F+ E +L R
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 539 HLVSL-IGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWK---QRLEISIGSARG 592
+ +L + DEN+ + LV +Y G L + LP + + ++I S
Sbjct: 62 WITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKGSF 648
L Y +HRD+K N+LLD N +++DFG L D G + AV G+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---GTVQSNVAV-GTP 167
Query: 649 GYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVL 678
Y+ PE + + + + D +S GV + E+L
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 18/157 (11%)
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEI- 585
TE +L + H ++ L G N L+ ++ LY L+ K+ + I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPR-----YKTDLYCY----LAAKRNIAIC 182
Query: 586 ---SIGSA--RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640
+I + R + YLH IIHRD+K+ NI ++ + DFG + +
Sbjct: 183 DILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEV 677
G+ PE R D++S G+VL E+
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 13/119 (10%)
Query: 565 FRDHLY---GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621
+R LY G L PL Q ++ + Y+H +GIIHRD+K+ N+L++
Sbjct: 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPED 298
Query: 622 AKVSDFGLSKDAPIGQGHVSTAVK-GSFGYLD---PEYFRRQQLTEKSDVYSFGVVLLE 676
+ DFG A +G ST G G +D PE T D++S G+V+ E
Sbjct: 299 ICLGDFGA---ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 44/185 (23%), Positives = 66/185 (35%), Gaps = 54/185 (29%)
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGL---------SKDAPIGQGH-------------- 639
G IHRD+K NIL+D + K++DFGL SK G H
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 640 -------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA 680
++ ++ G+ Y+ PE R T+ D +S GV+L E+L
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 681 RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL---KKFAEAAEKCLA 737
+P P E Q K + P ++ E+ + AE L
Sbjct: 241 QPPFLADTPAE--------TQLKVINWETTLHIPS-QAKLSREASDLILRLCCGAEDRLG 291
Query: 738 DHGVD 742
+G D
Sbjct: 292 KNGAD 296
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 490 IGVGGFGNVYLGEIDDGT-----KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
IG G FG V+L + K RG + E+ ++ E+ ++ +L+H+++V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYI 78
Query: 545 G--YCDENSEMILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHT-- 598
N ++ ++ E+ G ++ K + ++I+ L Y H
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138
Query: 599 --GTAQGIIHRDVKSTNILLDDNY-----------------VAKVSDFGLSKDAPIGQGH 639
+ ++HRD+K NI L +AK+ DFGLSK+ IG
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN--IGIES 196
Query: 640 VSTAVKGSFGYLDPEYF--RRQQLTEKSDVYSFGVVLLEVLCA 680
++ + G+ Y PE + +KSD+++ G ++ E LC+
Sbjct: 197 MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE-LCS 238
|
Length = 1021 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 30/145 (20%), Positives = 59/145 (40%), Gaps = 15/145 (10%)
Query: 493 GGFGN-VYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS--LIGYCDE 549
GG N VYL +K + + + + E+ +L L + L ++ +
Sbjct: 8 GGLTNRVYLLG-TKDEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLASGES 64
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ L+ E++ G+ L +S +++ +I+ A L LH + H D+
Sbjct: 65 DGWSYLLMEWIE---------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAP 634
NIL+DD + + D+ + P
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 489 IIGVGGFGNVY------LGEIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKL-RHRHL 540
+G G FG V LG+ D+ +VAVK + E +E+++LS L +H+++
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGK 572
V+L+G C ++++ EY G + L K
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 10/197 (5%)
Query: 490 IGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
IG G FG V D ++ +++ + S +T E +L+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
++ LV +++ G HL + LS + + A L LH +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHK---FNVI 115
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS 665
+RD+K NILLD + DFGL K + + G+ YL PE T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 666 DVYSFGVVLLEVLCARP 682
D ++ GV+L E+L P
Sbjct: 175 DWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 61/283 (21%), Positives = 91/283 (32%), Gaps = 96/283 (33%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEF-QTEIQMLSKLRHRHLVSLIGYC- 547
+G G FG VY K+ + TE+ EI M ++R S +
Sbjct: 140 LGEGAFGVVYKAS---LVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVY 196
Query: 548 --------DENSEMILVYEYMSNGPFRDHLYGKNLP----PLSWKQRLEISIGSAR---- 591
+ E LV+ Y D + K P P + ++ G R
Sbjct: 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKI 256
Query: 592 -------------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVA-KVSDFGLSKDAPIGQ 637
GLH + GI+HRDVK NI+ + + K+ D G + D +G
Sbjct: 257 IQTIMRQILFALDGLH------STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG- 309
Query: 638 GHVSTAVKGSFGY------LDPEYFRRQQ---------------------------LTEK 664
Y LDP Y +Q L ++
Sbjct: 310 ----------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359
Query: 665 SDVYSFGVVLLEVLCARP---------AINPQLPREQVNLAEW 698
D+YS G++ L++ A P N QL R +L W
Sbjct: 360 FDIYSAGLIFLQM--AFPNLRSDSNLIQFNRQLKRNDYDLVAW 400
|
Length = 566 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 17/28 (60%), Positives = 20/28 (71%)
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLS 630
G IHRD+K NIL+D K+SDFGLS
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKV-AVKRGNPQSEQGITE---FQTEIQMLSKLRHR 538
+F+ +IG G FG V + ++ ++ A+K N E F+ E +L +
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 539 HLVSL-IGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHY 595
+ +L + DEN + LV +Y G L + LP + + + + +H
Sbjct: 62 WITTLHYAFQDEN-YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG----LSKDAPIGQGHVSTAVKGSFGYL 651
LH +HRD+K N+LLD N +++DFG +++D G S AV G+ Y+
Sbjct: 121 LH------YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD---GTVQSSVAV-GTPDYI 170
Query: 652 DPEYFRRQQ-----LTEKSDVYSFGVVLLEVL 678
PE + + + D +S GV + E+L
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 506 GTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563
G V V+R N + + + +T Q E+ + H ++V ++E+ +V +M+ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623
+D + + +S I G + L Y+H G +HR VK+++IL+ + K
Sbjct: 85 SAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD--GK 139
Query: 624 VSDFGL-SKDAPIGQGHVSTAVKGSFGY-------LDPEYFRR--QQLTEKSDVYSFGVV 673
V GL S + I G V Y L PE ++ Q KSD+YS G+
Sbjct: 140 VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 199
Query: 674 LLEV 677
E+
Sbjct: 200 ACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 832 | |||
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 | |
| KOG3593 | 355 | consensus Predicted receptor-like serine/threonine | 98.34 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.57 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.52 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.48 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.26 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.03 | |
| PLN02236 | 344 | choline kinase | 96.89 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.67 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.12 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.8 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.71 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.61 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.57 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.55 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.44 |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-58 Score=505.53 Aligned_cols=311 Identities=35% Similarity=0.562 Sum_probs=248.9
Q ss_pred EccCCCCCCC-CCCCCceeccCCCCccccccCccccccC---CCCCCCCcccccccccCCCeEEEee-cc--CCceE-EE
Q 047569 38 IDCGGKSSNP-LPDGRTFKSDKEALPFLQTKEDIQVSVP---SADVPSPIYLSARVFKEESTYTFQL-NQ--PGWHW-VR 109 (832)
Q Consensus 38 i~CG~~~~~~-~~~~~~~~~~~~~~~~~~~g~~~~~~~~---~~~~~~~~~~t~R~f~~~~~~cy~l-~~--~g~~~-vR 109 (832)
||||++.+.+ |.|..|++.|++|..|+++|++++++.. ......++|+|||+||+|.||||++ +. +|.|| ||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR 80 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR 80 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence 8999987776 8884344444444899999998888422 2345567899999999999999999 55 46688 99
Q ss_pred EEe------------------ecCCCCcccccceeeeeec-CceEEEEEEeec-CCeEEEEEEeCCCCc-eeeeeeEEEe
Q 047569 110 LHF------------------FALPAKEADLQKASFHVAT-DNCCEEFMLNLT-ESTFSIKFTPMKNSV-AFINAIEVVS 168 (832)
Q Consensus 110 ~~f------------------f~~~~~~~~~~~~~~~~~~-~~~~~E~i~~~~-~~~~~vc~~~~~~~~-pFi~~iEl~~ 168 (832)
+|| |||++|++.|++|+.+... ..+++|+|+.+. +++++|||+|+++|+ ||||+||||+
T Consensus 81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~ 160 (347)
T PF12819_consen 81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRP 160 (347)
T ss_pred EEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEE
Confidence 999 7888899999999988721 368999888888 799999999999777 9999999999
Q ss_pred cCCccccCCCCcccccccCCcchhhhhhheeeeecCCCC--CCCCCCCCccccccCC-CceeccCCCcceeccCCeeecC
Q 047569 169 APDTLISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPS--ITPQNDSLGRTWVPDS-NFLKEKNLATTASVESNAVQYP 245 (832)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~r~n~Gg~~--~~~~~D~~~R~W~~d~-~~~~~~~~~~~~~~~~~~~~~~ 245 (832)
||+++|.+ ..+..+++|++++|+||||.. +++|+|++||+|.+.. ...|...++ ...++..
T Consensus 161 lp~~ly~~----------~~~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist------~~~i~~~ 224 (347)
T PF12819_consen 161 LPDSLYPD----------TDANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNIST------TSNININ 224 (347)
T ss_pred CCccceec----------cccCCCceeEEEEeecCCCcccccCCCCCcceeeccccccCcccccccc------ceeeecc
Confidence 98888853 112577899999999999998 9999999999999652 222333222 2224322
Q ss_pred CCCCCcccchhhHHhhhccCCCCCCCCCcceeEEeccCCCCceEEEEEeeeeee--cccCcEEEEEEEcCeeecccCchh
Q 047569 246 DGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVS--KSLNDLYFNVYVNGKTAISALDLS 323 (832)
Q Consensus 246 ~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~~t~~~~~~~~~~Y~v~LhFae~~~--~~~~~R~Fdi~in~~~~~~~~di~ 323 (832)
...+.|.+|..|||||+++.+++. ++||+|.+ ++++.+|+|+||||||+. .+.++|+|||||||+.+.+ |+.
T Consensus 225 ~~~~~~~~P~~V~~TA~~~~~~s~---~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~--~~~ 298 (347)
T PF12819_consen 225 SSNNPYDAPSAVYQTARTPSNSSD---PLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS--DVS 298 (347)
T ss_pred cCCccCcChHHHHHhhhccccccc---ceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC--ccC
Confidence 346789999999999999998763 59999999 999999999999999987 3456899999999999997 555
Q ss_pred h-hhcCcCcceEEEEEEEeccccCc-eEEEEccCCCCCCCcccccccceeecc
Q 047569 324 T-VAQGLATPYYRDIVVNASLMHNG-LNVQIGPNKENTGTRNAILNGLEVIKM 374 (832)
Q Consensus 324 ~-~~~~~~~~~~~d~~~~~~~~~~g-l~~s~~~~~~~~~~~~~~lng~ei~~l 374 (832)
. ..+....+++.|+.+.++ ..+ ++|+|++...+ ..+|||||+|||+|
T Consensus 299 ~~~~~~~~~~~~~d~~~~~~--~~~~~~isL~~t~~S--~lppiLNalEIy~v 347 (347)
T PF12819_consen 299 PPYLGADTVPYYSDYVVNVP--DSGFLNISLGPTPDS--TLPPILNALEIYKV 347 (347)
T ss_pred cccccCcceEeecceEEEec--CCCEEEEEEEeCCCC--CcCceeEeeeeEeC
Confidence 4 344566788999999987 444 89999887775 44999999999986
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=502.13 Aligned_cols=316 Identities=22% Similarity=0.332 Sum_probs=252.8
Q ss_pred CCCcEEEccCCCCCC-CCCCCCceeccCCCCccccccCccccccCCCCCCCCcccccccccC--CCeEEEee-ccCCceE
Q 047569 32 PRDNFLIDCGGKSSN-PLPDGRTFKSDKEALPFLQTKEDIQVSVPSADVPSPIYLSARVFKE--ESTYTFQL-NQPGWHW 107 (832)
Q Consensus 32 p~~~~~i~CG~~~~~-~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~t~R~f~~--~~~~cy~l-~~~g~~~ 107 (832)
..|+|+||||++.+. +|.++|+|++| ..|. .|.....+.+ +...++|+|+|+||. +.+|||++ ++++++|
T Consensus 22 ~~~~~~I~CGs~~~~~~d~~~~~w~~D---~~~~-~~~~~~~~~~--~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~y 95 (623)
T PLN03150 22 EPFTMRISCGARVNVRTAPTNTLWYKD---FAYT-GGIPANATRP--SFIAPPLKTLRYFPLSDGPENCYNINRVPKGHY 95 (623)
T ss_pred CCccEEEeCCCCCCcccCCCCCEEcCC---cccc-cCccccccCc--ccccchhhccccCCcccccccceEeeecCCCcE
Confidence 467899999998665 55789999999 5554 3333333322 345678999999995 56999999 4676677
Q ss_pred -EEEEe-------------ecCCCCcccccceee--eeecCceEEEEEEeecCCeEEEEEEeCCCCceeeeeeEEEecCC
Q 047569 108 -VRLHF-------------FALPAKEADLQKASF--HVATDNCCEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPD 171 (832)
Q Consensus 108 -vR~~f-------------f~~~~~~~~~~~~~~--~~~~~~~~~E~i~~~~~~~~~vc~~~~~~~~pFi~~iEl~~~~~ 171 (832)
||+|| ||+++|++.|.+++. +..+..+++|+|+++++++++|||+++++++||||+||||+||+
T Consensus 96 lVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~~l~~ 175 (623)
T PLN03150 96 SVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDD 175 (623)
T ss_pred EEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEEEcCc
Confidence 99999 999999999999975 33455678999999999999999999999999999999999988
Q ss_pred ccccCCCCcccccccCCcchhhhhhheeeeecCCCC----CCCCCCCC--ccccccCCCceeccCCCcceeccCCeeecC
Q 047569 172 TLISDEGSSLFPVDSYEGLSKFSYQYVYRLNMGGPS----ITPQNDSL--GRTWVPDSNFLKEKNLATTASVESNAVQYP 245 (832)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~r~n~Gg~~----~~~~~D~~--~R~W~~d~~~~~~~~~~~~~~~~~~~~~~~ 245 (832)
++|. ..+.. ..+.+|++++|+||||.. +++|+|++ ||+|.+|+.|+.. .....+....|+++
T Consensus 176 ~~y~-----~~~~~----~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~---~~~~~st~~~I~~~ 243 (623)
T PLN03150 176 KAYN-----FGPSW----GQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG---SDQAISTENVIKKA 243 (623)
T ss_pred cccc-----ccccc----cCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCC---cccccccccccccc
Confidence 8873 11101 236679999999999875 45699998 9999999887511 11112233356555
Q ss_pred CCCCCcccchhhHHhhhccCCCCCCCCCcceeEEeccCCCCceEEEEEeeeeee--cccCcEEEEEEEcCeeecccCchh
Q 047569 246 DGVTPLIAPATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVS--KSLNDLYFNVYVNGKTAISALDLS 323 (832)
Q Consensus 246 ~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~~t~~~~~~~~~~Y~v~LhFae~~~--~~~~~R~Fdi~in~~~~~~~~di~ 323 (832)
+.+.+.+|+.||||||++.+. ..+++|.++++++++|+|+|||||++. ...++|+|||||||+.+++++||.
T Consensus 244 -~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~ 317 (623)
T PLN03150 244 -SNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIV 317 (623)
T ss_pred -cCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChh
Confidence 356788999999999998874 367999999999999999999999974 356899999999999999999999
Q ss_pred hhhcCcCcceEEEEEEEeccccCceEEEEccCCCCCCCcccccccceeecccCC
Q 047569 324 TVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKENTGTRNAILNGLEVIKMSNS 377 (832)
Q Consensus 324 ~~~~~~~~~~~~d~~~~~~~~~~gl~~s~~~~~~~~~~~~~~lng~ei~~ls~~ 377 (832)
..+++...+++.|+.+.+. .+.|+|+++|... .+|||||+|||+++..
T Consensus 318 ~~~g~~~~~~~~~~~v~~~--~g~l~isl~p~~~----s~pilNaiEI~~~~~~ 365 (623)
T PLN03150 318 KMSGERYTALVLNKTVAVS--GRTLTIVLQPKKG----THAIINAIEVFEIITA 365 (623)
T ss_pred hhcCCcccceEEEeEEeec--CCeEEEEEeeCCC----Ccceeeeeeeeecccc
Confidence 9888788899999999876 4449999988653 2699999999999763
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=460.06 Aligned_cols=290 Identities=53% Similarity=0.867 Sum_probs=257.4
Q ss_pred CCcccCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEe
Q 047569 468 LGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547 (832)
Q Consensus 468 ~~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~ 547 (832)
..+.|+++|+..||++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34679999999999999999999999999999999999999999988766543145699999999999999999999999
Q ss_pred ccCC-cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEec
Q 047569 548 DENS-EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSD 626 (832)
Q Consensus 548 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 626 (832)
.+.+ +.+||||||++|+|.++|+.....+++|.++++|+.++|+||+|||+.+...||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999876544899999999999999999999998877899999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 627 FGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 627 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
||+++.......+......||.+|+|||++..+..++|+|||||||+|+||++|+++.+...+.....+.+|+.....++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997665311111111179999999999999999999999999999999999999998776666777999999999999
Q ss_pred ccccccCCCCC-CCCCh-hHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 707 LLEKIIDPHLV-GTINP-ESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 707 ~~~~i~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.+.+++|+.+. ..... +...++.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999997 55554 67888999999999999999999999998886543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=377.04 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=213.7
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEecc
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~ 549 (832)
+++.|++. .+.||+|..|+|||+.++ +++.+|+|.+... .+...+++.+|++++++.+||+||++||.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 55566544 678999999999999876 6899999998544 45567889999999999999999999999999
Q ss_pred CC-cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 550 NS-EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 550 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
++ +..++||||++|+|++++... +.+++...-+|+.++++||.|||+ .++||||||||+|||++..|++||+|||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 88 599999999999999999654 469999999999999999999995 2889999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCCh--hhhhhHHHHHHHHhhhc
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLP--REQVNLAEWAMQWKRKG 706 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~--~~~~~l~~~~~~~~~~~ 706 (832)
.+...... ...+..||..|||||.+++..|+.++||||||++++|+.+|+-||....+ .....+
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L----------- 290 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL----------- 290 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH-----------
Confidence 99876543 45677899999999999999999999999999999999999999977511 111222
Q ss_pred ccccccCCCCCCCCCh-hHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 707 LLEKIIDPHLVGTINP-ESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 707 ~~~~i~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+..|++.... .++. .++++++.++..||++||.+||++.|++++
T Consensus 291 -l~~Iv~~ppP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 291 -LCAIVDEPPP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -HHHHhcCCCC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2333332222 2233 478899999999999999999999999754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=390.83 Aligned_cols=253 Identities=36% Similarity=0.572 Sum_probs=212.9
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcc--cHHHHHHHHHHHHhCCCcceeeEEEEeccCC-cEEEEEEecCCC
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ--GITEFQTEIQMLSKLRHRHLVSLIGYCDENS-EMILVYEYMSNG 563 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~~g 563 (832)
.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+|+|||||+++|+|.+.. .+++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999975445999998865322 2569999999999999999999999999887 799999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeeccCCCCceeeCCCC-ceEEecccccccCCCCCCcee
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG-IIHRDVKSTNILLDDNY-VAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 641 (832)
+|.+++++.....+++..+++++.|||+||.|||+ ++ ||||||||+||||+.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 99999987545689999999999999999999999 66 99999999999999997 99999999998765322 233
Q ss_pred eccccCccccChhccc--cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~--~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
+...||+.|||||++. ...++.|+||||||++||||+||+.||....+ .+.. . .+.....+..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~--~------------~v~~~~~Rp~ 266 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVA--S------------AVVVGGLRPP 266 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHH--H------------HHHhcCCCCC
Confidence 3467999999999999 66999999999999999999999999987655 2111 1 1111222333
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
++..++..+..++.+||+.||.+||++.+++..|+.+..
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 444577889999999999999999999999999997755
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=377.20 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=205.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
..+|...+.||+|+|++||+|+++ ++..||||.+... ..+..+-+..|+++|+.++|||||+++++++..+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356788888999999999999875 6899999988776 5666777899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC------CceEEecccccc
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN------YVAKVSDFGLSK 631 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGla~ 631 (832)
|||.||+|.++|+.++ .+++..+..++.|||.||++||+ ++||||||||+||||+.. -.+||+|||+++
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999997665 79999999999999999999999 999999999999999764 468999999999
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
... .+....+.+|++-|||||+++.++|+.|+|+||+|++||||++|++||......+....++ +
T Consensus 164 ~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~-------k------ 228 (429)
T KOG0595|consen 164 FLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK-------K------ 228 (429)
T ss_pred hCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-------c------
Confidence 876 3445567899999999999999999999999999999999999999998876655432211 1
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDV 749 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 749 (832)
+......++......+.+++...++.++.+|-+..+.
T Consensus 229 -~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 229 -GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred -cccccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 1111222223333445566677777777777555444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=390.20 Aligned_cols=248 Identities=25% Similarity=0.441 Sum_probs=215.0
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.+|...++||+|||+.||.++. .+|+.||+|++.+. .....+...+||++.++|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999987 78999999987763 4555678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|+|+.++|.+++.+ ..++++.++..+.+||+.||.|||+ ++|+|||||-.|+||+++.++||+|||||.....+
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 99999999999963 4589999999999999999999999 99999999999999999999999999999987643
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
+....+.+|||.|+|||++.+...+..+||||+||+||-||.|+|||+...-.+..+.+.. ..
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~---------------~~-- 234 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL---------------NE-- 234 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh---------------cC--
Confidence 3455678899999999999999999999999999999999999999986643332222211 01
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
-.++...+.+..+||.++|+.+|.+|||+++|+..
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01233566788999999999999999999999843
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.67 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=210.1
Q ss_pred CCCccceEeecCceeEEEEE-EeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEE-EeccCCc-EEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIG-YCDENSE-MILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~-~~~~~~~-~~lV~ 557 (832)
+|++.++||+|.||+||++. ..+|..+|.|.++-. +.+..+++..|+.+|++|+|||||++++ .+.++++ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46778899999999999995 568999999987643 5677788999999999999999999998 4555555 89999
Q ss_pred EecCCCChhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLY--GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~--~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
|||++|+|.+.+. ++....+++..+++++.|+++||..+|+.-++ -|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999985 34456799999999999999999999984433 38999999999999999999999999999876
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.. .......+|||.||+||.+...+|+.|+||||+||++|||..-++||.+.. +.+... +|-..
T Consensus 180 s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~---------KI~qg 243 (375)
T KOG0591|consen 180 SK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCK---------KIEQG 243 (375)
T ss_pred ch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHH---------HHHcC
Confidence 43 334456789999999999999999999999999999999999999998762 222111 11122
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
..........+..+.++|..|+..||+.||+...+++.+..
T Consensus 244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22212225578899999999999999999996555554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=368.67 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=206.1
Q ss_pred hcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCCcc-------cHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQ-------GITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
.+.|.+.+.||+|+||.|-+|. .++|+.||||++++..-. .....++|+++|++|+|||||+++++++..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4567789999999999999995 458999999988754211 12235799999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC---CceEEecccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN---YVAKVSDFGL 629 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGl 629 (832)
.|||||||+||.|.+.+..++ .+.+.....++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999996655 56677778899999999999999 999999999999999755 7899999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCC---CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL---TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
++... ......+.+||+.|.|||++.++.. ..++|+||+||+||-+|+|.+||....... .+.+
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e--------- 392 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE--------- 392 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH---------
Confidence 99865 4566788999999999999987643 347899999999999999999998764332 1111
Q ss_pred ccccccCCCCC--CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 707 LLEKIIDPHLV--GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 707 ~~~~i~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
++....+. .....+.+++..++|.+||..||++||++.|+++.-+
T Consensus 393 ---QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 393 ---QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ---HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 11111111 1122456788999999999999999999999985543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=375.65 Aligned_cols=252 Identities=32% Similarity=0.448 Sum_probs=216.3
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
..+.||+|.||+||.|.++....||+|.+.... ...+.|.+|+++|++|+|+|||+++++|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 367899999999999999888899999887653 2347899999999999999999999999998899999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 645 (832)
.++|.......+...+.+.++.|||+|++||++ +++|||||..+||||+++..+||+||||++....+.-.......
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 999987667789999999999999999999999 99999999999999999999999999999965555444444444
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 724 (832)
-...|.|||.+....++.|||||||||+|+||+| |+.|+......+....++ ...+-..++.+
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le----------------~GyRlp~P~~C 429 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE----------------RGYRLPRPEGC 429 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh----------------ccCcCCCCCCC
Confidence 5678999999999999999999999999999998 788887665544433222 12222345668
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 725 LKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 725 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
+..+.+++..||+.+|++|||++.+.+.|+...
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 889999999999999999999998887777654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=362.39 Aligned_cols=242 Identities=25% Similarity=0.384 Sum_probs=206.7
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.++||+|+||.||.++.+ +++.+|+|++++. ..++.+...+|..+|.+++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367899999999999999999755 6899999998775 345567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
+||+.||.|..+|.+++ .+++..+.-++..|+.||.|||+ ++||||||||+|||||.+|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 99999999999997665 68999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.+....+.+||+.|||||++.+..++..+|.||||+++|||++|.+||.........+.+ ....
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I---------------~~~k- 241 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI---------------LKGK- 241 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH---------------hcCc-
Confidence 233455678999999999999999999999999999999999999999877543322211 1111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCC
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRP 744 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RP 744 (832)
....+.-.+.+.++++.+.|..+|++|-
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1112223567899999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=344.32 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=213.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc--ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE--QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
+.|+...++|+|++|+|||++.+ +|+.||||++....+ .-.+-.++|+++|++|+|||+|.++++|..+..++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999876 699999999875533 334557899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
||+..-|.++= +. ...++.....+++.|+++|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.... .+
T Consensus 82 ~~dhTvL~eLe-~~-p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE-RY-PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHH-hc-cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 99865555443 22 2358889999999999999999999 9999999999999999999999999999998763 44
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH--------Hh-hhccc
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ--------WK-RKGLL 708 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~--------~~-~~~~~ 708 (832)
...+..+.|.+|+|||++.+ .+|...+||||+||++.||++|.+.|.+..+-++..++..... .. ..+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 55677789999999999987 6899999999999999999999999999988887766654321 10 11111
Q ss_pred c-----cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 E-----KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~-----~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. +.-++.....--+..+.-+.+++..||+.||++|++.++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 111222222222445667899999999999999999999873
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=361.02 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=213.1
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|...+.||+|+|++|++|+. ++++.||||++.+. .++..+-...|-++|.+| .||.|++|+-.|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46788999999999999999964 47999999998764 445556678899999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
|+||+++|+|.++|.+.+ .+++.....++.+|+.||+|||+ +|||||||||+|||||+++++||+|||.++.+..
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999997664 79999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCc----------ee--eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh
Q 047569 636 GQGH----------VS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 636 ~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
.... .. ...+||..|.+||++.....+..+|+|+|||+||+|+.|.+||.+..+.-..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF---------- 296 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF---------- 296 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH----------
Confidence 2211 11 4478999999999999999999999999999999999999999876543221
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
++|++- .-.+++..++.+.+|+.+.|..||.+|+|..+|-+.
T Consensus 297 -----qkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 -----QKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 222221 124556667889999999999999999999888644
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=382.27 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=218.1
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
.+.+..+.||+|.||.||+|+.. +...||||.++..... ..++|++|+++|+.|+|||||+|+|.|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455788999999999999643 3568999999887655 7889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 555 LVYEYMSNGPFRDHLYGKN------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
||+|||..|+|.++|.... .++|+..+.+.|+.|||.||+||-+ +.+|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEE
Confidence 9999999999999995321 2348999999999999999999999 899999999999999999999
Q ss_pred EEecccccccCCCCCCceee-ccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVST-AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 700 (832)
||+||||++..-..+-.... ...-..+||+||.++.++++.+||||||||+|||+++ |+.||.+-...+.+..++
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~--- 719 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR--- 719 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH---
Confidence 99999999875433222211 2234578999999999999999999999999999998 888988776655443322
Q ss_pred HHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 701 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
+..+ -..+..++.++.+|+.+||+..|.+||+++||-..|+...+.
T Consensus 720 ------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 720 ------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2333 345677899999999999999999999999999999877543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=350.36 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=213.7
Q ss_pred cCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~~lV 556 (832)
+.|+..++||+|.||.||+|+ ..+|+.||+|++.... +....-..+||.+|++|+||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456668899999999999996 5689999999876554 44455668999999999999999999988766 789999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
+|||+ -+|.-++.... -.+++.++..++.|++.||+|||+ ++|+|||||.+|||||.+|.+||+||||++.+...
T Consensus 197 FeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99996 57777775433 379999999999999999999999 99999999999999999999999999999988766
Q ss_pred CCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc--cccC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE--KIID 713 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~--~i~d 713 (832)
.....+..+-|.+|++||++.+. .|+.++|+||.||||.||+.|++.|.+....+++..+-.......+..+. ++..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 65567777889999999998874 89999999999999999999999999998888776654433222222222 1111
Q ss_pred CCCC---CCCC-------hhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 714 PHLV---GTIN-------PESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 714 ~~l~---~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
.... ..+. ...+....+|+..+|..||.+|.|+.+++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 0110 1111 12346778899999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=363.23 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=214.2
Q ss_pred cCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
..|.....||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.+..++++|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457777899999999999995 4578999999988777776777899999999999999999999998889999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+||+|.+.+... .+++.++..||+++++||+|||. ++|+|||||.+||||+.+|.+||+|||++........ .
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 999999998544 48999999999999999999999 9999999999999999999999999999987764433 4
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
..+.+||++|||||+.....|++|.||||||+++.||+.|++||-...+.....++. . ...+.-..
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------------~--ng~P~lk~ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------T--NGTPKLKN 491 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------------h--cCCCCcCC
Confidence 456779999999999999999999999999999999999999997654433222211 1 11122233
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+...+..+.+++.+||+.|+++|+++.|+|+.
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 45678899999999999999999999999854
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.44 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=206.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC--cEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS--EMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~--~~~lV~E 558 (832)
.++...+.||+|.||.||++... +|+..|||.....+....+.+.+|+++|++|+|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34566889999999999999765 48999999876654333677999999999999999999999854444 6899999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEecccccccCCC--
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKDAPI-- 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~-- 635 (832)
|+++|+|.+++.+.+. .+++..+.....||++||+|||+ +++|||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999987766 79999999999999999999999 99999999999999999 79999999999987652
Q ss_pred CCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
..........||+.|||||++..+ ....++|||||||++.||+||++||.... + ...+... .+ ..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~---~~~~~~~---ig------~~ 238 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--E---EAEALLL---IG------RE 238 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--c---hHHHHHH---Hh------cc
Confidence 222234457899999999999853 34459999999999999999999997531 1 0111111 00 11
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.....++...+.+..+++.+|++.+|++|||+.+++...-
T Consensus 239 ~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 239 DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1122556667888999999999999999999999986544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=355.61 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=212.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. .+++.+.+.+|++++++|+|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999765 6889999987765 45667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+.| +|..+|...+ .++++++..++.++..||.|||+ .+|+|||+||.||||+.+|.+|++|||+++.+.. ..
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9976 9999996544 79999999999999999999999 9999999999999999999999999999998754 34
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc-CCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII-DPHLV 717 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~-d~~l~ 717 (832)
...+.+.|||.|||||++.+++|+..+|+|||||+||||.+|+|||....-. .+++ .|. |+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv~------------~I~~d~v-- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLVK------------SILKDPV-- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHHH------------HHhcCCC--
Confidence 5667788999999999999999999999999999999999999999754321 1111 111 221
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+...+..+..++...|.+||.+|-+..+++..
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1334677889999999999999999999998743
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=329.37 Aligned_cols=236 Identities=27% Similarity=0.387 Sum_probs=206.1
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+.. .+..+...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778999999999999999876 68899999988653 344566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||++||.|..+|++.+ ++++..+..++.||+.||+|||+ ++|++|||||+|||||.+|.+||+|||.++....
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 9999999999996554 79999999999999999999999 9999999999999999999999999999997642
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
...+.+|||.|+|||.++.+.+..++|.|||||++|||+.|.+||....+... .++|+...+
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i---------------Y~KI~~~~v- 258 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI---------------YEKILEGKV- 258 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH---------------HHHHHhCcc-
Confidence 25678999999999999999999999999999999999999999988766322 223333332
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCC
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDR 743 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~R 743 (832)
.++.-....+.+|+...|+.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3455566789999999999999998
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.60 Aligned_cols=263 Identities=28% Similarity=0.445 Sum_probs=215.2
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCccc-HHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQG-ITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.....+.++||+|-||+|.++....+.+||||.++....+. ..+|.+|+++|.+|+||||++++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34566789999999999999999888999999999875544 58999999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
|++|+|.++|..+..+.+......+||.||+.||+||.+ .++|||||.+.|+|++.++++||+|||+++.+-.+...
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999987766556777888999999999999999 99999999999999999999999999999966544333
Q ss_pred -eeeccccCccccChhccccCCCCccccEEechhHHHHHh--hCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 640 -VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL--CARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 640 -~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ell--tG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.....+-...|||+|.+..++++.++|||+||+++||++ +...||..-.+++. ++-...+...+-.+.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~------ 764 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQV------ 764 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcce------
Confidence 223334567999999999999999999999999999985 46678865443332 222222222211111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
....++-++.++.+++.+||..+-.+||+++++...|..
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 112345577889999999999999999999999876653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=354.53 Aligned_cols=265 Identities=24% Similarity=0.343 Sum_probs=216.0
Q ss_pred HhcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHH--HHHHHHHHhCC-CcceeeEEEEeccCC-cEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEF--QTEIQMLSKLR-HRHLVSLIGYCDENS-EMI 554 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f--~~Ei~~L~~l~-HpnIv~l~~~~~~~~-~~~ 554 (832)
..++|.+.+.||.|.||.||+|+. .+|..||||+++..-.. +++. .+|++.|++|+ |||||++.+.+.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 356788899999999999999965 47999999988765433 3333 57999999998 999999999998887 999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+|||||+ .+|.+++..+ ...+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||...
T Consensus 87 fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 9999995 7999999877 5689999999999999999999999 999999999999999988899999999999875
Q ss_pred CCCCceeeccccCccccChhccc-cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc------
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL------ 707 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~------ 707 (832)
.. ...+..+.|.+|+|||++. ..-|+.+.|+|++|||++|+.+-++.|.+....+++..+..+..-..+..
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 33 3446678899999999775 57899999999999999999999999999888877665544422111111
Q ss_pred cccccC-------CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 708 LEKIID-------PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 708 ~~~i~d-------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+...+. +.-...+-+..+.++.+++.+||+.||.+|||+.|.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 111112234477899999999999999999999998743
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=322.76 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=214.3
Q ss_pred cCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCCcc--cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQ--GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.+|...++||+|.||.||+|+ .++|+.||||++.....+ ......+|++.|++++|+||+.++++|...+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778899999999999996 457999999987765332 23457899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
||+ .+|...+..+. ..++..++..++.++++||+|||+ +.|+||||||.|+|++++|.+||+|||+++.......
T Consensus 82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 995 78988886554 378999999999999999999999 9999999999999999999999999999998764432
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc-----
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII----- 712 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~----- 712 (832)
.....+-|.+|+|||.+.+ +.|+..+|+||.||++.||+-|.|.|.+..+-++...+-.+..-..+..+.++.
T Consensus 157 -~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 -IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred -ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 2233367999999998876 579999999999999999999999999988888776554443222222221111
Q ss_pred ------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 713 ------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 713 ------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.......+-+.++....+++..++..||.+|.++.|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111112334456677999999999999999999998743
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.76 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=206.3
Q ss_pred hcCCCccceEeecCceeEEEEEE------eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccC-C
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDEN-S 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~-~ 551 (832)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++|+++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999964 235689999987543 33456799999999999 899999999988654 5
Q ss_pred cEEEEEEecCCCChhhhhccCC----------------------------------------------------------
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN---------------------------------------------------------- 573 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 573 (832)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999886421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc-eeeccccCccc
Q 047569 574 --LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGY 650 (832)
Q Consensus 574 --~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y 650 (832)
..++++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1347888999999999999999999 99999999999999999999999999999865322111 12233466889
Q ss_pred cChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHH
Q 047569 651 LDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFA 729 (832)
Q Consensus 651 ~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 729 (832)
+|||++.+..++.++|||||||+||||++ |+.||......+.. ... ...+. . ...+...+..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-----~~~-~~~~~-----~----~~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-----CQR-LKDGT-----R----MRAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-----HHH-HhcCC-----C----CCCCCCCCHHHH
Confidence 99999999999999999999999999997 99999764332211 001 11111 0 112234556799
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 730 EAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 730 ~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+++.+||+.+|.+||++.|+++.|+.+++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=338.78 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=210.7
Q ss_pred hcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.+.|++.+.||.|..++||+|+ ...++.||||++.-.. ....+.+++|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3568889999999999999996 4578999999987653 3347889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
||.+|++.+.+...-...+++..+..|.+++++||.|||. +|.||||||+.||||+++|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999977666679999999999999999999999 9999999999999999999999999998765432221
Q ss_pred ce---eeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 639 HV---STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 639 ~~---~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.. ..+..||++|||||+++. ..|+.|+||||||++..||.+|+.||..-.+.+..-+ .... ......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-----tLqn--~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-----TLQN--DPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-----HhcC--CCCCccc
Confidence 11 145689999999999644 4799999999999999999999999987665543211 1111 1000000
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
..+...-.......+++++..||++||.+|||+++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0111112233566899999999999999999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=352.61 Aligned_cols=248 Identities=29% Similarity=0.424 Sum_probs=208.2
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC----Cc-ccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCc
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ----SE-QGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSE 552 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~ 552 (832)
..++|.+.+.||+|+||.|+.|... +++.||+|.+... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3567899999999999999999654 7899999976653 12 33456778999999998 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-CceEEecccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSK 631 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 631 (832)
.++||||+.||+|.+++... .++.+.++..++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999763 478889999999999999999999 999999999999999999 999999999998
Q ss_pred cCCCCCCceeeccccCccccChhccccCC-CC-ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQ-LT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......... .
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~------k-------- 234 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR------K-------- 234 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH------H--------
Confidence 764 3344566788999999999999877 76 78999999999999999999998743322111 1
Q ss_pred cccCCCCCCCCChhH-HHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 710 KIIDPHLVGTINPES-LKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
+..... .++... +.++..++.+||..+|.+|+++.+++
T Consensus 235 -i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 -IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111111 122333 77899999999999999999999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=350.75 Aligned_cols=268 Identities=28% Similarity=0.463 Sum_probs=215.4
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~ 549 (832)
.+.++++...+.+.+...||+|.||+||+|.+. ..||||++... ..+..+.|++|+.+|++-+|.||+-+.|+|.+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344455555566677899999999999999986 46999988755 45568899999999999999999999999988
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
... .+|..+|+|.+|..+|+-.. ..++..+.+.|+.|||+|+.|||. ++|||||||..||+|.+++.+||+||||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 777 99999999999999998655 478999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-CCceeeccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 630 SKDAPIG-QGHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 630 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
+.....- .........|...|||||+++. .+|+..+||||||+|+|||++|..||... ..+++-. +...
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIif------mVGr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIF------MVGR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEE------Eecc
Confidence 8754321 1112233457889999999864 47899999999999999999999999833 3332210 1111
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
|.+ .+++ .....++++++.+|+..||..++++||.+.+++..|+..+.
T Consensus 608 G~l----~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 608 GYL----MPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccc----Cccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111 1111 12335677899999999999999999999999998887755
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=337.55 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=201.9
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCccc---HHHHHHHHHHHHhCCCcceeeEEEEecc----CCcEEEEEEe
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQG---ITEFQTEIQMLSKLRHRHLVSLIGYCDE----NSEMILVYEY 559 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~f~~Ei~~L~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 559 (832)
...||+|++|.||+|.. +|+.||||++....... .+.|.+|+++|++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999988 58999999987653332 5778899999999999999999999866 4578999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++|+|.+++.... .+++...++++.+++.||.|||+ ..+++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 99999999996543 68899999999999999999997 137889999999999999999999999998865321
Q ss_pred eeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... .... ...
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~------i~~~---------~~~ 240 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL------IINK---------NNS 240 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhc---------CCC
Confidence 123458899999999976 6899999999999999999999999986543321111 0001 111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
...+...+..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1223345678999999999999999999999999888653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=344.83 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=207.5
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
-.++|+++..||+|+||.||+|+.+ +|..+|+|++++.. ....+..+.|-.+|....+|.||+|+-.|++...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3578999999999999999999755 69999999998763 4456678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||++||++..+|.+.+ .|++..+...+.+++.|++.||+ .|+|||||||+|+|||..|++||+||||+.-...
T Consensus 219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999997665 79999999999999999999999 9999999999999999999999999999852210
Q ss_pred -----------------------CCCc----ee-------------------eccccCccccChhccccCCCCccccEEe
Q 047569 636 -----------------------GQGH----VS-------------------TAVKGSFGYLDPEYFRRQQLTEKSDVYS 669 (832)
Q Consensus 636 -----------------------~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDV~S 669 (832)
.... .. ...+|||-|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 00 1135999999999999999999999999
Q ss_pred chhHHHHHhhCCCCCCCCChhhhh-hHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC---
Q 047569 670 FGVVLLEVLCARPAINPQLPREQV-NLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT--- 745 (832)
Q Consensus 670 lGvvl~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt--- 745 (832)
||||+||||.|.|||....+.+.. .+..|...+.. .-......+..+||.+||. ||++|-.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999998876643 33344322211 1112344788999999999 9999965
Q ss_pred HHHHH
Q 047569 746 MGDVL 750 (832)
Q Consensus 746 ~~evl 750 (832)
+.||-
T Consensus 439 ~~EIK 443 (550)
T KOG0605|consen 439 AEEIK 443 (550)
T ss_pred HHHHh
Confidence 55553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=357.22 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=220.6
Q ss_pred CCCccceEeecCceeEEEEEEeC----CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
...+.++||.|.||+||+|+++. ...||||.++.. .++.+.+|+.|+.+|.+++||||++|.|+........+|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45678899999999999998762 357999999876 4666788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|||++|+|+.+|+.+. +++++.+..-+.++||.|+.||.+ .++|||||..+|||++.+..+|++||||++...++.
T Consensus 710 EyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999998766 469999999999999999999999 999999999999999999999999999999876544
Q ss_pred Cceeecccc--CccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHVSTAVKG--SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
....++.-| ...|.|||.+..+.++.++||||||+++||.++ |..||-.....+.+..++ .
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe----------------~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE----------------Q 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH----------------h
Confidence 333333222 468999999999999999999999999999876 888987665554433222 2
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
..+-..+.+++..|.+|+..||++|-.+||.+.+|+..|++..+..
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2333456788999999999999999999999999999999887643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=338.59 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=204.9
Q ss_pred CCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999976 478999999876432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++|+|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 9999999988865554578999999999999999999999 99999999999999999999999999998865322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......||..|+|||++.+..++.++|||||||++|||++|+.||............ ... +.. ...
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~--------~~~--~~~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRR--------VKE--DQE 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHH--------hhc--ccc
Confidence 1223456899999999999999999999999999999999999999765432211110 000 000 011
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPT-----MGDVLWN 752 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 752 (832)
.++...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 233445678999999999999999997 7777643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=350.80 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=211.1
Q ss_pred CCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
-|++.+.||+|+-|.|-+|++ .+|+.+|||++.+. .......+.+|+-+|+.+.|||++++++.++++.++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 366788999999999999976 48999999988765 23334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|++||-|.+++.+++ ++++.++.+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.... .+
T Consensus 93 yv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PG 165 (786)
T ss_pred ecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc--CC
Confidence 999999999997665 79999999999999999999999 999999999999999999999999999998754 34
Q ss_pred ceeeccccCccccChhccccCCCC-ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
....+.+|++.|.+||.+++.+|+ .++||||.|||||.||+|+.||++.........+ +.|..
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV-------~~G~f--------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV-------QRGVF--------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH-------HcCcc---------
Confidence 556778899999999999999885 6899999999999999999999865433222111 12211
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+++...+.+.++|+.+||..||++|-|++||+++
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2345667889999999999999999999999854
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=344.23 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=211.3
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
..|+..+.||+|.||.||+|.. +.++.||+|++.-. .....+++++|+.+|.+++|+||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3466678999999999999964 57899999998754 455678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
|.||++.+.|.... .+.+....-++++++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+.........
T Consensus 93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999995443 45788888899999999999999 99999999999999999999999999999877654433
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
. .+.+||+.|||||++.+..|+.|+||||||++.+||++|.||+....+.... -++.......
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~PP~ 230 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSAPPR 230 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCCCCc
Confidence 3 6778999999999999989999999999999999999999999876653321 1122222223
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+....++.+.+++..||+++|+.||++.++++
T Consensus 231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33456778999999999999999999999983
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=342.03 Aligned_cols=246 Identities=29% Similarity=0.513 Sum_probs=208.0
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS 551 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~ 551 (832)
++|++|.+ ++.||+|+.|.||+|+++ ++.||||+.+... ..+|+-|++|+||||+.+.|+|....
T Consensus 121 iPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 121 IPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred CCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 56677655 578999999999999996 7899999865332 35788999999999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
.+|||||||..|.|.+.|.... .+.......|..+||.|+.|||. +.|||||||.-||||..+..+||+|||-++
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchH
Confidence 9999999999999999996544 78889999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..... .....+.||..|||||++++.+.++|+|||||||||||||||..||....... .+=.+
T Consensus 261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwGV 323 (904)
T KOG4721|consen 261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWGV 323 (904)
T ss_pred hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEec
Confidence 76532 33345779999999999999999999999999999999999999986432211 01111
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
-...|.-..+..+++.+.-|+++||+..|.+||++.+++..|+
T Consensus 324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 1223334556778889999999999999999999999997764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=359.57 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=216.2
Q ss_pred hcCCCccceEeecCceeEEEEEEeCC-cEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEe-c-----c-CC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDG-TKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYC-D-----E-NS 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~-~-----~-~~ 551 (832)
..+.++.+.|.+|||+.||.|....+ ..+|+|++-..++...+...+|+++|++|+ |+|||.+++.. . . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45778899999999999999987765 999999988888899999999999999997 99999999932 1 1 24
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
+.+|.||||.||.|-+++..+....|++.++++|+.++|+|+++||.. ..+|||||||-+||||+.++..||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 678999999999999999766555699999999999999999999983 3569999999999999999999999999987
Q ss_pred cCCCCCCcee--------eccccCccccChhcc---ccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH
Q 047569 632 DAPIGQGHVS--------TAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 632 ~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 700 (832)
.......... -...-|+.|+|||++ .+...++|+|||+|||+||-|.....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 5432221111 112368999999976 578999999999999999999999999976532
Q ss_pred HHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 701 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
..|++....-...+..+..|.+||..||+.+|++||++-++++.+-.+...
T Consensus 264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 234455554444467899999999999999999999999998777766543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=314.68 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=213.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+-.+++.+|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356889999999999999999765 6789999987754 234456899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
+||..+|.|...|......++++.....+..|+|.||.|+|. ++|+||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999987777789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.....+.+||..|.+||+..+...+..+|+|++|++.||++.|.+||......+. . +++..-++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---Y------------krI~k~~~ 239 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---Y------------KRIRKVDL 239 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---H------------HHHHHccc
Confidence 2344567899999999999999999999999999999999999999986652221 1 11111111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.++...+....++|.+|+..+|.+|.+..|++..
T Consensus 240 --~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 --KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2234566789999999999999999999998754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.22 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=210.3
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688899999999999999998888899999876543 335789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.......+++.+++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 9999999976655678999999999999999999999 8999999999999999999999999999987543322222
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......... .. ...+ ... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~----~~~~-----~~~----~~ 225 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SA----LQRG-----YRM----PR 225 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HH----HHcC-----CCC----CC
Confidence 23345678999999998899999999999999999998 99999765432211 11 0111 000 11
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
....+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12345679999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.18 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=217.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc-EEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE-MILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~-~~lV~ 557 (832)
++|..++++|+|+||.++..+++ +++.+++|.+.-. .....+..++|+.++++++|||||.+.+.+.+++. +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999765 6789999976544 44455578899999999999999999999999888 99999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
+||+||+|.+.|.+++...+++++++.++.|++.|+.|||+ +.|+|||||+.|||++.++.+||+|||+++......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999988777789999999999999999999998 999999999999999999999999999999886544
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
. ...++.||+.||+||.+.+.+|..|+|||||||++|||++-+++|.......... ++.. ...
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~---------------ki~~-~~~ 223 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL---------------KINR-GLY 223 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH---------------HHhh-ccC
Confidence 2 3456779999999999999999999999999999999999999998765433221 1111 112
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..++...+.++..++..||+.+|..||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 34556778899999999999999999999999866
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=343.02 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=199.0
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
+.||+|+||.||++..+ +|+.||+|++... ......++.+|+++|++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 6899999987653 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeec
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA 643 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 643 (832)
+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 9999986543 68999999999999999999999 99999999999999999999999999998753221 222334
Q ss_pred cccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChh
Q 047569 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 723 (832)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............ ..+ +. .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~-------~~~------~~----~~p~~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LME------EI----RFPRT 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH-------HcC------CC----CCCCC
Confidence 56999999999999999999999999999999999999999765432211110 000 11 22334
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 724 SLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 724 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
.+.++.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 567799999999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=345.01 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=207.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +++.||||++... .......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999876 5899999987643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... .+++.++..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999996543 68899999999999999999999 9999999999999999999999999999876532
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... .+ .........
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~------~~~~~~~~~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---YW------KETLQRPVY 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH---hc------cccccCCCC
Confidence 2334569999999999999999999999999999999999999998765433221111 00 011111111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.......+.++.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11112456788999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=344.63 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=202.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999875 6899999987643 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999996543 68889999999999999999999 99999999999999999999999999999865422
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+....+
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---------------~i~~~~~- 232 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE---------------KILAGRL- 232 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH---------------HHhcCCc-
Confidence 223569999999999999999999999999999999999999997654322111 0111111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPT-----MGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 752 (832)
.++......+.+++.+||+.||.+||+ +.+++..
T Consensus 233 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 122234567899999999999999987 5666533
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=332.75 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=206.6
Q ss_pred cCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999753 35689999887653 34456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999986543 368999999999999999999999 99999999999999999999999999987654322
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.........++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.. +. ...+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~---~~----~~~~--------- 224 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI---KA----VEDG--------- 224 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HH----HHCC---------
Confidence 1111122335678999999999999999999999999999775 99999765433211 11 1111
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.....+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112344667899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=343.72 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=200.7
Q ss_pred CCCccceEeecCceeEEEEEE----eCCcEEEEEecCCC----CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI----DDGTKVAVKRGNPQ----SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~ 553 (832)
+|++.+.||+|+||.||+++. .+++.||+|++... .....+.+.+|+++|+++ +||||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999965 35889999987642 223456688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999986543 68899999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ........ .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-------~ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-------C 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------C
Confidence 43333333445799999999999865 47899999999999999999999996543221111 00001000 1
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
++ .++...+..+.+++.+||+.||++|| ++.++++
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 22334566789999999999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=367.01 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=213.9
Q ss_pred CCCccceEeecCceeEEEEEEeC--Cc----EEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDD--GT----KVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
+-+..+.||+|.||.||.|...+ |. .||||.+.+. +.+...+|.+|..+|+.++|||||+++|.|-+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 44567889999999999997653 43 4899988765 56778899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 556 VYEYMSNGPFRDHLYGK-----NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~-----~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
++|||++|+|..+|++. ....++..+.+.++.|||+|+.|||+ +++|||||..+|+||+....+||+|||++
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999754 13468999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCceee-ccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 631 KDAPIGQGHVST-AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 631 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
+......-.... ..+-...|||||.+..+.++.|+|||||||+|||++| |..||......+..... ...+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg-- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG-- 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC--
Confidence 954332221111 1123468999999999999999999999999999998 78899877655433211 1222
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
+-..+..++..+.+++..||+.+|++||++..+++.+..+...
T Consensus 922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1234567888999999999999999999999999987776654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.55 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=203.8
Q ss_pred cCCCccceEeecCceeEEEEEEeC-----------------CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-----------------GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSL 543 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l 543 (832)
++|++.+.||+|+||.||++.+++ +..||+|.+.... .....+|.+|+++|++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 3469999887653 3445679999999999999999999
Q ss_pred EEEeccCCcEEEEEEecCCCChhhhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 047569 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKN-----------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606 (832)
Q Consensus 544 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivH 606 (832)
++++.+.+..++||||+++++|.+++.... ...+++.++++++.|++.||+|||+ .+++|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999885421 1347888999999999999999999 89999
Q ss_pred ccCCCCceeeCCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh--CCCC
Q 047569 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC--ARPA 683 (832)
Q Consensus 607 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt--G~~p 683 (832)
|||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999876543221 11223345788999999998899999999999999999987 4567
Q ss_pred CCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 684 INPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 684 f~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
|......+. .............. .....++.++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 765433221 12121111111100 001122345678999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.70 Aligned_cols=263 Identities=29% Similarity=0.429 Sum_probs=214.3
Q ss_pred HHhcCCCccceEeecCceeEEEEEEeC--C--cE-EEEEecCC---CCcccHHHHHHHHHHHHhCCCcceeeEEEEeccC
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEIDD--G--TK-VAVKRGNP---QSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN 550 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~ 550 (832)
...++-...++||+|+||.||+|.+.. + .. ||||.... .......+|.+|+++|++++|||||+++|++..+
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 334555567899999999999997653 2 23 89998774 3466788999999999999999999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
..+++|||+|.||+|.++|..... .++..+++.++.+.|+||+|||+ ++++||||-.+|+|++.++.+||+|||++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999976543 69999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
+.... .........-...|+|||.+....++.++|||||||++||+++ |..||.+....+...
T Consensus 310 ~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~--------------- 373 (474)
T KOG0194|consen 310 RAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA--------------- 373 (474)
T ss_pred cCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH---------------
Confidence 86531 1111111234578999999999999999999999999999998 788998765543211
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
.+.........+...+..+..++.+|+..+|++||+|.++.+.|+.+.....
T Consensus 374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111122223344667889999999999999999999999999987765433
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=337.64 Aligned_cols=265 Identities=19% Similarity=0.246 Sum_probs=205.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||.||++..+ +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999876 5889999987653 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|++++.|..+... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9998877655432 2368999999999999999999999 9999999999999999999999999999987643333
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH---------HHhhhcccc
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM---------QWKRKGLLE 709 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~---------~~~~~~~~~ 709 (832)
.......|++.|+|||++.+..++.++|||||||++|||++|++||......+......... .........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 23334568999999999999899999999999999999999999998765433222111110 000000000
Q ss_pred cccCCCCC------CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHLV------GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+... .......+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001000 0011224567999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=351.40 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=204.8
Q ss_pred hcCCCccceEeecCceeEEEEEE------eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|.. +++..||||++.... ....+.+.+|+++|+.+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35688899999999999999963 246689999986542 34456789999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC-----------------------------------------------------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKN----------------------------------------------------------- 573 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 573 (832)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999885421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 574 --------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 574 --------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
...+++..+++++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1247889999999999999999999 99999999999999999999999999999865432211
Q ss_pred -eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 640 -VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 640 -~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......++..|+|||++.+..++.++|||||||++|||++ |..||........ ... ....+. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~----~~~~~~---------~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK----MIKEGY---------R 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH----HHHhCc---------c
Confidence 1122335668999999999999999999999999999998 8888865432211 111 111111 0
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
...+...+.++.+++.+||+.||++||++.|+++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011122356799999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=332.34 Aligned_cols=256 Identities=29% Similarity=0.419 Sum_probs=206.8
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--------------cccHHHHHHHHHHHHhCCCcceeeE
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--------------EQGITEFQTEIQMLSKLRHRHLVSL 543 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------------~~~~~~f~~Ei~~L~~l~HpnIv~l 543 (832)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....++..+||.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34588999999999999999999765 79999999876542 1124678999999999999999999
Q ss_pred EEEecc--CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc
Q 047569 544 IGYCDE--NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621 (832)
Q Consensus 544 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 621 (832)
+++..+ .+.+|||+|||..|.+...-. ....++..++.++++++..||+|||. ++||||||||+|+||+++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 999865 478999999999888754321 12238999999999999999999999 99999999999999999999
Q ss_pred eEEecccccccCCCCC----CceeeccccCccccChhccccCC----CCccccEEechhHHHHHhhCCCCCCCCChhhhh
Q 047569 622 AKVSDFGLSKDAPIGQ----GHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693 (832)
Q Consensus 622 ~kl~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~ 693 (832)
+||+|||.+.....+. ........|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-- 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-- 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--
Confidence 9999999988663221 11223367999999999987632 3568999999999999999999997654322
Q ss_pred hHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 694 NLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 694 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
...+|+...+.-...+++.+.+.+|+.++|.+||++|-+..+|.....
T Consensus 327 -------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 -------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 223445555544445667889999999999999999999999875443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=345.53 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=209.1
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~ 554 (832)
..++|...++||+|.||.|+++..+ +++.+|||.+++. ..++.+..+.|.+++... +||.+++++.++..+++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3578999999999999999999876 6889999998876 466788889999999888 4999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+||||+.||++..+.+ ...+++..+..++..++.||+|||+ ++|||||||-+|||||.+|.+||+|||+++...
T Consensus 446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999544443 3469999999999999999999999 999999999999999999999999999999754
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
. .+....+.+|||.|||||++.++.|+.++|.|||||+|||||.|..||.+....+..+-+ +..
T Consensus 520 ~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI---------------~~d 583 (694)
T KOG0694|consen 520 G-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI---------------VND 583 (694)
T ss_pred C-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------hcC
Confidence 2 344667889999999999999999999999999999999999999999987665543221 111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
. ..++..++.+...++.++|.++|++|-.+
T Consensus 584 ~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 E--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 12445567889999999999999999766
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.31 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=199.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999764 7899999987543 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998644 368899999999999999999999 999999999999999999999999999986322100
Q ss_pred C----------------------------------------------ceeeccccCccccChhccccCCCCccccEEech
Q 047569 638 G----------------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 671 (832)
Q Consensus 638 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlG 671 (832)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 000124699999999999999999999999999
Q ss_pred hHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCC---CCHHH
Q 047569 672 VVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDR---PTMGD 748 (832)
Q Consensus 672 vvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~e 748 (832)
|++|||++|++||......+.... ...+ . ..+ .+. -....+..+.+++.+||. +|.+| +++.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~---i~~~--~---~~~---~~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRK---IINW--R---ETL---YFP--DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHH---HHcc--C---Ccc---CCC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999976654332111 0000 0 000 000 011245678999999997 66665 58988
Q ss_pred HHHH
Q 047569 749 VLWN 752 (832)
Q Consensus 749 vl~~ 752 (832)
+++.
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.45 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=213.3
Q ss_pred hcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++. ++++.-.+.+|+++|+.|+||||++++++|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4678889999999999999995 468999999987764 566677789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||..+|.|.+++.+.+ .|++.++..+++||..|+.|+|. ++++|||||.+|||||+++++||+||||+..+.
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~-- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-- 204 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence 99999999999996554 79999999999999999999999 999999999999999999999999999998875
Q ss_pred CCceeeccccCccccChhccccCCCC-ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.....++++|++-|.+||.+.+.+|. +.+|.|||||+||-|+.|.-||++..-. .+ +++ |-...
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l---vrQ---------Is~Ga 269 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL---VRQ---------ISRGA 269 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH---HHH---------hhccc
Confidence 34456788999999999999999884 7899999999999999999999876422 11 222 11111
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
. ..++.+....-||++||..+|++|.|+.+|....+
T Consensus 270 Y---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 Y---REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred c---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1 12344556788999999999999999999985543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=350.05 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=205.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.+ +|+||++++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999998642 34579999987543 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC-----------------------------------------------------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKN----------------------------------------------------------- 573 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 573 (832)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc-eeec
Q 047569 574 ---------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH-VSTA 643 (832)
Q Consensus 574 ---------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~ 643 (832)
..++++.++++++.|+++||+|||+ ++++||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1247888999999999999999999 99999999999999999999999999998765432211 1122
Q ss_pred cccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .....+ .....+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~---------~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG---------YQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc---------cCccCCC
Confidence 335678999999999999999999999999999997 9999975432211 00 001111 0111122
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
..+.++.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.58 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=204.5
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||++.++++..+|+|.+... ....++|.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999888889999987643 2334678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999986543 368999999999999999999999 9999999999999999999999999999876543222222
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.... . ..+. .. ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~---i----~~~~--~~-------~~ 222 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM---I----SRGF--RL-------YR 222 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H----HCCC--CC-------CC
Confidence 22335668999999998899999999999999999999 8999976543222111 1 1110 00 11
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 122346789999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.20 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=209.4
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|++|.||+|...+++.||+|.+.... ...+++.+|++++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999988778899999886543 33567999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 99999999976555578999999999999999999999 899999999999999999999999999998764221111
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+ ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~---------~~~~ 224 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-------VDQG---------YRMP 224 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcC---------CCCC
Confidence 111223457999999999999999999999999999999 9999976543221110 0000 0011
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
.....+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 223456789999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=327.73 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=209.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.+|++.+.||+|++|.||+|..+ .++.|++|++... ....+++.+|++++++++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34777899999999999999765 5889999987654 334678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++..++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 99999999976555678999999999999999999999 899999999999999999999999999988654332222
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.... ... .....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~---------~~~~~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------LEK---------GYRME 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHC---------CCCCC
Confidence 222334668999999999999999999999999999998 8999876533221110 000 11112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2344567899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.05 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=203.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999765 68999999876442 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 97 48988885443 357889999999999999999999 9999999999999999999999999999876432221
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc-------
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI------- 711 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i------- 711 (832)
......|++.|+|||++.+ ..++.++|||||||++|||++|++||......+...................+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233458999999998865 56899999999999999999999999876654433222111100000001111
Q ss_pred --cCCCCCC----CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 --IDPHLVG----TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 --~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+.... ...+....++.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111000 011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=341.07 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=207.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||++... ++..+|+|.+... .....+++.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999776 6889999987754 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999996543 58899999999999999999997 136999999999999999999999999998765322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh-h------------
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR-K------------ 705 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~-~------------ 705 (832)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+........ .... .
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRP-VVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccc-ccccccCCccccCccccc
Confidence 223456899999999999999999999999999999999999999765432211110000 0000 0
Q ss_pred -------------------cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 706 -------------------GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 706 -------------------~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.....+.............+.++.+++.+||+.||++|||+.++++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000000011111235678999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.38 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=214.3
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
..+|++.+.||+|+||.||+|...+++.+++|.+.........++.+|+++++.++||||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999998889999999988776656778999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++.+++.++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence 99999999977655678999999999999999999999 8999999999999999999999999999876543221 1
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|++||.+.+..++.++||||||+++|+|++ |+.||......+.... .. . .....
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~----~---------~~~~~ 224 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---IT----A---------GYRMP 224 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HH----h---------CCcCC
Confidence 223345678999999998899999999999999999998 8999976543222111 00 0 11112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
.+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 234556789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.65 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=200.9
Q ss_pred cCCCccceEeecCceeEEEEEEe--CCcEEEEEecCCCC--cccHHHHHHHHHHHHhC---CCcceeeEEEEec-----c
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID--DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKL---RHRHLVSLIGYCD-----E 549 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l---~HpnIv~l~~~~~-----~ 549 (832)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999763 46889999876432 22334567788877776 6999999999884 3
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
...+++||||+. ++|.+++.......+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 689999876555568999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc-
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL- 708 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~- 708 (832)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.................
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9765432 2234456899999999999889999999999999999999999999876554332211100000000000
Q ss_pred ------ccccCCCCC---CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 ------EKIIDPHLV---GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ------~~i~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+... ..+.+..+..+.+++.+||+.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 001111100 0111334567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=337.61 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=202.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +++.||+|++... ..+..+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999765 6899999987643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999996543 68899999999999999999999 99999999999999999999999999998765321
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~---------------i~~~~-- 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK---------------ILAGK-- 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHhCC--
Confidence 2234689999999999999999999999999999999999999976543321111 00000
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPT-----MGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 752 (832)
..++......+.+++.+||+.||.+||+ +.++++.
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0122334567899999999999999995 7776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.56 Aligned_cols=255 Identities=26% Similarity=0.450 Sum_probs=207.7
Q ss_pred cCCCccceEeecCceeEEEEEEeC------CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD------GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
++|++.+.||+|+||.||+|.... ...|++|.+.... .....+|.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467889999999999999997642 2579999886543 334567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNL--------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY 620 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 620 (832)
++|||+++++|.+++..... ..+++.+++.++.|++.||+|||+ ++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999864321 458889999999999999999999 8999999999999999999
Q ss_pred ceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHH
Q 047569 621 VAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEW 698 (832)
Q Consensus 621 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~ 698 (832)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM--- 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999876432211 12233446788999999998899999999999999999998 9999976544321111
Q ss_pred HHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 699 AMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 699 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
...+ .....+...+.++.+++.+||+.+|.+||++.|+++.|+.
T Consensus 239 ----i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 1112344567889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=337.89 Aligned_cols=239 Identities=24% Similarity=0.345 Sum_probs=194.2
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHH---HhCCCcceeeEEEEeccCCcEEEE
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQML---SKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L---~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999765 6899999987643 233445677777665 456799999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|..++.. ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 358999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........|++.|+|||++.+..++.++|||||||++|||++|+.||......+.... .... ..
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~------i~~~-------~~-- 218 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IVND-------EV-- 218 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhC-------CC--
Confidence 1223346699999999999999999999999999999999999999976644322111 0000 01
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
..+...+..+.+++.+||+.||.+||++
T Consensus 219 --~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 --RYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 1223456678999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.62 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=210.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCccc--HHHHHHHHHHHHhCCCcceeeEEEEec--cCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQG--ITEFQTEIQMLSKLRHRHLVSLIGYCD--ENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~f~~Ei~~L~~l~HpnIv~l~~~~~--~~~~~~lV 556 (832)
+.|+.++.|++|.||.||+|+.+ +++.||+|+++...++. --.-.+||.+|.+++|||||.+..+.. +-+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34667889999999999999765 78999999987654322 123578999999999999999998764 44679999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
||||+ -+|..++.... .++...++..+..|+++||+|||. +.|+|||||++|+|++..|.+||+|||+|+.+...
T Consensus 156 Me~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99996 58888887655 579999999999999999999999 99999999999999999999999999999988644
Q ss_pred CCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
....+..+.|.+|+|||++.+ ..|+.+.|+||+|||+.||++++|.|.+....++.+.+-.......+..+..+....
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 334566778999999998876 579999999999999999999999999988877776654443333332222222211
Q ss_pred C--------------CCCCChh-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 716 L--------------VGTINPE-SLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 716 l--------------~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. .+.+... ....-.+|+..+|..||.+|-|+.+.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1 1111111 3467788999999999999999998764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.08 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=199.4
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
+.||+|+||.||++... +++.||+|++... ......++.+|+++|+.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 6899999987653 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeec
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA 643 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 643 (832)
+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9998886543 68999999999999999999999 999999999999999999999999999987543211 12234
Q ss_pred cccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChh
Q 047569 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 723 (832)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .. . +. .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~----~---~~----~~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM----E---DI----KFPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------cc----C---Cc----cCCCC
Confidence 56999999999999999999999999999999999999999765432211110 00 0 11 12334
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047569 724 SLKKFAEAAEKCLADHGVDRP-----TMGDVLWN 752 (832)
Q Consensus 724 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 752 (832)
.+..+.+++.+||+.||.+|+ ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 566789999999999999997 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.20 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=206.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +++.||||++... .......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999765 6899999987643 2244567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 468999999999999999999999 999999999999999999999999999987654322
Q ss_pred ----------------------------CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCCh
Q 047569 638 ----------------------------GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLP 689 (832)
Q Consensus 638 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~ 689 (832)
........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345699999999999999999999999999999999999999987653
Q ss_pred hhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 047569 690 REQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT-MGDVLWN 752 (832)
Q Consensus 690 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 752 (832)
...... ...+. ..+........+..+.+++.+||. +|.+||+ +.++++.
T Consensus 236 ~~~~~~---i~~~~----------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNK---IINWK----------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHH---HhccC----------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 321110 00000 011111112246789999999997 9999999 9999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=336.35 Aligned_cols=238 Identities=22% Similarity=0.243 Sum_probs=195.9
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
||+|+||.||++... +++.||+|++... .......+.+|+++|++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999765 5889999987643 334456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 645 (832)
.+++.... .+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99996543 68999999999999999999999 999999999999999999999999999987543221 2233456
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..... ... ..++...+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~---------~~~--~~~~~~~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKIL---------QEP--LRFPDGFD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHH---------cCC--CCCCCcCC
Confidence 99999999999999999999999999999999999999976543221 11111 111 12234456
Q ss_pred HHHHHHHHHhhhcCCCCCCC---HHHHH
Q 047569 726 KKFAEAAEKCLADHGVDRPT---MGDVL 750 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RPt---~~evl 750 (832)
..+.+++.+||+.||.+||+ +.|++
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 77899999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=323.61 Aligned_cols=253 Identities=30% Similarity=0.420 Sum_probs=206.7
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++.+ ...+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 46788999999999999999888888999998875433 34679999999999999999999998854 56899999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.......+++.+++.++.|++.||+|||+ ++++||||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 9999999976555568999999999999999999999 8999999999999999999999999999976543222222
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|+|||++.+..++.++||||||+++|||++ |.+||......+... ... . ......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~------~~~-~---------~~~~~~ 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE------QVE-R---------GYRMPC 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH------HHH-c---------CCCCCC
Confidence 22345678999999988899999999999999999999 889997644322111 100 0 011122
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 33456789999999999999999999999887763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.24 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=202.2
Q ss_pred cCCCccceEeecCceeEEEEEEeC--CcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD--GTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||.||+|..+. +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999997543 368999987542 234456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999996543 68899999999999999999999 99999999999999999999999999999765321
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.....||+.|+|||++.+..++.++|||||||++|||++|++||....+...... +....
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---------------i~~~~- 244 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK---------------ILEGI- 244 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH---------------HhcCC-
Confidence 2345699999999999998899999999999999999999999976543221110 11110
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 752 (832)
..++...+..+.+++.+||+.+|.+|+ +++++++.
T Consensus 245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 012333456789999999999999995 78777643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=337.94 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=198.3
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
+.||+|+||.||++... +|+.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 6899999987653 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeec
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA 643 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 643 (832)
+|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence 9998886543 68999999999999999999999 99999999999999999999999999998753221 122234
Q ss_pred cccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChh
Q 047569 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 723 (832)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............ ... .. .++..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~-------~~----~~p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LME-------EI----RFPRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcC-------CC----CCCCC
Confidence 56999999999999999999999999999999999999999765432211110 000 01 12334
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 724 SLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 724 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
.+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 567789999999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=324.05 Aligned_cols=254 Identities=30% Similarity=0.441 Sum_probs=207.3
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||+|..++...||+|++..... ..++|.+|++++++++||||+++++.+.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 56889999999999999999887777899999875332 34678999999999999999999998754 56899999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 9999999976544568999999999999999999999 9999999999999999999999999999976543322222
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|++||+..+..++.++|||||||++|||++ |+.||......+..... ..+ .....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------~~~---------~~~~~ 224 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERG---------YRMPC 224 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------hcC---------CCCCC
Confidence 23446778999999998999999999999999999999 88888765432211110 000 00112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
....+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 344567899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=324.02 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=212.4
Q ss_pred HHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCC--CCcccHHHHHHHHHHHHhCCCcceeeEEEEecc-----
Q 047569 478 QEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNP--QSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE----- 549 (832)
Q Consensus 478 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~----- 549 (832)
..+...|...+.||+|++|.|+.+... +|+.||||++.. .+.-..++-.+|+++|++++|+||+.+++.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344556666789999999999999654 799999999873 355667888999999999999999999998754
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
-+..|+|+|+| +.+|...++.+. .++...+..++.|+++||.|+|+ .+|+||||||+|+|++.+..+||+|||+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence 46789999999 688999985443 58999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-CCceeeccccCccccChhccc-cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 630 SKDAPIG-QGHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 630 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
++..... .....+..+.|.+|.|||.+. ...|+.+.||||.||++.|||+|++.|.+.....+..++........+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987432 122335667899999999774 57899999999999999999999999998877666655443322111111
Q ss_pred ccccc--------------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 LEKII--------------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 ~~~i~--------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+..+- .+......-+.......+|+.+||..||.+|+|++|.++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111 001011112355678899999999999999999998864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=353.13 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=205.8
Q ss_pred CCCccceEeecCceeEEEEEEe-C-CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-D-GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.|.+.+.||+|+||.||+|... + ++.||+|............+.+|+++|+.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999654 4 6789999876665555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 561 SNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 561 ~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
++|+|.++|... ...++++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988532 33468899999999999999999999 9999999999999999999999999999986543221
Q ss_pred -ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 639 -HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 639 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... . +.....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~---------~~~~~~- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------Q---------VLYGKY- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H---------HHhCCC-
Confidence 12344569999999999999999999999999999999999999997654322111 1 000000
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122345567999999999999999999999874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.11 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=207.7
Q ss_pred cCCCccceEeecCceeEEEEEEeC----CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||.||+|.+.. ...|++|.+.... .....+|.+|+.++++++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999997642 4589999887543 33456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... ..+++.++++++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999996543 378999999999999999999999 99999999999999999999999999999876422
Q ss_pred CCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 637 QGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 637 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........ ... ...+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~----~~~~~------- 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKA----VEDGY------- 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHH----HHcCC-------
Confidence 211 1122335678999999999999999999999999999998 9999865432221 111 11110
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
....+...+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011234567899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=334.52 Aligned_cols=241 Identities=25% Similarity=0.385 Sum_probs=197.3
Q ss_pred ceEeecCceeEEEEEE----eCCcEEEEEecCCC----CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 488 AIIGVGGFGNVYLGEI----DDGTKVAVKRGNPQ----SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+.||+|+||.||+++. .+++.||+|.+... .......+.+|+++|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 35789999987642 223445678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.... .+.+..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 99999999986543 57888999999999999999999 999999999999999999999999999987543221 2
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.... ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~---------------~~~~~~--~~ 218 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID---------------KILKGK--LN 218 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH---------------HHHcCC--CC
Confidence 2234569999999999999899999999999999999999999997654322111 111111 12
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
+++..+..+.+++.+||+.+|++|| ++.+++.
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 3344567789999999999999999 6777754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=336.31 Aligned_cols=238 Identities=24% Similarity=0.334 Sum_probs=195.9
Q ss_pred ceEeecCceeEEEEEE----eCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 488 AIIGVGGFGNVYLGEI----DDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
+.||+|+||.||+++. .+|+.+|+|++.... .....++.+|+++|++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999964 358899999876532 2334567889999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 99999998654 368999999999999999999999 999999999999999999999999999987653321 223
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||........... .. ... ..++
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~------i~---------~~~--~~~p 218 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM------IL---------KAK--LGMP 218 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH------HH---------cCC--CCCC
Confidence 345699999999999998999999999999999999999999976543222111 00 000 1123
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGD 748 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~e 748 (832)
...+..+.+++.+||+.||.+||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 345667899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.53 Aligned_cols=264 Identities=25% Similarity=0.330 Sum_probs=199.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----CcEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN-----SEMI 554 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~-----~~~~ 554 (832)
+|++.+.||+|+||.||+|... +++.||||++... ......++.+|+++|++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788999999999999999764 6899999987643 233456789999999999999999999987432 3589
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 78988885443 68999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCC--ceeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH---------H
Q 047569 635 IGQG--HVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM---------Q 701 (832)
Q Consensus 635 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~---------~ 701 (832)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||................ .
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 11234568999999999876 678999999999999999999999997665433222111000 0
Q ss_pred Hh---hhcccccccCCCC--CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 702 WK---RKGLLEKIIDPHL--VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 702 ~~---~~~~~~~i~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.. ....+..+..... .....+.....+.+++.+||+.+|++||++.|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0000011100000 000112345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=380.91 Aligned_cols=262 Identities=28% Similarity=0.469 Sum_probs=213.0
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
...|...+.||+|+||.||+|.. .++..||||++...... ...|++.+++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999986 47899999988654322 23568899999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++|+|.++++ .++|.++.+++.|+++||+|||..+..+++||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999994 37899999999999999999996555899999999999999999888875 665443221
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+|+...........++|+.+...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1223588999999999999999999999999999999999999964332 23345666655444444555666665432
Q ss_pred --CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 720 --INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 720 --~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...+...++.+++.+||+.+|++||+|.|+++.|+.+.+
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 344567788999999999999999999999999987654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.84 Aligned_cols=249 Identities=38% Similarity=0.559 Sum_probs=198.1
Q ss_pred ccceEeecCceeEEEEEEe-----CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 486 SSAIIGVGGFGNVYLGEID-----DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+.+.||.|.||.||+|.+. .+..|+||.+... ..+..++|.+|++.+++++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999876 3578999998654 344578999999999999999999999999988889999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC-C
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-G 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 638 (832)
+++|+|.++|.......+++.+++.|+.|+++||+|||+ ++++|+||+++|||+++++.+||+|||++....... .
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999988755689999999999999999999999 899999999999999999999999999998763221 1
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
...........|+|||.+....++.++||||||+++|||++ |+.||......+. .... .++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~------~~~~-~~~~~--------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI------IEKL-KQGQR--------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH------HHHH-HTTEE---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccc-ccccc---------
Confidence 22233456788999999999999999999999999999999 6788865533221 1111 11111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
...+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112334567799999999999999999999998875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.97 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=208.3
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||+|..++++.||+|.+..... ...+|.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 457888999999999999999988899999998875433 3568999999999999999999999874 45789999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999876665678999999999999999999999 899999999999999999999999999987654322222
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++....++.++||||||+++|||++ |++||......+.... . ..+ ....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------~-~~~---------~~~~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN------L-ERG---------YRMP 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH------H-HcC---------CCCC
Confidence 233346678999999998899999999999999999999 9999976543221110 0 000 0111
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.+...+.++.+++.+||+.+|++||++++++..|+
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 22334567999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=343.21 Aligned_cols=252 Identities=24% Similarity=0.296 Sum_probs=203.8
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999765 6889999987542 23344568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998543 47888899999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceeeccccCccccChhccccC----CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..........||+.|+|||++.+. .++.++|||||||++|||++|++||......... ..+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---------------~~i 259 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---------------SKI 259 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH---------------HHH
Confidence 222223345699999999998653 4789999999999999999999999865432211 111
Q ss_pred cCC--CCCCCCChhHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047569 712 IDP--HLVGTINPESLKKFAEAAEKCLADHGVD--RPTMGDVLWN 752 (832)
Q Consensus 712 ~d~--~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 752 (832)
... .+.-......+..+.+++.+||+.+|.+ |+++.+++..
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 260 MDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111 0111111235678999999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.51 Aligned_cols=252 Identities=31% Similarity=0.411 Sum_probs=204.4
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||+|+..++..+|+|.+.... ...++|.+|+.++++++||||+++++++.+....+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577889999999999999988777789999876543 334679999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++..... .+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999865432 68999999999999999999999 9999999999999999999999999999876543222222
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|++||++.+..++.++|||||||++|||++ |+.||......+.. ... ..+. ....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~----~~~~---------~~~~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV---EKV----SQGL---------RLYR 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHH----hcCC---------CCCC
Confidence 22335678999999998889999999999999999998 99998755432211 111 0000 0011
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1224578999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=340.66 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=199.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.|+..+.||+|+||+||+|... +++.||+|++... .....+.+.+|+++|++++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999764 6889999988653 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999986543 68889999999999999999999 9999999999999999999999999999753211000
Q ss_pred ----------------------------------------------ceeeccccCccccChhccccCCCCccccEEechh
Q 047569 639 ----------------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 672 (832)
Q Consensus 639 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGv 672 (832)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012346999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHH--hhhcCCCCCCCHHHHH
Q 047569 673 VLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEK--CLADHGVDRPTMGDVL 750 (832)
Q Consensus 673 vl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl 750 (832)
++|||++|++||......+..... ... ...+........+.++.+++.+ |+..++..||++.+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i------~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKV------INW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHH------Hcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999765543221100 000 0001001112245667888877 5566677799999997
Q ss_pred HH
Q 047569 751 WN 752 (832)
Q Consensus 751 ~~ 752 (832)
..
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=333.73 Aligned_cols=256 Identities=22% Similarity=0.347 Sum_probs=204.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+... .....++|.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999754 333 4899998754 344567899999999999999999999999764 5789
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999986543 358899999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCcee-eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGHVS-TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+... ....+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-------~~~~~------- 227 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKG------- 227 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHhCC-------
Confidence 322211 22234678999999999999999999999999999997 999997653322111 01111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.....++.+...+.+++.+||+.+|.+||++.+++..+..+.+
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0111123345678999999999999999999999988776643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=342.61 Aligned_cols=259 Identities=23% Similarity=0.358 Sum_probs=206.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~ 552 (832)
.++|.+.++||+|+||.||+|... .+..||||++.... ....+.|.+|+++|+++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999752 23479999987543 334567999999999996 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC-----------------------------------------------------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKN----------------------------------------------------------- 573 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 573 (832)
.+|||||+++|+|.++|....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998875421
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC
Q 047569 574 -----------------------------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618 (832)
Q Consensus 574 -----------------------------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 618 (832)
...+++.+++.++.|+++||+|||+ .+++||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 1247888899999999999999999 89999999999999999
Q ss_pred CCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHH
Q 047569 619 NYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLA 696 (832)
Q Consensus 619 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~ 696 (832)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--Y 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--H
Confidence 999999999998865432211 1223346788999999999999999999999999999997 88898654322111 0
Q ss_pred HHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 697 EWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 697 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.....+ .....+...+..+.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 351 ----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 ----NKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 001111 011122345678999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=340.77 Aligned_cols=254 Identities=23% Similarity=0.289 Sum_probs=202.2
Q ss_pred HHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 478 QEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 478 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
....++|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999875 5889999987542 233445688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999998543 47889999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCceeeccccCccccChhccccCC----CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
............||+.|+|||++.+.. ++.++|||||||++|||++|+.||..........
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~--------------- 257 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS--------------- 257 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 432222234567999999999987643 7889999999999999999999997654322111
Q ss_pred cccCCCCCCCC--ChhHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047569 710 KIIDPHLVGTI--NPESLKKFAEAAEKCLADHGVD--RPTMGDVLWN 752 (832)
Q Consensus 710 ~i~d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 752 (832)
.+.+......+ ....+..+.+++.+||..++.+ |+++.|+++.
T Consensus 258 ~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111100011 1234667889999999855543 8899988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.18 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=204.7
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
+|++.+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999764 68999999876532 2233567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.......+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999998866555578999999999999999999999 899999999999999999999999999987653222
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
......|++.|+|||++.+..++.++|||||||++|||++|+.||............ ...... ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~----------~~~ 222 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKE----------DQE 222 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhh----------ccc
Confidence 122346899999999999999999999999999999999999999765432211111 000000 011
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLWN 752 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 752 (832)
.++...+..+.+++.+||+.||.+|| ++++++..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22344567799999999999999999 77777643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=340.60 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=201.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+++|+.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999765 6899999987643 2334566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999996543 68999999999999999999999 999999999999999999999999999987543211
Q ss_pred Cc-------------------------------------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhC
Q 047569 638 GH-------------------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA 680 (832)
Q Consensus 638 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG 680 (832)
.. ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124599999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 047569 681 RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT---MGDVLWN 752 (832)
Q Consensus 681 ~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 752 (832)
++||......+... ....+ . ..+........+..+.+++.+|+. +|.+|++ +.++++.
T Consensus 236 ~~Pf~~~~~~~~~~---~i~~~--~--------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQETYR---KIINW--K--------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHHHH---HHHcC--C--------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99998765432211 00000 0 000000111345678899999996 9999987 8888643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.82 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=210.6
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.+|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999642 356799999877666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc
Q 047569 556 VYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 621 (832)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999986432 2348899999999999999999999 99999999999999999999
Q ss_pred eEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHH
Q 047569 622 AKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWA 699 (832)
Q Consensus 622 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~ 699 (832)
+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99999999876532211 11223446788999999999999999999999999999998 9999876544332111
Q ss_pred HHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 700 MQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 700 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...+... ......+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 238 ---~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111111 1122345679999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.94 Aligned_cols=253 Identities=29% Similarity=0.424 Sum_probs=206.2
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|++|.||++..+.+..+++|++.... ...+.+.+|++++++++|||++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4588899999999999999988777789999876543 334678999999999999999999998854 56889999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 9999999976555568999999999999999999999 8999999999999999999999999999976543222222
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|+|||...+..++.++||||||+++|||++ |+.||......+.. .+ . ..+ .....
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~---~-~~~---------~~~~~ 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQ---V-ERG---------YRMPC 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH---H-HcC---------CCCCC
Confidence 23346678999999998899999999999999999999 89999765432211 11 0 010 01112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 33456789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.80 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=207.0
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
++|.+.+.||+|+||.||+|... +++.||+|.+...... ..+.|.+|+++|++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45778899999999999999753 3478999998765443 4678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 555 LVYEYMSNGPFRDHLYGKN------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
+||||+++++|.+++...+ ...+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999996432 2457889999999999999999999 899999999999999999999
Q ss_pred EEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 623 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 700 (832)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+.... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~---~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---I- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---H-
Confidence 9999999875432211 11223345788999999999999999999999999999998 9999876543322111 1
Q ss_pred HHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 701 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
..+.. ...+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 238 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 1122345678999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.83 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=203.2
Q ss_pred CCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+|++.+.||+|+||.||++.++++..+|+|.+.... ....+|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467789999999999999988777899999876432 2345788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999986543 368999999999999999999999 89999999999999999999999999998765432211111
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... . ...+ .. ...+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~----~~~~-----~~----~~~~ 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE---S----VSAG-----YR----LYRP 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH---H----HHcC-----Cc----CCCC
Confidence 2223457999999999999999999999999999999 789987554322111 0 0010 01 1122
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
...+.++.+++.+||+.+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 33567899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.94 Aligned_cols=237 Identities=27% Similarity=0.369 Sum_probs=191.8
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHH-HHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQ-MLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~-~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||+||+|... +|+.||+|++... .....+++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999775 6899999987643 2223345555655 56789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|.+++.... .+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 99999886543 68899999999999999999999 99999999999999999999999999998754222 12233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .. +.... ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~---------i~~~~--~~~~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DN---------ILNKP--LRLKP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HH---------HHcCC--CCCCC
Confidence 456999999999999999999999999999999999999999765432211 11 11111 11233
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
..+..+.+++.+||+.+|.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 4567799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.91 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=204.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||++... +++.||+|++... ..+..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47889999999999999999765 6899999987653 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999996542 368999999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeeccccCccccChhccc------cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 638 GHVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ..... ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~---~~- 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNF---QR- 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcC---CC-
Confidence 33334456999999999986 4567899999999999999999999997654432211 10000 00
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+.-...+..+..+.+++.+||+ +|.+||++.+++.
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 ---FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00001112356778999999998 9999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.72 Aligned_cols=238 Identities=24% Similarity=0.369 Sum_probs=193.3
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|... +++.||+|++... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 5889999987643 233445566777777755 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999886543 68899999999999999999999 999999999999999999999999999987643222 2234
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .. .. ...++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~------i~---------~~--~~~~~~ 217 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS------IL---------ND--RPHFPR 217 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH------HH---------cC--CCCCCC
Confidence 45699999999999999999999999999999999999999986543221111 00 00 111233
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGD 748 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~e 748 (832)
..+..+.+++.+||+.+|.+||++.+
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChH
Confidence 35567899999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=337.11 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=205.1
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEecc-CCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE-NSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~-~~~ 552 (832)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999532 35789999887543 33456788999999999 79999999998754 567
Q ss_pred EEEEEEecCCCChhhhhccCC-----------------------------------------------------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKN----------------------------------------------------------- 573 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 573 (832)
++++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce-eeccccCccccC
Q 047569 574 LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-STAVKGSFGYLD 652 (832)
Q Consensus 574 ~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~a 652 (832)
..++++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1268999999999999999999999 999999999999999999999999999998654222111 223345678999
Q ss_pred hhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHH
Q 047569 653 PEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEA 731 (832)
Q Consensus 653 PE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 731 (832)
||++.+..++.++|||||||+||||++ |..||......+. +.. ....+. ....+...+.++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGT---------RMRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccC---------CCCCCccCCHHHHHH
Confidence 999999999999999999999999998 9999976433221 111 111111 011123345679999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 732 AEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 732 i~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+.+||+.+|++||++.|+++.|+.+++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.56 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=205.0
Q ss_pred cCCCccceEeecCceeEEEEEE-----eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|++.+.||+|+||.||+|.. .+++.+++|.+... ..+...+|.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999974 24678999988754 33445789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC
Q 047569 556 VYEYMSNGPFRDHLYGKN---------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY 620 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 620 (832)
||||+++++|.+++.... ...+++.+.+.++.|++.||+|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 2347889999999999999999999 8999999999999999999
Q ss_pred ceEEecccccccCCCCC-CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHH
Q 047569 621 VAKVSDFGLSKDAPIGQ-GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEW 698 (832)
Q Consensus 621 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~ 698 (832)
.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |.+||............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-- 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 99999999997653221 112233345678999999988889999999999999999998 88898765432211111
Q ss_pred HHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 699 AMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 699 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
.... ....+...+.++.+++.+||+.+|.+||++.++++.|..
T Consensus 240 -----~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 -----RKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----HcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1100 111223456789999999999999999999999887763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.40 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=197.6
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCC-cceeeEEEEeccCCcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRH-RHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~H-pnIv~l~~~~~~~~~~~lV~ 557 (832)
+|++.+.||+|+||.||+|... +++.||||++... .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999765 5789999987643 23455678899999999976 56889999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999986543 68899999999999999999999 999999999999999999999999999987532211
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~---------------i~~~~-- 217 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS---------------IMEHN-- 217 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHcCC--
Confidence 223345699999999999999999999999999999999999999976543322111 00100
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
..++...+..+.+++.+||+.+|.+|++.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12233456678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.94 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=210.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999642 34678999988776666778999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceE
Q 047569 555 LVYEYMSNGPFRDHLYGKN-----------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 623 (832)
+||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 2358999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHH
Q 047569 624 VSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 624 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 701 (832)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |.+||......+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~------ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC------ 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------
Confidence 999999875532211 11123345778999999999999999999999999999998 8999876543221111
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...+.. . ..+...+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 235 -i~~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 -ITQGRV-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HHcCCc-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111110 0 1112345679999999999999999999999998887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.60 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=204.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||++..+ ++..+|+|.+... ......++.+|+++|++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999876 6888999987654 33345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.... .+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999996543 58889999999999999999997 146999999999999999999999999998754321
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh-h------------
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR-K------------ 705 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~-~------------ 705 (832)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.................... .
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 22334689999999999998999999999999999999999999976543221110000000000 0
Q ss_pred ----------------cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 706 ----------------GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 706 ----------------~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.....+...............++.+++.+||+.||++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000000011234678999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.06 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=198.3
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
+.||+|+||.||++... +|+.||+|++... ......++.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 6899999987653 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeec
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA 643 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 643 (832)
+|.+++.... .+++.++..++.||+.||+|||+ .++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKT 155 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccc
Confidence 9999886543 68999999999999999999995 258999999999999999999999999998754322 122234
Q ss_pred cccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChh
Q 047569 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 723 (832)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............. .+ .. .++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-------~~------~~----~~p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------ME------EI----RFPRT 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-------cC------CC----CCCCC
Confidence 569999999999999999999999999999999999999997654332211110 00 01 12234
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047569 724 SLKKFAEAAEKCLADHGVDRP-----TMGDVLWN 752 (832)
Q Consensus 724 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 752 (832)
.+.++.+++.+||+.||++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 556789999999999999996 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.61 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=199.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.+|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+++|++++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999765 6899999987643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC-
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG- 636 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 636 (832)
||+++|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999996543 68889999999999999999999 99999999999999999999999999997532100
Q ss_pred -----------------------------------------CCceeeccccCccccChhccccCCCCccccEEechhHHH
Q 047569 637 -----------------------------------------QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLL 675 (832)
Q Consensus 637 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ 675 (832)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000112346999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 047569 676 EVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRP---TMGDVLWN 752 (832)
Q Consensus 676 elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 752 (832)
||++|+.||......+..... ..+ . ..+........+..+.+++.+|+ .+|.+|+ ++.+++..
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i---~~~------~----~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKV---INW------E----TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHH---hcc------C----ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999876543321110 000 0 00000111234566788888876 5999999 88888744
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=319.91 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=210.8
Q ss_pred cCCCccceEeecCceeEEEEEEeC-CcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
+.|++.+.||+|.-|+||+++.++ +..+|+|++.+. +.+...+.+.|.+||+.++||.++.||..++.....||+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346668899999999999998874 689999998875 3556678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC--
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI-- 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~-- 635 (832)
|||+||+|..+++++....+++..+..++..++-||+|||. .|||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999999988899999999999999999999999 9999999999999999999999999998653210
Q ss_pred -------------------------------C-C---------------------CceeeccccCccccChhccccCCCC
Q 047569 636 -------------------------------G-Q---------------------GHVSTAVKGSFGYLDPEYFRRQQLT 662 (832)
Q Consensus 636 -------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 662 (832)
. . +..+...+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0011224699999999999999999
Q ss_pred ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCC
Q 047569 663 EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVD 742 (832)
Q Consensus 663 ~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~ 742 (832)
.++|.|+|||+|||||.|..||.+....+. +..++...+.-.-.++.+..+.+||++.|.+||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999999999999999999988765443 22333333332233467789999999999999999
Q ss_pred CCC----HHHH
Q 047569 743 RPT----MGDV 749 (832)
Q Consensus 743 RPt----~~ev 749 (832)
|-. +.||
T Consensus 379 Rlg~~rGA~eI 389 (459)
T KOG0610|consen 379 RLGSKRGAAEI 389 (459)
T ss_pred hhccccchHHh
Confidence 977 5555
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=339.58 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=197.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++|++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999764 68899999876532 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC-
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ- 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 637 (832)
|+++|+|.+++.+.+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999986543 68889999999999999999999 999999999999999999999999999975321000
Q ss_pred ---------------------------------------------CceeeccccCccccChhccccCCCCccccEEechh
Q 047569 638 ---------------------------------------------GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 672 (832)
Q Consensus 638 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGv 672 (832)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC---HHHH
Q 047569 673 VLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT---MGDV 749 (832)
Q Consensus 673 vl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev 749 (832)
+||||++|++||....+.+..... .. ....+........+.++.+++.+|+ .+|.+|++ +.++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i------~~-------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKV------IN-------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHH------Hc-------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 999999999999876543221100 00 0011111111234566778887766 59999987 7776
Q ss_pred HH
Q 047569 750 LW 751 (832)
Q Consensus 750 l~ 751 (832)
+.
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.91 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=204.7
Q ss_pred HhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
.+++|++.+.||+|+||.||+|... .++.||+|.+... ......+|.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999653 3567999987643 23345678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEE
Q 047569 553 MILVYEYMSNGPFRDHLYGKN--------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV 624 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 624 (832)
.++||||+++++|.+++.... ...+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999985422 1246788999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHH
Q 047569 625 SDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 625 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 702 (832)
+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |.+||...........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~------- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------
Confidence 999998754322111 1112345778999999999999999999999999999999 6888876543221111
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
...+.. ...+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 011100 1122345567999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.13 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=197.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||+||++... +++.||+|++... .......+.+|++++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999765 6899999988653 2334467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999996543 68999999999999999999999 999999999999999999999999999987543110
Q ss_pred C----------------------------------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCC
Q 047569 638 G----------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPA 683 (832)
Q Consensus 638 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~p 683 (832)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001234699999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 047569 684 INPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLA--DHGVDRPTMGDVLWN 752 (832)
Q Consensus 684 f~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 752 (832)
|......+.... ...+ . ..+. ... ....+.++.+++.+++. .++..||++.|+++.
T Consensus 236 f~~~~~~~~~~~---i~~~--~---~~~~---~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQETYKK---VMNW--K---ETLI---FPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHHHHH---HHcC--c---Cccc---CCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 986654332111 0000 0 0000 100 01234567777777543 333456899998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.06 Aligned_cols=254 Identities=30% Similarity=0.466 Sum_probs=209.6
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||+|..++++.++||.+.... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788999999999999999988888899999887543 34578999999999999999999999999989999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++.+++.++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 99999999976655678999999999999999999999 899999999999999999999999999987654322111
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||.+.+..++.++|+||||+++|||++ |+.||........... . ..+ ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~------~-~~~---------~~~~ 224 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ------V-ERG---------YRMP 224 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------H-HcC---------CCCC
Confidence 122234568999999998899999999999999999998 9999976543322111 0 000 0111
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.+...+..+.+++.+||+.+|++||+++++++.|+
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 22334567999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.73 Aligned_cols=258 Identities=25% Similarity=0.448 Sum_probs=208.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||++... ....+|+|.+... ..+...++.+|+++++++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456888999999999999999754 2368999988754 334456789999999999 79999999999999999
Q ss_pred EEEEEEecCCCChhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC
Q 047569 553 MILVYEYMSNGPFRDHLYGK--------------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 618 (832)
.+++|||+++++|.+++... ....+++..++.++.|++.||+|||+ ++++||||||+|||+++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 99999999999999998542 23468999999999999999999999 99999999999999999
Q ss_pred CCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHH
Q 047569 619 NYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLA 696 (832)
Q Consensus 619 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~ 696 (832)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~- 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL- 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH-
Confidence 999999999999865432211 1122235678999999999999999999999999999997 8889875543221111
Q ss_pred HHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 697 EWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 697 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
...+ .....+...+..+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 247 ------~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 ------LKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0110 111223345678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.84 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=194.2
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++|++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445788999999999999765 68999999986543 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+.. ...+..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-ccc
Confidence 99986543 34567888999999999999999 999999999999999999999999999988654221 122
Q ss_pred eccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 642 TAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
....||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+.... .. ..
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~---------~~ 292 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CM---------SQ 292 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hc---------cC
Confidence 34568999999998743 23456899999999999999999999743322211111100 00 00
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
........+.++.+++.+||+.+|++||++.|+++.
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233456789999999999999999999999753
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.49 Aligned_cols=271 Identities=24% Similarity=0.378 Sum_probs=204.7
Q ss_pred cCCCccceEeecCceeEEEEEE-----eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~~ 554 (832)
++|++.+.||+|+||.||++.. .+++.|++|++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678899999999999999964 2578999999887776667889999999999999999999998743 45689
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+||||+++++|.+++.... ..+++..++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986443 368999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCcee--eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 635 IGQGHVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 635 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
....... ....++..|+|||++.+..++.++|||||||++|||++|..++.......................+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3222111 11223456999999998899999999999999999999887654321100000000000000000000011
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
............+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111112334567899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.79 Aligned_cols=237 Identities=25% Similarity=0.345 Sum_probs=190.8
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHH-HHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQ-MLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~-~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
++||+|+||.||+|+.. +++.||+|++.... .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999775 68899999876432 223345555654 57889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|..++... ..+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9999888543 368889999999999999999999 999999999999999999999999999987532222 2233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|++||......... + . +.... ..+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~---~---------i~~~~--~~~~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY---D---N---------ILHKP--LQLPG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH---H---H---------HhcCC--CCCCC
Confidence 456899999999999999999999999999999999999999765432211 1 1 11111 12334
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
.....+.+++.+||+.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 4567899999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.80 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=206.7
Q ss_pred cCCCccceEeecCceeEEEEEEeC-Cc--EEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-GT--KVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||.||+|..++ +. .+++|.+... .....+.|.+|+++++++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999997653 33 5788887643 334456799999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 557 YEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
+||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999986432 1358899999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 701 (832)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.||......+... .
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~------~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE------K 230 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------H
Confidence 99999998643211 11111223457999999999899999999999999999997 999997654332111 1
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
. .. ......+...+..+.+++.+||+.+|.+||++.++++.|+.+.+..+
T Consensus 231 ~-~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 L-PQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred H-hc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 00 11111223456789999999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.01 Aligned_cols=241 Identities=23% Similarity=0.346 Sum_probs=197.6
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
+|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999765 5789999987653 233345677788888887 5899999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 9999999999886543 68899999999999999999999 99999999999999999999999999998754321
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........... +....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~---------------i~~~~-- 217 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS---------------IMEHN-- 217 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH---------------HHhCC--
Confidence 1223345699999999999999999999999999999999999999976544322111 11111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
..++...+.++.+++.+||+.+|.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11233456778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=339.50 Aligned_cols=259 Identities=20% Similarity=0.203 Sum_probs=198.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||++... +++.||+|... .+.+.+|+++|++|+||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999764 68999999743 24578999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+. ++|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 94 78888885443 68899999999999999999999 89999999999999999999999999998754322222
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhh-----hhhHHHHHHHHh--h-------h
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE-----QVNLAEWAMQWK--R-------K 705 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~-----~~~l~~~~~~~~--~-------~ 705 (832)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.......- . .
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3344579999999999999999999999999999999999998765432111 000000000000 0 0
Q ss_pred cccccc---------cCCCCCCCC--ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKI---------IDPHLVGTI--NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i---------~d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+..+ ..+...... ....+.++.+++.+||+.||.+|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000000 0134568899999999999999999999974
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.82 Aligned_cols=238 Identities=22% Similarity=0.357 Sum_probs=194.9
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|..+ +++.||+|++... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 5889999987643 234456778899999877 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccc
Confidence 99999886543 68899999999999999999999 99999999999999999999999999998754321 12233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... . ..... ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~------i---------~~~~~--~~~~ 217 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------I---------LNDEV--VYPT 217 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH------H---------hcCCC--CCCC
Confidence 45699999999999999999999999999999999999999976543322111 0 00000 1223
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGD 748 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~e 748 (832)
..+..+.+++.+||+.||.+||++.+
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 34567899999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.14 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=194.4
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
++||+|+||.||++... +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999765 6889999988653 233456788999999998 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|.+++... ..+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 9999988544 368999999999999999999999 99999999999999999999999999998753221 22233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhh--hhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE--QVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....++..+.... ... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------KQI--RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--------CCC--CC
Confidence 4579999999999999999999999999999999999999996432111 11111111111111 111 12
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
+...+..+.+++.+||+.||.+|+++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 33455678999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.09 Aligned_cols=241 Identities=20% Similarity=0.324 Sum_probs=196.4
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|... +++.||+|++... .....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 5789999987653 234456678899999876 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 99999886543 68899999999999999999999 999999999999999999999999999987543222 2233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... .... ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~------~i~---------~~~~--~~p~ 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE------SIL---------HDDV--LYPV 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH------HHH---------cCCC--CCCC
Confidence 4568999999999999999999999999999999999999998765432211 100 0000 1122
Q ss_pred hHHHHHHHHHHHhhhcCCCCCC-------CHHHHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRP-------TMGDVLW 751 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RP-------t~~evl~ 751 (832)
..+.++.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 3456789999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=300.69 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=210.8
Q ss_pred HhcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc-----CCcE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-----NSEM 553 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-----~~~~ 553 (832)
..++|++.+.||+|||+-||.++ ..+++.+|+|++...+.++.+..++|++..++++|||+++++++... ..+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35789999999999999999996 55789999999887777888999999999999999999999998743 3458
Q ss_pred EEEEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 554 ILVYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
||++.|...|+|.+.+... +...+++.+.+.|+.++++||++||+.. ..+.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999988643 3346999999999999999999999832 249999999999999999999999999987
Q ss_pred cCCCCCCcee--------eccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH
Q 047569 632 DAPIGQGHVS--------TAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 632 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 700 (832)
.......... ..-.-|.-|+|||++.- ...++++|||||||+||+|+.|..||+....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 6542211111 11235788999999864 4678999999999999999999999964321
Q ss_pred HHhhhccc-ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 701 QWKRKGLL-EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 701 ~~~~~~~~-~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
+.+.+ -.+..+.+.-+-....++.+.+++.+||+.||.+||++.+++..++..
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 222233333223334788999999999999999999999999887754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=336.62 Aligned_cols=261 Identities=21% Similarity=0.270 Sum_probs=205.5
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEecc
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~ 549 (832)
+.++....++|++.+.||+|+||.||++..+ +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556689999999999999999999775 6889999987542 23344568899999999999999999999999
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
.+..++||||+++|+|.+++... .++...+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998543 47888899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCC----CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... .....
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HHHcC
Confidence 9865433222334567999999999987543 7899999999999999999999998654322111 10000
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVD--RPTMGDVLWNL 753 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 753 (832)
. ..+.-......+..+.+++.+||..++.+ |+++.++++..
T Consensus 263 ~-------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 K-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred C-------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 00111112345677899999999844433 67888887654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=326.21 Aligned_cols=265 Identities=20% Similarity=0.283 Sum_probs=199.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999876 68999999876543 2233467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+. ++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 67877775432 468889999999999999999999 999999999999999999999999999987543221
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhh-hhHHHHHHHHhhhcccccc-----
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ-VNLAEWAMQWKRKGLLEKI----- 711 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~~~~i----- 711 (832)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..................+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22234568999999999865 4688999999999999999999999976533211 1111000000000000000
Q ss_pred cCCCCCCCCC----------hhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 IDPHLVGTIN----------PESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~d~~l~~~~~----------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.++....... ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 012356889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.09 Aligned_cols=247 Identities=26% Similarity=0.439 Sum_probs=201.3
Q ss_pred ceEeecCceeEEEEEEeCCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChh
Q 047569 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFR 566 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 566 (832)
++||+|+||.||+|...+++.+|+|++..... .....|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999998876543 33457899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeecccc
Q 047569 567 DHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646 (832)
Q Consensus 567 ~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 646 (832)
+++.... ..+++.+++.++.|++.+|.|||+ ++++||||||+||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9886543 368899999999999999999999 999999999999999999999999999987543222111222334
Q ss_pred CccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 647 t~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
+..|+|||++.+..++.++||||||+++|||++ |..||.......... ....+ .....+...+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-------~~~~~---------~~~~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-------QVEKG---------YRMSCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHHcC---------CCCCCCCCCC
Confidence 678999999998899999999999999999998 999997553322111 01111 1112233456
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 726 KKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.62 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=206.9
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|+..+.||+|++|.||++..+ +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999765 6899999987643 345567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.......+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 999999999976545578999999999999999999999 8999999999999999999999999999886543221
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......|++.|+|||++.+..++.++|+|||||+++||++|+.||......... . . ...+. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~-~~~~~---------~~~ 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI---L---K-IIRGV---------FPP 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HHcCC---------CCC
Confidence 223446889999999999999999999999999999999999999765432211 1 0 01111 111
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+....+..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 22245577999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.92 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=203.7
Q ss_pred CCccceEeecCceeEEEEEE-----eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcEEE
Q 047569 484 FDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEMIL 555 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~~l 555 (832)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......|.+|+++|++++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988642 357899999887543 3345778999999999999999999998765 346899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
+|||+++++|.+++... .+++.+++.++.|+++||+|||+ ++++||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998643 48999999999999999999999 8999999999999999999999999999886543
Q ss_pred CCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... ......++..|++||.+.+..++.++||||||+++|||++|+.|+....... ...............+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 2211 1122235667999999998899999999999999999999999986532211 011100000000001111112
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.......+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222223345667899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=325.84 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=206.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc--EEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT--KVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||.||+|.++ ++. .+++|.+... ......++.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888999999999999999764 444 4678876543 334556789999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 557 YEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
|||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999986432 2357899999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 701 (832)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+.. . .
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~---~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E---K 235 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---H---H
Confidence 99999998643211 11111224567999999988889999999999999999998 99999654332211 1 1
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAF 763 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 763 (832)
. ..+ .....+...+..+.+++.+||+.+|++||++.++++.|+.+++....+
T Consensus 236 ~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 236 L-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred H-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 0 000 011112234567899999999999999999999999998877655433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=349.13 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=207.0
Q ss_pred HHHhcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC---
Q 047569 478 QEATKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS--- 551 (832)
Q Consensus 478 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~--- 551 (832)
....++|++.+.||+|+||+||++.. .+|+.||||++... +......+.+|+.+|..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33457899999999999999999975 47899999987643 3455677899999999999999999988764322
Q ss_pred -----cEEEEEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEE
Q 047569 552 -----EMILVYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV 624 (832)
Q Consensus 552 -----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 624 (832)
.+++||||+++|+|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998643 23468999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCC-CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh
Q 047569 625 SDFGLSKDAPIGQ-GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 625 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~------~~- 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH------KT- 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH-
Confidence 9999987654221 122344579999999999999999999999999999999999999997654322111 10
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+. ....++..+.++.+++.+||+.+|.+||++.+++..
T Consensus 258 ~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0010 112334556789999999999999999999999754
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=322.37 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=206.6
Q ss_pred CCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
+|++.+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999653 23578999876543 3445779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccC----------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 047569 556 VYEYMSNGPFRDHLYGK----------------------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTN 613 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~----------------------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 613 (832)
++||+.+++|.+++... ....+++.+++.++.|++.||+|||+ ++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999987532 12358899999999999999999999 999999999999
Q ss_pred eeeCCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhh
Q 047569 614 ILLDDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPRE 691 (832)
Q Consensus 614 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~ 691 (832)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999998764322211 1122345678999999988899999999999999999998 999997654332
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.... ...+ .....+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 238 ~~~~-------~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNL-------LKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHH-------HhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2211 1111 1111223455689999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.42 Aligned_cols=255 Identities=18% Similarity=0.233 Sum_probs=199.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999765 6789999987642 2233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999996532 368899999999999999999999 999999999999999999999999999987654333
Q ss_pred CceeeccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
........||+.|+|||++.+ +.++.++|||||||+||||++|+.||......+... .......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~----- 225 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEE----- 225 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCC-----
Confidence 223334569999999999875 567899999999999999999999997654322111 1000000
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVD--RPTMGDVLWN 752 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 752 (832)
...+. ......+.++.+++.+||..++.+ |+++.++++.
T Consensus 226 ~~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00011 111234677899999999865544 4577777643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=328.10 Aligned_cols=255 Identities=18% Similarity=0.253 Sum_probs=199.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||++..+ +++.+|+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999876 5788999987542 2233456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999996532 368899999999999999999999 999999999999999999999999999987653332
Q ss_pred CceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 638 GHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+... ...... ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~--~~~- 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHK--ERF- 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCC--ccc-
Confidence 22333456999999999986 3468899999999999999999999997654322211 111100 000
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVD--RPTMGDVLWN 752 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 752 (832)
.. .......+..+.+++.+||..++.+ |+++.|+++.
T Consensus 228 --~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 --QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0111234667889999988654444 6888888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.16 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=207.8
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||++...++..+++|.+.... ...+.|.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35788999999999999999988778889999876543 345679999999999999999999999887 7889999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 99999999976555678999999999999999999999 899999999999999999999999999987654322222
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++....++.++|+|||||++|||++ |+.||......... .+ ...+ ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~----~~~~---------~~~~ 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RA----LERG---------YRMP 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----HhCC---------CCCC
Confidence 223345678999999998899999999999999999998 89999764332211 11 1111 0011
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223455679999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.56 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=207.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||++... .+..+|+|++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999999642 35589999877543 34456799999999999 79999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+++|||+.+++|.+++.......+++.+++.++.|++.||+|||+ ++++|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999976554458999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 633 APIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 633 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.. .. ....+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~----~~~~~---- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YK----LIKEG---- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HH----HHHcC----
Confidence 5432211 1122345778999999999999999999999999999998 99998654332211 11 01111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.....+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111223456899999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.76 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=204.1
Q ss_pred CCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
+|++.+.||+|+||.||+|... .++.||+|++..... ...+.|.+|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667889999999999999753 257899999875543 234678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc
Q 047569 556 VYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 621 (832)
++||+.+++|.+++.... ...+++..+++++.|+++||+|||+ ++++||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999885321 2357888999999999999999999 99999999999999999999
Q ss_pred eEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHH
Q 047569 622 AKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWA 699 (832)
Q Consensus 622 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~ 699 (832)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM---- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 99999999886542221 11223345789999999988889999999999999999998 8888876543221111
Q ss_pred HHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 700 MQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 700 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
+.+.. ....+..++..+.+++.+||+.+|.+||++.+++..|+.
T Consensus 239 -----------i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 -----------IRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----------HHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111 112334566789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=329.49 Aligned_cols=243 Identities=24% Similarity=0.359 Sum_probs=193.3
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999765 6889999987653 334456688899998877 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence 99998885443 68999999999999999999999 99999999999999999999999999998753221 12233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhh--hhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE--QVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+....... .. ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------~~--~~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------KQ--IRI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--------CC--CCC
Confidence 4579999999999999999999999999999999999999996321111 01111111111111 11 123
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
+...+..+.+++.+||+.||.+||++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 34456778999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=326.57 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=207.9
Q ss_pred cCCCccceEeecCceeEEEEEEe--------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID--------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENS 551 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~ 551 (832)
++|.+.+.||+|+||.||++... +...+|+|.+... ......++.+|+++++++ +||||+++++++.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56889999999999999999642 2357999998754 334556788999999999 7999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999996532 1358899999999999999999999 8999999999999999
Q ss_pred CCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhH
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNL 695 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l 695 (832)
.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |.+||......+....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 9999999999998755321111 1112224568999999998899999999999999999998 8888865433221111
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
...+ .....+...+.++.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 255 -------~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 255 -------LKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -------HHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 0111 01122334567899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=335.90 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=203.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC-----cEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS-----EMI 554 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~-----~~~ 554 (832)
+|++.+.||+|+||.||++... +++.||||++... .....+++.+|+++|+.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778999999999999999764 7899999987653 2334567899999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+||||+. ++|.+.+... ..+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 6788877543 368999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH------------
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ------------ 701 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~------------ 701 (832)
...........+++.|+|||++.+. .++.++|||||||++|||++|++||....+.+..........
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3333333344688999999998774 579999999999999999999999987765544332211000
Q ss_pred HhhhcccccccCCCC---CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHL---VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
............+.. ........+.++.+++.+||+.||.+|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 001122345678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=327.51 Aligned_cols=240 Identities=25% Similarity=0.337 Sum_probs=192.1
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHH-HHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQ-MLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~-~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||+||++... +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 57889999876431 222334444444 56788999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|.+++.... .+.+..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence 99999986543 57888899999999999999999 99999999999999999999999999998754322 12234
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|++||......+... ... ... ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~---------~~~--~~~~~ 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NIL---------NKP--LQLKP 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH------HHH---------hCC--cCCCC
Confidence 4569999999999999999999999999999999999999997654332211 100 000 11234
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
..+..+.+++.+||+.+|.+||++.+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 4567799999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=316.69 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=200.8
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccC---C--cEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN---S--EMILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~---~--~~~lV 556 (832)
.|...+++|+|+||.||+|... +++.||||+.-...+ --.+|+++|+.++|||||++.-++... + ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4566899999999999999765 579999998654432 124799999999999999999887432 2 34689
Q ss_pred EEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-CceEEecccccccC
Q 047569 557 YEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDA 633 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~ 633 (832)
||||+ .+|.+.++. .....++...+.-+..||.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 688888853 223467788888899999999999999 999999999999999965 99999999999987
Q ss_pred CCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc-
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI- 711 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i- 711 (832)
..++.. ....-|..|+|||++.+ ..|+.+.||||.|||+.||+-|++-|.+....++...+-.+.....++.+..+
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 655443 44456899999999876 58999999999999999999999999998777765544333222111111111
Q ss_pred ------cCCCCC-----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 ------IDPHLV-----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ------~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
-.+.+. .-+....+.+..+++.++|+.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111111 1133456678999999999999999999998874
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=315.22 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=198.5
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
+.||+|+||.||+|... +++.+|+|..... ..+....|.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999765 7899999987644 334456799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee-ecc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS-TAV 644 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 644 (832)
.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986443 368999999999999999999999 8999999999999999999999999999875432111100 111
Q ss_pred ccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChh
Q 047569 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723 (832)
Q Consensus 645 ~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 723 (832)
.++..|+|||.+.++.++.++|||||||++|||++ |..||............ . .......+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------~---------~~~~~~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------E---------QGVRLPCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------H---------cCCCCCCccc
Confidence 23457999999999899999999999999999998 88888654332211110 0 0111122334
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 724 SLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 724 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.+..+.+++.+||+.+|++||++.++++.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 5678999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=316.28 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=204.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-----cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-----EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|++.+.||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999754 68999999865432 2234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999986543 58889999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCcee--eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGHVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
...... ....|+..|+|||++.+..++.++||||||+++|||++|+.||.......... . ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~---------~~~ 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------K---------IAT 221 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH------H---------Hhc
Confidence 211111 23457889999999999999999999999999999999999997543322110 0 001
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
......++......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122334556789999999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.70 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=206.4
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|+..+.||+|+||.||++... ++..+++|.+........+.|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999632 356899999887777777889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 556 VYEYMSNGPFRDHLYGKNL-------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
+|||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999865321 358899999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 623 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 700 (832)
||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |.+||......+.....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----
Confidence 9999999875532211 11122335678999999999999999999999999999998 89998654433221110
Q ss_pred HHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 701 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
..+. . ...+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 238 ---~~~~-----~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 ---TQGR-----E----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HcCc-----c----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0100 0 0112234567899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.25 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=196.6
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 68999999876432 23346678899999999999999999999999999999999999999
Q ss_pred hhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeec
Q 047569 566 RDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA 643 (832)
Q Consensus 566 ~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 643 (832)
.+++.. .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988743 233468999999999999999999999 9999999999999999999999999999876543221 2234
Q ss_pred cccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChh
Q 047569 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 723 (832)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ...+.... ..++..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~---------~~~~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KEL---------KQRILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHH---------HHhhcccC--CCCccc
Confidence 56899999999999999999999999999999999999999764322110 000 00111111 122344
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 724 SLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 724 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
.+..+.+++.+||+.+|++|| ++++++.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 667899999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.73 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=196.7
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
||+|+||.||+++.+ +|+.+|+|++.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 68999999876431 12234566799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 645 (832)
.+++.......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 998876655578999999999999999999999 99999999999999999999999999998765432 2223456
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+.... ....... ......+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~---------~~~~~~~-~~~~~~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR---------TLEDEVK-FEHQNFT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH---------hhccccc-cccccCC
Confidence 89999999999998999999999999999999999999975432111 1111110 1111110 0112345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 726 KKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.++.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhh
Confidence 678999999999999999999877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.88 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=206.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+|++.+.||+|+||.||++... +++.+++|.+... .....+.+.+|+.++++++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999765 6899999987543 3445678889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++..++.++.|++.||.|||+ ++++|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99999998866555568899999999999999999999 999999999999999999999999999987654321 22
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||.......... .. ..+.. ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~-~~~~~---------~~~ 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KV-CQGSY---------KPL 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HH-hcCCC---------CCC
Confidence 234568899999999999999999999999999999999999997654322110 10 11110 112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+...+..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 23455678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.28 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=206.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcc--cHHHHHHHHHHHHhCCCcc-eeeEEEEeccCC------
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQ--GITEFQTEIQMLSKLRHRH-LVSLIGYCDENS------ 551 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~f~~Ei~~L~~l~Hpn-Iv~l~~~~~~~~------ 551 (832)
..|...++||+|.||+||+|+.+ +|+.||+|+++-..++ .-....+|+.+|++|+|+| ||.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556778999999999999765 7899999987765432 2344689999999999999 999999998776
Q ss_pred cEEEEEEecCCCChhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNL--PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
.++||+||+ .-+|..++..... ..++...+..++.||++||+|||+ ++|+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 889999999 5789999865442 357778999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
++...... ...+...+|.+|+|||++.+. .|+...||||+||++.||+++++.|.+....++...+-.......+..+
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99765332 224556689999999999876 7999999999999999999999999988775554333222221212222
Q ss_pred cccc---CC--CCCCC-----CC---hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 709 EKII---DP--HLVGT-----IN---PESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 709 ~~i~---d~--~l~~~-----~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+. +- ..... +. +.......+++.+||+.+|.+|.|+...+.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 11 11111 11 1122478899999999999999999988754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=327.64 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=194.6
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|... +|+.||+|.+... .......+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999775 6889999987653 123455677788888765 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|.+++... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999988654 368899999999999999999999 999999999999999999999999999987532211 2234
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... . .. ..+. ++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~------~-~~------~~~~----~~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES------I-RV------DTPH----YPR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------H-Hh------CCCC----CCC
Confidence 46699999999999999999999999999999999999999976543221110 0 00 0111 222
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMG-DVL 750 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~-evl 750 (832)
..+.++.+++.+||+.||.+||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3456789999999999999999984 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=317.45 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=207.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +++.||||.+... ..+...++.+|++++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999765 6899999976542 3344567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 558 EYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||+++++|.+++.. .....+++..++.++.|+++||+|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 223458899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....... ..+.... ... .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~------~~~---~ 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKI------EQC---D 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHH------hcC---C
Confidence 221 1123458889999999998889999999999999999999999986432211 1111110 010 1
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.........+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11112234557899999999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.99 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=199.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||++... +++.||+|++... .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999865 5899999987642 2334566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999643 2368899999999999999999999 999999999999999999999999999987654333
Q ss_pred CceeeccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+... ....... ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~~---~~ 227 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKE---HF 227 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCCC---cc
Confidence 222333569999999999863 457889999999999999999999997654322211 1110000 00
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCC--CCCCHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGV--DRPTMGDVLWN 752 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~ 752 (832)
.+ .......+..+.+++.+||..++. .|+++.+++..
T Consensus 228 --~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 --QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 011123566788888887754333 37898888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=321.16 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=203.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
+++|.+.+.||+|++|.||+|.+. .+..|++|...... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467889999999999999999765 35689999876543 33346799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC---ceEEe
Q 047569 554 ILVYEYMSNGPFRDHLYGKNL-----PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY---VAKVS 625 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~ 625 (832)
++||||+++++|.+++..... ..+++.++++++.||+.||+|||+ ++++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999865431 358999999999999999999999 8999999999999998654 69999
Q ss_pred cccccccCCCCCCce-eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHh
Q 047569 626 DFGLSKDAPIGQGHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 626 DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~------- 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV------- 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------
Confidence 999988653211111 112223568999999999999999999999999999997 99999765443221110
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.. ......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 235 ~~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TG---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Hc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 0111223445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.01 Aligned_cols=249 Identities=31% Similarity=0.511 Sum_probs=207.8
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|++|.||+|... |+.|++|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 56788999999999999999875 78999999876544 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 9999999976655578999999999999999999999 999999999999999999999999999988653221
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|+|||++....++.++||||||+++|||++ |+.||......+.. ... ..+ .....
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~----~~~---------~~~~~ 220 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PHV----EKG---------YRMEA 220 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----hcC---------CCCCC
Confidence 12334668999999988889999999999999999997 99998765432211 110 111 01112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 23456789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=328.25 Aligned_cols=239 Identities=26% Similarity=0.347 Sum_probs=192.6
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHH-HHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQ-MLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~-~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||++... +|+.+|+|++... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 6899999987643 2233455666665 46778999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|..++... ..+++.++..++.||++||+|||+ ++++||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 9999888544 368999999999999999999999 99999999999999999999999999998754221 12233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|++||......+.. .... ...+ ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~---------~~~~--~~~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNIL---------HKPL--VLRP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHH---------cCCc--cCCC
Confidence 456999999999999999999999999999999999999999765432211 1111 1111 1223
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGDV 749 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~ev 749 (832)
..+..+.+++.+||+.+|.+||++.+.
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 455678899999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=326.45 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=194.5
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|... +++.||+|++... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 5789999987653 123445677788888765 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|.+++... ..+++.++..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 9999998643 368899999999999999999999 999999999999999999999999999987543221 1233
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .. ..+. ++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-------~~------~~~~----~~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RM------DNPC----YPR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hh------CCCC----CCc
Confidence 456999999999999999999999999999999999999999765433221111 00 0111 122
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMG-DVL 750 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~-evl 750 (832)
.....+.+++.+||+.+|.+||++. ++.
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 3456789999999999999999996 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=315.20 Aligned_cols=248 Identities=30% Similarity=0.477 Sum_probs=203.3
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEe-ccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC-DENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~-~~~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||.||++... |+.+++|...... ..+.|.+|+.++++++|+|++++++++ .+++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999765 7889999876432 356799999999999999999999975 4567789999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999976655568999999999999999999999 999999999999999999999999999987643221
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. .. . ...+ ....
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~---~-~~~~---------~~~~ 219 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP---R-VEKG---------YKMD 219 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---H-HhcC---------CCCC
Confidence 22335678999999999899999999999999999997 9999865432211 11 1 1111 1112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
..+..+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 233456789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.32 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=199.5
Q ss_pred CccceEeecCceeEEEEEEeC-Cc--EEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------CcE
Q 047569 485 DSSAIIGVGGFGNVYLGEIDD-GT--KVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------SEM 553 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------~~~ 553 (832)
.+.+.||+|+||.||+|...+ +. .+|+|.+... +....+.|.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467899999999999998754 33 6899987653 345567899999999999999999999987432 356
Q ss_pred EEEEEecCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 554 ILVYEYMSNGPFRDHLYGK----NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 23358999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCce-eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 630 SKDAPIGQGHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 630 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
++......... .....+++.|++||.+.+..++.++|||||||++|||++ |+.||......... + . ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~---~-~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY---D---Y-LRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---H-HHcCC
Confidence 88654322111 122345678999999999999999999999999999999 78898764332211 1 1 11111
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
. ....+..+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 232 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 012234566799999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.16 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=202.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|++.+.||+|+||+||+|.+. +++ .+++|...... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777899999999999999764 344 47888875443 2345678889999999999999999999864 56789
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999996543 368999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
... .......++..|++||++.+..++.++|||||||++|||++ |+.||..........+. ..+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~--~~-- 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGE--RL-- 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCC--cC--
Confidence 221 12233457788999999998999999999999999999998 99999765433221111 1111 00
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
..+..+...+.+++.+|+..+|.+||++.|+++.|+.+.+
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 -----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0111234567889999999999999999999988877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.59 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=206.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-C---CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-D---GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.+|++.+.||+|+||.||+|... + +..+|+|.+.... ....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999764 2 3479999886543 33456899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999996543 368999999999999999999999 99999999999999999999999999999866433
Q ss_pred CCceeec--cccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 637 QGHVSTA--VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 637 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
....... ..++..|++||++.+..++.++|+|||||++||+++ |+.||......+.. ... .++.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~----~~~~------ 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAI----EEGY------ 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHH----hCCC------
Confidence 2222111 223568999999998899999999999999999886 99998765433211 111 1110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
........+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111233566789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=320.84 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=198.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhC---CCcceeeEEEEecc-----CC
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKL---RHRHLVSLIGYCDE-----NS 551 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l---~HpnIv~l~~~~~~-----~~ 551 (832)
+|++.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5788999999999999999765 68999999876532 22234566777777766 69999999998754 34
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..+++|||+. ++|.+++.......+++.++..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999997 589888876555568999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc--
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE-- 709 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~-- 709 (832)
..... .......||..|+|||++.+..++.++|||||||++|||++|++||......+................+.
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 65422 12234568999999999998899999999999999999999999997665433221110000000000000
Q ss_pred -----cccCCCC---CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 -----KIIDPHL---VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 -----~i~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+.. .....+.....+.+++.+||+.||++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 01122345677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.72 Aligned_cols=261 Identities=25% Similarity=0.441 Sum_probs=209.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe--------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID--------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDEN 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~ 550 (832)
.++|.+.+.||+|+||.||+++.. ++..||+|..... .....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788999999999999999641 2457999987654 234567899999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
...+++|||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999986532 1357888999999999999999999 899999999999999
Q ss_pred CCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 99999999999998865432211 1122345678999999998899999999999999999998 788886553322111
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
.. ..+. ....+...+..+.+++.+||+.+|.+||++.|+++.|+.+....
T Consensus 251 ------~~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 251 ------LL-KEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ------HH-HcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11 1110 01122345678999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=317.79 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=203.5
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999976 46889999998766555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... ..+++.++..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 9999999998644 368999999999999999999999 899999999999999999999999999987653221 1
Q ss_pred eeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.+.... ... .....+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~---~~~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSK---SNFQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eec---CCCCCCCC
Confidence 122345889999999884 34578899999999999999999999854432211100 000 00011111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
......+..+.+++.+||+.+|++||+++++++.
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0112345789999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.87 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=206.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|... .+..|++|.+.... ......+.+|+.+|+.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457888999999999999999754 24689999976543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 554 ILVYEYMSNGPFRDHLYGKN--------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 2347889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHh
Q 047569 626 DFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 626 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |++||......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF---V---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH---H----
Confidence 9999876543221 12233446789999999988899999999999999999998 8999876543322111 1
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
..+. ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1110 01122334678999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.72 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=197.9
Q ss_pred eEeecCceeEEEEEEe---CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 489 IIGVGGFGNVYLGEID---DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
.||+|+||.||+|.++ +++.+|+|++.... ....+++.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999643 57899999876543 3345779999999999999999999999864 5678999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee--
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS-- 641 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-- 641 (832)
+|.+++.... .+++..++.++.|++.||+|||+ ++++||||||.|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999996443 68899999999999999999999 9999999999999999999999999999986543322211
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|+|||.+....++.++|||||||++|||++ |++||......+.... ...+. ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------i~~~~---------~~~~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-------IESGE---------RMEC 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCC---------CCCC
Confidence 12234578999999988889999999999999999998 9999976543322111 11111 1122
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
+...+.++.+++.+||+.+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 34456789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=304.07 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=205.3
Q ss_pred hcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
+++|++.+.||+|.|+.||++. ..+|+.+|+|.+... +..+.+++.+|+++-+.|+|||||++.+...+.+..+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567778899999999999995 457999999976543 4456788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 634 (832)
|+|+|++|..-|-.+ .-.++..+-..+.||+++|.|+|. ++|||||+||+|+||- ..--+||+|||++....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997766433 246778888899999999999999 9999999999999994 34468999999999876
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.+.......|||+|||||+++..+++..+|||+.||+||-||.|++||.+..... +.+.+. ..-.
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---lye~I~--------~g~y-- 229 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYEQIK--------AGAY-- 229 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HHHHHh--------cccc--
Confidence 4455567789999999999999999999999999999999999999998743322 221111 1111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+..-+...++..+|+++||..||.+|.|+.|.+.
T Consensus 230 d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1112222445677899999999999999999999873
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.78 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=195.3
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999765 5789999988754 234456788999999988 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence 99998885443 68999999999999999999999 99999999999999999999999999998753221 12234
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............+........ .. ..++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~--~~~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------KP--IRIPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------CC--CCCCC
Confidence 456999999999999999999999999999999999999999643322211111111111111 11 11233
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
..+..+.+++.+||+.||.+|+++.
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 4556789999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.49 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=202.0
Q ss_pred CCccceEeecCceeEEEEEEeC----CcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc-----
Q 047569 484 FDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE----- 552 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~----- 552 (832)
|++.+.||+|+||.||+|.... +..||+|++... .......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997642 368999987754 33445689999999999999999999998866544
Q ss_pred -EEEEEEecCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 553 -MILVYEYMSNGPFRDHLYGK----NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 553 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
.++++||+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988432 22368999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 628 GLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 628 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |.+||......+. .+. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~----~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDY----LRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHc
Confidence 998865432211 1112234678999999988999999999999999999999 8888865443221 111 111
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
+ . ....+...+..+.+++.+||+.+|.+||++.|+++.|+.+
T Consensus 231 ~--------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 G--------N-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C--------C-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 0 1112334567899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=326.86 Aligned_cols=240 Identities=24% Similarity=0.357 Sum_probs=196.6
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||++... +++.||||++... .......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 5789999987643 234456778899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|.+++.... .+++.++..++.|++.||.|||+ ++++||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 99999886543 68999999999999999999999 999999999999999999999999999987532211 2223
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .... .++.
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~------~i~---------~~~~--~~~~ 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ------SIL---------EDEV--RYPR 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH------HHH---------cCCC--CCCC
Confidence 4568999999999999999999999999999999999999997654322111 000 0011 1223
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCH-----HHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTM-----GDVL 750 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~-----~evl 750 (832)
..+..+.+++.+||+.||.+||++ .+++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll 250 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIK 250 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHh
Confidence 455678999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=317.34 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=208.3
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|++|.||++.. .+++.++||.+... .....+++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999975 47899999976543 2334568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 558 EYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||+++++|.+++.. .....+++.+++.++.|+++||+|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 223468999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
... ......|+..|+|||++.+..++.++|+||||+++|||++|..||....... ..... . +.....+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~------~~~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---K------IEQCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh---h------hhcCCCCC
Confidence 221 1223458899999999999899999999999999999999999986543211 11111 0 11111111
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
......+..+.+++.+||+.+|.+|||+.+|++.+++.
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 ---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11234567899999999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.24 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=206.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CC---cEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DG---TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|+..+.||+|+||.||+|... ++ ..+++|.+... .....+++.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356788999999999999999765 33 37999988655 34446779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999986543 468999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCCceee--ccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 636 GQGHVST--AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 636 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
....... ....+..|++||++.+..++.++|||||||++|||++ |+.||......+.. . .. ..+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~---~---~i-~~~------ 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM---K---AI-NDG------ 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---H---HH-hcC------
Confidence 2221111 1123457999999998889999999999999999997 99999655432211 1 11 110
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.........+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223457789999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=322.14 Aligned_cols=262 Identities=24% Similarity=0.409 Sum_probs=203.3
Q ss_pred hcCCCccceEeecCceeEEEEEEeC---------------CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD---------------GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLI 544 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~ 544 (832)
.++|++.+.||+|+||.||++.... ...||+|..... .......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999986532 235899988764 334456799999999999999999999
Q ss_pred EEeccCCcEEEEEEecCCCChhhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 047569 545 GYCDENSEMILVYEYMSNGPFRDHLYGKN----------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNI 614 (832)
Q Consensus 545 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 614 (832)
+++...+..++||||+++++|.+++.... ...+++.+++.++.|+++||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 99999999999999999999999885432 1247889999999999999999999 9999999999999
Q ss_pred eeCCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh--CCCCCCCCChhh
Q 047569 615 LLDDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC--ARPAINPQLPRE 691 (832)
Q Consensus 615 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt--G~~pf~~~~~~~ 691 (832)
++++++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999998765322211 1122345678999999998899999999999999999988 566776543322
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
... .......... .......++..+..+.+++.+||+.+|++||++.++++.|+
T Consensus 241 ~~~---~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIE---NTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHH---HHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 1111111000 00001112234568999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.70 Aligned_cols=246 Identities=23% Similarity=0.380 Sum_probs=200.0
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|+++|++++|+||+++++++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667889999999999999765 68999999876542 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999998876555579999999999999999999999 999999999999999999999999999987643221
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......|+..|+|||.+.+..++.++|+|||||++|||++|+.||............. . .+... ...
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~--------~~~~~--~~~ 223 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---R--------RVLET--EEV 223 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---H--------hhhcc--ccc
Confidence 2234568999999999998999999999999999999999999997654322211111 0 00000 011
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
+....+..+.+++.+||+.+|++||++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 2334556789999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=353.30 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=206.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.++||+|+||.||+|... +++.||+|++... .....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999765 5899999988653 2233567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 558 EYMSNGPFRDHLYGK---------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 558 E~~~~gsL~~~l~~~---------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
||++|++|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 12346678889999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCC-----------------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhh
Q 047569 629 LSKDAPIGQG-----------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE 691 (832)
Q Consensus 629 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~ 691 (832)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521100 01122469999999999999999999999999999999999999997643221
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRP-TMGDVLWNLEYALQL 759 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 759 (832)
... . ..+.++... ....+.+..+.+++.+||+.||++|| +++++++.|+..++.
T Consensus 239 i~~----------~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISY----------R---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh----------h---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 110 0 001111110 01123456789999999999999995 577777777776554
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=335.09 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=206.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~ 552 (832)
.++|.+.+.||+|+||.||+|.+. .++.||+|++.... ....+.+.+|+++|.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345777899999999999999753 34689999987543 333457899999999997 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC-----------------------------------------------------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKN----------------------------------------------------------- 573 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 573 (832)
.++||||+++|+|.+++++..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986431
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 574 -------------------------------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 574 -------------------------------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
...+++.+++.++.|++.||+|||+ .+++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 1246788899999999999999998 899999999999999
Q ss_pred CCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~- 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF- 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-
Confidence 9999999999999876432211 11122346788999999998889999999999999999998 88898654322211
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
. .....+ .....+...+..+.+++.+||+.+|.+||++.+++..|+.++
T Consensus 352 -~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 -Y----NAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -H----HHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 001111 111123345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.35 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=205.6
Q ss_pred hcCCCccceEeecCceeEEEEEEeC-----------------CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceee
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD-----------------GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVS 542 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~ 542 (832)
.++|++.+.||+|+||.||++.... +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999986542 2468999877543 345678999999999999999999
Q ss_pred EEEEeccCCcEEEEEEecCCCChhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 047569 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKN---------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTN 613 (832)
Q Consensus 543 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 613 (832)
+++++..++..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999986433 1268999999999999999999999 999999999999
Q ss_pred eeeCCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh--CCCCCCCCChh
Q 047569 614 ILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC--ARPAINPQLPR 690 (832)
Q Consensus 614 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt--G~~pf~~~~~~ 690 (832)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876432211 12233456788999999988899999999999999999998 66777644322
Q ss_pred hhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 691 EQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.. ........... ........++..+.++.+++.+||+.+|.+||++.|+++.|+
T Consensus 241 ~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV---IENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 11111111110 011111122345578999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.39 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=204.4
Q ss_pred CCCccceEeecCceeEEEEEEeC-C---cEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDD-G---TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.|++.+.||+|+||.||+|.... + ..|+||.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47789999999999999997652 3 36999998754 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999986543 468999999999999999999999 999999999999999999999999999987554322
Q ss_pred Cce--eeccc--cCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 638 GHV--STAVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 638 ~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
... ..... .+..|++||++.+..++.++|||||||++|||++ |..||......+. .++. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i----~~~------ 227 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAI----EQD------ 227 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHH----HcC------
Confidence 111 11111 2457999999999999999999999999999886 9999976543221 1111 000
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.....+.+.+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ---YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112234566789999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.36 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=210.0
Q ss_pred CCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-C-----cceeeEEEEeccCCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-H-----RHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-H-----pnIv~l~~~~~~~~~~~l 555 (832)
+|++.++||+|.||.|-+|.. ++++.||||+++... ....+-+.|+.+|..|+ | -|+|++++++..++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 789999999999999999954 579999999987653 34566788999999996 4 489999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC--CCceEEecccccccC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD--NYVAKVSDFGLSKDA 633 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~ 633 (832)
|+|.+ ..+|.++|.......++...+..++.||+.||..||+ .+|||+||||+||||.+ ...+||+|||.++..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 6899999998888889999999999999999999999 99999999999999974 348999999999875
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh--------
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK-------- 705 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~-------- 705 (832)
... . ....-+..|+|||++.+.+|+.+.||||||||+.||.+|.+.|.+....++...+.-.......
T Consensus 342 ~q~---v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQR---V-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCc---c-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 422 1 2455688999999999999999999999999999999999999998888776554333211110
Q ss_pred ---------cccc-----c-----------------cc---CCCCCCCC----ChhHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 706 ---------GLLE-----K-----------------II---DPHLVGTI----NPESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 706 ---------~~~~-----~-----------------i~---d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
+... . .. -|.-.... ....-..+.+++.+||..||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0000 0 00 00000000 112346789999999999999999998
Q ss_pred HHHHH
Q 047569 748 DVLWN 752 (832)
Q Consensus 748 evl~~ 752 (832)
+.+..
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 88643
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=333.02 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=198.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|+..+.||+|+||.||++... +++.||+|++... .......+.+|++++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999765 6899999987643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999996543 68899999999999999999999 999999999999999999999999999987442110
Q ss_pred C----------------------------------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCC
Q 047569 638 G----------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPA 683 (832)
Q Consensus 638 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~p 683 (832)
. .......||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234699999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 047569 684 INPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT---MGDVL 750 (832)
Q Consensus 684 f~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl 750 (832)
|....+....... ..+ . ..+. ... ....+.++.+++.+|+. +|.+|++ +.|++
T Consensus 236 f~~~~~~~~~~~i---~~~--~---~~~~---~p~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 236 FCSETPQETYRKV---MNW--K---ETLV---FPP--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCHHHHHHHH---HcC--C---Ccee---cCC--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 9876543321110 000 0 0000 000 11245678888888774 9999985 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.34 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=203.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999765 68999999876532 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.......+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999999866555578999999999999999999999 999999999999999999999999999987653222
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. .. .... ..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~-----~~~~-----~~ 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RL-----VKEV-----QE 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hh-----hhhh-----hh
Confidence 2223468999999999999999999999999999999999999997643221111100 00 0000 01
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPT-----MGDVLWN 752 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 752 (832)
......+..+.+++.+||+.||.+||+ +.|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 122334567899999999999999999 7788754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.14 Aligned_cols=265 Identities=19% Similarity=0.294 Sum_probs=202.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999765 67899999876543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++ +|.+++.... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 974 8888775443 357899999999999999999999 9999999999999999999999999999876432221
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc------c
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI------I 712 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i------~ 712 (832)
......+++.|+|||++.+ ..++.++|||||||++|||++|++||......+...................+ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2223457899999998865 46899999999999999999999999876554433222111000000000000 0
Q ss_pred ---CCCCC----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 713 ---DPHLV----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 713 ---d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.+... ....+..+.++.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 00112345678999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.91 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=208.8
Q ss_pred hcCCCccceEeecCceeEEEEEEeC-----CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEecc-CCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD-----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-NSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-~~~~ 553 (832)
.++|++.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999998765 688999987654 34446778999999999999999999998765 5778
Q ss_pred EEEEEecCCCChhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNL------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865322 468999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCce-eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 628 GLSKDAPIGQGHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 628 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
|+++......... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....+.+ +..+. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL----KD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH----Hc
Confidence 9998654322221 122345678999999998899999999999999999999 999997654322 11111 11
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+. . ......++..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 235 ~~-----~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GY-----R----LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC-----C----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 0 01122345678999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.24 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=202.3
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEecc------C
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE------N 550 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~------~ 550 (832)
.+++.|++.+.||+|+||.||+|... +++.+|+|+..... .....+.+|+.+++++ +|+||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999765 68899999876543 3456788999999998 69999999999864 2
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
...+++|||+.+++|.+++.......+++..+..++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 468999999999999999976555578999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||............ ..
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-------~~ 230 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-------PR 230 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------hc
Confidence 7653222 1233456899999999986 346788999999999999999999999654332211100 00
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+. ......+..+.+++.+||+.+|.+||++.+++.
T Consensus 231 -----~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -----NPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00111 112234567899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.52 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=206.0
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.+|++.+.||+|++|.||+|.. .+++.|++|.+........+.+.+|+++++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788899999999999999975 468999999887666556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++... .+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999998543 47899999999999999999999 9999999999999999999999999999876432221 1
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....|++.|+|||.+.+..++.++|||||||++|||++|++||....+..... . . .. ........
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~---~-~~--------~~~~~~~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--L---I-AT--------NGTPELQN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--H---H-hc--------CCCCCCCC
Confidence 233468899999999998889999999999999999999999997654322111 0 0 00 11111112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+......+.+++.+||..+|++||++.+++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 2345567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.45 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=197.8
Q ss_pred eEeecCceeEEEEEEe---CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 489 IIGVGGFGNVYLGEID---DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
.||+|+||.||+|.+. .+..||+|++.... ....++|.+|++++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999654 35679999887653 3345679999999999999999999998864 57899999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee--e
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS--T 642 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~ 642 (832)
|.+++.... ..+++.++++++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986432 468999999999999999999999 8999999999999999999999999999875543222111 1
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... ...+. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~---------~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-------IEQGK---------RLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-------HHCCC---------CCCCC
Confidence 1223578999999988889999999999999999996 9999976543322111 11111 11233
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
...+.++.+++.+||+.+|++||++.++.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 44567899999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.28 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=204.9
Q ss_pred HhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .....++.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 24589999876443 2334568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEE
Q 047569 553 MILVYEYMSNGPFRDHLYGKN--------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV 624 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 624 (832)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996421 2456778899999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHH
Q 047569 625 SDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 625 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 702 (832)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~-------~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-------F 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------H
Confidence 99999875432211 11122235678999999999999999999999999999998 788887644322111 0
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
. .+... ...+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 234 ~--------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 V--------MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred H--------HcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0 11110 011223457899999999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.15 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=197.2
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~ 557 (832)
+|+..+.||+|+||.||++... +|+.||+|++... .....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999765 6899999987643 2334566888999998885 678889999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 9999999999986543 68999999999999999999999 99999999999999999999999999998754322
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
........||+.|+|||++.+..++.++|||||||++|||++|++||......... + . +....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~---~---------i~~~~-- 217 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---Q---S---------IMEHN-- 217 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H---H---------HHhCC--
Confidence 12233456899999999999999999999999999999999999999765432211 1 1 11111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
..++...+..+.+++.+||+.+|.+|++..
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 112234456789999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.26 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=204.3
Q ss_pred cCCCccceEeecCceeEEEEEE-----eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~ 553 (832)
+.|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 357899999987553 44456799999999999999999999998765 568
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++.+.. ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999986543 368999999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhh---------hhhHHHHHHHH
Q 047569 634 PIGQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE---------QVNLAEWAMQW 702 (832)
Q Consensus 634 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~---------~~~l~~~~~~~ 702 (832)
...... ......++..|+|||.+.+..++.++|||||||++|||++++.|........ ......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-V 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-H
Confidence 432221 1123446778999999988889999999999999999999886643221100 000000000 0
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
...+ .........+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 01112234567899999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.08 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=214.5
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc---ccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE---QGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~ 554 (832)
....|++.+.||+|.||.||++..+ +|+.+|+|.+.+... .....+.+|+++|+++. |||||.+++.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3567888899999999999999776 599999998876543 34568999999999998 999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC----CCceEEeccccc
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD----NYVAKVSDFGLS 630 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla 630 (832)
+|||+++||.|.+.+... .+++..+..++.|++.+++|||+ .+|+||||||+|+|+.. ++.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999766 39999999999999999999999 99999999999999963 357999999999
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
..... .......+||+.|+|||++....++..+||||+||++|.|++|.+||...........+ ..+
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~---- 253 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRG---- 253 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcC----
Confidence 98765 45567788999999999999999999999999999999999999999877643322211 111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+.......-+..+..+.+++..||..||.+|+++.++++.
T Consensus 254 --~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 --DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1123333345667889999999999999999999999864
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.41 Aligned_cols=245 Identities=26% Similarity=0.444 Sum_probs=206.0
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChh
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFR 566 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 566 (832)
-+||+|.+|+||.|+.. +...+|||.+.....+..+-++.|+.+.++|+|.|||+++|+|.+++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999765 56789999998888788888999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCceEEecccccccCCCCCCceeec
Q 047569 567 DHLYGKNLPPL--SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTA 643 (832)
Q Consensus 567 ~~l~~~~~~~l--~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 643 (832)
++|..+= +++ .+..+-...+||++||.|||+ +.|||||||-+|||++ -.|.+||+|||-++... +......+
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTET 735 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhc-cCCccccc
Confidence 9996542 355 677888899999999999999 9999999999999996 67899999999988653 33445567
Q ss_pred cccCccccChhccccC--CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 644 VKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~--~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
..||..|||||++..+ .|..++|||||||++.||.||+|||..-..... .+ .+-|.. .....++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AM-------FkVGmy------KvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AM-------FKVGMY------KVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hh-------hhhcce------ecCCCCc
Confidence 7899999999999765 588999999999999999999999965432211 11 111111 1223567
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+.+.+...++.+|+.++|.+||++.++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 788999999999999999999999999874
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.06 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=205.2
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
++|+..+.||+|+||.||+|..+ +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999754 3467999987765443 4678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 555 LVYEYMSNGPFRDHLYGKN-------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~-------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999996543 1268999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
|++...............++..|++||.+.+...+.++||||||+++|||++ |..||......... . . ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~---~---~-~~~- 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL---N---R-LQA- 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH---H---H-HHc-
Confidence 9986543222222233346778999999988889999999999999999998 77888643322211 1 1 010
Q ss_pred ccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 707 LLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 707 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
..+........+..+.+++.+||+.+|.+||++.+++..|+
T Consensus 234 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111122345678999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.28 Aligned_cols=258 Identities=23% Similarity=0.423 Sum_probs=205.9
Q ss_pred cCCCccceEeecCceeEEEEEEe--------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID--------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENS 551 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~ 551 (832)
++|.+.+.||+|+||.||++... ....+|+|.+... ......++.+|+++++++ +||||+++++++.+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788999999999999999642 2457999987754 334466789999999999 6999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
..+++|||+++|+|.+++.... ...+++.++++++.|++.||+|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 9999999999999999985432 2358899999999999999999999 9999999999999999
Q ss_pred CCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhH
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNL 695 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l 695 (832)
+++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999865422111 1112234567999999999999999999999999999999 8888865543222111
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...+. ....+...+.++.+++.+||+.+|++||++.++++.|+.+..
T Consensus 249 -------~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 -------LREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -------HHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11110 011233456688999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.04 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=209.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|++|.||+|... +|+.|++|.++.. .....+++.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 7899999987532 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 558 EYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||+++++|.+++.. .....+++.+++.++.++++||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 223468999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+..... ..+ .
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~--------~ 224 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-EKC--------D 224 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhh-hcC--------C
Confidence 221 12334588899999999988999999999999999999999999864431 111111110 001 1
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.........+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111224566899999999999999999999999888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.64 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=201.8
Q ss_pred ceEeecCceeEEEEEEeC--C--cEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEIDD--G--TKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|++|.||+|.+.+ + ..||||.+..... ...++|.+|++++++++||||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 3 3699999887655 567789999999999999999999999988 889999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc--e
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH--V 640 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 640 (832)
++|.+++.......+++..++.++.|+++||+|||+ ++++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999976543578999999999999999999999 99999999999999999999999999999876432221 1
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... . .... . ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~---~~~~-------~--~~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK---I---DKEG-------E--RLE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H---HhcC-------C--cCC
Confidence 122457789999999999999999999999999999998 9999965543321111 0 0000 0 011
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12334578999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.07 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=206.1
Q ss_pred cCCCccceEeecCceeEEEEEEeC----CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|.+.+.||+|+||.||+|...+ ...|++|...... .+..+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457889999999999999997643 3478999877654 4556789999999999999999999999876 457899
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999996543 368999999999999999999999 89999999999999999999999999998765433
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.........++..|+|||.+....++.++||||||+++|||++ |+.||......+.... .. .+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~------~~-~~~-------- 225 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR------IE-NGE-------- 225 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HH-cCC--------
Confidence 2222222334568999999988889999999999999999986 9999976543322111 00 000
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....++..+..+.+++.+|+..+|++||++.+++..|+.+..
T Consensus 226 -~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 -RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001234456789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.02 Aligned_cols=251 Identities=31% Similarity=0.477 Sum_probs=203.6
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
.+|++.+.||+|+||.||++.+.+++.+++|.+..... ...+|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35778899999999999999887788999998765432 34679999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.... ..+++..++.++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999986543 358899999999999999999999 8999999999999999999999999999876543222112
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++.+|+|||++.++.++.++||||||+++|||++ |+.||.......... . ..++. ... .
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~------~-~~~~~--~~~-------~ 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE------T-INAGF--RLY-------K 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH------H-HhCCC--CCC-------C
Confidence 22335678999999998899999999999999999998 999997654322111 1 01110 001 1
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 122356799999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.50 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=203.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|+..+.||+|+||+||+|.+. +++ .||+|.+... .....+++.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788999999999999999753 444 4899987654 33445678999999999999999999999975 45789
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
++||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999986533 368999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCce-eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
..... .....++..|++||.+.+..++.++|||||||++|||++ |..||........ ..+. ..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~------ 228 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLL----EKGE------ 228 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCC------
Confidence 22211 112235678999999999999999999999999999998 8999875433221 1111 1110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
....+...+..+.+++.+||+.||++||++.+++..|+.+.
T Consensus 229 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 ---RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112345567899999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.53 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=204.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||.||++... ++..+++|.+... ......++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999765 6888999987654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999654 468899999999999999999996 148999999999999999999999999998754321
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh--------------
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK-------------- 705 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~-------------- 705 (832)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 123456889999999998888999999999999999999999998654322211110000000000
Q ss_pred -------cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 706 -------GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 706 -------~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.....+.............+..+.+++.+||+.+|++||++.++++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000000000001124567999999999999999999999986544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.56 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=199.7
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.++||+|+||.||+|.. .+++.||+|.+... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999975 46899999987644 334456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|..+. .+++..+..++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999996553 46788899999999999999999 99999999999999999999999999998765322
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhh-HHHHHHHHhhhcccccccCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVN-LAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~-l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ..+.+.....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 219 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL---------QCIVDEDPPV 219 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH---------HHHhccCCCC
Confidence 2233568999999999999999999999999999999999999996532211110 00100 0011111111
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
......+.++.+++.+||+.+|++||+++|++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122345678999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.50 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=199.0
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------ 550 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------ 550 (832)
..++|++.+.||+|+||.||++... +|+.||+|++... ......++.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999764 6899999987643 334456788999999999999999999988544
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
...++||||+++ +|.+.+.. .+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 357999999964 56666532 47888999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH-------------
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE------------- 697 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~------------- 697 (832)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 754321 22234568999999999999999999999999999999999999998664332211000
Q ss_pred ---HHHHHhhh-ccc-----ccccCCCCC---CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 698 ---WAMQWKRK-GLL-----EKIIDPHLV---GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 698 ---~~~~~~~~-~~~-----~~i~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
....+... ... .+....... ..........+.+++.+||+.||++|||+.|++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000 000000000 00111234678999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=312.44 Aligned_cols=249 Identities=29% Similarity=0.479 Sum_probs=197.3
Q ss_pred ceEeecCceeEEEEEEe-CCc--EEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGT--KVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|..+ ++. .+++|.+... .....+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 343 5688887653 344556789999999999 799999999999999999999999999
Q ss_pred CChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 563 GPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 563 gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1357899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
++...... ........+..|+|||++....++.++|||||||++|||++ |+.||......+.. ... ..+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~------~~~-~~~- 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKL-PQG- 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH------HHH-hCC-
Confidence 98632211 11111223567999999988899999999999999999997 99999654322211 110 000
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.....+...+..+.+++.+|++.+|.+||++.++++.|+.++
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=326.85 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=202.9
Q ss_pred hcCCCccceEeecCceeEEEEEE------eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEecc-CC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE-NS 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~-~~ 551 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|.++ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999963 357899999987543 33456788999999999 68999999998754 45
Q ss_pred cEEEEEEecCCCChhhhhccCC----------------------------------------------------------
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN---------------------------------------------------------- 573 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 573 (832)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6889999999999999885421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC-ceeeccc
Q 047569 574 -------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVK 645 (832)
Q Consensus 574 -------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~ 645 (832)
...+++.++..++.|+++||+|||+ ++++||||||+|||+++++.+||+|||++........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1246888899999999999999999 9999999999999999999999999999876432211 1112233
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 724 (832)
++..|+|||.+.+..++.++||||||+++|||++ |..||......... . .....+.. ...+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~----~~~~~~~~---------~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGTR---------MRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--H----HHHhccCC---------CCCCCCC
Confidence 5678999999999999999999999999999997 88898654322111 0 00111110 0111223
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 725 LKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 725 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+.++.+++.+||+.+|++||++.|+++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=338.68 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=196.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc--------CC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--------NS 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--------~~ 551 (832)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+|++++||||+++++++.. ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999764 68999999875432 234579999999999999999887632 12
Q ss_pred cEEEEEEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEeccc
Q 047569 552 EMILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFG 628 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG 628 (832)
.+++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999997 467666642 233478999999999999999999999 9999999999999999654 79999999
Q ss_pred ccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+..............+.
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 998654322 2234568999999999866 4689999999999999999999999987655433221111000000000
Q ss_pred -------ccc-----ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 708 -------LEK-----IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 708 -------~~~-----i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
... +....+...++...+.++.+++.+||+.+|.+|||+.|+++.-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 000 0011111122333557899999999999999999999998553
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.22 Aligned_cols=265 Identities=21% Similarity=0.321 Sum_probs=203.1
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999765 68899999876442 33345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
++ ++|.+++.... ..+++..+..++.|+++||+|||+ .+++|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 68988886543 368899999999999999999999 9999999999999999999999999999876432221
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC-----
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID----- 713 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d----- 713 (832)
......+++.|+|||++.+ ..++.++|||||||++|||++|++||......+................+..+++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1223357889999998865 4578899999999999999999999987654433221111100000111111111
Q ss_pred ----CCCC----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 ----PHLV----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ----~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+... ....+..+..+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1100 01122345678999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.60 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=204.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||++... ++..+|+|++.... .+...+|.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999753 46789999887543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCc
Q 047569 554 ILVYEYMSNGPFRDHLYGKN--------------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTN 613 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 613 (832)
+++|||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999985321 1357888999999999999999999 899999999999
Q ss_pred eeeCCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhh
Q 047569 614 ILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPRE 691 (832)
Q Consensus 614 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~ 691 (832)
||+++++.+||+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 11122234667999999998999999999999999999997 888886543322
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.. . . ...+ ... ..+...+.++.+++.+||+.+|++||++.|+++.|+
T Consensus 241 ~~---~---~-~~~~--------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VI---Y---Y-VRDG--------NVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HH---H---H-HhcC--------CCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11 1 1 1111 110 122345678999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.72 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=202.6
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHH--HHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGIT--EFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
|++.+.||+|+||+||++... +++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999876 5678999998876544332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.. ...+++.+++.++.|+++||++||+ .+++|+||||+||+++.++.++|+|||++.... .....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 99999999972 2368999999999999999999999 999999999999999999999999999987542 12233
Q ss_pred eeccccCccccChhccc-cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~-~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++. +...+.++||||||+++|+|++|+.||......+.............. ... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-------~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP---SSS-------Q 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH---HHT-------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc---ccc-------c
Confidence 44566899999999998 889999999999999999999999999876333322222211110000 000 0
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
........+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00112378999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.28 Aligned_cols=261 Identities=23% Similarity=0.378 Sum_probs=203.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-----------------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-----------------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSL 543 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l 543 (832)
++|++.+.||+|+||.||++... ++..+|+|++... .....++|.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998532 2346899988754 34445789999999999999999999
Q ss_pred EEEeccCCcEEEEEEecCCCChhhhhccCCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCce
Q 047569 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNL---------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNI 614 (832)
Q Consensus 544 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NI 614 (832)
++++...+..++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 9999999999999999999999999865321 247788999999999999999999 8999999999999
Q ss_pred eeCCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh--CCCCCCCCChhh
Q 047569 615 LLDDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC--ARPAINPQLPRE 691 (832)
Q Consensus 615 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt--G~~pf~~~~~~~ 691 (832)
|++.++.++|+|||+++........ ......++..|++||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999998765322211 1122334678999999888899999999999999999998 667886543322
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
... .......... .... ...+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus 242 ~~~---~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIE---NTGEFFRDQG-RQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHhhcc-cccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 1111111110 0000 0112334578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=308.31 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=207.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|+..+.||.|+||.||.++.. +++.+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788999999999999999654 6889999986543 345567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.......+++.++..++.|++++|+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999976545578999999999999999999999 8999999999999999999999999999886543321
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......|++.|+|||++.+..++.++||||||+++|||++|+.||......+... ... ...+ ..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~---------~~~~-~~ 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KIV---------QGNY-TP 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH---------cCCC-CC
Confidence 2234568999999999988889999999999999999999999997654322111 110 1111 11
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.....+..+.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 123456779999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.18 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=208.3
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.+.|+.-++||+||||.||.++.+ +|+.+|+|++.+. .+++....++|-.+|++++.+.||.+--.++.++.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888999999999999999765 7999999987654 344556678999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
+..|.||+|.-+|...+.+.+++..+...+.+|+.||++||+ .+||+|||||+|||||+.|+++|+|+||+.....+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999998888899999999999999999999999 99999999999999999999999999999987755
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
... ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||..........- +. +.+.. -
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vd--------rr~~~--~ 405 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VD--------RRTLE--D 405 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HH--------HHHhc--c
Confidence 433 444799999999999999999999999999999999999999965433221100 00 01110 0
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
...++...+++...+.+..|++||.+|-..
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 113445667778888889999999999643
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=307.92 Aligned_cols=248 Identities=32% Similarity=0.493 Sum_probs=204.3
Q ss_pred ceEeecCceeEEEEEEeC----CcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|.... +..+++|.+...... ..+++.+|++++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997653 789999998765433 367899999999999999999999999999999999999999
Q ss_pred CChhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 563 GPFRDHLYGKN-------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 563 gsL~~~l~~~~-------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
++|.+++.... ...+++.+++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999996542 3578999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+... . ...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~-~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE------Y-LRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHH------H-HHcC-------
Confidence 221 12233457889999999988899999999999999999999 599997664322111 1 0000
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.....+...+.++.+++.+||+.+|.+||++.+++..|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223445678999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.67 Aligned_cols=250 Identities=22% Similarity=0.415 Sum_probs=202.9
Q ss_pred CCCccceEeecCceeEEEEEEeCCcEEEEEecCCCC------cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
+|++.+.||+|+||.||+|...+++.+|+|.+.... .+..+.+.+|+++|++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999876432 22345689999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
+||+++++|.+++.+.. .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 67899999999999999999999 89999999999999999999999999998754211
Q ss_pred C-----CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 637 Q-----GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 637 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||............ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~------ 223 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAH------ 223 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhc------
Confidence 1 11122345889999999999989999999999999999999999999754322211000 000
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 224 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 --RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111223445677899999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.19 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=204.6
Q ss_pred HHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 477 LQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 477 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++.+++++.....||+|+||.||+|... +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455677777789999999999999754 678899998877766667889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEeccccccc
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPL--SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKD 632 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l--~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 632 (832)
|+||+++++|.+++.... ..+ ++..+..++.|+++||+|||+ ++++||||||+||+++. ++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999986542 234 788899999999999999999 99999999999999976 67999999999876
Q ss_pred CCCCCCceeeccccCccccChhccccCC--CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
..... .......|+..|+|||++.+.. ++.++||||||+++|||++|++||......... .+... .
T Consensus 159 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~-----~--- 226 (268)
T cd06624 159 LAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVG-----M--- 226 (268)
T ss_pred cccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhh-----h---
Confidence 53221 1222345789999999986643 789999999999999999999998653321111 00000 0
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
......++.....++.+++.+||+.+|.+||++.|++.
T Consensus 227 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 ---FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00111233445677999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=313.21 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=202.2
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
|++.+.||+|+||.||+|... ++..+++|.+.....+..+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999775 5788999998776666778899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|..++.+.. .++++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99998876433 368999999999999999999999 999999999999999999999999999987643221 1223
Q ss_pred ccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 643 AVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
...++..|+|||++. +..++.++|||||||++|||++|++||.......... .... .. .+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~-----~~~~- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL------KIAK-SE-----PPTL- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH------HHhh-cC-----CCCC-
Confidence 346889999999884 4567889999999999999999999997654322111 0000 00 0111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122345679999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=310.66 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=193.5
Q ss_pred ceEeecCceeEEEEEEeC---CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 488 AIIGVGGFGNVYLGEIDD---GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
+.||+|+||.||+|...+ +..+++|.+.... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 4679999876543 334457899999999999999999999999999999999999999
Q ss_pred ChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC-c
Q 047569 564 PFRDHLYGKN---LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-H 639 (832)
Q Consensus 564 sL~~~l~~~~---~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 639 (832)
+|.+++.... ....++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2346778888999999999999999 9999999999999999999999999999875432211 1
Q ss_pred eeeccccCccccChhccccC-------CCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 640 VSTAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+.... ...+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-------TVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-------HhhcccCCC
Confidence 12234577889999998642 35789999999999999996 9999975543322111 001111112
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.++.+ .......+.+++.+|+ .+|++||++.|+++.|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222 2234456888999998 58999999999997764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.52 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=203.6
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc-CCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-NSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-~~~~~lV~E 558 (832)
+|++.+.||+|++|.||++... +++.+++|++... .....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999765 5789999987643 33445678999999999999999999998764 446799999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.......+++.+++.++.+++.||++||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 9999999999976545568999999999999999999999 899999999999999999999999999987654322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......+++.|+|||++.+..++.++|||||||+++||++|+.||......... .... .+. ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~------~~~~-~~~---------~~ 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV------YRII-EGK---------LP 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHH-hcC---------CC
Confidence 2223456889999999999999999999999999999999999999755432211 1110 111 11
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 223445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=307.53 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=200.6
Q ss_pred ceEeecCceeEEEEEEeCCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChh
Q 047569 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFR 566 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 566 (832)
++||+|+||.||++...+++.|++|+...... +..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999877799999998776533 35678999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee-eccc
Q 047569 567 DHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS-TAVK 645 (832)
Q Consensus 567 ~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 645 (832)
+++.... ..+++..++.++.+++.+|+|||+ ++++||||||+|||++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986543 368899999999999999999999 8999999999999999999999999999876532111111 1122
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 724 (832)
++..|+|||.+.+..++.++|+|||||++|||++ |..||............ .. ......+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-------~~---------~~~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-------ES---------GYRMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-------hc---------CCCCCCCccC
Confidence 3567999999998899999999999999999999 78888665432211110 00 0011122345
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 725 LKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 725 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
+..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 678999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=308.90 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=198.3
Q ss_pred ceEeecCceeEEEEEEe-C---CcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-D---GTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|... . +..+|+|.+..... ...+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999653 2 36899998876543 34567999999999999999999999876 4568999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee-
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS- 641 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 641 (832)
++|.+++.... .+++..++.++.|++.+|+|||+ .+++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996544 68999999999999999999999 8999999999999999999999999999886543222111
Q ss_pred -eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 642 -TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 642 -~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
....++..|+|||.+.+..++.++|||||||++|||++ |++||......+. ..+.. .+. ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~----~~~---------~~~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLE----SGE---------RLP 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHH----cCC---------cCC
Confidence 11223567999999998999999999999999999998 9999976543221 11111 110 011
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.+...+..+.+++.+||..+|++||++.++++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2234557899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.02 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=206.6
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999975 478999999887665556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999988543 58999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||....+....... .... .+.+ ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-------~~~~-----~~~~--~~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNG-----TPEL--QN 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcC-----Cccc--CC
Confidence 23345889999999999888999999999999999999999999776543321110 0000 0011 11
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+...+..+.+++.+||..+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 23455678999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=313.91 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=203.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999875 58999999988777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|..++.... ..+++..++.++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999988875433 368999999999999999999999 899999999999999999999999999887543221 12
Q ss_pred eeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 641 STAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.....++..|+|||++. ...++.++|||||||++|||++|++||......... ..... ...+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~------~~~~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAK------SEPPT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH------HHHhc------CCCcc
Confidence 23345888999999984 345788999999999999999999998654332111 11100 00111
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ..+...+.++.+++.+||+.+|++||++.++++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 112345567899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=295.96 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=207.4
Q ss_pred HHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-----cc---cHHHHHHHHHHHHhC-CCcceeeEEEEe
Q 047569 478 QEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-----EQ---GITEFQTEIQMLSKL-RHRHLVSLIGYC 547 (832)
Q Consensus 478 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~---~~~~f~~Ei~~L~~l-~HpnIv~l~~~~ 547 (832)
+..-++|...+.||.|..++|-++.++ +|...|+|++.... +. -.+.-.+|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888999999999999998654 78899999765431 11 233456799999998 599999999999
Q ss_pred ccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 548 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
+.+..+++|+|.|+.|.|.++|...- .+++++..+|++|+.+|++|||. ++||||||||+|||++++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999996554 79999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccccChhcccc------CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
|.++.... +......+|||+|+|||.+.+ ..|+..+|+|++||++|-||.|.+||.-.. +.-+..
T Consensus 168 GFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR---- 238 (411)
T KOG0599|consen 168 GFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLR---- 238 (411)
T ss_pred ceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHH----
Confidence 99998754 445677899999999998864 357889999999999999999999995321 111111
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
++.+|..+ +..+--.+.+....+|+.+||+.||.+|-|++|+++.--.
T Consensus 239 ~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 239 MIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 11122111 1111113456788999999999999999999999865443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=322.66 Aligned_cols=243 Identities=28% Similarity=0.415 Sum_probs=200.7
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.|...+.||.|+||.||.|+.. +.+.||||++.-. +.+.++++..|++.|.+++|||++.+.||+..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3566788999999999999654 6889999987654 44557889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|| -|+-.++|.-.. .++-+.++..|+.+.+.||+|||+ ++.||||||..||||++.|.+||+|||.+....
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 99 467667664322 368889999999999999999999 999999999999999999999999999987653
Q ss_pred ceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
....++|||.|||||++. .+.|+-|+||||||+++.||...+||+-........ ...+ .--.|.
T Consensus 178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL--YHIA----------QNesPt 244 (948)
T KOG0577|consen 178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA----------QNESPT 244 (948)
T ss_pred -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH--HHHH----------hcCCCC
Confidence 335678999999999874 578999999999999999999999997544332221 1111 111222
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
+ ...+.+..++.++..||++-|.+|||..+++
T Consensus 245 L---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 245 L---QSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred C---CCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 2 2456788999999999999999999999887
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.17 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=200.6
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN----- 550 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~----- 550 (832)
...++|++.+.||+|+||.||++... .++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999764 6899999988654 333456788999999999999999999987543
Q ss_pred -CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 551 -SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 551 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
...++||||+++ +|.+.+.. .+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999964 67666632 47889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH-----------
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW----------- 698 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~----------- 698 (832)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865322 222345689999999999999999999999999999999999999987654332211100
Q ss_pred -----HHHHhhh-cccccccCCCC--------CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 699 -----AMQWKRK-GLLEKIIDPHL--------VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 699 -----~~~~~~~-~~~~~i~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...+... .....+..+.. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000000000 001112235678999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=310.15 Aligned_cols=239 Identities=23% Similarity=0.378 Sum_probs=191.4
Q ss_pred ceEeecCceeEEEEEEeC-------------CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 488 AIIGVGGFGNVYLGEIDD-------------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
+.||+|+||.||+|...+ ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997432 2358999887766666678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc-------eEEecc
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV-------AKVSDF 627 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kl~DF 627 (832)
+||||+++++|..++..+. ..+++..+++++.|+++||+|||+ ++++||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998886443 368999999999999999999999 99999999999999987654 899999
Q ss_pred cccccCCCCCCceeeccccCccccChhccc-cCCCCccccEEechhHHHHHh-hCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVL-CARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~SlGvvl~ell-tG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
|++..... .....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+.... ..
T Consensus 157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~~- 223 (262)
T cd05077 157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------YE- 223 (262)
T ss_pred CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------Hh-
Confidence 98865432 12345788999999886 567899999999999999998 58888765432221110 00
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
+. . .........+.+++.+||+.||.+||++.++++.+
T Consensus 224 ~~--------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQ--------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cC--------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0 01112346789999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.02 Aligned_cols=246 Identities=23% Similarity=0.369 Sum_probs=211.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcc--cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQ--GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.-|.+.+.||+|.|..|-+|++- +|.+||||++.+..-. ....+.+|++.|+.++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34666788999999999999754 7999999998876433 34567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee-CCCCceEEecccccccCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL-DDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~ 637 (832)
+-++|+|.++|.+.. ..+.+..+.+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+..
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 999999999997654 368899999999999999999999 899999999999976 5678999999999987654
Q ss_pred CceeeccccCccccChhccccCCCC-ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
+....+.+|+..|-|||.+.+..|+ +++||||||||||.|++|++||+...+.+. +..|+|-..
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY 236 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY 236 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc
Confidence 4455778899999999999999887 579999999999999999999987665443 233445443
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
.++...+.++++||..||..||.+|.+.+||+
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 45667889999999999999999999999987
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=321.10 Aligned_cols=258 Identities=25% Similarity=0.444 Sum_probs=206.1
Q ss_pred cCCCccceEeecCceeEEEEEEe--------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID--------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENS 551 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~ 551 (832)
.+|++.+.||+|+||.||++... .+..||+|.+... .....+++.+|+++++++ +||||+++++++.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999642 1236899987754 334567899999999999 7999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
..+++|||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 9999999999999999986432 2357889999999999999999999 9999999999999999
Q ss_pred CCCceEEecccccccCCCCCCce-eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhH
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNL 695 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l 695 (832)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999987654321111 122234567999999999999999999999999999998 8888876543222111
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
. ..+ .....+...+..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 249 ------~-~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 249 ------L-KEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ------H-HcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 010 0111223455689999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.35 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=207.6
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEec-
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCD- 548 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~- 548 (832)
.++.++....+.|++.+.||+|+||.||+|... +++.+|+|+..... ....++..|+.+++++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456677777889999999999999999999764 68899999875543 3346788999999999 6999999999984
Q ss_pred -----cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceE
Q 047569 549 -----ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623 (832)
Q Consensus 549 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 623 (832)
.....+++|||+++++|.+++.......+++..++.++.|+++||+|||+ .+++|+||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 34678999999999999999976555568899999999999999999999 8999999999999999999999
Q ss_pred EecccccccCCCCCCceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH
Q 047569 624 VSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW 698 (832)
Q Consensus 624 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~ 698 (832)
|+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||....+......
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--- 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--- 237 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence 999999875432211 223356889999999885 34678899999999999999999999975543222110
Q ss_pred HHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 699 AMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 699 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+.............+..+.+++.+||+.+|.+||++.|+++
T Consensus 238 ------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00011111112335678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.63 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=202.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346778889999999999999764 6899999988766555566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++...+ .+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 99999999986443 68999999999999999999999 899999999999999999999999999987653221 1
Q ss_pred eeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
......|+..|+|||++. ...++.++|||||||++|||++|+.||....+....... ... ....+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~~~----~~~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------TKS----NFQPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------hcc----CCCCCcc
Confidence 223446899999999874 456889999999999999999999998654332211100 000 0001111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. ....+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 10 1124457899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.57 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=206.5
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46789999999999999999975 47999999998766555567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... .+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 9999999998543 57899999999999999999999 8999999999999999999999999999876543221
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......+++.|++||.+.+..++.++|+|||||++|+|++|+.||....+..... ...........
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------------~~~~~~~~~~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------------LIATNGTPELQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------------eeccCCCCCCC
Confidence 2233468899999999999999999999999999999999999997654322110 00000111111
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+...+..+.+++.+||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22345567899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.17 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=201.3
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc---------ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE---------QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
+|.+...||+|++|.||+|... +++.+++|.+..... +..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999764 688999998764422 123568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 368889999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCCC-----ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 633 APIGQG-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 633 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
...... .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||.......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~------ 223 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF------K------ 223 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH------H------
Confidence 642111 11123457889999999998899999999999999999999999997643221110 0
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...... ...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000111 1223345678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=307.66 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=205.5
Q ss_pred cCCCccceEeecCceeEEEEEEeC-CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999998764 78999998765433 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999986433 468999999999999999999999 8999999999999999999999999999886543221 2
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....++..|++||++.+..++.++||||||+++|||++|++||....+....... .....+. ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~--~~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------PNKPPPT--LSD 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------------ccCCCCC--CCc
Confidence 23345889999999999999999999999999999999999999765432211100 0000000 112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2334567999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=311.14 Aligned_cols=248 Identities=28% Similarity=0.400 Sum_probs=205.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||.|++|.||+|... +++.+++|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999765 68999999876543 44567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999998643 68999999999999999999999 899999999999999999999999999998765332 2
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......++..|++||++.+..++.++|||||||++|||++|++||....+..... . .... ..+.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~------~-~~~~-----~~~~---- 217 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF------L-IPKN-----NPPS---- 217 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH------H-hhhc-----CCCC----
Confidence 2233468889999999999889999999999999999999999997654322110 0 0011 1111
Q ss_pred CChh-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 720 INPE-SLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 720 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.... .+..+.+++.+||..+|++||++++++..
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 45678999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=346.34 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=199.8
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcE
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEM 553 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~ 553 (832)
...++|++.+.||+|+||+||++... ++..+|+|.+... .......|..|+.+|++|+|||||++++++.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999765 5778999987643 34456779999999999999999999998743 4678
Q ss_pred EEEEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeeeccCCCCceeeCC---------
Q 047569 554 ILVYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGT----AQGIIHRDVKSTNILLDD--------- 618 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~----~~~ivHrDlkp~NILl~~--------- 618 (832)
+|||||+++++|.++|... ....+++..++.|+.||+.||+|||+.. .++||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998642 2346999999999999999999999832 145999999999999964
Q ss_pred --------CCceEEecccccccCCCCCCceeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCC
Q 047569 619 --------NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQL 688 (832)
Q Consensus 619 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~ 688 (832)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 335899999999865422 22234569999999999854 458899999999999999999999997543
Q ss_pred hhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 689 PREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 689 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..... ..... . .+.+ .....+..+.+|+.+||+.+|.+||++.+++.
T Consensus 248 ~~~ql-----i~~lk-~-------~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFSQL-----ISELK-R-------GPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHHHH-----HHHHh-c-------CCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 32211 11110 0 0111 11224567999999999999999999999974
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.85 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=205.5
Q ss_pred CCccceEeecCceeEEEEEEeC-CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 484 FDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
|+++..||.|+||.||+|..++ +-..|-|.+...+...+++|.-||++|+.+.||+||+|++.+.-.+.+|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4457789999999999997664 555678888888899999999999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|-....+..-+ ..|.+.++.-+|.|++.||.|||+ ++|||||||..|||++-+|.++|+|||.+..... ......
T Consensus 114 GAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD 188 (1187)
T ss_pred chHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence 99888775443 379999999999999999999999 9999999999999999999999999998765432 122334
Q ss_pred ccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 643 AVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.+.|||+|||||+.++ .+|+.++||||||++|.||..+.||-..-.+...+-.+ .+--.|.+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi------------aKSePPTL- 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI------------AKSEPPTL- 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH------------hhcCCCcc-
Confidence 5779999999998764 68999999999999999999999997665443322111 11111222
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.-+...+..+.+++.+||.++|..||++.++++
T Consensus 256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 123456788999999999999999999999983
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=313.75 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=204.9
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEec-
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCD- 548 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~- 548 (832)
+.++.+..+.++|++.+.||+|+||.||++... +++.+++|++.... ....++.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666677899999999999999999999764 58899999876432 2235688999999999 6999999999873
Q ss_pred ----cCCcEEEEEEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 549 ----ENSEMILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 549 ----~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
.++..++||||+++++|.+++.. .....+++..+..++.|+++||.|||+ .+++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 44678999999999999998753 223468899999999999999999999 899999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE 697 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~ 697 (832)
||+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|||++|+.||.......... .
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--K 240 (286)
T ss_pred EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--h
Confidence 999999987654221 12233468999999998853 457889999999999999999999987553322110 0
Q ss_pred HHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 698 WAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 698 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
. ... ..+.+ ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 241 ----~-~~~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 ----I-PRN-----PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----c-ccc-----CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000 00010 0112234579999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.51 Aligned_cols=246 Identities=31% Similarity=0.468 Sum_probs=201.1
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||++.. +++.+|+|...... ..+.+.+|+.++++++||||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578899999999999999975 57889999876432 346789999999999999999999998664 4799999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 9999999976655568999999999999999999999 999999999999999999999999999987643211
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....+..|+|||.+.+..++.++|+|||||++|||++ |++||......+.... ...+. ....
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~---------~~~~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-------VEKGY---------RMEP 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------HhCCC---------CCCC
Confidence 12234568999999998899999999999999999997 9999976543321111 11111 1112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
....+..+.+++.+||+.+|++||++.++++.|+
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 2345678899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=340.85 Aligned_cols=268 Identities=20% Similarity=0.279 Sum_probs=198.7
Q ss_pred HHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCC------cceeeEEEEe
Q 047569 475 QELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH------RHLVSLIGYC 547 (832)
Q Consensus 475 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H------pnIv~l~~~~ 547 (832)
+++...+++|++.+.||+|+||+||+|... +++.||||+++... ....++..|++++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455789999999999999999999764 58899999986432 233456678888877754 4588999988
Q ss_pred ccC-CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC------
Q 047569 548 DEN-SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY------ 620 (832)
Q Consensus 548 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~------ 620 (832)
... ...++|||++ +++|.+++... ..+++.++..++.||+.||+|||+ ..+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence 654 5789999988 78898888654 368999999999999999999996 14899999999999998765
Q ss_pred ----------ceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChh
Q 047569 621 ----------VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPR 690 (832)
Q Consensus 621 ----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~ 690 (832)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|++||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999876432 2234567999999999999999999999999999999999999999876654
Q ss_pred hhhhHHHHHHH-----Hhhhc---ccccccCC--CCCCCCC---------------hhHHHHHHHHHHHhhhcCCCCCCC
Q 047569 691 EQVNLAEWAMQ-----WKRKG---LLEKIIDP--HLVGTIN---------------PESLKKFAEAAEKCLADHGVDRPT 745 (832)
Q Consensus 691 ~~~~l~~~~~~-----~~~~~---~~~~i~d~--~l~~~~~---------------~~~~~~l~~li~~cl~~dP~~RPt 745 (832)
+.......... +.... ...++.+. .+..... ......+.+|+.+||+.||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 44333221110 00000 00000000 0000000 012356789999999999999999
Q ss_pred HHHHHHH
Q 047569 746 MGDVLWN 752 (832)
Q Consensus 746 ~~evl~~ 752 (832)
+.|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999753
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=313.18 Aligned_cols=262 Identities=21% Similarity=0.273 Sum_probs=200.0
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|++.+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999765 6899999987643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 560 MSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
++ ++|.+++.... ...+++.++..++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888875432 2568999999999999999999999 999999999999999999999999999987553221
Q ss_pred ceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHH--------hhhcc--
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW--------KRKGL-- 707 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~--------~~~~~-- 707 (832)
.......+++.|+|||.+.+. .++.++|||||||++|||++|++||......+... ...... .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcchhhH
Confidence 122233578899999988654 57899999999999999999999998654332211 000000 00000
Q ss_pred -cccccCCCCC---CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 -LEKIIDPHLV---GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 -~~~i~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+.... .......+.++.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0011234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.85 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=205.7
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|+..+.||+|+||.+|++... +|+.+++|++... .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999764 6899999987643 334456899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.......+++.++++++.|++.||+|||+ ++++|+||+|+|||++.++.++|+|||++....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 999999999876554568899999999999999999999 899999999999999999999999999987654322 1
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......|++.|+|||++.+...+.++|+|||||+++||++|+.||......+.. ..... +. ...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~~-~~---------~~~ 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------LKIIR-GS---------YPP 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------HHHhc-CC---------CCC
Confidence 122345888999999999989999999999999999999999999765433211 11110 10 011
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+......+.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 23345677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.69 Aligned_cols=251 Identities=31% Similarity=0.515 Sum_probs=203.7
Q ss_pred CCccceEeecCceeEEEEEEeC-----CcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 484 FDSSAIIGVGGFGNVYLGEIDD-----GTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
|.+.+.||.|+||.||++...+ +..||+|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999997653 388999998765433 5678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.......+++.++..++.|++.||++||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999976543338999999999999999999999 899999999999999999999999999987665332
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........++..|++||.+.+..++.++||||||+++|||++ |++||......... +.. ..+.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~----~~~~--------- 221 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL---EYL----KKGY--------- 221 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----hcCC---------
Confidence 222212336789999999988889999999999999999998 78888764332211 111 0000
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
........+.++.+++.+||..+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0112233567899999999999999999999998653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.86 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=206.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|++|.||++... +++.+|+|..........+.|.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999765 6899999998777666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999886533 368999999999999999999999 8999999999999999999999999998875432221
Q ss_pred eeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 640 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
......+++.|++||++. ...++.++|||||||++|||++|++||......... .... .+ ..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~-----~~~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL------LKIL-KS-----EPP 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH------HHHh-cC-----CCC
Confidence 223446899999999875 345778999999999999999999999765432211 0110 00 001
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.+ ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11 1123355678999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=313.15 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=189.5
Q ss_pred eEeecCceeEEEEEEeC-------------------------CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeE
Q 047569 489 IIGVGGFGNVYLGEIDD-------------------------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l 543 (832)
.||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13588998876555556678999999999999999999
Q ss_pred EEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC---
Q 047569 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY--- 620 (832)
Q Consensus 544 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~--- 620 (832)
+++|.+....++||||+++++|..++... ...+++..++.++.|+++||+|||+ ++++||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999988643 2468899999999999999999999 8999999999999997643
Q ss_pred ----ceEEecccccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHH-hhCCCCCCCCChhhhhh
Q 047569 621 ----VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEV-LCARPAINPQLPREQVN 694 (832)
Q Consensus 621 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~el-ltG~~pf~~~~~~~~~~ 694 (832)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||| ++|+.||....+.+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999987643221 12347788999998865 5689999999999999998 47899987654332211
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
.. .. ... .+......+.+++.+||+.+|++||++.++++.|
T Consensus 233 ~~-------~~-------~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 233 FY-------EK-------KHR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH-------Hh-------ccC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 10 00 000 1112234689999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.47 Aligned_cols=192 Identities=26% Similarity=0.372 Sum_probs=165.0
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
...+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999775 5788999975432 23569999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
++. ++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 994 68888875433 468999999999999999999999 89999999999999999999999999998753321
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAI 684 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf 684 (832)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999865544
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.18 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=195.1
Q ss_pred ceEeecCceeEEEEEEe----CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEec-cCCcEEEEEEecC
Q 047569 488 AIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD-ENSEMILVYEYMS 561 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 561 (832)
+.||+|+||.||+|... ++..+|+|++... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2457999987543 3345678899999999999999999999775 4567899999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC---
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG--- 638 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 638 (832)
+++|.+++.... ..+++..++.++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986543 346788889999999999999999 8999999999999999999999999999875432111
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhC-CCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA-RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......++..|+|||.+.+..++.++|||||||++|||++| .+||......+ +.... . .+. .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~-~~~-----~~--- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---L-QGR-----RL--- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---h-cCC-----CC---
Confidence 011223457789999999888999999999999999999995 56665433221 11111 0 000 00
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
..+...+..+.+++.+||+.+|++||++.+++..|+.+.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 111223567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.40 Aligned_cols=267 Identities=27% Similarity=0.414 Sum_probs=196.3
Q ss_pred CccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhC--CCcceeeEEEEeccCC----cEEEEEE
Q 047569 485 DSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL--RHRHLVSLIGYCDENS----EMILVYE 558 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l--~HpnIv~l~~~~~~~~----~~~lV~E 558 (832)
...++||+|.||.||||.+. ++.||||++. .+..+.|++|.++.+.. +|+||+++++.-+... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34678999999999999986 5999999976 44567899999888764 7999999999876555 8999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG------TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
|.+.|+|.++|..+ .++|....+|+..+++||+|||+. +..+|+|||||++||||.+|++..|+|||++..
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999654 589999999999999999999974 345799999999999999999999999999987
Q ss_pred CCCCCC-ceeeccccCccccChhccccC-CCC-----ccccEEechhHHHHHhhCCCCCCC-CChhhhhhHHHHHHHH--
Q 047569 633 APIGQG-HVSTAVKGSFGYLDPEYFRRQ-QLT-----EKSDVYSFGVVLLEVLCARPAINP-QLPREQVNLAEWAMQW-- 702 (832)
Q Consensus 633 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~-----~~sDV~SlGvvl~elltG~~pf~~-~~~~~~~~l~~~~~~~-- 702 (832)
+..+.. ......+||.+|||||++.+. .+. .+.||||+|.|||||++...-+.. ..+.-+...-..+...
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 763322 122236799999999999763 222 478999999999999987644421 1110000000000000
Q ss_pred ---hhhcccccccCCCCCCCCC-hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 703 ---KRKGLLEKIIDPHLVGTIN-PESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 703 ---~~~~~~~~i~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.++-.+++-..|.+..... -.....+++.++.||+.|++.|-|+.=+.+++.....
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 0000011111222221111 1346789999999999999999999888776665543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=324.73 Aligned_cols=263 Identities=20% Similarity=0.250 Sum_probs=199.7
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------ 550 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------ 550 (832)
..++|++.+.||+|+||.||++... .++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999764 6889999988653 334456788999999999999999999987543
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
...++||||++ ++|.+.+.. .+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 45799999996 467777632 47889999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH---------HH-
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW---------AM- 700 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~---------~~- 700 (832)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....... ..
T Consensus 174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 765322 222345689999999999999999999999999999999999999987654332211100 00
Q ss_pred ------HHhh-hccc-----ccccCCCC---CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 701 ------QWKR-KGLL-----EKIIDPHL---VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 701 ------~~~~-~~~~-----~~i~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.... .... .+...... ...........+.+++.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 00000000 001111234578999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.26 Aligned_cols=239 Identities=23% Similarity=0.367 Sum_probs=192.2
Q ss_pred ceEeecCceeEEEEEEeC--------CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 488 AIIGVGGFGNVYLGEIDD--------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+.||+|+||.||+|.... ...+++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999996532 235888887665555667899999999999999999999999998999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc--------eEEecccccc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV--------AKVSDFGLSK 631 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFGla~ 631 (832)
+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999996544 368999999999999999999999 99999999999999987765 6999999886
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCC-CCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. +|+............ ..
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~---- 220 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------ED---- 220 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------Hc----
Confidence 5432 123457889999999976 45799999999999999999995 665543332211110 00
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
...++.....++.+++.+||+.+|++||+++++++.|
T Consensus 221 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 -------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0112233446789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.36 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=203.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-----cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-----EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+++.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999776 78999999865432 33457799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
+||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999998654 368899999999999999999999 89999999999999999999999999998765432
Q ss_pred CCceeeccccCccccChhccccCC-CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|++||.......... ......
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~--------- 218 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF------KIGRSK--------- 218 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH------HHHhcc---------
Confidence 2 223456889999999987776 8999999999999999999999997654222111 000000
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....++......+.+++.+||+.+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011223345677899999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.21 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=203.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc---ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE---QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|+..+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|++++++++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999765 589999998875432 34567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+.+++|.+++.......+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999976555679999999999999999999999 999999999999999999999999999987543211
Q ss_pred Cc----------------------------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCCh
Q 047569 638 GH----------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLP 689 (832)
Q Consensus 638 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~ 689 (832)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11123578899999999998899999999999999999999999976543
Q ss_pred hhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC----HHHHH
Q 047569 690 REQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT----MGDVL 750 (832)
Q Consensus 690 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl 750 (832)
.... ..+......-......+..+.+++.+||+.+|++||+ +.|++
T Consensus 238 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 238 DETF---------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHHH---------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 2211 0111111111111225678999999999999999999 55554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=320.21 Aligned_cols=240 Identities=23% Similarity=0.278 Sum_probs=188.8
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC---CCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL---RHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
||+|+||+||+|+.. +++.||+|++... .......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 6899999987643 222334556677777765 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|.+++... ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 9999988654 368999999999999999999999 999999999999999999999999999987543221 2233
Q ss_pred ccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 643 AVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... .. ..+ ...+. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~------~i-~~~------~~~~~---~ 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR------NI-AFG------KVRFP---K 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH------HH-HcC------CCCCC---C
Confidence 45699999999998764 58999999999999999999999997654322111 10 000 00111 1
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPT----MGDVLW 751 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 751 (832)
...+..+.+++.+||+.+|.+||+ +.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 124567889999999999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.49 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=207.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++.+++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999765 57899999887666666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.... ..+++.++..++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999999886542 368899999999999999999999 899999999999999999999999999987654221 12
Q ss_pred eeccccCccccChhccccC---CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~---~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....++..|++||.+.+. .++.++|||||||++|||++|++||....+....... ... ....+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~------~~~----~~~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI------SKS----NFPPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hhc----cCCCccc-
Confidence 2345688899999999776 8899999999999999999999999765433322110 000 0001111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
......+..+.+++.+||..+|.+||++.+++.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122345678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=312.88 Aligned_cols=270 Identities=27% Similarity=0.422 Sum_probs=205.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-----CCcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-----DGTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~ 553 (832)
+.|+..+.||+|+||.||++.+. +++.+|+|.+...... ..++|.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667889999999999999753 3689999998765443 46789999999999999999999999877 5678
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999996543 258999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 634 PIGQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 634 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
...... ......++..|++||.+.+..++.++||||||+++|||++|+.|+................... ...+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI-VTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc-HHHHHHH
Confidence 522211 1112334567999999988899999999999999999999998876532211000000000000 0000001
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
+........+..++.++.+++.+||+.+|++||++.|++++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111112234457899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.15 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=190.6
Q ss_pred eEeecCceeEEEEEEeC---CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 489 IIGVGGFGNVYLGEIDD---GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
.||+|+||.||+|...+ ...+++|.+.... ......|.+|+++++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996543 3578899776443 3345678999999999999999999999999999999999999999
Q ss_pred hhhhhccCCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC-ce
Q 047569 565 FRDHLYGKNL---PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-HV 640 (832)
Q Consensus 565 L~~~l~~~~~---~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 640 (832)
|.+++..... ...++...+.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999965432 235678889999999999999999 9999999999999999999999999999865432211 11
Q ss_pred eeccccCccccChhcccc-------CCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 641 STAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....+.+... . .... ....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--~----~~~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK--Q----VVRE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH--H----Hhhc-cCccCC
Confidence 123345678999998743 456889999999999999999 778886554322111 0 0111 111111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
.+ ......+..+.+++..|+ .||++||++++|++.|
T Consensus 232 ~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 22 223345567788888888 5999999999998776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.79 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=205.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.+|++.+.||+|+||.||+|... +|+ .+++|...... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999764 333 58999876553 3445778999999999999999999999987 78999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999996543 358999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCcee-eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGHVS-TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
...... ....++..|++||.+....++.++|+||||+++|||++ |+.||......+.. .. ...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~------ 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---DL----LEKGE------ 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH----HhCCC------
Confidence 222111 12223568999999988899999999999999999998 99999765432211 11 11110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....+......+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011122344678999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.03 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=197.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-----cccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-----EQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~ 553 (832)
.+|+..+.||+|+||.||++... +++.|++|++.... .+....+.+|++++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999764 68999999875432 2345678899999999999999999998865 4678
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999996543 58899999999999999999998 89999999999999999999999999998754
Q ss_pred CCCC--CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 634 PIGQ--GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 634 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
.... ........++..|+|||++.+..++.++|||||||++|||++|+.||.......... .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~~-----~~ 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIAT-----QP 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHhc-----CC
Confidence 3211 111123458899999999999899999999999999999999999997543222110 0000 00
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. ..++......+.+++ +||..+|++||+++|++.
T Consensus 226 ~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11 122334455677777 788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=330.30 Aligned_cols=261 Identities=19% Similarity=0.222 Sum_probs=195.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
..+|.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++|+|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999999999765 57899999632 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC-
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG- 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 638 (832)
+. ++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 94 78888875433 369999999999999999999999 9999999999999999999999999999976542211
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCC-CChhh----hhhHHHHHHHHhh--hcc----
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINP-QLPRE----QVNLAEWAMQWKR--KGL---- 707 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~-~~~~~----~~~l~~~~~~~~~--~~~---- 707 (832)
.......||..|+|||++.+..++.++|||||||+||||++|..++.. ..... ...+.+....... ...
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 122345699999999999999999999999999999999998765432 11100 0111111111000 000
Q ss_pred ----ccccc---CCCCCCCCC-------hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 708 ----LEKII---DPHLVGTIN-------PESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 708 ----~~~i~---d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..... ......... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 000000000 0123468899999999999999999999854
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=313.73 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=205.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||+||++... +++.+|+|++... .....+++.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56778899999999999999765 6889999986654 344567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... ..+++..+..++.+++.+|.|||+ ..+++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999988654 368999999999999999999996 247999999999999999999999999998654221
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhh-----hhHHHHHHHHhhhcccccccCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ-----VNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~-----~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ..+..+... +...
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 228 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---------IVQE 228 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---------Hhhc
Confidence 12234689999999999888999999999999999999999999976543211 111111111 1111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
..........+..+.+++.+||+.+|++||++.|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1111111235567999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=319.28 Aligned_cols=257 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred ccceEeec--CceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 486 SSAIIGVG--GFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 486 ~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+.++||+| +|++||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999764 78999999986542 334456788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc-
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH- 639 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 639 (832)
++++|.+++.......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999965544568999999999999999999999 99999999999999999999999999865433211100
Q ss_pred -----eeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 640 -----VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 640 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .... .+......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHh-----cCCccccc
Confidence 1122346778999999976 46899999999999999999999999754322110 0000 00000000
Q ss_pred C------------------------------------CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 713 D------------------------------------PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 713 d------------------------------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+ ..............+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 000001122345689999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=324.18 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=199.2
Q ss_pred HHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccC---
Q 047569 477 LQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--- 550 (832)
Q Consensus 477 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--- 550 (832)
.....++|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|+++|++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3455688999999999999999999754 68899999876532 23345688999999999999999999987532
Q ss_pred ---CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 551 ---SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 551 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
...++++|++ +++|.+++.. ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence 4578999998 7899888743 358999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...............
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865422 234468999999999876 578999999999999999999999997654332211110000000000
Q ss_pred cc--------ccccC--CCCC----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 707 LL--------EKIID--PHLV----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 707 ~~--------~~i~d--~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.. ..... +... ..........+.+++.+||+.||.+|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000 0000 00001123457899999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.58 Aligned_cols=248 Identities=28% Similarity=0.437 Sum_probs=197.8
Q ss_pred ceEeecCceeEEEEEEeC-------CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 488 AIIGVGGFGNVYLGEIDD-------GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+.||+|+||.||+|...+ ++.+++|.+.... .....+|.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997542 2579999876542 34467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-----ceEEecccc
Q 047569 560 MSNGPFRDHLYGK-----NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-----VAKVSDFGL 629 (832)
Q Consensus 560 ~~~gsL~~~l~~~-----~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGl 629 (832)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999643 22347899999999999999999998 8999999999999999877 899999999
Q ss_pred cccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 630 SKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 630 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.. ... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~---~~~----~~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL---QHV----TAG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH---HHH----hcC-
Confidence 875532211 11122345678999999999999999999999999999998 99998754432211 100 000
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.........+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 011122345678899999999999999999999988775
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=327.37 Aligned_cols=262 Identities=22% Similarity=0.257 Sum_probs=199.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe---CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID---DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
..+|++.+.||+|+||.||++... .++.|++|.+... +.+.+|+++|++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999653 3678999987643 23568999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|++. ++|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 688888843 3478999999999999999999999 999999999999999999999999999987654322
Q ss_pred C-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc---------
Q 047569 638 G-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL--------- 707 (832)
Q Consensus 638 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~--------- 707 (832)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....................
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2 122345699999999999999999999999999999999999999976543221111111111000000
Q ss_pred --------cccccCCCCC--CCC-ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 708 --------LEKIIDPHLV--GTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 708 --------~~~i~d~~l~--~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
......+... ..+ .......+.+++.+||..+|++||++.|++..-
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000 000 012345788999999999999999999998653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.77 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=198.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-----CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-----SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~ 553 (832)
++|++.+.||+|+||.||+|... +++.|++|.+... ..+..+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999764 5899999986532 123356788999999999999999999988653 567
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
+++|||+++++|.+++.... .+++...++++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986543 57889999999999999999999 89999999999999999999999999998754
Q ss_pred CCCCC--ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 634 PIGQG--HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 634 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||......... . ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~----~~--------- 221 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI--F----KI--------- 221 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--H----HH---------
Confidence 32111 1122345889999999998888999999999999999999999999654322111 0 00
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.........+......+.+++.+|+. +|++||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00011122344566778899999995 8999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.50 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=205.5
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|++.+.||+|++|.||+|... +|+.|++|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999765 68999999876543 33457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+ +++|.+++.... ..+++.+++.++.|++++|+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999986543 468999999999999999999999 89999999999999999999999999998876543322
Q ss_pred eeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc------------
Q 047569 640 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG------------ 706 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------------ 706 (832)
......|+..|+|||.+.+. .++.++|||||||++|||++|+++|........... ........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI---VFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH---HHHHcCCCChHHHhhccCcc
Confidence 23345689999999998654 468999999999999999999988876554332211 11100000
Q ss_pred ccccccCCCC----CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 707 LLEKIIDPHL----VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 707 ~~~~i~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
....+..+.. .....++....+.+++.+||+.+|.+||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 011123345789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.85 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=203.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999876 58999999875432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|..++... ..+++.+++.++.|++++|+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999888876433 368999999999999999999999 9999999999999999999999999999986543221
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH-HH--------hhhccc
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM-QW--------KRKGLL 708 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~-~~--------~~~~~~ 708 (832)
......++..|+|||.+.+ ..++.++||||||+++|||++|++||......+......... .. ......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2223457889999999876 567899999999999999999999998665433221111000 00 000000
Q ss_pred ccccCCCCCCCC-----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKIIDPHLVGTI-----NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+...... .+..+..+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 011111111000 1224567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.70 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=204.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|++|.||+|... +++.|++|++... .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999765 5889999987653 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|++++.|..++... ..+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987776655432 358999999999999999999999 8999999999999999999999999999887654333
Q ss_pred ceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH---------Hhhhccc
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ---------WKRKGLL 708 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~---------~~~~~~~ 708 (832)
.......++..|+|||++.+. .++.++||||||+++|||++|++||......+.......... +......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233445688999999999888 889999999999999999999999976544332111111000 0000000
Q ss_pred cc-----ccCCCC-CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EK-----IIDPHL-VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~-----i~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. ..++.. ...++...+.++.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000 00112224678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.34 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=204.3
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|+..+.||+|++|.||++... +++.+++|++... .......+.+|+++|++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788999999999999999764 6889999987654 334567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-CceEEecccccccCCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 638 (832)
+++++|.+++.......+++..++.++.+++++|+|||+ ++++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999976555568999999999999999999999 999999999999999854 468999999988654322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ...... . ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~------~~~~~~-~---------~~ 219 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV------LKIMSG-T---------FA 219 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH------HHHHhc-C---------CC
Confidence 223356889999999999888999999999999999999999999765432211 111100 0 11
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.++...+..+.+++.+||+.+|++||++.|+++
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 122335667999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.94 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=202.2
Q ss_pred CCCccceEeecCceeEEEEEEeC--CcEEEEEecCCC----------CcccHHHHHHHHHHHHh-CCCcceeeEEEEecc
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDD--GTKVAVKRGNPQ----------SEQGITEFQTEIQMLSK-LRHRHLVSLIGYCDE 549 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~f~~Ei~~L~~-l~HpnIv~l~~~~~~ 549 (832)
+|++.+.||+|+||.||+|..+. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998764 688999976532 22344567889988875 799999999999999
Q ss_pred CCcEEEEEEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
++..+++|||+++++|.+++.. .....+++..++.++.|++.+|.|||+ ..+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 233468999999999999999999995 257999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
|++....... ......|+..|++||.+.+..++.++||||||+++|||++|++||.......... .. .
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~------~~-~--- 226 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KI-V--- 226 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH------HH-h---
Confidence 9998654332 3344568899999999998889999999999999999999999996543322111 00 0
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
+...........+..+.+++.+||+.+|++||++.|+.++++
T Consensus 227 -----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 -----EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111111134567999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.21 Aligned_cols=196 Identities=22% Similarity=0.349 Sum_probs=160.6
Q ss_pred cceEeecCceeEEEEEEe---CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcEEEEEEecC
Q 047569 487 SAIIGVGGFGNVYLGEID---DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEMILVYEYMS 561 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ 561 (832)
.++||+|+||+||+|... +++.+|+|.+.... ....+.+|+++|++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999764 46789999876542 23467889999999999999999998843 456899999995
Q ss_pred CCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee----CCCCceEEeccccc
Q 047569 562 NGPFRDHLYGK-------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLS 630 (832)
Q Consensus 562 ~gsL~~~l~~~-------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla 630 (832)
++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5787776421 12358899999999999999999999 999999999999999 45679999999999
Q ss_pred ccCCCCCC--ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCC
Q 047569 631 KDAPIGQG--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQL 688 (832)
Q Consensus 631 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~ 688 (832)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 86543221 12234568999999999876 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.46 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=202.1
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|+..+.||+|+||.||+|.+. +++ .+|+|.+.... .....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46777899999999999999754 444 57899876543 23345789999999999999999999998754 4679
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999986543 358899999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... ......++..|++||++.+..++.++|||||||++|||++ |+.||..........+ ...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~------ 228 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-------LEKGE------ 228 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCC------
Confidence 2221 1122335678999999999999999999999999999997 8899865432221111 11110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
. ...++..+..+.+++.+||..+|++||++.++++.|+.+..
T Consensus 229 -~--~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 229 -R--LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -C--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 01122345678999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.33 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=205.2
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEecc
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE 549 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~ 549 (832)
+.++++..++++|++.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445666677899999999999999999999764 68899999876542 2346678899999999 79999999999864
Q ss_pred C-----CcEEEEEEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 550 N-----SEMILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 550 ~-----~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
. +..++||||+++++|.+++.. .....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 468999999999999998853 223468999999999999999999999 899999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccC-----CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE 697 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~ 697 (832)
||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|++||......... ..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--FK 244 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--HH
Confidence 9999999876542221 12234588999999988643 3689999999999999999999999754332211 11
Q ss_pred HHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 698 WAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 698 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. .+.... + ..+......+.+++.+||+.+|++||++.|+++
T Consensus 245 ----~~-~~~~~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 ----IP-RNPPPT-----L--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ----Hh-cCCCCC-----C--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 010001 1 112234567999999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.78 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=202.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|+..+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999765 57899999876543 334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 368999999999999999999999 899999999999999999999999999986421100
Q ss_pred --------------CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh
Q 047569 638 --------------GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 638 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
........++..|+|||.+.+..++.++|+|||||++|||++|+.||.+....+... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH
Confidence 001112357889999999988899999999999999999999999997654322111 100
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
. .....+. .....+..+.+++.+||+.+|++||+..++.+.|+.
T Consensus 230 ~----~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 S----DDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred h----cccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 0111111 112355678999999999999999997666554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.81 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=205.6
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667889999999999999765 5889999987644 3445678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.. .++++.+...++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 99999999854 258889999999999999999999 899999999999999999999999999987654322 12
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....++..|+|||++.+..++.++|+|||||++|||++|..||....+...... .........
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~~~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKNNPPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcCCCCCC
Confidence 2334578899999999988999999999999999999999999976543321110 011111233
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
....+..+.+++.+||+.+|++||++.+++..
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 44567889999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=311.08 Aligned_cols=246 Identities=27% Similarity=0.388 Sum_probs=202.0
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556778999999999999754 57899999876442 3455679999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.. ..+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++....... ...
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 9999998853 358899999999999999999999 999999999999999999999999999987654321 112
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
....|+..|+|||++.+..++.++|||||||++|||++|+.|+....+..... .. .........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~---------~~~~~~~~~ 222 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LI---------PKNSPPTLE 222 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hh---------hcCCCCCCC
Confidence 23457889999999999999999999999999999999999986543322110 00 001111223
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...+..+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3456779999999999999999999999865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.50 Aligned_cols=237 Identities=26% Similarity=0.421 Sum_probs=190.1
Q ss_pred ceEeecCceeEEEEEEeCCc-----------EEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 488 AIIGVGGFGNVYLGEIDDGT-----------KVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.+|++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999876432 5788876654433 6789999999999999999999999988 788999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-------ceEEecccc
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-------VAKVSDFGL 629 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~DFGl 629 (832)
|||+++++|.+++..... .+++..++.++.|++.||+|||+ ++++||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999965432 68999999999999999999999 9999999999999999887 799999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccC--CCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.......... .+..
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~------~~~~-- 221 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER------FYQD-- 221 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH------HHhc--
Confidence 876532 2233467789999999876 78999999999999999999 577775543221111 0000
Q ss_pred ccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 707 LLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 707 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
... .+......+.+++.+||..+|.+||++.++++.|
T Consensus 222 -------~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 -------QHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -------CCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 0111126889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.87 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=203.1
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||.||++... +++.||+|.+... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788999999999999999876 7899999987654 334457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 560 MSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
+++++|.+++.... ...+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999886532 2368999999999999999999996 158999999999999999999999999998765322
Q ss_pred ceeeccccCccccChhccccC------CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
......++..|+|||++.+. .++.++|+|||||++|||++|+.||............ ..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------------~~~~ 223 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL------------SAIV 223 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH------------HHHh
Confidence 22234578899999998554 3588999999999999999999999754322211110 1111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+.. ....++.....+.+++.+||+.+|++||++.+++..
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 112334567789999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.29 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=216.0
Q ss_pred CCCccceEeecCceeEEEEEEe---CC--cEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID---DG--TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~---~g--~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.....++||.|-||.||+|... .| -.||||..+.. .....+.|..|.-+|++++||||++++|.|.+. ..|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3455788999999999999642 23 35889987763 455578899999999999999999999999765 68999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
||+++-|.|.++|..+. ..++......++.||+.+|+|||+ ..+|||||..+|||+...-.+||+|||+++.....
T Consensus 469 mEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999997554 478899999999999999999999 99999999999999999999999999999988765
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.-.......-...|||||.+.-.+++.++|||-|||.+||++. |..||.+-...+.+ ..+-. .
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------~~iEn-G 608 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------GHIEN-G 608 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------EEecC-C
Confidence 5444444445678999999999999999999999999999976 88999876543322 22211 1
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
-+...++.++..|..+..+||+.+|.+||.+.|+...|..+++.+.
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 1234678899999999999999999999999999999999887544
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.57 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=208.2
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
|.++++||+|++|.||++.++ .|..+|||..... .+++++..|+.+|++++.|++|++||.+.....+|+|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667889999999999999654 7999999986543 4578999999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+..+.+..++ .+|++.++..+++..++||+|||. ..-+|||||..||||+.+|.+||+|||.+-.+.... ....
T Consensus 113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN 187 (502)
T ss_pred CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence 99999886543 589999999999999999999999 888999999999999999999999999987665332 2335
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
++.||+-|||||++..-.|+.++||||||++..||..|++||..-.+...+- .--..|...-..+.
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------------MIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------------MIPTKPPPTFKKPE 253 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------------eccCCCCCCCCChH
Confidence 6779999999999999999999999999999999999999997654432111 00011222122345
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+.++.++++.||-+.|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 56789999999999999999999988874
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=303.11 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=206.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++|+.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999754 68899999886542 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 560 MSNGPFRDHLYGKNL-PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965432 468999999999999999999999 9999999999999999999999999999876653322
Q ss_pred c---eeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 639 H---VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 639 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
. ......|+..|++||++... .++.++|+|||||++|||++|+.||......... .. .... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~----~~~~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--ML----TLQN------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HH----HhcC------CCC
Confidence 2 22344688999999998777 7899999999999999999999999755432211 00 0000 011
Q ss_pred CCCCCC-ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+.... ....+..+.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1245678999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=316.47 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=215.3
Q ss_pred CCCccceEeecCceeEEEEEEeC-CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
+.....+||-|.||.||.|.|+. .-.||||.++.. .-..++|+.|+.+|+.++|||+|+|+|+|..+..+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44567889999999999998874 578999988754 4457899999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
.|+|.++|.+-+...++....+.++.||..|++||.. +++|||||...|+|+.++..+|++||||++++..+.....
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 9999999988777778888999999999999999998 9999999999999999999999999999999865543333
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....-...|.|||-+....++.|+|||+|||+|||+.| |-.||.+-.-.....+ ..++ .+-.-
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-------LEkg---------yRM~~ 487 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-------LEKG---------YRMDG 487 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-------Hhcc---------ccccC
Confidence 33334578999999999999999999999999999988 6677765432221111 1122 12223
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+..+++++.+|++.||+..|.+||++.|+.+.+|....
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 45688899999999999999999999999999987653
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.15 Aligned_cols=252 Identities=26% Similarity=0.445 Sum_probs=203.3
Q ss_pred CCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC------cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... .+..+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 468999999876432 1235678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccccccCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAP 634 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 634 (832)
|+||+++++|.+++.... ++++..++.++.|++.||+|||+ ++++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999986543 68899999999999999999999 8999999999999998775 59999999987654
Q ss_pred CCCC---ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 635 IGQG---HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 635 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
.... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||............ . ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~---------~~ 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---F---------KI 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---H---------HH
Confidence 3211 1122345889999999998888999999999999999999999999654322111111 0 00
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.........+......+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111112334456678999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.88 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=202.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 58999999876432 2235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.++..... .+++.+++.++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988775432 58999999999999999999999 899999999999999999999999999987654322
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH--------Hhhh-ccc
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ--------WKRK-GLL 708 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~--------~~~~-~~~ 708 (832)
.......++..|+|||.+.+ ..++.++||||||+++|||++|++||......+.......... .... ...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22233457899999998875 4578899999999999999999999976543222111110000 0000 000
Q ss_pred ccccCCCCC-----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKIIDPHLV-----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+..+... ....+..+..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000011100 0112345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=304.43 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=200.5
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC----------cccHHHHHHHHHHHHhCCCcceeeEEEEeccCC
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS----------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS 551 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~ 551 (832)
+|.+.+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999754 68999999765321 112346888999999999999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999655 368999999999999999999999 899999999999999999999999999987
Q ss_pred cCCCCCC-ceeeccccCccccChhccccCC--CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 632 DAPIGQG-HVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 632 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
....... .......|+..|+|||.+.... ++.++|+||||+++|||++|..||......... . ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~----~~~~---- 226 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--F----KLGN---- 226 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--H----Hhhc----
Confidence 6532211 1123345889999999987654 889999999999999999999999644322111 0 0000
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+.......+..+..+.+++.+||+.+|++||++.++++
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 -KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 001111112223345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.64 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=197.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999765 689999998765432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+. ++|.+++.... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++...... .
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 97 48999886543 368899999999999999999999 899999999999999999999999999987543211 1
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCCh-hhhhhHHHHHHHHhhhccccccc-----
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLP-REQVNLAEWAMQWKRKGLLEKII----- 712 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~-~~~~~l~~~~~~~~~~~~~~~i~----- 712 (832)
......++..|+|||++.+ ..++.++||||||+++|||++|++||..... .+...................+.
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346889999998865 4588999999999999999999999976542 22111110000000000000000
Q ss_pred --------CCCCCCCCChhH--HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 713 --------DPHLVGTINPES--LKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 713 --------d~~l~~~~~~~~--~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+.......+.. ...+.+++.+||+.+|.+||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000111 267789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=301.90 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=202.7
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc--ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE--QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|++.+.||+|+||.||+|... +++.+++|.+..... ...+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999764 689999998765543 3678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.... .+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999996543 57889999999999999999999 99999999999999999999999999998876433222
Q ss_pred ee---eccccCccccChhccccCC---CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 640 VS---TAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 640 ~~---~~~~gt~~y~aPE~~~~~~---~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.. ....++..|++||++.+.. .+.++||||||++++||++|+.||.......... . . ...+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~---~-~~~~-----~~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--F---H-VGAG-----HK 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--H---H-HhcC-----CC
Confidence 11 1345788999999998766 8899999999999999999999996543211110 0 0 0000 01
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+.+. ........+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 11123667889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.86 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=201.4
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCC------
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENS------ 551 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~------ 551 (832)
.+++|++.+.||+|++|.||+|..+ +++.+++|.+..... ..+++.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999875 578999998765543 346799999999999 6999999999986544
Q ss_pred cEEEEEEecCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
..++||||+++++|.+++.... ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886432 4578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
+....... .......|+..|+|||++.. ..++.++|||||||++|||++|++||......... . +..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~- 231 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--F----KIP- 231 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--H----Hhh-
Confidence 87653222 12233458899999998753 34678999999999999999999999754322111 0 000
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+ ..+.. ......+..+.+++.+||..||++|||+.++++
T Consensus 232 ~~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RN-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cc-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 01111 112235678999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.71 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=200.8
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|+..+.||+|++|.||+|... +++.|+||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788999999999999999765 68999999876442 23346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+. ++|.+++.......+++.+++.++.|+++||+|||+ .+++||||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 95 689998876555678999999999999999999999 899999999999999999999999999987653221 1
Q ss_pred eeeccccCccccChhccccCC-CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh-------------
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK------------- 705 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~------------- 705 (832)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||......+.. .+........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhhhhHHHH
Confidence 122334688999999887644 688999999999999999999999765433221 1111000000
Q ss_pred --cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 --GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 --~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..........+ ....+.....+.+++.+||+.||.+||++++++.
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0111223467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.19 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=201.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|++|.||++... +++.+|+|.+... ..+..+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999765 6899999987643 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999655 368999999999999999999999 99999999999999999999999999998875432
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||......... + .+....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~------------~~~~~~-- 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY---E------------KILEGK-- 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H------------HHhcCC--
Confidence 23446889999999998888999999999999999999999999765422111 0 000100
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVL 750 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 750 (832)
..++......+.+++.+||+.+|.+|+ ++.|++
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 112233467889999999999999998 566654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=302.62 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=190.3
Q ss_pred eEeecCceeEEEEEEeCC---cEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 489 IIGVGGFGNVYLGEIDDG---TKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
.||+|+||.||+|...++ ..+++|.+.... .+..+.|.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 356677665443 3456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC-CCcee
Q 047569 565 FRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-QGHVS 641 (832)
Q Consensus 565 L~~~l~~~~--~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~~ 641 (832)
|.+++.+.. ...+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++...... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999996542 2356777888999999999999999 89999999999999999999999999987643211 11122
Q ss_pred eccccCccccChhcccc-------CCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 642 TAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~-------~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+... ..... ......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~~~-~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVIKD-QQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhh-cccccCC
Confidence 33457889999998753 245789999999999999997 567876543322111 11111 1112223
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
+.+. ......+.+++..|+ .+|++||+++++++.|.
T Consensus 232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322 234567888999999 67999999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.25 Aligned_cols=278 Identities=24% Similarity=0.374 Sum_probs=209.9
Q ss_pred CCcccCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHh--CCCcceeeEEE
Q 047569 468 LGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSK--LRHRHLVSLIG 545 (832)
Q Consensus 468 ~~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~--l~HpnIv~l~~ 545 (832)
.+.-.++--.+...++..+.+.||+|.||+||+|+++ |+.||||++...++ +.+.+|.++.+. |+|+||+.+++
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhh
Confidence 3334455555667788889999999999999999997 89999999876544 456778888776 59999999998
Q ss_pred EeccC----CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeeeccCCCCceee
Q 047569 546 YCDEN----SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT-----GTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 546 ~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~-----~~~~~ivHrDlkp~NILl 616 (832)
.-..+ .++|||.+|.+.|||.|+|.+. .++....++++..+|.||++||. +....|.|||||+.|||+
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 76433 4789999999999999999653 68999999999999999999995 234569999999999999
Q ss_pred CCCCceEEecccccccCCCCCC---ceeeccccCccccChhccccC----CC--CccccEEechhHHHHHhhC-------
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQG---HVSTAVKGSFGYLDPEYFRRQ----QL--TEKSDVYSFGVVLLEVLCA------- 680 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~----~~--~~~sDV~SlGvvl~elltG------- 680 (832)
..++...|+|+||+........ ......+||.+|||||++... .+ -..+||||||.|+||+...
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 9999999999999976553322 223456799999999998642 12 2469999999999999852
Q ss_pred ---CCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC-CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 681 ---RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG-TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 681 ---~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
++||.+-.+.+... .+ +++-...+-+.|.+.. ....+.+..+.++++.||..+|.-|-|+-.+-+.|.++
T Consensus 430 eey~~Pyyd~Vp~DPs~-ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSF-EE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred hhhcCCcccCCCCCCCH-HH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 26776544333210 00 0111111112233322 22356788999999999999999999998887777766
Q ss_pred HH
Q 047569 757 LQ 758 (832)
Q Consensus 757 ~~ 758 (832)
.+
T Consensus 504 ~~ 505 (513)
T KOG2052|consen 504 SN 505 (513)
T ss_pred hc
Confidence 54
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=303.21 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=203.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEec--cCCcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD--ENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~--~~~~~~lV~ 557 (832)
+|++.+.||+|+||.||++... +++.+++|++... .....+++.+|++++++++||||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999654 6889999987643 3445667899999999999999999999775 345689999
Q ss_pred EecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 558 EYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGT--AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 558 E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
||+++++|.+++... ....+++.+++.++.|+++||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 2347899999999999999999999221 289999999999999999999999999998876
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
..... ......+++.|++||.+.+..++.++|+||||+++++|++|+.||....... +.+ . ...+
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~------- 225 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS---K-IKEG------- 225 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH---H-HhcC-------
Confidence 43322 1233468999999999998889999999999999999999999997654221 111 1 1111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....++...+..+.+++.+||+.+|++||++.++++
T Consensus 226 --~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 --KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 112234456678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.94 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=201.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcc-----cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQ-----GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999765 6899999987654322 345577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+ +++|.+++.... ..+++..++.++.|+++||+|||+ ++++|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999996544 368999999999999999999999 99999999999999999999999999999865432
Q ss_pred CCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH------HHhhhcccc
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM------QWKRKGLLE 709 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~------~~~~~~~~~ 709 (832)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|......+......... .+.......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 21 2223346788999998855 467899999999999999999988887655433211110000 000000000
Q ss_pred cccCCCCC-----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHLV-----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
........ .......+..+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000 0111334678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=296.18 Aligned_cols=241 Identities=26% Similarity=0.358 Sum_probs=204.3
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|+.+++||+|.||.|.+++-+ +++.+|+|++++. .......-..|-++|+..+||.+..+.-.++..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999754 7999999998875 344455567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||..||.|.-+|.+.. .+++.........|..||.|||+ ++||+||||.+|+|||.+|++||+||||++... .
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K 320 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-c
Confidence 99999999999996544 68888889999999999999999 999999999999999999999999999998653 3
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.+....+.+|||.|+|||++....|..++|.|.+||++|||+||+.||..........++- +. |-
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl----------~e---d~-- 385 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL----------ME---DL-- 385 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH----------hh---hc--
Confidence 4556677899999999999999999999999999999999999999998765443333221 11 11
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCC
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRP 744 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RP 744 (832)
.++...+.+...|+...|.+||.+|.
T Consensus 386 --kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 --KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 23344556678888899999999994
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.09 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=200.9
Q ss_pred ccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 486 SSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
....||+|+||.||++... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999765 689999999876555556778999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeecc
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 644 (832)
|.+++.. ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... ......
T Consensus 105 L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred HHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 9998744 358899999999999999999999 899999999999999999999999999987543222 122335
Q ss_pred ccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhH
Q 047569 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724 (832)
Q Consensus 645 ~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 724 (832)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....+.+.... . ... ..+.. ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~------~-~~~-----~~~~~--~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR------L-RDS-----PPPKL--KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H-hcc-----CCCCc--cccCCC
Confidence 689999999999988999999999999999999999999975543322111 0 000 00000 111234
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 725 LKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 725 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+..+.+++.+||+.+|.+||++.++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 5678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=302.87 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=199.5
Q ss_pred CCccceEeecCceeEEEEEEe----CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC------
Q 047569 484 FDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS------ 551 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~------ 551 (832)
|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999753 3689999987654 3445677999999999999999999999885432
Q ss_pred cEEEEEEecCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 552 EMILVYEYMSNGPFRDHLYGK----NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
..++++||+.+|+|.+++... ....+++...+.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998887432 22357889999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 628 GLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 628 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |++||......+ +..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---cC
Confidence 998865422211 1122335678999999998899999999999999999999 889887543322 111110 00
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
. .+ ...+..+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 232 ~--------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N--------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C--------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 11234557899999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.95 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=201.1
Q ss_pred ccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 486 SSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
....||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3567999999999999764 688999999876666667789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeecc
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 644 (832)
|.+++... .+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||++........ .....
T Consensus 106 L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 106 LTDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 99988432 58899999999999999999999 8999999999999999999999999999875432221 22334
Q ss_pred ccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhH
Q 047569 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724 (832)
Q Consensus 645 ~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 724 (832)
.|+..|+|||.+.+..++.++||||||+++|||++|+.||............ .....+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI------------RDNLPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HhcCCCcccc--cccc
Confidence 5889999999998889999999999999999999999999765432221110 0111111111 1234
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 725 LKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 725 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+..+.+++.+||..+|.+||++.++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 5578899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=301.44 Aligned_cols=249 Identities=24% Similarity=0.419 Sum_probs=204.0
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|++.+.||+|+||.||++... +|..+|+|.+... .....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999765 5889999987653 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccccccCCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 638 (832)
+++++|.+++.......+++..++.++.|+++||+|||+ .+++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 999999999976555568999999999999999999999 8999999999999999875 46999999987654322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......|++.|+|||++.+..++.++|+||||++++||++|+.||......+. ...... + . ..
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~--------~-~~ 220 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKICQ-G--------Y-FA 220 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhc-c--------c-CC
Confidence 222334588999999999888899999999999999999999999975433221 111111 0 1 11
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+..+..+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 123345568999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.96 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=205.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999754 68899999987655555678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++... .+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999998643 47889999999999999999999 9999999999999999999999999998875543222 2
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....|++.|++||.+.+..++.++|+|||||++|||++|+.||............ ...+......
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--------------~~~~~~~~~~ 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPELQN 237 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--------------hcCCCCCCCC
Confidence 23346888999999998888999999999999999999999999765432211100 0011111111
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
....+..+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22345679999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.39 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=197.2
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|+..+.||+|+||.||+|... +|+.+++|++.... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999765 68999999876432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
++ ++|.+++.... ..+++..++.++.||++||.|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 57888775432 368999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCCh-hhhhhHHHHHHHHhhhc---ccccccCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLP-REQVNLAEWAMQWKRKG---LLEKIIDP 714 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~-~~~~~l~~~~~~~~~~~---~~~~i~d~ 714 (832)
......++..|+|||++.+. .++.++|||||||++|||++|+.|+..... .+............... .+....+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234578899999998764 478999999999999999999887643322 11111100000000000 00000000
Q ss_pred C----CC-----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 H----LV-----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~----l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. .. ....+..+..+.+++.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00 0112335678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=310.31 Aligned_cols=195 Identities=22% Similarity=0.353 Sum_probs=159.9
Q ss_pred cceEeecCceeEEEEEEe---CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEec--cCCcEEEEEEecC
Q 047569 487 SAIIGVGGFGNVYLGEID---DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD--ENSEMILVYEYMS 561 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~ 561 (832)
...||+|+||.||+|... +++.||+|.+.... ....+.+|+++|++++||||+++++++. .+...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999864 35789999876543 2346789999999999999999999884 4567899999996
Q ss_pred CCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee----CCCCceEEeccccc
Q 047569 562 NGPFRDHLYGK-------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLS 630 (832)
Q Consensus 562 ~gsL~~~l~~~-------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla 630 (832)
++|.+++... ....+++..+..++.|++.||+|||+ ++++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5777766321 22358899999999999999999999 999999999999999 56679999999999
Q ss_pred ccCCCCCC--ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCC
Q 047569 631 KDAPIGQG--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQ 687 (832)
Q Consensus 631 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~ 687 (832)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86543221 12234568999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.91 Aligned_cols=249 Identities=29% Similarity=0.442 Sum_probs=206.5
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999875 689999999887665567889999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.... ..+++..+..++.|++++|++||+ .+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999986543 468999999999999999999999 9999999999999999999999999999877653322 3
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
....++..|++||.+.+...+.++||||||+++|+|++|+.||............ ...... .+. ..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~-----~~~--~~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------ATNGPP-----GLR--NP 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------HhcCCC-----CcC--cc
Confidence 3456889999999999888999999999999999999999999765332211110 000000 110 01
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+..+.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112567999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.94 Aligned_cols=247 Identities=25% Similarity=0.412 Sum_probs=201.2
Q ss_pred CCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCC---CcceeeEEEEeccCCcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLR---HRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.|+..+.||+|+||.||+|.. .+++.+++|.+... .....+++.+|++++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999976 46899999987654 3445678899999999997 999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++... .+++..++.++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988543 68899999999999999999999 999999999999999999999999999987665332
Q ss_pred CceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||.......... .......+.+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------------~~~~~~~~~~ 222 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------------LIPKSKPPRL 222 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------------ccccCCCCCC
Confidence 2 2233468899999998865 457899999999999999999999997653322110 0011111111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ....+..+.+++.+||+.+|++||++.+++.
T Consensus 223 ~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 E---DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred C---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 1125568999999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.80 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=194.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHH-HHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQM-LSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~-L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||.||++... +|+.||+|++.... .+...++..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999765 69999999876542 2333456666665 566789999999999999999999999
Q ss_pred ecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
|++ ++|.+++... ....+++..++.++.|++.||+|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6887777432 23468999999999999999999998 6 899999999999999999999999999876532
Q ss_pred CCCceeeccccCccccChhcccc----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
. .......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... ..+. ... .+
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~----~~~-~~----- 223 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK----QVV-EE----- 223 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH----HHH-hc-----
Confidence 1 12233458889999998865 456889999999999999999999996432110 0110 000 00
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+.+ .....+..+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 112345679999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.36 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=202.0
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecC--CCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~ 557 (832)
...|++.++||+||.+.||++...+.+.+|+|+.. ..+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34578899999999999999998888889988643 346677888999999999995 999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||= ..+|..+|..+......| .+..+..|++.++.++|+ +||||.||||.|+|+-. |.+||+|||++.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 986 578999997666544445 778889999999999999 99999999999999975 489999999998776443
Q ss_pred -CceeeccccCccccChhccccCC-----------CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 638 -GHVSTAVKGSFGYLDPEYFRRQQ-----------LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 638 -~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
.-.....+||+.||+||.+.... .+.++|||||||+||+|+.|++||..-. +..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~--------- 579 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI--------- 579 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH---------
Confidence 33345678999999999885432 5578999999999999999999995321 111
Q ss_pred cccccccCCCCCCCCChh-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPE-SLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+..+.+|.-.-+++.- ...++.+++..||+.||.+||+..|+++
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 124556666443233221 1223999999999999999999999983
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.33 Aligned_cols=246 Identities=27% Similarity=0.398 Sum_probs=202.3
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
|+..+.||+|+||.||+|... +++.+|+|...... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667889999999999999764 68899999876432 3445678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.. ..+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 86 GGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 9999999853 258899999999999999999999 999999999999999999999999999987654321 122
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
....++..|++||.+.+..++.++|+|||||++|||++|..||.......... . ... .......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~-~~~---------~~~~~~~ 222 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF------L-IPK---------NNPPTLE 222 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH------H-Hhc---------CCCCCCC
Confidence 33457889999999988889999999999999999999999997543322111 0 000 0111223
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3456779999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.78 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=208.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|++|.||++... +++.|++|++..... ...+++.+|++.+++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999776 599999998876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... ..+++..++.++.|++++|+|||+ ..+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999654 468999999999999999999996 278999999999999999999999999998866432222
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||..........+.... ..... ..
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------------~~~~~-~~ 222 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP-PS 222 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH------------hcCCC-CC
Confidence 12445789999999999999999999999999999999999999765421111111111 11111 11
Q ss_pred CChh-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 720 INPE-SLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 720 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2233 56789999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.51 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=204.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|+..+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999776 68999999877653 34556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.... ..+++..+.+++.|++++|+|||+ ..+++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999999986543 478899999999999999999997 36899999999999999999999999999875532211
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
....++..|++||.+.+..++.++||||||+++|+|++|+.||....... ....+.... +...... .
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~---------~~~~~~~-~ 223 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQY---------IVNEPPP-R 223 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHH---------HhcCCCC-C
Confidence 12568899999999999999999999999999999999999996542111 111111111 1111111 1
Q ss_pred CCh-hHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 720 INP-ESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 720 ~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
... ..+..+.+++.+||..+|++||++.+++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 112 256779999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.63 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=201.6
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444679999999999999754 6889999988665555567789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|.+++.. ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++....... ....
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 999999865 358899999999999999999999 999999999999999999999999999877543222 1223
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...|+..|+|||.+.+..++.++|||||||++|||++|+.||....+..... .. ..+ ..+... ...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~------~~-~~~-----~~~~~~--~~~ 239 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK------RI-RDN-----LPPKLK--NLH 239 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HH-Hhc-----CCCCCc--ccc
Confidence 3458999999999998889999999999999999999999997654322211 10 110 011111 112
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+..+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 24568999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.84 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=207.4
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.+++|+..+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999876 689999999876544 56778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 999999999997644 368999999999999999999999 999999999999999999999999999886543221
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......++..|++||.+.+..++.++|+|||||++|+|++|+.||....+...... .... .. +..
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~------~~~~-~~-----~~~-- 236 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL------ITTK-GI-----PPL-- 236 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhc-CC-----CCC--
Confidence 122334578899999999988899999999999999999999999976543321110 0000 00 000
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
......+..+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112255779999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.02 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=197.9
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++++|++.+.||+|+||.||+|... +++.|++|++.... ......+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999764 68999999876543 233356789999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+. ++|.+++.... ..+.+.++..++.|+++||+|||+ .+++|+||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 67777664432 357888899999999999999999 899999999999999999999999999987543221
Q ss_pred CceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH----------Hhh-h
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ----------WKR-K 705 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~----------~~~-~ 705 (832)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.||.............|... ... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 112233478999999998764 578899999999999999999999976543211100000000 000 0
Q ss_pred cccccccCCCCCCCC-----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKIIDPHLVGTI-----NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
............... .......+.+++.+|++.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0012457889999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=301.70 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=204.6
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
+|++.+.||.|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999775 68999999876542 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+.+++|.+++... ..+++.++..++.|+++||.|||+ ++++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999654 478999999999999999999999 899999999999999999999999999987654322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
......|+..|++||.+.+..++.++|+||||+++|+|++|+.||..........+. ..... ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~----------~~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET----------ADV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc----------ccc
Confidence 223456888999999999888999999999999999999999999866532111111 10000 111
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTM--GDVL 750 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 750 (832)
..++..+..+.+++.+||+.+|.+||+. .|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2334456789999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.19 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=208.6
Q ss_pred ccceEeecCceeEEEEEEe--CCc--EEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 486 SSAIIGVGGFGNVYLGEID--DGT--KVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
..++||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|||+++|||...+ ..+.||+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3678999999999999875 343 6899999877654 67889999999999999999999999987 6788999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+.|+|.+.|++.....|-......++.|||.||.||.+ +++|||||...|+||-....+||+||||.+.+...+.+-
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999987566678889999999999999999999 999999999999999989899999999999876544332
Q ss_pred --eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 641 --STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 641 --~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....-...|.|||.++...++.++|||+|||+||||++ |..||.+......... +|..-+
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----------------iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----------------IDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----------------cccccc
Confidence 112234568999999999999999999999999999998 5688877655433222 122222
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
-.-++.+++.+.+++.+||..+|++||++..+.+.+-
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2345678999999999999999999999999975544
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=319.70 Aligned_cols=243 Identities=23% Similarity=0.394 Sum_probs=195.0
Q ss_pred cceEeecCceeEEEEEEe-CCcEEEEEecC----CCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC--cEEEEEEe
Q 047569 487 SAIIGVGGFGNVYLGEID-DGTKVAVKRGN----PQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS--EMILVYEY 559 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~----~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~--~~~lV~E~ 559 (832)
..+||+|.|-+||+|.+. +|..||.-.++ ..++...++|..|+.+|+.|+||||+++++++.+.. ...+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 347999999999999654 68888754222 124566789999999999999999999999886654 48899999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCceEEecccccccCCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~ 638 (832)
|..|+|+.|+.+.+ .++.+.+..|++||++||.|||+.. .+|||||||-+||||+ ..|.+||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 99999999996654 6888999999999999999999965 5899999999999998 56899999999999875322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
...+.|||.|||||++. ..|++.+||||||++++||+|+.-||..-....++. .++.......
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY--------------KKV~SGiKP~ 263 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY--------------KKVTSGIKPA 263 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH--------------HHHHcCCCHH
Confidence 23378999999999997 889999999999999999999999997665443321 1121111111
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+..-..++++++|++||.. ..+|||+.|+|.
T Consensus 264 sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11111235789999999999 999999999974
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.99 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=202.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~~lV~ 557 (832)
++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+ .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999875 68899999877543 3445779999999999999999999998854 45789999
Q ss_pred EecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 558 EYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||+++++|.+++.. .....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988743 233468899999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCCh--hhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLP--REQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~--~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.. .....++..|++||.+.+..++.++|||||||++|||++|+.||..... ........+... .. .
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~-----~ 225 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MP-----N 225 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CC-----c
Confidence 21 1234578899999999999999999999999999999999999976532 111122221111 00 0
Q ss_pred CCCCCCC--ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 PHLVGTI--NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+.+.... ....+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1111111 12346789999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.34 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=201.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~~lV 556 (832)
++|++.+.||+|++|.||+|... +++.+++|.+.... ......+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999876 58899999876442 22334678899999999999999999998776 899999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||++ ++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 58988886543 368999999999999999999999 89999999999999999999999999998866433
Q ss_pred CCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH------Hh------
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ------WK------ 703 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~------~~------ 703 (832)
. .......+++.|+|||.+.+. .++.++|+||||+++|||++|++||......+.......... +.
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 2 112234578899999988764 468999999999999999999999987654332211100000 00
Q ss_pred --hhcccccccCCCCCCCCChh-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 704 --RKGLLEKIIDPHLVGTINPE-SLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 704 --~~~~~~~i~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
............+...++.. ....+.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000011111111222222 4677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.11 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=199.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999765 68999999876432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEecccccccCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 637 (832)
|++ ++|.+++.......+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 588888765544457888999999999999999999 89999999999999985 5679999999997653221
Q ss_pred CceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh---cccc----
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK---GLLE---- 709 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~---~~~~---- 709 (832)
.......+++.|++||.+.+ ..++.++|||||||++|+|++|++||......+..... ...... ....
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEETWPGVTS 233 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhcccccc
Confidence 11223457889999998866 45789999999999999999999999765443322111 000000 0000
Q ss_pred --ccc--CCC----CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 --KII--DPH----LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 --~i~--d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... -+. ......+..+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 000112334567899999999999999999999975
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=304.17 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=200.5
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
|++.+.||.|++|.||+|... +|+.|++|++.... ......+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999764 79999999876543 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+ ++|.+++.......+++..++.++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 689999866554578999999999999999999999 8999999999999999999999999999876532211 1
Q ss_pred eeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh------------hcc
Q 047569 641 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR------------KGL 707 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~------------~~~ 707 (832)
.....++..|+|||++.+. .++.++||||||+++|||++|++||......... ......... .+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhhhhhchhh
Confidence 1223468899999988664 5789999999999999999999999765443221 111100000 000
Q ss_pred ccccc--CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 LEKII--DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 ~~~i~--d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..... .........+..+..+.+++.+||+.+|.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000011122345578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=311.96 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=200.6
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------ 550 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------ 550 (832)
..++|+..+.||+|+||.||+|... +++.||+|++... ......++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999764 7899999987643 334456788899999999999999999988543
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
...++||||+. ++|.+.+... ++..++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5888877432 7889999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH---------HH--
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE---------WA-- 699 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~---------~~-- 699 (832)
+...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||............. +.
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 8654321 2233457899999999999999999999999999999999999997654322211100 00
Q ss_pred -----HHHhhh-c-----ccccccC----CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 700 -----MQWKRK-G-----LLEKIID----PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 700 -----~~~~~~-~-----~~~~i~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+... . ...++.. +..........+..+.+++.+||+.||++||++.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0 0000100 000011122346678999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.16 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=201.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+|++.+.||+|++|.||+|... +|+.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999875 689999998775532 33467788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 561 SNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 561 ~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
++ +|.+++.... ...+++.+++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 74 8888875433 3468999999999999999999999 8999999999999999999999999999875532211
Q ss_pred eeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc-----C
Q 047569 640 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII-----D 713 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~-----d 713 (832)
......++..|++||++.+. .++.++|||||||++|||++|++||......+................+..+. .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12234578899999988664 56889999999999999999999998765433221110000000000000000 0
Q ss_pred CCCC-------CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 714 PHLV-------GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 714 ~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.... ..+.+..+..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.02 Aligned_cols=267 Identities=24% Similarity=0.299 Sum_probs=200.4
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCC-----
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS----- 551 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~----- 551 (832)
..++|++.+.||+|+||.||+|..+ +++.|++|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999875 58899999876542 233456788999999999999999999886654
Q ss_pred -----cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEec
Q 047569 552 -----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSD 626 (832)
Q Consensus 552 -----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 626 (832)
..++|+||+++ +|.+.+... ...+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999975 677766543 3468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 627 FGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 627 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
||++...............++..|++||++.+ ..++.++|||||||++|||++|++||......+..............
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99988664333222233346788999998865 45789999999999999999999999765443322111110000000
Q ss_pred cccccccCCCCC----------C---CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKIIDPHLV----------G---TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i~d~~l~----------~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+...... . ......+..+.+++.+||+.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000000 0 001124578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=296.47 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=200.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-----CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-----SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~ 553 (832)
.+|++.+.||+|+||.||+|... +++.|++|.+... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999764 6899999986432 234456889999999999999999999998653 568
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++++||+++++|.+++.... .+++....+++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986543 58899999999999999999999 89999999999999999999999999998765
Q ss_pred CCCC--CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 634 PIGQ--GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 634 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
.... ........|+..|+|||++.+..++.++|+|||||++|||++|++||.......... + +
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~---------~ 221 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF------K---------I 221 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH------H---------H
Confidence 3211 111223458899999999998889999999999999999999999997543222110 0 0
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
........++......+.+++.+||+ ++..||+..+++.
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111223445567789999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=330.09 Aligned_cols=269 Identities=19% Similarity=0.242 Sum_probs=192.1
Q ss_pred HHhcCCCccceEeecCceeEEEEEEeC--CcEEEEE------------------ecCCCCcccHHHHHHHHHHHHhCCCc
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEIDD--GTKVAVK------------------RGNPQSEQGITEFQTEIQMLSKLRHR 538 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~f~~Ei~~L~~l~Hp 538 (832)
...++|++.+.||+|+||+||++..+. +...++| ... .......++.+|+++|++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 346789999999999999999986542 2222222 111 1223345688999999999999
Q ss_pred ceeeEEEEeccCCcEEEEEEecCCCChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCcee
Q 047569 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKN---LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNIL 615 (832)
Q Consensus 539 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 615 (832)
||+++++++...+..++|+|++. ++|.+++.... .......++..++.|++.||+|||+ ++|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99999999999999999999994 67777764332 1223456788899999999999999 99999999999999
Q ss_pred eCCCCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCC-CCCCCChhhhhh
Q 047569 616 LDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP-AINPQLPREQVN 694 (832)
Q Consensus 616 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~-pf~~~~~~~~~~ 694 (832)
++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|.. |+..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999998765433333344679999999999999999999999999999999999875 444332222122
Q ss_pred HHHHHHHHh--hhcc------cccccCC----CCCCCCC-----hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 695 LAEWAMQWK--RKGL------LEKIIDP----HLVGTIN-----PESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 695 l~~~~~~~~--~~~~------~~~i~d~----~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+.+...... .++. +.+.++. .....+. ...+..+.+++.+||+.||.+||++.|+++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 221111100 0000 0000000 0000000 1123467888999999999999999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.29 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=197.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCc-----
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSE----- 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~----- 552 (832)
++|++.+.||+|+||.||+|... +++.||+|...... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999765 68999999866442 223467889999999995 6999999999876655
Q ss_pred EEEEEEecCCCChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEeccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKN---LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFG 628 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG 628 (832)
.++||||+++ +|.+++.... ...+++..++.++.||++||+|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888875432 2468999999999999999999999 99999999999999998 8899999999
Q ss_pred ccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh--h
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR--K 705 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~--~ 705 (832)
+++....... ......+++.|+|||.+.+ ..++.++||||||+++|||++|.+||.......... ........ .
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL--HIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHhCCCCh
Confidence 9876532211 1122346889999998865 467999999999999999999999997654332211 10000000 0
Q ss_pred ccccccc-----------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKII-----------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....... .+.......+..+.++.+++.+||+.+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 000000111345677999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=293.42 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=207.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEMILVY 557 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~~lV~ 557 (832)
+|+..+.||+|++|.||+|... +++.+++|+..... ....+.+.+|++++++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999876 68999999876554 25567899999999999999999999999888 8899999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... .+++.+++.++.|++++|+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999996554 78999999999999999999999 999999999999999999999999999988765432
Q ss_pred Cc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.. ......++..|++||.+.+...+.++||||||+++|+|++|+.||........ .. ..+.....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~---------~~~~~~~~ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----AL---------YKIGSSGE 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HH---------HhccccCC
Confidence 21 12345688999999999888899999999999999999999999976541111 00 01111112
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...++...+..+.+++.+|++.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 22334445678999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.33 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=201.2
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcEEEEEE
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEMILVYE 558 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~~lV~E 558 (832)
|++.+.||+|++|.||+|... +++.+++|++.... ......+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999776 58999999987653 34456788999999999999999999999887 89999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|++ ++|.+++.... ..+++.+++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 48988886543 478999999999999999999999 8999999999999999999999999999987654332
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC----
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID---- 713 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d---- 713 (832)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........................+.+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 22333456888999998765 4678999999999999999999999977654332221111000000000000000
Q ss_pred ----------CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 714 ----------PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 714 ----------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+...+...++..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000011112668899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.42 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=198.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
+.|+..+.||+|+||.||+|... +++.|++|++.... .+..+++.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55888899999999999999765 68999999876432 234467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||++ |+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 67777764332 368999999999999999999999 89999999999999999999999999998764322
Q ss_pred CceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
....++..|+|||++. ...++.++||||||+++|||++|++||........... ... .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~------~~~---------~ 229 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQ---------N 229 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH------Hhc---------C
Confidence 2345788999999874 45688999999999999999999999875543221110 000 0
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..........+..+.+++.+||+.+|++||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00111123356789999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=312.73 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=198.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----CcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN-----SEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~-----~~~ 553 (832)
+++|++.+.||+|+||.||+|... +|+.||+|++.... .....++.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999754 68999999886532 33456788999999999999999999886543 458
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++++||+. ++|.+++.. ..+++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 588777743 258999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc--eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh---cc
Q 047569 634 PIGQGH--VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK---GL 707 (832)
Q Consensus 634 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~---~~ 707 (832)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|++||........... ....... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCCHHH
Confidence 432211 1123468999999998754 5689999999999999999999999976543221111 0000000 00
Q ss_pred cccccCCC---------CCC-----CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 708 LEKIIDPH---------LVG-----TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 708 ~~~i~d~~---------l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+..+.+.. ... ...+..+.++.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000 0112345678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.49 Aligned_cols=266 Identities=26% Similarity=0.317 Sum_probs=199.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~~l 555 (832)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367889999999999999999765 68999999876432 22234567899999999999999999998654 56899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||++ ++|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58888876432 468999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|++||....+.+.....................+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 22 11223345788999999865 56789999999999999999999999876554432221110000000000000000
Q ss_pred ------CCC----CCC---ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 715 ------HLV----GTI---NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 715 ------~l~----~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.+. ... ....+..+.+++.+||+.||++||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000 01235678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.31 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=196.3
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455678999999999999765 68999999876543 344567899999999996 99999999999999999999999
Q ss_pred cCCCChhhh---hccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 560 MSNGPFRDH---LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 560 ~~~gsL~~~---l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
+. ++|.++ +.......+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 455443 333334578999999999999999999996 148999999999999999999999999998765322
Q ss_pred CCceeeccccCccccChhccccC---CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ..+....... ...
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~~~ 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------GDP 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------CCC
Confidence 1 12233588999999998766 689999999999999999999999965431 1111111000 011
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+.+........+..+.+++.+||+.+|++||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222222223466789999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.92 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=207.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|++.+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999765 68999999887553 35567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
+++++|.+++.... ...+++.++..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986543 3579999999999999999999999 899999999999999999999999999987654332
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......|++.|+|||.+.+..++.++|+||||+++++|++|+.||......... ..... . ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~---------~-~~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA------LKILK---------G-QY 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH------HHHhc---------C-CC
Confidence 2233456889999999999989999999999999999999999999765422111 11110 0 01
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..++...+..+.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1223355678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.12 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=197.3
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
||+|++|.||++... +++.+++|++.... ....+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 48999999876532 23456799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 645 (832)
.+++.+.. .+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99996543 58899999999999999999999 999999999999999999999999999988764332 223346
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
|+..|++||.+.+..++.++|+||||+++|||++|..||....... ... . ..+.+......++...+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~---~---------~~~~~~~~~~~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEI---Y---------NDILKGNGKLEFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHH---H---------HHHhccCCCCCCCcccC
Confidence 8899999999988889999999999999999999999997654211 111 1 11111111122333346
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 047569 726 KKFAEAAEKCLADHGVDRPT-----MGDVLW 751 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RPt-----~~evl~ 751 (832)
..+.+++.+||+.+|++||+ +.|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 78999999999999999999 666653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.33 Aligned_cols=243 Identities=23% Similarity=0.378 Sum_probs=195.2
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
||+|+||+||++... +|+.+++|.+.... ......+.+|+++|++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 68999999876432 23345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 645 (832)
.+++.......+++.+++.++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 999976655578999999999999999999999 9999999999999999999999999999876532 12223345
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
++..|++||.+.+..++.++|||||||++|+|++|+.||............ .. .+.. .....+...+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~----~~~~--~~~~~~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------KR----RTLE--MAVEYPDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------Hh----cccc--ccccCCccCC
Confidence 788999999998888999999999999999999999999765431111100 00 0000 0112233456
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHH
Q 047569 726 KKFAEAAEKCLADHGVDRP-----TMGDVL 750 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RP-----t~~evl 750 (832)
..+.+++.+||+.+|.+|| ++.+++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 7789999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=314.34 Aligned_cols=271 Identities=27% Similarity=0.396 Sum_probs=208.4
Q ss_pred CCccceEeecCceeEEEEEE-eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC------cEEE
Q 047569 484 FDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS------EMIL 555 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~------~~~l 555 (832)
+...+.||+|+||.||+|+. ++|+.||||.++.. .....++..+|+++|++|+|+|||++++.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 33467899999999999984 57999999988775 3455678889999999999999999999865543 5689
Q ss_pred EEEecCCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC--CCC--ceEEeccccc
Q 047569 556 VYEYMSNGPFRDHLYGK-NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD--DNY--VAKVSDFGLS 630 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~-~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla 630 (832)
|||||.||+|+..|.+. +...|++.+.+.+..+++.||.|||+ ++|+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999653 34579999999999999999999999 9999999999999984 333 4699999999
Q ss_pred ccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh-hhccc
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK-RKGLL 708 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~-~~~~~ 708 (832)
+....+. ....+.||..|++||++.+ +.|+..+|.|||||++||++||..||.+........-..|..... ..+..
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9876443 6677889999999999985 889999999999999999999999997765443211122221111 11110
Q ss_pred ----ccccCC-------CCCCCCChhHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHH
Q 047569 709 ----EKIIDP-------HLVGTINPESLKKFAEAAEKCLADHGVDRP--TMGDVLWNLEYALQL 759 (832)
Q Consensus 709 ----~~i~d~-------~l~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~~~~ 759 (832)
++.-+| .......+.....+.+++..+|..+|.+|- ...+....+..++..
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 000000 111223344556777888888999999997 777777777766654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.35 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=203.1
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc--ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE--QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
|++.+.||+|++|.||++... +++.+++|++..... .....+.+|+++|++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999765 689999998765432 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++ +|.+++.... ..+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 8888876543 478999999999999999999999 999999999999999999999999999987765432 12
Q ss_pred eeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC------
Q 047569 641 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID------ 713 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d------ 713 (832)
.....++..|++||.+.+. .++.++|+||||+++|+|++|++||......+...................+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234578899999998776 789999999999999999999999976654332211110000000000001000
Q ss_pred -------CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 714 -------PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 714 -------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
........+..+.++.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00001122345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.06 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=210.5
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
....|.+...||+|.|+.|.+|.+. ++..||||.+++.. ...++.+.+|+++|+.|+|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567899999999999999999765 69999999988763 33345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+.+|.+.++|.+.+ .+.+..+..++.|+.++++|||+ +.|||||||.+||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999997655 56668899999999999999999 999999999999999999999999999998876
Q ss_pred CCceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
......+.+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||++..-.+ .-++.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rv 267 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRV 267 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchh
Confidence 4456677889999999999998876 579999999999999999999998764221 11222
Q ss_pred CCCC--CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 716 LVGT--INPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 716 l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+.+. ++--...++.++++++|-.+|.+|++++++.+.
T Consensus 268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2222 233356678899999999999999999998743
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.10 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----Cc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN-----SE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~-----~~ 552 (832)
.++|.+.+.||+|+||+||++... +++.||||.+... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467899999999999999999764 6899999987653 333456778899999999999999999987543 35
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++|+||+. ++|.+++... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999995 7898888544 368999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.......................+..+
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 54322 22234457889999998865 46899999999999999999999999765432221111100000000000000
Q ss_pred ---------------cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 712 ---------------IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 712 ---------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.++.. ....+..+.++.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 01123456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.45 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=188.8
Q ss_pred eEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHh---CCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 489 IIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSK---LRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~---l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 68999999876432 1222334555544443 479999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999886543 68999999999999999999999 999999999999999999999999999987543221 1
Q ss_pred eccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+... . ......+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~----------~~~~~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----T----------LTVNVEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----h----------hcCCcCC
Confidence 23458999999999864 5689999999999999999999999975433221111110 0 0011123
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRP-----TMGDVLWN 752 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 752 (832)
++..+.++.+++.+||+.||.+|| +++|+++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 344567899999999999999999 58887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.94 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=202.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEec----cCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCD----ENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~----~~~~~ 553 (832)
.++|++.+.||+|++|.||+|... +|+.|++|++.... ....+.+.+|+.+|++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468899999999999999999765 68999999877542 234567889999999999999999998875 33568
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+. ++|.+++.... .+++..+..++.|+++||+|||+ ++++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 68999886443 58999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCCCc---eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh------
Q 047569 634 PIGQGH---VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK------ 703 (832)
Q Consensus 634 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~------ 703 (832)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|++||...................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 1123468899999998865 468999999999999999999999997665433222111100000
Q ss_pred --hhcccccccC---CCCC---CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 704 --RKGLLEKIID---PHLV---GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 704 --~~~~~~~i~d---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
......+..+ .... ....+..+..+.+++.+||+.+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 0000 01123356789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=290.80 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=205.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc--ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE--QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999765 678999998876643 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... ..+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998654 478999999999999999999999 89999999999999999999999999999876533221
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|++||.+.+...+.++||||||+++|+|++|+.||......... .. .. . .....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~----~~-~---------~~~~~ 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FR----IV-Q---------DDHPP 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HH----Hh-c---------cCCCC
Confidence 23346889999999998888999999999999999999999999754321111 00 00 0 01112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
++...+..+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 23345678999999999999999999999873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=283.84 Aligned_cols=244 Identities=24% Similarity=0.385 Sum_probs=196.2
Q ss_pred ccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEecCC
Q 047569 486 SSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
.+..||.|..|.|++++.+ +|...|||.+... +.+..++++..++++...+ +|+||+.+|+|..+...++.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 3567999999999999766 5899999987765 5566778888888877765 899999999999999999999998 3
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
..+..+|.+-. .++++..+-++...+.+||.||.+ .++|+|||+||+|||+|+.|++||+|||++-.+.... ..+
T Consensus 175 ~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 175 TCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred HHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 45555554433 468888888999999999999987 4789999999999999999999999999997765433 345
Q ss_pred ccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC---CCC
Q 047569 643 AVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID---PHL 716 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d---~~l 716 (832)
...|.+.|||||.+.- ..|+.++||||||++|+||.||+.||......-. .+.++++ |.+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--------------~ltkvln~ePP~L 315 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--------------VLTKVLNEEPPLL 315 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--------------HHHHHHhcCCCCC
Confidence 5568999999999864 4688999999999999999999999987543211 1112222 222
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. ....+..+++++..||.+|+.+||...++++
T Consensus 316 ~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred Cc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 1226788999999999999999999999874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=303.09 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=197.4
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCC------
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS------ 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~------ 551 (832)
-++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999765 68999999875432 223345678999999999999999999986543
Q ss_pred --cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 552 --EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 552 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
..++||||+. ++|.+++.... ..+++.+++.++.|+++||+|||+ ++++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 57888775443 368999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCc---eeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 630 SKDAPIGQGH---VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 630 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|++||.....................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8765432211 11234578899999988664 4788999999999999999999999876554433322221110000
Q ss_pred ccccccc-----CC-CCCCCC---------ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKII-----DP-HLVGTI---------NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i~-----d~-~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....... +. ...... .......+.+++.+||+.+|.+||+++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 00 000000 0012356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=298.13 Aligned_cols=260 Identities=24% Similarity=0.280 Sum_probs=195.1
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCC-CcceeeEEEEeccC--CcEEEEEE
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDEN--SEMILVYE 558 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~--~~~~lV~E 558 (832)
|++.+.||+|+||.||+|... +++.+|+|++.... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999764 68999999876542 222234557899999985 99999999999877 89999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|++ ++|.+.+.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 58888775433 368999999999999999999999 89999999999999999 9999999999986543221
Q ss_pred ceeeccccCccccChhccc-cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH--------HHHhhhcccc
Q 047569 639 HVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA--------MQWKRKGLLE 709 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~~~ 709 (832)
.....++..|+|||++. ++.++.++|||||||++|||++|.+||......+........ ..........
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 12345789999999764 456789999999999999999999999776543321111000 0000000000
Q ss_pred cccCCCCC----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHLV----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+... ....+..+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 0112245688999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=302.11 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=198.2
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.|+..+.||+|+||.||++... ++..+|+|++... ..+...++.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667889999999999999764 6899999987643 22345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+. |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 996 57777765432 368999999999999999999999 9999999999999999999999999998875432
Q ss_pred ceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.....|+..|+|||++. .+.++.++|||||||++|||++|++||........... ... ..
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~---------~~ 240 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQ---------NE 240 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHh---------cc
Confidence 12345888999999874 45789999999999999999999999865432221110 000 01
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.........+..+.+++.+||+.+|.+||++.++++.+.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 111112345567999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.68 Aligned_cols=266 Identities=22% Similarity=0.303 Sum_probs=201.1
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhC-CCcceeeEEEEecc--CCcE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE--NSEM 553 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~--~~~~ 553 (832)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++.. ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999765 6889999987542 233456678899999999 99999999998854 3468
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5998888543 67899999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCC----ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH--------
Q 047569 634 PIGQG----HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM-------- 700 (832)
Q Consensus 634 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~-------- 700 (832)
..... .......|+..|+|||.+.+ ..++.++||||||+++|||++|++||......+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43221 12233468999999998765 567899999999999999999999997655433221111000
Q ss_pred -H---HhhhcccccccCCCC--CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 701 -Q---WKRKGLLEKIIDPHL--VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 701 -~---~~~~~~~~~i~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
. ......+..+..... .....+..+..+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 000000111100000 011122356789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.66 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=205.1
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|++.+.||+|++|.||++... +++.+++|.+... ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999654 6889999987654 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
+++++|.+++.+. ....+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988552 23468999999999999999999999 99999999999999999999999999998876533
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......++..|++||.+.+..++.++|+||||+++|||++|+.||.......... . ... ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~------~-~~~---------~~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY------K-VQR---------GKY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-Hhc---------CCC
Confidence 2223457899999999999999999999999999999999999997654322111 0 011 111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.........++.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1223456678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=305.22 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=196.6
Q ss_pred ceEeec--CceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVG--GFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
..||+| +||+||++... +|+.||+|+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999764 7999999987643 333457889999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce--
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-- 640 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 640 (832)
++|.+++.......+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999876554568999999999999999999999 899999999999999999999999998654322111100
Q ss_pred ----eeccccCccccChhccccC--CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH-------------
Q 047569 641 ----STAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ------------- 701 (832)
Q Consensus 641 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~------------- 701 (832)
.....++..|++||++.+. .++.++|||||||++|||++|++||......... ......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccch
Confidence 0112345679999999763 5789999999999999999999999765432211 000000
Q ss_pred -------------------HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 702 -------------------WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 702 -------------------~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
....+....+.+..+...........+.+++.+||+.||++|||+.|+++.-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00000000111111222223346778999999999999999999999986544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=303.34 Aligned_cols=265 Identities=21% Similarity=0.278 Sum_probs=197.2
Q ss_pred CCCccceEeecCceeEEEEEEe---CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID---DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEMI 554 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~~ 554 (832)
+|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999764 47899999887633 34456788999999999999999999999887 8899
Q ss_pred EEEEecCCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC----CCceEEecc
Q 047569 555 LVYEYMSNGPFRDHLYGK---NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD----NYVAKVSDF 627 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DF 627 (832)
+||||+++ +|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 676666322 22368899999999999999999999 99999999999999999 999999999
Q ss_pred cccccCCCCCC--ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhh-------hhhHHH
Q 047569 628 GLSKDAPIGQG--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE-------QVNLAE 697 (832)
Q Consensus 628 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~-------~~~l~~ 697 (832)
|++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543221 11233467899999998876 457899999999999999999999997554322 011111
Q ss_pred HHHHHhh-----------hcccccccCCCCCCCCC---------h--hHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 698 WAMQWKR-----------KGLLEKIIDPHLVGTIN---------P--ESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 698 ~~~~~~~-----------~~~~~~i~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+.. ........+.......+ . ....++.+++.+||+.+|++|||+.|++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1100000 00000000000000011 0 23457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=295.77 Aligned_cols=244 Identities=26% Similarity=0.336 Sum_probs=197.0
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCCCc---ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQSE---QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
||+|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999998865432 4567789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC-------
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG------- 638 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------- 638 (832)
.+++.+.. .+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99996544 68999999999999999999999 9999999999999999999999999999876432211
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......++..|++||...+...+.++||||||+++|||++|+.||......+.... ... + ....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~~-~--------~~~~ 220 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN------ILN-G--------KIEW 220 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hhc-C--------CcCC
Confidence 122334578899999999888899999999999999999999999976553322111 000 0 0000
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
......+..+.+++.+||+.+|.+||++.++.+.|
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00111367889999999999999999995554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=308.20 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=204.7
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCC-----cEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS-----EMI 554 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~-----~~~ 554 (832)
+|++.+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999865 58999999887653 444578999999999999999999999987765 789
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
++|||++ ++|.+++.... .+++..++.++.|+++||+|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58988886543 79999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCC--ceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc----
Q 047569 635 IGQG--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL---- 707 (832)
Q Consensus 635 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---- 707 (832)
.... .......++..|+|||++.+. .++.++|+||||+++|+|++|++||......+................
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 122334578899999999887 889999999999999999999999987654432221111000000000
Q ss_pred ----cccccC------CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 708 ----LEKIID------PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 708 ----~~~i~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
....+. +.......+..+..+.+++.+||+.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 000011123356788999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.40 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=198.5
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhC---CCcceeeEEEEeccCCc-----
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKL---RHRHLVSLIGYCDENSE----- 552 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l---~HpnIv~l~~~~~~~~~----- 552 (832)
|++.+.||+|+||.||+|..+ +++.+|+|++.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999876 48999999886432 22234566788877766 59999999999987776
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+++|||+. ++|.+++.......+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 589888866544468999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc----
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL---- 708 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~---- 708 (832)
..... ......++..|+|||.+.+..++.++|+|||||++|||++|++||......+... ............
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChHhcCC
Confidence 54322 1223347889999999999999999999999999999999999997655433221 111110000000
Q ss_pred -----ccccCCCC---CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 -----EKIIDPHL---VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 -----~~i~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
........ .....+.....+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 01112345577889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.01 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=199.3
Q ss_pred cceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 487 SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
...||+|+||.||++..+ +++.||+|++..........+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999764 6899999988765555667799999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 645 (832)
.+++... .+++.....++.|++.+|+|||+ .+++||||||+||+++.++.++|+|||++....... .......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 9987432 57899999999999999999999 899999999999999999999999999887554322 1223356
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
|+..|++||.+.+..++.++|+||||+++|||++|..||............ ... ..+.+. .....+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-------~~~-----~~~~~~--~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDN-----LPPKLK--NLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hhh-----CCcccC--CcccCC
Confidence 889999999998888999999999999999999999999765433221111 000 111111 112345
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 726 KKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+.+++.+||+.+|.+||++.+++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 57889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.15 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=197.4
Q ss_pred CCCccceEeecCceeEEEEEE----eCCcEEEEEecCCCC----cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI----DDGTKVAVKRGNPQS----EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~ 553 (832)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+++|+++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999975 368999999876532 23346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++.... .+++.++..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999986543 68899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccCccccChhccccC--CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~------ 227 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS------ 227 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc------
Confidence 43322222345688999999998753 468899999999999999999999964322111 11111111000
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVL 750 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 750 (832)
. ..++......+.+++.+||+.+|++|| ++.+++
T Consensus 228 -~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 228 -E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred -C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 1 112334567789999999999999997 556654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.16 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=189.9
Q ss_pred ceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHH-HhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQML-SKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|++|.||+|... +++.||+|.+.... ......+..|..++ ..++|+||+++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999764 68999999876543 22223445555544 445899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999996543 68899999999999999999999 8999999999999999999999999999875432 22
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
...|+..|++||.+.+..++.++||||||+++|||++|..||............ ..+. .........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~------~~~~~~~~~ 218 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-------LSRR------INWPEEVKE 218 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------Hhcc------cCCCCcccc
Confidence 345888999999998888999999999999999999999999765443221110 0000 011111223
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 723 ESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 723 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.++..+.+++.+||+.+|++||++.++.+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 45678999999999999999997765543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.78 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=200.0
Q ss_pred CCCccceEeecCceeEEEEEE----eCCcEEEEEecCCCC----cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI----DDGTKVAVKRGNPQS----EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~ 553 (832)
+|++.+.||+|++|.||++.. .+++.||||.+.... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999964 357889999876432 23346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++... ..+++..+..++.|++++|+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998654 368899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeeccccCccccChhccccCC--CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
............|+..|++||.+.+.. .+.++||||||+++|||++|..||........ ..+...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~-----~~- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRIL-----KS- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHH-----cc-
Confidence 433322233345889999999987654 78899999999999999999999964322111 111111110 00
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.+ ..+......+.+++.+||+.+|++|||+.++.+.|+
T Consensus 228 -~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 -KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred -CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 11 122334567899999999999999999887765544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.98 Aligned_cols=265 Identities=23% Similarity=0.379 Sum_probs=204.9
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEE-EEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCC
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENS 551 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~ 551 (832)
++++...| .+.||+|+++.|--+ .+.+|.++|||++.+.....+.+..+|++++.+++ |+||++|+++|+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 56666666 578999999999988 46789999999999887777889999999999996 999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC---ceEEeccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY---VAKVSDFG 628 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFG 628 (832)
.+|||||.|.||+|..+|.++. .+++.++.++..+|+.||.+||. +||.||||||+|||..... -+||+||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999997654 69999999999999999999999 9999999999999997544 47999998
Q ss_pred ccccCCCC------CCceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhh-hhHH
Q 047569 629 LSKDAPIG------QGHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ-VNLA 696 (832)
Q Consensus 629 la~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~-~~l~ 696 (832)
|..-.... ......+.+|+..|||||+.. ..-|+.+.|.||||||||-||+|.+||.+.=..+. ++--
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 86533211 111223457999999999763 34689999999999999999999999976543221 1100
Q ss_pred HHHHHHhhhcccccccCCCCCCCCCh----hHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 697 EWAMQWKRKGLLEKIIDPHLVGTINP----ESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 697 ~~~~~~~~~~~~~~i~d~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+..+.. ++.+.+.|-+... +++. ..+.+..+++...|..++.+|-++.+++.
T Consensus 305 e~Cr~C-Q~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVC-QNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHH-HHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000 0011122222221 2222 34667888999999999999999888874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=305.88 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=195.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------C
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------S 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------~ 551 (832)
.++|...+.||+|+||.||+|... +|+.||+|++... .......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999764 6899999987643 233345688999999999999999999988654 3
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..++|+||+. .+|.+++. ..+++..+..++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4699999996 46766552 258899999999999999999999 899999999999999999999999999987
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc--
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL-- 708 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~-- 708 (832)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........................
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 64321 123457889999999876 46889999999999999999999999876543322111110000000000
Q ss_pred ------ccccC--CC-CCCC---CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 709 ------EKIID--PH-LVGT---INPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 709 ------~~i~d--~~-l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..... +. .... ..+.....+.+++.+||+.||.+||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00 0000 012345678899999999999999999999743
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=296.11 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=203.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV 556 (832)
++|.+.+.||+|++|.||++... +++.|++|++... .....+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999765 6899999987653 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999996543 69999999999999999999999 99999999999999999999999999998765432
Q ss_pred CC-------------------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH
Q 047569 637 QG-------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE 697 (832)
Q Consensus 637 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~ 697 (832)
.. .......++..|++||.+.+..++.++|+||||+++++|++|+.||......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF---Q 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH---H
Confidence 21 1222345789999999998888999999999999999999999999765421110 0
Q ss_pred HHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCH----HHHH
Q 047569 698 WAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTM----GDVL 750 (832)
Q Consensus 698 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl 750 (832)
. +. .....++...+..+.+++.+||+.+|.+||++ .+++
T Consensus 233 ---~---------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 233 ---K---------IL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred ---H---------HH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 0 00 01112334446779999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.89 Aligned_cols=256 Identities=17% Similarity=0.213 Sum_probs=185.0
Q ss_pred cCCCccceEeecCceeEEEEEEeC----CcEEEEEecCCCCcccH-----------HHHHHHHHHHHhCCCcceeeEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQSEQGI-----------TEFQTEIQMLSKLRHRHLVSLIGY 546 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~f~~Ei~~L~~l~HpnIv~l~~~ 546 (832)
++|++.++||+|+||.||+|...+ +..+++|.......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578999999999999999997653 45667775433322111 112233445566789999999997
Q ss_pred eccCC----cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 547 CDENS----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 547 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
+.... ..++++|++. .++.+.+... ...++..+..++.|+++||+|||+ ++++||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 75443 3467788763 4666665432 245788899999999999999999 899999999999999999999
Q ss_pred EEecccccccCCCCCC------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhh-hhH
Q 047569 623 KVSDFGLSKDAPIGQG------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ-VNL 695 (832)
Q Consensus 623 kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~-~~l 695 (832)
+|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999986532211 111234699999999999999999999999999999999999999976532221 111
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
.. .+.+..+..... ..+..+..+.+++..|+..+|++||++.++++.+
T Consensus 246 ~~-------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AK-------CDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hH-------HHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 001111111111 1123457799999999999999999999998765
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.42 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=199.5
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEec
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
|++.+.||+|++|+||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999875 578999998765432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+++|.+++.......+++.+++.++.|++++|.|||+ ++++|+||||+||++++++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 8899998876554578999999999999999999999 899999999999999999999999999987654321 1
Q ss_pred eeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH----------HHHHHhhhcccc
Q 047569 641 STAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE----------WAMQWKRKGLLE 709 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~----------~~~~~~~~~~~~ 709 (832)
.....++..|+|||++.+ ..++.++|+||||++++||++|++||......+...... |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 233457889999998754 567899999999999999999999997665433221110 000000000000
Q ss_pred cccCCCC---CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHL---VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....... .....+.....+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 00111122467999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=305.92 Aligned_cols=269 Identities=20% Similarity=0.285 Sum_probs=203.7
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEec
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~ 548 (832)
....++..++++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34567788899999999999999999999975 478999999886532 233467889999999999999999999875
Q ss_pred cC------CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 549 EN------SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 549 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCE
Confidence 32 4478888887 78998887533 58899999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||.................
T Consensus 160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999876432 2233467899999998866 5688999999999999999999999976543322111100000
Q ss_pred Hhhhcccc---------------cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 702 WKRKGLLE---------------KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 702 ~~~~~~~~---------------~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
........ .+..... .......+..+.+++.+||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000 0000000 00011235678999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=292.32 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=188.3
Q ss_pred eEeecCceeEEEEEEe-CCcEEEEEecCCCCc---ccHHHHHHHHHH---HHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 489 IIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE---QGITEFQTEIQM---LSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~f~~Ei~~---L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
+||+|+||.||++... +++.||+|.+..... .....+..|..+ ++...||||+++++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 589999998765421 112234445444 444579999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
|++|.+++... ..+++.++..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999988544 369999999999999999999999 899999999999999999999999999987543221 2
Q ss_pred eccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....|+..|+|||++.++ .++.++||||+||++|||++|+.||.............. . ....+ .+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~----~------~~~~~----~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----T------LTMAV----EL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH----h------hccCC----CC
Confidence 234689999999998754 689999999999999999999999976533221111100 0 00111 12
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 233467899999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.98 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=201.2
Q ss_pred HHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc-CC
Q 047569 476 ELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-NS 551 (832)
Q Consensus 476 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-~~ 551 (832)
++..++++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999755 7899999987543 23345678899999999999999999998865 56
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..++++||+ +++|.+++... .+++.....++.|+++||+|||+ .+++||||||+|||+++++.+||+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999999 57898887532 47888889999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH-H--------HHH
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE-W--------AMQ 701 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~-~--------~~~ 701 (832)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||............. + ...
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 5432 1123457889999998766 578999999999999999999999997665432211111 0 000
Q ss_pred HhhhcccccccCCCCCCC-----CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGT-----INPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
........-+..-..... ..+..+..+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000001 112345789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=312.27 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=207.3
Q ss_pred cceEeecCceeEEEEEE-eCC----cEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 487 SAIIGVGGFGNVYLGEI-DDG----TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~-~~g----~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++||+|+||+||+|.+ ..| -+||+|++... ..+...++.+|+-+|.+|+|||+++|+++|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 67999999999999954 333 46899987654 5566788999999999999999999999998765 88999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+.|+|.++++.++ ..+-.+..+.|+.|||+||.|||+ +.++||||-.+|||+.....+||.|||+++....+...-
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999997543 478889999999999999999999 999999999999999999999999999999876443322
Q ss_pred e-eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 641 S-TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 641 ~-~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
. ....-.+.|||-|.+....++.++|||||||++|||+| |..|+.+....+..++.+ + ..+-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~---------geRL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------K---------GERL 919 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------c---------cccC
Confidence 2 22234568999999999999999999999999999998 888887765554433322 1 1112
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
..++.+...+.-++.+||..|+..||+++++...+....+
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 3456677889999999999999999999999877766544
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=289.13 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=194.1
Q ss_pred HHHHHHhcCCCccceE--eecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccC
Q 047569 475 QELQEATKNFDSSAII--GVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDEN 550 (832)
Q Consensus 475 ~el~~~~~~f~~~~~L--G~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~ 550 (832)
.+.....++|++.+.+ |+|+||.||++..+ +++.+|+|......... .|+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444555677777776 99999999999764 68899999876442221 123333323 699999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGL 629 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGl 629 (832)
+..++||||+++++|.+++.... .+++.+++.++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999996554 78999999999999999999999 8999999999999999988 999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
++..... ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .....+....
T Consensus 157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------- 223 (267)
T PHA03390 157 CKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ------- 223 (267)
T ss_pred ceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-------
Confidence 8765322 22358899999999999999999999999999999999999997443221 1111111110
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT-MGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 751 (832)
.... ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ---~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ---QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 112345678999999999999999996 588763
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=323.53 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=189.2
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEecc--------
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-------- 549 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-------- 549 (832)
-..+|+..++||+||||.||+++.+ ||+.||||++... +.+......+|+.+|++|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467888899999999999999877 8999999987755 44455678899999999999999987621100
Q ss_pred --------------------------------------------------------------------------------
Q 047569 550 -------------------------------------------------------------------------------- 549 (832)
Q Consensus 550 -------------------------------------------------------------------------------- 549 (832)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 047569 550 -----------------------N--------SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598 (832)
Q Consensus 550 -----------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~ 598 (832)
+ ..+|+-||||+..+|.+++.++.... .....++++++|++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 0 13578899999888888886554221 457789999999999999999
Q ss_pred CCCCCeeeccCCCCceeeCCCCceEEecccccccCC----------------CC-CCceeeccccCccccChhccccC--
Q 047569 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP----------------IG-QGHVSTAVKGSFGYLDPEYFRRQ-- 659 (832)
Q Consensus 599 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~----------------~~-~~~~~~~~~gt~~y~aPE~~~~~-- 659 (832)
++||||||||.||+|+++..+||+|||++.... .+ .....+...||.-|+|||++.+.
T Consensus 716 ---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 ---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred ---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999998621 00 11123456799999999999765
Q ss_pred -CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC--CChhHHHHHHHHHHHhh
Q 047569 660 -QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT--INPESLKKFAEAAEKCL 736 (832)
Q Consensus 660 -~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~cl 736 (832)
.|+.|+|+|||||||+||+. ||..... .... +..+.++.+... +..+....=.++|.+++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~i------------L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASI------------LTNLRKGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHH--HHHH------------HHhcccCCCCCCcccccccchHHHHHHHHHh
Confidence 49999999999999999984 4654322 2111 111112222221 22233345578999999
Q ss_pred hcCCCCCCCHHHHH
Q 047569 737 ADHGVDRPTMGDVL 750 (832)
Q Consensus 737 ~~dP~~RPt~~evl 750 (832)
+.||.+|||+.|++
T Consensus 856 ~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 856 SHDPSKRPTATELL 869 (1351)
T ss_pred cCCCccCCCHHHHh
Confidence 99999999999987
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=295.17 Aligned_cols=248 Identities=28% Similarity=0.391 Sum_probs=196.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
+.|...+.||+|+||.||+|... +++.+++|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999765 5789999987542 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+. ++|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 68877775433 358899999999999999999999 89999999999999999999999999998764321
Q ss_pred CceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
....++..|+|||++. ...++.++|||||||++|||++|+.||.......... ... .+. .+
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~-~~~-----~~ 232 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIA-QNE-----SP 232 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HHh-hcC-----CC
Confidence 2345788999999874 3567889999999999999999999986543222111 000 000 01
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.......+..+.+++.+||+.+|++||++.+++....
T Consensus 233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1112345677899999999999999999999985533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.57 Aligned_cols=263 Identities=22% Similarity=0.340 Sum_probs=199.8
Q ss_pred HHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC--
Q 047569 477 LQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS-- 551 (832)
Q Consensus 477 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~-- 551 (832)
+....++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+++|++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4456788999999999999999999754 7899999987543 2333457889999999999999999999886543
Q ss_pred ----cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 552 ----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 552 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 7899888753 358899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHH-H--------
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLA-E-------- 697 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~-~-------- 697 (832)
|++...... .....+++.|++||.+.+ ..++.++|+|||||++|+|++|++||............ .
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 998765321 223457889999999876 46889999999999999999999999765432211100 0
Q ss_pred HHHHHhhh---cccc---cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 698 WAMQWKRK---GLLE---KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 698 ~~~~~~~~---~~~~---~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+....... .... ...... .....+.....+.+++.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKD-FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcch-HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0000 000000 01112344567899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=332.34 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=202.1
Q ss_pred HHhcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCC--CCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNP--QSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~--~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
..+-++.....||.|.||.||.|. .++|...|+|.+.. ...+..+...+|+.+|..|+|||+|+++|+-.+++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345677788899999999999995 56799999996543 345566778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
.||||++|+|.+++...+ -+++.....+..|++.|+.|||+ +|||||||||.||+|+.+|.+|++|||.+.....
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999995443 35555666788999999999999 9999999999999999999999999999987654
Q ss_pred CCC---ceeeccccCccccChhccccC---CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 636 GQG---HVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 636 ~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
... ......+||+-|||||++.+. .-..++||||||||+.||+||+.||..-...-++ +.....|.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI------My~V~~gh-- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI------MYHVAAGH-- 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH------HhHHhccC--
Confidence 321 122356799999999999763 4567899999999999999999999654322111 01111111
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
...++...+.+-.+++.+||..||.+|.++.|++
T Consensus 1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 1234555778889999999999999998777665
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.45 Aligned_cols=261 Identities=22% Similarity=0.230 Sum_probs=194.7
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44455555555555544 6899999987654 44566789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC------
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG------ 638 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------ 638 (832)
|.+++.......+++.....++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999976554568899999999999999999999 8999999999999999999999999998865432111
Q ss_pred ceeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh----hc------
Q 047569 639 HVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR----KG------ 706 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~----~~------ 706 (832)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ +.+....... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhc
Confidence 11123457788999999876 4588999999999999999999999976433221 1111000000 00
Q ss_pred -cccc----ccCCCC----CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 707 -LLEK----IIDPHL----VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 707 -~~~~----i~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
.... ..++.. ..........++.+++.+||+.+|++||++.++++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0000 000000 0111233456889999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.94 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=195.1
Q ss_pred cCCCccceEeecCceeEEEEEEeC-CcEEEEEecCCCC-cccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|++|.||+|..++ ++.||||++.... .....++..|+.++.++. ||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567889999999999999998764 8999999986543 234456777888777775 9999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+. ++|.+++.... ..+++..+..++.|+++||+|||+ ..+++||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 985 57777664433 378999999999999999999996 1489999999999999999999999999987653222
Q ss_pred ceeeccccCccccChhccccCC----CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ... ...... . .+
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~---~~~~~~-~-----~~ 237 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVL---TKILQE-E-----PP 237 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHH---HHHhcC-C-----CC
Confidence 122335788999999987554 7889999999999999999999996532211 100 010000 0 00
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
.. ......+.++.+++.+||+.+|.+||++.+++...
T Consensus 238 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 SL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 01 01113456799999999999999999999997553
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=278.90 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=201.0
Q ss_pred HhcCCCc-cceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEecc----CCc
Q 047569 480 ATKNFDS-SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE----NSE 552 (832)
Q Consensus 480 ~~~~f~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~----~~~ 552 (832)
++++|.+ .++||-|-.|.|-.+..+ +++++|+|++... ...++|+++.-.. .|||||++++++++ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4666766 467999999999999655 7999999998644 3457788876666 59999999998754 567
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGL 629 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGl 629 (832)
+++|||.|+||.|.+.+..++...+++.++-.|+.||+.|+.|||+ .+|.||||||+|+|.+ .+..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 8899999999999999988888889999999999999999999999 9999999999999996 455799999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
++.... .....+.+-|+.|.|||++....|+...|+||+||++|-||+|.+||....... +..|.-.
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispgMk~ 277 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGMKR 277 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChhHHh
Confidence 987542 223345567999999999999999999999999999999999999998654311 0111111
Q ss_pred cccCCCC--CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHL--VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+|..... ..+--...++...++|+.+|..+|.+|-|+.+++.
T Consensus 278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2211111 11111346778899999999999999999999874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.42 Aligned_cols=266 Identities=24% Similarity=0.290 Sum_probs=196.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccC-------
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------- 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------- 550 (832)
.++|++.+.||+|++|.||+|... +++.+++|++.... ......+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999765 68999999875432 22234678899999999999999999977433
Q ss_pred -CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 551 -SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 551 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
..+++|+||+. ++|...+... ...+++.++..++.|+++||+|||+ ++++|+||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999996 4677766543 2369999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC----------ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH
Q 047569 630 SKDAPIGQG----------HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW 698 (832)
Q Consensus 630 a~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~ 698 (832)
++....... .......+++.|+|||.+.+ ..++.++|||||||++|||++|++||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 876532211 11123457889999998765 4588999999999999999999999987655433222111
Q ss_pred HHHHhhh------cccccccCCCCCCCCC-------hhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 699 AMQWKRK------GLLEKIIDPHLVGTIN-------PESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 699 ~~~~~~~------~~~~~i~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....... ..+....+.......+ ......+.+++.+||+.+|.+|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 0000000000000011 123367889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=294.01 Aligned_cols=244 Identities=26% Similarity=0.397 Sum_probs=194.9
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
|...+.||+|+||+||+|... +++.|++|++.... ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555778999999999999764 68899999876432 23446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+. ++|.+++.... .++++.+++.++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 57777775433 368999999999999999999999 8999999999999999999999999998864321
Q ss_pred eeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.....|+..|+|||++. ...++.++|||||||++|||++|.+||........... .... ..
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~~---------~~ 237 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQN---------DS 237 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------HHhc---------CC
Confidence 22346889999999984 45688999999999999999999999876543222111 0000 00
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
........+..+.+++.+||+.+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122344578999999999999999999999843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=299.47 Aligned_cols=261 Identities=20% Similarity=0.273 Sum_probs=196.1
Q ss_pred cCCCc-cceEeecCceeEEEEEEe-CCcEEEEEecCCCCccc--------------HHHHHHHHHHHHhCCCcceeeEEE
Q 047569 482 KNFDS-SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQG--------------ITEFQTEIQMLSKLRHRHLVSLIG 545 (832)
Q Consensus 482 ~~f~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~f~~Ei~~L~~l~HpnIv~l~~ 545 (832)
++|.. .+.||+|+||+||+|... +++.||||.+....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 567999999999999765 68999999875432111 125788999999999999999999
Q ss_pred EeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 546 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
++..++..++||||+. ++|.+++... ..+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 6899988543 358899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC-------------CceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhh
Q 047569 626 DFGLSKDAPIGQ-------------GHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPRE 691 (832)
Q Consensus 626 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~ 691 (832)
|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|++||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999987654110 1111223468899999998764 46899999999999999999999997665433
Q ss_pred hhhHHHHHHHHhhhcc---ccccc--------C---CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGL---LEKII--------D---PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~---~~~i~--------d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... .......... +.... . +.......+..+..+.+++.+||+.+|++||++.+++.
T Consensus 242 ~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 221 1111110000 00000 0 00000111234567899999999999999999999974
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=299.66 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=195.1
Q ss_pred CCCccceEeecCceeEEEEEEe-C--CcEEEEEecCCC--CcccHHHHHHHHHHHHhC-CCcceeeEEEEecc----CCc
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-D--GTKVAVKRGNPQ--SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE----NSE 552 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~----~~~ 552 (832)
+|++.+.||+|+||.||++... . +..||+|++... .....+.+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999765 3 779999987643 223356788999999999 59999999987532 245
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++++||+. ++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999985 6898888543 368999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCCc---eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 633 APIGQGH---VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 633 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|++||.....................+.+
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5422111 1123468999999998765 56899999999999999999999999765433221111100000000000
Q ss_pred ccc-----------c---CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 709 EKI-----------I---DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 709 ~~i-----------~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.++ . .........+.....+.+++.+||+.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 0 0000011122345679999999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=302.81 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=197.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccC---------
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--------- 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--------- 550 (832)
..+|.+.+.||.|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367899999999999999999764 6899999988766666677899999999999999999999876543
Q ss_pred -----CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCceEE
Q 047569 551 -----SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKV 624 (832)
Q Consensus 551 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl 624 (832)
...++||||++ ++|.+++... .+++..+..++.|+++||+|||+ .+++||||||+||+++ +++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 5888887432 58899999999999999999999 8999999999999997 5567899
Q ss_pred ecccccccCCCCCCc--eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 625 SDFGLSKDAPIGQGH--VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 625 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+............
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998765322111 1122357889999998754 5688999999999999999999999976654332211100000
Q ss_pred Hhh----h----ccccccc----CC-CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 702 WKR----K----GLLEKII----DP-HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 702 ~~~----~----~~~~~i~----d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... . .....+. .+ .......+....++.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0 0000000 00 0000111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=321.09 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=212.4
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCC---CCcccHHHHHHHHHHHHhCCCcceeeEEEEecc
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNP---QSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~ 549 (832)
..+++...++|+++++||+|+||.|..++++ +++.||+|++.+ ........|..|-.+|..-+.+-|++++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566666789999999999999999999876 689999999887 345556789999999999999999999999999
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
+.++|||||||+||+|..++.+.. ++++..+..++..|..||.-||+ .|+|||||||+|||||..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999996555 79999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceeeccccCccccChhccc----c-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFR----R-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
+-.+..+..-.+...+|||-|++||++. + +.|++.+|.||+||++||||.|..||....-.+
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve------------- 288 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE------------- 288 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-------------
Confidence 8777655444556677999999999985 2 578999999999999999999999997643221
Q ss_pred hcccccccCCCCCCCCC--hhHHHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 047569 705 KGLLEKIIDPHLVGTIN--PESLKKFAEAAEKCLADHGVDRPT---MGDVL 750 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~evl 750 (832)
...+|++..-.-.++ ...+....+||.+.+. +|+.|-. ++++-
T Consensus 289 --TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 289 --TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred --HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 123333331111223 3467788899988665 7778876 77764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=304.80 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=199.6
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc---
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE--- 552 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~--- 552 (832)
...++|++.+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999875 5889999987643 23344668889999999999999999988766554
Q ss_pred ---EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 553 ---MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 553 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 6799998854 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....................+...
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 8765322 233457889999998865 46789999999999999999999999765543321111000000000000
Q ss_pred ccc--------cCC---CCCC---CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKI--------IDP---HLVG---TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i--------~d~---~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+ +.. .... ......+..+.+++.+||+.+|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 000 0000 001123678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=290.68 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=200.7
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
|+..+.||+|++|.||+|... +++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999776 58999999887653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+ ++|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58999996543 368999999999999999999999 8999999999999999999999999999876543221 2
Q ss_pred eeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc---------cc
Q 047569 641 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL---------EK 710 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~---------~~ 710 (832)
.....++..|+|||.+.+. .++.++|||||||++|||++|++||......+................. ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233467889999998776 8899999999999999999999999765533221111000000000000 00
Q ss_pred ccCC---CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 IIDP---HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 i~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.... .......+.....+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 0000111223568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=286.08 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=195.9
Q ss_pred CCCccceEeecCceeEEEEEEeC-CcEEEEEecCCC-----CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQ-----SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999997653 444555544321 223345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 557 YEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
|||+++++|.+++.. .....+++.+++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998853 233578999999999999999999999 99999999999999986 569999999987654
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
... .......|+..|++||.+.+..++.++|+||||+++|+|++|+.||......... ... ...
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~------~~~---------~~~ 220 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV------LRI---------VEG 220 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHH---------HcC
Confidence 322 2223445888999999998888999999999999999999999999654321111 110 000
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+...+..+.+++.+||+.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111223455678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.14 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=213.9
Q ss_pred CHHHHHHHhcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEec--
Q 047569 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCD-- 548 (832)
Q Consensus 473 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~-- 548 (832)
.++.+-.-++-|++.+.||+|.+|.||+++. ++++..|+|++..... .-++...|.++|+.+ .|||++.+++++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444444567789999999999999999964 5789999998776543 336778899999988 5999999999883
Q ss_pred ---cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 549 ---ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 549 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
.++++|||||||.+|+..|++.+-....+.|..+..|++.++.||.+||. ..++|||||-.||||+.++.+||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 45789999999999999999977667789999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccCccccChhccccC-----CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH
Q 047569 626 DFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 626 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 700 (832)
|||++....... ....+..||+.|||||++... .|+.++|+||||++..||.-|.+|+....+...+
T Consensus 166 DFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------- 237 (953)
T KOG0587|consen 166 DFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------- 237 (953)
T ss_pred eeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------
Confidence 999998765433 234456799999999999753 4678999999999999999999999776553321
Q ss_pred HHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 701 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
+.-...|.+.-.-+.....++.++|..||.+|-.+||++.+++
T Consensus 238 -------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 238 -------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred -------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 1112233333333566789999999999999999999999987
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=316.89 Aligned_cols=145 Identities=30% Similarity=0.419 Sum_probs=131.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|.+.+.||+|+||.||+|... +++.||||++.... .....++.+|+.+++.++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999876 68999999876532 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
||+.+++|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999996543 58889999999999999999999 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=284.49 Aligned_cols=241 Identities=24% Similarity=0.382 Sum_probs=201.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
.+|..+.+||+|+||.|-+|..+ +.+.+|||++++. ...+.+--+.|-++|+.. +-|.+++++.++..-+++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46788999999999999999765 5688999998765 233344456788888876 578999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+.||+|--++..- +.+.+..+...+..||-||-+||+ ++||+||||.+|||||.+|++||+|||+++....
T Consensus 429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 9999999998888543 367788899999999999999999 9999999999999999999999999999986543
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
......+.+|||.|+|||.+..++|+..+|.||+||+|||||.|++||++....+.. +.|++...
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~ehnv 567 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIMEHNV 567 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHHccC
Confidence 334456788999999999999999999999999999999999999999987654422 22223222
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCC
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPT 745 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt 745 (832)
.++...+.+..++....|.++|.+|..
T Consensus 568 --syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 --SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --cCcccccHHHHHHHHHHhhcCCccccC
Confidence 356667788889999999999999943
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=287.29 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=200.3
Q ss_pred cceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 487 SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
.++||+|.||+||-|.++ +|+.||||++.+. ..+...++++|+.+|++++||.||.+...|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 678999999999999754 7999999988765 3444578999999999999999999999999999999999999 56
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEecccccccCCCCCCce
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+..+.|.....++|++.....+..||+.||.|||. ++|+|+||||+||||.+ --.+||+|||.++... +...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecc--hhhh
Confidence 66676666666789999999999999999999999 99999999999999963 3489999999999865 3445
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
...++||+.|+|||+++++.|...-|+||.||++|--|+|.-||+...+.. +.++-+ .-+..+...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNA---------aFMyPp~PW--- 788 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNA---------AFMYPPNPW--- 788 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhcc---------ccccCCCch---
Confidence 567889999999999999999999999999999999999999997654322 111111 112222222
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
.+.+....++|...|+..-.+|-+.++-+
T Consensus 789 -~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 -SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 34455688899999999999999988765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=278.62 Aligned_cols=236 Identities=27% Similarity=0.365 Sum_probs=194.4
Q ss_pred EeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 490 IGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
||+|+||.||++... +++.+++|.+.... ......+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 58999999876543 22456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 645 (832)
.+++.... .+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99996543 68999999999999999999999 999999999999999999999999999987654321 1233456
Q ss_pred cCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 646 gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
++..|++||...+...+.++|+||||+++|||++|+.||........ .. . +... ...++...+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~---------~~~~--~~~~~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YE---K---------ILKD--PLRFPEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---H---------HhcC--CCCCCCCCC
Confidence 88899999999988899999999999999999999999965543111 11 0 0000 112233346
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHH
Q 047569 726 KKFAEAAEKCLADHGVDRPTMGD 748 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RPt~~e 748 (832)
..+.+++.+||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 77899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=281.41 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=196.8
Q ss_pred cCCCccceEeecCceeEEEE-EEeCCcEEEEEecCCC-------CcccHHHHHHHHHHHHhCCCcceeeEEEEec-cCCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQ-------SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD-ENSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~-~~~~g~~vavK~~~~~-------~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~-~~~~ 552 (832)
++|-++.+||+|||++||+| .+...+.||||+-... .+...+...+|.++.+.|.||.||++|+++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 56778889999999999999 4556889999974322 1122344678999999999999999999984 6678
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGL 629 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGl 629 (832)
+|-|+|||+|.+|.-+|.... .++++++..|+.||+.||.||.+.. .+|||-||||.||||. ..|.+||+||||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecch
Confidence 999999999999999996544 6899999999999999999999744 6899999999999994 568999999999
Q ss_pred cccCCCCCCc------eeeccccCccccChhcccc----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH
Q 047569 630 SKDAPIGQGH------VSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA 699 (832)
Q Consensus 630 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~ 699 (832)
++.+..+... ......||.+|++||.+-- -..+.|+||||.||++|+++.|+.||.-..... ++.+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILq-- 695 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQ-- 695 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHh--
Confidence 9987543211 2234579999999998743 356889999999999999999999997654322 1111
Q ss_pred HHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 700 MQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 700 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
+..+-+.. ...-...|..+.+..++|++||+..-++|....++.
T Consensus 696 -----eNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -----ENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----hhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111111 111122345677889999999999999998776653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=249.41 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=203.0
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+|+..++||+|.+|+||+|+.. +++.||+|+.+-. ++.--....+|+-+|++|+|.|||++++....++.+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556788999999999999754 6899999976543 333345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
|+ .+|..+...- .+.++.+.+..++.|+++||.++|+ ++++||||||.|.||+.+|++||+|||+++.+.....
T Consensus 83 cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred hh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 94 6777776433 3478899999999999999999999 9999999999999999999999999999998765432
Q ss_pred eeeccccCccccChhccccC-CCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccc---cccCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLE---KIIDP 714 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~---~i~d~ 714 (832)
.....+.|.+|.+|.++.+. -|+...|+||-||++.||.. |++.|.+....++...+-|......+..+. ++.|-
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 23334579999999998774 68999999999999999975 777787776666554444443333333322 22222
Q ss_pred CCCCCCC---------hhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTIN---------PESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....++ +.....=++++...|.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222222 233345577888889999999999887653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-33 Score=275.41 Aligned_cols=248 Identities=25% Similarity=0.284 Sum_probs=193.2
Q ss_pred cceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 487 SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
...||.|.||+|+|-.++ .|+..|||+++... +++.++++.|.+...+- ++||||+++|.+-.++..|+.||+|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 567999999999999765 79999999988764 46678899999876555 69999999999999999999999994 6
Q ss_pred Chhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 564 PFRDHL---YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 564 sL~~~l---~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+|..+- +......+++...-.|.....+||.||.+ ...|||||+||+||||+..|.+||||||++-.+.. ...
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence 665433 33334468888888899999999999987 47899999999999999999999999999876532 223
Q ss_pred eeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC-CC
Q 047569 641 STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH-LV 717 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~-l~ 717 (832)
.+.-.|...|||||.+.. ..|+.++||||||++|||+.||+-|+..... +.+...+... -|+. +.
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-------gdpp~l~ 291 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-------GDPPILL 291 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-------CCCCeec
Confidence 344568889999999854 4589999999999999999999999875432 1111111110 1221 11
Q ss_pred CCC-ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... .-+.+..+..++.-||.+|-.+||...++.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 1346778999999999999999999998864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=305.55 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=206.8
Q ss_pred cCCCccceEeecCceeEEEEEEe----C----CcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID----D----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENS 551 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~----~----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~ 551 (832)
++..+.+.||+|.||.|++|... . ...||||.+... ...+.+.+..|+++|+.+ +|+||+.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34455669999999999999643 1 457999988765 345678899999999999 5999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCC------C--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN------L--------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
..++|+||+..|+|.++|.... . ..++..+.+.++.|||.|++||++ .++|||||..+|||++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence 9999999999999999996544 0 138899999999999999999999 8999999999999999
Q ss_pred CCCceEEecccccccCCCCCCceeecccc--CccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGHVSTAVKG--SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
++..+||+|||+++..............| ...|||||.+....++.|+|||||||+||||++ |..||.+-.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~-- 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE-- 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH--
Confidence 99999999999999654333322222222 345999999999999999999999999999998 6788865321111
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
+.+ +.++|. +-..+..+..++.+++..||+.+|++||++.++.+.++..+
T Consensus 531 l~~----~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 LLE----FLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH----HHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 222222 11223456778999999999999999999999999999854
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=275.22 Aligned_cols=221 Identities=20% Similarity=0.182 Sum_probs=178.9
Q ss_pred cCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChhhhhcc
Q 047569 493 GGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYG 571 (832)
Q Consensus 493 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 571 (832)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999764 68999999986543 234555666667799999999999999999999999999999999865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCcccc
Q 047569 572 KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651 (832)
Q Consensus 572 ~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 651 (832)
.. .+++..+..++.|+++||+|||+ ++++||||||+||+++.++.++++|||++...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 43 58999999999999999999999 99999999999999999999999999987654321 12234577899
Q ss_pred ChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHH
Q 047569 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEA 731 (832)
Q Consensus 652 aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 731 (832)
|||.+.+..++.++||||+|+++|||++|+.|+....... . ......++...+..+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~----~~~~~~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------N----THTTLNIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------c----cccccCCcccCCHHHHHH
Confidence 9999988889999999999999999999998774321100 0 000011233455678999
Q ss_pred HHHhhhcCCCCCCCHHH
Q 047569 732 AEKCLADHGVDRPTMGD 748 (832)
Q Consensus 732 i~~cl~~dP~~RPt~~e 748 (832)
+.+||+.||++||++.+
T Consensus 209 i~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHccCCHHHhcCCCc
Confidence 99999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=276.46 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=208.3
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-C-c----ceeeEEEEeccCCc
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-H-R----HLVSLIGYCDENSE 552 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-H-p----nIv~l~~~~~~~~~ 552 (832)
.+++|.+...+|+|.||.|-.+... .+..||||+++.-. +..+..+-|+++|+++. + | -+|++.+|++-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999544 57899999876543 33455677999999993 2 2 37888899999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC--------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-------------- 618 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------------- 618 (832)
.|+|+|.+ |-|+.++|..++..+++..++..++.|+++++++||+ .+++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999 7799999988888899999999999999999999999 99999999999999932
Q ss_pred ------CCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhh
Q 047569 619 ------NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ 692 (832)
Q Consensus 619 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~ 692 (832)
+..+||+|||.+...... ...++.|..|+|||++.+..++.++||||+||||+||.+|...|+...+.+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 336899999999865422 2566789999999999999999999999999999999999999988876665
Q ss_pred hhHHHHHHHHhhhcccccc----------cC---------------C-CCCC---CCChhHHHHHHHHHHHhhhcCCCCC
Q 047569 693 VNLAEWAMQWKRKGLLEKI----------ID---------------P-HLVG---TINPESLKKFAEAAEKCLADHGVDR 743 (832)
Q Consensus 693 ~~l~~~~~~~~~~~~~~~i----------~d---------------~-~l~~---~~~~~~~~~l~~li~~cl~~dP~~R 743 (832)
..+-+.+..-.....+.+. +| + .+.. .....+..+|.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 5444433221111111110 11 0 0000 0123456689999999999999999
Q ss_pred CCHHHHHHH
Q 047569 744 PTMGDVLWN 752 (832)
Q Consensus 744 Pt~~evl~~ 752 (832)
+|+.|+++.
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.66 Aligned_cols=240 Identities=22% Similarity=0.306 Sum_probs=196.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++.|.....+|.|+|+.|-++... +++..++|++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888888999999999999654 68899999987652 2345677777666 69999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee-CCCCceEEecccccccCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL-DDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~ 637 (832)
.+.|+-|.+.+..... + ..++..|+.+|+.++.|||+ +|+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~-~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--F-CSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--h-HHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988887755442 2 26777899999999999999 999999999999999 68999999999999876543
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
..+.+-|..|.|||++....+++++|+||||++||+||+|+.||...... ..+. ..+..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~------------~~i~~---- 528 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH------------TRIQM---- 528 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH------------HhhcC----
Confidence 22334688999999999999999999999999999999999999765433 1111 11111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+.+....+....+|+.+||+.||.+||+|.++...
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22235567789999999999999999999998744
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=284.37 Aligned_cols=206 Identities=26% Similarity=0.409 Sum_probs=177.0
Q ss_pred cCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.-|..++.||-|+||+|.+++ .++...+|+|.+++.+ +......+.|..||++-..+-||+||-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347778899999999999995 4567789999887753 444566788999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||++||++-.+|.+.+ -+.+..+..++..+..|+++.|. .|+|||||||+|||||.+|++||+||||+.-+....
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999997765 57888888999999999999999 999999999999999999999999999976321100
Q ss_pred --------Cc---------------------------------eeeccccCccccChhccccCCCCccccEEechhHHHH
Q 047569 638 --------GH---------------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLE 676 (832)
Q Consensus 638 --------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~e 676 (832)
.+ .....+||+.|+|||++....++..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00 0012459999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhh
Q 047569 677 VLCARPAINPQLPREQ 692 (832)
Q Consensus 677 lltG~~pf~~~~~~~~ 692 (832)
|+.|++||....+.+.
T Consensus 864 m~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhCCCCccCCCCCcc
Confidence 9999999988776553
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=265.80 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=199.8
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc--------CCc
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--------NSE 552 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--------~~~ 552 (832)
|+...+||+|.||+||+|+.+ +|+.||+|+..-. .+..-....+|+++|..|+|+|++.+++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444678999999999999765 5888998864332 22233456789999999999999999998743 345
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
++||+++|+ -+|.-+|... ...++..++.+++.++..||.|+|+ ..|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 99 ~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 899999996 5777777433 2468899999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCc---eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 633 APIGQGH---VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 633 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
+...... ..+..+.|.+|++||.+.+ ..++++.|||+.||++.||+++.+-+.+.....+..++........++.+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 6533222 2234556999999998876 57999999999999999999999999988777766665543322222222
Q ss_pred ccccCCC---------C-CCCCC--hhHH------HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 709 EKIIDPH---------L-VGTIN--PESL------KKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 709 ~~i~d~~---------l-~~~~~--~~~~------~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+..-. + .+... ++.. ....+|+..+|..||.+|+.+.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2221111 1 11110 1111 267889999999999999999998743
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=286.34 Aligned_cols=241 Identities=22% Similarity=0.320 Sum_probs=203.5
Q ss_pred CCCccceEeecCceeEEEEEEeCCc-EEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDGT-KVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
+++.+..||-||||.|=+.+.+... .+|+|++++. +.+..+....|-++|..++.|.||++|-.+.+....|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3455778999999999999776433 4788876653 44445667889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
-|-||.|...|..++ .++......++..+.+|++|||+ ++||+|||||+|+||+.+|-+||.|||+++.... +
T Consensus 501 aClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--g 573 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--G 573 (732)
T ss_pred hhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc--C
Confidence 999999999996554 78889999999999999999999 9999999999999999999999999999998753 4
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
....+.+|||.|.|||.+.++..+.++|.||||+++||||+|.+||.+..+...-+++-.... . -
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--------~-------i 638 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--------K-------I 638 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--------h-------h
Confidence 456778999999999999999999999999999999999999999999887765544321111 1 1
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCC
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPT 745 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt 745 (832)
.++....+...+++++.+..+|.+|-.
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 233445667889999999999999965
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.51 Aligned_cols=243 Identities=29% Similarity=0.400 Sum_probs=189.9
Q ss_pred CCccceEeecCcee-EEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEecC
Q 047569 484 FDSSAIIGVGGFGN-VYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 484 f~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
|...+++|.|+.|+ ||+|..+ |+.||||++-... .+..++|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 55567799999875 7999885 8899999976433 34568999999998 5999999999999999999999999
Q ss_pred CCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-----CCceEEecccccccCC
Q 047569 562 NGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-----NYVAKVSDFGLSKDAP 634 (832)
Q Consensus 562 ~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~ 634 (832)
.-+|.+++... ......-...+.+..|+++||++||+ .+||||||||.||||+. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 57999999763 11112224557888999999999999 99999999999999975 3579999999999887
Q ss_pred CCCCcee--eccccCccccChhccccCCCCccccEEechhHHHHHhhC-CCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 635 IGQGHVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA-RPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 635 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
.+..... ....||-+|+|||++....-+.++|||||||++|+.++| .+||......+. ++.. ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~------------~~ 729 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILT------------GN 729 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhc------------Cc
Confidence 5543332 356799999999999998889999999999999999997 799976543321 1110 00
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
..+. .+.+....+..+||.+|++++|..||++.+|+
T Consensus 730 --~~L~-~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 730 --YTLV-HLEPLPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred --ccee-eeccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 0000 11111111789999999999999999999998
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=263.98 Aligned_cols=205 Identities=23% Similarity=0.351 Sum_probs=168.7
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe---C--CcEEEEEecCCCCcc--cHHHHHHHHHHHHhCCCcceeeEEEEecc-C
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID---D--GTKVAVKRGNPQSEQ--GITEFQTEIQMLSKLRHRHLVSLIGYCDE-N 550 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~--~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-~ 550 (832)
+....|+....||+|.+|.||+|... + .+.+|||+++..+.. .....-+|+.++++++||||+.+..++.+ +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34466888999999999999999432 2 337899988755321 12456789999999999999999998866 7
Q ss_pred CcEEEEEEecCCCChhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC----CceE
Q 047569 551 SEMILVYEYMSNGPFRDHLYG---KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN----YVAK 623 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~---~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~k 623 (832)
...+|++||.+ -+|.+.|+- .....++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeE
Confidence 88999999996 467777742 223468889999999999999999999 889999999999999877 8999
Q ss_pred EecccccccCCCCCCc--eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCC
Q 047569 624 VSDFGLSKDAPIGQGH--VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQ 687 (832)
Q Consensus 624 l~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~ 687 (832)
|+|||+++.+...-.. ....++.|.+|+|||++.+ ..||.+.|||+.||++.|||+-+|.|.+.
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999987643222 2345678999999999877 57999999999999999999999988654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=265.13 Aligned_cols=237 Identities=30% Similarity=0.402 Sum_probs=194.4
Q ss_pred CceeEEEEEEe-CCcEEEEEecCCCCccc-HHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChhhhhcc
Q 047569 494 GFGNVYLGEID-DGTKVAVKRGNPQSEQG-ITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYG 571 (832)
Q Consensus 494 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 571 (832)
+||.||+|... +++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 48999999988765544 78899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCcccc
Q 047569 572 KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651 (832)
Q Consensus 572 ~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 651 (832)
.. .+++..++.++.+++++|.+||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 43 38899999999999999999999 899999999999999999999999999988765322 233455788999
Q ss_pred ChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC-CCChhHHHHHHH
Q 047569 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG-TINPESLKKFAE 730 (832)
Q Consensus 652 aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~l~~ 730 (832)
+||.+.+..++.++||||||+++++|++|..||........ ..+. ... ..... ......+.++.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~----~~~--------~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKK----IGK--------PKPPFPPPEWKISPEAKD 219 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHH----Hhc--------cCCCCccccccCCHHHHH
Confidence 99999988899999999999999999999999976322111 1111 011 11100 001115578999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 047569 731 AAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 731 li~~cl~~dP~~RPt~~evl~ 751 (832)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=288.80 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=182.4
Q ss_pred hcCCCccceEeecCceeEEEEEE-----------------eCCcEEEEEecCCCCcccHHHH--------------HHHH
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-----------------DDGTKVAVKRGNPQSEQGITEF--------------QTEI 529 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~f--------------~~Ei 529 (832)
.++|++.++||+|+||+||+|.. ..++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999953 2357899999875543333333 3467
Q ss_pred HHHHhCCCcce-----eeEEEEecc--------CCcEEEEEEecCCCChhhhhccCC----------------------C
Q 047569 530 QMLSKLRHRHL-----VSLIGYCDE--------NSEMILVYEYMSNGPFRDHLYGKN----------------------L 574 (832)
Q Consensus 530 ~~L~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------~ 574 (832)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776554 667777643 457899999999999999886421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCccccChh
Q 047569 575 PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654 (832)
Q Consensus 575 ~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 654 (832)
..+++..+..++.|++++|+|||+ .+|+||||||+|||++.++.+||+|||++...............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 134677889999999999999999 89999999999999999999999999998765432222222234588999999
Q ss_pred ccccCCC----------------------CccccEEechhHHHHHhhCCC-CCCCCChhhh------hhHHHHHHHHhhh
Q 047569 655 YFRRQQL----------------------TEKSDVYSFGVVLLEVLCARP-AINPQLPREQ------VNLAEWAMQWKRK 705 (832)
Q Consensus 655 ~~~~~~~----------------------~~~sDV~SlGvvl~elltG~~-pf~~~~~~~~------~~l~~~~~~~~~~ 705 (832)
.+..... ..+.||||+||++|||++|.. |+........ .++..|..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~----- 455 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM----- 455 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-----
Confidence 8754321 134799999999999999875 6643211110 01111110
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHG---VDRPTMGDVLWN 752 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~ 752 (832)
.......-...........+++.++|..+| .+|+|++|++++
T Consensus 456 -----~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 -----YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -----hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000011011123345678899999999766 689999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=297.59 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=171.3
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-C----CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEE------ec
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-D----GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY------CD 548 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~------~~ 548 (832)
..++|++.+.||+|+||.||+|.+. + +..||+|++...... +.+..| .+.+..+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999765 4 689999987643221 111111 1222222222222111 34
Q ss_pred cCCcEEEEEEecCCCChhhhhccCCCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 047569 549 ENSEMILVYEYMSNGPFRDHLYGKNLP------------------PLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVK 610 (832)
Q Consensus 549 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlk 610 (832)
+....+|||||+.+++|.+++...... ......+..++.|++.||+|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 667899999999999999988643211 11223456799999999999999 899999999
Q ss_pred CCceeeCC-CCceEEecccccccCCCCCCceeeccccCccccChhccccC----------------------CCCccccE
Q 047569 611 STNILLDD-NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ----------------------QLTEKSDV 667 (832)
Q Consensus 611 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDV 667 (832)
|+|||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 67999999999986654444444566789999999966322 23456799
Q ss_pred EechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc----ccccccCCCCCCC----C--ChhHHHHHHHHHHHhhh
Q 047569 668 YSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG----LLEKIIDPHLVGT----I--NPESLKKFAEAAEKCLA 737 (832)
Q Consensus 668 ~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~----~~~~i~d~~l~~~----~--~~~~~~~l~~li~~cl~ 737 (832)
|||||+||||+++..++.... ..........+ .+.....+..... + .........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999765543211 11111100000 0011111111000 0 01112345589999999
Q ss_pred cCCCCCCCHHHHHHH
Q 047569 738 DHGVDRPTMGDVLWN 752 (832)
Q Consensus 738 ~dP~~RPt~~evl~~ 752 (832)
.||.+|||+.++++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999843
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=264.19 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=213.2
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEE
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGY 546 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~ 546 (832)
.+|+..-..+++...++.+|.||.||+|.+. +.+.|.+|.++.. ++-....+..|.-+|..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566666778999999999999999999543 3456777865543 55567789999999999999999999998
Q ss_pred ec-cCCcEEEEEEecCCCChhhhhc-----c-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC
Q 047569 547 CD-ENSEMILVYEYMSNGPFRDHLY-----G-KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN 619 (832)
Q Consensus 547 ~~-~~~~~~lV~E~~~~gsL~~~l~-----~-~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 619 (832)
+. +....+.++.++.-|+|..+|. + +....++..+...++.|++.|++|||+ +++||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 74 4577899999999999999996 1 234467888999999999999999999 999999999999999999
Q ss_pred CceEEecccccccCCCCCCcee-eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHH
Q 047569 620 YVAKVSDFGLSKDAPIGQGHVS-TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAE 697 (832)
Q Consensus 620 ~~~kl~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~ 697 (832)
.++||+|=.+++..-..+-+.. ..-.....||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.+.....
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl- 511 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL- 511 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-
Confidence 9999999999987654433322 22234668999999999999999999999999999987 88898777665543221
Q ss_pred HHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 698 WAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 698 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.+|. ++ .-+-+++.++..++.-||+..|++||+.++++.-|.+-
T Consensus 512 ------kdGy-------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 ------KDGY-------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ------hccc-------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2221 11 22346788999999999999999999999999887754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=258.68 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=200.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.++||+|++..|-.++++ +.+.+|+|++++. ..++.+-.+.|-.+..+. +||.+|.++.++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 67899999999999999999865 6789999987653 445566778888888777 699999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
.||++||+|--++.++. .++++.+......|+-||.|||+ +|||+||||..|||||..|.+||+|+|+++... .
T Consensus 330 ieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l-~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G 403 (593)
T ss_pred EEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC-C
Confidence 99999999977775544 68999999999999999999999 999999999999999999999999999998754 3
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChh-hhhhHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPR-EQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.+....+.+|||.|.|||.+++..|...+|.|+|||+++||+.|+.||+-.... ...+.-++..+.+ +...
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------lekq 475 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LEKQ 475 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------hhhc
Confidence 445566788999999999999999999999999999999999999999643211 1111111111111 1111
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCC
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPT 745 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 745 (832)
+ .++...+.+...++..-|++||.+|..
T Consensus 476 i--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 I--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred c--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1 233445566778888899999999943
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=256.15 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=203.1
Q ss_pred CccceEeecCceeEEEEEE-eCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----CcEEEE
Q 047569 485 DSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN-----SEMILV 556 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~-----~~~~lV 556 (832)
+..+.||-|+||.||...+ ++|+.|++|++..- +-...+++.+|+++|..++|.|++..++..... .++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3467899999999999965 47999999987653 233457788999999999999999998876443 356888
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
.|.| ..+|...|-. ...++...+.-+..||++||.|||+ .+|+||||||.|.|++.+..+||+|||+++....+
T Consensus 136 TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8988 4678877743 3478888899999999999999999 99999999999999999999999999999987766
Q ss_pred CCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH--------HHHhhhcc
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA--------MQWKRKGL 707 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~ 707 (832)
+....+..+.|.+|+|||.+++ ..|+.+.||||.||++.|||..+..|....+.++.+++.-. +....+|.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 5555566667999999999987 47999999999999999999999999998888877665422 22222332
Q ss_pred cccccCCCCCCC-----C----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 708 LEKIIDPHLVGT-----I----NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 708 ~~~i~d~~l~~~-----~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
-..++....... + +...-.+...+...++..||++|.+..+.+..
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 222222211110 1 11223456677888999999999998877644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=234.74 Aligned_cols=201 Identities=23% Similarity=0.312 Sum_probs=165.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.......||+|++|.|=+-++. +|...|+|++... +.+..++..+|+.+..+. .+|.+|.++|........++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3344677999999999988764 7999999987754 455667788899887766 699999999999999999999999
Q ss_pred cCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|+ .+|..+-.+ .....+++...-+|+..+.+||.|||+ ...++|||+||+||||+.+|++|+||||++-.+.+.
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS- 202 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS- 202 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh-
Confidence 94 677654422 234578888999999999999999998 467999999999999999999999999998765432
Q ss_pred CceeeccccCccccChhcccc----CCCCccccEEechhHHHHHhhCCCCCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLLEVLCARPAINPQL 688 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~SlGvvl~elltG~~pf~~~~ 688 (832)
-..+.-.|...|||||.+.. ..|+-|+||||||+++.||.+++.||....
T Consensus 203 -iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 203 -IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred -hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 12233458889999998753 478999999999999999999999997543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=236.80 Aligned_cols=210 Identities=37% Similarity=0.600 Sum_probs=183.5
Q ss_pred EeecCceeEEEEEEeC-CcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChhh
Q 047569 490 IGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRD 567 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 567 (832)
||+|.+|.||++.... ++.+++|+....... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998764 899999998766443 45789999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEecccccccCCCCCCceeecccc
Q 047569 568 HLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKDAPIGQGHVSTAVKG 646 (832)
Q Consensus 568 ~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 646 (832)
++.... ..+++..+..++.+++++|++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 986542 368899999999999999999999 89999999999999999 89999999999886643221 1233457
Q ss_pred CccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHH
Q 047569 647 SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725 (832)
Q Consensus 647 t~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 725 (832)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 888999999999999998
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 726 KKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 726 ~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+.+++.+|++.+|++||++.+++..
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 458899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=232.19 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=196.5
Q ss_pred hcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccC--CcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDEN--SEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~--~~~~lV 556 (832)
.++|++.+.+|+|.+++||.|. ..++++++||.+++.. .+.+.+|+.+|+.|+ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5678999999999999999995 5578999999988654 356889999999997 99999999998654 567899
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEecccccccCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 635 (832)
+||+.+.+...+- +.++...+...+.++++||.|+|+ .||+|||+||.|+|||. ...++|+|+|++.....
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999988876654 357778889999999999999999 99999999999999984 45799999999988764
Q ss_pred CCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCC-CCCChhhhhhHHHHHH------HHhhh--
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAI-NPQLPREQVNLAEWAM------QWKRK-- 705 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf-~~~~~~~~~~l~~~~~------~~~~~-- 705 (832)
+. .....+.+..|--||++-. +.++..-|+|||||+|..|+..+.|| .+....++.-.+..+. .+..+
T Consensus 186 ~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 43 2233456778899998865 57899999999999999999988665 4555555432222111 01111
Q ss_pred ----cccccccCCCCCCCC----C----hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 706 ----GLLEKIIDPHLVGTI----N----PESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 706 ----~~~~~i~d~~l~~~~----~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.....++........ + .-..++..+++.+.|..|-.+|+|+.|.+..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 011111111111111 1 1124678899999999999999999998754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=244.00 Aligned_cols=259 Identities=21% Similarity=0.233 Sum_probs=196.9
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc------CCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE------NSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~------~~~ 552 (832)
.+|.-.+.+|.|.- .|..+.+ -.++.||+|+.... .....++..+|..++..+.|+||++++.++.- ..+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555777888888 5666643 36899999976543 45566788999999999999999999999843 356
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.|+|||+| ..+|.+.+. -.++-+.+..|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+++.
T Consensus 96 ~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcc
Confidence 79999999 578988885 246778899999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH-------------
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA------------- 699 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~------------- 699 (832)
.... ...+....|..|.|||++.+..+.+.+||||+||++.||++|+..|.+..-.++.....-.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 5432 4556678899999999999988999999999999999999999998876544433222111
Q ss_pred ---HHHhh-------hcccccccCCCCCCC--CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 700 ---MQWKR-------KGLLEKIIDPHLVGT--INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 700 ---~~~~~-------~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+.+.+ -..-+.+-|...... .++.....+++++.+||-.+|++|-++++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00000 000011111111111 11234567889999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=264.93 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=206.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|+....+|.|.+|.|||++.. .++..|+|.++-.......-.++|+-+++..+|||||.+++.+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999754 7899999998877777778889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
|.||+|.+.-+.. .++++.++..+++..++||+|||+ .+-+|||||-.|||+++.|.+|++|||.+-.....- .
T Consensus 94 cgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred cCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 9999999876544 479999999999999999999999 899999999999999999999999999987654322 2
Q ss_pred eeeccccCccccChhcc---ccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 640 VSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
......||+.|||||+. +.+.|.+++|||++|+...|+-.-++|...-.+....-+ ..+ .-.+|.-
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mTk----S~~qpp~ 236 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MTK----SGFQPPT 236 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hhc----cCCCCCc
Confidence 23456799999999976 467899999999999999999888888654443322111 111 1112221
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
.+. .......+.++++.||-++|.+||+++.++
T Consensus 237 lkD-k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 LKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ccC-CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111 123456799999999999999999998876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=236.80 Aligned_cols=199 Identities=34% Similarity=0.493 Sum_probs=174.2
Q ss_pred CCccceEeecCceeEEEEEEeC-CcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 484 FDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
|++.+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5668899999999999998764 899999998876554 67889999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++..... .+++.....++.+++.+|.+||+ .+++|+||+|.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999965442 28899999999999999999999 8999999999999999999999999999887654321122
Q ss_pred eccccCccccChhcc-ccCCCCccccEEechhHHHHHhhCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLLEVLCARPAINP 686 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~-~~~~~~~~sDV~SlGvvl~elltG~~pf~~ 686 (832)
....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=251.05 Aligned_cols=273 Identities=21% Similarity=0.256 Sum_probs=207.4
Q ss_pred ccCHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC------CcceeeE
Q 047569 471 YFSFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR------HRHLVSL 543 (832)
Q Consensus 471 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~------HpnIv~l 543 (832)
++.+.--+..-.+|.+....|+|-|++|.+|... .|..||||++.... --.+.=+.|+++|++|+ --|.+++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 4444444555678999999999999999999765 47899999987652 22344568999999995 3589999
Q ss_pred EEEeccCCcEEEEEEecCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-Cc
Q 047569 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YV 621 (832)
Q Consensus 544 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~ 621 (832)
+-.|...+++|||+|-+ ..+|.++|..-+ .-.|....+..++.|+.-||..|.. .+|+|.||||.|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence 99999999999999998 589999996533 2357788899999999999999998 899999999999999865 56
Q ss_pred eEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH-
Q 047569 622 AKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM- 700 (832)
Q Consensus 622 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~- 700 (832)
+||||||.|....... .+....+.-|.|||.+.+.+|+...|+||.||+||||.||+..|.+......+.+..-+.
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 8999999987654322 233445677999999999999999999999999999999999998887665544332221
Q ss_pred ----HHhhhccc-cccc--------------------------CC------CCCC--CCC---hhHHHHHHHHHHHhhhc
Q 047569 701 ----QWKRKGLL-EKII--------------------------DP------HLVG--TIN---PESLKKFAEAAEKCLAD 738 (832)
Q Consensus 701 ----~~~~~~~~-~~i~--------------------------d~------~l~~--~~~---~~~~~~l~~li~~cl~~ 738 (832)
.+.+++.. .+-+ .| .+.+ .++ +.....|.+|+..||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 11222111 0001 11 0000 012 23456889999999999
Q ss_pred CCCCCCCHHHHHH
Q 047569 739 HGVDRPTMGDVLW 751 (832)
Q Consensus 739 dP~~RPt~~evl~ 751 (832)
||++|-|..+.|+
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999888763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=241.45 Aligned_cols=133 Identities=26% Similarity=0.357 Sum_probs=114.8
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-----C---cceeeEEEEec---
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-----H---RHLVSLIGYCD--- 548 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-----H---pnIv~l~~~~~--- 548 (832)
..+|.+.++||-|.|++||++.. .+.+.||+|+.+.. +...+....||++|++++ | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 37899999999999999999954 56789999986543 334556789999999984 2 47999999985
Q ss_pred -cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 549 -ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 549 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
.+.+.|||+|++ |.+|..+|.......++...+.+|+.|++.||.|||+. .+|||-||||+||||.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 457899999999 88999999888778899999999999999999999984 5899999999999993
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=253.85 Aligned_cols=196 Identities=23% Similarity=0.406 Sum_probs=167.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--------cccHHHHHHHHHHHHhCC---CcceeeEEEEecc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--------EQGITEFQTEIQMLSKLR---HRHLVSLIGYCDE 549 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~ 549 (832)
.+|...+.||+|+||.|+.|.++ +...|+||.+.+.+ ...+-..-.|+.+|..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999766 46789999776542 122233567999999997 9999999999999
Q ss_pred CCcEEEEEEec-CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 550 NSEMILVYEYM-SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 550 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
++.+||+||-- ++.+|.++|..+ +.+++.++..|++|++.|+++||+ .+|||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 99999999975 566899999554 479999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCC
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAIN 685 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~ 685 (832)
.+.....+ .....+||..|.|||++.+..| ...-|||++|++||-++...-||.
T Consensus 716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98765432 3456789999999999999876 567899999999999998877764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=225.81 Aligned_cols=251 Identities=21% Similarity=0.341 Sum_probs=185.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEE-eccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGY-CDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~-~~~~~~~~lV~ 557 (832)
.+.|.+.+.||+|.||.+-+++++ ..+.+++|-.... ....++|.+|..---.| .|.||+..++. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 466888999999999999999876 5778999976543 34467899998766666 49999998874 67778889999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC--CCCceEEecccccccCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD--DNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~ 635 (832)
||++-|+|.+-+... .+-+....+++.|++.||.|+|+ +++||||||.+||||- +..++||||||+.+....
T Consensus 102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999988543 46677888999999999999999 9999999999999993 445899999999876432
Q ss_pred CCCceeeccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
. -....-+..|.+||.... -...+.+|||.||+++|.+|||++||+..... .....+|..-..++
T Consensus 176 t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~~rk----- 245 (378)
T KOG1345|consen 176 T----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWLKRK----- 245 (378)
T ss_pred e----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHhccc-----
Confidence 1 112234567999997743 24567899999999999999999999843222 22233332211111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+.+...+.+ .++.+.++.++-|..++++|--..++..
T Consensus 246 --~~~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 246 --NPALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred --CccCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 1122222222 3456777888889999999954444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=229.42 Aligned_cols=201 Identities=26% Similarity=0.373 Sum_probs=166.8
Q ss_pred HHHHhcCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCC
Q 047569 477 LQEATKNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENS 551 (832)
Q Consensus 477 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~ 551 (832)
+....+.|..+++||+|.|++||++.+. .++.||+|.+...+.. .+..+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678999999999999999999543 4689999988766543 57899999999995 999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCceEEeccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLS 630 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla 630 (832)
...+|+||++.....++.. .++..++...++.+..||+++|. +|||||||||+|+|.+ ..+.-.|+|||++
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence 9999999999999988874 35678899999999999999999 9999999999999998 4567899999998
Q ss_pred ccCCC-C----------------C--------------------------CceeeccccCccccChhcccc-CCCCcccc
Q 047569 631 KDAPI-G----------------Q--------------------------GHVSTAVKGSFGYLDPEYFRR-QQLTEKSD 666 (832)
Q Consensus 631 ~~~~~-~----------------~--------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sD 666 (832)
..... . . ........||+||.|||++.+ ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 71100 0 0 000012359999999998865 56789999
Q ss_pred EEechhHHHHHhhCCCCCCCC
Q 047569 667 VYSFGVVLLEVLCARPAINPQ 687 (832)
Q Consensus 667 V~SlGvvl~elltG~~pf~~~ 687 (832)
|||.||+++-+++++.||-..
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999998544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=270.13 Aligned_cols=195 Identities=19% Similarity=0.250 Sum_probs=140.3
Q ss_pred hCCC-cceeeEEEEe-------ccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 047569 534 KLRH-RHLVSLIGYC-------DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605 (832)
Q Consensus 534 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~iv 605 (832)
.++| +||++++++| .+...+++++|++ +++|.++|... ...+++.+++.++.||++||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4556 6888888877 2334678889988 67999999643 3469999999999999999999999 9999
Q ss_pred eccCCCCceeeCC-------------------CCceEEecccccccCCCCC---------------CceeeccccCcccc
Q 047569 606 HRDVKSTNILLDD-------------------NYVAKVSDFGLSKDAPIGQ---------------GHVSTAVKGSFGYL 651 (832)
Q Consensus 606 HrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~y~ 651 (832)
||||||+||||+. ++.+|++|||+++...... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4456666666665321100 00011235889999
Q ss_pred ChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHH
Q 047569 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEA 731 (832)
Q Consensus 652 aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 731 (832)
|||++.+..++.++|||||||+||||++|.+|+..... ..... . .....+.. .........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~----~-----~~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL----R-----HRVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH----H-----HhhcChhh-----hhcCHHHHHH
Confidence 99999999999999999999999999999887642210 00000 0 01111111 1112345678
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 047569 732 AEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 732 i~~cl~~dP~~RPt~~evl~ 751 (832)
+.+||+++|.+||++.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=206.69 Aligned_cols=168 Identities=24% Similarity=0.213 Sum_probs=126.5
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
|+|.+++...+ ..+++.+++.++.|+++||+|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68999996533 369999999999999999999998 55 999999999999999 99987654321
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCCh
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 722 (832)
..||+.|||||++.+..++.++|||||||++|||++|+.||........ .+....... ... ++.. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~------~~~-~~~~-~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGM------PAD-DPRD-RSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHh------ccC-Cccc-cccHH
Confidence 2589999999999999999999999999999999999999965432111 111111000 000 0000 01112
Q ss_pred hHHH--HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 723 ESLK--KFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 723 ~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.... .+.+++.+||+.+|.+||++.|+++.+....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 2333 6999999999999999999999998887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=220.57 Aligned_cols=261 Identities=23% Similarity=0.260 Sum_probs=198.9
Q ss_pred CCCccceEeecCceeEEEEEEeCC--cEEEEEecCCCCcccHHHHHHHHHHHHhCCC----cceeeEEEEe-ccCCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDG--TKVAVKRGNPQSEQGITEFQTEIQMLSKLRH----RHLVSLIGYC-DENSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H----pnIv~l~~~~-~~~~~~~l 555 (832)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.. .++..+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999976543 5899998665433322378889999999863 6899999999 57788999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-----CceEEeccccc
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-----YVAKVSDFGLS 630 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla 630 (832)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+ .|++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99998 8999998865555689999999999999999999999 999999999999999754 46999999999
Q ss_pred c--cCCCCCCc------e-eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 631 K--DAPIGQGH------V-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 631 ~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
+ ........ . .....||..|.++....+...+.+.|+||++.++.||+.|..||............. .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---K 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---H
Confidence 8 32211111 1 233569999999999999999999999999999999999999996544322211111 1
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.... ..... .....+..+.++...+-..+..++|....+...|+.+...
T Consensus 252 ~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 DPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred Hhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0010 00110 1222345566666666668999999999998887766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=223.04 Aligned_cols=164 Identities=22% Similarity=0.201 Sum_probs=128.7
Q ss_pred HhcCCCccceEeecCceeEEEEEEe--CCcEEEEEecCCC-----CcccHHHHHHHHHHHHhCCCcceee-EEEEeccCC
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID--DGTKVAVKRGNPQ-----SEQGITEFQTEIQMLSKLRHRHLVS-LIGYCDENS 551 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~f~~Ei~~L~~l~HpnIv~-l~~~~~~~~ 551 (832)
..++|++.+.||+|+||+||+|.++ +++.+|||++... .....+.|.+|+++|++++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4567999999999999999999764 5778899986533 1223567999999999999999985 4432 4
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC-CCCceeeCCCCceEEeccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV-KSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla 630 (832)
..+|||||++|++|... . . .. ...++.|++++|+|||+ ++|+|||| ||+|||++.++.+||+|||++
T Consensus 92 ~~~LVmE~~~G~~L~~~-~-~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R-P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-C-c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 57999999999999632 1 1 11 14678899999999999 99999999 999999999999999999999
Q ss_pred ccCCCCCCce-------eeccccCccccChhccccC
Q 047569 631 KDAPIGQGHV-------STAVKGSFGYLDPEYFRRQ 659 (832)
Q Consensus 631 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 659 (832)
+......... -....+++.|++||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 8764322111 1345688899999998643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=204.20 Aligned_cols=259 Identities=18% Similarity=0.225 Sum_probs=202.2
Q ss_pred cCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
-+|++.++||+|.||+.+.|. +-+++.||||.....+ ...++..|.+..+.|. .++|..++-+..++.+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368899999999999999995 5579999999754443 3467888999999985 79999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-----CceEEecccccccCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-----YVAKVSDFGLSKDAP 634 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~~~~ 634 (832)
+ |-+|.|+..- ....++.++++.++.|++.-++|+|+ +.+|+|||||+|+||... ..+.|+|||+++...
T Consensus 106 L-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9 8899887743 33479999999999999999999999 999999999999999643 368999999999876
Q ss_pred CCCCce------eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 635 IGQGHV------STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 635 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
+..... .....||..||+-....+.+.+.+.|+-|||-++++.|.|..||.+-.........
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY------------ 248 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY------------ 248 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH------------
Confidence 544332 23466999999999999999999999999999999999999999875443322221
Q ss_pred ccccCCCCC---CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 709 EKIIDPHLV---GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 709 ~~i~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
++|-+.... ..+....+.++..-+.-.-..+-.+-|..+-+...+..++..
T Consensus 249 eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 249 EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 222221111 112234556677766666667777888887776666655543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=206.45 Aligned_cols=245 Identities=20% Similarity=0.326 Sum_probs=194.8
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
..+|.+...|+.|+|+++ |..+++|++... .....++|..|.-.|+.+.||||+.+++.|.....+.++..||+-|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346888899999999997 455566655432 33344679999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe--cccccccCCCCCCceee
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS--DFGLSKDAPIGQGHVST 642 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~--DFGla~~~~~~~~~~~~ 642 (832)
|...|++...-..+..++.+++.++|+|++|||+.. .-|.---|.+..+++|++.+++|. |--++. ...
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--------qe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEV 344 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--------ecc
Confidence 999999887667788899999999999999999843 224444789999999999988875 222111 112
Q ss_pred ccccCccccChhccccCCCC---ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 643 AVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~---~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
...-.+.||+||.++.++-+ .++|+|||+++||||.|...||..-.+.+..- ++.-..++..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccccc
Confidence 22346889999999877654 57999999999999999999998776655321 1222344556
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
++|..+..+.+++.-|++.||.+||.+..++-.||+.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7888889999999999999999999999999888864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=193.74 Aligned_cols=259 Identities=19% Similarity=0.220 Sum_probs=201.6
Q ss_pred hcCCCccceEeecCceeEEEEE-EeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCC-cceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH-RHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H-pnIv~l~~~~~~~~~~~lV~E 558 (832)
..+|++++.||+|+||.+|.|. ..+|+.||||........ .++..|.++...|+| ..|..+..+..++..-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4679999999999999999995 568999999986554332 467789999999975 778888888999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~ 635 (832)
.+ |-+|.++..- ....++.++.+.++-|++.-++|+|. +++|||||||+|+|.. ....+.|+|||+++...+
T Consensus 92 LL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 99 8899887742 22368899999999999999999999 9999999999999996 345789999999987653
Q ss_pred CCCce------eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 636 GQGHV------STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 636 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
..... .....||..|.+-....+...+.+.|+-|+|.+|.++..|..||++-.........+.+.+..-.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s---- 242 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS---- 242 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC----
Confidence 32221 23456999999998888888899999999999999999999999887655544443333222111
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
.....+....+.++.-.+.-|-...-++-|...-+.+.+.-
T Consensus 243 -----~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 243 -----TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred -----CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 11112234456778888888888888888887666554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-20 Score=202.60 Aligned_cols=259 Identities=29% Similarity=0.406 Sum_probs=197.6
Q ss_pred CCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcc---cHHHHHHHHHHHHhCCCc-ceeeEEEEeccCCcEEEEEEe
Q 047569 484 FDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ---GITEFQTEIQMLSKLRHR-HLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~f~~Ei~~L~~l~Hp-nIv~l~~~~~~~~~~~lV~E~ 559 (832)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999876 88899987765332 467899999999999988 799999999777778999999
Q ss_pred cCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKNL-PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 637 (832)
+.+++|.+++..... ..+.......+..|++.+++|+|+ .+++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976643322 268889999999999999999999 8899999999999999988 79999999988554332
Q ss_pred Cc-----eeeccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChh-hhhhHHHHHHHHhhhccc
Q 047569 638 GH-----VSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPR-EQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 638 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~-~~~~l~~~~~~~~~~~~~ 708 (832)
.. ......||..|++||.+.+ .......|+||+|++++++++|..||...... ........ ......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----ILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH----HHhcCC
Confidence 21 2456679999999999987 57889999999999999999999997655431 00001110 000000
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
. .................+.+++.+|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000002223678899999999999999998877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.6e-21 Score=192.75 Aligned_cols=170 Identities=16% Similarity=0.202 Sum_probs=133.8
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCccc---HHH------HHHHHHHHHhCCCcceeeEEEEeccC-
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQG---ITE------FQTEIQMLSKLRHRHLVSLIGYCDEN- 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~------f~~Ei~~L~~l~HpnIv~l~~~~~~~- 550 (832)
.++|+..++||.|+||.||.... ++..+|+|.+.+..... ... +.+|++.+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 68999999999999999999766 57789999987653222 222 68999999999999999998885432
Q ss_pred -------CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceE
Q 047569 551 -------SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623 (832)
Q Consensus 551 -------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 623 (832)
+..+|+|||++|.+|.++. .++. ....+++.+|..||+ .+++|||+||+||++++++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EE
Confidence 4689999999999998874 1222 245689999999999 9999999999999999988 99
Q ss_pred EecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHh
Q 047569 624 VSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678 (832)
Q Consensus 624 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ell 678 (832)
|+|||........... ..+.....+..++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999987654211110 11344556778999999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=226.47 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=189.0
Q ss_pred ccceEeecCceeEEEEEEe-CCcEEEEEecC----CC-Cc-ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 486 SSAIIGVGGFGNVYLGEID-DGTKVAVKRGN----PQ-SE-QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~----~~-~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
..+++|.|.+|.|+..... ..+..+.|... .. .+ +....+..|+.+-..|+|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3678999999988877433 33444444322 11 11 112226667777788899999988888877777666799
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
||++ +|..++... ..+...++..++.|++.|++|||+ .||.|||||++|++++.+|.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999998654 357888999999999999999999 9999999999999999999999999999876653322
Q ss_pred ---ceeeccccCccccChhccccCCCCc-cccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 639 ---HVSTAVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 639 ---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.......|+..|+|||.+.+..|++ ..||||.|++++.|++|+.||......+.... ........-..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQRNIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhccccccccc
Confidence 4566778999999999999999987 58999999999999999999976544332210 00000000011
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.-...+....+...+.++.++|+.+|.+|-|+++|++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11112234466788999999999999999999999753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=185.92 Aligned_cols=139 Identities=19% Similarity=0.222 Sum_probs=107.8
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcc--c-------HHHH-----------------HHHHHHHHhCCCcce
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ--G-------ITEF-----------------QTEIQMLSKLRHRHL 540 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~f-----------------~~Ei~~L~~l~HpnI 540 (832)
...||+|+||.||+|...+|+.||||+++..... . ..+| .+|++.|.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998878999999987654211 1 1122 349999999987776
Q ss_pred eeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeeccCCCCceeeCCC
Q 047569 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL-HTGTAQGIIHRDVKSTNILLDDN 619 (832)
Q Consensus 541 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yL-H~~~~~~ivHrDlkp~NILl~~~ 619 (832)
........ ...+|||||+++++|...+... ..+++.+.+.++.|++.+|++| |+ .+|+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 43332222 2238999999988776553222 3688999999999999999999 67 8999999999999998 4
Q ss_pred CceEEecccccccC
Q 047569 620 YVAKVSDFGLSKDA 633 (832)
Q Consensus 620 ~~~kl~DFGla~~~ 633 (832)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-20 Score=183.66 Aligned_cols=148 Identities=24% Similarity=0.370 Sum_probs=91.6
Q ss_pred heeeeecCCCCCCCCCCCCccccccCCCceeccCCCcceeccCCeeecCCCCCCcccchhhHHhhhccCCCCCCCCCcce
Q 047569 197 YVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNV 276 (832)
Q Consensus 197 ~~~r~n~Gg~~~~~~~D~~~R~W~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~~ 276 (832)
+++|+||||... .|..+..|++|..+..+...-...........-.......+.++.||||+|.... +|
T Consensus 1 ~~~~IN~Gg~~~---~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--------~f 69 (174)
T PF11721_consen 1 VVLRINAGGPAY---TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--------SF 69 (174)
T ss_dssp EEEEEEETSSSE---EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--------SE
T ss_pred CEEEEECCCCcc---cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--------ce
Confidence 468999999987 5888999999998854433100000000000000112234557899999999544 39
Q ss_pred eEEeccCCCCceEEEEEeeeeeecc------cCcEEEEEEEcCeeecccCchhhhhcCcCcceEEEE-EEEeccccCceE
Q 047569 277 TWTFDVDSTFSYLLRLHFCDIVSKS------LNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDI-VVNASLMHNGLN 349 (832)
Q Consensus 277 t~~~~~~~~~~Y~v~LhFae~~~~~------~~~R~Fdi~in~~~~~~~~di~~~~~~~~~~~~~d~-~~~~~~~~~gl~ 349 (832)
+|.+|+.++|+|.|+|||||+++.. .|+|+|||+|||++++++|||++++|+..++...-+ .+.+. +..|+
T Consensus 70 ~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~--dg~L~ 147 (174)
T PF11721_consen 70 SYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVT--DGTLN 147 (174)
T ss_dssp EEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEE--TTEEE
T ss_pred EEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEe--CCcEE
Confidence 9999988899999999999998866 999999999999999999999999998886656655 66664 55598
Q ss_pred EEEccCCC
Q 047569 350 VQIGPNKE 357 (832)
Q Consensus 350 ~s~~~~~~ 357 (832)
|.|.+..+
T Consensus 148 i~f~~~~~ 155 (174)
T PF11721_consen 148 IQFVWAGK 155 (174)
T ss_dssp TTEEEE--
T ss_pred EEEEecCC
Confidence 88875444
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-20 Score=217.50 Aligned_cols=247 Identities=21% Similarity=0.235 Sum_probs=180.9
Q ss_pred CCCccceEeecCceeEEEEEEeCCcEEEEEecCCCC-cccHHHHHHHHHH--HHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS-EQGITEFQTEIQM--LSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~--L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++...+.||++.|=.|.+|+++.|. |+||++-+.. .-.+..|.++++- ...++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677899999999999999998877 8888765543 3334445444443 4445899999998887777888999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC--
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-- 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 637 (832)
+. -+|.|.|. .++-+...+...|+.|++.||.-+|. .+|+|||||.+||||+.-.-+.|+||..-+..-..+
T Consensus 103 vk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 84 68888884 34467788899999999999999999 999999999999999999999999998765332111
Q ss_pred ----CceeeccccCccccChhcccc----------CC-CCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHH
Q 047569 638 ----GHVSTAVKGSFGYLDPEYFRR----------QQ-LTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 638 ----~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 701 (832)
.....+...-.+|+|||.+-. .. .+++.||||+||++.||++ |+|+|.-.+ .-..+....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCc
Confidence 111122334468999997743 12 6789999999999999987 688885321 100000001
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...+..+++|-| ..+++++..|++.||++|-++++.++.
T Consensus 253 ~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111122333322 257999999999999999999999876
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=177.30 Aligned_cols=186 Identities=16% Similarity=0.105 Sum_probs=141.7
Q ss_pred CccceEeecCceeEEEEEEeCCcEEEEEecCCCCcc----cHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEe
Q 047569 485 DSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ----GITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4577899999999998766 5788887776654321 1235889999999995 5889999886 456999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC-CCCceeeCCCCceEEecccccccCCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV-KSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
++|.+|.+.+.. ....++.|++++|+++|+ +||+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754421 123577899999999999 99999999 79999999999999999999985443221
Q ss_pred c----e--------eeccccCccccChhccccC-CCC-ccccEEechhHHHHHhhCCCCCCCC
Q 047569 639 H----V--------STAVKGSFGYLDPEYFRRQ-QLT-EKSDVYSFGVVLLEVLCARPAINPQ 687 (832)
Q Consensus 639 ~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDV~SlGvvl~elltG~~pf~~~ 687 (832)
. . ......++.|++|+...-. ..+ .+.+.++.|+-+|.++|++.+.-..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 1123368889999865432 233 5778999999999999999776443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=175.78 Aligned_cols=141 Identities=19% Similarity=0.212 Sum_probs=110.3
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcc---------------------c-----HHHHHHHHHHHHhCCCcce
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ---------------------G-----ITEFQTEIQMLSKLRHRHL 540 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~f~~Ei~~L~~l~HpnI 540 (832)
.+.||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999998778999999987754211 0 1224679999999999987
Q ss_pred eeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC
Q 047569 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY 620 (832)
Q Consensus 541 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 620 (832)
.....+... ..+|||||++|+++....... ..++..+..+++.|++.+|.+||+ ..+|+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence 544333322 248999999988654432222 257788999999999999999996 26899999999999999 78
Q ss_pred ceEEecccccccCC
Q 047569 621 VAKVSDFGLSKDAP 634 (832)
Q Consensus 621 ~~kl~DFGla~~~~ 634 (832)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.9e-20 Score=201.77 Aligned_cols=225 Identities=23% Similarity=0.279 Sum_probs=180.6
Q ss_pred eEeecCceeEEEEE----EeCCcEEEEEecCCCCcc--cHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEecC
Q 047569 489 IIGVGGFGNVYLGE----IDDGTKVAVKRGNPQSEQ--GITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|+|.+|.|++++ .+.|..+|+|.+.+.... .......|..++...+ ||.+|++.-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999773 345788999987765321 1124566888899987 9999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
||.|...+.... .++..........++-+++++|+ .+++|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999988885443 56677777778888999999999 9999999999999999999999999999987543221
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
.+||..|||||.+. ....++|.||||++++||++|..||.. +. . ..|+. .....+
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~---~------------~~Il~--~~~~~p 207 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT---M------------KRILK--AELEMP 207 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH---H------------HHHhh--hccCCc
Confidence 17999999999998 568899999999999999999999976 11 0 11111 112345
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
.+.+.....++.+++..+|.+|-..
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 6677888999999999999999554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=179.97 Aligned_cols=232 Identities=20% Similarity=0.271 Sum_probs=150.9
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCC---CCcccHHHHHHHHHHHHhCCC----------cceeeEEEEe-
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNP---QSEQGITEFQTEIQMLSKLRH----------RHLVSLIGYC- 547 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~f~~Ei~~L~~l~H----------pnIv~l~~~~- 547 (832)
.....+.||.|+++.||.+.+. +|+.+|+|.... ......+++++|.-....+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455789999999999999876 589999996432 234457778777765555322 1222222211
Q ss_pred --------cc---CC-----cEEEEEEecCCCChhhhhc---cC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 047569 548 --------DE---NS-----EMILVYEYMSNGPFRDHLY---GK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606 (832)
Q Consensus 548 --------~~---~~-----~~~lV~E~~~~gsL~~~l~---~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivH 606 (832)
.. .. ..+++|+-+ .++|.+++. .. ....+....++.+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11 11 236788877 578877653 21 11234455667788999999999999 99999
Q ss_pred ccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCccccChhcccc--------CCCCccccEEechhHHHHHh
Q 047569 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLLEVL 678 (832)
Q Consensus 607 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDV~SlGvvl~ell 678 (832)
+||||+|++++.+|.++|+||+...... ........+..|.+||.... -.++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAG----TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETT----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecC----ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999776543 12222345678999997744 25788999999999999999
Q ss_pred hCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCC
Q 047569 679 CARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDR 743 (832)
Q Consensus 679 tG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 743 (832)
|++.||....+.... ........ +.++.+..||..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~--------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP--------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS--------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc--------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999765432211 10122334 788899999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-18 Score=189.98 Aligned_cols=216 Identities=25% Similarity=0.392 Sum_probs=161.3
Q ss_pred HHhCCCcceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eeccCC
Q 047569 532 LSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI-IHRDVK 610 (832)
Q Consensus 532 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~i-vHrDlk 610 (832)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..+++.....+.++|++||+|||. ..| .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeec
Confidence 457899999999999999999999999999999999997633 479999999999999999999998 333 999999
Q ss_pred CCceeeCCCCceEEecccccccCCC-CCCceeeccccCccccChhccccC-------CCCccccEEechhHHHHHhhCCC
Q 047569 611 STNILLDDNYVAKVSDFGLSKDAPI-GQGHVSTAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLLEVLCARP 682 (832)
Q Consensus 611 p~NILl~~~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDV~SlGvvl~elltG~~ 682 (832)
+.|+++|....+||+|||+...... ..........-..-|.|||.++.. ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999999999999999999876532 011111112234579999998763 25778999999999999999999
Q ss_pred CCCCCChhhh-hhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 683 AINPQLPREQ-VNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 683 pf~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
||........ ..++..+.. .-.....|.+... .+....+..++.+||..+|.+||+++++...++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9976432221 122222111 0111122222111 1344579999999999999999999999876665544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=197.98 Aligned_cols=254 Identities=22% Similarity=0.247 Sum_probs=186.3
Q ss_pred HHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC---CcceeeEEEEeccCCc
Q 047569 476 ELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR---HRHLVSLIGYCDENSE 552 (832)
Q Consensus 476 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~~~ 552 (832)
+.+.-...|.+.+.||+|++|.||+|...+|+.||+|+-.+.+..+ |.--.+++.+|+ -+.|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3344456789999999999999999988889999999977765432 333344555555 2344444555556677
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-------CCCceEEe
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-------DNYVAKVS 625 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-------~~~~~kl~ 625 (832)
-+||+||.+.|+|.+++. ....++|...+.+..|+++.++.||. .+|||+||||+|+||. +...++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 899999999999999996 44579999999999999999999999 9999999999999994 34469999
Q ss_pred cccccccCCC-CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 626 DFGLSKDAPI-GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 626 DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
|||.+..+.. ..+......++|-.+-.+|+..+..++..+|.|.|+.+++-||.|+.- + . .
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------------q-~-~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------------E-V-K 905 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------H-h-c
Confidence 9999876542 233455667899999999999999999999999999999999999720 0 0 0
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.|. ...++..+...+..+. .-+++.++|+.|-..=|...++...++.++..
T Consensus 906 ~g~-~~~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 906 NGS-SWMVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred CCc-ceeccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 111 1111222222222333 34556667774444448888888888777653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=167.58 Aligned_cols=135 Identities=15% Similarity=0.200 Sum_probs=106.1
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-----CCcceeeEEEEeccCC---c-EEEE
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-----RHRHLVSLIGYCDENS---E-MILV 556 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-----~HpnIv~l~~~~~~~~---~-~~lV 556 (832)
-.+.||+|+||.||. ..+++.. +||+.........+++.+|+++++++ .||||++++++++++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 367899999999996 3334444 69987765555567899999999999 5799999999998763 3 3378
Q ss_pred EEe--cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeeccCCCCceeeCC----CCceEEecccc
Q 047569 557 YEY--MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGL-HYLHTGTAQGIIHRDVKSTNILLDD----NYVAKVSDFGL 629 (832)
Q Consensus 557 ~E~--~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L-~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGl 629 (832)
+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+ ++|+||||||+|||++. ++.++|+||+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 999 5579999999543 35444 35677888777 99999 99999999999999973 34899999553
Q ss_pred c
Q 047569 630 S 630 (832)
Q Consensus 630 a 630 (832)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=167.81 Aligned_cols=141 Identities=18% Similarity=0.172 Sum_probs=111.9
Q ss_pred CCCccceEeecCceeEEEEE--EeCCcEEEEEecCCCCcc------------------------cHHHHHHHHHHHHhCC
Q 047569 483 NFDSSAIIGVGGFGNVYLGE--IDDGTKVAVKRGNPQSEQ------------------------GITEFQTEIQMLSKLR 536 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~f~~Ei~~L~~l~ 536 (832)
-|++.+.||+|++|.||+|. ..+|+.||+|+....... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 458999999987643210 1123678999999997
Q ss_pred C--cceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeeccCCCCc
Q 047569 537 H--RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG-IIHRDVKSTN 613 (832)
Q Consensus 537 H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~-ivHrDlkp~N 613 (832)
+ ..+.+++++ ...++||||++|.+|....... ..+...+...++.|++.+|++||+ .+ ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 5 334555553 2358999999998887765322 245666778999999999999999 88 9999999999
Q ss_pred eeeCCCCceEEecccccccC
Q 047569 614 ILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 614 ILl~~~~~~kl~DFGla~~~ 633 (832)
|+++ ++.++|+|||++...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=163.94 Aligned_cols=134 Identities=27% Similarity=0.439 Sum_probs=113.0
Q ss_pred ceEeecCceeEEEEEEeCCcEEEEEecCCCCcc--------cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ--------GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+.||+|++|.||+|.. .|..+++|+....... ...++.+|++++..++|++|.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999975543211 124678899999999999988777777677788999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
++|++|.+++.... + ++..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985432 2 788999999999999999 9999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=161.21 Aligned_cols=146 Identities=23% Similarity=0.203 Sum_probs=114.5
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCc----------------------ccHHHHHHHHHH
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE----------------------QGITEFQTEIQM 531 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~f~~Ei~~ 531 (832)
++++......|.+.+.||+|+||.||++..++|+.||||+...... .....+..|+.+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 3455555555888999999999999999888899999997553220 011236778999
Q ss_pred HHhCCCc--ceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 047569 532 LSKLRHR--HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609 (832)
Q Consensus 532 L~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDl 609 (832)
+..+.|+ .+.+.++. ...++||||++|++|.+.... .....++.++++++.++|+ .+++||||
T Consensus 87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 9999877 45555543 345899999999999776421 2356788999999999999 99999999
Q ss_pred CCCceeeCCCCceEEecccccccCC
Q 047569 610 KSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 610 kp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7e-18 Score=183.81 Aligned_cols=238 Identities=22% Similarity=0.270 Sum_probs=156.7
Q ss_pred ccceEeecCceeEEEEEEeC----CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEE-------Ee-----cc
Q 047569 486 SSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG-------YC-----DE 549 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~-------~~-----~~ 549 (832)
+.+..+..+++.+...+... ...++-|+....+........+++-.+....|-+..-+.+ .. ..
T Consensus 248 ~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~ 327 (516)
T KOG1033|consen 248 ISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGK 327 (516)
T ss_pred ccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccc
Confidence 34556666666666554332 2334444444333222233334444444444333322222 11 11
Q ss_pred CCcEEEEEEecCCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGK-NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
...+++.|++|+..+|.+||.++ .....++...+.++.|++.+++| ++.+|||+||.||+...+..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 34578999999999999999643 34567888999999999999999 679999999999999999999999999
Q ss_pred ccccCCCCC-----CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHH
Q 047569 629 LSKDAPIGQ-----GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 629 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 702 (832)
+........ ....+...||..||+||++.++.|+.|+||||||++|+||+. -...+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------------- 464 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------------- 464 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------------
Confidence 987665333 223355679999999999999999999999999999999987 221111
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGD 748 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 748 (832)
+.+.+.++-|..+...+..+. ++=..++.+++.+.|.+||++.+
T Consensus 465 -r~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 465 -RIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -HHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 111122222222211111111 12357888999999999994433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.3e-16 Score=159.16 Aligned_cols=130 Identities=28% Similarity=0.415 Sum_probs=105.6
Q ss_pred eEeecCceeEEEEEEeCCcEEEEEecCCCCc--------ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE--------QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.||+|++|.||+|.+ ++..+++|....... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998554321 11356788999999999887655444455566779999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
+|++|.+++..... .++.+++++|.+||+ .+++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743221 789999999999999 9999999999999999 78999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=183.27 Aligned_cols=138 Identities=22% Similarity=0.296 Sum_probs=112.0
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEe-cCCC-C------cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKR-GNPQ-S------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~-~~~~-~------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
...|...+.||+|+||+||+|.+... .+++|+ .... . ....+++.+|++++++++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456688999999999999987544 344443 2111 1 1123568899999999999999988877777778
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++||||++|++|.+++. ....++.+++++|.+||+ .+++||||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999884 457889999999999999 999999999999999 577999999999875
Q ss_pred C
Q 047569 633 A 633 (832)
Q Consensus 633 ~ 633 (832)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.5e-17 Score=186.97 Aligned_cols=208 Identities=25% Similarity=0.358 Sum_probs=147.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
..+|+.+++|..|++|.||..+++ ..+.+|+|. ++.+. +.+- +|.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence 467888999999999999999876 467788853 22210 1110 23333344444
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC--
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-- 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 637 (832)
|+-...+...+ +++... +.+++|||+ .+|+|||+||+|.+|+.-|.+|+.|||+++......
T Consensus 136 ---gDc~tllk~~g--~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG--PLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCC--CCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 44444443222 333322 668999999 999999999999999999999999999987532111
Q ss_pred ------------CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 638 ------------GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 638 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
......++||+.|+|||++..+.|...+|.|++|+++||.+-|+.||.+..+++.....- .
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------s- 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------S- 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------h-
Confidence 011234679999999999999999999999999999999999999999987766432211 0
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRP 744 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 744 (832)
|.....+-......+.++++.+.|+.+|..|-
T Consensus 273 -------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 -------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -------hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 00011111334556789999999999999993
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=159.24 Aligned_cols=191 Identities=18% Similarity=0.218 Sum_probs=135.9
Q ss_pred CCcceeeEEEEecc---------------------------CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHH
Q 047569 536 RHRHLVSLIGYCDE---------------------------NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIG 588 (832)
Q Consensus 536 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ 588 (832)
+|||||++.++|.+ ...+|+||...+ -+|++++..+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999876522 346789998774 68999986543 556677789999
Q ss_pred HHHHHHHHhcCCCCCeeeccCCCCceeeC--CCC--ceEEecccccccCCC-----CCCceeeccccCccccChhccccC
Q 047569 589 SARGLHYLHTGTAQGIIHRDVKSTNILLD--DNY--VAKVSDFGLSKDAPI-----GQGHVSTAVKGSFGYLDPEYFRRQ 659 (832)
Q Consensus 589 ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~ 659 (832)
+++|+.|||. ++|.|||+|++||||. +|+ .+.|+|||++-.... .........-|...-||||.....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999 9999999999999993 443 568899998753321 011111233477889999988643
Q ss_pred C------CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHH
Q 047569 660 Q------LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAE 733 (832)
Q Consensus 660 ~------~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~ 733 (832)
+ --.|+|.|+.|.+.||++...-||...... ..+... .++- -...++..++..+++++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~----------Yqe~----qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT----------YQES----QLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh----------hhhh----hCCCCcccCChHHHHHHH
Confidence 2 125899999999999999999999764221 111111 1111 112234456677999999
Q ss_pred HhhhcCCCCCCCHHH
Q 047569 734 KCLADHGVDRPTMGD 748 (832)
Q Consensus 734 ~cl~~dP~~RPt~~e 748 (832)
..|+.||.+|++..-
T Consensus 492 ~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNI 506 (598)
T ss_pred HHhcCCccccCCccH
Confidence 999999999988543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=139.81 Aligned_cols=135 Identities=19% Similarity=0.228 Sum_probs=115.8
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCC--cceeeEEEEeccCCcEEEEEEecCCC
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH--RHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999998764 7899998765543 5678999999999976 58999999988888999999999988
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 564 PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 564 sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||++..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77544 4567778899999999999985445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5e-14 Score=146.92 Aligned_cols=135 Identities=19% Similarity=0.212 Sum_probs=105.6
Q ss_pred cceEe-ecCceeEEEEEEeCCcEEEEEecCCCC-------------cccHHHHHHHHHHHHhCCCcce--eeEEEEeccC
Q 047569 487 SAIIG-VGGFGNVYLGEIDDGTKVAVKRGNPQS-------------EQGITEFQTEIQMLSKLRHRHL--VSLIGYCDEN 550 (832)
Q Consensus 487 ~~~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~f~~Ei~~L~~l~HpnI--v~l~~~~~~~ 550 (832)
...|| .||.|+||+.... +..++||+..... .....++.+|++++.+|+|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999875 7788998764311 1233568899999999998775 6777765432
Q ss_pred C----cEEEEEEecCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 551 S----EMILVYEYMSN-GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 551 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
. ..++|||+++| .+|.+++... .++.. .+.+++.+|.+||+ .||+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6898887542 34443 35688999999999 999999999999999998899999
Q ss_pred ccccccc
Q 047569 626 DFGLSKD 632 (832)
Q Consensus 626 DFGla~~ 632 (832)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-14 Score=143.23 Aligned_cols=138 Identities=22% Similarity=0.231 Sum_probs=98.9
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcc--cHHH----------------------HHHHHHHHHhCCCc--ce
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ--GITE----------------------FQTEIQMLSKLRHR--HL 540 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------f~~Ei~~L~~l~Hp--nI 540 (832)
.+.||+|+||.||+|...+++.||||+....... .... ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998878999999987653211 1111 13566666666433 34
Q ss_pred eeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC
Q 047569 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY 620 (832)
Q Consensus 541 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 620 (832)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. ..+++||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 455543 245899999998654321111110 11 5678899999999999996 36899999999999999 88
Q ss_pred ceEEecccccccCC
Q 047569 621 VAKVSDFGLSKDAP 634 (832)
Q Consensus 621 ~~kl~DFGla~~~~ 634 (832)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.2e-15 Score=171.94 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=189.4
Q ss_pred cCCCccceEeecCceeEEEEEEe--CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID--DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV 556 (832)
..|.+.+.||+|.|+.|-..... ....+|+|...... .........|..+-..+. |.|++++++...+....++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34666778999999999888653 34566777655443 333344555777777776 99999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeeccCCCCceeeCCCC-ceEEecccccccCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH-TGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAP 634 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 634 (832)
+||.+|+++.+-+........+....-..+.|+..++.|+| . .++.||||||+|.+++..+ ..++.|||++....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999998884333324555667788999999999999 7 8999999999999999999 99999999998776
Q ss_pred C--CCCceeecccc-CccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 635 I--GQGHVSTAVKG-SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 635 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
. +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~------------ 243 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSW------------ 243 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceee------------
Confidence 5 33334445668 9999999999884 556789999999999999999999875543221 11111
Q ss_pred ccCCC--CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 711 IIDPH--LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 711 i~d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
.... ..............++..+++..+|..|.+.+++.
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 244 -KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -cccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 1111 00111223445677888888989999999988874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.9e-13 Score=149.34 Aligned_cols=141 Identities=24% Similarity=0.276 Sum_probs=100.7
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccH----------------------------------------HHHH
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGI----------------------------------------TEFQ 526 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~f~ 526 (832)
.+.||.|++|.||+|++.+|+.||||+.++...+.. -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999766421110 0255
Q ss_pred HHHHHHHhCC----CcceeeEEEEe-ccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHhcCC
Q 047569 527 TEIQMLSKLR----HRHLVSLIGYC-DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR-GLHYLHTGT 600 (832)
Q Consensus 527 ~Ei~~L~~l~----HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~-~L~yLH~~~ 600 (832)
+|++.+.+++ |.+-+.+-..+ ...+..+|||||++|++|.++...... .. ...+++..+++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh--
Confidence 5666666652 32223332222 224567999999999999887643211 12 23456666655 4678888
Q ss_pred CCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 601 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
.|++|+|+||.||+++++++++++|||++....
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.3e-12 Score=139.88 Aligned_cols=246 Identities=20% Similarity=0.193 Sum_probs=178.2
Q ss_pred CCCccceEee--cCceeEEEEEE---eCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEE
Q 047569 483 NFDSSAIIGV--GGFGNVYLGEI---DDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 483 ~f~~~~~LG~--G~fg~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~ 554 (832)
.|.+...+|. |.+|.||.+.. .++..+|+|+-+.. ......+=.+|+.....++ |+|.++.+..+++.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999965 46889999974433 2233333456666666664 999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeeccCCCCceeeCCC-CceEEecccc
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR----GLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGL 629 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~----~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGl 629 (832)
+-.|++ +.+|.++.+.... .++....+....+..+ ||.++|. .+++|-|+||.||++..+ ...+++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 999999 5788888765432 3556667777777777 9999999 999999999999999998 8999999999
Q ss_pred cccCCCCCCc----eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 630 SKDAPIGQGH----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 630 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
........-. ......|...|++||..+ .-++...|+|++|.++.+-.++..+........ |
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W------- 335 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W------- 335 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------c-------
Confidence 8876643311 112225788899999885 456889999999999999998876553321100 1
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
.++-...+..++......++...+..+++.++..|++...+.
T Consensus 336 ---~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 ---SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 000000111222233345666688999999999999877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-11 Score=139.94 Aligned_cols=142 Identities=20% Similarity=0.227 Sum_probs=94.5
Q ss_pred cCCCccceEeecCceeEEEEEEeC-CcEEEEEecCCCCcc----------------------------------cHH---
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQ----------------------------------GIT--- 523 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~--- 523 (832)
..|+. +.||+|++|.||+|++++ |+.||||+.++.-.+ ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45766 789999999999999887 999999998765211 011
Q ss_pred ---HHHHHHHHHHhCC----CcceeeEEEEecc-CCcEEEEEEecCCCChhhhh--ccCCC--CCCCHHHHHHHHHHHHH
Q 047569 524 ---EFQTEIQMLSKLR----HRHLVSLIGYCDE-NSEMILVYEYMSNGPFRDHL--YGKNL--PPLSWKQRLEISIGSAR 591 (832)
Q Consensus 524 ---~f~~Ei~~L~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~--~~l~~~~~l~i~~~ia~ 591 (832)
+|.+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+++.+.- ...+. ..+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2444555555552 3333443333332 45678999999999998742 22211 01222222222333
Q ss_pred HHHHHhcCCCCCeeeccCCCCceeeCCCC----ceEEecccccccCC
Q 047569 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNY----VAKVSDFGLSKDAP 634 (832)
Q Consensus 592 ~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~ 634 (832)
++. .|++|+|+||.||+++.++ +++++|||+.....
T Consensus 276 ----if~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 334 7899999999999999888 99999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-11 Score=119.83 Aligned_cols=131 Identities=17% Similarity=0.108 Sum_probs=96.9
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcce-eeEEEEeccCCcEEEEEEecCCCCh
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL-VSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
.+.|+.|.++.||+++.. ++.+++|....... ....+.+|+++++.+.+.++ .+++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467899999999999875 78899998765432 22356889999999865444 45555543 335899999999887
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT--AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+.. . ....+..+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6431 0 11245678999999999832 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-11 Score=125.05 Aligned_cols=198 Identities=23% Similarity=0.320 Sum_probs=136.7
Q ss_pred HHHhCCCcceeeEEEEecc-----CCcEEEEEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 047569 531 MLSKLRHRHLVSLIGYCDE-----NSEMILVYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603 (832)
Q Consensus 531 ~L~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ 603 (832)
-|-++-|.|||+++.++.+ ..+..++.|||..|+|.++|++. ....+......+|+-||..||.|||++. ..
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 4556679999999998744 45688999999999999999653 3446777888899999999999999854 68
Q ss_pred eeeccCCCCceeeCCCCceEEecccccccC---CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhC
Q 047569 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDA---PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA 680 (832)
Q Consensus 604 ivHrDlkp~NILl~~~~~~kl~DFGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG 680 (832)
|+|+++..+-|++..+|-+|+.--.-.... ............+-++|.+||.=.....+.++|||+||+..+||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998887521110000 00000111122367899999987777888899999999999999877
Q ss_pred CCCC-CCCChh-hhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 681 RPAI-NPQLPR-EQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 681 ~~pf-~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
..-- ...... ...+. ... ..+ -.-..-+.++..|++..|..||+|.+++
T Consensus 279 Eiq~tnseS~~~~ee~i-------------a~~----i~~----len~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENI-------------ANV----IIG----LENGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred eeccCCCcceeehhhhh-------------hhh----eee----ccCccccCcCcccccCCCCCCcchhhhh
Confidence 6321 111100 00000 000 000 0001124567789999999999999886
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.4e-10 Score=126.67 Aligned_cols=167 Identities=17% Similarity=0.197 Sum_probs=126.9
Q ss_pred EEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHH
Q 047569 502 EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ 581 (832)
Q Consensus 502 ~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~ 581 (832)
+..++.+|.|+.....+........+-++.|+.|+||||+++++..+..+..|||.|.+ ..|..++.+.. ...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHH
Confidence 44568888888766665544556778888999999999999999999999999999998 47777775433 456
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCccccChhccccCCC
Q 047569 582 RLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661 (832)
Q Consensus 582 ~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 661 (832)
..-.+.||+.||.+||+ ..+++|++|.-..|+++..|+.||++|-++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 66778999999999986 37899999999999999999999999998765432211 111111122456666543222
Q ss_pred CccccEEechhHHHHHhhC
Q 047569 662 TEKSDVYSFGVVLLEVLCA 680 (832)
Q Consensus 662 ~~~sDV~SlGvvl~elltG 680 (832)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.6e-10 Score=115.71 Aligned_cols=143 Identities=22% Similarity=0.333 Sum_probs=113.0
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCC--cceeeEEEEeccC---CcEEEEEEec
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRH--RHLVSLIGYCDEN---SEMILVYEYM 560 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~ 560 (832)
.+.|+.|..+.||++...+|+.+++|....... ....++.+|+++++.+++ .++.+++.+..+. +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999887778999998765432 235678999999999975 4467788877664 3678999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT---------------------------------------- 600 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~---------------------------------------- 600 (832)
+|.+|.+.+.. ..++..+...++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99998876532 35777888888899999999998521
Q ss_pred -------------CCCeeeccCCCCceeeCC--CCceEEeccccccc
Q 047569 601 -------------AQGIIHRDVKSTNILLDD--NYVAKVSDFGLSKD 632 (832)
Q Consensus 601 -------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 632 (832)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.1e-10 Score=110.87 Aligned_cols=136 Identities=15% Similarity=0.136 Sum_probs=98.3
Q ss_pred cceEeecCceeEEEEEEeC-------CcEEEEEecCCC-------------C---------cccHHHHH----HHHHHHH
Q 047569 487 SAIIGVGGFGNVYLGEIDD-------GTKVAVKRGNPQ-------------S---------EQGITEFQ----TEIQMLS 533 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~-------------~---------~~~~~~f~----~Ei~~L~ 533 (832)
...||.|.-+.||.|...+ +..+|||+.+.. . ....+.+. +|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999996543 479999963221 0 11123344 8999999
Q ss_pred hCC--CcceeeEEEEeccCCcEEEEEEecCCCChhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeeccC
Q 047569 534 KLR--HRHLVSLIGYCDENSEMILVYEYMSNGPFRD-HLYGKNLPPLSWKQRLEISIGSARGLHYL-HTGTAQGIIHRDV 609 (832)
Q Consensus 534 ~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~l~i~~~ia~~L~yL-H~~~~~~ivHrDl 609 (832)
++. .-++.+.+++ ..-+|||||+.+..+.. .+.. ..++..+...+..+++.+|..| |+ .+++|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 995 3456666664 45689999997654422 2211 1344556677889999999998 88 89999999
Q ss_pred CCCceeeCCCCceEEecccccccC
Q 047569 610 KSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 610 kp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++.|||+++ +.+.|+|||.+...
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeC
Confidence 999999974 68999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.1e-10 Score=105.86 Aligned_cols=143 Identities=20% Similarity=0.214 Sum_probs=106.0
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCC--------cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS--------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
...+|-+|+-+.|+++.+. |+...||.-.... .-..++..+|++.|.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999885 7888888533221 112456788999999987545443333444555567899
Q ss_pred EecCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC---ceEEeccccccc
Q 047569 558 EYMSN-GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY---VAKVSDFGLSKD 632 (832)
Q Consensus 558 E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 632 (832)
||++| .++.+++...............++..|-+.+.-||. .+++|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 478888865544344444447889999999999999 9999999999999997554 458999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-10 Score=129.73 Aligned_cols=245 Identities=17% Similarity=0.167 Sum_probs=176.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe--CCcEEEEEecCCCCcccHHH--HHHHHHHHHhC-CCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID--DGTKVAVKRGNPQSEQGITE--FQTEIQMLSKL-RHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~l 555 (832)
+.+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+-+...+ .|.++++....+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888999999999999998543 68899999876654333322 23566666666 49999998887777778889
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-CceEEecccccccCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDAP 634 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~ 634 (832)
-.|||+++++...+ .-...++...++++..|++.++.++|+ ..++|+|+||+||++..+ +..++.|||+.....
T Consensus 344 p~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred chhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999887655 222346777889999999999999998 999999999999999876 788999999886422
Q ss_pred CCCCceeeccccCcccc--ChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 635 IGQGHVSTAVKGSFGYL--DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
- ........-+++ +++......+-.+.|++|||..+.|.+++.+.-.... + ...+.
T Consensus 419 ~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~----------~~~i~ 476 (524)
T KOG0601|consen 419 F----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------Q----------SLTIR 476 (524)
T ss_pred e----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------c----------ceeee
Confidence 1 111112223344 6666677788899999999999999999974321110 0 01111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
...+. ..+.....+..+...++.+++..||.+.++....+
T Consensus 477 ~~~~p--~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 477 SGDTP--NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccccc--CCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111 11233367788888899999999999887765444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-09 Score=104.43 Aligned_cols=131 Identities=26% Similarity=0.367 Sum_probs=98.5
Q ss_pred ceEeecCceeEEEEEEeCCcEEEEEecCCCC--cc------cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS--EQ------GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~------~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
..+++|+-+.+|.+.+. |..+++|.--++. .. ...+-.+|+++|.+++--.|.--+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 4557777432221 11 123467899999998754554444444566778899999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
++|..|.+.+... ...++..+-+-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888544 24567777777889999 9999999999999998774 99999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.7e-08 Score=105.18 Aligned_cols=266 Identities=14% Similarity=0.166 Sum_probs=168.1
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEE------eccCC-cEEEEE
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGY------CDENS-EMILVY 557 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~------~~~~~-~~~lV~ 557 (832)
..+.||+|+-+.+|---.- +-.+.|+.+........+ .+..|... .||-+-.-+.| ..+++ ...+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3678999999999965211 122445554433322222 22334443 56654431221 22233 367888
Q ss_pred EecCCCC-hhhhh----ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 558 EYMSNGP-FRDHL----YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 558 E~~~~gs-L~~~l----~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
..+.+.- ...++ .++..+...|...+++++.++.+.+.||. .|.+-+|++++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 8887653 22222 12345678999999999999999999999 8999999999999999999999998654333
Q ss_pred CCCCCCceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhC-CCCCCCCChhh------hhhHHHHHH
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCA-RPAINPQLPRE------QVNLAEWAM 700 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG-~~pf~~~~~~~------~~~l~~~~~ 700 (832)
. ..+......+|...|.+||.-. +..-+...|.|.||+++++||.| ++||.+-.... ..++..-.-
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2 2344556667999999999764 44567889999999999999887 89997532111 001110000
Q ss_pred HHhhhcccccccCCCCCCCCC-hhHHHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhh
Q 047569 701 QWKRKGLLEKIIDPHLVGTIN-PESLKKFAEAAEKCLADH--GVDRPTMGDVLWNLEYALQLQEAFT 764 (832)
Q Consensus 701 ~~~~~~~~~~i~d~~l~~~~~-~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~~~~~~~~~ 764 (832)
....+.... ..+. ...++ .-.+..+..+..+|+... +.-||+++..+..|..+.+....++
T Consensus 245 ~ya~~~~~g--~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 245 AYASDQRRG--LKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred eechhccCC--CCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 000000000 0111 11122 234567888999999765 4579999999999988777665554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.4e-10 Score=131.59 Aligned_cols=248 Identities=20% Similarity=0.248 Sum_probs=170.4
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
..+.+.+.+-+-+|.++.++.+.-. .|...++|..... .....+....+-.++-..+||-++...--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456677778899999999987543 2333333322111 12222333334334333456777766555556778899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
+++|..+++|...|+... ..+..-.......+..++++||. ..++|+|++|.|++...++..++.|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999986554 45555555566677888999998 6799999999999999999999999984321110
Q ss_pred ------C------------------------CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCC
Q 047569 636 ------G------------------------QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAIN 685 (832)
Q Consensus 636 ------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~ 685 (832)
. .........||+.|.+||...+......+|.|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0011223568999999999999999999999999999999999999998
Q ss_pred CCChhhhhhHHHHHHHHhhhcccccccCCCCC-CCCChhHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 686 PQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV-GTINPESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 686 ~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
...+.... +.+...... ..-+.+......+++.+.+..+|.+|-.+.
T Consensus 1037 a~tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 77654321 122221111 122334566788899999999999996654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.9e-08 Score=107.78 Aligned_cols=212 Identities=15% Similarity=0.198 Sum_probs=147.6
Q ss_pred ceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEec----cCCcEEEEEEecCC-CChhhh
Q 047569 495 FGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD----ENSEMILVYEYMSN-GPFRDH 568 (832)
Q Consensus 495 fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~ 568 (832)
-.+.||+... ||..|++||++....+.......-+++++++.|+|+|++.+++. ....++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999654 89999999995544333333455678899999999999999875 35678999999986 467664
Q ss_pred hccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 569 LYGK-------------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 569 l~~~-------------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
-... .....++..++.++.|+..||.++|+ .|+..+-|.+.+||++.+.+++|...|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4211 12356788999999999999999999 8999999999999999999999999888765432
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
+.. |.+. -.++-|.=.||.+++.|.||..--...+......
T Consensus 446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------------------- 486 (655)
T KOG3741|consen 446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------------------- 486 (655)
T ss_pred CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHH---------------------
Confidence 220 1111 1245677789999999999964211111100000
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
...+....+.++++++.-.....+++ -+..+++
T Consensus 487 -~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 487 -LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred -HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 11233455667777777777777765 4555554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.4e-08 Score=103.53 Aligned_cols=142 Identities=13% Similarity=0.092 Sum_probs=101.7
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcc-----------cHHHHHHHHHHHHhCCCcc--eeeEEEEecc----
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ-----------GITEFQTEIQMLSKLRHRH--LVSLIGYCDE---- 549 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~f~~Ei~~L~~l~Hpn--Iv~l~~~~~~---- 549 (832)
.+.+-.-....|.+... +|+.+.||+....... ....+.+|.+.+.+|..-+ ..+.+++.+.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555555555777766 5789999976443211 1124788999998885333 3344445432
Q ss_pred -CCcEEEEEEecCCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-------CC
Q 047569 550 -NSEMILVYEYMSNG-PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-------NY 620 (832)
Q Consensus 550 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------~~ 620 (832)
....+||+|++++. +|.+++......+.+......++.++++.+.-||+ .||+|+|++++|||++. ++
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999886 89888753222345567778999999999999999 99999999999999975 46
Q ss_pred ceEEeccccccc
Q 047569 621 VAKVSDFGLSKD 632 (832)
Q Consensus 621 ~~kl~DFGla~~ 632 (832)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999997753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.9e-08 Score=95.83 Aligned_cols=125 Identities=27% Similarity=0.308 Sum_probs=82.0
Q ss_pred eEEEEEEeCCcEEEEEecCCCC--------------c------------ccHHHHHHHHHHHHhCCCc--ceeeEEEEec
Q 047569 497 NVYLGEIDDGTKVAVKRGNPQS--------------E------------QGITEFQTEIQMLSKLRHR--HLVSLIGYCD 548 (832)
Q Consensus 497 ~Vy~~~~~~g~~vavK~~~~~~--------------~------------~~~~~f~~Ei~~L~~l~Hp--nIv~l~~~~~ 548 (832)
.||.|...+|..+|||..+... . .......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999633210 0 0123467899999999754 566777653
Q ss_pred cCCcEEEEEEecC--CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 549 ENSEMILVYEYMS--NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHY-LHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 549 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~y-LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|. .|++|+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence 3479999998 65665443221 1123445666777775555 577 899999999999999988 99999
Q ss_pred cccccccC
Q 047569 626 DFGLSKDA 633 (832)
Q Consensus 626 DFGla~~~ 633 (832)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=111.84 Aligned_cols=149 Identities=12% Similarity=0.209 Sum_probs=100.8
Q ss_pred eeeecCCCCCCCCCCCCccccccCCCceeccCCCcceeccCCeeecCCCCCCcccchhhHHhhhccCCCCCCCCCcceeE
Q 047569 199 YRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTW 278 (832)
Q Consensus 199 ~r~n~Gg~~~~~~~D~~~R~W~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~~t~ 278 (832)
++||||+.... ..|..+|.|.+|..+. ........ .. .. +...|+|+|.=.... .-+..|
T Consensus 26 ~~I~CGs~~~~-~~d~~~~~w~~D~~~~--~~~~~~~~-~~-~~-----------~~~~~~t~R~F~~~~----g~~~cY 85 (623)
T PLN03150 26 MRISCGARVNV-RTAPTNTLWYKDFAYT--GGIPANAT-RP-SF-----------IAPPLKTLRYFPLSD----GPENCY 85 (623)
T ss_pred EEEeCCCCCCc-ccCCCCCEEcCCcccc--cCcccccc-Cc-cc-----------ccchhhccccCCccc----ccccce
Confidence 68999988432 2466899999996652 21111111 11 11 455799999966421 124689
Q ss_pred EeccCCCCceEEEEEeeeeee-cccCcEEEEEEEcCeeec---ccCchhhhhcCcCcceEEEEEEEeccccCceEEEEcc
Q 047569 279 TFDVDSTFSYLLRLHFCDIVS-KSLNDLYFNVYVNGKTAI---SALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGP 354 (832)
Q Consensus 279 ~~~~~~~~~Y~v~LhFae~~~-~~~~~R~Fdi~in~~~~~---~~~di~~~~~~~~~~~~~d~~~~~~~~~~gl~~s~~~ 354 (832)
.+|+.++++|+|||||..... .......|||+++|..+. .+++. ....++++++++++ .+.+.+.|.+
T Consensus 86 ~~~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~------~~~~v~~E~i~~~~--~~~l~vcf~~ 157 (623)
T PLN03150 86 NINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSS------HDEQVFAEALVFLT--DGSASICFHS 157 (623)
T ss_pred EeeecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCccc------CCCcEEEEEEEEec--CCcEEEEEec
Confidence 999888999999999998754 223577899999995544 33321 12356789988886 5569999976
Q ss_pred CCCCCCCcccccccceeecccCCCC
Q 047569 355 NKENTGTRNAILNGLEVIKMSNSVN 379 (832)
Q Consensus 355 ~~~~~~~~~~~lng~ei~~ls~~~~ 379 (832)
.. .+ .|++|||||..+..+..
T Consensus 158 ~~--~~--~pFIs~iEv~~l~~~~y 178 (623)
T PLN03150 158 TG--HG--DPAILSIEILQVDDKAY 178 (623)
T ss_pred CC--CC--CCceeEEEEEEcCcccc
Confidence 43 22 68999999999976543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.2e-07 Score=97.15 Aligned_cols=134 Identities=23% Similarity=0.217 Sum_probs=95.7
Q ss_pred CCccceEeecCceeEEEEEEeCCcEEEEEecCCC--------------------C--cccHHHHHHHHHHHHhCCCc--c
Q 047569 484 FDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--------------------S--EQGITEFQTEIQMLSKLRHR--H 539 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--------------------~--~~~~~~f~~Ei~~L~~l~Hp--n 539 (832)
..+...||.|.-+.||.|....|.+++||.-+.. + .-.....++|.++|++|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999942111 0 01123467899999999644 6
Q ss_pred eeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC
Q 047569 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN 619 (832)
Q Consensus 540 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~ 619 (832)
+.+.+++ +.-.+||||++|-.|...-. +....-.++..|++-+.-+-. .|+||+|+++-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence 7777765 56689999999877755431 122233333344444433334 799999999999999999
Q ss_pred CceEEecccccc
Q 047569 620 YVAKVSDFGLSK 631 (832)
Q Consensus 620 ~~~kl~DFGla~ 631 (832)
|.+.++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999997544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.9e-07 Score=90.15 Aligned_cols=139 Identities=19% Similarity=0.153 Sum_probs=105.8
Q ss_pred EeecCceeEEEEEEeCCcEEEEEecCCC---C---cccHHHHHHHHHHHHhCCC--cceeeEEEEecc----CCcEEEEE
Q 047569 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQ---S---EQGITEFQTEIQMLSKLRH--RHLVSLIGYCDE----NSEMILVY 557 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~f~~Ei~~L~~l~H--pnIv~l~~~~~~----~~~~~lV~ 557 (832)
-|+||-+.|++-..+ |..+-+|+-... + +-....|.+|...|.+|.. -.+.+...+... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477999999998775 457999975421 1 3356789999999999953 224455522212 22367999
Q ss_pred EecCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc--eEEeccccccc
Q 047569 558 EYMSN-GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV--AKVSDFGLSKD 632 (832)
Q Consensus 558 E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 632 (832)
|-++| .+|.+++......+.+..++..+..++++.+.-||+ .++.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 588888866555567888889999999999999999 99999999999999986666 99999986653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.7e-08 Score=111.03 Aligned_cols=149 Identities=20% Similarity=0.289 Sum_probs=103.0
Q ss_pred HHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC--------ceeeccccCccccChhcccc
Q 047569 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG--------HVSTAVKGSFGYLDPEYFRR 658 (832)
Q Consensus 587 ~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~ 658 (832)
.+++.||.|+|. ..++||++|.|++|.++..+..||+.|+.+........ .......-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999998 46899999999999999999999999998765432111 11111224567999999999
Q ss_pred CCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhh
Q 047569 659 QQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLA 737 (832)
Q Consensus 659 ~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~ 737 (832)
...+.++|+||+||++|.+.. |+.-+............ .-.+..-...+..+.+.++++-+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHhc
Confidence 888999999999999999994 55444333211111000 0001111112234566778888889999
Q ss_pred cCCCCCCCHHHHH
Q 047569 738 DHGVDRPTMGDVL 750 (832)
Q Consensus 738 ~dP~~RPt~~evl 750 (832)
.++.-||++.++.
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999887765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=7.4e-07 Score=91.00 Aligned_cols=106 Identities=25% Similarity=0.277 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHHhCCC--cceeeEEEEeccC----CcEEEEEEecCCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 522 ITEFQTEIQMLSKLRH--RHLVSLIGYCDEN----SEMILVYEYMSNG-PFRDHLYGKNLPPLSWKQRLEISIGSARGLH 594 (832)
Q Consensus 522 ~~~f~~Ei~~L~~l~H--pnIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~ 594 (832)
..+..+|.+.+.+|.. -...+.+++.+.. ...+||+|++++. +|.+++.... .++......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 3467888888888853 3345566665543 2458999999884 7999886533 2556678899999999999
Q ss_pred HHhcCCCCCeeeccCCCCceeeCCCC---ceEEeccccccc
Q 047569 595 YLHTGTAQGIIHRDVKSTNILLDDNY---VAKVSDFGLSKD 632 (832)
Q Consensus 595 yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 632 (832)
-||+ .||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 9999999999999999887 899999997765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=7.5e-07 Score=101.85 Aligned_cols=140 Identities=20% Similarity=0.250 Sum_probs=94.2
Q ss_pred ceEeecCceeEEEEEEeCCcEEEEEecCCCCcc------------------------------cHH----------HHHH
Q 047569 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ------------------------------GIT----------EFQT 527 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------------------------------~~~----------~f~~ 527 (832)
+.|+.++-|.||+|++++|+.||||+.++.-.+ ..+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999987654211 011 2445
Q ss_pred HHHHHHhCC-----CcceeeEEEEec-cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 047569 528 EIQMLSKLR-----HRHLVSLIGYCD-ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601 (832)
Q Consensus 528 Ei~~L~~l~-----HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~ 601 (832)
|...+.+++ .++ +++=..+. -.+...|+|||++|..+.+....+. ..++.+.+.....++. +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~--- 283 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLR--- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHh---
Confidence 666666552 233 22223332 3467799999999999988753222 2344333333222222 222222
Q ss_pred CCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 602 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
.|++|.|.+|.||+++.+|++.+.|||+.....
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 689999999999999999999999999987654
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1e-06 Score=97.00 Aligned_cols=153 Identities=22% Similarity=0.393 Sum_probs=102.2
Q ss_pred eecCCCCCC--CCCCCCccccccCCCceeccCCCcceeccCCeeecCCCCCCcccchhhHHhhhccCCCCCCCCCcceeE
Q 047569 201 LNMGGPSIT--PQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFNVTW 278 (832)
Q Consensus 201 ~n~Gg~~~~--~~~D~~~R~W~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~~t~ 278 (832)
||||+.... +.||.-+|.|.+|..+.....+. +.....+. .-..+...|+|||.=..+. +..|
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~-~i~~~~~~--------~~~~~~~~y~taR~F~~g~------r~cY 65 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSG-NISSQPDS--------SSSDSSPPYQTARIFPEGS------RNCY 65 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCcc-ccccccCC--------cCCccccccceEEEcCCCC------ccEE
Confidence 689977443 56777899999999885432211 11000000 0012577999999977442 3789
Q ss_pred EeccC--CCCceEEEEEeeeeeeccc------CcEEEEEEEcCeeecccCchhhhhcCcCcceEEEEEEEeccccC-ceE
Q 047569 279 TFDVD--STFSYLLRLHFCDIVSKSL------NDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHN-GLN 349 (832)
Q Consensus 279 ~~~~~--~~~~Y~v~LhFae~~~~~~------~~R~Fdi~in~~~~~~~~di~~~~~~~~~~~~~d~~~~~~~~~~-gl~ 349 (832)
.+|+. .+++|+|||||-=....+. ..-.||++++...+.. .++.. ....++++++++.+. ++ .|.
T Consensus 66 ~l~~~~~~~~~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~t-V~~~~---~~~~~~~~E~ii~v~--~~~~l~ 139 (347)
T PF12819_consen 66 TLPVTPPGGGKYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWST-VNLSN---SPSSPVVKEFIINVT--WSDTLS 139 (347)
T ss_pred EeeccCCCCceEEEEEEeccccccccccccccCCcceEEEECCceeEE-EEecC---CCcceEEEEEEEEEc--CCCcEE
Confidence 99987 5679999999985532221 2456999999987643 22211 112568999999997 54 499
Q ss_pred EEEccCCCCCCCcccccccceeecccCC
Q 047569 350 VQIGPNKENTGTRNAILNGLEVIKMSNS 377 (832)
Q Consensus 350 ~s~~~~~~~~~~~~~~lng~ei~~ls~~ 377 (832)
|.|.+...++ -|++||||+..|...
T Consensus 140 vclv~~~~g~---~pFIsaiEl~~lp~~ 164 (347)
T PF12819_consen 140 VCLVPTGSGT---FPFISAIELRPLPDS 164 (347)
T ss_pred EEEEeCCCCC---CCceeEEEEEECCcc
Confidence 9998877521 389999999999665
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.8e-06 Score=86.18 Aligned_cols=139 Identities=16% Similarity=0.173 Sum_probs=86.8
Q ss_pred ceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc--eeeEEEEeccCCcEEEEEEecCCCC-
Q 047569 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH--LVSLIGYCDENSEMILVYEYMSNGP- 564 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs- 564 (832)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25568889876533 2345688999999986433 4677888877788899999999863
Q ss_pred hhhhh---------------------ccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhcC-CCCCeeeccCC
Q 047569 565 FRDHL---------------------YGKNLPPLSWKQRLE-ISI----------GSAR-GLHYLHTG-TAQGIIHRDVK 610 (832)
Q Consensus 565 L~~~l---------------------~~~~~~~l~~~~~l~-i~~----------~ia~-~L~yLH~~-~~~~ivHrDlk 610 (832)
+.+.+ +.-............ +.. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 111001111111100 000 0011 12222211 12457899999
Q ss_pred CCceeeCCCCceEEeccccccc
Q 047569 611 STNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 611 p~NILl~~~~~~kl~DFGla~~ 632 (832)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999997653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3593 consensus Predicted receptor-like serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3e-07 Score=92.79 Aligned_cols=79 Identities=16% Similarity=0.297 Sum_probs=68.4
Q ss_pred chhhHHhhhccCCCCCCCCCcceeEEeccCCCCceEEEEEeeeeeecccCcEEEEEEEc-CeeecccCchhhhhcCcCcc
Q 047569 254 PATVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVN-GKTAISALDLSTVAQGLATP 332 (832)
Q Consensus 254 P~~vy~ta~~~~~~~~~~~~~~~t~~~~~~~~~~Y~v~LhFae~~~~~~~~R~Fdi~in-~~~~~~~~di~~~~~~~~~~ 332 (832)
...+|||+|..... |.|..|.+..|.|-+.|.|||++|+..+..+|||-+| ++.+.+++||+...|+.+++
T Consensus 107 d~ily~ter~neet--------Fgyd~pik~dgdyalvlkfaevyF~~~q~kvfdvrln~sh~vVk~ldi~~~vg~rg~A 178 (355)
T KOG3593|consen 107 DIILYQTERYNEET--------FGYDVPIKEDGDYALVLKFAEVYFKTCQHKVFDVRLNCSHCVVKALDIFDQVGDRGKA 178 (355)
T ss_pred hhhhhhhcccchhh--------hcccccccCCCceehhhhHHHHHHHhhhhhheeeeeccceeEEeccchhhhcCCCccc
Confidence 56799999997544 8899999999999999999999999999999999999 99999999999998866665
Q ss_pred eEEEEEEEec
Q 047569 333 YYRDIVVNAS 342 (832)
Q Consensus 333 ~~~d~~~~~~ 342 (832)
.|-.++..
T Consensus 179 --hDe~i~~~ 186 (355)
T KOG3593|consen 179 --HDEIIPCL 186 (355)
T ss_pred --ccceEEEE
Confidence 35555544
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.7e-07 Score=90.24 Aligned_cols=127 Identities=20% Similarity=0.340 Sum_probs=63.5
Q ss_pred EEEccCCCCCCCCCCCCceeccCCC--Cc--ccccc----CccccccCCCC-CCCCcccccccccCCCeEEEeeccCCce
Q 047569 36 FLIDCGGKSSNPLPDGRTFKSDKEA--LP--FLQTK----EDIQVSVPSAD-VPSPIYLSARVFKEESTYTFQLNQPGWH 106 (832)
Q Consensus 36 ~~i~CG~~~~~~~~~~~~~~~~~~~--~~--~~~~g----~~~~~~~~~~~-~~~~~~~t~R~f~~~~~~cy~l~~~g~~ 106 (832)
|+||||+... ++.++.+|.+|..- +. |.... .......+-.+ ..+++|+|.|.=+..++|.+++ .+...
T Consensus 3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~-~~~G~ 80 (174)
T PF11721_consen 3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPV-VPNGT 80 (174)
T ss_dssp EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE---S-EE
T ss_pred EEEECCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEec-CCCcE
Confidence 7899999766 66789999999332 11 11110 00001111111 1125799999855554555553 45555
Q ss_pred E-EEEEe------------------ecCCCCccc-ccceeeeeec---C-ceEEEE-EEeecCCeEEEEEEe--------
Q 047569 107 W-VRLHF------------------FALPAKEAD-LQKASFHVAT---D-NCCEEF-MLNLTESTFSIKFTP-------- 153 (832)
Q Consensus 107 ~-vR~~f------------------f~~~~~~~~-~~~~~~~~~~---~-~~~~E~-i~~~~~~~~~vc~~~-------- 153 (832)
| ||||| ||+.+.+.. ....++.... . ..++++ -+.+.++.|.|+|..
T Consensus 81 Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~i 160 (174)
T PF11721_consen 81 YTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTLCI 160 (174)
T ss_dssp EEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEEEE
T ss_pred EEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcEEe
Confidence 7 99999 666666521 1111111111 1 245566 456788999999995
Q ss_pred ---CCCCceeeeee
Q 047569 154 ---MKNSVAFINAI 164 (832)
Q Consensus 154 ---~~~~~pFi~~i 164 (832)
...+.|.||||
T Consensus 161 ~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 161 PFIGSYGNPLISAI 174 (174)
T ss_dssp EEESSSSSSSEEEE
T ss_pred eccccCCCcEEeeC
Confidence 33566888876
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.7e-06 Score=81.75 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=91.0
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHH---------HHHHHHHhCCC---cceeeEEEEe-
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQ---------TEIQMLSKLRH---RHLVSLIGYC- 547 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~---------~Ei~~L~~l~H---pnIv~l~~~~- 547 (832)
.++|...+++-.....-|.+-.. +|+.+++|..+.......+.|. +++..+.+++. -....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46788888887777666666655 4799999987765433333332 33443444432 2222323222
Q ss_pred ----ccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceE
Q 047569 548 ----DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623 (832)
Q Consensus 548 ----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 623 (832)
.-....+|+|||++|..|.+... ++. .+...+.+++.-||+ .|++|+|.+|.|++++++ .++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEE
Confidence 22345679999999998876542 222 244556778899999 999999999999999966 499
Q ss_pred Eeccccccc
Q 047569 624 VSDFGLSKD 632 (832)
Q Consensus 624 l~DFGla~~ 632 (832)
++||+.-+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=81.44 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=85.5
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc--ceeeEEEEe---ccCCcEEEEEEecC
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR--HLVSLIGYC---DENSEMILVYEYMS 561 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp--nIv~l~~~~---~~~~~~~lV~E~~~ 561 (832)
++.|+.|..+.||+....+ +.+++|..... .....+.+|..+++.|... .+.+++.++ ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999876 69999986544 4456788899999888522 355666644 23345789999999
Q ss_pred CCChhh----------------hh---ccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc
Q 047569 562 NGPFRD----------------HL---YGK--NLPPLSWKQ---------RLEI------------SIGSAR-GLHYLHT 598 (832)
Q Consensus 562 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~l~i------------~~~ia~-~L~yLH~ 598 (832)
|.++.. .+ +.. ...++.... .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 11 111 111111111 0000 011222 2333332
Q ss_pred ----CCCCCeeeccCCCCceeeC-CCCceEEecccccc
Q 047569 599 ----GTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSK 631 (832)
Q Consensus 599 ----~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~ 631 (832)
.....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2346799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.6e-05 Score=83.44 Aligned_cols=139 Identities=17% Similarity=0.156 Sum_probs=86.4
Q ss_pred eEeecCc-eeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEecCCCChh
Q 047569 489 IIGVGGF-GNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYMSNGPFR 566 (832)
Q Consensus 489 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 566 (832)
.|-.|.. ..||+...+ +..+++|+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 789999765 4788999875443 345678999988884 444667888887777789999999998876
Q ss_pred hhh-------------------ccCCC--CCCC--HHHHHHHHH--------------------HHHHHHHHHhc----C
Q 047569 567 DHL-------------------YGKNL--PPLS--WKQRLEISI--------------------GSARGLHYLHT----G 599 (832)
Q Consensus 567 ~~l-------------------~~~~~--~~l~--~~~~l~i~~--------------------~ia~~L~yLH~----~ 599 (832)
+.. +.... .++. ....+.... .+.+.++.|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11100 0111 001110000 01111222211 1
Q ss_pred CCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 600 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
....++|+|+.|.|||+++++...|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12458999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.4e-05 Score=77.18 Aligned_cols=152 Identities=20% Similarity=0.255 Sum_probs=99.1
Q ss_pred cCHHHHHHHhcCCCccce---EeecCceeEEEEEEeCCcEEEEEecCCCCcc-------------------cHH-----H
Q 047569 472 FSFQELQEATKNFDSSAI---IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ-------------------GIT-----E 524 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~---LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~-----~ 524 (832)
.+++.+.....+..+... |.+|..+.||+|...++..+|+|+....... ..+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 456666666666666555 5567778899998888999999975432110 111 1
Q ss_pred HHHHHHHHHhCC--CcceeeEEEEeccCCcEEEEEEecCCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 047569 525 FQTEIQMLSKLR--HRHLVSLIGYCDENSEMILVYEYMSNGPF-RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601 (832)
Q Consensus 525 f~~Ei~~L~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~ 601 (832)
...|..-|.++. +-.+.+-+++. .-.|||||+...-+ .-.|..- ++...+...+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--h
Confidence 345777777773 44445555543 33799999954311 1122111 22333566666777777776643 2
Q ss_pred CCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 602 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
.++||+||+.-|||+. ++.+.|+|||-+...
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 6899999999999999 779999999977654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=7e-07 Score=100.35 Aligned_cols=186 Identities=17% Similarity=0.101 Sum_probs=133.8
Q ss_pred CCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc-eeeEEEEeccCCcEEEEEEecCC
Q 047569 484 FDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH-LVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+....-+++|+++.++|.+--..+....+..... ....-++++|.+++||| .+..++-++.+...+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3334557899999999986543344445543322 33456889999999999 77777778888899999999987
Q ss_pred C-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 563 G-PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 563 g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+ +-..... .....+...+...+++.-.++|++||+ ..-+|+| ||+..+ +..|..||+....+.... ..
T Consensus 319 ~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 319 GRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred CccccccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 7 2211111 011123344555667777889999998 4458888 777766 589999999887665332 34
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAIN 685 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~ 685 (832)
....+++.+++||+.....+..+.|+|++|+--.++--|-+|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 55679999999999999999999999999998778877776643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.4e-05 Score=87.21 Aligned_cols=140 Identities=20% Similarity=0.212 Sum_probs=91.1
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcc-------------------------------cH------HHHHHHH
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ-------------------------------GI------TEFQTEI 529 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-------------------------------~~------~~f~~Ei 529 (832)
.+.||.-+.|.||+|++++|+.||||+-++.-++ .. -+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4679999999999999999999999986654211 00 1255566
Q ss_pred HHHHhC----CCcc------eeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 047569 530 QMLSKL----RHRH------LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599 (832)
Q Consensus 530 ~~L~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~ 599 (832)
+-..+. .|-+ |.+++-. -.....|+||||+|..+.+.-.-... .++...+.. .+.++ |++..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~---~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILN---KLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHH---HHHHH--HHHHH
Confidence 555444 3544 3333322 23567999999999988775422211 244443333 33322 22222
Q ss_pred CCCCeeeccCCCCceeeCC----CCceEEecccccccCC
Q 047569 600 TAQGIIHRDVKSTNILLDD----NYVAKVSDFGLSKDAP 634 (832)
Q Consensus 600 ~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~ 634 (832)
...|++|+|=+|.||+++. ++.+.+.|||+.....
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2268999999999999983 6789999999987653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=90.33 Aligned_cols=79 Identities=20% Similarity=0.404 Sum_probs=59.3
Q ss_pred cceEeecCceeEEEEEEeCC---cEEEEEecCCCC-cccHHHHHHHHHHHHhCC-Ccce--eeEEEEeccC---CcEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDDG---TKVAVKRGNPQS-EQGITEFQTEIQMLSKLR-HRHL--VSLIGYCDEN---SEMILV 556 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~-HpnI--v~l~~~~~~~---~~~~lV 556 (832)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 66788999999999876654 467888754432 223457889999999995 6665 7888888764 567899
Q ss_pred EEecCCCCh
Q 047569 557 YEYMSNGPF 565 (832)
Q Consensus 557 ~E~~~~gsL 565 (832)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=7.8e-05 Score=77.79 Aligned_cols=74 Identities=15% Similarity=0.197 Sum_probs=48.6
Q ss_pred cceEeecCcee-EEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc---ceeeEEEEeccC---CcEEEEEEe
Q 047569 487 SAIIGVGGFGN-VYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR---HLVSLIGYCDEN---SEMILVYEY 559 (832)
Q Consensus 487 ~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp---nIv~l~~~~~~~---~~~~lV~E~ 559 (832)
++.|+.||... ||+. +..+++|..... ....++.+|.++|..|... -+.++++.+... ...+++||+
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 35678787764 8976 245778875432 2345788999999888532 344555544332 245899999
Q ss_pred cCCCChh
Q 047569 560 MSNGPFR 566 (832)
Q Consensus 560 ~~~gsL~ 566 (832)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=5.6e-05 Score=75.74 Aligned_cols=103 Identities=22% Similarity=0.262 Sum_probs=82.3
Q ss_pred HHHHHHHHhCCC-cceeeEEEEeccCCcEEEEEEecCCCChhhhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 047569 526 QTEIQMLSKLRH-RHLVSLIGYCDENSEMILVYEYMSNGPFRDHL-YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603 (832)
Q Consensus 526 ~~Ei~~L~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l-~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ 603 (832)
..|.-+|+.+++ +++.+++|+|.. ++|.||...+++...- .-......+|.++.+|+.++++.+++|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 699999999943 6799999877654210 0011125689999999999999999999866666
Q ss_pred eeeccCCCCceeeCCCCceEEeccccccc
Q 047569 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 604 ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
+.-.|++++|+-+++++++|++|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999986654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.8e-05 Score=71.97 Aligned_cols=128 Identities=22% Similarity=0.272 Sum_probs=89.4
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCccee-eEEEEeccCCcEEEEEEecCCCC
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV-SLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
..+.|++|.+|.||+|.+. |..+|+|+-+..+. ...+..|+++|..+.-.++- +++.+..+ ++.|||++|-+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 4678999999999999986 56888987654443 46789999999999866654 56665443 34599999988
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC-CCceeeCCCCceEEeccccccc
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVK-STNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlk-p~NILl~~~~~~kl~DFGla~~ 632 (832)
|.++-... +-++.+ .+++.---|.. .||-|+.|. |...+|..++.+.|+||.-+..
T Consensus 99 L~~~~~~~-----~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-----DRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-----cHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87765321 222333 33344233444 789999987 5555555555999999998774
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00034 Score=75.69 Aligned_cols=77 Identities=13% Similarity=0.052 Sum_probs=57.9
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCC---cceeeEEEEecc---CCcEEEEEEe
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH---RHLVSLIGYCDE---NSEMILVYEY 559 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H---pnIv~l~~~~~~---~~~~~lV~E~ 559 (832)
..+.||.|..+.||+....++ .+++|..+.. .....|.+|.+.|+.|.. -.+.+++++|.. .+..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 366799999999999976655 4667764321 123578999999999852 467888888754 3678999999
Q ss_pred cCCCCh
Q 047569 560 MSNGPF 565 (832)
Q Consensus 560 ~~~gsL 565 (832)
++|+++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0004 Score=69.96 Aligned_cols=130 Identities=22% Similarity=0.310 Sum_probs=91.0
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCC----------------cccHHHHHHHHHHHHhCC------CcceeeEE
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS----------------EQGITEFQTEIQMLSKLR------HRHLVSLI 544 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~f~~Ei~~L~~l~------HpnIv~l~ 544 (832)
...||+|+.-.||.- .+.....||+..... ....++..+|+.-..++. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 567999999999864 334556777665544 223566777877766665 88999999
Q ss_pred EEeccCCcEEEEEEecCC------CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC
Q 047569 545 GYCDENSEMILVYEYMSN------GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618 (832)
Q Consensus 545 ~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 618 (832)
|+.+.+....+|+|.+.+ -+|.+++.... ++. ...+.+.+ -.+||-+ ..|+.+||+|.||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~---f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDE---FKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHH---HHHHHHH---cCCeecCCCcccEEEEe
Confidence 999999999999999754 25777774332 444 33333333 3456666 78999999999999953
Q ss_pred C--C--ceEEec-cc
Q 047569 619 N--Y--VAKVSD-FG 628 (832)
Q Consensus 619 ~--~--~~kl~D-FG 628 (832)
. + .+.|+| ||
T Consensus 154 ~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLG 168 (199)
T ss_pred cCCCceEEEEEeCCC
Confidence 2 2 466666 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00044 Score=72.00 Aligned_cols=74 Identities=15% Similarity=0.120 Sum_probs=49.8
Q ss_pred cceEeecCceeEEEEEEeC--CcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEecCCC
Q 047569 487 SAIIGVGGFGNVYLGEIDD--GTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
.+.|..|-...+|+....+ ++.+++|+........ -.-.+|+.+++.+. +.-..++++.+.. .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence 4567777788999997664 6789999866543221 22357888888885 3334455554432 4899999987
Q ss_pred Ch
Q 047569 564 PF 565 (832)
Q Consensus 564 sL 565 (832)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 76
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00039 Score=73.52 Aligned_cols=137 Identities=20% Similarity=0.166 Sum_probs=79.0
Q ss_pred EeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcce-eeEEEEeccCCcEEEEEEecCCCChhhh
Q 047569 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL-VSLIGYCDENSEMILVYEYMSNGPFRDH 568 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~~~ 568 (832)
+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++..+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45566778998874 577888997654432221235789999998863323 34454432 3689999998765421
Q ss_pred -----------------hccCC--CCCCCHHHHH-HHHHH---------HHHHHHHHhc-----CCCCCeeeccCCCCce
Q 047569 569 -----------------LYGKN--LPPLSWKQRL-EISIG---------SARGLHYLHT-----GTAQGIIHRDVKSTNI 614 (832)
Q Consensus 569 -----------------l~~~~--~~~l~~~~~l-~i~~~---------ia~~L~yLH~-----~~~~~ivHrDlkp~NI 614 (832)
|+... ..+++....+ ....+ +.+.+..+-. ..+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 1122222111 11111 1111222211 1124689999999999
Q ss_pred eeCCCCceEEeccccccc
Q 047569 615 LLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 615 Ll~~~~~~kl~DFGla~~ 632 (832)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00065 Score=67.94 Aligned_cols=125 Identities=29% Similarity=0.372 Sum_probs=89.6
Q ss_pred cCCCccceEeecCc-eeEEEEEEeCCcEEEEEecCC---CC---------c---------ccHHHHHHHHHHHHhCC---
Q 047569 482 KNFDSSAIIGVGGF-GNVYLGEIDDGTKVAVKRGNP---QS---------E---------QGITEFQTEIQMLSKLR--- 536 (832)
Q Consensus 482 ~~f~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~~~~---~~---------~---------~~~~~f~~Ei~~L~~l~--- 536 (832)
.+++..+.||.|.- |.||++++. |+.+|+|.+.. .. . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999985 78999998221 10 0 11235888999888874
Q ss_pred Ccce--eeEEEEecc------------------CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 047569 537 HRHL--VSLIGYCDE------------------NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596 (832)
Q Consensus 537 HpnI--v~l~~~~~~------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yL 596 (832)
+.++ |+++||..- .....+|.||++... .+.. +-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence 5566 899998711 112457888775432 1222 2345566678889
Q ss_pred hcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 597 H~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
|. .+|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 98 99999999999986 4589999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00067 Score=73.34 Aligned_cols=142 Identities=19% Similarity=0.207 Sum_probs=85.5
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc--ceeeEEEE------eccCCcEEEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR--HLVSLIGY------CDENSEMILVYE 558 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp--nIv~l~~~------~~~~~~~~lV~E 558 (832)
.+.|..|....+|+....+ ..+++|+... ....+...|++++..|.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4557777778999987654 4788898764 2335667788888888432 24444432 123456789999
Q ss_pred ecCCCChhh----hh----------cc--CC--C-----CCCCHHHHH----------HHHHHHHHHHHHHhc----CCC
Q 047569 559 YMSNGPFRD----HL----------YG--KN--L-----PPLSWKQRL----------EISIGSARGLHYLHT----GTA 601 (832)
Q Consensus 559 ~~~~gsL~~----~l----------~~--~~--~-----~~l~~~~~l----------~i~~~ia~~L~yLH~----~~~ 601 (832)
+++|..+.. .+ +. .. . ....|.... .....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 00 10 00 0 011222111 011112333444442 224
Q ss_pred CCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 602 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 6799999999999999987778999997653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0014 Score=71.66 Aligned_cols=157 Identities=16% Similarity=0.207 Sum_probs=85.7
Q ss_pred cCHHHHHHHhcCCCc-----cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc--ceeeEE
Q 047569 472 FSFQELQEATKNFDS-----SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR--HLVSLI 544 (832)
Q Consensus 472 ~~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp--nIv~l~ 544 (832)
++.+++......|.+ .+.|+.|....+|+.+.++| .+++|+..... .+....|++++..|... .+.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence 345555555555644 34466777788999887655 68889865222 23344455666655311 123333
Q ss_pred E------EeccCCcEEEEEEecCCCChhh-----------hh---cc--CC-------CCCCCH-HHHHHH---------
Q 047569 545 G------YCDENSEMILVYEYMSNGPFRD-----------HL---YG--KN-------LPPLSW-KQRLEI--------- 585 (832)
Q Consensus 545 ~------~~~~~~~~~lV~E~~~~gsL~~-----------~l---~~--~~-------~~~l~~-~~~l~i--------- 585 (832)
. +....+..++++||++|..+.. .| +. .. ...+.| .+...-
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1223566799999999875421 11 11 00 001112 111111
Q ss_pred ---HHH-HHHHHHHHhc----CCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 586 ---SIG-SARGLHYLHT----GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 586 ---~~~-ia~~L~yLH~----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
..+ +...++.+.. ..+.+++|+|+++.|||++++...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 111 1112222221 1346899999999999999765568999997653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0029 Score=68.88 Aligned_cols=155 Identities=18% Similarity=0.212 Sum_probs=89.4
Q ss_pred HHHHHHHhcCCCc-----cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc--ceeeEEEE
Q 047569 474 FQELQEATKNFDS-----SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR--HLVSLIGY 546 (832)
Q Consensus 474 ~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp--nIv~l~~~ 546 (832)
-++|....++|.+ .+.++.|....+|+.+.++| .+++|+.+... ..++...|++++..|... .+.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 4555555555544 34566676688999876555 57788765432 134456677777777422 23444432
Q ss_pred e------ccCCcEEEEEEecCCCChhh-----------h---hcc--CCC--C------CCCHHHHHH------------
Q 047569 547 C------DENSEMILVYEYMSNGPFRD-----------H---LYG--KNL--P------PLSWKQRLE------------ 584 (832)
Q Consensus 547 ~------~~~~~~~lV~E~~~~gsL~~-----------~---l~~--~~~--~------~l~~~~~l~------------ 584 (832)
. ...+..++++||++|..+.. . ++. .+. . .-.|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 1 23456789999999865421 1 111 000 0 011211110
Q ss_pred HHHHHHHHHHHHhc----CCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 585 ISIGSARGLHYLHT----GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 585 i~~~ia~~L~yLH~----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
....+.+.++++.. ..+.+++|+|+++.||++++++...|+||+.+.
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 01123334555532 235789999999999999988777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0015 Score=70.95 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=83.7
Q ss_pred ceEeecCceeEEEEEEeC-------CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc-eeeEEEEeccCCcEEEEEEe
Q 047569 488 AIIGVGGFGNVYLGEIDD-------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH-LVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~ 559 (832)
+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456556667899987654 57899998665432 2234578888888885322 3456666542 368999
Q ss_pred cCCCChhhh-h----------------ccCCCC-------CCC--HHHHHH--------------------------HHH
Q 047569 560 MSNGPFRDH-L----------------YGKNLP-------PLS--WKQRLE--------------------------ISI 587 (832)
Q Consensus 560 ~~~gsL~~~-l----------------~~~~~~-------~l~--~~~~l~--------------------------i~~ 587 (832)
++|.++... + |..... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 1 111110 011 111111 011
Q ss_pred HHHHHHHHHhc------CCCCCeeeccCCCCceeeCCC----CceEEeccccccc
Q 047569 588 GSARGLHYLHT------GTAQGIIHRDVKSTNILLDDN----YVAKVSDFGLSKD 632 (832)
Q Consensus 588 ~ia~~L~yLH~------~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 632 (832)
.+.+-+..|.. ..+..++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 12222333431 244679999999999999974 8899999997653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0032 Score=70.32 Aligned_cols=76 Identities=21% Similarity=0.225 Sum_probs=56.2
Q ss_pred cceEeecCceeEEEEEEeCC-cEEEEEecCCC------C-cccHHHHHHHHHHHHhCC---CcceeeEEEEeccCCcEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDDG-TKVAVKRGNPQ------S-EQGITEFQTEIQMLSKLR---HRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~------~-~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~~~~~l 555 (832)
.+.||.|.+..||+....+| +.++||.-.+. . +-..+++..|.+.|+.+. ..++.+++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 45789999999999998776 58999974422 1 224567888999988873 346777887743 55789
Q ss_pred EEEecCCCC
Q 047569 556 VYEYMSNGP 564 (832)
Q Consensus 556 V~E~~~~gs 564 (832)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.00072 Score=81.75 Aligned_cols=195 Identities=20% Similarity=0.223 Sum_probs=132.9
Q ss_pred HHHHHHHHHHhCCCcceeeEEEEeccCCcE----EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 047569 524 EFQTEIQMLSKLRHRHLVSLIGYCDENSEM----ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599 (832)
Q Consensus 524 ~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~ 599 (832)
...-|++.+..+.|+|++.++.|..++... .+..|++..-++...+.... ..+....+.+..++.+||+|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH-
Confidence 344577778888999999999987654333 34567788888888875443 67788899999999999999999
Q ss_pred CCCCeeeccCCCC---ceeeCCCCceEEe--cccccccCCCCCCceeeccccCccccChhccccCCCCc--cccEEechh
Q 047569 600 TAQGIIHRDVKST---NILLDDNYVAKVS--DFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE--KSDVYSFGV 672 (832)
Q Consensus 600 ~~~~ivHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDV~SlGv 672 (832)
..+.|.-|..+ +.-.+.++...++ ||+.+.......... ...-+..+.++|......++. ..|+|.+|.
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 55555555444 4455666677777 898887665332221 222345677888776665554 479999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 673 VLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 673 vl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+..+..|..+-.... ....+++. .....+.+...+|+..+.++|++..+++.
T Consensus 381 l~~~~~~~~~i~~~~~------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHhhhhhcCccccccc------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999998875421110 00111110 11115677888999999999999988864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0007 Score=71.32 Aligned_cols=133 Identities=19% Similarity=0.191 Sum_probs=92.3
Q ss_pred CCCccceEeecCceeEEEEEEeCCcEEEEEecCC--C-------C--------c-c--c--HHHHHHHHHHHHhCC-Cc-
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNP--Q-------S--------E-Q--G--ITEFQTEIQMLSKLR-HR- 538 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~-------~--------~-~--~--~~~f~~Ei~~L~~l~-Hp- 538 (832)
-+.+.++||-|.-+.||.+-..+|++.++|.-+- . . . . . +-...+|...|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3677899999999999999998999999984111 0 0 0 0 0 112456888888884 32
Q ss_pred ceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC
Q 047569 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618 (832)
Q Consensus 539 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 618 (832)
-+.+.+++ +.-++|||++.|-+|.+.-+-.. ..++..-+. .-+.-|.. +|+||+|..-=||++++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d-----~~~ly~~lm---~~Iv~la~---~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVED-----PPTLYDDLM---GLIVRLAN---HGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCC-----hHHHHHHHH---HHHHHHHH---cCceecccchheeEEec
Confidence 24455544 46689999999999876553232 233333222 22344555 89999999999999999
Q ss_pred CCceEEeccccc
Q 047569 619 NYVAKVSDFGLS 630 (832)
Q Consensus 619 ~~~~kl~DFGla 630 (832)
++.++++||--.
T Consensus 238 d~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 DDKIVVIDFPQM 249 (465)
T ss_pred CCCEEEeechHh
Confidence 999999999644
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0086 Score=66.20 Aligned_cols=140 Identities=16% Similarity=0.208 Sum_probs=82.6
Q ss_pred ceEeecCceeEEEEEEeC-----CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcce-eeEEEEeccCCcEEEEEEecC
Q 047569 488 AIIGVGGFGNVYLGEIDD-----GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL-VSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 561 (832)
..|-.|-.-.+|+....+ ++.+++|+..........+ .+|..+++.+..-++ .++++.+... .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345446667889886532 3689999877655444443 679999988854333 3556665432 5899998
Q ss_pred CCChhhh-----------------hccCCC---C-CCCHHHHHHHHHHH-----------------HHHHHHH----hc-
Q 047569 562 NGPFRDH-----------------LYGKNL---P-PLSWKQRLEISIGS-----------------ARGLHYL----HT- 598 (832)
Q Consensus 562 ~gsL~~~-----------------l~~~~~---~-~l~~~~~l~i~~~i-----------------a~~L~yL----H~- 598 (832)
+.+|... +|.... . ...+.+..++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 111110 0 11123322322111 1112222 21
Q ss_pred CCCCCeeeccCCCCceeeCC-CCceEEeccccccc
Q 047569 599 GTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKD 632 (832)
Q Consensus 599 ~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 632 (832)
..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22357899999999999986 46899999987654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0098 Score=63.55 Aligned_cols=31 Identities=23% Similarity=0.396 Sum_probs=25.5
Q ss_pred CCeeeccCCCCceeeCCCCc-eEEeccccccc
Q 047569 602 QGIIHRDVKSTNILLDDNYV-AKVSDFGLSKD 632 (832)
Q Consensus 602 ~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 632 (832)
..++|+|+++.|||++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0069 Score=64.85 Aligned_cols=74 Identities=23% Similarity=0.356 Sum_probs=49.5
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC---CcceeeEEEEeccCCcEEEEEEecCC
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR---HRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
..+.|+.|....+|+.+ .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+|||||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 35678888899999987 568899999854 333457889999998883 45577889888777778999999987
Q ss_pred C
Q 047569 563 G 563 (832)
Q Consensus 563 g 563 (832)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.02 Score=61.88 Aligned_cols=134 Identities=16% Similarity=0.256 Sum_probs=78.9
Q ss_pred ecCce-eEEEEEEeCCcEEEEEecC-CCCcccHHHHHHHHHHHHhCC--CcceeeEEEEeccCC--cEEEEEEecCCCCh
Q 047569 492 VGGFG-NVYLGEIDDGTKVAVKRGN-PQSEQGITEFQTEIQMLSKLR--HRHLVSLIGYCDENS--EMILVYEYMSNGPF 565 (832)
Q Consensus 492 ~G~fg-~Vy~~~~~~g~~vavK~~~-~~~~~~~~~f~~Ei~~L~~l~--HpnIv~l~~~~~~~~--~~~lV~E~~~~gsL 565 (832)
+||++ .+|..... ++++++.+-. ...........+|.++|+.+. ---+...+++|.++. ..+.||+|++|..+
T Consensus 34 ~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 34 SGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred cCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 34443 33444332 7788887321 122233455677888888774 233456677776665 78999999998543
Q ss_pred hhhhccCCCCCCCHHHHHHHH-HHHHHHH--------------------------------------------------H
Q 047569 566 RDHLYGKNLPPLSWKQRLEIS-IGSARGL--------------------------------------------------H 594 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~-~~ia~~L--------------------------------------------------~ 594 (832)
.+.+.... .. .+.+ ..+++.| .
T Consensus 113 ~~~~~~~~-----~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 113 WSALPPES-----LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred cCcCCccc-----ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 32221100 00 0111 1223333 3
Q ss_pred HHhcC-----CCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 595 YLHTG-----TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 595 yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
+|+.. ....++|+|+++.||++++++-+-|.||+++...
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 33321 2345999999999999998888999999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.00022 Score=87.56 Aligned_cols=162 Identities=15% Similarity=0.004 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHhCCCcceeeEEEEec--cCCcEEEEEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHh
Q 047569 522 ITEFQTEIQMLSKLRHRHLVSLIGYCD--ENSEMILVYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLH 597 (832)
Q Consensus 522 ~~~f~~Ei~~L~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH 597 (832)
.+....|...++...|+++.....-.. +..+.+.+++|+.+|.+.+.|.+. ..+.+...-+.....+......-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 344555666677778999988877654 345678999999999999988543 2233444444444444355555555
Q ss_pred cCC--CCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHH
Q 047569 598 TGT--AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLL 675 (832)
Q Consensus 598 ~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ 675 (832)
+.. ..-.+|++||+-|.+|..+.++|+.++|+.+.... .........+++.|+.|++...-.++.++|+|..|+.+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 422 24479999999999999999999999999983322 122223445788999999999999999999999999999
Q ss_pred HHhhCCCCC
Q 047569 676 EVLCARPAI 684 (832)
Q Consensus 676 elltG~~pf 684 (832)
++-.|.++|
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998887665
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.061 Score=60.05 Aligned_cols=73 Identities=15% Similarity=0.186 Sum_probs=51.3
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCC----Cc---ccHHHHHHHHHHHHhCC---CcceeeEEEEeccCCcEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ----SE---QGITEFQTEIQMLSKLR---HRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~---~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~~~~~lV 556 (832)
.+.||-|....||+.... ++.++||+-... .. -...+-..|.+.|+.+. ..++.+++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 567899999999998764 567999975421 11 13344455677777664 3578889998874 46788
Q ss_pred EEecCC
Q 047569 557 YEYMSN 562 (832)
Q Consensus 557 ~E~~~~ 562 (832)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.046 Score=59.92 Aligned_cols=72 Identities=17% Similarity=0.204 Sum_probs=48.3
Q ss_pred eEeecCceeEEEEEEeCC-cEEEEEecCC-------CCcccHHHHHHHHHHHHhCC--Cc-ceeeEEEEeccCCcEEEEE
Q 047569 489 IIGVGGFGNVYLGEIDDG-TKVAVKRGNP-------QSEQGITEFQTEIQMLSKLR--HR-HLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~f~~Ei~~L~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 557 (832)
.||-|....||++...+| +.|+||.-.+ .-+-...+..-|.+.|+... .| ++.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 468899999999987654 6899995322 11334556667888887763 35 45556554 344557999
Q ss_pred EecCC
Q 047569 558 EYMSN 562 (832)
Q Consensus 558 E~~~~ 562 (832)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.056 Score=58.99 Aligned_cols=139 Identities=20% Similarity=0.249 Sum_probs=83.0
Q ss_pred EeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC---Ccceee---EEE----EeccCCcEEEEEEe
Q 047569 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR---HRHLVS---LIG----YCDENSEMILVYEY 559 (832)
Q Consensus 490 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~---HpnIv~---l~~----~~~~~~~~~lV~E~ 559 (832)
|.+ .-..+|+....+|+. ++|+.+.. ....+...|+..|..|. .+-.++ +=| ........+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789998887777 88887765 34466777888888873 221122 212 11222377899999
Q ss_pred cCCCChhh-hh----c------------cCC--------CCCCCHHH-------------HHHHHHHHHHHHHHHhc---
Q 047569 560 MSNGPFRD-HL----Y------------GKN--------LPPLSWKQ-------------RLEISIGSARGLHYLHT--- 598 (832)
Q Consensus 560 ~~~gsL~~-~l----~------------~~~--------~~~l~~~~-------------~l~i~~~ia~~L~yLH~--- 598 (832)
++|..+.. .. . .++ .....|.. ......++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988772 11 0 011 11233320 01122333444444443
Q ss_pred -CCCCC---eeeccCCCCceeeCCCCc-eEEeccccccc
Q 047569 599 -GTAQG---IIHRDVKSTNILLDDNYV-AKVSDFGLSKD 632 (832)
Q Consensus 599 -~~~~~---ivHrDlkp~NILl~~~~~-~kl~DFGla~~ 632 (832)
..+.. +||+|+.|.||+++++.. +.++||+-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 22233 999999999999998875 88999997653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.058 Score=59.29 Aligned_cols=140 Identities=14% Similarity=0.186 Sum_probs=79.3
Q ss_pred ceEeecCceeEEEEEEeC----CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcce-eeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL-VSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.|..|=-..+|+....+ +..|++|+.......... -.+|..+++.+..-++ .++++++.. + +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 345445556788886543 348999987765443332 3678889988864444 456666532 2 58999987
Q ss_pred CChhhh-------h----------ccCCC---CCC-CHHHHHHHHHHH----------------------HHHHHH---H
Q 047569 563 GPFRDH-------L----------YGKNL---PPL-SWKQRLEISIGS----------------------ARGLHY---L 596 (832)
Q Consensus 563 gsL~~~-------l----------~~~~~---~~l-~~~~~l~i~~~i----------------------a~~L~y---L 596 (832)
.+|... + |.... ... -|....++..++ .+-+.. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765320 1 11111 011 122222222111 111111 1
Q ss_pred hc--CCCCCeeeccCCCCceeeCC-CCceEEeccccccc
Q 047569 597 HT--GTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKD 632 (832)
Q Consensus 597 H~--~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 632 (832)
.. ..+.-++|.|+.+.|||+++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12234799999999999974 57899999997653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.079 Score=57.65 Aligned_cols=32 Identities=13% Similarity=0.184 Sum_probs=28.7
Q ss_pred CCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 601 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
..+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 46899999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.052 Score=54.62 Aligned_cols=102 Identities=17% Similarity=0.147 Sum_probs=67.0
Q ss_pred EEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHH
Q 047569 509 VAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISI 587 (832)
Q Consensus 509 vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~ 587 (832)
..+|++....-. ...-|.++.+++++++ .|+++.. .+.-...++.|+|-... ....-.|..
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~--------------i~~~N~i~a 149 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK--------------INFSNFITA 149 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc--------------cchhHHHHH
Confidence 344544433323 3456788899988875 4667663 24456679999984211 011111222
Q ss_pred HHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 588 ~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
+ ++.|.-.|+.+ .+.+|+|..|+|||-|..|.+||.|=+..
T Consensus 150 g-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 150 G-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred h-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 2 35678889754 68999999999999999999999998753
|
The function of this family is unknown. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.072 Score=57.60 Aligned_cols=140 Identities=20% Similarity=0.217 Sum_probs=89.7
Q ss_pred CccceEeecCceeEEEEEEeCCcEEEEEecCCC----------------------CcccHH----HHHHHHHHHHhCCCc
Q 047569 485 DSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ----------------------SEQGIT----EFQTEIQMLSKLRHR 538 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----------------------~~~~~~----~f~~Ei~~L~~l~Hp 538 (832)
++..+|..|.-+.||.+...+|..+|||+.+.. ....++ ....|++-|.+|+.-
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345678999999999999999999999964321 001111 234688888888643
Q ss_pred ceeeEEEEeccCCcEEEEEEecCCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 539 HLVSLIGYCDENSEMILVYEYMSNGPF-RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 539 nIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
.|..---... ..-.|||+|+..... .-.|. ...++...+..+-.|++.-+.-|-+. .++||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE
Confidence 3321100000 123699999942211 11221 12456666777777777777777552 5799999999999987
Q ss_pred CCCceEEeccccccc
Q 047569 618 DNYVAKVSDFGLSKD 632 (832)
Q Consensus 618 ~~~~~kl~DFGla~~ 632 (832)
+ |.+.|+|-+-+..
T Consensus 300 d-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVE 313 (520)
T ss_pred C-CEEEEEEcccccc
Confidence 5 4899999886654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.15 Score=55.32 Aligned_cols=30 Identities=37% Similarity=0.501 Sum_probs=26.0
Q ss_pred CCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 601 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367999999999999988 578999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.029 Score=57.40 Aligned_cols=122 Identities=17% Similarity=0.199 Sum_probs=60.8
Q ss_pred CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc-eeeEEEEeccCCcEEEEEEecCCCChhhh-h--------------
Q 047569 506 GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH-LVSLIGYCDENSEMILVYEYMSNGPFRDH-L-------------- 569 (832)
Q Consensus 506 g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l-------------- 569 (832)
++.|+||+....... .-.-.+|..+++.+..-+ -.++++++.+. +|+||+++.+|..- +
T Consensus 2 ~~~~~~Ri~g~~t~~-~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTEN-FIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGCS-HHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCccc-ccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 467888887665433 345577889998886433 35666665443 67799977665221 1
Q ss_pred --cc--C---CCCCCCHHHHHHH----------------------HHHHHHHHHHHhc-----CCCCCeeeccCCCCcee
Q 047569 570 --YG--K---NLPPLSWKQRLEI----------------------SIGSARGLHYLHT-----GTAQGIIHRDVKSTNIL 615 (832)
Q Consensus 570 --~~--~---~~~~l~~~~~l~i----------------------~~~ia~~L~yLH~-----~~~~~ivHrDlkp~NIL 615 (832)
|. . ....--|.....+ ...+.+-+..+.+ ..+..++|.|+.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0 0001111222222 0111111222211 12246899999999999
Q ss_pred e-CCCCceEEeccccccc
Q 047569 616 L-DDNYVAKVSDFGLSKD 632 (832)
Q Consensus 616 l-~~~~~~kl~DFGla~~ 632 (832)
+ +.++.++++||..+..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999987653
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.058 Score=59.85 Aligned_cols=74 Identities=16% Similarity=0.148 Sum_probs=50.7
Q ss_pred cceEeecCceeEEEEEEeC-CcEEEEEecCC------CCcccHHHHHHHHHHHHhCC--Cc-ceeeEEEEeccCCcEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDD-GTKVAVKRGNP------QSEQGITEFQTEIQMLSKLR--HR-HLVSLIGYCDENSEMILV 556 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~f~~Ei~~L~~l~--Hp-nIv~l~~~~~~~~~~~lV 556 (832)
.+.||-|...-||++...+ ++.|+||.-.+ .-+-..++..-|.+.|+.+. .| ++.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999998753 57899995322 11334567777888888773 45 45566654 34456788
Q ss_pred EEecCC
Q 047569 557 YEYMSN 562 (832)
Q Consensus 557 ~E~~~~ 562 (832)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 832 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-99 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-98 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-23 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-23 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-23 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-21 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-21 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-20 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-20 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-20 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-20 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-20 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-20 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-20 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-20 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 573 bits (1479), Expect = 0.0
Identities = 189/321 (58%), Positives = 226/321 (70%), Gaps = 16/321 (4%)
Query: 455 GSHKSGFTNSTLG----------LGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEID 504
GS S TNS +L+EAT NFD +IG G FG VY G +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 505 DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564
DG KVA+KR P+S QGI EF+TEI+ LS RH HLVSLIG+CDE +EMIL+Y+YM NG
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 565 FRDHLYGKNLP--PLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622
+ HLYG +LP +SW+QRLEI IG+ARGLHYLHT IIHRDVKS NILLD+N+V
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178
Query: 623 KVSDFGLSKDAPIG-QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR 681
K++DFG+SK Q H+ST VKG+ GY+DPEYF + +LTEKSDVYSFGVVL EVLCAR
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 682 PAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGV 741
AI LPRE VNLAEWA++ G LE+I+DP+L I PESL+KF + A KCLA
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 742 DRPTMGDVLWNLEYALQLQEA 762
DRP+MGDVLW LEYAL+LQE+
Sbjct: 299 DRPSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-133
Identities = 105/299 (35%), Positives = 163/299 (54%), Gaps = 21/299 (7%)
Query: 470 RYFSFQELQEATKNFDSSA------IIGVGGFGNVYLGEIDDGTKVAVKR----GNPQSE 519
FSF EL+ T NFD +G GGFG VY G ++ T VAVK+ + +E
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTE 71
Query: 520 QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYG-KNLPPLS 578
+ +F EI++++K +H +LV L+G+ + ++ LVY YM NG D L PPLS
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 579 WKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638
W R +I+ G+A G+++LH IHRD+KS NILLD+ + AK+SDFGL++ +
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 639 -HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE 697
+++ + G+ Y+ PE R ++T KSD+YSFGVVLLE++ PA++ RE L +
Sbjct: 189 TVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLD 245
Query: 698 WAMQ-WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755
+ + +E ID + + S++ A +CL + RP + V L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 386 bits (993), Expect = e-128
Identities = 121/294 (41%), Positives = 175/294 (59%), Gaps = 5/294 (1%)
Query: 466 LGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGIT-E 524
LG + FS +ELQ A+ NF + I+G GGFG VY G + DGT VAVKR + QG +
Sbjct: 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ 73
Query: 525 FQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGK--NLPPLSWKQR 582
FQTE++M+S HR+L+ L G+C +E +LVY YM+NG L + + PPL W +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
I++GSARGL YLH IIHRDVK+ NILLD+ + A V DFGL+K HV+T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ--VNLAEWAM 700
AV+G+ G++ PEY + +EK+DV+ +GV+LLE++ + A + V L +W
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
++ LE ++D L G E +++ + A C ++RP M +V+ LE
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 1e-82
Identities = 70/321 (21%), Positives = 123/321 (38%), Gaps = 32/321 (9%)
Query: 457 HKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNP 516
H +S + + L + + G FG V+ ++ VAVK
Sbjct: 3 HHHHHHSSGVD----LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI 57
Query: 517 QSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE----NSEMILVYEYMSNGPFRDHLYGK 572
Q +Q + + E+ L ++H +++ IG + ++ L+ + G D L
Sbjct: 58 QDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
Query: 573 NLPPLSWKQRLEISIGSARGLHYLHTGTAQ-------GIIHRDVKSTNILLDDNYVAKVS 625
+SW + I+ ARGL YLH I HRD+KS N+LL +N A ++
Sbjct: 117 ---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 626 DFGLSKDAPIGQGHV-STAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLC 679
DFGL+ G+ + G+ Y+ PE ++ + D+Y+ G+VL E+
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 680 ARPAINPQLPREQVNLAEWAMQWK-----RKGLLEKIIDPHLVGTINP-ESLKKFAEAAE 733
A + + + E Q ++ ++ K P L + E E
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 734 KCLADHGVDRPTMGDVLWNLE 754
+C R + G V +
Sbjct: 294 ECWDHDAEARLSAGCVGERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-66
Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 27/269 (10%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
++G G FG V VA+K+ +SE+ F E++ LS++ H ++V L G C
Sbjct: 15 VVGRGAFGVVCKA-KWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACL 71
Query: 549 ENSEMILVYEYMSNGPFRDHLYG-KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
+ LV EY G + L+G + LP + + + ++G+ YLH+ + +IHR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 608 DVKSTNILLDDNY-VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
D+K N+LL V K+ DFG + D T KGS ++ PE F +EK D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK-RKGLLEKIIDPHLVGTINPESL 725
V+S+G++L EV+ + P +++ + + W G +I +
Sbjct: 186 VFSWGIILWEVITR------RKPFDEIGGPAFRIMWAVHNGTRPPLIK-----NLPKP-- 232
Query: 726 KKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
+C + RP+M +++ +
Sbjct: 233 --IESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 7e-65
Identities = 82/269 (30%), Positives = 127/269 (47%), Gaps = 23/269 (8%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G FG V+ E G+ VAVK Q + + EF E+ ++ +LRH ++V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNL-PPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ + +V EY+S G L+ L ++RL ++ A+G++YLH I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVH 162
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
R++KS N+L+D Y KV DFGLS+ S + G+ ++ PE R + EKSD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL- 725
VYSFGV+L E+ Q P +N A+ K +I P +L
Sbjct: 222 VYSFGVILWELATL------QQPWGNLNPAQVVAAVGFKCKRLEI----------PRNLN 265
Query: 726 KKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
+ A E C + RP+ ++ L
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-62
Identities = 67/333 (20%), Positives = 116/333 (34%), Gaps = 46/333 (13%)
Query: 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQM 531
+ E N +IG G +G VY G +D VAVK + + Q I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE-KNIYR 60
Query: 532 LSKLRHRHLVSLIGYCDENS-----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEIS 586
+ + H ++ I + + E +LV EY NG +L W ++
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLA 117
Query: 587 IGSARGLHYLHTGTAQG------IIHRDVKSTNILLDDNYVAKVSDFGLSK-------DA 633
RGL YLHT +G I HRD+ S N+L+ ++ +SDFGLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 634 PIGQGHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLLEVLCARPAINP 686
P + + + + G+ Y+ PE + ++ D+Y+ G++ E+ + P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 687 QLPREQVNLAEWAMQWKRKGLLEKI-----------IDPHLVGTINPESLKKFAEAAEKC 735
+ +A + N +++ E E C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDC 295
Query: 736 LADHGVDRPTMGDVLWNLEYALQLQEAFTQGKA 768
R T + +L + + K+
Sbjct: 296 WDQDAEARLTAQXAEERMA---ELMMIWERNKS 325
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-61
Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 36/279 (12%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGIT----EFQTEIQMLSKLRHRHLVSLI 544
IIG+GGFG VY G +VAVK ++ I+ + E ++ + L+H ++++L
Sbjct: 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
G C + + LV E+ GP L GK +P + ++ ARG++YLH I
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 605 IHRDVKSTNILLD--------DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYF 656
IHRD+KS+NIL+ N + K++DFGL++ + G++ ++ PE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWMAPEVI 186
Query: 657 RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716
R ++ SDV+S+GV+L E+L ++P ++ A L I
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAYGVAMNKLALPI----- 235
Query: 717 VGTINPESL-KKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
P + + FA+ E C RP+ ++L L
Sbjct: 236 -----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-61
Identities = 55/291 (18%), Positives = 115/291 (39%), Gaps = 43/291 (14%)
Query: 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQM 531
F++L TK + G ++ G G + VK + S + +F E
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 532 LSKLRHRHLVSLIGYCDE--NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS 589
L H +++ ++G C L+ +M G + L+ + Q ++ ++
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
ARG+ +LHT I + S ++++D++ A++S + S +
Sbjct: 121 ARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFS------FQSPGRMYAPA 173
Query: 650 YLDPEYFRRQQL---TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706
++ PE +++ +D++SF V+L E++ ++P ++ E M+ +G
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR------EVPFADLSNMEIGMKVALEG 227
Query: 707 LLEKI---IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
L I I PH+ + + C+ + RP ++ LE
Sbjct: 228 LRPTIPPGISPHVSKLM------------KICMNEDPAKRPKFDMIVPILE 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-60
Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 36/281 (12%)
Query: 489 IIGVGGFGNVYLGE-IDDGTKVAVKR-------GNPQSEQGITEFQTEIQMLSKLRHRHL 540
IG GGFG V+ G + D + VA+K G + + EFQ E+ ++S L H ++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
V L G +V E++ G L K P+ W +L + + A G+ Y+
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 601 AQGIIHRDVKSTNILLD-----DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY 655
I+HRD++S NI L AKV+DFGLS+ H + + G+F ++ PE
Sbjct: 143 PP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPET 197
Query: 656 FRRQQL--TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713
++ TEK+D YSF ++L +L + P + + +++ + I +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTG------EGPFD--EYSYGKIKF-----INMIRE 244
Query: 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
L TI + + E C + RP ++ L
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-59
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G FG VY G+ VAVK N + Q + F+ E+ +L K RH +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
I V ++ HL+ K+ ++I+ +ARG+ YLH A+ IIHR
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 608 DVKSTNILLDDNYVAKVSDFGLSK-DAPIGQGHVSTAVKGSFGYLDPEYFRRQQL---TE 663
D+KS NI L ++ K+ DFGL+ + H + GS ++ PE R Q +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 664 KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723
+SDVY+FG+VL E++ QLP +N + ++ +G L + +
Sbjct: 205 QSDVYAFGIVLYELMTG------QLPYSNINNRDQIIEMVGRGSLSPDLSK-----VRSN 253
Query: 724 SLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
K+ +CL +RP+ +L +E
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 7e-59
Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 41/283 (14%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
+IG G FG VY G +VA++ + + +E + F+ E+ + RH ++V +G
Sbjct: 40 LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
C + ++ + L + +I+ +G+ YLH A+GI+H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSK----DAPIGQGHVSTAVKGSFGYLDPEYFRRQQL- 661
+D+KS N+ D+ V ++DFGL + G +L PE R+
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 662 --------TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE--WAMQWKRKGLLEKI 711
++ SDV++ G + E+ + P + W M G+ +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAR------EWPFKTQPAEAIIWQMG---TGMKPNL 263
Query: 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
+ + + C A +RPT ++ LE
Sbjct: 264 SQIGM-----GKEISDI---LLFCWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-58
Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 32/279 (11%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG + G + +K E+ F E++++ L H +++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
++ + + EY+ G R + + W QR+ + A G+ YLH + IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 609 VKSTNILLDDNYVAKVSDFGLS-------------KDAPIGQGHVSTAVKGSFGYLDPEY 655
+ S N L+ +N V+DFGL+ + V G+ ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715
+ EK DV+SFG+VL E++ A LPR ++ + +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR-TMDFGLNVRGFLD---------RY 243
Query: 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
P F +C RP+ + LE
Sbjct: 244 CPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-53
Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 32/291 (10%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQ--TEIQMLSKLRHRHLVSLIGY 546
IG G +G V++G+ G KVAVK E + TEI +RH +++ I
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAA 99
Query: 547 C----DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
+++ L+ +Y NG D+L L K L+++ S GL +LHT
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 603 -----GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV---STAVKGSFGYLDPE 654
I HRD+KS NIL+ N ++D GL+ V G+ Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 655 ------YFRRQQLTEKSDVYSFGVVLLEVL--CARPAINP--QLPREQVNLAEWAMQWKR 704
Q +D+YSFG++L EV C I QLP + ++ + + R
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 705 KGLLEKIIDPHLVGTINPES-LKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
+ + K + P + + L++ + +C A + R T V L
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 38/294 (12%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQ--TEIQMLSKLRHRHLVSLIGY 546
+G G +G V+ G G VAVK + + E+ + TE+ LRH +++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIAS 70
Query: 547 C----DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
++++ L+ Y G D+L L L L I + A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 603 -----GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV---STAVKGSFGYLDPE 654
I HRD+KS NIL+ N ++D GL+ + + G+ Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 655 ------YFRRQQLTEKSDVYSFGVVLLEVLC----ARPAINPQLPREQVNLAEWAMQWKR 704
++ D+++FG+VL EV + + P V + + + R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 705 KGLLEK----IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
K + I + +L A+ ++C + R T + L
Sbjct: 248 KVVCVDQQRPNIPNRW---FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 9e-50
Identities = 70/289 (24%), Positives = 133/289 (46%), Gaps = 28/289 (9%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC- 547
IG G FG V+ G+ G +VAVK + + E+ + EI LRH +++ I
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 106
Query: 548 ---DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-- 602
+++ LV +Y +G D+L N ++ + +++++ +A GL +LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 603 ---GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV---STAVKGSFGYLDPE-- 654
I HRD+KS NIL+ N ++D GL+ + G+ Y+ PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 655 ----YFRRQQLTEKSDVYSFGVVLLEVL--CARPAINP--QLPREQVNLAEWAMQWKRKG 706
+ + +++D+Y+ G+V E+ C+ I+ QLP + ++ +++ RK
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283
Query: 707 LLEKIIDPHL-VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
+ E+ + P++ + E+L+ A+ +C +G R T + L
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-42
Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 24/269 (8%)
Query: 490 IGVGGFGNVYLGEI-DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G FG V+ G + D T VAVK +F E ++L + H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
+ + +V E + G F L L K L++ +A G+ YL ++ IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY--LDPEYFRRQQLTEKS 665
D+ + N L+ + V K+SDFG+S++ G + ++ PE + + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 666 DVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725
DV+SFG++L E P ++ + ++ G L P L P+++
Sbjct: 297 DVWSFGILLWETF-----SLGASPYPNLSNQQTREFVEKGGRLPC---PELC----PDAV 344
Query: 726 KKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
E+C A RP+ + L+
Sbjct: 345 ---FRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-40
Identities = 64/190 (33%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG V++G + T+VA+K P + F E Q++ KLRH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
E I V EYMS G D L G+ L Q ++++ A G+ Y+ +HRD
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 668
+++ NIL+ +N V KV+DFGL++ + K + PE + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 669 SFGVVLLEVL 678
SFG++L E+
Sbjct: 366 SFGILLTELT 375
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 62/235 (26%), Positives = 111/235 (47%), Gaps = 18/235 (7%)
Query: 489 IIGVGGFGNVYLGEID-----DGTKVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG V L D G +VAVK P I + + EI++L L H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 543 LIGYCDENSE--MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
G C E+ + L+ E++ +G +++L KN ++ KQ+L+ ++ +G+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLG--- 143
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRR 658
++ +HRD+ + N+L++ + K+ DFGL+K + + + + PE +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 659 QQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
+ SDV+SFGV L E+ C + L + + M R L+ +
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR--LVNTL 256
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 17/234 (7%)
Query: 489 IIGVGGFGNVYLGEID-----DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG+V L D G VAVK+ +FQ EIQ+L L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 544 IGYCDENSE--MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
G + LV EY+ +G RD L ++ L + L S +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLG---S 145
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH--VSTAVKGSFGYLDPEYFRRQ 659
+ +HRD+ + NIL++ K++DFGL+K P+ + + V + + PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 660 QLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
+ +SDV+SFGVVL E+ C + + R LLE +
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR--LLELL 257
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 489 IIGVGGFGNVYLGEID-----DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG+V + D G VAVK+ +E+ + +F+ EI++L L+H ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 544 IGYCDENSE--MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
G C + L+ EY+ G RD+L K+ + + L+ + +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLG---T 132
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRRQ 659
+ IHRD+ + NIL+++ K+ DFGL+K P + G + PE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 660 QLTEKSDVYSFGVVLLEVL 678
+ + SDV+SFGVVL E+
Sbjct: 193 KFSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-40
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 489 IIGVGGFGNVYLGEID-----DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG+V + D G VAVK+ +E+ + +F+ EI++L L+H ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 544 IGYCDENSE--MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
G C + L+ EY+ G RD+L K+ + + L+ + +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLG---T 163
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRRQ 659
+ IHRD+ + NIL+++ K+ DFGL+K P + + G + PE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 660 QLTEKSDVYSFGVVLLEVL 678
+ + SDV+SFGVVL E+
Sbjct: 224 KFSVASDVWSFGVVLYELF 242
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-39
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 9/193 (4%)
Query: 489 IIGVGGFGNVYLGEI-DDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G G +G VY G VAVK + + + EF E ++ +++H +LV L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 283
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
C ++ E+M+ G D+L N +S L ++ + + YL + I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS 665
HR++ + N L+ +N++ KV+DFGLS+ K + PE + + KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 666 DVYSFGVVLLEVL 678
DV++FGV+L E+
Sbjct: 401 DVWAFGVLLWEIA 413
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 9/192 (4%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
+G G FG V++G + TKVAVK + S F E ++ +L+H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAV 76
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ I + EYM NG D L + L+ + L+++ A G+ ++ + IH
Sbjct: 77 VTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+++ NIL+ D K++DFGL++ + K + PE T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 667 VYSFGVVLLEVL 678
V+SFG++L E++
Sbjct: 193 VWSFGILLTEIV 204
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-39
Identities = 64/190 (33%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG V++G + T+VA+K P + F E Q++ KLRH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
E I V EYMS G D L G+ L Q ++++ A G+ Y+ +HRD
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 668
+++ NIL+ +N V KV+DFGL++ + K + PE + T KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 669 SFGVVLLEVL 678
SFG++L E+
Sbjct: 449 SFGILLTELT 458
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 67/191 (35%), Positives = 101/191 (52%), Gaps = 11/191 (5%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG G FG+V LG+ G KVAVK + F E ++++LRH +LV L+G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 549 ENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E + +V EYM+ G D+L + L L+ S+ + YL +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 667
D+ + N+L+ ++ VAKVSDFGL+K+A Q VK + PE R ++ + KSDV
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSDV 369
Query: 668 YSFGVVLLEVL 678
+SFG++L E+
Sbjct: 370 WSFGILLWEIY 380
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-39
Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 5/190 (2%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG V++ + TKVAVK P S F E ++ L+H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
+ I + E+M+ G D L + ++ S A G+ ++ + IHRD
Sbjct: 254 KEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 668
+++ NIL+ + V K++DFGL++ + K + PE T KSDV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 669 SFGVVLLEVL 678
SFG++L+E++
Sbjct: 370 SFGILLMEIV 379
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 29/200 (14%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
IG G FG+V LG+ G KVAVK + F E ++++LRH +LV L+G
Sbjct: 28 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 549 ENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E + +V EYM+ G D+L + L L+ S+ + YL +HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHR 141
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDA---------PIGQGHVSTAVKGSFGYLDPEYFRR 658
D+ + N+L+ ++ VAKVSDFGL+K+A P+ TA PE R
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW----TA---------PEALRE 188
Query: 659 QQLTEKSDVYSFGVVLLEVL 678
++ + KSDV+SFG++L E+
Sbjct: 189 KKFSTKSDVWSFGILLWEIY 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 473 SFQELQEATKNFDSSAI------IGVGGFGNVYLGEI---DDGTKVAVK--RGNPQSEQG 521
+ +E++ D + +G G FG V G VAVK +
Sbjct: 2 ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 61
Query: 522 ITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ 581
E E ++ +L + ++V +IG C+ S M+ V E GP +L + + K
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYL--QQNRHVKDKN 118
Query: 582 RLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641
+E+ + G+ YL +HRD+ + N+LL + AK+SDFGLSK + +
Sbjct: 119 IIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 642 TAVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLLEVL 678
G + + PE + + KSDV+SFGV++ E
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 474 FQELQEATKNFDSSAI-----IGVGGFGNVYLGEIDDG----TKVAVKRGNPQ-SEQGIT 523
Q +Q S + IG G FG VY G + D AVK N ++
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 71
Query: 524 EFQTEIQMLSKLRHRHLVSLIGYC-DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQR 582
+F TE ++ H +++SL+G C ++V YM +G R+ + + K
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDL 130
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
+ + A+G+ YL ++ +HRD+ + N +LD+ + KV+DFGL++D + +
Sbjct: 131 IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYS 185
Query: 643 AVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEVL 678
+ L E + Q+ T KSDV+SFGV+L E++
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 70/224 (31%), Positives = 103/224 (45%), Gaps = 18/224 (8%)
Query: 489 IIGVGGFGNVYLGEIDD-----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVS 542
+G G FG V L D G VAVK Q + ++ EI +L L H H++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 543 LIGYCDENSE--MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
G C++ + LV EY+ G RD+L ++ Q L + G+ YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI---GLAQLLLFAQQICEGMAYLH--- 151
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH--VSTAVKGSFGYLDPEYFRR 658
AQ IHRD+ + N+LLD++ + K+ DFGL+K P G + V + PE +
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 659 QQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQVNLAEWAM 700
+ SDV+SFGV L E+ C P E + +A+ M
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG V+LG + KVA+K R SE+ +F E +++ KL H LV L G
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
C E + + LV E+M +G D+L + + L + + G+ YL +IH
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY--LDPEYFRRQQLTEK 664
RD+ + N L+ +N V KVSDFG+++ + +++ F PE F + + K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 665 SDVYSFGVVLLEVL 678
SDV+SFGV++ EV
Sbjct: 186 SDVWSFGVLMWEVF 199
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 52/199 (26%), Positives = 79/199 (39%), Gaps = 14/199 (7%)
Query: 489 IIGVGGFGNVYLGE----IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
+G G FG V GE VAVK + + +F E+ + L HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L G + V E G D L K+ ++ A G+ YL +
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLE---S 139
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY--LDPEYFRRQ 659
+ IHRD+ + N+LL + K+ DFGL + P H + PE + +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 660 QLTEKSDVYSFGVVLLEVL 678
+ SD + FGV L E+
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 68/285 (23%), Positives = 117/285 (41%), Gaps = 41/285 (14%)
Query: 469 GRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEF 525
GR+ F IG G F VY G + + +VA + ++ F
Sbjct: 25 GRFLKFDIE------------IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 72
Query: 526 QTEIQMLSKLRHRHLVSLIGY----CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ 581
+ E +ML L+H ++V ++LV E M++G + +L K + K
Sbjct: 73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKV 130
Query: 582 RLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAPIGQGHV 640
+GL +LHT T IIHRD+K NI + K+ D GL+ + +
Sbjct: 131 LRSWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASF 186
Query: 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM 700
+ AV G+ ++ PE + ++ E DVY+FG+ +LE+ + P + + A
Sbjct: 187 AKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEY------PYSEC---QNAA 236
Query: 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT 745
Q R+ + PE +K+ E C+ + +R +
Sbjct: 237 QIYRRV-TSGVKPASFDKVAIPE-VKEI---IEGCIRQNKDERYS 276
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 489 IIGVGGFGNVYLGE-IDDG----TKVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVS 542
++G G FG VY G I +G VA+K S + E E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L+G C ++ + + + M G D++ ++ + + L + A+G++YL +
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA-----VKGSFGYLDPEYFR 657
++HRD+ + N+L+ K++DFGL+K + +K ++ E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 658 RQQLTEKSDVYSFGVVLLEVL 678
+ T +SDV+S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 64/192 (33%), Positives = 94/192 (48%), Gaps = 9/192 (4%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
+G G FG V LG+ VAVK + SE EF E Q + KL H LV G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
C + + +V EY+SNG ++L + L Q LE+ G+ +L + IH
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
RD+ + N L+D + KVSDFG+++ Q S K + PE F + + KSD
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 667 VYSFGVVLLEVL 678
V++FG+++ EV
Sbjct: 188 VWAFGILMWEVF 199
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 70/300 (23%), Positives = 109/300 (36%), Gaps = 35/300 (11%)
Query: 469 GRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQT 527
YF + K++ +G GGF V L E + DG A+KR +Q E Q
Sbjct: 16 NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR 75
Query: 528 EIQMLSKLRHRHLVSLIGYC----DENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQ 581
E M H +++ L+ YC E L+ + G + + L+ Q
Sbjct: 76 EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135
Query: 582 RLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641
L + +G RGL +H +G HRD+K TNILL D + D G A I
Sbjct: 136 ILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192
Query: 642 TAVK--------GSFGYLDPEYF---RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPR 690
A+ + Y PE F + E++DV+S G VL + + P
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA-MMFG-----EGPY 246
Query: 691 EQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ V ++ + L P +L + + RP + +L
Sbjct: 247 DMVFQKGDSVALAVQNQLSIPQSPRH-----SSALWQL---LNSMMTVDPHQRPHIPLLL 298
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
+G G FG V G+ VA+K + SE EF E +++ L H LV L G
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
C + + ++ EYM+NG ++L + +Q LE+ + YL ++ +H
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY--LDPEYFRRQQLTEK 664
RD+ + N L++D V KVSDFGLS+ + +++V F PE + + K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 665 SDVYSFGVVLLEVL 678
SD+++FGV++ E+
Sbjct: 202 SDIWAFGVLMWEIY 215
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 490 IGVGGFGNVYLGE---IDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 544
+G G FG+V G VA+K + + E E Q++ +L + ++V LI
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLI 76
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
G C + M+ V E GP L + E+ + G+ YL +
Sbjct: 77 GVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL---EEKNF 131
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRRQQLT 662
+HRD+ + N+LL + + AK+SDFGLSK + + G + + PE ++ +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 663 EKSDVYSFGVVLLEVL 678
+SDV+S+GV + E L
Sbjct: 192 SRSDVWSYGVTMWEAL 207
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 68/337 (20%), Positives = 131/337 (38%), Gaps = 35/337 (10%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHR 538
+ + IG G FG L + +DG + +K + S + E + E+ +L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
++V +EN + +V +Y G + + Q L+ + L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
+ I+HRD+KS NI L + ++ DFG+++ + G+ YL PE
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 659 QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718
+ KSD+++ G VL E+ + E ++ L+ KII G
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKH------AFEAGSMKN---------LVLKIIS----G 240
Query: 719 TINP------ESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEES 772
+ P L+ + + DRP++ +L A ++++ + EE
Sbjct: 241 SFPPVSLHYSYDLRSL---VSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEF 297
Query: 773 QSAATAAASPAAVAAPAATSASDDRPVSAPKENVGPA 809
+ + A S + V ++ PA
Sbjct: 298 CLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPA 334
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 474 FQELQEATKNFDSSAI-----IGVGGFGNVYLGEIDDG----TKVAVKRGNPQ-SEQGIT 523
Q +Q S + IG G FG VY G + D AVK N ++
Sbjct: 76 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 135
Query: 524 EFQTEIQMLSKLRHRHLVSLIGYC--DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ 581
+F TE ++ H +++SL+G C E S ++++ YM +G R+ + + K
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIR-NETHNPTVKD 193
Query: 582 RLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641
+ + A+G+ +L ++ +HRD+ + N +LD+ + KV+DFGL++D +
Sbjct: 194 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFD 248
Query: 642 TAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEVL 678
+ + L E + Q+ T KSDV+SFGV+L E++
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 489 IIGVGGFGNVYLGEIDDG----TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSL 543
+IG G FG VY GE D + A+K + Q + F E ++ L H ++++L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 544 IGYC--DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
IG E +L+ YM +G + + K + + ARG+ YL
Sbjct: 88 IGIMLPPEGLPHVLL-PYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL-----DPEYF 656
Q +HRD+ + N +LD+++ KV+DFGL++D I + + L E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTALESL 200
Query: 657 RRQQLTEKSDVYSFGVVLLEVL 678
+ + T KSDV+SFGV+L E+L
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELL 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 53/215 (24%), Positives = 82/215 (38%), Gaps = 42/215 (19%)
Query: 489 IIGVGGFGNVYLGE--------IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL 540
+G G F ++ G T+V +K + F M+SKL H+HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
V G C E ILV E++ G +L KN ++ +LE++ A +H+L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 601 AQGIIHRDVKSTNILLD--------DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
+IH +V + NILL + K+SD G+S V +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDILQE 179
Query: 653 P---------EYFRRQQLTEKSDVYSFGVVLLEVL 678
E + L +D +SFG L E+
Sbjct: 180 RIPWVPPECIENPKN--LNLATDKWSFGTTLWEIC 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 14/197 (7%)
Query: 489 IIGVGGFGNVYLGE----IDDGTKVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVSL 543
I+G G FG VY G + VAVK + +F +E ++ L H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
IG +E I + E G +L +N L + S+ + + YL +
Sbjct: 79 IGIIEEEPTWI-IMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLE---SIN 133
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRRQQL 661
+HRD+ NIL+ K+ DFGLS+ I A ++ PE ++
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 662 TEKSDVYSFGVVLLEVL 678
T SDV+ F V + E+L
Sbjct: 192 TTASDVWMFAVCMWEIL 208
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 9/193 (4%)
Query: 489 IIGVGGFGNVYLGEI-DDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G G +G VY G VAVK + + + EF E ++ +++H +LV L+G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 76
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
C ++ E+M+ G D+L N +S L ++ + + YL + I
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKS 665
HRD+ + N L+ +N++ KV+DFGLS+ K + PE + + KS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 666 DVYSFGVVLLEVL 678
DV++FGV+L E+
Sbjct: 194 DVWAFGVLLWEIA 206
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 59/270 (21%), Positives = 107/270 (39%), Gaps = 29/270 (10%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKR---GNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
IG G F VY + DG VA+K+ + + + EI +L +L H +++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 546 YCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
E++E+ +V E G + + K + + + + L ++H ++
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
++HRD+K N+ + V K+ D GL + + V G+ Y+ PE
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 215
Query: 664 KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID---PHLVGTI 720
KSD++S G +L E+ + +++NL L +KI P L
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFY----GDKMNLYS---------LCKKIEQCDYPPLPSDH 262
Query: 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
E L++ C+ RP + V
Sbjct: 263 YSEELRQL---VNMCINPDPEKRPDVTYVY 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 72/254 (28%), Positives = 105/254 (41%), Gaps = 44/254 (17%)
Query: 471 YFSFQELQEATKNFDSSAI-----IGVGGFGNVYLGEIDDG------TKVAVKRGNPQSE 519
YFS + I +G G FG V+L E + VAVK SE
Sbjct: 29 YFSDACVHH----IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 84
Query: 520 QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL---------- 569
+FQ E ++L+ L+H+H+V G C E +++V+EYM +G L
Sbjct: 85 SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 570 ---YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSD 626
PL Q L ++ A G+ YL +HRD+ + N L+ V K+ D
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGD 201
Query: 627 FGLSKDAPIGQGHVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV--LC 679
FG+S+D G L PE ++ T +SDV+SFGVVL E+
Sbjct: 202 FGMSRDIY----STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 680 ARPAINPQLPREQV 693
+P QL +
Sbjct: 258 KQPW--YQLSNTEA 269
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 489 IIGVGGFGNVYLG----EIDDGTKVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVSL 543
IIG G G V G VA+K +E+ +F +E ++ + H +++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
G ++V EYM NG L + + Q + + G G+ YL + G
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL--DPEYFRRQQL 661
+HRD+ + N+L+D N V KVSDFGLS+ T G PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 662 TEKSDVYSFGVVLLEVL 678
+ SDV+SFGVV+ EVL
Sbjct: 232 SSASDVWSFGVVMWEVL 248
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 489 IIGVGGFGNVYLGEIDDG---TKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSL 543
+IG G FG V I A+KR S+ +F E+++L KL H ++++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHL--------------YGKNLPPLSWKQRLEISIGS 589
+G C+ + L EY +G D L LS +Q L +
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
ARG+ YL + + IHRD+ + NIL+ +NYVAK++DFGLS+ VK + G
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEVYVKKTMG 201
Query: 650 YL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
L E T SDV+S+GV+L E+
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 14/197 (7%)
Query: 489 IIGVGGFGNVYLGEIDDG----TKVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVSL 543
IG G FG+V+ G VA+K S+ +F E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
IG EN I + E + G R L L + + + L YL ++
Sbjct: 82 IGVITENPVWI-IMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL---ESKR 136
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRRQQL 661
+HRD+ + N+L+ N K+ DFGLS+ + A KG ++ PE ++
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 662 TEKSDVYSFGVVLLEVL 678
T SDV+ FGV + E+L
Sbjct: 195 TSASDVWMFGVCMWEIL 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 489 IIGVGGFGNVYLGEIDDG----TKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
++G G FG+V ++ KVAVK + + + I EF E + + H H+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 543 LIGYC------DENSEMILVYEYMSNGPFRDHL----YGKNLPPLSWKQRLEISIGSARG 592
L+G +++ +M +G L G+N L + + + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL- 651
+ YL +++ IHRD+ + N +L ++ V+DFGLS+ I G +G L
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--IYSG--DYYRQGCASKLP 202
Query: 652 ----DPEYFRRQQLTEKSDVYSFGVVLLEVL 678
E T SDV++FGV + E++
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 490 IGVGGFGNVYLGEI------DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G G FG V+L E D VAVK + +FQ E ++L+ L+H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHL--------------YGKNLPPLSWKQRLEISIGS 589
G C + +I+V+EYM +G L + L Q L I+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA---VKG 646
A G+ YL +Q +HRD+ + N L+ N + K+ DFG+S+D V + G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD-------VYSTDYYRVG 192
Query: 647 SFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQV 693
L PE ++ T +SDV+SFGV+L E+ +P QL +V
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW--FQLSNTEV 244
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 489 IIGVGGFGNVYLGEIDDG-----TKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
++G G FG V+ G V +K Q + + L H H+V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L+G C +S + V +Y+ G DH+ ++ L + L + A+G++YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA-----VKGSFGYLDPEYF 656
G++HR++ + N+LL +V+DFG++ P + + +K ++ E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMALESI 189
Query: 657 RRQQLTEKSDVYSFGVVLLEVL 678
+ T +SDV+S+GV + E++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELM 211
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 489 IIGVGGFGNVYLGEI----DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSL 543
++G G FG V G + VA+K +E+ +F E ++ + H +++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
G ++ +++V EYM NG L K+ + Q + + G A G+ YL + G
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL--DPEYFRRQQL 661
+HRD+ + NIL++ N V KVSDFGL + T G PE ++
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 662 TEKSDVYSFGVVLLEVL 678
T SDV+S+G+VL EV+
Sbjct: 228 TSASDVWSYGIVLWEVM 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 489 IIGVGGFGNVYLGE-IDDG----TKVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVS 542
++G G FG VY G I +G VA+K S + E E +++ + + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L+G C ++ + + + M G D++ ++ + + L + A+G++YL +
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA-----VKGSFGYLDPEYFR 657
++HRD+ + N+L+ K++DFGL+K + +K ++ E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 658 RQQLTEKSDVYSFGVVLLEVL 678
+ T +SDV+S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 489 IIGVGGFGNVYLG-----EIDDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVS 542
+IG G FG VY G VA+K +E+ +F E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L G + M+++ EYM NG L + S Q + + G A G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY--LDPEYFRRQQ 660
+HRD+ + NIL++ N V KVSDFGLS+ T G PE ++
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 661 LTEKSDVYSFGVVLLEVL 678
T SDV+SFG+V+ EV+
Sbjct: 227 FTSASDVWSFGIVMWEVM 244
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 489 IIGVGGFGNVYLGEIDDG----TKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
I+G G FG+V G + KVAVK + + S++ I EF +E + H +++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 543 LIGYCDEN------SEMILVYEYMSNGPFRDHL----YGKNLPPLSWKQRLEISIGSARG 592
L+G C E M+++ +M G +L + + L+ + A G
Sbjct: 101 LLGVCIEMSSQGIPKPMVIL-PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL- 651
+ YL + + +HRD+ + N +L D+ V+DFGLSK I G +G +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--IYSGDYYR--QGRIAKMP 212
Query: 652 ----DPEYFRRQQLTEKSDVYSFGVVLLEVL 678
E + T KSDV++FGV + E+
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-36
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 14/197 (7%)
Query: 489 IIGVGGFGNVYLG----EIDDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSL 543
IG G FG+V+ G + VA+K S+ +F E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
IG EN I + E + G R L L + + + L YL ++
Sbjct: 457 IGVITENPVWI-IMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLE---SKR 511
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF--GYLDPEYFRRQQL 661
+HRD+ + N+L+ N K+ DFGLS+ + A KG ++ PE ++
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 662 TEKSDVYSFGVVLLEVL 678
T SDV+ FGV + E+L
Sbjct: 570 TSASDVWMFGVCMWEIL 586
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 73/336 (21%), Positives = 116/336 (34%), Gaps = 47/336 (13%)
Query: 423 HKRPQDWQRRNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFS-FQELQEAT 481
H D N + + L SF + +S + + + FQ L
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSR-- 64
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKL-RH 537
+G G +G V+ +DG AVKR + + E+ K+ +H
Sbjct: 65 --------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLP-PLSWKQRLEISIGSARGLH 594
V L +E + L E + H +G +LP W + L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDT----LLALA 171
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
+LH+ QG++H DVK NI L K+ DFGL + +G +G Y+ PE
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQEGDPRYMAPE 226
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714
+ +DV+S G+ +LEV C LP + L + + P
Sbjct: 227 LL-QGSYGTAADVFSLGLTILEVACNME-----LPHGGEGWQQ---------LRQGYLPP 271
Query: 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
++ E L+ L R T +L
Sbjct: 272 EFTAGLSSE-LRSV---LVMMLEPDPKLRATAEALL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 63/311 (20%), Positives = 110/311 (35%), Gaps = 62/311 (19%)
Query: 469 GRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGN-PQSEQGITEFQ 526
GRY + +F+ +G GGFG V+ + D A+KR P E +
Sbjct: 1 GRYLT---------DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM 51
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMI------------LVYEYMSNGPFRDHL-YGKN 573
E++ L+KL H +V E + + + +D +
Sbjct: 52 REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT 111
Query: 574 LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK-- 631
+ L I + A + +LH ++G++HRD+K +NI + V KV DFGL
Sbjct: 112 IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 632 ---------DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
P+ T G+ Y+ PE + K D++S G++L E+L
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS 228
Query: 683 AINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAE---KCLADH 739
R L + + P +K+ L+
Sbjct: 229 TQME-----------------RVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 740 GVDRPTMGDVL 750
++RP +++
Sbjct: 268 PMERPEAINII 278
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 489 IIGVGGFGNVYLGEIDDG------TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLV 541
+G G FG VY G T+VA+K N S + EF E ++ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHL--------YGKNLPPLSWKQRLEISIGSARGL 593
L+G + +++ E M+ G + +L L P S + ++++ A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 594 HYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL-- 651
YL+ A +HRD+ + N ++ +++ K+ DFG+++D I + KG G L
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYET--DYYRKGGKGLLPV 204
Query: 652 ---DPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQV 693
PE + T SDV+SFGVVL E+ L +P L EQV
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQV 249
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 61/284 (21%), Positives = 104/284 (36%), Gaps = 38/284 (13%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRHR 538
++++ IG G +G DG + K + +E +E+ +L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 539 HLVSLIG-YCDENSEMI-LVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLH 594
++V D + + +V EY G + K L + L + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 595 YLHT--GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
H ++HRD+K N+ LD K+ DFGL++ T V G+ Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712
PE R EKSD++S G +L E+ P + E L KI
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKE---------LAGKIR 229
Query: 713 DPHLVGTINP------ESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ G + L + + L RP++ ++L
Sbjct: 230 E----GKFRRIPYRYSDELNEI---ITRMLNLKDYHRPSVEEIL 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 49/287 (17%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL 540
+F +IG GGFG V+ + DG +KR +E + + E++ L+KL H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 541 VSLIGY----------------CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE 584
V G + + + E+ G + + L LE
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
+ +G+ Y+H+ + +I+RD+K +NI L D K+ DFGL + T
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDGKRTRS 181
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWK 703
KG+ Y+ PE Q ++ D+Y+ G++L E+L A
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------------------ 223
Query: 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ D + + + K +K L+ DRP ++L
Sbjct: 224 TSKFFTDLRDGIISDIFDKK-EKTL---LQKLLSKKPEDRPNTSEIL 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 59/305 (19%)
Query: 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGN--PQSEQGITEFQTEIQ 530
FQ + + + IG GG V+ + A+K N Q + ++ EI
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 531 MLSKLRH--RHLVSLIGYCDENSEMILVYEYMSNGPFRDHL-YGKNLPPLS----WKQRL 583
L+KL+ ++ L Y + + +V E N L K++ P WK L
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML 137
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-GHVST 642
E +H +H GI+H D+K N L+ D + K+ DFG++ V
Sbjct: 138 E-------AVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKD 186
Query: 643 AVKGSFGYLDPE-----------YFRRQQLTEKSDVYSFGVVLLEVLCARP---AINPQL 688
+ G+ Y+ PE + +++ KSDV+S G +L + + I Q+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 689 PREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP---ESLKKFAEAAEKCLADHGVDRPT 745
+ L IIDP+ + L+ + CL R +
Sbjct: 247 SK-----------------LHAIIDPNHEIEFPDIPEKDLQDV---LKCCLKRDPKQRIS 286
Query: 746 MGDVL 750
+ ++L
Sbjct: 287 IPELL 291
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 64/303 (21%), Positives = 118/303 (38%), Gaps = 58/303 (19%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
+F+ A++G G FG V D A+K+ +E+ ++ +E+ +L+ L H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 540 LVSLIG-YCDENSEMI------------LVYEYMSNGPFRDHLYGKNLPP---LSWKQRL 583
+V + + + + + EY NG D ++ +NL W+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK------------ 631
+I L Y+H +QGIIHRD+K NI +D++ K+ DFGL+K
Sbjct: 124 QI----LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 632 --DAPIGQGHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCA-RPAINPQ 687
+ P ++++A+ G+ Y+ E EK D+YS G++ E++ +
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 688 LPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMG 747
+++ R P KK + RP
Sbjct: 236 NILKKL----------RSV--SIEFPPDFDDNKMKV-EKKI---IRLLIDHDPNKRPGAR 279
Query: 748 DVL 750
+L
Sbjct: 280 TLL 282
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-35
Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 490 IGVGGFGNVYLGE---IDDGTKVAVKRGNP-QSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G G FG+V G VA+K + E E Q++ +L + ++V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605
C + M+ V E GP L + E+ + G+ YL + +
Sbjct: 404 VCQAEALML-VMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL---EEKNFV 458
Query: 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY--LDPEYFRRQQLTE 663
HR++ + N+LL + + AK+SDFGLSK + + G + PE ++ +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 664 KSDVYSFGVVLLEVL 678
+SDV+S+GV + E L
Sbjct: 519 RSDVWSYGVTMWEAL 533
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 35/220 (15%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK-----------------RGNPQSEQGITEFQTEIQML 532
+ G F + L E D A+K + +F+ E+Q++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 533 SKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR- 591
+ +++ + ++ G E+ ++YEYM N L I I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF--VLDKNYTCFIPIQVIKC 155
Query: 592 -------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
Y+H + I HRDVK +NIL+D N K+SDFG S+ + +
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR 211
Query: 645 KGSFGYLDPEYFRRQQLT--EKSDVYSFGVVLLEVLCARP 682
G++ ++ PE+F + K D++S G+ L +
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 64/285 (22%), Positives = 109/285 (38%), Gaps = 53/285 (18%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRH--RHLVSLIG 545
IG GG V+ + A+K N Q + ++ EI L+KL+ ++ L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 546 YCDENSEMILVYEYMSNGPFRDHL-YGKNLPPLS----WKQRLEISIGSARGLHYLHTGT 600
Y + + +V E N L K++ P WK LE +H +H
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH--- 125
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD-APIGQGHVSTAVKGSFGYLDPE----- 654
GI+H D+K N L+ D + K+ DFG++ P V + G+ Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 655 ------YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708
+ +++ KSDV+S G +L + + P + + L
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT---P-----------FQQIINQISKL 230
Query: 709 EKIIDPHLVGTINP---ESLKKFAEAAEKCLADHGVDRPTMGDVL 750
IIDP+ + L+ + CL R ++ ++L
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDV---LKCCLKRDPKQRISIPELL 272
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 50/232 (21%), Positives = 93/232 (40%), Gaps = 37/232 (15%)
Query: 490 IGVGGFGNVYLGEIDDG------TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVS 542
+G FG VY G + VA+K + EF+ E + ++L+H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL--------------YGKNLPPLSWKQRLEISIG 588
L+G ++ + +++ Y S+G + L L + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF 648
A G+ YL ++ ++H+D+ + N+L+ D K+SD GL ++ +
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAA--DYYKLLGN 189
Query: 649 GYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQV 693
L PE + + SD++S+GVVL EV +P + V
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--CGYSNQDV 239
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 489 IIGVGGFGNVYLGEIDDG------TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLV 541
+G G FG V T VAVK S + + +E +L ++ H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHL----------------------YGKNLPPLSW 579
L G C ++ ++L+ EY G R L + L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 580 KQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639
+ + ++G+ YL ++HRD+ + NIL+ + K+SDFGLS+D + +
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD--VYEED 204
Query: 640 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
VK S G + E T +SDV+SFGV+L E+
Sbjct: 205 S--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 67/266 (25%), Positives = 114/266 (42%), Gaps = 56/266 (21%)
Query: 469 GRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDD---GTKVAVKRGNPQ---SEQGI 522
RY ++ + +G GG VYL E D KVA+K E+ +
Sbjct: 11 ERY----KIVD---------KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETL 55
Query: 523 TEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQR 582
F+ E+ S+L H+++VS+I +E+ LV EY+ +++ ++ PLS
Sbjct: 56 KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTA 113
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK---DAPIGQGH 639
+ + G+ + H I+HRD+K NIL+D N K+ DFG++K + + Q
Sbjct: 114 INFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-- 168
Query: 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP----------------- 682
+ V G+ Y PE + + E +D+YS G+VL E+L P
Sbjct: 169 -TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD 227
Query: 683 -------AINPQLPREQVNLAEWAMQ 701
+ +P+ N+ A +
Sbjct: 228 SVPNVTTDVRKDIPQSLSNVILRATE 253
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 59/217 (27%), Positives = 109/217 (50%), Gaps = 36/217 (16%)
Query: 490 IGVGGFGNVYLGEI--------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRH 539
+G G FG V + E + VAVK +E+ +++ +E++M+ + +H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHL--------------YGKNLPPLSWKQRLEI 585
+++L+G C ++ + ++ EY S G R++L +++K +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
+ ARG+ YL +Q IHRD+ + N+L+ +N V K++DFGL++D I K
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD--INNIDYYK--K 215
Query: 646 GSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
+ G L PE + T +SDV+SFGV++ E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 33/214 (15%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRH--RHLVSLIG 545
IG GG V+ + A+K N Q + ++ EI L+KL+ ++ L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 546 YCDENSEMILVYEYMSNGPFRDHLY-GKNLPPLS----WKQRLEISIGSARGLHYLHTGT 600
Y + + +V E N L K++ P WK LE +H +H
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH--- 172
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD-APIGQGHVSTAVKGSFGYLDPE----- 654
GI+H D+K N L+ D + K+ DFG++ P V + G+ Y+ PE
Sbjct: 173 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 655 ------YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ +++ KSDV+S G +L + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 79/301 (26%), Positives = 118/301 (39%), Gaps = 64/301 (21%)
Query: 489 IIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLV 541
+G G FG VY G++ +VAVK SEQ +F E ++SK H+++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHL-----YGKNLPPLSWKQRLEISIGSARGLHYL 596
IG ++ ++ E M+ G + L L+ L ++ A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 597 HTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL-- 651
IHRD+ + N LL VAK+ DFG+++D S KG L
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY----RASYYRKGGCAMLPV 209
Query: 652 ---DPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQVNLAEWAMQWKRKG 706
PE F T K+D +SFGV+L E+ L P P ++V +++ G
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV------LEFVTSG 261
Query: 707 -LLEKIID-PHLVGTI-------NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757
++ + P V I PE DRP +L +EY
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPE------------------DRPNFAIILERIEYCT 303
Query: 758 Q 758
Q
Sbjct: 304 Q 304
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 36/218 (16%)
Query: 489 IIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHL 540
+G G FG V D VAVK P +E+++LS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHL----------------YGKNLPPLSWKQRLE 584
V+L+G C +++ EY G + L + L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
S A+G+ +L ++ IHRD+ + NILL + K+ DFGL++D I
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKNDSNYV-- 202
Query: 645 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
L PE T +SDV+S+G+ L E+
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 489 IIGVGGFGNVYLGEI--------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHR 538
+G G FG V + E + VAVK +E+ +++ +E++M+ + +H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHL--------------YGKNLPPLSWKQRLE 584
++++L+G C ++ + ++ EY S G R++L +++K +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
+ ARG+ YL +Q IHRD+ + N+L+ +N V K++DFGL++D I
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD--INNI--DYYK 260
Query: 645 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
K + G L PE + T +SDV+SFGV++ E+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 489 IIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHL 540
+G G FG V D KVAVK +E++++S L +H ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHL------------YGKNLPPLSWKQRLEISIG 588
V+L+G C ++++ EY G + L + S + L S
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF 648
A+G+ +L ++ IHRDV + N+LL + +VAK+ DFGL++D I S +
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD--IMND--SNYIVKGN 225
Query: 649 GYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
L PE T +SDV+S+G++L E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 489 IIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHL 540
++G G FG V +VAVK + +E++M+++L H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHL---------------------YGKNLPPLSW 579
V+L+G C + + L++EY G ++L ++L L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 580 KQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639
+ L + A+G+ +L + +HRD+ + N+L+ V K+ DFGL++D I
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMSDS 226
Query: 640 VSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
V L PE T KSDV+S+G++L E+
Sbjct: 227 N--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSLIGY 546
I+G G NV+ G G A+K N S + E ++L KL H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 547 --CDENSEMILVYEYMSNGPFRDHLYGK-NLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+L+ E+ G L N L + L + G+++L G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 604 IIHRDVKSTNILL----DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
I+HR++K NI+ D V K++DFG +++ + ++ G+ YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 660 QL--------TEKSDVYSFGVVLLEVLCARP 682
L D++S GV
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-34
Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVK----RGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
+G GGFG V D G +VA+K +P++ + EIQ++ KL H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSA 77
Query: 544 I------GYCDENSEMILVYEYMSNGPFRDHLYGK-NLPPLSWKQRLEI--SIGSARGLH 594
N +L EY G R +L N L + I SA L
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LR 135
Query: 595 YLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
YLH IIHRD+K NI+L + K+ D G +K+ + QG + T G+ YL
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFVGTLQYL 190
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ 692
PE +++ T D +SFG + E + P Q
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 489 IIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHL 540
+G G FG V + VAVK + +E+++L + H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 541 VSLIGYC-DENSEMILVYEYMSNGPFRDHL--------------YGKNLPPLSWKQRLEI 585
V+L+G C ++++ E+ G +L L+ + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
S A+G+ +L ++ IHRD+ + NILL + V K+ DFGL++D I + +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPDYV--R 206
Query: 646 GSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
L PE + T +SDV+SFGV+L E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 31/227 (13%)
Query: 489 IIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLV 541
+G G FG VY G++ +VAVK SEQ +F E ++SK H+++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHL-----YGKNLPPLSWKQRLEISIGSARGLHYL 596
IG ++ ++ E M+ G + L L+ L ++ A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 597 HTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL-- 651
IHRD+ + N LL VAK+ DFG+++D KG L
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY----RAGYYRKGGCAMLPV 250
Query: 652 ---DPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQV 693
PE F T K+D +SFGV+L E+ L P P ++V
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 64/240 (26%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 490 IGVGGFGNVYLGEIDDG------TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVS 542
IG G FG V+ T VAVK + S +FQ E ++++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL----------------------YGKNLPPLSWK 580
L+G C M L++EYM+ G + L PPLS
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 581 QRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640
++L I+ A G+ YL + + +HRD+ + N L+ +N V K++DFGLS++ I
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN--IYSA-- 227
Query: 641 STAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV--LCARPAINPQLPREQV 693
+ PE + T +SDV+++GVVL E+ +P + E+V
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY--YGMAHEEV 285
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-33
Identities = 69/391 (17%), Positives = 117/391 (29%), Gaps = 69/391 (17%)
Query: 453 KCGSHKSGFTNSTLGL---GRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEID---DG 506
CGS S G G+Y E++ I GG G +YL D +G
Sbjct: 61 YCGSPYSFLPQLNPGDIVAGQY----EVKG---------CIAHGGLGWIYLAL-DRNVNG 106
Query: 507 TKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSLIGYCDENSEMI-----LVYEYM 560
V +K + E Q L+++ H +V + + + +V EY+
Sbjct: 107 RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY 620
+ L + + + L YLH + G+++ D+K NI+L +
Sbjct: 167 GGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQ 219
Query: 621 VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA 680
+ K+ D G I + G+ G+ PE R T +D+Y+ G L +
Sbjct: 220 L-KLIDLGAVS--RINS---FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLD 272
Query: 681 RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHG 740
P N + + + V + + +
Sbjct: 273 LPTRNGRYVDG-------------------LPEDDPVLKTYDS----YGRLLRRAIDPDP 309
Query: 741 VDRPT----MGDVLWNLEYALQLQEAFTQ--GKAEEESQSAATAAASPAAVAAPAATSAS 794
R T M L + + Q+ G + S S +T
Sbjct: 310 RQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQ 369
Query: 795 DDRPVSAPKENVGPAEVHAIDEHSGTAMFAQ 825
E V V +D A Q
Sbjct: 370 VHAEKLTANEIVTALSVPLVDPTDVAASVLQ 400
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 73/324 (22%), Positives = 114/324 (35%), Gaps = 70/324 (21%)
Query: 455 GSHKSGFTNSTLG--LGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDD---GTKV 509
GSH G S G G Y L+ ++G GG G+VY E D V
Sbjct: 18 GSHMDGTAESREGTQFGPY----RLRR---------LVGRGGMGDVYEAE--DTVRERIV 62
Query: 510 AVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFR 566
A+K + T Q E + +L+ H+V + + + + ++ + ++
Sbjct: 63 ALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLA 122
Query: 567 DHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSD 626
L + PL+ + + I L H A G HRDVK NIL+ + A + D
Sbjct: 123 AML--RRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVD 177
Query: 627 FGLSK---DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP- 682
FG++ D + Q G+ Y+ PE F T ++D+Y+ VL E L P
Sbjct: 178 FGIASATTDEKLTQ---LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 683 ---------------------AINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721
+ P +P + M K +P
Sbjct: 235 YQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMA-K---------NPED----R 280
Query: 722 PESLKKFAEAAEKCLADHGVDRPT 745
+ + AA LA DR T
Sbjct: 281 YVTCGDLSAAAHAALATADQDRAT 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-33
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 36/217 (16%)
Query: 490 IGVGGFGNVYLGEI--------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRH 539
+G G FG V L E + TKVAVK +E+ +++ +E++M+ + +H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHL--------------YGKNLPPLSWKQRLEI 585
+++L+G C ++ + ++ EY S G R++L LS K +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
+ ARG+ YL ++ IHRD+ + N+L+ ++ V K++DFGL++D H+ K
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 249
Query: 646 GSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLLEV 677
+ G L PE + T +SDV+SFGV+L E+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 77/276 (27%), Positives = 108/276 (39%), Gaps = 58/276 (21%)
Query: 462 TNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDD---GTKVAVKRGNPQ- 517
T S L RY EL E I+G GG V+L D VAVK
Sbjct: 6 TPSHLS-DRY----ELGE---------ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADL 49
Query: 518 --SEQGITEFQTEIQMLSKLRHRHLVSL--IGYCDENSEMILVY---EYMSNGPFRDHLY 570
F+ E Q + L H +V++ G E L Y EY+ RD +
Sbjct: 50 ARDPSFYLRFRREAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIV- 107
Query: 571 GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630
P++ K+ +E+ + + L++ H GIIHRDVK NI++ KV DFG++
Sbjct: 108 -HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 163
Query: 631 KDAPIGQGHV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP------ 682
+ V + AV G+ YL PE R + +SDVYS G VL EVL P
Sbjct: 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 683 -----------------AINPQLPREQVNLAEWAMQ 701
A + L + + A+
Sbjct: 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALA 259
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSLIGY 546
I+G G NV+ G G A+K N S + E ++L KL H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 547 --CDENSEMILVYEYMSNGPFRDHLYGK-NLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
+L+ E+ G L N L + L + G+++L G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 604 IIHRDVKSTNILL----DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
I+HR++K NI+ D V K++DFG +++ + ++ G+ YL P+ + R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 660 QL--------TEKSDVYSFGVVLLEVLCARP 682
L D++S GV
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
++G G +G VY G ++ + ++A+K + + EI + L+H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSW---------KQRLEISIGSARGLHYLHT 598
EN + + E + G L PL KQ LE GL YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLH- 139
Query: 599 GTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
I+HRD+K N+L++ + V K+SDFG SK T G+ Y+ PE
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIID 196
Query: 658 RQQL--TEKSDVYSFGVVLLEVLCARP 682
+ + +D++S G ++E+ +P
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 48/208 (23%), Positives = 88/208 (42%), Gaps = 19/208 (9%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLV 541
+F ++G G G + + D VAVKR P+ E+Q+L + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+ + E + ++++ K+ + + + + GL +LH +
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---S 136
Query: 602 QGIIHRDVKSTNILL-----DDNYVAKVSDFGLSKDAPIGQG--HVSTAVKGSFGYLDPE 654
I+HRD+K NIL+ A +SDFGL K +G+ + V G+ G++ PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 655 YFRR---QQLTEKSDVYSFGVVLLEVLC 679
+ T D++S G V V+
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK-------RGNPQSEQGITEFQTEIQMLS 533
++F+ +G G FGNVYL E +A+K Q + E+++ S
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ----LRREVEIQS 64
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSAR 591
LRH +++ L GY + + + L+ EY G L K + E+ A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL----AN 120
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
L Y H ++ +IHRD+K N+LL K++DFG S AP + G+ YL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC-GTLDYL 174
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
PE + EK D++S GV+ E L +P
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 35/331 (10%), Positives = 80/331 (24%), Gaps = 54/331 (16%)
Query: 476 ELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQM 531
L + + + VG V+L +++ A+K G S +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 532 LSKLRHRHLVSLIGYC--------------------------DENSEMILVYEYMS---- 561
++L + +L+ S
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621
++ R L ++G++H N+ + +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGR 232
Query: 622 AKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLLEVLC 679
+ D G A Y E+ T + + G+ + V C
Sbjct: 233 LMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 680 ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADH 739
P + + +++ L L P+ +K + L
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL-----PDFVKTL---IGRFLNFD 340
Query: 740 GVDRPTMGDVL---WNLEYALQLQEAFTQGK 767
R + + L+ ++ + + G+
Sbjct: 341 RRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHR 538
+FD +G G FGNVYL E + +A+K + + E + + EI++ S LRH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHYL 596
+++ + Y + + L+ E+ G L +G+ S E+ A LHY
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALHYC 130
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYF 656
H + +IHRD+K N+L+ K++DFG S AP + G+ YL PE
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMI 184
Query: 657 RRQQLTEKSDVYSFGVVLLEVLCARP 682
+ EK D++ GV+ E L P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-31
Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 478 QEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-R 536
Q S I+G G G V G VAVKR EI++L++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDD 67
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS-----AR 591
H +++ + + + E N +D + KN+ + K + E + S A
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLD-------------DNYVAKVSDFGLSKDAPIGQG 638
G+ +LH + IIHRD+K NIL+ +N +SDFGL K GQ
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 639 HVSTAVK---GSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLLEVLC 679
T + G+ G+ PE +++LT D++S G V +L
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 26/205 (12%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G GGF + + D A K + + EI + L H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLH 597
+ ++N + +V E + K+R ++ AR G YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH----------KRRKALTEPEARYYLRQIVLGCQYLH 132
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
+IHRD+K N+ L+++ K+ DFGL+ G+ Y+ PE
Sbjct: 133 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLS 188
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
++ + + DV+S G ++ +L +P
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 30/187 (16%), Positives = 57/187 (30%), Gaps = 30/187 (16%)
Query: 196 QYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPA 255
+ ++ +N GG S D G + D + + P
Sbjct: 5 KVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNP-------EDQ 54
Query: 256 TVYSSASMMADSHTVQPNFNVTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKT 315
+Y + + + + Y+L L F ++ F+V VNG T
Sbjct: 55 VLYQTERYN--------EDSFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHT 106
Query: 316 AISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPNKEN---------TGTRNAIL 366
+ LD+ G +T + I ++ L+VQ + N +
Sbjct: 107 VVKDLDIFDRV-GHSTAHDEIIPISIK--KGKLSVQGEVSTFTGKLSVEFVKGYYDNPKV 163
Query: 367 NGLEVIK 373
L ++K
Sbjct: 164 CALFIMK 170
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 16/167 (9%), Positives = 47/167 (28%), Gaps = 34/167 (20%)
Query: 36 FLIDCGGKSSNPLPDGRTFKSDKEALPFLQT---KEDIQVSVPSADVPSPIYLSARVFKE 92
+ ++ GG+S G ++ D + + + + + +Y + R ++
Sbjct: 8 WAVNAGGESHVD-VHGIHYRKDPLEGRVGRASDYGMKLPILRSNPE-DQVLYQTERYNED 65
Query: 93 ESTYTFQLNQPGWHWVRLHFF------------------ALPAKEADLQKAS-------- 126
Y + + G + + L F K+ D+
Sbjct: 66 SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDE 125
Query: 127 ---FHVATDNCCEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAP 170
+ + ++ S++F + A+ ++
Sbjct: 126 IIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGT 172
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 38/248 (15%), Positives = 73/248 (29%), Gaps = 24/248 (9%)
Query: 456 SHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGE------IDDGTKV 509
S L E Q +K ++G G F VY + K
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 510 AVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL 569
+K P + ++ L + + +LV E S G + +
Sbjct: 99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 570 ---YGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA---- 622
+ + ++ + +H IIH D+K N +L + ++
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 623 -------KVSDFGLSKDAPI-GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 674
+ D G S D + +G + TA + G+ E + + D + +
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
Query: 675 LEVLCARP 682
+L
Sbjct: 276 YCMLFGTY 283
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 26/213 (12%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRH 537
+ + +G GGF + + D A K + + EI + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR------ 591
+H+V G+ ++N + +V E + K+R ++ AR
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----------KRRKALTEPEARYYLRQI 150
Query: 592 --GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
G YLH +IHRD+K N+ L+++ K+ DFGL+ G+
Sbjct: 151 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPN 206
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Y+ PE ++ + + DV+S G ++ +L +P
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 50/220 (22%), Positives = 83/220 (37%), Gaps = 30/220 (13%)
Query: 476 ELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSK 534
E +E +G G FG V+ + G + AVK+ + + E+ +
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAG 106
Query: 535 LRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQRLEISI 587
L +V L G E + + E + G + K + L Q LE
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALE--- 161
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSK----DAPIGQGHVST 642
GL YLH + I+H DVK+ N+LL + A + DFG + D
Sbjct: 162 ----GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ G+ ++ PE + K D++S ++L +L
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRH 537
++F ++G G F VY I G +VA+K + + Q E+++ +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLP-PLSWKQRLEISIGSARGLH 594
++ L Y ++++ + LV E NG +L K + +I G+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGML 126
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
YLH + GI+HRD+ +N+LL N K++DFGL+ + T G+ Y+ PE
Sbjct: 127 YLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPE 182
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
R +SDV+S G + +L RP
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 8e-30
Identities = 49/354 (13%), Positives = 92/354 (25%), Gaps = 65/354 (18%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLR------- 536
++G + G V I + + E+ L LR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 537 ---HRHLVSLI-------------GYCDENSEMILVY------EYMSNGPFRDHL--YGK 572
H + DE +L + F + L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 573 NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632
L RL++++ R L LH G++H ++ +I+LD ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLLEVLCARPAINPQ 687
Q +T D ++ G+ + + CA P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL---PN 317
Query: 688 LPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMG 747
+ +EW + ++ P+ ++ E L DR
Sbjct: 318 TDDAALGGSEWIFR----------SCKNI-----PQPVRAL---LEGFLRYPKEDRLLPL 359
Query: 748 DVLWNLEYALQLQEAFTQGKAEEESQSAATAAASPAAVAAPAATSASDDRPVSA 801
+ EY QL+ + ++ T A V+A
Sbjct: 360 QAMETPEYE-QLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 53/256 (20%), Positives = 93/256 (36%), Gaps = 36/256 (14%)
Query: 452 SKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVA 510
G +S F T+ LG ++ GGF VY + + G + A
Sbjct: 9 GASGRDQSDFVGQTVELGEL-----------RLRVRRVLAEGGFAFVYEAQDVGSGREYA 57
Query: 511 VKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYC--------DENSEMILVYEYMS 561
+KR E+ E+ + KL H ++V +E +L+ E
Sbjct: 58 LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621
++ PLS L+I + R + ++H IIHRD+K N+LL +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGT 176
Query: 622 AKVSDFGLSKDAPIGQGHVSTAVK-----------GSFGYLDPE---YFRRQQLTEKSDV 667
K+ DFG + + +A + + Y PE + + EK D+
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236
Query: 668 YSFGVVLLEVLCARPA 683
++ G +L + +
Sbjct: 237 WALGCILYLLCFRQHP 252
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 48/206 (23%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
+ ++ +G G FG VY + G A K +SE+ + ++ EI++L+ H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V L+G + ++ ++ E+ G + + L+ Q + L++LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH-- 134
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF-G---YLDPE- 654
++ IIHRD+K+ N+L+ +++DFG+S + + + SF G ++ PE
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 655 ----YFRRQQLTEKSDVYSFGVVLLE 676
+ K+D++S G+ L+E
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
+ FD +G G +G+VY + G VA+K+ +S+ + E EI ++ + H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V G +N+++ +V EY G D + L+ + I + +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF- 143
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF-G---YLDPEY 655
IHRD+K+ NILL+ AK++DFG++ GQ + A + + G ++ PE
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 656 FRRQQLTEKSDVYSFGVVLLE 676
+ +D++S G+ +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 44/229 (19%), Positives = 83/229 (36%), Gaps = 34/229 (14%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKL-R 536
T F IG G FG+V+ + DG A+KR E+ + L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLH 594
H H+V E+ M++ EY + G D + + + + ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDN-------------------YVAKVSDFGLSKDAPI 635
Y+H + ++H D+K +NI + + K+ D G
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 636 GQGHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPA 683
+ +G +L E + K+D+++ + ++ A P
Sbjct: 183 -RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
K F ++G G F V+L + G A+K + + EI +L K++H +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHL-----YGKNLPPLSWKQRLEISIGSARGLH 594
+V+L + + LV + +S G D + Y + L +Q L +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AVK 120
Query: 595 YLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
YLH GI+HRD+K N+L ++N ++DFGLSK G +STA G+ GY+
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTAC-GTPGYV 174
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
PE ++ ++ D +S GV+ +LC P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 15/209 (7%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLR 536
+ + ++G G FG V L + G + AVK + + + E+Q+L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
H +++ L + ++ LV E + G D + + S I G+ Y+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYM 142
Query: 597 HTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDP 653
H I+HRD+K N+LL + ++ DFGLS G+ Y+ P
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTAYYIAP 197
Query: 654 EYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
E EK DV+S GV+L +L P
Sbjct: 198 EVLHG-TYDEKCDVWSTGVILYILLSGCP 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
+D +G G FG V+ E G K N + EI ++++L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 540 LVSLIGYCDENSEMILVYEYMSNGP-F-----RDHLYGKNLPPLSWKQRLEISIGSARGL 593
L++L ++ EM+L+ E++S G F D+ + +Q E GL
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GL 162
Query: 594 HYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY 650
++H I+H D+K NI+ + V K+ DFGL+ + + + +
Sbjct: 163 KHMH---EHSIVHLDIKPENIMCETKKASSV-KIIDFGLATK--LNPDEIVKVTTATAEF 216
Query: 651 LDPEYFRRQQLTEKSDVYSFGVVLLEVLC 679
PE R+ + +D+++ GV+ +L
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
K + IG G G VY ++ G +VA+++ N Q + EI ++ + ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V+ + E+ +V EY++ G D + + Q + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH-- 133
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
+ +IHRD+KS NILL + K++DFG Q ST V G+ ++ PE R+
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 660 QLTEKSDVYSFGVVLLE 676
K D++S G++ +E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 42/274 (15%), Positives = 80/274 (29%), Gaps = 55/274 (20%)
Query: 456 SHKSGFTNSTLGLGRYFSFQ-ELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK- 512
+ S + S G+ F + EL E + ++G + + G V
Sbjct: 46 AADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHV 105
Query: 513 --RGNPQSEQGITEFQTEIQMLSKLR-------------------------HRHLVSLIG 545
I + + E+ L LR + ++ +
Sbjct: 106 PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 165
Query: 546 -YCDENSEMILVYEYMSNGPFRDHL-----YGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
D + + L RL++++ R L LH
Sbjct: 166 DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-- 223
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYF--- 656
G++H ++ +I+LD ++ F G + S G+ PE
Sbjct: 224 -HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD----GARVVSS-VSRGFEPPELEARR 277
Query: 657 --------RRQQLTEKSDVYSFGVVLLEVLCARP 682
RR +T D ++ G+V+ + CA
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 64/240 (26%), Positives = 98/240 (40%), Gaps = 45/240 (18%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK-------RGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
+G G +G V + + AVK R P E + + EIQ+L +LRH++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV---KKEIQLLRRLRHKNVI 69
Query: 542 SL--IGYCDENSEMILVYEYMSNGPFR--DHLYGKNLP-PLSWK--QRLEISIGSARGLH 594
L + Y +E +M +V EY G D + K P + +L I GL
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL-ID-----GLE 123
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS-KDAPIGQGHVSTAVKGSFGYLDP 653
YLH +QGI+H+D+K N+LL K+S G++ P +GS + P
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 654 EYFRRQQLTE--KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
E K D++S GV L + P E N+ + L E I
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL------YPFEGDNIYK---------LFENI 225
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 8/197 (4%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
DS IG G G V L E G +VAVK + + +Q E+ ++ +H +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V + E+ ++ E++ G D + + L+ +Q + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQV--RLNEEQIATVCEAVLQALAYLH-- 158
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
AQG+IHRD+KS +ILL + K+SDFG + V G+ ++ PE R
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRS 216
Query: 660 QLTEKSDVYSFGVVLLE 676
+ D++S G++++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRH 537
++ + +G G +G V L + + A+K R S ++ E+ +L L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
+++ L + ++ LV E G D + + + I G+ YLH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH 153
Query: 598 TGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
I+HRD+K N+LL + + + K+ DFGLS G+ Y+ PE
Sbjct: 154 ---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTAYYIAPE 208
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
R+ + EK DV+S GV+L +L P
Sbjct: 209 VLRK-KYDEKCDVWSIGVILFILLAGYP 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-28
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 46/249 (18%)
Query: 465 TLGLGRYFSFQELQEATKNFDSSAI---------IGVGGFGNVYLG-EIDDGTKVAVK-- 512
+L + F F +L ++ A+ +G G G V L E KVA++
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 513 ------RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFR 566
G+ + +TEI++L KL H ++ + + D +V E M G
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELF 227
Query: 567 DHLYGKNLPPLS-------WKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL--- 616
D + G L + Q L + YLH GIIHRD+K N+LL
Sbjct: 228 DKVVGNK--RLKEATCKLYFYQMLL-------AVQYLHE---NGIIHRDLKPENVLLSSQ 275
Query: 617 DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE---YFRRQQLTEKSDVYSFGVV 673
+++ + K++DFG SK +G+ + + G+ YL PE D +S GV+
Sbjct: 276 EEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 674 LLEVLCARP 682
L L P
Sbjct: 334 LFICLSGYP 342
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 48/239 (20%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK-----RGNPQSEQGITEFQTEIQMLSKLRHRHLVSL 543
IG G F V L I G +VA+K + NP S Q + E++++ L H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEIS--------IGSARGLHY 595
+ + L+ EY S G D+L R++ I SA + Y
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL--------VAHGRMKEKEARSKFRQIVSA--VQY 129
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY 655
H + I+HRD+K+ N+LLD + K++DFG S + +G + G+ Y PE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPEL 184
Query: 656 FRRQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713
F+ ++ + DV+S GV+L ++ LP + NL E L E+++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKE---------LRERVLR 228
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGN-PQSEQGITEFQTEIQMLSKLRHR 538
+ F IG G FG V+ G + VA+K + ++E I + Q EI +LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
++ G +++++ ++ EY+ G D L PL Q I +GL YLH+
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS 137
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF-G---YLDPE 654
+ IHRD+K+ N+LL ++ K++DFG++ GQ + + +F G ++ PE
Sbjct: 138 ---EKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPE 189
Query: 655 YFRRQQLTEKSDVYSFGVVLLE 676
++ K+D++S G+ +E
Sbjct: 190 VIKQSAYDSKADIWSLGITAIE 211
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 48/212 (22%), Positives = 81/212 (38%), Gaps = 29/212 (13%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVK-----RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+IG G F V + G + AVK + + + E + L+H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHL--YGKNLPPLS-------WKQRLEISIGSARGL 593
L+ + + +V+E+M + S +Q LE L
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 143
Query: 594 HYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGY 650
Y H IIHRDVK +LL +++ K+ FG++ V G+ +
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHF 199
Query: 651 LDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ PE +R+ + DV+ GV+L +L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 29/227 (12%)
Query: 477 LQEATKNFDS----SAIIGVGGFGNVYLG-EIDDGTKVAVK-------------RGNPQS 518
+++ +G G +G V L E + ++ A+K N
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 519 EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS 578
E+ E EI +L L H +++ L ++ LV E+ G + + ++
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFD 144
Query: 579 WKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPI 635
I G+ YLH I+HRD+K NILL + K+ DFGLS
Sbjct: 145 ECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--F 199
Query: 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ + G+ Y+ PE ++ + EK DV+S GV++ +LC P
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK------RGNPQSEQGITEFQTEIQMLS 533
+D +G G F V E G + A K + E + E+ +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNG------PFRDHLYGKNLPPLSWKQRLEISI 587
++ H ++++L + ++++L+ E +S G ++ L + KQ L+
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD--- 126
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSKDAPIGQGHVSTA 643
G++YLH + I H D+K NI+L K+ DFGL+ + I G
Sbjct: 127 ----GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKN 177
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC 679
+ G+ ++ PE + L ++D++S GV+ +L
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 65/248 (26%), Positives = 100/248 (40%), Gaps = 37/248 (14%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSLIGYC 547
+G G +G V L VAVK + + E + EI + L H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLHTG 599
E + L EY S G D + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--------EPDIGM--PEPDAQRFFHQLMAGVVYLH-- 122
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ--GHVSTAVKGSFGYLDPEYFR 657
GI HRD+K N+LLD+ K+SDFGL+ ++ G+ Y+ PE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 658 RQQLT-EKSDVYSFGVVLLEVLCAR-----PAINPQLPREQVNLAEWAMQWKR-----KG 706
R++ E DV+S G+VL +L P+ + Q + + WK+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 707 LLEKIIDP 714
LL KI+
Sbjct: 241 LLHKILVE 248
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 61/229 (26%), Positives = 92/229 (40%), Gaps = 41/229 (17%)
Query: 478 QEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--------RGNPQSEQGITEFQTE 528
+ + S +G G G V L E KVA+K G+ + +TE
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 529 IQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP-F-----RDHLY---GKNLPPLSW 579
I++L KL H ++ + + D +V E M G F L K +
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY----F 120
Query: 580 KQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIG 636
Q L + YLH GIIHRD+K N+LL +++ + K++DFG SK +G
Sbjct: 121 YQMLL-------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILG 168
Query: 637 QGHVSTAVKGSFGYLDPE---YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ + + G+ YL PE D +S GV+L L P
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---------RGNPQSEQGITEFQTEIQ 530
+N++ I+G G V + AVK + ++ E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 531 MLSKL-RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQR 582
+L K+ H +++ L + N+ LV++ M G D+L K LS +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRAL 133
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
LE + LH I+HRD+K NILLDD+ K++DFG S + G
Sbjct: 134 LE-------VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLR 181
Query: 643 AVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
V G+ YL PE ++ D++S GV++ +L P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGN-PQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G V KVA+KR N + + + E EIQ +S+ H ++VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL-EISIGSA-----RGLHYLHTGTA 601
E+ LV + +S G D + L E +I + GL YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF-G---YLDPEYFR 657
G IHRDVK+ NILL ++ +++DFG+S G V+ +F G ++ PE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 658 RQQL-TEKSDVYSFGVVLLE 676
+ + K+D++SFG+ +E
Sbjct: 200 QVRGYDFKADIWSFGITAIE 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
+ I+G G FG V+ E G K+A K + + E + EI ++++L H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 542 SLIGYCDENSEMILVYEYMSNGP-F-----RDHLYGKNLPPLSWKQRLEISIGSARGLHY 595
L + ++++LV EY+ G F + + L KQ E G+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIRH 202
Query: 596 LHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
+H I+H D+K NIL D + K+ DFGL++ G+ +L
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARR--YKPREKLKVNFGTPEFLA 256
Query: 653 PEYFRRQQLTEKSDVYSFGVVL 674
PE ++ +D++S GV+
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 70/262 (26%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK---------------RGNPQSEQGITEFQT------ 527
IG G +G V L +D T A+K R P+ +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 528 -----EIQMLSKLRHRHLVSLIGYCDENSE--MILVYEYMSNGPFRDHLYGKNLPPLSWK 580
EI +L KL H ++V L+ D+ +E + +V+E ++ GP + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME---------VPTL 131
Query: 581 QRLEISIGSAR--------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632
+ L S AR G+ YLH Q IIHRD+K +N+L+ ++ K++DFG+S +
Sbjct: 132 KPL--SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLLEVLCARPAINPQLP 689
+S V G+ ++ PE + + DV++ GV L + + P
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ------CP 239
Query: 690 REQVNLAEWAMQWKRKGLLEKI 711
+ L KI
Sbjct: 240 FMDERIMC---------LHSKI 252
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK------RGNPQSEQGITEFQTEIQMLS 533
+D +G G F V E G + A K + E + E+ +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNG------PFRDHLYGKNLPPLSWKQRLEISI 587
++ H ++++L + ++++L+ E +S G ++ L + KQ L+
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD--- 126
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSKDAPIGQGHVSTA 643
G++YLHT + I H D+K NI+L K+ DFGL+ + I G
Sbjct: 127 ----GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKN 177
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 674
+ G+ ++ PE + L ++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK------RGNPQSEQGITEFQTEIQMLS 533
+++ +G G F V + G + A K + + E + E+ +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQRLEIS 586
++RH ++++L + ++++L+ E +S G D L K L+ KQ L+
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILD-- 119
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSKDAPIGQGHVST 642
G+HYLH+ + I H D+K NI+L N K+ DFG++ I G+
Sbjct: 120 -----GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFK 169
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 674
+ G+ ++ PE + L ++D++S GV+
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 59/271 (21%), Positives = 94/271 (34%), Gaps = 54/271 (19%)
Query: 463 NSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK-----RGNP 516
+S+ YF L E K + IG G +G V + E A+K +
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 517 QSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPP 576
+ + + +TE++++ KL H ++ L ++ + LV E G D L
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 577 LSWKQRLEISIGSAR--------------------------------------GLHYLHT 598
+ LHYLH
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH- 185
Query: 599 GTAQGIIHRDVKSTNILL--DDNYVAKVSDFGLSK---DAPIGQGHVSTAVKGSFGYLDP 653
QGI HRD+K N L + ++ K+ DFGLSK G+ + T G+ ++ P
Sbjct: 186 --NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 654 EYFR--RQQLTEKSDVYSFGVVLLEVLCARP 682
E + K D +S GV+L +L
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRH 537
+ ++ ++G G FG V + + AVK + + E+++L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
+++ L +++S +V E + G D + + S I G+ Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH 138
Query: 598 TGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
I+HRD+K NILL + + K+ DFGLS Q G+ Y+ PE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPE 193
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
R EK DV+S GV+L +L P
Sbjct: 194 VLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 65/248 (26%), Positives = 100/248 (40%), Gaps = 37/248 (14%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSLIGYC 547
+G G +G V L VAVK + + E + EI + L H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLHTG 599
E + L EY S G D + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI--------EPDIGM--PEPDAQRFFHQLMAGVVYLH-- 122
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ--GHVSTAVKGSFGYLDPEYFR 657
GI HRD+K N+LLD+ K+SDFGL+ ++ G+ Y+ PE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 658 RQQLT-EKSDVYSFGVVLLEVLCAR-----PAINPQLPREQVNLAEWAMQWKR-----KG 706
R++ E DV+S G+VL +L P+ + Q + + WK+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 707 LLEKIIDP 714
LL KI+
Sbjct: 241 LLHKILVE 248
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 26/232 (11%)
Query: 462 TNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQ 520
++S L++ F+ ++G G +G VY G + G A+K + ++
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 521 GITEFQTEIQMLSKL-RHRHLVSLIG------YCDENSEMILVYEYMSNGPFRDHLYGKN 573
E + EI ML K HR++ + G + ++ LV E+ G D +
Sbjct: 64 -EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 574 LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633
L + I RGL +LH +IHRD+K N+LL +N K+ DFG+S
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--- 176
Query: 634 PIGQGHVSTAVKGSF-G---YLDPEYFRRQQLTE-----KSDVYSFGVVLLE 676
Q + + +F G ++ PE + + KSD++S G+ +E
Sbjct: 177 --AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 26/199 (13%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHR-HLVSLIG 545
+G G F V G + A K + + + E EI +L + +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQRLEISIGSARGLHYLHT 598
+ SE+IL+ EY + G + +S KQ LE G++YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLHQ 149
Query: 599 GTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY 655
I+H D+K NILL K+ DFG+S+ IG + G+ YL PE
Sbjct: 150 ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIMGTPEYLAPEI 204
Query: 656 FRRQQLTEKSDVYSFGVVL 674
+T +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 14/197 (7%)
Query: 491 GVGGFGNVYLG-EIDDGTKVAVKRGN--PQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
G V L G V V+R N S + +T Q E+ + H ++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
++E+ +V +M+ G +D + + ++ I G + L Y+H G +HR
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHR 152
Query: 608 DVKSTNILLDDNYVAKVSDFGLS---KDAPIGQGHVSTAVKGSFG---YLDPEYFRRQQL 661
VK+++IL+ + +S + Q V K S +L PE ++
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 662 --TEKSDVYSFGVVLLE 676
KSD+YS G+ E
Sbjct: 213 GYDAKSDIYSVGITACE 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGN-PQSEQGITEFQTEIQMLSKLRHR 538
F +G G FG+V+L E G + +K N +S+ + + + EI++L L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQR----LEISIGSARGLH 594
+++ + ++ M +V E G + + + + L + +A L
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA--LA 138
Query: 595 YLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
Y H +Q ++H+D+K NIL + K+ DFGL++ ST G+ Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTALYM 193
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
PE F+R +T K D++S GVV+ +L
Sbjct: 194 APEVFKR-DVTFKCDIWSAGVVMYFLLTGCL 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 43/235 (18%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+GVG FG V +GE G KVAVK R +S + + + EIQ L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLH 597
++ +V EY+S G D++ R+ AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI--------CKHGRV--EEMEARRLFQQILSAVDYCH 128
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
++HRD+K N+LLD + AK++DFGLS + + T+ GS Y PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAPEVIS 183
Query: 658 RQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
+ + D++S GV+L +LC LP + ++ L +KI
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGT------LPFDDEHVPT---------LFKKI 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-26
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
++D +G G FG V+ E G A K E + EIQ +S LRH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQRLEISIGSARG 592
LV+L ++++EM+++YE+MS G + + ++ +S +Q + G
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCK-------G 267
Query: 593 LHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
L ++H +H D+K NI+ N + K+ DFGL+ + G+
Sbjct: 268 LCHMHE---NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTA--HLDPKQSVKVTTGTAE 321
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ PE + + +D++S GV+ +L
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK-----RGNPQSEQGITEFQTEIQMLSK 534
+ N+D +G G F V G + A K + + + Q + + E ++ K
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL---EREARICRK 61
Query: 535 LRHRHLVSLIGYCDENSEMILVYEYMSNGP-F-----RDHLYGKNLPPLSWKQRLEISIG 588
L+H ++V L E S LV++ ++ G F R+ + +Q LE
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-QQILE---- 116
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
+ Y H + GI+HR++K N+LL K++DFGL+ + +
Sbjct: 117 ---SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA 168
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ GYL PE ++ ++ D+++ GV+L +L P
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK------RGNPQSEQGITEFQTEIQMLS 533
+D+ +G G F V E G + A K + + + + E+ +L
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 534 KLRHRHLVSLIGYCDENSEMILVYEYMSNGP-F-----RDHLYGKNLPPLSWKQRLEISI 587
+++H ++++L + +++IL+ E ++ G F ++ L + KQ L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILN--- 125
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSKDAPIGQGHVSTA 643
G++YLH+ I H D+K NI+L K+ DFGL+ I G+
Sbjct: 126 ----GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKN 176
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ G+ ++ PE + L ++D++S GV+ +L
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 40/215 (18%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 478 QEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR 536
+E + + + +G G FG V+ E K + + EI +L+ R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQRLEISIGS 589
HR+++ L + E+++++E++S + + L+ Q E
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCE----- 113
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILL--DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS 647
L +LH + I H D++ NI+ + K+ +FG ++ + G + +
Sbjct: 114 --ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFTA 166
Query: 648 FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Y PE + ++ +D++S G ++ +L
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 12/198 (6%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G +G V + + + A K+ + + F+ EI+++ L H +++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
++N+++ LV E + G + + K I + Y H + HR
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---KLNVAHR 130
Query: 608 DVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEK 664
D+K N L + K+ DFGL+ G + G+ Y+ P+ +
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVSPQVLEG-LYGPE 187
Query: 665 SDVYSFGVVLLEVLCARP 682
D +S GV++ +LC P
Sbjct: 188 CDEWSAGVMMYVLLCGYP 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 25/239 (10%)
Query: 456 SHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRG 514
S +G G F + + N+D +G G F V G + A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 515 N--PQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP-F-----R 566
N S + + + E ++ KL+H ++V L E S LV++ ++ G F R
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 567 DHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAK 623
+ + +Q LE + Y H + GI+HR++K N+LL K
Sbjct: 123 EFYSEADASHCI-QQILE-------SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVK 171
Query: 624 VSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
++DFGL+ + + G+ GYL PE ++ ++ D+++ GV+L +L P
Sbjct: 172 LADFGLAIE--VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR---GNPQSEQGITEFQTEIQMLSKLR 536
K F IG G FG VY ++ + VA+K+ QS + + E++ L KLR
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
H + + G LV EY G D L + PL + ++ G+ +GL YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE-- 654
H+ +IHRDVK+ NILL + + K+ DFG + + + G+ ++ PE
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVI 222
Query: 655 -YFRRQQLTEKSDVYSFGVVLLE 676
Q K DV+S G+ +E
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIE 245
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 473 SFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--------RGNPQSEQGIT 523
+ +E + +D +IG G V G + AVK Q E+
Sbjct: 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 524 EFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS---- 578
+ E +L ++ H H+++LI + +S M LV++ M G D+L K LS
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKET 202
Query: 579 ---WKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635
+ LE + +LH A I+HRD+K NILLDDN ++SDFG S +
Sbjct: 203 RSIMRSLLE-------AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--L 250
Query: 636 GQGHVSTAVKGSFGYLDPEYFRRQQL------TEKSDVYSFGVVLLEVLCARP 682
G + G+ GYL PE + ++ D+++ GV+L +L P
Sbjct: 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 45/248 (18%), Positives = 89/248 (35%), Gaps = 39/248 (15%)
Query: 518 SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHL-YGKNLPP 576
S + +I+ + ++ V + + + + +D + +L
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 577 LSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD---- 632
L I I A + +LH ++G++HRD+K +NI + V KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 633 -------APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAIN 685
P+ T G+ Y+ PE + K D++S G++L E+L +
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-- 275
Query: 686 PQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAE---KCLADHGVD 742
M+ R ++ + + +K+ + L+ +
Sbjct: 276 -------------QME--RVRIITDVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTE 316
Query: 743 RPTMGDVL 750
RP D++
Sbjct: 317 RPEATDII 324
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRH 537
+ ++ ++G G FG V + + AVK + + E+++L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
+++ L +++S +V E + G D + + S I G+ Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH 138
Query: 598 TGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
I+HRD+K NILL + + K+ DFGLS Q G+ Y+ PE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPE 193
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
R EK DV+S GV+L +L P
Sbjct: 194 VLRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 49/201 (24%), Positives = 80/201 (39%), Gaps = 18/201 (8%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGY 546
+G G F AVK + + E Q EI L H ++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEI--SIGSARGLHYLHTGTAQGI 604
+ LV E ++ G + + K S + I + SA + ++H G+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSA--VSHMHD---VGV 127
Query: 605 IHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+HRD+K N+L +DN K+ DFG ++ P + T + Y PE +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGY 186
Query: 662 TEKSDVYSFGVVLLEVLCARP 682
E D++S GV+L +L +
Sbjct: 187 DESCDLWSLGVILYTMLSGQV 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-25
Identities = 70/235 (29%), Positives = 107/235 (45%), Gaps = 43/235 (18%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+GVG FG V +G+ G KVAVK R +S + + + EIQ L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLH 597
S++ +V EY+S G D++ RL+ +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDEK--ESRRLFQQILSGVDYCH 133
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
++HRD+K N+LLD + AK++DFGLS G + T+ GS Y PE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVIS 188
Query: 658 RQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
+ + D++S GV+L +LC LP + ++ L +KI
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGT------LPFDDDHVPT---------LFKKI 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRH 537
T+ + +G G F V ++ G + A S + + + E ++ L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGP-F-----RDHLYGKNLPPLSWKQRLEISIGSAR 591
++V L E L+++ ++ G F R++ + +Q LE
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-QQILE------- 121
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF 648
+ + H G++HR++K N+LL K++DFGL+ + Q G+
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
GYL PE R+ + D+++ GV+L +L P
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/207 (28%), Positives = 83/207 (40%), Gaps = 34/207 (16%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
IG G FG L VAVK RG E Q EI LRH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLH 597
+ + ++ EY S G + + R S AR G+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI--------CNAGRF--SEDEARFFFQQLLSGVSYCH 133
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVA--KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY 655
+ I HRD+K N LLD + K+ DFG SK + + + V G+ Y+ PE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEV 188
Query: 656 FRRQQLT-EKSDVYSFGVVLLEVLCAR 681
RQ+ + +DV+S GV L +L
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKR------GNPQSEQGITEFQTEIQMLSKLRHR--HL 540
+G GGFG+VY G + D VA+K + T E+ +L K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------G 592
+ L+ + + +L+ E P +D L+ ++ + L+ + AR
Sbjct: 111 IRLLDWFERPDSFVLILERPE--PVQD-LFDF----ITERGALQEEL--ARSFFWQVLEA 161
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYV-AKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
+ + H G++HRD+K NIL+D N K+ DFG A + + G+ Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD-GTRVYS 215
Query: 652 DPEYFRRQQLT-EKSDVYSFGVVLLEVLC 679
PE+ R + + V+S G++L +++C
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 65/235 (27%), Positives = 99/235 (42%), Gaps = 44/235 (18%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIG 545
+G G FG V L KVA+K R + + EI L LRH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR--------GLHYLH 597
+++++V EY + G D++ K+R+ + R + Y H
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYI--------VEKKRM--TEDEGRRFFQQIICAIEYCH 125
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
I+HRD+K N+LLDDN K++DFGLS G + T+ GS Y PE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSC-GSPNYAAPEVIN 180
Query: 658 RQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
+ + DV+S G+VL +L R LP + + L +K+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR------LPFDDEFIPN---------LFKKV 220
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK--------RGNPQSEQGITEFQTEIQMLSKLRHRHL 540
+G G FG V+ + +V VK + + + EI +LS++ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS------ARGLH 594
+ ++ + LV E +G L+ + RL+ + S +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGL---DLFAF----IDRHPRLDEPLASYIFRQLVSAVG 144
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-STAVKGSFGYLDP 653
YL + IIHRD+K NI++ +++ K+ DFG + A + +G + T G+ Y P
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA--AYLERGKLFYTFC-GTIEYCAP 198
Query: 654 EYFRRQQLT-EKSDVYSFGVVLLEVLC 679
E + +++S GV L ++
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 55/245 (22%), Positives = 99/245 (40%), Gaps = 19/245 (7%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 546
+G G G V+ G +A K + + E+Q+L + ++V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-RNQIIRELQVLHECNSPYIVGFYGA 99
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ E+ + E+M G D + K + + ++SI +GL YL I+H
Sbjct: 100 FYSDGEISICMEHMDGGSL-DQVL-KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMH 155
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF----GYLDPEYFRRQQLT 662
RDVK +NIL++ K+ DFG+S G + ++ SF Y+ PE + +
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 663 EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722
+SD++S G+ L+E+ R I P +E + ++ + P
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 723 ESLKK 727
+
Sbjct: 269 MDSRP 273
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 35/233 (15%)
Query: 469 GRYFSFQELQEATKNFD-----SSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGI 522
G FQ + S ++G+G G V G K A+K +
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL--------L 62
Query: 523 T---EFQTEIQMLSKL-RHRHLVSLIG-YCDENSEMILVY---EYMSNGPFRDHLYGKNL 574
+ + E+ + H+V ++ Y + + + E M G + +
Sbjct: 63 YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122
Query: 575 PPLSWKQRLEI--SIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGL 629
+ ++ EI IG+A + +LH + I HRDVK N+L + + V K++DFG
Sbjct: 123 QAFTEREAAEIMRDIGTA--IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+K Q + T + Y+ PE ++ + D++S GV++ +LC P
Sbjct: 178 AK--ETTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 24/221 (10%)
Query: 474 FQELQEATKNFDS----SAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTE 528
Q+L + F IGVG + + AVK + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEE 65
Query: 529 IQMLSKL-RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ--RLEI 585
I++L + +H ++++L D+ + +V E M G D + + S ++ +
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLF 123
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSKDAPIGQGHVS 641
+I + YLH AQG++HRD+K +NIL + ++ DFG +K G +
Sbjct: 124 TITKT--VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
T + ++ PE RQ D++S GV+L +L
Sbjct: 179 TPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 27/242 (11%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGY 546
++G G V + + AVK Q + E++ML + + HR+++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEI--SIGSARGLHYLHTGTAQGI 604
+E LV+E M G H++ + + + + + SA L +LH +GI
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASA--LDFLHN---KGI 132
Query: 605 IHRDVKSTNILL---DDNYVAKVSDFGLSK-------DAPIGQGHVSTAVKGSFGYLDPE 654
HRD+K NIL + K+ DF L +PI + T GS Y+ PE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPE 191
Query: 655 YFRRQQLTEKS-----DVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709
D++S GV+L +L P + + A + L E
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 710 KI 711
I
Sbjct: 252 SI 253
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH 539
+ F+ + +G G VY + A+K + +TEI +L +L H +
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQRLEISIGSARG 592
++ L + +E+ LV E ++ G D + K S KQ LE
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILE-------A 160
Query: 593 LHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG 649
+ YLH GI+HRD+K N+L + K++DFGLSK + + V G+ G
Sbjct: 161 VAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVCGTPG 215
Query: 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Y PE R + D++S G++ +LC
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKR------GNPQSEQGITEFQTEIQMLSKLR----HR 538
+G GGFG V+ G + D +VA+K E+ +L K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL-EISIGSAR------ 591
++ L+ + + +LV E +D L+ ++ K L E G +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA--QD-LFDY----ITEKGPLGE---GPSRCFFGQV 148
Query: 592 --GLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF 648
+ + H+ +G++HRD+K NIL+D AK+ DFG A + + G+
Sbjct: 149 VAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD-GTR 202
Query: 649 GYLDPEYFRRQQLT-EKSDVYSFGVVLLEVLC 679
Y PE+ R Q + V+S G++L +++C
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-24
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 472 FSFQELQEATKN-FDSSAIIGVGGFGNVYLGEIDDGTKV-AVK---RGNPQSEQGITEFQ 526
+ + E Q ++ F ++G GGFG V+ ++ K+ A K + + +G
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEI 585
E ++L+K+ R +VSL Y E + LV M+ G R H+Y + +
Sbjct: 234 VEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVD------EDNPGF 286
Query: 586 SIGSAR--------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637
A GL +LH + II+RD+K N+LLDD+ ++SD GL+ + GQ
Sbjct: 287 QEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ G++ PE ++ D ++ GV L E++ AR
Sbjct: 344 TKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 472 FSFQELQEATKN-FDSSAIIGVGGFGNVYLGEIDDGTKV-AVK---RGNPQSEQGITEFQ 526
+ + E Q TKN F ++G GGFG V ++ K+ A K + + +G
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 527 TEIQMLSKLRHRHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-- 583
E Q+L K+ R +VSL Y E + + LV M+ G + H+Y + +
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 584 --EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641
EI G L LH + I++RD+K NILLDD+ ++SD GL+ + +G
Sbjct: 292 AAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVH--VPEGQTI 342
Query: 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ GY+ PE + ++ T D ++ G +L E++ +
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 39/329 (11%), Positives = 80/329 (24%), Gaps = 75/329 (22%)
Query: 465 TLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDD--GTKVAVK---RGNPQSE 519
+ GRY L G + D +VA+ +
Sbjct: 27 RIANGRY----RLLI---------FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPD 72
Query: 520 QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSW 579
+ E + LS++ + ++ + ++V E++ G ++ P
Sbjct: 73 DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV--- 129
Query: 580 KQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639
+ A H G+ + + + + +
Sbjct: 130 -GAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVL--------------- 170
Query: 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA 699
+ + D+ G L +L R + R + AE
Sbjct: 171 ------AYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-- 215
Query: 700 MQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759
+ + I+P + P + + A + + G R A L
Sbjct: 216 -----RDTAGQPIEPADIDRDIPFQI---SAVAARSVQGDGGIR-----------SASTL 256
Query: 760 QEAFTQGKAEEESQSAATAAASPAAVAAP 788
Q A + AAP
Sbjct: 257 LNLMQQATAVADRTEVLGPIDEAPVSAAP 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 53/282 (18%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKR----GNPQSEQGITEFQTEIQMLSKL-RHRHLVSL 543
+G G G V+ G +AVK+ GN + + I ++ ++ K ++V
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI---LMDLDVVLKSHDCPYIVQC 89
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
G N+++ + E M + L + P+ + ++++ + L+YL G
Sbjct: 90 FGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF----GYLDPEYFRRQ 659
+IHRDVK +NILLD+ K+ DFG+S G+ V K Y+ PE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGIS-----GR-LVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 660 QLTE-----KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID- 713
T+ ++DV+S G+ L+E+ + P ++ +L K++
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQF---P--------YKNCKTDFE---VLTKVLQE 245
Query: 714 --PHLVGTINPESL---KKFAEAAEKCLADHGVDRPTMGDVL 750
P L P + F + CL RP +L
Sbjct: 246 EPPLL-----PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 56/278 (20%), Positives = 108/278 (38%), Gaps = 44/278 (15%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQS-EQGITEFQTEIQM-LSKLRHRHLVSLIGY 546
+G G +G V + G +AVKR Q ++ + + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLP---PLSWKQRLEISIGSARGLHYLHTGTAQG 603
++ + E M D Y + + + +I++ + L +LH+
Sbjct: 75 LFREGDVWICMELMDTSL--DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF----GYLDPE----Y 655
+IHRDVK +N+L++ K+ DFG+S V K Y+ PE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAPERINPE 184
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID-- 713
++ + KSD++S G+ ++E+ R P W ++ L+++++
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRF---P--------YDSWGTPFQ---QLKQVVEEP 230
Query: 714 -PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
P L F +CL + +RPT +++
Sbjct: 231 SPQLPADKFSAEFVDF---TSQCLKKNSKERPTYPELM 265
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 68/280 (24%), Positives = 106/280 (37%), Gaps = 44/280 (15%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQS-EQGITEFQTEIQ-MLSKLRHRHLVSLIGY 546
IG G +G+V G +AVKR E+ + ++ ++ ++V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE------ISIGSARGLHYLHTGT 600
+ + E MS D Y L + I++ + + L++L
Sbjct: 90 LFREGDCWICMELMSTSF--DKFYKYVYSVL--DDVIPEEILGKITLATVKALNHLKE-- 143
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFG---YLDPE--- 654
IIHRD+K +NILLD + K+ DFG+S GQ S A G Y+ PE
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERID 198
Query: 655 -YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713
RQ +SDV+S G+ L E+ R P +W + L +++
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRF---P--------YPKWNSVFD---QLTQVVK 244
Query: 714 ---PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
P L + E F CL RP ++L
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-21
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGY 546
++G+G G V K A+K Q + + E+++ + + H+V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 547 CDENSEMI----LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEI--SIGSARGLHYLHTGT 600
+ +V E + G + + + ++ EI SIG A + YLH+
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS-- 179
Query: 601 AQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
I HRDVK N+L N + K++DFG +K+ ++T + Y+ PE
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLG 236
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
++ + D++S GV++ +LC P
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKV-AVK---RGNPQSEQGITEFQTEIQMLSKL-- 535
+F IIG GGFG VY D K+ A+K + + +QG T E MLS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 536 -RHRHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR-- 591
+V + Y + + + + M+ G HL Q S R
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS----------QHGVFSEADMRFY 297
Query: 592 ------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
GL ++H + +++RD+K NILLD++ ++SD GL+ D + H +V
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV- 351
Query: 646 GSFGYLDPEYFRRQQLTEKS-DVYSFGVVLLEVLCARP 682
G+ GY+ PE ++ + S D +S G +L ++L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGT----KVAVKRGNPQSEQGITEFQTEIQMLSKLRH 537
+F+ IG G FG V + + D K K+ + + + E+Q++ L H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEH 74
Query: 538 RHLVSLIGYC--DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR---- 591
LV+L Y DE +M +V + + G R HL Q + + +
Sbjct: 75 PFLVNLW-YSFQDE-EDMFMVVDLLLGGDLRYHLQ----------QNVHFKEETVKLFIC 122
Query: 592 ----GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGS 647
L YL Q IIHRD+K NILLD++ ++DF ++ P + A G+
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GT 177
Query: 648 FGYLDPEYFRRQQLTEKS---DVYSFGVVLLEVLCARP 682
Y+ PE F ++ S D +S GV E+L R
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 32/217 (14%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRH 537
++F I+G G F V L E+ + A+K + E + E ++S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR------ 591
V L ++ ++ Y NG ++ K R
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---------KIGS-FDETCTRFYTAEI 139
Query: 592 --GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF- 648
L YLH +GIIHRD+K NILL+++ +++DFG +K SF
Sbjct: 140 VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---NSFV 193
Query: 649 G---YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G Y+ PE + + SD+++ G ++ +++ P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 12/159 (7%)
Query: 524 EFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL 583
+ + + + R L S+ S + + +S+ + L+ + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA 643
S A+G+ +L ++ IHRD+ + NILL + V K+ DFGL++D
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI----YKDPDY 249
Query: 644 VKGSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLLEV 677
V+ L PE + T +SDV+SFGV+L E+
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 30/154 (19%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHLVSLIGY 546
IG G +G V+ D G VA+K+ + + + EI+ML +L+H +LV+L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 547 CDENSEMILVYEYMSNGPFRDH-------LYGKNLPPLSWK----QRLEISIGSARGLHY 595
+ LV+EY DH Y + +P K Q L + +++
Sbjct: 71 FRRKRRLHLVFEYC------DHTVLHELDRYQRGVPEHLVKSITWQTL-------QAVNF 117
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629
H IHRDVK NIL+ + V K+ DFG
Sbjct: 118 CH---KHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRH 539
+++ ++G G +G V D G VA+K+ + + + EI++L +LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDH-------LYGKNLPPLSWK----QRLEISIG 588
LV+L+ C + LV+E++ DH L+ L + Q +
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFV------DHTILDDLELFPNGLDYQVVQKYLFQII----- 134
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630
G+ + H + IIHRD+K NIL+ + V K+ DFG +
Sbjct: 135 --NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 35/229 (15%)
Query: 475 QELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKV-AVKRGNPQ---SEQGITEFQTEIQ 530
+E++ +F+ +IG G F V + ++ +V A+K N ++ F+ E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 531 MLSKLRHRHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS 589
+L R + L + ++ + LV EY G L K I
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS---------KFGERIPAEM 163
Query: 590 AR--------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK-DAPIGQGHV 640
AR + +H G +HRD+K NILLD +++DFG G
Sbjct: 164 ARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 641 STAVKGSFGYLDPEYFRRQQLTEKSDVY-------SFGVVLLEVLCARP 682
AV G+ YL PE + + Y + GV E+ +
Sbjct: 221 LVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 50/238 (21%)
Query: 470 RYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQT-- 527
+ ++ + + +IG G FG V+ ++ + +VA+K+ + + +
Sbjct: 28 LASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK--------VLQDKRFK 79
Query: 528 --EIQMLSKLRHRHLVSLIGYCDENSEMI------LVYEYMSNGPFRDHLY--------- 570
E+Q++ ++H ++V L + N + LV EY+ + +Y
Sbjct: 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKL 134
Query: 571 GKNLPPLSWK----QRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVS 625
+ +P L K Q L R L Y+H+ GI HRD+K N+LLD + V K+
Sbjct: 135 KQTMPMLLIKLYMYQLL-------RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 626 DFGLSKDAPIGQGHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
DFG +K G+ +VS S Y PE F T D++S G V+ E++ +P
Sbjct: 185 DFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 63/310 (20%), Positives = 111/310 (35%), Gaps = 72/310 (23%)
Query: 450 MTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTK 508
M S+ + F K + + IG G G V +
Sbjct: 1 MGSR-SKRDNNFY-------SVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN 52
Query: 509 VAVKR-GNPQSEQGITEFQT---------EIQMLSKLRHRHLVSLI------GYCDENSE 552
VA+K+ P FQ E+ ++ + H++++ L+ +E +
Sbjct: 53 VAIKKLSRP--------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104
Query: 553 MILVYEYMS---NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ +V E M + L + + L + Q L G+ +LH+ GIIHRD+
Sbjct: 105 VYIVMELMDANLCQVIQMELDHERMSYLLY-QML-------CGIKHLHSA---GIIHRDL 153
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQ---GHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
K +NI++ + K+ DFGL++ A +V T Y PE E D
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVD 208
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLK 726
++S G ++ E++ +Q K+I+ +GT PE +K
Sbjct: 209 IWSVGCIMGEMIKGGVLFPGTDHIDQ---------------WNKVIE--QLGTPCPEFMK 251
Query: 727 KFAEAAEKCL 736
K +
Sbjct: 252 KLQPTVRTYV 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 54/225 (24%), Positives = 87/225 (38%), Gaps = 32/225 (14%)
Query: 475 QELQEATKNFDSSAIIGVGGFGNVYL-GEIDDGTKVAVKRGNPQ---SEQGITEFQTEIQ 530
++L+ ++++ +IG G FG V L A+K + F E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 531 MLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA 590
+++ +V L ++ + +V EYM G + + ++ A
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-----------SNYDVPEKWA 170
Query: 591 R--------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK-DAPIGQGHVS 641
R L +H + G IHRDVK N+LLD + K++DFG G
Sbjct: 171 RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 642 TAVKGSFGYLDPEYFRRQQLTEK----SDVYSFGVVLLEVLCARP 682
TAV G+ Y+ PE + Q D +S GV L E+L
Sbjct: 228 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 51/231 (22%)
Query: 478 QEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT----EIQML 532
+ ++ + +IG G FG VY D G VA+K+ + + + E+Q++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIM 101
Query: 533 SKLRHRHLVSLIGYCDENSEMI------LVYEYMSNGPFRDHLY---------GKNLPPL 577
KL H ++V L + + E LV +Y+ + +Y + LP +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVI 156
Query: 578 SWK----QRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKD 632
K Q R L Y+H+ GI HRD+K N+LLD D V K+ DFG +K
Sbjct: 157 YVKLYMYQLF-------RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206
Query: 633 APIGQGHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ +VS S Y PE F T DV+S G VL E+L +P
Sbjct: 207 LVRGEPNVSYIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 52/248 (20%), Positives = 84/248 (33%), Gaps = 60/248 (24%)
Query: 470 RYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKR--GNPQSEQGITEFQT 527
EL + I G +G V G +G VA+KR + +
Sbjct: 10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSD 69
Query: 528 ---------EIQMLSKLRHRHLVSLI-----GYCDENSEMILVYEYM----------SNG 563
EI++L+ H +++ L ++ LV E M
Sbjct: 70 SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 564 PFRD-H----LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618
H +Y L GLH LH G++HRD+ NILL D
Sbjct: 130 VISPQHIQYFMY----------HIL-------LGLHVLHEA---GVVHRDLHPGNILLAD 169
Query: 619 NYVAKVSDFGLSKDAPIGQ---GHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVL 674
N + DF L+++ +V+ Y PE + + T+ D++S G V+
Sbjct: 170 NNDITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 675 LEVLCARP 682
E+ +
Sbjct: 225 AEMFNRKA 232
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 24/154 (15%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT---EIQMLSKLRHRHLVSLIG 545
+G G + VY G G VA+K SE+G T EI ++ +L+H ++V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLYD 70
Query: 546 YCDENSEMILVYEYMSNGPFRDH---LYGKNLPPLSWKQRLEISIGSA------RGLHYL 596
+++ LV+E+M D+ Y + + + LE+++ +GL +
Sbjct: 71 VIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630
H I+HRD+K N+L++ K+ DFGL+
Sbjct: 125 H---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 31/226 (13%)
Query: 475 QELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKV-AVKRGNPQ---SEQGITEFQTEIQ 530
++++ ++F+ +IG G FG V + ++ + KV A+K N F+ E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 531 MLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSA 590
+L + + +L +++ + LV +Y G L K + A
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS---------KFEDRLPEEMA 177
Query: 591 R--------GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK-DAPIGQGHVS 641
R + +H +HRD+K NIL+D N +++DFG G S
Sbjct: 178 RFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 642 TAVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLLEVLCARP 682
AV G+ Y+ PE + + + D +S GV + E+L
Sbjct: 235 VAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 39/233 (16%)
Query: 473 SFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQM 531
+ + ++ F + G G FG V LG E G VA+K+ E Q +Q
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQD 72
Query: 532 LSKLRHRHLVSLIGYCDENSE-------MILVYEYMSNGPFRDHLY---------GKNLP 575
L+ L H ++V L Y E + +V EY+ D L+ P
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPP 127
Query: 576 PLSWK----QRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLS 630
P+ K Q + R + LH + + HRD+K N+L++ + K+ DFG +
Sbjct: 128 PILIKVFLFQLI-------RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 631 KDAPIGQGHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLLEVLCARP 682
K + +V+ S Y PE F Q T D++S G + E++ P
Sbjct: 180 KKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHR 538
F+ ++G G FG V L + G A+K + ++ + TE ++L RH
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 539 HLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EIS 586
L +L Y + + + V EY + G HL ++R+ EI
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLS---------RERVFSEDRARFYGAEIV 258
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646
L YLH+ + +++RD+K N++LD + K++DFGL K+ I G G
Sbjct: 259 SA----LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCG 311
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ YL PE D + GVV+ E++C R
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 29/163 (17%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGI--TEFQTEIQMLSKLRHR 538
+ + +G G + VY G VA+K + E+G T + E+ +L L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 539 HLVSLIGYCDENSEMILVYEYM----------SNGPFRDHLYGKNLPPLSWKQRLEISIG 588
++V+L + LV+EY+ H L Q L
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-----FQLL----- 110
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
RGL Y H Q ++HRD+K N+L+++ K++DFGL++
Sbjct: 111 --RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 23/161 (14%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQ-GITEFQT---EIQMLSKLR 536
+NF IG G +G VY G VA+K+ +E G+ T EI +L +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP--STAIREISLLKELN 60
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSN--GPFRDHLYGKNLPPLSWK----QRLEISIGSA 590
H ++V L+ +++ LV+E++ F D +P K Q L
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------- 113
Query: 591 RGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
+GL + H + ++HRD+K N+L++ K++DFGL++
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 44/243 (18%), Positives = 86/243 (35%), Gaps = 52/243 (21%)
Query: 451 TSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKV 509
S+ + +S+ + ++ +IG G +G+V + + V
Sbjct: 22 GSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 510 AVKR-GNPQSEQGITEFQT---EIQMLSKLRHRHLVSLI-----GYCDENSEMILVYEYM 560
A+K+ + + EI +L++L H H+V ++ ++ E+ +V E
Sbjct: 82 AIKKILRVFEDLIDC--KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139
Query: 561 ---------SNGPFRD-H----LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+ + H LY L G+ Y+H+ GI+H
Sbjct: 140 DSDFKKLFRTPVYLTELHIKTLLY----------NLL-------VGVKYVHSA---GILH 179
Query: 607 RDVKSTNILLDDNYVAKVSDFGLS------KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
RD+K N L++ + KV DFGL+ ++ + ++Q
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239
Query: 661 LTE 663
LT
Sbjct: 240 LTG 242
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 54/242 (22%), Positives = 90/242 (37%), Gaps = 66/242 (27%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT---------E 528
+ +F +++G G +G V G VA+K+ P F E
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLRE 59
Query: 529 IQMLSKLRHRHLVSLI-----GYCDENSEMILVYEYM--------SNGPFRD-H----LY 570
I++L +H +++++ + +E+ ++ E M S D H +Y
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 571 GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630
Q L R + LH +IHRD+K +N+L++ N KV DFGL+
Sbjct: 120 ----------QTL-------RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 631 KDAPIGQGHVSTAVKGSFG---------YLDPEY-FRRQQLTEKSDVYSFGVVLLEVLCA 680
+ S G Y PE + + DV+S G +L E+
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 681 RP 682
RP
Sbjct: 220 RP 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 41/163 (25%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKR----GNPQSEQGITEFQT---EIQMLSKLRHRHLV 541
+G G F VY + + VA+K+ +++ GI +T EI++L +L H +++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNII 75
Query: 542 SLIGYCDENSEMILVYEYM----------SNGPFRDHLYGKNLPPL--SW-KQRLEISIG 588
L+ S + LV+++M ++ P ++ L
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL--------TPSHIKAYMLMTL----- 122
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
+GL YLH I+HRD+K N+LLD+N V K++DFGL+K
Sbjct: 123 --QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 9e-16
Identities = 63/291 (21%), Positives = 109/291 (37%), Gaps = 66/291 (22%)
Query: 470 RYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDD--GTKVAVKR-GNPQSEQGITEFQ 526
K + + IG G G V D VA+K+ P FQ
Sbjct: 50 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRP--------FQ 100
Query: 527 T---------EIQMLSKLRHRHLVSLI------GYCDENSEMILVYEYMS---NGPFRDH 568
E+ ++ + H++++SL+ +E ++ LV E M +
Sbjct: 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 160
Query: 569 LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628
L + + L + Q L G+ +LH+ GIIHRD+K +NI++ + K+ DFG
Sbjct: 161 LDHERMSYLLY-QML-------CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 629 LSKDAPIGQ---GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAIN 685
L++ A +V T Y PE E D++S G ++ E++ +
Sbjct: 210 LARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 686 PQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCL 736
+ +Q K+I+ +GT PE +KK +
Sbjct: 265 GRDYIDQ---------------WNKVIE--QLGTPCPEFMKKLQPTVRNYV 298
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 40/221 (18%)
Query: 483 NFDSSAIIGVGGFGNVYLGEI----DDGT----KVAVKRGNPQSEQGITEFQTEIQMLSK 534
F+ ++G GG+G V+ + G KV K ++ + + E +L +
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 535 LRHRHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL---------- 583
++H +V LI Y + + L+ EY+S G L ++ +
Sbjct: 78 VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE---------REGIFMEDTACFYL 127
Query: 584 -EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVS 641
EIS+ L +LH +GII+RD+K NI+L+ +V K++DFGL K++ I G V+
Sbjct: 128 AEISMA----LGHLH---QKGIIYRDLKPENIMLNHQGHV-KLTDFGLCKES-IHDGTVT 178
Query: 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE R D +S G ++ ++L P
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 59/232 (25%)
Query: 463 NSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-GNPQSEQ 520
+S+ YF + N+ +IG G +G VYL + + VA+K+
Sbjct: 7 HSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---- 62
Query: 521 GITEFQT---------EIQMLSKLRHRHLVSLI-----GYCDENSEMILVYEYM------ 560
F+ EI +L++L+ +++ L + E+ +V E
Sbjct: 63 ----FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK 118
Query: 561 ---SNGPFRD-H----LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKST 612
+ + H LY L G +++H GIIHRD+K
Sbjct: 119 LFKTPIFLTEEHIKTILY----------NLL-------LGENFIHES---GIIHRDLKPA 158
Query: 613 NILLDDNYVAKVSDFGLS-KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
N LL+ + KV DFGL+ ++ ++ + ++QLT
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 61/303 (20%), Positives = 112/303 (36%), Gaps = 88/303 (29%)
Query: 456 SHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR- 513
K GF + + E K + S +G G +G+V + G KVA+K+
Sbjct: 5 IRKKGFY-------KQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL 57
Query: 514 GNPQSEQGITEFQT---------EIQMLSKLRHRHLVSLI------GYCDENSEMILVYE 558
P FQ+ E+ +L ++H +++ L+ + LV
Sbjct: 58 SRP--------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109
Query: 559 YM--------SNGPFRDH----LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIH 606
+M + +Y Q L +GL Y+H+ G++H
Sbjct: 110 FMQTDLQKIMGLKFSEEKIQYLVY----------QML-------KGLKYIHSA---GVVH 149
Query: 607 RDVKSTNILLDDNYVAKVSDFGLSKDA-PIGQGHVSTAVKGSFGYLDPE-YFRRQQLTEK 664
RD+K N+ ++++ K+ DFGL++ A G+V T Y PE +
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQT 204
Query: 665 SDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPES 724
D++S G ++ E+L + + +Q L +I+ + G E
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQ---------------LTQILK--VTGVPGTEF 247
Query: 725 LKK 727
++K
Sbjct: 248 VQK 250
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHR 538
+FD ++G G FG V L G A+K + ++ + TE ++L RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 539 HLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL----------EISI 587
L +L Y + + + V EY + G HL S ++ EI
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHL--------SRERVFTEERARFYGAEIVS 116
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKG 646
L YLH ++ +++RD+K N++LD D ++ K++DFGL K+ I G G
Sbjct: 117 A----LEYLH---SRDVVYRDIKLENLMLDKDGHI-KITDFGLCKEG-ISDGATMKTFCG 167
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ YL PE D + GVV+ E++C R
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 40/170 (23%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQ-G--ITEFQTEIQMLSKLRHR 538
++ A IG G FG V+ G KVA+K+ ++E+ G IT + EI++L L+H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHE 76
Query: 539 HLVSLIGYCDENSEMI--------LVYEYMSNGPFRDH----LYGKNLPPLSW------- 579
++V+LI C + LV+++ +H L L +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 580 KQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629
+ L GL+Y+H I+HRD+K+ N+L+ + V K++DFGL
Sbjct: 131 QMLLN-------GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 71/241 (29%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT---------E 528
+ + + + IG G +G V + + +VA+K+ I+ F+ E
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLRE 75
Query: 529 IQMLSKLRHRHLVSLI-----GYCDENSEMILVYEYM---------SNGPFRDH----LY 570
I++L + RH +++ + ++ ++ +V + M + DH LY
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 571 GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630
Q L RGL Y+H+ ++HRD+K +N+LL+ K+ DFGL+
Sbjct: 136 ----------QIL-------RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 631 K--DAPIGQGHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLLEVLCAR 681
+ D T Y+ ++R + T+ D++S G +L E+L R
Sbjct: 176 RVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
Query: 682 P 682
P
Sbjct: 230 P 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 40/159 (25%), Positives = 80/159 (50%), Gaps = 20/159 (12%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQ-GI--TEFQTEIQMLSKLRH 537
+ ++ IG G +G V+ + VA+KR + G+ + + EI +L +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60
Query: 538 RHLVSLIGYCDENSEMILVYEYMSN--GPFRDHLYGKNLPPL--SW-KQRLEISIGSARG 592
+++V L + ++ LV+E+ + D G P + S+ Q L +G
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL-------KG 113
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
L + H ++ ++HRD+K N+L++ N K+++FGL++
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 38/219 (17%)
Query: 483 NFDSSAIIGVGGFGNVYLGE----IDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLR 536
F+ ++G G FG V+L + D A+K + + + E +L ++
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 537 HRHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------E 584
H +V L Y + + L+ +++ G L K+ + E
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS---------KEVMFTEEDVKFYLAE 134
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTA 643
+++ L +LH + GII+RD+K NILLD + ++ K++DFGLSK++ I + +
Sbjct: 135 LALA----LDHLH---SLGIIYRDLKPENILLDEEGHI-KLTDFGLSKES-IDHEKKAYS 185
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE R+ T+ +D +SFGV++ E+L
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 31/164 (18%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ-GI--TEFQTEIQMLSKLRHR 538
+ + +G G +G VY + G VA+KR +E GI T + EI +L +L H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHP 79
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDH-------LYGKNLPPLSWK----QRLEISI 587
++VSLI + LV+E+M + L K Q L
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM------EKDLKKVLDENKTGLQDSQIKIYLYQLL---- 129
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
RG+ + H I+HRD+K N+L++ + K++DFGL++
Sbjct: 130 ---RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 44/205 (21%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIG- 545
++G+G G V K A+K Q + + E+++ + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 546 YCDENSEMILVY---EYMSNGPFRDHLYGKNLPPLSWKQRLEI--SIGSARGLHYLHTGT 600
Y + + + E + G + + + ++ EI SIG A + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLH--- 134
Query: 601 AQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
+ I HRDVK N+L N + K++DFG + E
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KE-TT 171
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
++ + D++S GV++ +LC P
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYP 196
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 6e-15
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQ-GITEFQT---EIQMLSKLRH 537
+ + IG G +G VY + + G A+K+ + E GI T EI +L +L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP--STTIREISILKELKH 59
Query: 538 RHLVSLIGYCDENSEMILVYEYMSN--GPFRDHLYGKNLPPL--SW-KQRLEISIGSARG 592
++V L ++LV+E++ D G S+ Q L G
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL-------NG 112
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
+ Y H + ++HRD+K N+L++ K++DFGL++
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 26/195 (13%)
Query: 452 SKCGSHKSGFTNSTLGLGRYFSFQELQEATK--NFDSSAIIGVGGFGNVYLG-EIDDGTK 508
+ H G + S AT + +G G +G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 509 VAVKRGNPQSEQ-GITEFQT---EIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGP 564
VA+KR + E+ G+ T E+ +L +L+HR+++ L N + L++EY
Sbjct: 62 VAIKRIRLEHEEEGVP--GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA---- 115
Query: 565 FRDH---LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621
++ Y P +S + G+++ H+ + +HRD+K N+LL +
Sbjct: 116 --ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDA 170
Query: 622 A-----KVSDFGLSK 631
+ K+ DFGL++
Sbjct: 171 SETPVLKIGDFGLAR 185
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQ-GITEF-QT---EI---QMLS 533
++ A IGVG +G VY + G VA+K + G + E+ + L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 534 KLRHRHLVSLI-----GYCDENSEMILVYEYMSN--GPFRDHLYGKNLPPLSWK----QR 582
H ++V L+ D ++ LV+E++ + D LP + K Q
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
L RGL +LH A I+HRD+K NIL+ K++DFGL++
Sbjct: 130 L-------RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSK-LRH 537
+FD +IG G + V L A+K + ++ I QTE + + H
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 538 RHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EI 585
LV L C + + V EY++ G H+ +QR EI
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEI 119
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
S+ L+YLH +GII+RD+K N+LLD K++D+G+ K+ + G ++
Sbjct: 120 SLA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTSTFC 171
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE R + D ++ GV++ E++ R
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 65/236 (27%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-GNPQSEQGITEFQT--------- 527
E + +G G +G V + G KVA+K+ P FQ+
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--------FQSELFAKRAYR 73
Query: 528 EIQMLSKLRHRHLVSLI------GYCDENSEMILVYEYM--------SNGPFRD-H---- 568
E+++L +RH +++ L+ D+ ++ LV +M + +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 133
Query: 569 LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628
+Y Q L +GL Y+H GIIHRD+K N+ ++++ K+ DFG
Sbjct: 134 VY----------QML-------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173
Query: 629 LSKDA-PIGQGHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLLEVLCARP 682
L++ A G+V T Y PE + T+ D++S G ++ E++ +
Sbjct: 174 LARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 65/236 (27%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-GNPQSEQGITEFQT--------- 527
E + + + + +G G +G+V + G +VAVK+ P FQ+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--------FQSIIHAKRTYR 77
Query: 528 EIQMLSKLRHRHLVSLI------GYCDENSEMILVYEYM---------SNGPFRDH---- 568
E+++L ++H +++ L+ +E +++ LV M DH
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 569 LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628
+Y Q L RGL Y+H+ IIHRD+K +N+ ++++ K+ DFG
Sbjct: 138 IY----------QIL-------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 629 LSKDA-PIGQGHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
L++ G+V+T Y PE + D++S G ++ E+L R
Sbjct: 178 LARHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 55/212 (25%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKR-GNPQSEQGITEFQT--------- 527
+ ++ +G G +G V+ + G VAVK+ + FQ
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--------FQNSTDAQRTFR 57
Query: 528 EIQMLSKLR-HRHLVSL--IGYCDENSEMILVYEYM---------SNGPFRDH----LYG 571
EI +L++L H ++V+L + D + ++ LV++YM +N H +Y
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY- 116
Query: 572 KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
Q + + + YLH+G G++HRD+K +NILL+ KV+DFGLS+
Sbjct: 117 ---------QLI-------KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
+ + + + LT+
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSK-LRH 537
+FD +IG G + V L + ++ VK+ ++ I QTE + + H
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 538 RHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EI 585
LV L C + + V EY++ G H+ +QR EI
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEI 162
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
S+ L+YLH +GII+RD+K N+LLD K++D+G+ K+ + G ++
Sbjct: 163 SLA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTTSTFC 214
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE R + D ++ GV++ E++ R
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 42/166 (25%)
Query: 490 IGVGGFGNVYLG---EIDDGTKVAVKR----GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G +G+VY + D A+K+ G S EI +L +L+H +++S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82
Query: 543 LIGYCDENSEMI--LVYEYM---------SNGPFRDHLYGKNLPPLSWK----QRLEISI 587
L +++ L+++Y + + + LP K Q L
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---- 138
Query: 588 GSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGL 629
G+HYLH A ++HRD+K NIL+ + K++D G
Sbjct: 139 ---DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQ------TEIQMLSKL 535
FD +G G FG V L + G A+K +Q + + + E ++L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 536 RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR---- 591
LV L +NS + +V EY++ G HL + S AR
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---------RIG-RFSEPHARFYAA 148
Query: 592 ----GLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDAPIGQGHVSTAVKG 646
YLH + +I+RD+K N+L+D Y+ +V+DFG +K G T G
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI-QVTDFGFAKRVK---GRTWTLC-G 200
Query: 647 SFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
+ L PE + + D ++ GV++ E+ P
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 7e-14
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGTKV----AVKRGNPQSEQGITEFQTEIQMLSK-LRH 537
+F+ ++G G FG V L E ++ +K+ + + E ++L+ +
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 538 RHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLY--GKNLPPLSWKQRLEISIGSARGLH 594
L L C + + + V EY++ G H+ G+ P + EI+IG L
Sbjct: 402 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LF 456
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
+L ++GII+RD+K N++LD K++DFG+ K+ I G + G+ Y+ PE
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE 512
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
Q + D ++FGV+L E+L +
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 49/260 (18%), Positives = 93/260 (35%), Gaps = 83/260 (31%)
Query: 481 TKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT----EIQMLSKL 535
+K + +G G FG V +I+ G + A+K+ + + E+ ++ L
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVL 57
Query: 536 RHRHLVSLIGYCDENSEMI--------------------------------------LVY 557
H +++ L+ Y + ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 558 EYMSNGPFRDHLY---------GKNLPPLSWK----QRLEISIGSARGLHYLHTGTAQGI 604
EY+ D L+ G+++P Q R + ++H+ GI
Sbjct: 118 EYVP-----DTLHKVLKSFIRSGRSIPMNLISIYIYQLF-------RAVGFIHS---LGI 162
Query: 605 IHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE-YFRRQQLT 662
HRD+K N+L++ + K+ DFG +K + V+ S Y PE + T
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYT 220
Query: 663 EKSDVYSFGVVLLEVLCARP 682
D++S G V E++ +P
Sbjct: 221 PSIDLWSIGCVFGELILGKP 240
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSK-LRH 537
+F ++G G FG V+L E A+K + + + E ++LS H
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 538 RHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EI 585
L + + E + V EY++ G H+ EI
Sbjct: 78 PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ---------SCHKFDLSRATFYAAEI 127
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
+G L +LH ++GI++RD+K NILLD + K++DFG+ K+ + +
Sbjct: 128 ILG----LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN-MLGDAKTNTFC 179
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE Q+ D +SFGV+L E+L +
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSK-LRH 537
+F +IG G FG V L + AVK + ++ +E +L K ++H
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 538 RHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EI 585
LV L + + ++ + V +Y++ G HL ++R EI
Sbjct: 99 PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ---------RERCFLEPRARFYAAEI 148
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAV 644
+ L YLH + I++RD+K NILLD ++ ++DFGL K+ I ++
Sbjct: 149 ASA----LGYLH---SLNIVYRDLKPENILLDSQGHI-VLTDFGLCKEN-IEHNSTTSTF 199
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ YL PE +Q D + G VL E+L P
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSK-LRH 537
NF+ ++G G FG V L + G AVK + + + TE ++LS H
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 538 RHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EI 585
L L C + + + V E+++ G H+ K R EI
Sbjct: 84 PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ---------KSRRFDEARARFYAAEI 133
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK 645
L +LH +GII+RD+K N+LLD K++DFG+ K+ I G +
Sbjct: 134 ISA----LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG-ICNGVTTATFC 185
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE + D ++ GV+L E+LC
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSK-LRH 537
+F+ ++G G FG V L E AVK + + + E ++L+ +
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 538 RHLVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EI 585
L L C + + + V EY++ G H+ + EI
Sbjct: 81 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ---------QVGRFKEPHAVFYAAEI 130
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAV 644
+IG L +L ++GII+RD+K N++LD + ++ K++DFG+ K+ I G +
Sbjct: 131 AIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKEN-IWDGVTTKTF 181
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE Q + D ++FGV+L E+L +
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 30/152 (19%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSL--IG 545
+G G + V+ I + KV VK P ++ + + EI++L LR ++++L I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLS-------WKQRLEISIGSARGLHYLHT 598
+ LV+E+++N F+ + L+ + L + L Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFK-----QLYQTLTDYDIRFYMYEIL-------KALDYCHS 148
Query: 599 GTAQGIIHRDVKSTNILLD-DNYVAKVSDFGL 629
GI+HRDVK N+++D ++ ++ D+GL
Sbjct: 149 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 40/223 (17%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGT--------KVAVKRGNPQSEQGITEFQTEIQMLSK 534
NF+ ++G G +G V+L G KV K Q + +TE Q+L
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 535 LRHRH-LVSLIGYCDENSEMI-LVYEYMSNGPFRDHLYGKNLPPLSWKQRL--------- 583
+R LV+L Y + + L+ +Y++ G HL ++
Sbjct: 115 IRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS---------QRERFTEHEVQIY 164
Query: 584 --EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641
EI + L +LH GII+RD+K NILLD N ++DFGLSK+ + +
Sbjct: 165 VGEIVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 642 TAVKGSFGYLDPEYFRRQQL--TEKSDVYSFGVVLLEVLCARP 682
G+ Y+ P+ R + D +S GV++ E+L
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 53/301 (17%), Positives = 106/301 (35%), Gaps = 99/301 (32%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQT---------E 528
+ + +G GG G V+ + D +VA+K+ I E
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--------IV-LTDPQSVKHALRE 58
Query: 529 IQMLSKLRHRHLVSLI--------------GYCDENSEMILVYEYM---------SNGPF 565
I+++ +L H ++V + G E + + +V EYM
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL 118
Query: 566 RDH----LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNY 620
+H +Y Q L RGL Y+H+ ++HRD+K N+ ++ ++
Sbjct: 119 EEHARLFMY----------QLL-------RGLKYIHSA---NVLHRDLKPANLFINTEDL 158
Query: 621 VAKVSDFGLSK--DAPIGQGHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFG 671
V K+ DFGL++ D + L +++R T+ D+++ G
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 672 VVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEA 731
+ E+L + EQ ++ I++ + ++ E ++
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQ---------------MQLILE--SIPVVHEEDRQELLSV 255
Query: 732 A 732
Sbjct: 256 I 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (167), Expect = 2e-12
Identities = 39/214 (18%), Positives = 59/214 (27%), Gaps = 54/214 (25%)
Query: 470 RYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVK--------RGNPQSEQG 521
F T+ IG G FG V+ I D T VA+K N ++
Sbjct: 9 GPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 522 ITEFQTEIQML-----------------SKLRHRHLV------SLIGYCDE--------- 549
E EI + L H V L+ D
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 550 -------NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
+ ++ +V E+ G + + K S I L +
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEA--SL 181
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636
HRD+ N+LL + K+ K + I
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 30/168 (17%)
Query: 483 NFDSSAIIGVGGFGNVYLG--EIDDGTKVAVKRGNPQSEQG---ITEFQTEIQMLSKLR- 536
++ A IG G +G V+ + G VA+KR Q+ + ++ + E+ +L L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLET 70
Query: 537 --HRHLVSLI-----GYCDENSEMILVYEYMSN--GPFRDHLYGKNLPPLSWK----QRL 583
H ++V L D +++ LV+E++ + D + +P + K Q L
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 584 EISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631
RGL +LH + ++HRD+K NIL+ + K++DFGL++
Sbjct: 131 -------RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 39/217 (17%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGT----KVAVKRGNPQSEQGITEFQTEIQMLSKLRH 537
+F +G G FG V+L +G KV K + +Q + E MLS + H
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTH 65
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRL-----------EIS 586
++ + G + ++ ++ +Y+ G L K + E+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---------KSQRFPNPVAKFYAAEVC 116
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKDAPIGQGHVSTAVK 645
+ L YLH ++ II+RD+K NILLD N ++ K++DFG +K V+ +
Sbjct: 117 LA----LEYLH---SKDIIYRDLKPENILLDKNGHI-KITDFGFAKYV----PDVTYTLC 164
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
G+ Y+ PE + + D +SFG+++ E+L
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 12/147 (8%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH-RHLVSLIGYC 547
IG G FG++YLG I G +VA+K +++ E ++ ++ + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E ++V E + GP + L+ S K L ++ + Y+H ++ IHR
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 608 DVKSTNILL---DDNYVAKVSDFGLSK 631
DVK N L+ + + DFGL+K
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 56/295 (18%), Positives = 109/295 (36%), Gaps = 48/295 (16%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQ-SEQGITEFQTEIQMLSKLR------- 536
+G G F V+L + + + T VA+K RG+ +E + EI++L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKE 80
Query: 537 ----HRHLVSLIG---YCDENSE-MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIG 588
H++ L+ + N +++V+E + + + +IS
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDD------NYVAKVSDFGLSKDAPIGQGHVST 642
GL Y+H GIIH D+K N+L++ K++D G + H +
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTN 194
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702
+++ Y PE +D++S ++ E++ P +
Sbjct: 195 SIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD----- 248
Query: 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757
+ +II+ L+G + L+ + G+ R W LE L
Sbjct: 249 ----HIAQIIE--LLGELPSYLLRN-GKYTRTFFNSRGLLRNISKLKFWPLEDVL 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 31/149 (20%), Positives = 58/149 (38%), Gaps = 14/149 (9%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH-RHLVSLIGYC 547
IG G FG ++ G + + +VA+K +S+ E + L + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E +LV + + GP + L S K + + +H + +++R
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 130
Query: 608 DVKSTNILLDDNYVAK-----VSDFGLSK 631
D+K N L+ V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYC 547
IG G FG +YLG I +VA+K N +++ + E ++ L+ + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E +LV + + GP + L+ LS K L ++ + ++H+ + +HR
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
Query: 608 DVKSTNILL---DDNYVAKVSDFGLSK 631
D+K N L+ + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 14/149 (9%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH-RHLVSLIGYC 547
IG G FG + LG+ + VA+K +S + E + +L + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
+V E + GP + L+ S K L I+I + Y+H+ + +I+R
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYR 129
Query: 608 DVKSTNILL-----DDNYVAKVSDFGLSK 631
DVK N L+ V + DF L+K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 34/165 (20%), Positives = 63/165 (38%), Gaps = 28/165 (16%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK---------RGNPQ--SEQGITEFQTEIQMLSKLRHR 538
IG GGFG +YL +++ V N +E + + + + K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 539 HLVSLIG----------YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIG 588
+ +G + S ++ + G +Y N S K L++S+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 589 SARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV--SDFGLSK 631
L Y+H +H D+K++N+LL+ +V D+GL+
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 28/182 (15%), Positives = 57/182 (31%), Gaps = 44/182 (24%)
Query: 490 IGVGGFGNVYLGE---------IDDGTKVAVK----RGNPQSEQGITEFQTEIQMLSKLR 536
G +Y K ++K G +EQ + + ++K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 537 HRHLVSLIG-----YC--DENSEMILVYEYMSNGPFRDHLYGKNL---------PPLSWK 580
+ L+ ++ LV G++L LS +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSALDVSPKHVLSER 159
Query: 581 QRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV--SDFGLSKDAPIGQG 638
L+++ L +LH +H +V + NI +D ++V + +G +
Sbjct: 160 SVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 639 HV 640
HV
Sbjct: 217 HV 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 24/208 (11%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQ-SEQGITEFQTEIQMLSKLRHR----- 538
++IG G FG V + VA+K + Q Q E+++L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 539 -HLVSLIGYCDENSEMILVYEYMS-NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
++V L + + + LV+E +S N D L N +S + + L +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 597 HTGTAQGIIHRDVKSTNILL--DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
T IIH D+K NILL K+ DFG S + ++ F Y PE
Sbjct: 174 ATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRF-YRSPE 228
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARP 682
D++S G +L+E+ P
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 28/203 (13%)
Query: 488 AIIGVGGFGNVYLGEIDDGTK--VAVK--RGNPQ-SEQGITEFQTEIQMLSKLRHR---- 538
+IG G FG V D VA+K R + Q EI++L LR +
Sbjct: 103 KVIGKGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDN 157
Query: 539 --HLVSLIGYCDENSEMILVYEYMS-NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHY 595
+++ ++ + + + +E +S N + + S + + + L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVA--KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDP 653
LH IIH D+K NILL + KV DFG S V T ++ F Y P
Sbjct: 216 LHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYTYIQSRF-YRAP 268
Query: 654 EYFRRQQLTEKSDVYSFGVVLLE 676
E + D++S G +L E
Sbjct: 269 EVILGARYGMPIDMWSLGCILAE 291
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 4e-09
Identities = 60/441 (13%), Positives = 116/441 (26%), Gaps = 142/441 (32%)
Query: 320 LDLSTVAQGLATPYYRDIV-VNASLMHNGLNVQIGPNKENTGTRNAILNGLEVIKMSNSV 378
+D T Y+DI+ V + + + + + ++ +I ++V
Sbjct: 7 MDFETGEHQYQ---YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID--HIIMSKDAV 61
Query: 379 NSLDGEFGVDGSKANSSSRGPVVAVGFAVMFGAFVG------LGAMVIKWHKRPQD-WQR 431
+ F SK M FV ++ +
Sbjct: 62 SGTLRLFWTLLSKQEE-------------MVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 432 RNSFSSWLLPLHTGDTSFMTSKCGSHKSGFTNSTLGLGRYFSFQELQEATKNFDSSAII- 490
+ L+ + F + + R + +L++A + +
Sbjct: 109 TRMYIEQRDRLYNDNQVF--------------AKYNVSRLQPYLKLRQALLELRPAKNVL 154
Query: 491 --GVGGFGNVYL-GEI--DDGTKVA-------VKRGNPQSEQGITEFQTEIQMLSKLRHR 538
GV G G ++ ++ + + N S + + ++ML KL ++
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV------LEMLQKLLYQ 208
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
+ D + SN R H S + L + S + L
Sbjct: 209 IDPNWTSRSD----------HSSNIKLRIH---------SIQAELRRLLKSKPYENCL-- 247
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFG---LSKDAPIGQGHVSTAVKGSFGYLDPEY 655
++ +V++ + L ++T K +L
Sbjct: 248 -----LVLLNVQNAKAW-------NAFNLSCKIL----------LTTRFKQVTDFLSAAT 285
Query: 656 FRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID-- 713
L S + P E K LL K +D
Sbjct: 286 TTHISLDHHSMTLT-------------------PDEV------------KSLLLKYLDCR 314
Query: 714 ----PHLVGTINPESLKKFAE 730
P V T NP L AE
Sbjct: 315 PQDLPREVLTTNPRRLSIIAE 335
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 43/306 (14%), Positives = 89/306 (29%), Gaps = 63/306 (20%)
Query: 24 PPTAATFSPRDNFLIDCGGKSSNPLPDG-------RTFKSDKEALPFLQTKEDIQVSVPS 76
P T +P + +S + DG + DK I+ S+
Sbjct: 319 PREVLTTNP---RRLSIIAES---IRDGLATWDNWKHVNCDK-------LTTIIESSLNV 365
Query: 77 ADVPS---PIYLSARVFKEESTYTFQLNQPGWHWVRLHFFALPAKEADLQKASFH----V 129
+ P+ ++ VF + L W F + + + H V
Sbjct: 366 LE-PAEYRKMFDRLSVFPPSAHIPTILLSLIW-------FDVIKSDVMVVVNKLHKYSLV 417
Query: 130 ATDNCCEEFMLNLTESTFSIKFTPMKNSVAFINAIEVVSAPDTLISDEGSSLFPVDSYEG 189
E +++ +K + ++ + P T SD+ +D Y
Sbjct: 418 EKQPK--ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP-YLDQY-- 472
Query: 190 LSKFSYQYV-YRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGV 248
Y ++ + L + +L R D FL++K + A +
Sbjct: 473 ----FYSHIGHHLKNIEHP---ERMTLFRMVFLDFRFLEQKIRHDST-----AWNASGSI 520
Query: 249 TPLIAPATVYSSASMMADSHTVQPNF----NVTWTFDVDSTFSYLLRLHFCDIVSKSLND 304
+ Y + D+ P + N F + L+ + D++ +L
Sbjct: 521 LNTLQQLKFYKP--YICDND---PKYERLVNAILDF-LPKIEENLICSKYTDLLRIALMA 574
Query: 305 LYFNVY 310
++
Sbjct: 575 EDEAIF 580
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 32/167 (19%), Positives = 58/167 (34%), Gaps = 35/167 (20%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVK------RGNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
IG GGFG +YL + K A + N +E++ ++ + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-------SELKFYQRVAKKDCIK 97
Query: 543 LIGYCDENSEM-ILVYEYMSNGPFRDH--------LYGKNL-------PPLSWKQRLEIS 586
+ + I ++ F+ G +L L++
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV--SDFGLSK 631
I L Y+H +H D+K+ N+LL +V +D+GLS
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 43/225 (19%), Positives = 81/225 (36%), Gaps = 54/225 (24%)
Query: 488 AIIGVGGFGNVY--LGEIDDGTKVAVK--RGNPQ-SEQGITEFQTEIQMLSKLRHR---- 538
+G G FG V L ++VA+K R + E + EI +L K++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKEN 80
Query: 539 --HLVSLIGYCDENSEMILVYEYMS-NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHY 595
V + + + + M + +E + N + L N P ++ L +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKN--TFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK----GSFGYL 651
LH + H D+K NIL ++ + + S + + +T+++ GS +
Sbjct: 139 LHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK---NTSIRVADFGSATFD 192
Query: 652 D--------------PE------YFRRQQLTEKSDVYSFGVVLLE 676
PE + + DV+S G +L E
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 50/226 (22%), Positives = 78/226 (34%), Gaps = 52/226 (23%)
Query: 488 AIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQ-SEQGITEFQTEIQMLSKLRHR----- 538
+G G FG V L + ID+ AVK R + + + E +L K+++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNN 96
Query: 539 HLVSLIGYCDENSEMILVYEYMS-NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
++V G M L++E + + + + N + I + L+YL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPS--LYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV---STAVK----GSFGY 650
+ H D+K NILLDD Y K ST +K G +
Sbjct: 155 K---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 651 LD--------------PE------YFRRQQLTEKSDVYSFGVVLLE 676
PE + SD++SFG VL E
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 43/225 (19%), Positives = 84/225 (37%), Gaps = 54/225 (24%)
Query: 488 AIIGVGGFGNVY--LGEIDDGTKVAVK--RGNPQ-SEQGITEFQTEIQMLSKLRHR---- 538
+G G FG V + G VAVK + + E ++EIQ+L L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNS 75
Query: 539 --HLVSLIGYCDENSEMILVYEYMS-NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHY 595
V ++ + + + + +V+E + + D + P +++ + +++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVK----GSFGYL 651
LH+ + H D+K NIL + + + + +D + +K GS Y
Sbjct: 134 LHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI---NPDIKVVDFGSATYD 187
Query: 652 D--------------PE------YFRRQQLTEKSDVYSFGVVLLE 676
D PE + ++ DV+S G +L+E
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 62/358 (17%), Positives = 103/358 (28%), Gaps = 109/358 (30%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEF-QTEIQMLSKLR--------HRH 539
+G G F V+L I VA+K S + TE EI++L +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 540 LVSLIGYCDENSE----MILVYEYMSNGP----FRDHLYGKNLPPLSWKQRLEISIGSAR 591
+V L+ + + +V+E + G + + LP K+ I +
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK---IIQQVLQ 157
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILL--DDNYVAKVSDFGLSKDAPIGQGHVSTAVK---- 645
GL YLHT IIH D+K NILL ++ Y+ +++ +AV
Sbjct: 158 GLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 646 ----------------------GSFG-----------------YLDPEYFRRQQLTEKSD 666
G Y E +D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVN----LA-----------EWAMQWKRK------ 705
++S + E+ P E +A + + K
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335
Query: 706 -------------GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
GL E +++ + + E F + L R T + L
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYE---WSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 832 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.48 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.17 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.25 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.48 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.74 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.22 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.82 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=465.19 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=208.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....++|.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999765 6999999988654 44557789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
||+||+|.++|..+....+++.+++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++..... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 9999999999987666678999999999999999999999 99999999999999999999999999999875421 1
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
......+||+.|||||++.+..|+.++|||||||+||||++|++||......+.... ... +. . .
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i~~-~~--------~-~ 243 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK------IIS-GS--------F-P 243 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHH-TC--------C-C
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH------HHc-CC--------C-C
Confidence 223456799999999999999999999999999999999999999987654332111 111 11 1 1
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2334566789999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=450.45 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=212.2
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|.+.+.||+|+||+||+|++. +++.||||+++..+.+..++|.+|+++|++|+|||||+++++|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777899999999999999764 478999999988887888899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 556 VYEYMSNGPFRDHLYGKN-------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
|||||++|+|.++|+... ..+++|.+++.++.|||+||+|||+ ++||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999996532 2469999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCC-CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQ-GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 623 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~ 700 (832)
||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+....+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 999999998654322 223345679999999999999999999999999999999999 89999876543322111
Q ss_pred HHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 701 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
..+. ....+..++.++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 274 ---~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 ---TQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ---HHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111 112334566789999999999999999999999999987755
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=447.66 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=216.8
Q ss_pred cCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|.+.+.||+|+||+||+|++. +++.||||+++..+.+..++|.+|+++|++|+|||||+++++|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788999999999999999763 478899999988877778899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEE
Q 047569 556 VYEYMSNGPFRDHLYGKN-----------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV 624 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 624 (832)
|||||++|+|.++|+..+ ...++|.+++.++.||++||+|||+ ++||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 3479999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHH
Q 047569 625 SDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 625 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 702 (832)
+|||+++........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||......+....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~------- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC------- 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------
Confidence 999999865432222 2234569999999999999999999999999999999998 8999987654332211
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...+. ....+..++.++.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 112344567789999999999999999999999988887644
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=442.17 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=211.8
Q ss_pred CCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++++.+.||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.+|++|+|||||+++|+|.+.+.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566889999999999999762 4689999998765 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc
Q 047569 556 VYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV 621 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~ 621 (832)
|||||++|+|.++|..+. ...++|.++++++.|||+||+|||+ ++||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 999999999999996432 2368999999999999999999999 99999999999999999999
Q ss_pred eEEecccccccCCCCC-CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHH
Q 047569 622 AKVSDFGLSKDAPIGQ-GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWA 699 (832)
Q Consensus 622 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~ 699 (832)
+||+|||+++...... ........||+.|||||++.++.++.++|||||||+||||+| |++||.+....+....
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~---- 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM---- 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH----
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 9999999998654222 222345679999999999999999999999999999999998 8999987654332211
Q ss_pred HHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 700 MQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 700 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
...+. ....++.++..+.+++.+||+.||++|||+.||++.|+.
T Consensus 260 ---i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 260 ---IRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ---HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---HHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111 112345677889999999999999999999999998874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=438.49 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=207.1
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
+++++.+.||+|+||+||+|+++ ..||||+++.. +.+..++|.+|+++|++++|||||+++++|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56778999999999999999865 36999988643 44567889999999999999999999999865 568999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC-C
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-G 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 638 (832)
|+||+|.++|+... ..+++.+++.|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+++...... .
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997543 469999999999999999999999 999999999999999999999999999998754322 2
Q ss_pred ceeeccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.......||+.|||||++.+ ..++.++|||||||+||||+||+.||........... ....+ ...|.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~------~~~~~----~~~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF------MVGRG----YASPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------HHHTT----CCCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH------HHhcC----CCCCC
Confidence 23345679999999999964 3589999999999999999999999976554332211 11111 11222
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
+ ...+..++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2 234456778899999999999999999999999988755
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=439.30 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=212.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+.|+..+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 69999999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+||+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 999999999653 58999999999999999999999 999999999999999999999999999998764332 23
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....+||+.|||||++.+..|+.++|||||||+||||++|++||......+....+ ..+ ..+.+ ..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~-----~~~~~--~~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDN-----LPPRL--KN 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHS-----SCCCC--SC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcC-----CCCCC--Cc
Confidence 45578999999999999999999999999999999999999999876544322211 111 11111 12
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+.++.+|+.+||+.||++|||+.|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2456678999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=437.65 Aligned_cols=254 Identities=22% Similarity=0.238 Sum_probs=210.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+.|+..++||+|+||.||+|++. +|+.||||+++.... +.+|+++|++|+|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888899999999999999865 699999999865432 247999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccccccCCCCCCc
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 639 (832)
+||+|.++|...+ .+++.++..++.||+.||+|||+ ++||||||||+||||+.+| .+||+|||+++........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997544 69999999999999999999999 9999999999999999987 6999999999876432211
Q ss_pred ----eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 640 ----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 640 ----~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.....+||+.|||||++.+..++.++|||||||+||||++|++||......+....+ .. .+.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~--------~~~ 273 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------AS--------EPP 273 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HH--------SCC
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------Hc--------CCC
Confidence 123457999999999999999999999999999999999999999765443321111 00 011
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
....+++.++..+.+++.+||+.||.+|||+.|+++.|..+++.
T Consensus 274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 11134456678899999999999999999999999998887653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=432.09 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=211.1
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|++|+|||||++++++++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999765 7999999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC-
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG- 636 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 636 (832)
|||+||+|.++|...+ .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999996544 69999999999999999999999 99999999999999999999999999999876532
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........+||+.|||||++.+..++.++|||||||+||||++|++||......+....+ .. + +.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~~-~------~~-- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI------IK-L------EY-- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-T------CC--
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-C------CC--
Confidence 223345678999999999999999999999999999999999999999876543321111 11 1 11
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
.++...+.++.+++.+||+.||.+|||+.|++
T Consensus 252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22344567799999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=425.08 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=198.9
Q ss_pred CccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc----CCcEEEEE
Q 047569 485 DSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE----NSEMILVY 557 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~----~~~~~lV~ 557 (832)
+..+.||+|+||+||+|.+. +++.||+|++... .....++|.+|+++|++|+|||||++++++.+ ++.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999765 6899999987643 44556789999999999999999999999854 45689999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCceeeC-CCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG--IIHRDVKSTNILLD-DNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 634 (832)
|||+||+|.++|.+.. .+++.++..++.||++||+|||+ ++ |+||||||+||||+ .++.+||+|||+++...
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999996543 69999999999999999999998 66 99999999999998 47899999999998643
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
. ......+||+.|||||++.+ .++.++|||||||+||||+||++||......... . .....+
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~----~~i~~~-------- 245 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y----RRVTSG-------- 245 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H----HHHTTT--------
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--H----HHHHcC--------
Confidence 2 23455689999999999865 6999999999999999999999999765432221 1 111111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....++...+.++.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122334567899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=441.42 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=213.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++|+|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 69999999987766666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+||+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+++...... ..
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 999999999643 58999999999999999999999 999999999999999999999999999998764332 23
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....+||+.|||||++.+..|+.++|||||||+||||++|++||......+....+ ..+ ..+.+ ..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~-----~~~~~--~~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDN-----LPPRL--KN 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHS-----CCCCC--SC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcC-----CCCCC--cc
Confidence 45678999999999999999999999999999999999999999876544332211 111 11111 12
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+..+.+|+.+||+.||++|||+.|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2345678999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=416.81 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=194.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||+||+|... +|+.||||++.+. .....+++.+|+++|++++|||||++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999764 6999999988654 2344678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+ +|+|.+++..++ .+++.++..++.||+.||+|||+ ++|+||||||+||||++++.+||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 689999996554 69999999999999999999999 99999999999999999999999999999865432
Q ss_pred CceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.......||+.|||||++.+..+ +.++|||||||++|||++|++||.......... .. ..+. .
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~------~i-~~~~------~-- 229 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK------NI-SNGV------Y-- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHTC------C--
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH-HcCC------C--
Confidence 23345679999999999998876 589999999999999999999998754332111 11 1111 1
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.++...+.++.+++.+||+.||++|||+.|+++.
T Consensus 230 --~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 --TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1233456778999999999999999999999754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=433.75 Aligned_cols=267 Identities=23% Similarity=0.356 Sum_probs=218.6
Q ss_pred HHHHHHhcCCCccceEeecCceeEEEEEEeC------CcEEEEEecCCCC-cccHHHHHHHHHHHHhCCC-cceeeEEEE
Q 047569 475 QELQEATKNFDSSAIIGVGGFGNVYLGEIDD------GTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRH-RHLVSLIGY 546 (832)
Q Consensus 475 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~H-pnIv~l~~~ 546 (832)
.+++...++|++.+.||+|+||+||+|.+.. ++.||||++.... ....++|.+|+++|++++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444456789999999999999999997642 3689999987653 4456789999999999965 999999999
Q ss_pred ecc-CCcEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 047569 547 CDE-NSEMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKS 611 (832)
Q Consensus 547 ~~~-~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp 611 (832)
|.+ ++.++||||||++|+|.++|+... ...+++.+++.++.|||+||+|||+ ++||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence 865 467899999999999999996432 2458999999999999999999999 9999999999
Q ss_pred CceeeCCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCCh
Q 047569 612 TNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLP 689 (832)
Q Consensus 612 ~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~ 689 (832)
+||||++++.+||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |++||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654333 23345679999999999999999999999999999999998 9999976543
Q ss_pred hhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 690 REQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 690 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.+.. ......+. ....+..++.++.+++.+||+.||.+|||+.|+++.|+.+++.
T Consensus 294 ~~~~------~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 294 DEEF------CRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SHHH------HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH------HHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2211 11111111 1123345667899999999999999999999999999988653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=423.95 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=197.5
Q ss_pred cCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|++.+.||+|+||+||+|+.. +++.||||++.... .....++.+|+++|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999753 47899999886542 2334578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
|||||+||+|.++|.+.+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997544 69999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.. ......+||+.|||||++.+..++.++|||||||+||||++|++||.+....+....+ ..+ ..
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~------~~- 243 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-------LKA------KL- 243 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC------CC-
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-------HcC------CC-
Confidence 22 2334567999999999999999999999999999999999999999876543322111 111 01
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
.++...+.++.+++.+||+.||++|||+
T Consensus 244 ---~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 2234456789999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=425.23 Aligned_cols=267 Identities=24% Similarity=0.352 Sum_probs=201.1
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC----cEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS----EMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~----~~~lV~ 557 (832)
++|.+.+.||+|+||+||+|++ +|+.||||++.....+ ...+..|+..+.+++|||||+++++|.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999987 5899999998643221 122344666667889999999999997653 589999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG-----TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
|||++|+|.++|+.. +++|.++++++.|+++||+|||+. +..+||||||||+||||+.++++||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999754 589999999999999999999973 123899999999999999999999999999987
Q ss_pred CCCCCCc---eeeccccCccccChhccccC------CCCccccEEechhHHHHHhhCCCCCCCCChhh----h-----hh
Q 047569 633 APIGQGH---VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLLEVLCARPAINPQLPRE----Q-----VN 694 (832)
Q Consensus 633 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~----~-----~~ 694 (832)
....... ......||+.|||||++.+. .++.++|||||||+||||+||++||....... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6433222 22345799999999999764 46789999999999999999988775332111 0 01
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCC-ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
..... . .......+|.+.... ..+.+..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 238 ~~~~~-~----~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMR-K----VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHH-H----HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH-H----HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111 1 111122233322211 23567789999999999999999999999999987754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=407.89 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=189.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC--------
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS-------- 551 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~-------- 551 (832)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999865 6999999987644 3445578999999999999999999999986543
Q ss_pred ----cEEEEEEecCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEec
Q 047569 552 ----EMILVYEYMSNGPFRDHLYGKNL-PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSD 626 (832)
Q Consensus 552 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 626 (832)
.+|+|||||++|+|.+++..+.. ...++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999976542 345677889999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCc-----------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhH
Q 047569 627 FGLSKDAPIGQGH-----------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695 (832)
Q Consensus 627 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l 695 (832)
||+++........ .....+||+.|||||++.+..++.++|||||||+||||++ ||... .+....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 9999876432211 1234579999999999999999999999999999999996 66432 111111
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. . +...... .......+.+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~---~---------~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LT---D---------VRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH---H---------HHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH---H---------HhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 0 0111110 011233456788999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=403.25 Aligned_cols=287 Identities=63% Similarity=1.050 Sum_probs=253.0
Q ss_pred ccCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccC
Q 047569 471 YFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN 550 (832)
Q Consensus 471 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~ 550 (832)
.+++.++..++++|++.+.||+|+||.||+|.+++++.||||+.........+++.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34555666678999999999999999999999888999999998887777788999999999999999999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNL--PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
+..++||||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999965442 358999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 629 LSKDAPIG-QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 629 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+......|.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865422 22223445689999999999999999999999999999999999999988777666677777766666677
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
+..++++.+.....++.+..+.+++.+||+.||++||++.|+++.|+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 77888888888888999999999999999999999999999999999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=411.35 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=206.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEec------cCCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD------ENSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~------~~~~ 552 (832)
++|++.+.||+|+||+||+|... +|+.||||++... .....+++.+|+++|++|+|||||++++++. +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999765 7999999998754 3344577899999999999999999999875 3468
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
+|||||||+ |+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 999999995 7899999654 379999999999999999999999 9999999999999999999999999999986
Q ss_pred CCCC---CCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 633 APIG---QGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 633 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+....+............
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5422 12233457899999999998875 5699999999999999999999999887665544333211100000000
Q ss_pred ccc-----------cCCCCCC---CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKI-----------IDPHLVG---TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i-----------~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+ +.+.... ...+..+.++.+|+.+||+.||.+|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000 011234567899999999999999999998864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=396.80 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=200.3
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcE
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~ 553 (832)
...++|++.+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++|+.+ +|||||++++++.+++.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999754 46889999886543 346788999999998 699999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-CceEEeccccccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSKD 632 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~ 632 (832)
+||||||++|+|.+++. .+++.++..++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999983 48899999999999999999999 999999999999999876 7999999999976
Q ss_pred CCCCCC---------------------------ceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCC
Q 047569 633 APIGQG---------------------------HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAI 684 (832)
Q Consensus 633 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf 684 (832)
...... ......+||+.|||||++.+. .++.++||||+||++|||++|++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 542211 112335799999999999775 5899999999999999999999999
Q ss_pred CCCCh-hhhhhHHHHHHH---------Hhhhccc--------------ccc-----cCCCC---------CCCCChhHHH
Q 047569 685 NPQLP-REQVNLAEWAMQ---------WKRKGLL--------------EKI-----IDPHL---------VGTINPESLK 726 (832)
Q Consensus 685 ~~~~~-~~~~~l~~~~~~---------~~~~~~~--------------~~i-----~d~~l---------~~~~~~~~~~ 726 (832)
..... .++...+..... ....... ..+ ..+.+ ........+.
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 65433 222211111000 0000000 000 00000 0011123456
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 727 KFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 727 ~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
++.+|+.+||+.||.+|||++|+++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 7899999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=418.45 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=213.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|++|+|||||++++++.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999765 7999999998877766778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC--CceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN--YVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 637 (832)
|+||+|.++|..+. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999999986443 369999999999999999999999 999999999999999854 89999999999986532
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......+||+.|||||++.+..++.++|||||||+||||++|++||.+....+....+. .. +..+.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~-------~~------~~~~~ 376 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-------SC------DWNMD 376 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TT------CCCCC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------hC------CCCCC
Confidence 33455679999999999999999999999999999999999999998765543321110 00 11111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122345677899999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=391.36 Aligned_cols=287 Identities=41% Similarity=0.702 Sum_probs=244.7
Q ss_pred CcccCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCc-ccHHHHHHHHHHHHhCCCcceeeEEEEe
Q 047569 469 GRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE-QGITEFQTEIQMLSKLRHRHLVSLIGYC 547 (832)
Q Consensus 469 ~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~L~~l~HpnIv~l~~~~ 547 (832)
.+.+++.++..+.++|++.+.||+|+||.||+|...+++.||||++..... ....++.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 356899999999999999999999999999999988899999999876532 2234789999999999999999999999
Q ss_pred ccCCcEEEEEEecCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 548 DENSEMILVYEYMSNGPFRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 548 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
.+.+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+..+++||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997543 3459999999999999999999999222299999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCC--hhhhhhHHHHHHHHh
Q 047569 626 DFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQL--PREQVNLAEWAMQWK 703 (832)
Q Consensus 626 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~--~~~~~~l~~~~~~~~ 703 (832)
|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........|.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999998776555555556679999999999999999999999999999999999999995321 112233445555555
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
....+..+.+..+........+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 5566677777777778888899999999999999999999999999999885
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=412.64 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=200.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHH---HHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQ---TEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~---~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
++|++.++||+|+||.||+|+.. +|+.||||++.+.. .+....+. .++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999875 69999999875421 12223333 4466677789999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
||||||+||+|.++|...+ .+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+++...
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997554 69999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.. ...+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||......+...+.... ..
T Consensus 344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i------------~~ 408 (689)
T 3v5w_A 344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------LT 408 (689)
T ss_dssp SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH------------HH
T ss_pred CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh------------cC
Confidence 32 2345689999999999964 57999999999999999999999999754332221111111 01
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPT-----MGDVL 750 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl 750 (832)
.. ..++...+.++.+|+.+||+.||.+|++ +.|++
T Consensus 409 ~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 409 MA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 11 1233456678999999999999999998 56665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.73 Aligned_cols=259 Identities=30% Similarity=0.458 Sum_probs=208.0
Q ss_pred HhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
..++|++.+.||+|+||.||+|+. +|+.||||++.... ....++|.+|+++|++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356899999999999999999976 58999999987553 444578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNL-PPLSWKQRLEISIGSARGLHYLHTGTAQG--IIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++ |+||||||+|||++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999975431 248999999999999999999999 88 9999999999999999999999999997543
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... . .
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~------~---------~ 254 (309)
T 3p86_A 191 ST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------F---------K 254 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------H---------S
T ss_pred cc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h---------c
Confidence 22 122344569999999999999999999999999999999999999998765433221110 0 0
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
......+...+..+.+++.+||+.+|.+||++.++++.|+.+++
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11112344566789999999999999999999999999987754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.22 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=212.0
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999975 47899999998766556677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999654 48999999999999999999999 9999999999999999999999999999887653322
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+ .+ ...
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~~------~~--~~~ 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNG------TP--ELQ 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HHC------SC--CCS
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC------CC--CCC
Confidence 2345579999999999999999999999999999999999999997765433221110 000 01 112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 23456678999999999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=371.40 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=215.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||.||+|... +++.||+|++........+.|.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888999999999999999875 68999999987777777889999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999997643 469999999999999999999999 999999999999999999999999999998654322111
Q ss_pred -------------eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 641 -------------STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 641 -------------~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---------- 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---------- 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC----------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh----------
Confidence 114569999999999999999999999999999999999999986543322110000
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.....+. ..++.++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 236 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 236 VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000011 11234455789999999999999999999999999877554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=376.90 Aligned_cols=261 Identities=25% Similarity=0.451 Sum_probs=216.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe--------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID--------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDEN 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~ 550 (832)
.++|++.+.||+|+||.||+|... ++..||||++.... ....+++.+|+++|+++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367889999999999999999753 35679999987653 34567899999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
+..++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997543 2358999999999999999999999 999999999999999
Q ss_pred CCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986543221 12233457889999999999999999999999999999999 999997654433211
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
. ...+ .....+..++..+.+++.+||+.+|.+||++.|+++.|+.++.+.
T Consensus 317 ~-------~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 317 L-------LKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp H-------HHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H-------HhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111 111233456678999999999999999999999999999887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.81 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=215.3
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57889999999999999999988899999999876543 34679999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.... ..+++..++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999996543 468999999999999999999999 9999999999999999999999999999986543322233
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..... ..+ .....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-------~~~---------~~~~~ 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------STG---------FRLYK 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTT---------CCCCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------hcC---------ccCCC
Confidence 34457788999999999999999999999999999999 99999876543321111 111 11122
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+...+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 23346779999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=368.37 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=213.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|.+. .+..||||++... .....++|.+|+++|++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357889999999999999999874 3456999998765 44556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 469999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 636 GQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 636 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..... ..+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~~------ 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-------EEG------ 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTT------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------HcC------
Confidence 3221 2223446788999999999999999999999999999999 99999766543322111 111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.....+..++..+.+++.+||+.||.+||++.++++.|+.+++.
T Consensus 271 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 ---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11123345667899999999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=364.11 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=219.3
Q ss_pred cccCHHHHHHHhcC----------CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc
Q 047569 470 RYFSFQELQEATKN----------FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR 538 (832)
Q Consensus 470 ~~~~~~el~~~~~~----------f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp 538 (832)
..+++++++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35788999888764 777889999999999999876 7999999998877777778899999999999999
Q ss_pred ceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC
Q 047569 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618 (832)
Q Consensus 539 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 618 (832)
||+++++++...+..++||||+++++|.+++... .+++.+++.++.|+++||+|||+ ++++||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998543 58999999999999999999999 99999999999999999
Q ss_pred CCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH
Q 047569 619 NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW 698 (832)
Q Consensus 619 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~ 698 (832)
++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~--- 252 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR--- 252 (321)
T ss_dssp TCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---
T ss_pred CCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 9999999999988764322 223445799999999999999999999999999999999999999976644322111
Q ss_pred HHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 699 AMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 699 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.... ..+.+ ......+..+.+++.+||+.||.+||++.|+++.
T Consensus 253 ----~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 ----LRDS-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHHS-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HhcC-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 11111 1123456789999999999999999999999753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=368.81 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=208.9
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.++|++.+.||+|+||.||+|.+ .+|+.||||++... .....+++.+|+++|++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999987 47999999987643 4455678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++...+ .+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999996543 68999999999999999999999 99999999999999999999999999999865432
Q ss_pred CceeeccccCccccChhccccCCCC-ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.......||+.|+|||++.+..++ .++|||||||++|||++|+.||......+..... ..+ .
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-------~~~--------~- 230 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-------LRG--------K- 230 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC--------C-
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhC--------C-
Confidence 233456799999999999888765 7999999999999999999999876543322111 111 0
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..++...+..+.+++.+||+.||.+|||+.|+++
T Consensus 231 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 -YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0123345667899999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.46 Aligned_cols=279 Identities=37% Similarity=0.644 Sum_probs=228.8
Q ss_pred cccCHHHHHHHhcCCCcc------ceEeecCceeEEEEEEeCCcEEEEEecCCC----CcccHHHHHHHHHHHHhCCCcc
Q 047569 470 RYFSFQELQEATKNFDSS------AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ----SEQGITEFQTEIQMLSKLRHRH 539 (832)
Q Consensus 470 ~~~~~~el~~~~~~f~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~~~~~~f~~Ei~~L~~l~Hpn 539 (832)
..|+++++..++++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999887 8999999999999986 5889999987653 2345678999999999999999
Q ss_pred eeeEEEEeccCCcEEEEEEecCCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC
Q 047569 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGK-NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD 618 (832)
Q Consensus 540 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~ 618 (832)
|+++++++.+.+..++||||+++++|.+++... ....+++..++.++.|+++||+|||+ ++++||||||+|||++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998643 23469999999999999999999999 99999999999999999
Q ss_pred CCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH
Q 047569 619 NYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE 697 (832)
Q Consensus 619 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~ 697 (832)
++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|++||.......... .
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--D 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--H
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--H
Confidence 99999999999986543222 22334569999999998865 58899999999999999999999997654332211 1
Q ss_pred HHHHHh-hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 698 WAMQWK-RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 698 ~~~~~~-~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
+..... ....+...+++.+ .......+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111 1122333444433 345567888999999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=362.50 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=207.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|... +++.||+|++... .....++|.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367999999999999999999765 6899999987443 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... ++++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999996543 68999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... . .+..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-~-----~~~~ 232 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-S-----VPNV 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-C-----CCCH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-c-----CCCc
Confidence 333344567999999999999999999999999999999999999999876543221 010111 0 0111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRP-TMGDVLWNLEYA 756 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 756 (832)
.....+..+..+.+++.+||+.||.+|| ++.++.+.|+.+
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 1122344567899999999999999998 788888777654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=367.19 Aligned_cols=273 Identities=24% Similarity=0.378 Sum_probs=210.7
Q ss_pred hcCCCccceEeecCceeEEEEEE-----eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~ 553 (832)
.++|++.+.||+|+||.||+|++ .+++.||||++........++|.+|+++|++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788999999999999999974 2688999999988777778899999999999999999999999854 4568
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999996543 358999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCC--ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH-HHHhhhccccc
Q 047569 634 PIGQG--HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA-MQWKRKGLLEK 710 (832)
Q Consensus 634 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~-~~~~~~~~~~~ 710 (832)
..... .......++..|+|||++.+..++.++||||||+++|||++|..|+............... ...... .+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 243 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-HLIE 243 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH-HHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH-HHHH
Confidence 43221 1223345778899999999999999999999999999999999988643211000000000 000000 0000
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.+........+..++..+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111111222345567789999999999999999999999999987754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=354.62 Aligned_cols=255 Identities=28% Similarity=0.374 Sum_probs=214.1
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||+|+.+++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467899999999999999999988888999999875543 3467999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999996543 358999999999999999999999 999999999999999999999999999998765443333
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||............ ..+. ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~---------~~~ 225 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------SQGH---------RLY 225 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HTTC---------CCC
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-------HcCC---------CCC
Confidence 344556788999999999999999999999999999999 99999766543321110 0100 011
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1223456799999999999999999999999988765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=358.19 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=212.6
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||++...++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 467889999999999999999998888999999876543 3477999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999996532 369999999999999999999999 999999999999999999999999999998654332222
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||............ ..+ ....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------~~~---------~~~~ 241 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQG---------LRLY 241 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HTT---------CCCC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-------hcc---------cCCC
Confidence 333457788999999999999999999999999999998 99999766543322111 111 1111
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.+...+..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 223345679999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=372.56 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=203.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|+.. ++..||||++... .....++|.+|+++|++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999765 5778999998765 44556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999997543 469999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCce--eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 636 GQGHV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 636 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... ...+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-------i~~~------ 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-------VDEG------ 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-------HHTT------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcC------
Confidence 22211 122345778999999999999999999999999999998 9999976544322111 1111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1111233556789999999999999999999999999998765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=373.86 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=218.1
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeE
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSL 543 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l 543 (832)
+...++....++|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+++|+++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344555556789999999999999999999742 4679999998764 344557799999999999 79999999
Q ss_pred EEEeccCC-cEEEEEEecCCCChhhhhccCCC------------------------------------------------
Q 047569 544 IGYCDENS-EMILVYEYMSNGPFRDHLYGKNL------------------------------------------------ 574 (832)
Q Consensus 544 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 574 (832)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99987754 48999999999999999965432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC-
Q 047569 575 ----------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ- 637 (832)
Q Consensus 575 ----------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 637 (832)
..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 128899999999999999999999 999999999999999999999999999998654322
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+... .....+ .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~~~---------~ 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLKEG---------T 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH------HHHHHT---------C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH------HHHHcC---------C
Confidence 223345668999999999999999999999999999999998 999997654332211 011111 1
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
....+...+..+.+++.+||+.||.+||++.|+++.|+.+++.
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1122334566799999999999999999999999999988754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.32 Aligned_cols=271 Identities=25% Similarity=0.359 Sum_probs=209.1
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC----cEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS----EMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~----~~~lV 556 (832)
.++|++.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.+|++++||||+++++++.+.. .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367899999999999999999875 8999999986543 33455677999999999999999999997644 47999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeeeccCCCCceeeCCCCceEEec
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ----------GIIHRDVKSTNILLDDNYVAKVSD 626 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~----------~ivHrDlkp~NILl~~~~~~kl~D 626 (832)
|||+++|+|.+++... .+++.+++.++.|+++||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999654 48999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCCCc-eeeccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH
Q 047569 627 FGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 627 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 700 (832)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999765433221 2233569999999999986 356678999999999999999999997654322111111000
Q ss_pred H-----HhhhcccccccCCCCCCCC-ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 701 Q-----WKRKGLLEKIIDPHLVGTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 701 ~-----~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
. ............+.+.... ....+..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0000001111111111111 124567799999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=354.40 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=203.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|... .+..||+|+.... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 467899999999999999999764 2557999998764 3445678999999999999999999999985 467899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999996543 368999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
..........+|+.|+|||++.+..++.++|||||||++|||++ |++||......+..... ..+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-------~~~-------- 233 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENG-------- 233 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTT--------
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-------HcC--------
Confidence 33333334457889999999999999999999999999999996 99999876543322111 010
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
.....++..+..+.+++.+||+.||.+||++.++++.|+.+++.+
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 234 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 011233456678999999999999999999999999999887654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=358.91 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=223.0
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
..++|++.+.||+|+||.||+|.+. +++.||+|.+... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4577899999999999999999876 4889999998754 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999999987666679999999999999999999999 8999999999999999999999999999987665444
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......+|+.|+|||++.+..++.++||||||+++|||++ |++||............ . ....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-------~---------~~~~ 230 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------E---------KDYR 230 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------H---------TTCC
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------h---------ccCC
Confidence 44455667889999999999999999999999999999999 99999766543322111 0 1111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
...+...+..+.+++.+||+.||.+||++.++++.|+.+.+...
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 12334556789999999999999999999999999998876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=369.57 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=216.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe--------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID--------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDEN 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~ 550 (832)
.++|.+.+.||+|+||.||+|... .+..||||++... .....+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467899999999999999999753 2357999998765 345567899999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999997543 2459999999999999999999999 999999999999999
Q ss_pred CCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999986543221 22334457889999999999999999999999999999999 999997664432211
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
. ...+. ....+..++.++.+++.+||+.+|++||++.|+++.|+.+...
T Consensus 305 ~-------~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 305 L-------LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp H-------HHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------HHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 11111 1122344567899999999999999999999999999988764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=374.23 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=212.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|.+. +++.||||.+.... ....++|.+|+++|++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888999999999999999886 78999999987553 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++|+|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999996432 358999999999999999999999 9999999999999999999999999999986432211
Q ss_pred cee-eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 639 HVS-TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 639 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.... ...+.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~--------- 332 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-------VEKGG--------- 332 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-------HHTTC---------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------
Confidence 111 12235778999999999999999999999999999998 9999976654332111 11111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....+..++..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 112234456789999999999999999999999999987754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.07 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=208.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+++.. +|+.||+|++.+. .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57899999999999999999875 6899999987643 2345677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9999999999996543 68999999999999999999999 99999999999999999999999999999864322
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
........||+.|+|||++.+..++.++|||||||++|||++|++||........... .... ..
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~~~-------~~--- 222 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILME-------EI--- 222 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHC-------CC---
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH------HHcC-------CC---
Confidence 2233456799999999999999999999999999999999999999976543322111 0110 01
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 752 (832)
.++...+..+.+++.+||+.||.+|| ++.|+++.
T Consensus 223 -~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 12344567899999999999999999 88888643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=363.36 Aligned_cols=263 Identities=17% Similarity=0.180 Sum_probs=212.3
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+++.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36789999999999999999986 4789999998765432 24688999999999 89999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc-----eEEecccccccC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV-----AKVSDFGLSKDA 633 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~ 633 (832)
|+ +++|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999754 3479999999999999999999999 89999999999999998887 999999999865
Q ss_pred CCCCCc------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 634 PIGQGH------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 634 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 432221 12456799999999999999999999999999999999999999987543333222222111111100
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
... .....+ ++.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus 241 ~~~---------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 IEV---------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHH---------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHH---------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 011234 8999999999999999999999999998776543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=371.40 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=214.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|.+. +++.||||++... ..+...++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999742 4678999998654 445566799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC---ceEEe
Q 047569 554 ILVYEYMSNGPFRDHLYGKN-----LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY---VAKVS 625 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~ 625 (832)
++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 2468999999999999999999999 9999999999999999554 59999
Q ss_pred cccccccCCC-CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHh
Q 047569 626 DFGLSKDAPI-GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 626 DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i------- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------
Confidence 9999975321 11122334568999999999999999999999999999999998 99999876543322111
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
..+. ....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+...
T Consensus 300 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 300 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 1110 112234456779999999999999999999999999998866544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.80 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=206.3
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
.++|++.+.||+|+||.||+|.+. +++ +||+|.+... .....++|.+|++++++++||||++++++|.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 356889999999999999999754 344 4688887644 345668899999999999999999999999875 478
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997643 469999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 635 IGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 635 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||............ .
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-------~-------- 233 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------E-------- 233 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------H--------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-------H--------
Confidence 3322 22233457889999999999999999999999999999999 99999876543322111 1
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.......++..+..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 234 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 -KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1111123345667899999999999999999999999999887654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.11 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=215.8
Q ss_pred hcCCCccceEeecCceeEEEEEE------eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+++|++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46789999999999999999975 24588999998764 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNL----------------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKS 611 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp 611 (832)
++||||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++++||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999965432 348899999999999999999999 9999999999
Q ss_pred CceeeCCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCCh
Q 047569 612 TNILLDDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLP 689 (832)
Q Consensus 612 ~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~ 689 (832)
+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999866433222 1233457889999999999999999999999999999999 9999977654
Q ss_pred hhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 690 REQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 690 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....... ..+ .....+...+..+.+++.+||+.||.+||++.++++.|+.++.
T Consensus 259 ~~~~~~~-------~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ERLFNLL-------KTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGHHHHH-------HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHh-------hcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3322111 111 1112334566789999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=368.12 Aligned_cols=252 Identities=26% Similarity=0.347 Sum_probs=204.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999876 78999999876443 2334668999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC-C
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-Q 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~ 637 (832)
|+++++|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999999654 369999999999999999999999 99999999999999999999999999999765322 1
Q ss_pred CceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...+ ... ..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~----~~~---------~~ 226 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----KEK---------KT 226 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHH----HTT---------CT
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHH----hcc---------cc
Confidence 122334679999999999988775 78999999999999999999999765432211 1111 110 11
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11112345677899999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=382.64 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=213.1
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 46788999999999999999999888999999987654 45788999999999999999999999987 56789999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++|+|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 99999999975544468899999999999999999999 999999999999999999999999999998754322122
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++....++.++|||||||+||||++ |+.||......+..... ..+. ...
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~~---------~~~ 405 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGY---------RMP 405 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------HHTC---------CCC
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC---------CCC
Confidence 233446788999999999999999999999999999999 99999766543322111 1111 111
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.+..++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 2345667899999999999999999999999888754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=349.17 Aligned_cols=256 Identities=29% Similarity=0.404 Sum_probs=214.2
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||++...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57889999999999999999988889999999876543 34789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+++|.+++.... ..+++..++.++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999996543 368999999999999999999999 9999999999999999999999999999986543222222
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+... . ...+ .....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~-i~~~---------~~~~~ 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE------D-ISTG---------FRLYK 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------H-HHTT---------CCCCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH------H-HhcC---------CcCCC
Confidence 33457789999999999999999999999999999999 899997654432211 1 1111 01112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+...+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23346779999999999999999999999999987754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=352.11 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=214.2
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 46788999999999999999998888899999987543 346789999999999999999999999874 5689999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++++|.+++.......+++.+++.++.|+++||+|||+ ++++||||||+|||+++++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 99999999965433368999999999999999999999 999999999999999999999999999998765433222
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+... . ...+ ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~-~~~~---------~~~~ 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ------N-LERG---------YRMV 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------H-HHTT---------CCCC
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH------H-Hhcc---------cCCC
Confidence 334457889999999998999999999999999999999 899997654432211 1 1111 1112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.+...+..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 2334567899999999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=383.59 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=217.1
Q ss_pred hcCCCccceEeecCceeEEEEEEeC-CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...++|.+|+++|++++||||++++++|.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568889999999999999998764 8899999987553 3467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++|+|.+++.......+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 999999999977666679999999999999999999999 99999999999999999999999999999876433322
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
......++..|+|||++.+..++.++|||||||+||||++ |+.||......+.... ... ....
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~---------~~~~ 438 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------LEK---------DYRM 438 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------HHT---------TCCC
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHc---------CCCC
Confidence 2333456789999999999999999999999999999999 9999976654332111 111 1112
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
..+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 234456678999999999999999999999999888653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.31 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=215.7
Q ss_pred HHHHhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEecc
Q 047569 477 LQEATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549 (832)
Q Consensus 477 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~ 549 (832)
+....++|++.+.||+|+||.||+|... +++.||||++... .....++|.+|++++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3344678999999999999999999875 3488999998765 34446789999999999999999999999999
Q ss_pred CCcEEEEEEecCCCChhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKN----------------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHr 607 (832)
.+..++||||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 999999999999999999996532 1579999999999999999999999 999999
Q ss_pred cCCCCceeeCCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCC
Q 047569 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAIN 685 (832)
Q Consensus 608 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~ 685 (832)
||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999876532211 12234568899999999999999999999999999999999 999997
Q ss_pred CCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 686 PQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 686 ~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.....+... ....+. . ...+..++..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus 279 ~~~~~~~~~-------~~~~~~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAHEEVIY-------YVRDGN--------I-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCHHHHHH-------HHHTTC--------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCChHHHHH-------HHhCCC--------c-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 654332211 111111 1 12234556789999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=365.02 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=207.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc------ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE------QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... ...+.+.+|+++|++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 689999998765422 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC----ceEEecccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY----VAKVSDFGL 629 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGl 629 (832)
++||||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999654 379999999999999999999999 9999999999999998776 799999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+..... ..+.
T Consensus 166 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i-------~~~~-- 234 (361)
T 2yab_A 166 AHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-------TAVS-- 234 (361)
T ss_dssp CEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HTTC--
T ss_pred ceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcC--
Confidence 9876432 2234556999999999999999999999999999999999999999876543321111 0000
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...........+..+.+++.+||..||.+|||+.|+++
T Consensus 235 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 ----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000011234567899999999999999999999984
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.49 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=205.3
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||+||+|...+|+.||+|++.... ....+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999998889999999886542 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|++ ++|.+++.... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 997 58888776543 468999999999999999999999 999999999999999999999999999998754322
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc-------
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK------- 710 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~------- 710 (832)
.......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+...................
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 22334568999999999876 5689999999999999999999999987655443222111000000000000
Q ss_pred ------ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 ------IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 ------i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...........+..+.++.+++.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000112234567899999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=348.81 Aligned_cols=249 Identities=30% Similarity=0.507 Sum_probs=198.5
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCC----cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS----EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57889999999999999999875 8999999876542 234578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eeeccCCCCceeeCC--------CCceEEec
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG---IIHRDVKSTNILLDD--------NYVAKVSD 626 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~---ivHrDlkp~NILl~~--------~~~~kl~D 626 (832)
||+++++|.+++.. ..+++.+++.++.|+++||+|||+ ++ ++||||||+|||++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999853 368999999999999999999999 66 999999999999986 77899999
Q ss_pred ccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 627 FGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 627 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
||+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 160 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----------- 225 (271)
T 3dtc_A 160 FGLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG----------- 225 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-----------
T ss_pred CCcccccccc---cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-----------
Confidence 9999765422 22245689999999999999999999999999999999999999976543322110
Q ss_pred ccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 707 LLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 707 ~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
+.........+...+..+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 ----VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 011112223344566789999999999999999999999998874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=347.96 Aligned_cols=250 Identities=19% Similarity=0.290 Sum_probs=209.1
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|..+ ++.||||++... .....++|.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56889999999999999999885 899999988764 344567899999999999999999999999876 7889999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG--IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||+++++|.+++.......+++.+++.++.|+++||+|||+ ++ ++||||||+|||++.++.++|+|||+......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987665579999999999999999999998 78 99999999999999999999999988654321
Q ss_pred CCCceeeccccCccccChhccccCCCCc---cccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTE---KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
....||+.|+|||++.+...+. ++|||||||++|||++|+.||.......... ....
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~-------- 225 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVAL-------- 225 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHH--------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHh--------
Confidence 2346899999999998765544 7999999999999999999997654433211 1111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.......+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 226 -EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1111223445667899999999999999999999999998865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=357.90 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=215.4
Q ss_pred hcCCCccceEeecCceeEEEEEE------eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++|+++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46789999999999999999975 246899999987653 34567899999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 553 MILVYEYMSNGPFRDHLYGKNL----------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
.++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ ++++||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999975432 258999999999999999999999 999999999999999
Q ss_pred CCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 99999999999999876543322 2234557889999999999999999999999999999999 999997654322211
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
. ....+ .....+...+..+.+++.+||+.||.+||++.|+++.|+.++.
T Consensus 259 --~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 --K----MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp --H----HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H----HhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 11111 1111233456789999999999999999999999999998765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=359.97 Aligned_cols=254 Identities=16% Similarity=0.220 Sum_probs=210.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999875 68899999887543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC--CCceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD--NYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 637 (832)
+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999999996443 368999999999999999999999 99999999999999987 789999999999876432
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......||+.|+|||++.+..++.++|||||||++|||++|++||......+..... ... . ....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~-~------~~~~ 223 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNA-E------YTFD 223 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHT-C------CCCC
T ss_pred -CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------HcC-C------CCCC
Confidence 2334567999999999999988999999999999999999999999876543322111 110 0 0000
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
....+..+.++.+++.+||+.||.+|||+.|+++.-.
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 0001234568999999999999999999999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=377.92 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=208.0
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45688899999999999999999888889999987654 345789999999999999999999999976 6789999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++|+|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999975444468999999999999999999999 999999999999999999999999999998764333223
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+..... ..+ ....
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~---------~~~~ 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERG---------YRMP 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTT---------CCCC
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC---------CCCC
Confidence 334457889999999999999999999999999999999 99999766543322111 111 1112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.++.++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3345677899999999999999999999999888754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.03 Aligned_cols=263 Identities=16% Similarity=0.156 Sum_probs=213.4
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35799999999999999999986 4789999998764432 24688999999999 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc-----eEEecccccccC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV-----AKVSDFGLSKDA 633 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~ 633 (832)
|+ +++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997543 369999999999999999999999 99999999999999987776 999999999876
Q ss_pred CCCCC------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 634 PIGQG------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 634 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 53322 123455699999999999999999999999999999999999999987543322222221111111111
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
... .....+..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 111 1123457899999999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=374.05 Aligned_cols=252 Identities=30% Similarity=0.453 Sum_probs=210.8
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC-cEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS-EMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~-~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|... ++.||||+++... ..++|.+|+++|++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888999999999999999875 7899999987654 4578999999999999999999999986654 79999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++|+|.+++.......+++..++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999976655568999999999999999999999 99999999999999999999999999999864321
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... ...+ ...
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~---------~~~ 405 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKG---------YKM 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-------HHTT---------CCC
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcC---------CCC
Confidence 122357889999999999999999999999999999998 9999976544332111 1111 111
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
..+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 2344567789999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.46 Aligned_cols=270 Identities=20% Similarity=0.277 Sum_probs=213.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCC--cEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS--EMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~--~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57899999999999999999876 58999999987543 345678899999999999999999999987654 789999
Q ss_pred EecCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee----CCCCceEEeccccccc
Q 047569 558 EYMSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSKD 632 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~ 632 (832)
||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999996543 2349999999999999999999999 999999999999999 7888899999999987
Q ss_pred CCCCCCceeeccccCccccChhccc--------cCCCCccccEEechhHHHHHhhCCCCCCCCChhhh-hhHHHHHHHHh
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFR--------RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ-VNLAEWAMQWK 703 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~-~~l~~~~~~~~ 703 (832)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ...........
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 65332 223456999999999986 57889999999999999999999999975433221 12211111111
Q ss_pred hhccccccc-----------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 704 RKGLLEKII-----------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 704 ~~~~~~~i~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
....+..+. +......+.......+.+++.+||+.||++|||+.|+++.....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111111110 11112244567888999999999999999999999999877644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=363.11 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=211.9
Q ss_pred HhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCC
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENS 551 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~ 551 (832)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++|+++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3578999999999999999999862 4568999998754 334457899999999999 8999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCC
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNL---------------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVK 610 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlk 610 (832)
..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ ++|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 99999999999999999965432 248999999999999999999999 999999999
Q ss_pred CCceeeCCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCC
Q 047569 611 STNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQL 688 (832)
Q Consensus 611 p~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~ 688 (832)
|+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986543222 22334567889999999999999999999999999999998 999997654
Q ss_pred hhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 689 PREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 689 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
...... .....+ .....+...+..+.+++.+||+.||.+||++.++++.|+.++..
T Consensus 280 ~~~~~~------~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDANFY------KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHHHH------HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHHHH------HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 332111 111111 11122344567899999999999999999999999999877553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=359.12 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=208.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc------ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE------QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... ...+++.+|+++|++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456899999999999999999875 689999998754321 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC----ceEEecccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY----VAKVSDFGL 629 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGl 629 (832)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999644 469999999999999999999999 9999999999999999887 899999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... ..
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------~~---- 232 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------AV---- 232 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------HT----
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------hc----
Confidence 98764322 2334569999999999999999999999999999999999999997765433221110 00
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
............+..+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 ---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0001001112345678999999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=366.15 Aligned_cols=243 Identities=22% Similarity=0.341 Sum_probs=200.7
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|.++|+.+ +||||+++++++.+.+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999875 6899999987643 234456788999999998 69999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999996543 69999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
. ........||+.|+|||++.+..++.++|||||||++|||++|++||......+....+ .. ..
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~---------~~ 240 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LN---------DE 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH---------CC
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------Hc---------CC
Confidence 2 22344567999999999999999999999999999999999999999876543322111 11 11
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
..++...+..+.+++.+||+.||.+||++
T Consensus 241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 --VVYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 11233456679999999999999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=353.16 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc--------------------------ccHHHHHHHHHHHHh
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE--------------------------QGITEFQTEIQMLSK 534 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~f~~Ei~~L~~ 534 (832)
++|++.+.||+|+||.||+|... +++.||||++..... ...+++.+|+++|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67899999999999999999765 689999998754421 123568999999999
Q ss_pred CCCcceeeEEEEecc--CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 047569 535 LRHRHLVSLIGYCDE--NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKST 612 (832)
Q Consensus 535 l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 612 (832)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.+++.++.|+++||+|||+ ++|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 999999999999976 5789999999999999887643 369999999999999999999999 99999999999
Q ss_pred ceeeCCCCceEEecccccccCCCCCCceeeccccCccccChhccccCC---CCccccEEechhHHHHHhhCCCCCCCCCh
Q 047569 613 NILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLLEVLCARPAINPQLP 689 (832)
Q Consensus 613 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~SlGvvl~elltG~~pf~~~~~ 689 (832)
|||++.++.+||+|||+++...... .......||+.|+|||++.+.. .+.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999998764322 2234457999999999997765 47889999999999999999999976543
Q ss_pred hhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 690 REQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 690 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.... ... .... ......+..+..+.+++.+||+.||.+||++.|+++
T Consensus 246 ~~~~------~~~-~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MCLH------SKI-KSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHH------HHH-HHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHH------HHH-hccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2211 111 1110 111112345677999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.25 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=212.1
Q ss_pred hcCCCccceEeecCceeEEEEEEeC----CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|.... +..||+|.+... .....++|.+|++++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4678899999999999999997643 346999998765 344567899999999999999999999998754 5689
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.... ..+++..++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999996543 368999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..... ..+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-------~~~~------- 231 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-------EKGD------- 231 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-------HHTC-------
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-------hcCC-------
Confidence 33333344557889999999999999999999999999999998 99999765443322111 1110
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAF 763 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 763 (832)
....+...+..+.+++.+||+.+|.+||++.|+++.|+.+.+.....
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i 278 (281)
T 3cc6_A 232 --RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278 (281)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhh
Confidence 01122345677999999999999999999999999999998876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=363.34 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=209.4
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
...++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999775 6899999987654 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC---CceEEeccccccc
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN---YVAKVSDFGLSKD 632 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~ 632 (832)
||||+++|+|.+++... ..+++.++..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999998654 368999999999999999999999 999999999999999865 4599999999987
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
..... ......||+.|+|||++.+..++.++|||||||++|||++|++||........... ...+..
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~~~---- 247 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ-------IKAGAY---- 247 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCC----
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhCCC----
Confidence 64322 23346799999999999999999999999999999999999999976543322111 111110
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..........+..+.+++.+||+.||.+||++.++++.
T Consensus 248 --~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111113456789999999999999999999999854
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=353.79 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=202.9
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHh--CCCcceeeEEEEecc----CCcEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSK--LRHRHLVSLIGYCDE----NSEMI 554 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~--l~HpnIv~l~~~~~~----~~~~~ 554 (832)
.++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 6899999998643 34567777787777 789999999998643 45689
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeeccCCCCceeeCCCCceEEec
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH--------TGTAQGIIHRDVKSTNILLDDNYVAKVSD 626 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~D 626 (832)
+||||+++|+|.+++.. ..+++..++.++.|+++||+||| + ++|+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999953 36899999999999999999999 7 8999999999999999999999999
Q ss_pred ccccccCCCCCCce---eeccccCccccChhccccC------CCCccccEEechhHHHHHhhC----------CCCCCCC
Q 047569 627 FGLSKDAPIGQGHV---STAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLLEVLCA----------RPAINPQ 687 (832)
Q Consensus 627 FGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDV~SlGvvl~elltG----------~~pf~~~ 687 (832)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654332221 2234699999999999876 455799999999999999999 8888654
Q ss_pred ChhhhhhHHHHHHHHhhhcccccccCCCCC-CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 688 LPREQVNLAEWAMQWKRKGLLEKIIDPHLV-GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 688 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
...... .......... ....+.+. .......+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 237 ~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPS-FEDMRKVVCV-----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCC-HHHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc-hhhhhHHHhc-----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322211 1110000000 11111111 112234778999999999999999999999999998864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=358.13 Aligned_cols=261 Identities=24% Similarity=0.373 Sum_probs=199.8
Q ss_pred HhcCCCccceEeecCceeEEEEEEeC-C---cEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEIDD-G---TKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
..++|++.+.||+|+||.||+|.... + ..||||++... .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999997653 3 27999998764 445578899999999999999999999999776655
Q ss_pred ------EEEEEecCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceE
Q 047569 554 ------ILVYEYMSNGPFRDHLYGK----NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623 (832)
Q Consensus 554 ------~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 623 (832)
++||||+++++|.+++... ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999998532 22358999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHH
Q 047569 624 VSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 624 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 701 (832)
|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |++||......+.....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----- 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----- 252 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-----
Confidence 999999986543221 12233457889999999999999999999999999999999 99999876543322111
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.. . .....++..+..+.+++.+||+.||.+||++.++++.|+.++.-
T Consensus 253 -~~---------~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 -IG---------G-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -HT---------T-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -hc---------C-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00 0 01122345667899999999999999999999999999988663
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=352.50 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=203.5
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||.||+|...+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999988889999999886543 23347789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++ +|.+++.... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 975 8988886533 468999999999999999999999 999999999999999999999999999998654221 1
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc---cccc-----
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG---LLEK----- 710 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---~~~~----- 710 (832)
......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+..... ....... ....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHHCCCChhhchhhhccc
Confidence 2234468999999999976 45899999999999999999999999876543332211 1110000 0000
Q ss_pred ccCCCCC-------CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 IIDPHLV-------GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 i~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..++... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011110 1112345678899999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=371.02 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=208.5
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
..++|++.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4678999999999999999999764 78999999876543 34456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccccccC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDA 633 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~ 633 (832)
|||+++|+|.+.+.... .+++.++..++.||++||+|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999997654 69999999999999999999999 9999999999999998 5678999999999866
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+..... ..+..
T Consensus 164 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~~----- 230 (444)
T 3soa_A 164 EGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI-------KAGAY----- 230 (444)
T ss_dssp CTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------HHTCC-----
T ss_pred cCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HhCCC-----
Confidence 4322 2234467999999999999999999999999999999999999999776543322111 11110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.......+..+..+.+++.+||+.||.+|||+.|+++.
T Consensus 231 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 -DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111123456789999999999999999999999853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=364.27 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=210.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+++|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999775 6899999998776666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC--CCceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD--NYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 637 (832)
+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999986543 368999999999999999999999 99999999999999974 5789999999998765332
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ... . .....
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~------i~~-~------~~~~~ 270 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN------VKR-C------DWEFD 270 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HHH-C------CCCCC
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH------HHh-C------CCCCC
Confidence 23345699999999999999999999999999999999999999987654322111 111 0 01111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+..+.+++.+||+.||.+|||+.|+++
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1222345678999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.45 Aligned_cols=275 Identities=25% Similarity=0.353 Sum_probs=215.3
Q ss_pred hcCCCccceEeecCceeEEEEEE-----eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEec--cCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD--ENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~--~~~~~ 553 (832)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999984 368899999998877777788999999999999999999999875 55678
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999996532 258999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 634 PIGQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 634 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......... .............+.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHH
Confidence 533222 223345888899999999999999999999999999999999998643221100 00000000000001111
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
+........+...+..+.+++.+||+.||.+||++.|+++.|+.++...
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1122222334566788999999999999999999999999998775543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.56 Aligned_cols=262 Identities=25% Similarity=0.454 Sum_probs=215.4
Q ss_pred hcCCCccceEeecCceeEEEEEE--------eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI--------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDEN 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~ 550 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+++.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46789999999999999999976 34678999998765 345567899999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNL--------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
+..++||||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999975432 248999999999999999999999 999999999999999
Q ss_pred CCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 99999999999999876533221 1233457889999999999999999999999999999999 999997664332211
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
. ...+. ....+...+..+.+++.+||+.+|.+||++.|+++.|+.+.....
T Consensus 271 ~-------~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 271 L-------LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp H-------HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H-------HhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1 11111 112234456789999999999999999999999999998877543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=359.48 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=205.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcE----EEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTK----VAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|++.+.||+|+||.||+|.+. +++. |++|.+.... ....+++.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57889999999999999999764 4443 8888765442 344466889999999999999999999986 467899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999654 2368899999999999999999999 8999999999999999999999999999987653
Q ss_pred CCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
... .......||..|+|||++.+..++.++|||||||++|||++ |+.||......+..... ..+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~------ 234 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGE------ 234 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTTC------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCC------
Confidence 322 22344568889999999999999999999999999999999 99999876543322111 1110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....+...+..+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 235 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 ---RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111222344568899999999999999999999999987754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.34 Aligned_cols=254 Identities=26% Similarity=0.465 Sum_probs=201.9
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||+|... ++.||||++... ...+.|.+|+++|++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56888999999999999999875 789999998643 345789999999999999999999999874 4799999999
Q ss_pred CCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc-eEEecccccccCCCCCCc
Q 047569 562 NGPFRDHLYGKNL-PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV-AKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 562 ~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~ 639 (832)
+++|.+++..... ..+++..++.++.|+++||+|||+.+.++|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975442 35789999999999999999999865578999999999999998886 799999998754321
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... . .+ . ...+. . ..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~-~~--~-~~~~~-----~----~~ 224 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-I-MW--A-VHNGT-----R----PP 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-H-HH--H-HHTTC-----C----CC
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-H-HH--H-HhcCC-----C----CC
Confidence 23345899999999999999999999999999999999999999754332211 0 00 0 01110 1 11
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.....+..+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 223456679999999999999999999999999887643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.36 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=214.2
Q ss_pred hcCCCccceEeecCceeEEEEEEeC------CcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD------GTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+++|+++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999997642 2479999987653 34567799999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC
Q 047569 553 MILVYEYMSNGPFRDHLYGKN------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY 620 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 620 (832)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 999999999999999986421 3468999999999999999999999 8999999999999999999
Q ss_pred ceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHH
Q 047569 621 VAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEW 698 (832)
Q Consensus 621 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~ 698 (832)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.......... .
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~- 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--K- 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--H-
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--H-
Confidence 999999999986543222 22234557889999999999999999999999999999998 999997654332211 1
Q ss_pred HHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 699 AMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 699 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
....+ .....+...+..+.+++.+||+.+|.+||++.++++.|+.+.+..+
T Consensus 279 ---~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 279 ---LVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp ---HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---HHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 11111 1111223345679999999999999999999999999998766443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.25 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=206.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57899999999999999999875 6899999987643 2234577889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 9999999999997543 68999999999999999999999 9999999999999999999999999999986542
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......||+.|+|||++.+..++.++|||||||++|||++|++||.......... ... ...+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~---------~~~~- 220 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KIL---------NAEL- 220 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH---------HCCC-
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHH---------hCCC-
Confidence 2234579999999999999999999999999999999999999997764432211 111 1111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
.+++..+..+.+++.+||+.||.+|| ++.++++
T Consensus 221 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12344567899999999999999999 7777763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.38 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=206.4
Q ss_pred cCCCccceEeecCceeEEEEEEeC-----CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
++|++.+.||+|+||.||+|.... +..||||++... ......++.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567788999999999999997652 246999998764 34456679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999996543 468999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 636 GQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 636 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... ...+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-------~~~~------ 266 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-------INDG------ 266 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTT------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------HHCC------
Confidence 2211 1122346788999999999999999999999999999999 9999976544322111 1111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.....+...+..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 267 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112344567899999999999999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=356.82 Aligned_cols=269 Identities=27% Similarity=0.395 Sum_probs=211.2
Q ss_pred CCccceEeecCceeEEEEEEe-----CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcEEE
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-----DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEMIL 555 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~~l 555 (832)
|++.+.||+|+||.||++..+ +++.||||++.... .+..+.+.+|+++|++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988642 68899999987653 4556789999999999999999999999976 467899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 38999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... .....+.........+.+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence 3221 2234457889999999999999999999999999999999999986432110 000000000000000111112
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.......+..++..+.+++.+||+.||.+||++.|+++.|+.+.+.
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 2222333455677899999999999999999999999999877554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=378.05 Aligned_cols=263 Identities=18% Similarity=0.240 Sum_probs=212.8
Q ss_pred CHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEec
Q 047569 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548 (832)
Q Consensus 473 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~ 548 (832)
++.++....++|++.++||+|+||+||+|+.. +++.||+|++.+. .....+.+.+|+.+|..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555666789999999999999999999876 5789999987642 1122334889999999999999999999999
Q ss_pred cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 549 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
+.+.++||||||++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999999753 2469999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
+++..............||+.|+|||++. ...++.++|||||||++|||++|++||......+....+. ...
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~ 297 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NHK 297 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---THH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh---hcc
Confidence 99876544444445567999999999987 5678999999999999999999999998765443322111 000
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVD--RPTMGDVLW 751 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 751 (832)
. ...-+. .....+..+.+++.+||..+|++ ||+++|+++
T Consensus 298 ~-----~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 E-----RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp H-----HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred c-----cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 000111 11235667899999999888888 999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=372.51 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=210.6
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEecc
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~ 549 (832)
+.++....++|++.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+++|+.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444455689999999999999999999876 5899999987542 12223458899999999999999999999999
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
.+.++|||||++||+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999653 58999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCC----CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
++..............||+.|+|||++.+.. ++.++|||||||++|||++|++||......+....+. .. .
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~--~ 289 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---NH--K 289 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TH--H
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH---hc--c
Confidence 9876543333344667999999999998765 7899999999999999999999998765433221110 00 0
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVD--RPTMGDVLWN 752 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 752 (832)
. . +.-......+..+.+++.+||+.+|.+ ||++.|++++
T Consensus 290 ~---~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 N---S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H---H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c---c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 0 000111235677999999999999988 9999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.12 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=206.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
.++|++.+.||+|+||.||+|.+. +++ +|++|.+... .....+++.+|++++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367899999999999999999764 444 3578876543 4556788999999999999999999999998754 88
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+|+||+.+|+|.+++.... ..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997543 368999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 635 IGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 635 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |++||......+..... ..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~------- 234 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EK------- 234 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HT-------
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------Hc-------
Confidence 3221 12233457889999999999999999999999999999999 99999876544322111 11
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
......++..+..+.+++.+||+.||.+||++.|+++.|+.+.+...
T Consensus 235 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 235 --GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp --TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 11112334466789999999999999999999999999998875443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.34 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=202.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999875 6899999987644 33445788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++ +|.+.+.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9975 5655554332 469999999999999999999999 999999999999999999999999999998764322
Q ss_pred ceeeccccCccccChhccccCC-CCccccEEechhHHHHHhhCCCCCCCCCh-hhhhhHHHHHHHHhhh---cccc---c
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLLEVLCARPAINPQLP-REQVNLAEWAMQWKRK---GLLE---K 710 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~SlGvvl~elltG~~pf~~~~~-~~~~~l~~~~~~~~~~---~~~~---~ 710 (832)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .+... ........ .... .
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK---RIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH---HHHHHHCCCCTTTCTTGGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHHhCCCChhhhhhhcc
Confidence 2234456899999999997765 79999999999999999988877543332 22211 11111100 0000 0
Q ss_pred ccC---------CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 IID---------PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 i~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+ ........+..+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00111223456678999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.74 Aligned_cols=251 Identities=28% Similarity=0.484 Sum_probs=205.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcc-------cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQ-------GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
++|++.+.||+|+||.||+|... +++.||+|++...... ..+++.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67889999999999999999874 7899999988654321 1267999999999999999999999997665
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCceeeCCCCc-----eEEec
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG--IIHRDVKSTNILLDDNYV-----AKVSD 626 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~-----~kl~D 626 (832)
++||||+++++|.+++.... ..+++..++.++.|+++||+|||+ ++ ++||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999886543 479999999999999999999999 88 999999999999988776 99999
Q ss_pred ccccccCCCCCCceeeccccCccccChhcc--ccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 627 FGLSKDAPIGQGHVSTAVKGSFGYLDPEYF--RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 627 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||........... . ...
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~---~~~- 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-N---MIR- 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-H---HHH-
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-H---HHh-
Confidence 999975432 23446799999999998 445678999999999999999999999976543322111 1 111
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 755 (832)
........+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 244 --------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 --------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp --------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1112223344566789999999999999999999999988874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.22 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=197.7
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc----
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE---- 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~---- 552 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++... ......++.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36799999999999999999986 47899999998764 23445678999999999999999999999866543
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++||||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999996543 68999999999999999999999 9999999999999999999999999999986
Q ss_pred CCCCCC--ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 633 APIGQG--HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 633 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~--- 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDP--- 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCC---
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCC---
Confidence 543221 12234568999999999999999999999999999999999999998765433211 1111110
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..........+..+.+++.+||+.||.+||+..+++.
T Consensus 237 ----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 ----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp ----CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ----CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0000111235677999999999999999998777653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.35 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=197.0
Q ss_pred hcCCCccceEeecCceeEEEEEE----eCCcEEEEEecCCCC----cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI----DDGTKVAVKRGNPQS----EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++|++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36789999999999999999986 478999999987642 3345668899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++||||+++++|.+++.... .+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999996543 68899999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....
T Consensus 171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~~------- 236 (327)
T 3a62_A 171 SIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK------ILKC------- 236 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHHT-------
T ss_pred cccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhC-------
Confidence 4322 2223445799999999999999999999999999999999999999987654322111 1110
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
. ..+++..+..+.+++.+||+.||.+|| ++.|+++
T Consensus 237 --~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 --K--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --C--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --C--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 122344567899999999999999999 6666653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.22 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=201.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.++||+|+||.||+|+.+ +++.||+|++.+. .....+.+.+|..+|.++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367999999999999999999876 5889999987643 233345688999999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999996543 69999999999999999999999 9999999999999999999999999999986332
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh--hHHHHHHHHhhhcccccccC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV--NLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~--~l~~~~~~~~~~~~~~~i~d 713 (832)
.........||+.|+|||++.+..++.++|||||||++|||++|++||......+.. ............
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-------- 276 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------- 276 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--------
T ss_pred -CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--------
Confidence 223345567999999999999999999999999999999999999999643221110 000111111111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
.. ..++...+..+.+++.+||+.||.+||++
T Consensus 277 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 277 KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 12334456789999999999999999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=355.59 Aligned_cols=262 Identities=24% Similarity=0.430 Sum_probs=209.3
Q ss_pred cCCCccceEeecCceeEEEEEE-----eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~ 553 (832)
++|++.+.||+|+||.||+|.+ .+++.||+|++... .....+++.+|+++|++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 36899999998754 345568899999999999999999999999776 678
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999995433 368999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCC--ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChh---------hhhhHHHHHHHH
Q 047569 634 PIGQG--HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPR---------EQVNLAEWAMQW 702 (832)
Q Consensus 634 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~---------~~~~l~~~~~~~ 702 (832)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.|+...... .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 253 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV--- 253 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH---
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH---
Confidence 54332 2233456888999999999999999999999999999999999886432110 000000000
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
..+........++..+..+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 254 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 -------NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 011111122234556778999999999999999999999999998765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=361.87 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=205.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57899999999999999999765 5889999987543 2344678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999999654 369999999999999999999999 99999999999999999999999999999876432
Q ss_pred CceeeccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.......||+.|+|||++.+ ..++.++|||||||++|||++|++||..........+..... . .
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~-~-------- 235 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---T-T-------- 235 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---H-C--------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---h-c--------
Confidence 23345679999999999864 458999999999999999999999997654332222211110 0 0
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCC-HHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPT-MGDVL 750 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl 750 (832)
...++...+..+.+++.+||+.||.+||+ +.++.
T Consensus 236 --~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 --VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred --ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 11233445678999999999999999998 55554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.95 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=207.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 6899999987543 2244678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999996543 68999999999999999999999 99999999999999999999999999999875422
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....||+.|+|||++.+..++.++|||||||++|||++|++||......+.... .. .+ .
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~-~~--------~-- 254 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IV-SG--------K-- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HC--------C--
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH------HH-cC--------C--
Confidence 2345799999999999999999999999999999999999999987644322111 11 11 1
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPT-----MGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 751 (832)
..++...+..+.+++.+||+.||.+||+ +.++++
T Consensus 255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1123445678999999999999999998 777753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=361.27 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=207.0
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcE
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~ 553 (832)
...++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+..|.++|+.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999875 6899999987643 133456788999999987 899999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999996543 68999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+..... . .+ .
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~-~~------~ 234 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------R-MD------N 234 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HC------C
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------H-hC------C
Confidence 3222 2234567999999999999999999999999999999999999999876543321111 0 00 1
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMG-DVL 750 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 750 (832)
+ .++...+..+.+++.+||+.||.+||++. +++
T Consensus 235 ~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 12334567899999999999999999997 554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.40 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=205.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-----CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-----SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++|++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999765 6899999987532 2234678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc---eEEecccc
Q 047569 555 LVYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV---AKVSDFGL 629 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGl 629 (832)
+||||+++++|.+++... ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887542 23358999999999999999999999 99999999999999986654 99999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. ... .+...
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~---~i~-~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE---GII-KGKYK 250 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH---HHH-HTCCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH---HHH-cCCCC
Confidence 98765322 223445799999999999999999999999999999999999999976421 1111 110 11000
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+. .....+..+.+++.+||+.||.+||++.|+++.
T Consensus 251 --~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 002345679999999999999999999999854
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.44 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=204.3
Q ss_pred HhcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC-----cccHHHHHHHHHHHHhCC---CcceeeEEEEeccC
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS-----EQGITEFQTEIQMLSKLR---HRHLVSLIGYCDEN 550 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~ 550 (832)
..++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 367899999999999999999986 468999999875321 222346777888877764 99999999999765
Q ss_pred C-----cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 551 S-----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 551 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
. ..++||||+. ++|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999996 699999987766669999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 626 DFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 626 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+..............
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99999865432 2334567999999999999999999999999999999999999999876654432221110000000
Q ss_pred cccccc-------cCCC---CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 GLLEKI-------IDPH---LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ~~~~~i-------~d~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+... ..+. ......++.+..+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 0000 000111345678999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=363.72 Aligned_cols=272 Identities=21% Similarity=0.225 Sum_probs=213.8
Q ss_pred ccCHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-----CcceeeEE
Q 047569 471 YFSFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-----HRHLVSLI 544 (832)
Q Consensus 471 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-----HpnIv~l~ 544 (832)
.+++++.....++|++.+.||+|+||.||+|... +++.||||++... ......+..|++++++++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3455555556789999999999999999999874 6899999998643 344567888999999996 99999999
Q ss_pred EEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC------
Q 047569 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD------ 618 (832)
Q Consensus 545 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~------ 618 (832)
+++...+..++||||+ +++|.+++.......+++.+++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 9999999987766679999999999999999999999 99999999999999975
Q ss_pred -------------------CCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh
Q 047569 619 -------------------NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC 679 (832)
Q Consensus 619 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt 679 (832)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 78999999999986432 2234568999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhHHHHHHH---------HhhhcccccccCCCCCCCCC--------------------hhHHHHHHH
Q 047569 680 ARPAINPQLPREQVNLAEWAMQ---------WKRKGLLEKIIDPHLVGTIN--------------------PESLKKFAE 730 (832)
Q Consensus 680 G~~pf~~~~~~~~~~l~~~~~~---------~~~~~~~~~i~d~~l~~~~~--------------------~~~~~~l~~ 730 (832)
|+.||......+.......... ..............+....+ ......+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999987665443332221100 00000000000000000000 011257889
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 047569 731 AAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 731 li~~cl~~dP~~RPt~~evl~ 751 (832)
++.+||+.||.+|||+.|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=344.22 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=212.9
Q ss_pred cCCCccc-eEeecCceeEEEEEEe---CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSA-IIGVGGFGNVYLGEID---DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|.+.+ .||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999753 5788999998765 344567899999999999999999999999 45679999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++... ...+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999643 3469999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCce--eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 637 QGHV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 637 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... ...+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------i~~~------- 229 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQG------- 229 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTT-------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------HhcC-------
Confidence 2221 223446889999999998899999999999999999998 9999976654332111 1111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
.....++..+..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus 230 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 230 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1112344567789999999999999999999999999998866543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=381.97 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=212.3
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||+++++++.+ +..+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45688899999999999999999888899999987654 345789999999999999999999999976 6789999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++|+|.++|.......+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999965444468999999999999999999999 999999999999999999999999999998654321112
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||......+.... ...+ ....
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-------i~~~---------~~~~ 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERG---------YRMP 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-------HHTT---------CCCC
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcC---------CCCC
Confidence 233456789999999999999999999999999999999 9999976654332211 1111 1112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3345667899999999999999999999999888754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.40 Aligned_cols=269 Identities=23% Similarity=0.360 Sum_probs=217.2
Q ss_pred CHHHHHHHhcCCCccceEeecCceeEEEEEE------eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEE
Q 047569 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLI 544 (832)
Q Consensus 473 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~ 544 (832)
...++....++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445568899999999999999999974 246899999987653 34456799999999999 799999999
Q ss_pred EEeccCC-cEEEEEEecCCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccC
Q 047569 545 GYCDENS-EMILVYEYMSNGPFRDHLYGKNL--------------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609 (832)
Q Consensus 545 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDl 609 (832)
+++...+ ..++||||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++++||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9987654 58999999999999999975442 128899999999999999999999 99999999
Q ss_pred CCCceeeCCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCC
Q 047569 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQ 687 (832)
Q Consensus 610 kp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~ 687 (832)
||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986643322 22334568899999999999999999999999999999998 99999765
Q ss_pred ChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 688 LPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 688 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
...... .. . ...+. ....+...+..+.+++.+||+.+|.+||++.|+++.|+.+++.
T Consensus 255 ~~~~~~--~~---~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 255 KIDEEF--CR---R-LKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCSHHH--HH---H-HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHH--HH---H-hccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 432211 11 0 11111 1112234556799999999999999999999999999988754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.36 Aligned_cols=259 Identities=29% Similarity=0.530 Sum_probs=199.2
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|... ..||+|++... .....+.|.+|+++|++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467899999999999999999764 46999987654 345567899999999999999999999976 4557899999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC-C
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-Q 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~ 637 (832)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++..... .
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996443 469999999999999999999999 99999999999999999999999999999765421 1
Q ss_pred CceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
........||+.|+|||++. +..++.++|||||||++|||++|+.||......+.. .. ....+.. .+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~----~~~~~~~----~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IE----MVGRGSL----SP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HH----HHHHTSC----CC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HH----Hhccccc----Cc
Confidence 22233456999999999986 567889999999999999999999999765443321 11 1111111 11
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
. .......++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 246 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 D-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 11233456678999999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=370.59 Aligned_cols=262 Identities=20% Similarity=0.268 Sum_probs=210.5
Q ss_pred CHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEec
Q 047569 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548 (832)
Q Consensus 473 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~ 548 (832)
.++++....++|++.+.||+|+||.||+++.+ +|+.||||++.+. .....+.+.+|.++|.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555556789999999999999999999875 6999999997642 1223345889999999999999999999999
Q ss_pred cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 549 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
+.+.++|||||+++|+|.+++.+.+ ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999996532 368999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccccChhccc-------cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
+++..............||+.|+|||++. ...++.++|||||||++|||++|++||......+....+. .
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~---~ 284 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV---H 284 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---T
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH---h
Confidence 99876544333344567999999999987 3578999999999999999999999998765433221111 0
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDR---PTMGDVLW 751 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~ 751 (832)
... ...-+ ......+.++.+++.+||. +|.+| |+++|+++
T Consensus 285 ~~~-----~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKE-----HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHH-----HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccc-----CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 00001 1123456789999999999 99998 58888753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.35 Aligned_cols=266 Identities=21% Similarity=0.313 Sum_probs=193.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999765 68999999876543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 559 YMSNGPFRDHLYGK----NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 559 ~~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
|++ ++|.+++... ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 6999988542 22468999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc--
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI-- 711 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i-- 711 (832)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+...................+
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 322 12234568999999999976 46899999999999999999999999877654433222111000000000000
Q ss_pred ---cCCCCCC------------CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 ---IDPHLVG------------TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ---~d~~l~~------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+.... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 011134567999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=357.59 Aligned_cols=264 Identities=23% Similarity=0.382 Sum_probs=214.6
Q ss_pred HHHHHhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEec
Q 047569 476 ELQEATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548 (832)
Q Consensus 476 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~ 548 (832)
++....++|++.+.||+|+||.||+|... +++.||+|.+.... .....++.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999654 37889999987543 344567999999999999999999999999
Q ss_pred cCCcEEEEEEecCCCChhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC
Q 047569 549 ENSEMILVYEYMSNGPFRDHLYGK--------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY 620 (832)
Q Consensus 549 ~~~~~~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~ 620 (832)
+.+..++||||+++++|.+++... ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCC
Confidence 999999999999999999998642 12467899999999999999999999 8999999999999999999
Q ss_pred ceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHH
Q 047569 621 VAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEW 698 (832)
Q Consensus 621 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~ 698 (832)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--- 252 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--- 252 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH---
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH---
Confidence 999999999876532211 11223457889999999999999999999999999999999 8899976543322111
Q ss_pred HHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 699 AMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 699 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...+. . ...+...+..+.+++.+||+.+|.+||++.|+++.|+..+.
T Consensus 253 ----~~~~~--------~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 ----VMEGG--------L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ----HHTTC--------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----HHcCC--------c-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111 0 12234556789999999999999999999999998886543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.55 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=204.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|.++|+.+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999876 4789999987643 234467788999999988 79999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||++||+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999996543 68999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
. ........||+.|+|||++.+..++.++|||||||++|||++|++||......+... .... ..
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~---------~~ 237 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIME---------HN 237 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH---------CC
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH------HHHh---------CC
Confidence 2 223345679999999999999999999999999999999999999998764432211 1111 11
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
..++...+..+.+++.+||+.||.+||++
T Consensus 238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12334566789999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=361.90 Aligned_cols=268 Identities=20% Similarity=0.260 Sum_probs=206.5
Q ss_pred hcCCCccceEeec--CceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVG--GFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+| +||.||+|... +|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3678999999999 99999999876 6999999987644 34456778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.......+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999987655679999999999999999999999 9999999999999999999999999998764321
Q ss_pred CC------CceeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH--HHHHh--
Q 047569 636 GQ------GHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW--AMQWK-- 703 (832)
Q Consensus 636 ~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~--~~~~~-- 703 (832)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|++||.............. .....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 111223468999999999987 6799999999999999999999999976543332110000 00000
Q ss_pred ----hh-------------ccccccc--------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 704 ----RK-------------GLLEKII--------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 704 ----~~-------------~~~~~i~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. +....+. ............+..+.+++.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 0000000 000001122345677999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.64 Aligned_cols=259 Identities=23% Similarity=0.312 Sum_probs=202.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999875 68999999986542 33357799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999996543 68999999999999999999999 99999999999999999999999999998766543
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.........||+.|+|||++.+..++.++||||||+++|||++|+.||....... + ....... . ..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~----~~~~~~~----~---~~ 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---M----GAHINQA----I---PR 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---H----HHHHHSC----C---CC
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---H----HHHhccC----C---CC
Confidence 3333345569999999999999999999999999999999999999997653221 1 0111110 0 00
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRP-TMGDVLWNLEYALQ 758 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~ 758 (832)
.....+..+..+.+++.+||+.||.+|| +++++++.|+.++.
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 1122344566799999999999999999 89999988886644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=355.89 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=202.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++|+++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56889999999999999999875 6899999987653 334466788999999998 899999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999996543 68999999999999999999999 99999999999999999999999999999864322
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh--hHHHHHHHHhhhcccccccCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV--NLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~--~l~~~~~~~~~~~~~~~i~d~ 714 (832)
........||+.|+|||++.+..++.++|||||||++|||++|++||......... ............ .
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--------~ 234 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------K 234 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--------C
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--------C
Confidence 22334567999999999999999999999999999999999999999653211110 000111111111 1
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
. ..++...+..+.+++.+||+.||.+||++
T Consensus 235 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 Q--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 12334556789999999999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.14 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=202.8
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCC--cceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRH--RHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~H--pnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||++...+++.||||++... ..+..+.+.+|+++|++++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568999999999999999998888999999987643 44556789999999999976 9999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|| +.+++|.+++.... .+++.++..++.|+++||+|||+ ++|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 55889999997643 68999999999999999999999 9999999999999997 578999999999876432
Q ss_pred CC-ceeeccccCccccChhcccc-----------CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 637 QG-HVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 637 ~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------- 229 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----------- 229 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-----------
Confidence 22 12335579999999999865 67899999999999999999999999754322110
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
+..++++.....++...+..+.+++.+||+.||.+|||+.|+++...
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 230 ---LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ---HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ---HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 11222333333344445567999999999999999999999986544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.48 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=205.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CC-------cEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DG-------TKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|... ++ ..||+|++........+++.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357889999999999999999755 33 5799999887777778899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc--------eEE
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV--------AKV 624 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl 624 (832)
.++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997543 348999999999999999999999 99999999999999998887 999
Q ss_pred ecccccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCC-CCCCCCChhhhhhHHHHHHHH
Q 047569 625 SDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 625 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~~ 702 (832)
+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|. +|+........... .
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~------~ 231 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF------Y 231 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------H
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH------h
Confidence 99999875421 234568999999999987 77999999999999999999965 55544332211110 0
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.. .. ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 232 ~~--------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 232 ED--------RH----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HT--------TC----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred hc--------cC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 00 01 111222456899999999999999999999999888653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.56 Aligned_cols=270 Identities=16% Similarity=0.202 Sum_probs=207.4
Q ss_pred hcCCCccceEeecCceeEEEEEEeC------CcEEEEEecCCCCcccH-----------HHHHHHHHHHHhCCCcceeeE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD------GTKVAVKRGNPQSEQGI-----------TEFQTEIQMLSKLRHRHLVSL 543 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~f~~Ei~~L~~l~HpnIv~l 543 (832)
.++|++.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4679999999999999999998754 47899999766542211 123345566777889999999
Q ss_pred EEEeccC----CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC--
Q 047569 544 IGYCDEN----SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-- 617 (832)
Q Consensus 544 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-- 617 (832)
++++... ...+|||||+ +++|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 9998664 4589999999 99999999754 2469999999999999999999999 8999999999999999
Q ss_pred CCCceEEecccccccCCCCCCc------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhh
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGH------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE 691 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~ 691 (832)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999765422111 1133459999999999999999999999999999999999999997533222
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
.. ........ ...+..++++.+. ....+.++.+++.+||+.+|.+||++.++++.|+.+++...
T Consensus 269 ~~--~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 269 KY--VRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HH--HHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH--HHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 11 11111111 1112233332221 12345679999999999999999999999999998876543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=369.53 Aligned_cols=264 Identities=20% Similarity=0.244 Sum_probs=212.0
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCC-cceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH-RHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H-pnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++...... .++.+|+++++.|+| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36799999999999999999986 46899999986654332 358899999999976 667777777788889999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee---CCCCceEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 635 (832)
|+ +++|.+++.... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999996433 369999999999999999999999 999999999999999 6889999999999987653
Q ss_pred CCCc------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 636 GQGH------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 636 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......................+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3221 1225679999999999999999999999999999999999999998755433333222222211111111
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
.+ ...++.++.+++.+||+.+|++||++.++++.|+.++...
T Consensus 239 ~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 AL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11 1233567999999999999999999999999999887643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.13 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=203.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999875 58999999876543 3335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++... ..+++..+..++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999988544 368999999999999999999999 999999999999999999999999999998754322
Q ss_pred ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH---------HHhhhccc
Q 047569 639 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM---------QWKRKGLL 708 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~---------~~~~~~~~ 708 (832)
.......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+......... .+......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 22334568999999999976 678999999999999999999999998776554433222110 00000011
Q ss_pred ccccCCCCCCCC-----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKIIDPHLVGTI-----NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+...... .+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 110001100000 1235667999999999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.32 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=196.7
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999876 789999998865432 236788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc--eEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV--AKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~~~ 637 (832)
+++|+|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999996543 68999999999999999999999 99999999999999987765 999999998753321
Q ss_pred CceeeccccCccccChhccccCCCCcc-ccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ..... .+.....
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~---------~~~~~~~ 239 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQ---------RILSVKY 239 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHH---------HHHTTCC
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHH---------HHhcCCC
Confidence 22334569999999999988887665 89999999999999999999764332211 11111 1111111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
........+..+.+++.+||+.||.+|||+.|+++.-.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 11111234577899999999999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=343.08 Aligned_cols=260 Identities=25% Similarity=0.331 Sum_probs=211.6
Q ss_pred hcCCCccc-eEeecCceeEEEEEEe---CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 481 TKNFDSSA-IIGVGGFGNVYLGEID---DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 481 ~~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
.++|.+.+ .||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677877 9999999999999543 46889999987543 33367899999999999999999999999 567889
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+||||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999997643 68999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcee--eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 635 IGQGHVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 635 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
....... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ...+.
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~---- 237 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE---- 237 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC----
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCC----
Confidence 4332221 22346789999999999899999999999999999999 9999987654332111 11111
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEA 762 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 762 (832)
....+...+..+.+++.+||+.||.+||++.++++.|+........
T Consensus 238 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 238 -----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 1123345667899999999999999999999999999988765544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=355.74 Aligned_cols=251 Identities=23% Similarity=0.282 Sum_probs=192.5
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999876 58899999987543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 635 (832)
|+++++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999654 368999999999999999999999 89999999999999975 88999999999986542
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ...... ...
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~---~~i~~~-------~~~ 269 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--F---RRILNC-------EYY 269 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--H---HHHHTT-------CCC
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--H---HHHHhC-------CCc
Confidence 2 2234456999999999999999999999999999999999999999765433211 0 011110 001
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.........+..+.+++.+||+.||++||++.|+++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111222455678999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=359.09 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=206.0
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+++|+.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999986 47899999987542 1223457899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+ +|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 789999886543 69999999999999999999999 89999999999999999999999999999865432
Q ss_pred CceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ....+...
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~~~-- 223 (336)
T 3h4j_B 162 -NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVNSC-- 223 (336)
T ss_dssp -BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCCSS--
T ss_pred -cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHcC--
Confidence 22344569999999999988776 789999999999999999999997643221 11111111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
....+...+..+.+++.+||+.||.+|||+.|+++.-.
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 11234446678999999999999999999999975533
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=360.64 Aligned_cols=247 Identities=23% Similarity=0.286 Sum_probs=200.8
Q ss_pred cceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 487 SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
.+.||+|+||.||+|... +|+.||+|++........+++.+|+++|++++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 678999999999999764 6899999998877666778899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee--CCCCceEEecccccccCCCCCCceeec
Q 047569 566 RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL--DDNYVAKVSDFGLSKDAPIGQGHVSTA 643 (832)
Q Consensus 566 ~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~ 643 (832)
.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++...... ....
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~ 247 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV 247 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence 99886543 368999999999999999999999 999999999999999 577899999999998764322 2234
Q ss_pred cccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChh
Q 047569 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723 (832)
Q Consensus 644 ~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 723 (832)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ..... ..+.......
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------i~~~~-------~~~~~~~~~~ 314 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN------ILACR-------WDLEDEEFQD 314 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTC-------CCSCSGGGTT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcc-------CCCChhhhcc
Confidence 5699999999999999999999999999999999999999987654332211 11110 0011111123
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 724 SLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 724 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.+..+.+++.+||+.||.+||++.|+++.
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 46789999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=354.31 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=198.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC-------
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS------- 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~------- 551 (832)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++|++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999876 7999999987654 3445678999999999999999999999885543
Q ss_pred --------------------------------------------------cEEEEEEecCCCChhhhhccCCC-CCCCHH
Q 047569 552 --------------------------------------------------EMILVYEYMSNGPFRDHLYGKNL-PPLSWK 580 (832)
Q Consensus 552 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 580 (832)
..++||||+++++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999976432 346777
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC-----------ceeeccccCcc
Q 047569 581 QRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-----------HVSTAVKGSFG 649 (832)
Q Consensus 581 ~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~ 649 (832)
.++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 899999999999999999 9999999999999999999999999999987653321 12234569999
Q ss_pred ccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHH
Q 047569 650 YLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFA 729 (832)
Q Consensus 650 y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 729 (832)
|+|||++.+..++.++|||||||++|||++|..|+. +...... . ... ... ..........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~---~-~~~--------~~~-~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIIT---D-VRN--------LKF-PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHH---H-HHT--------TCC-CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHH---H-hhc--------cCC-CcccccCChhHH
Confidence 999999999999999999999999999999876531 1111110 0 000 000 011133456789
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q 047569 730 EAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 730 ~li~~cl~~dP~~RPt~~evl~ 751 (832)
+++.+||+.||.+||++.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=340.77 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=208.3
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
..++|++.+.||+|+||.||+|... ++..+|+|++........+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567999999999999999999876 578999999876655667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee---CCCCceEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 635 (832)
|+++++|.+++.... .+++.+++.++.|++.||+|||+ ++++||||||+|||+ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999886543 58999999999999999999999 999999999999999 7889999999999987543
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.. ......||+.|+|||++.+. ++.++||||||+++|||++|+.||......+..... ..+.. .
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~------~ 225 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------REGTF------T 225 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCC------C
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhCCC------C
Confidence 22 33445699999999998654 899999999999999999999999876543321111 11100 0
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.........+..+.+++.+||+.||.+||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001345789999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.11 Aligned_cols=260 Identities=24% Similarity=0.242 Sum_probs=203.9
Q ss_pred HHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-----CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC
Q 047569 477 LQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-----SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN 550 (832)
Q Consensus 477 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~ 550 (832)
+....++|++.+.||+|+||.||+|... +++.||+|++... .....+++.+|+++|++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4566788999999999999999999764 6889999986532 345667899999999999999999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccC--------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 047569 551 SEMILVYEYMSNGPFRDHLYGK--------------------------------------NLPPLSWKQRLEISIGSARG 592 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~l~i~~~ia~~ 592 (832)
+..++||||+++|+|.+++... ....+++..++.++.|+++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421 01123567788999999999
Q ss_pred HHHHhcCCCCCeeeccCCCCceeeCCCC--ceEEecccccccCCCC---CCceeeccccCccccChhcccc--CCCCccc
Q 047569 593 LHYLHTGTAQGIIHRDVKSTNILLDDNY--VAKVSDFGLSKDAPIG---QGHVSTAVKGSFGYLDPEYFRR--QQLTEKS 665 (832)
Q Consensus 593 L~yLH~~~~~~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~s 665 (832)
|+|||+ ++|+||||||+|||++.++ .+||+|||+++..... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 8999999999864321 1112345569999999999975 6789999
Q ss_pred cEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC
Q 047569 666 DVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT 745 (832)
Q Consensus 666 DV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 745 (832)
|||||||++|||++|+.||......+.... ..... ...........+..+.+++.+||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~------~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQ------VLNKK-------LCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCC-------CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHH------HHhcc-------cccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999987654332211 11110 00111111235678999999999999999999
Q ss_pred HHHHHHH
Q 047569 746 MGDVLWN 752 (832)
Q Consensus 746 ~~evl~~ 752 (832)
+.++++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.60 Aligned_cols=252 Identities=30% Similarity=0.439 Sum_probs=202.7
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc-CCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-NSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+++.. |+.||||++.... ..+++.+|++++++++||||+++++++.+ .+..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467899999999999999999874 8999999987543 45789999999999999999999998754 4578999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.......+++..++.++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999965543348899999999999999999999 99999999999999999999999999998764322
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ... ....
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-------~~~---------~~~~ 233 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEK---------GYKM 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------HTT---------TCCC
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------Hhc---------CCCC
Confidence 223457889999999999999999999999999999998 9999976543322110 011 1112
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
..+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 2334566789999999999999999999999999987754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.86 Aligned_cols=271 Identities=25% Similarity=0.377 Sum_probs=207.4
Q ss_pred CHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhC--CCcceeeEEEEeccC
Q 047569 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL--RHRHLVSLIGYCDEN 550 (832)
Q Consensus 473 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l--~HpnIv~l~~~~~~~ 550 (832)
+...-....++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34444556688999999999999999999875 899999987533 234556666666655 899999999998776
Q ss_pred ----CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeeeccCCCCceeeCC
Q 047569 551 ----SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ--------GIIHRDVKSTNILLDD 618 (832)
Q Consensus 551 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~--------~ivHrDlkp~NILl~~ 618 (832)
...++||||+++|+|.+++... .+++.+++.++.|++.||+|||+ + +|+||||||+|||++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECC
Confidence 7899999999999999999654 58999999999999999999998 6 9999999999999999
Q ss_pred CCceEEecccccccCCCCCCce---eeccccCccccChhccccCCCCcc------ccEEechhHHHHHhhC---------
Q 047569 619 NYVAKVSDFGLSKDAPIGQGHV---STAVKGSFGYLDPEYFRRQQLTEK------SDVYSFGVVLLEVLCA--------- 680 (832)
Q Consensus 619 ~~~~kl~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDV~SlGvvl~elltG--------- 680 (832)
++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997654322221 124569999999999988776665 9999999999999999
Q ss_pred -CCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC-ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 681 -RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 681 -~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+.||......... .... ..... .....+.+.... ..+++.++.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 258 ~~~p~~~~~~~~~~-~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 258 YQLPYHDLVPSDPS-YEDM-REIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCCTTTTTSCSSCC-HHHH-HHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCc-hhhh-HHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 6666543222111 0010 00000 111111111111 23678899999999999999999999999999998765
Q ss_pred H
Q 047569 759 L 759 (832)
Q Consensus 759 ~ 759 (832)
.
T Consensus 332 ~ 332 (337)
T 3mdy_A 332 S 332 (337)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.04 Aligned_cols=245 Identities=24% Similarity=0.298 Sum_probs=195.7
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.++||+|+||+||+|... +|+.||||++... ......++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999876 7999999987654 233344566666666665 899999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+ +++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 779999886543 369999999999999999999999 89999999999999999999999999998875432
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+....... . ...+ ..
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---------~-~~~~--------~~ 269 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---------Q-LRQG--------YL 269 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---------H-HTTT--------CC
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------H-Hhcc--------CC
Confidence 22344569999999999876 78999999999999999999977664321100 0 0111 11
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+....+..+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11112234578999999999999999999999974
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=343.99 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=205.7
Q ss_pred cCCCccceEeecCceeEEEEEEeC----CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEe-ccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYC-DENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~-~~~~~~~l 555 (832)
.+|++.+.||+|+||.||+|...+ ...+|+|.+... .....+++.+|++++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468889999999999999997542 236899987754 344567899999999999999999999986 45678899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999996533 468999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCC---ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 636 GQG---HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 636 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||......+..... ..+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-------~~~----- 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQG----- 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-------HTT-----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hcC-----
Confidence 221 12234457889999999999999999999999999999999 56676654433221110 000
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.....+...+..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 249 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 249 ----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111223345679999999999999999999999999998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=341.43 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=208.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999765 6899999987543 3445678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc---eEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV---AKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~ 634 (832)
||+++++|.+.+.... .+++.++..++.|++.||+|||+ ++++||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999886543 68999999999999999999999 99999999999999986655 9999999997654
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ..+..
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~------ 224 (284)
T 3kk8_A 160 DS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGAY------ 224 (284)
T ss_dssp SS--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC------
T ss_pred cC--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-------Hhccc------
Confidence 32 2233456999999999999999999999999999999999999999766443321111 11110
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01111123456779999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=361.53 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=202.5
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCC--CcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLR--HRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~--HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+++|++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999998888999999987543 4455678999999999996 599999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
| +.+++|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56899999997654 68899999999999999999999 9999999999999996 5799999999998764322
Q ss_pred C-ceeeccccCccccChhcccc-----------CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh
Q 047569 638 G-HVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705 (832)
Q Consensus 638 ~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 705 (832)
. .......||+.|+|||++.+ ..++.++|||||||+||||++|++||.........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~------------ 276 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------ 276 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH------------
Confidence 2 12345579999999999865 46899999999999999999999999754322110
Q ss_pred cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 706 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
+..++++.....++...+..+.+++.+||+.||.+||++.|+++...
T Consensus 277 --~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 277 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp --HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 11122222222333334567999999999999999999999986543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=343.86 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=206.3
Q ss_pred HhcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEe-ccCCcEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC-DENSEMILVY 557 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~-~~~~~~~lV~ 557 (832)
..++|++.+.||+|+||.||+|.. .+++.||||+....... +++.+|++++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 57899999975543322 3588999999999987766665554 6778889999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee---CCCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 634 (832)
||+ +++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999986433 369999999999999999999999 999999999999999 788999999999998764
Q ss_pred CCCC------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 635 IGQG------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 635 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 3322 1223457999999999999999999999999999999999999999765433322222211111110000
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
. ......+..+.+++.+||+.+|++||++.++++.|+.+.+...
T Consensus 240 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp H---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred h---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 0112235679999999999999999999999999998876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.31 Aligned_cols=272 Identities=24% Similarity=0.376 Sum_probs=212.9
Q ss_pred hcCCCccceEeecCceeEEEEEE-----eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccC--CcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-----DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN--SEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~--~~~ 553 (832)
.++|++.+.||+|+||.||++.. .+++.||||++........+++.+|+++|++++||||+++++++... ...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999984 36899999999877777778899999999999999999999998664 378
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997543 368999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCce--eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH--HHHhhhcccc
Q 047569 634 PIGQGHV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA--MQWKRKGLLE 709 (832)
Q Consensus 634 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~--~~~~~~~~~~ 709 (832)
....... .....++..|+|||++.+..++.++|||||||++|||++|+.|+....... ....... ...... .+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~ 273 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-MRMIGNDKQGQMIVF-HLI 273 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH-HHHHCTTCCTHHHHH-HHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH-HHhhccccchhhhHH-HHH
Confidence 5332211 223457788999999999899999999999999999999998875321100 0000000 000000 000
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+.+........+..++.++.+++.+||+.+|.+||++.|+++.|+.+.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111112344567789999999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=351.72 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=208.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEE--EEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKV--AVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~v--avK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||.||+|... ++..+ ++|++... .....+++.+|+++|+++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999765 56644 89987643 344556799999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 557 YEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
|||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999996543 2468999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 701 (832)
||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~------- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------- 252 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH-------
Confidence 9999999875331 112233457889999999999999999999999999999998 999997664332111
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
....+ .....+...+..+.+++.+||+.+|.+||++.++++.|+.+++.
T Consensus 253 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 11122345567899999999999999999999999999988664
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=349.89 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=210.2
Q ss_pred hcCCCccceEeecCceeEEEEEE------eCCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI------DDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999973 35789999998754 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEe
Q 047569 554 ILVYEYMSNGPFRDHLYGKNL-----PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVS 625 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~ 625 (832)
++||||+++++|.+++..... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975432 358999999999999999999999 99999999999999984 4569999
Q ss_pred cccccccCCCCC-CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHh
Q 047569 626 DFGLSKDAPIGQ-GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 626 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-------V 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-------H
Confidence 999987543221 122234568899999999999999999999999999999998 9999976544322111 1
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 761 (832)
..+. ....+...+..+.+++.+||+.||.+||++.++++.|+.+.+...
T Consensus 259 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 259 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred hcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 1110 112234456789999999999999999999999999998765443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=342.82 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=205.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999765 5789999987543 223356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... .+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999986543 68999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... .. .
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-----------~ 222 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SR-----------V 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH-----------T
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH------Hh-----------C
Confidence 223456899999999999999999999999999999999999999866543322111 00 0
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
...++...+..+.+++.+||+.+|.+||++.|+++.-.
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 11223345677899999999999999999999986543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.88 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=203.7
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC-
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS- 551 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~- 551 (832)
...++|.+.+.||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999764 3458999998754 3445678999999999999999999999987654
Q ss_pred ----cEEEEEEecCCCChhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceE
Q 047569 552 ----EMILVYEYMSNGPFRDHLYG----KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623 (832)
Q Consensus 552 ----~~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 623 (832)
..++||||+++++|.+++.. .....+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 45999999999999999843 233579999999999999999999999 8999999999999999999999
Q ss_pred EecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHH
Q 047569 624 VSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 624 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~ 701 (832)
|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |++||............
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----- 262 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL----- 262 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-----
Confidence 999999976543221 12233457889999999999999999999999999999999 88999766543322110
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
..+. ....+...+..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 263 --~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 263 --LHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --HTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0110 1122344567899999999999999999999999999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.24 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=208.7
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEe-ccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC-DENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~-~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++...... +++.+|++++++++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999986 57999999987654332 4689999999999987766555544 66788899999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee---CCCCceEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 635 (832)
|+ +++|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+|||+ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999996433 369999999999999999999999 999999999999999 4888999999999987653
Q ss_pred CCCc------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 636 GQGH------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 636 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 3221 1244579999999999999999999999999999999999999998644322222221111110000000
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
......+..+.+++.+||+.||.+||++.++++.|+.+.+..
T Consensus 241 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 241 ---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 011234567999999999999999999999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.29 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=207.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc------ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE------QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... ...+++.+|+++|++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999875 689999998764321 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC----ceEEecccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY----VAKVSDFGL 629 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGl 629 (832)
++||||+++++|.+++... ..+++..++.++.|+++||+|||+ ++++||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999654 368999999999999999999999 9999999999999999887 799999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... . ...
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~-~~~-- 234 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------T-SVS-- 234 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-TTC--
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------H-hcc--
Confidence 98764322 223456999999999999999999999999999999999999999766443321110 0 000
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...........+..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 ----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000011234567999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=346.20 Aligned_cols=263 Identities=19% Similarity=0.278 Sum_probs=202.3
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 47899999988753 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 557 YEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
|||+++++|.+++.. .....+++..++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999853 233468999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ........ ..
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~-~~-------- 253 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIE-QC-------- 253 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHHHH-TT--------
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHHhh-cc--------
Confidence 322 22234568999999999999999999999999999999999999996543211 11111111 11
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
..........+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1111112345678999999999999999999999999998876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.27 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=206.2
Q ss_pred CCCccceEeecCceeEEEEEEe-CC---cEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE-EEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DG---TKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM-ILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~-~lV 556 (832)
.|+..+.||+|+||.||+|.+. ++ ..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999754 22 379999887543 34567899999999999999999999999766555 999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+.+++|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999653 3468999999999999999999999 89999999999999999999999999999765322
Q ss_pred C---CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCC-CCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 637 Q---GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 637 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
. ........+|+.|+|||.+.+..++.++|||||||++|||++|. +||......+..... ..+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-------~~~------ 244 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------AQG------ 244 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-------HTT------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-------hcC------
Confidence 1 11223456789999999999999999999999999999999955 555444332221111 111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.....+...+..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 245 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 245 ---RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01122334567899999999999999999999999999987653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=353.61 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=205.0
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
..++|++.+.||+|+||.||++..+ +++.||||++...... +.+|+++|.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999875 6899999998655432 45788888888 7999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC----CceEEecccccccC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN----YVAKVSDFGLSKDA 633 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~ 633 (832)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999996543 69999999999999999999999 999999999999998533 35999999999865
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... .......||+.|+|||++.+..++.++|||||||++|||++|++||..........+... ...+.
T Consensus 171 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~------ 239 (342)
T 2qr7_A 171 RAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGK------ 239 (342)
T ss_dssp BCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCC------
T ss_pred cCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCC------
Confidence 4332 223445789999999999988899999999999999999999999976432222111111 11111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
..+........+..+.+++.+||+.||.+||++.++++.-.
T Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 11112223456678999999999999999999999986533
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=365.02 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=199.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------C
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------S 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------~ 551 (832)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++|++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999765 6899999998654 445567889999999999999999999998554 4
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..+|||||+++ +|.+.+.. .+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999975 46666632 48899999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH-----Hhhh-
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ-----WKRK- 705 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~-----~~~~- 705 (832)
.... ........||+.|+|||++.+..++.++|||||||++|||++|++||.+....++......... ....
T Consensus 213 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 213 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 6543 2233456799999999999999999999999999999999999999988765444322211100 0000
Q ss_pred -cccccccCC---------------CCCCC---CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 706 -GLLEKIIDP---------------HLVGT---INPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 706 -~~~~~i~d~---------------~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
......+.. .+... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00000 001126789999999999999999999999854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=373.23 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=210.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++|++++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 6999999987543 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||++||+|.+++.......+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999977665569999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh-hHHHHHHHHhhhcccccccCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV-NLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
. ......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+.... ..
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i----~~---------- 403 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KE---------- 403 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH----HH----------
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh----hc----------
Confidence 2 234457999999999999999999999999999999999999999865432111 111110 00
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
....++...+..+.+++.+||+.||.+|| ++.|+++
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01123344567899999999999999999 6777764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.71 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=211.0
Q ss_pred CHHHHHHHhcCCCcc-ceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCC-CcceeeEEEEe
Q 047569 473 SFQELQEATKNFDSS-AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLR-HRHLVSLIGYC 547 (832)
Q Consensus 473 ~~~el~~~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~ 547 (832)
.++......++|.+. +.||+|+||.||+|... +++.||+|++... ......++.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455566778887 89999999999999776 6899999987653 3445678999999999995 79999999999
Q ss_pred ccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEE
Q 047569 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKV 624 (832)
Q Consensus 548 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl 624 (832)
.+.+..++||||+++++|.+++.......+++.+++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999999976656689999999999999999999999 99999999999999997 789999
Q ss_pred ecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 625 SDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 625 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... .
T Consensus 176 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~ 247 (327)
T 3lm5_A 176 VDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS------Q 247 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H
T ss_pred eeCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH------h
Confidence 999999876432 22234569999999999999999999999999999999999999997765433211110 0
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.............+..+.+++.+||+.||.+|||+.++++
T Consensus 248 -------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 -------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0111112222445678999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=360.10 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=196.3
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCC-CcceeeEEEEeccC--Cc
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDEN--SE 552 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~--~~ 552 (832)
...++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+|+++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999764 6899999988653 3455677889999999997 99999999998644 47
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++|||||+ ++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 6899988653 58899999999999999999999 9999999999999999999999999999986
Q ss_pred CCCC--------------------CCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhh
Q 047569 633 APIG--------------------QGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE 691 (832)
Q Consensus 633 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~ 691 (832)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 1112234579999999999976 678999999999999999999999998876554
Q ss_pred hhhHHHHHHHHhhhccccccc------------------CCCCCCC------------CChhHHHHHHHHHHHhhhcCCC
Q 047569 692 QVNLAEWAMQWKRKGLLEKII------------------DPHLVGT------------INPESLKKFAEAAEKCLADHGV 741 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~------------------d~~l~~~------------~~~~~~~~l~~li~~cl~~dP~ 741 (832)
................+..+. ....... .....+..+.+++.+||+.||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 433221110000000000000 0000000 0113456789999999999999
Q ss_pred CCCCHHHHHH
Q 047569 742 DRPTMGDVLW 751 (832)
Q Consensus 742 ~RPt~~evl~ 751 (832)
+|||+.|+++
T Consensus 319 ~R~t~~e~l~ 328 (388)
T 3oz6_A 319 KRISANDALK 328 (388)
T ss_dssp GSCCHHHHTT
T ss_pred cCCCHHHHhC
Confidence 9999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=360.03 Aligned_cols=272 Identities=21% Similarity=0.283 Sum_probs=214.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCC--cEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS--EMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~--~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57899999999999999999876 58999999987543 344678899999999999999999999987654 789999
Q ss_pred EecCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee----CCCCceEEeccccccc
Q 047569 558 EYMSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKVSDFGLSKD 632 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~ 632 (832)
||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996543 2349999999999999999999999 999999999999999 7788899999999987
Q ss_pred CCCCCCceeeccccCccccChhcccc--------CCCCccccEEechhHHHHHhhCCCCCCCCChhh-hhhHHHHHHHHh
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPRE-QVNLAEWAMQWK 703 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~-~~~l~~~~~~~~ 703 (832)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred ccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 6432 22334569999999999875 567889999999999999999999997543221 111111111101
Q ss_pred hhccccccc-----------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 704 RKGLLEKII-----------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 704 ~~~~~~~i~-----------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....+..+. +......+.......+.+++.+||+.||++||++.++++.++.++.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111110000 1111223456788899999999999999999999999999987765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=375.45 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=206.4
Q ss_pred CCCccc-eEeecCceeEEEEEEe---CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 483 NFDSSA-IIGVGGFGNVYLGEID---DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 483 ~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999764 46689999987653 3467889999999999999999999999976 5699999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++... ...+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999654 3469999999999999999999999 999999999999999999999999999998764322
Q ss_pred Cce--eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||......+.... ...+.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~~~------- 556 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGK------- 556 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-------HHTTC-------
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcCC-------
Confidence 211 122345689999999999999999999999999999998 9999987654432211 11111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....+..++..+.+++.+||+.+|++||++.++++.|+....
T Consensus 557 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 557 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112344567889999999999999999999999999987754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.43 Aligned_cols=264 Identities=15% Similarity=0.191 Sum_probs=208.2
Q ss_pred cCCCccceEeecCceeEEEEEEeC---------CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceee----------
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD---------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVS---------- 542 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~---------- 542 (832)
++|++.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 678999999999999999998753 789999997644 36889999999999999998
Q ss_pred -----EEEEecc-CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 543 -----LIGYCDE-NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 543 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
+++++.. ....++||||+ +++|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 5677765 78899999999 9999999976544579999999999999999999999 899999999999999
Q ss_pred CCCC--ceEEecccccccCCCCCCc------eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCC
Q 047569 617 DDNY--VAKVSDFGLSKDAPIGQGH------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQL 688 (832)
Q Consensus 617 ~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~ 688 (832)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999765422111 1233479999999999999999999999999999999999999997653
Q ss_pred hhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 689 PREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 689 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
.... .+......... ....+.+... .....+..+.+++.+||+.||.+||++.++++.|+.+++..
T Consensus 273 ~~~~-~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 273 PNTE-DIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TCHH-HHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCHH-HHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 2211 11111111111 1111111110 11234578999999999999999999999999999886653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.56 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=200.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|.+.+.||+|+||.||++... +++.+|+|++... .....+++.+|+++|++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467899999999999999999865 6899999987654 33456889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee---CCCCceEEecccccccC
Q 047569 559 YMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 559 ~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~ 633 (832)
|+++++|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988532 23479999999999999999999999 999999999999999 45678999999999765
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
... .......||+.|+|||++. ..++.++|||||||++|||++|+.||......+...... .. .
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~------~~-------~ 241 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------YK-------E 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-------C
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc------cC-------C
Confidence 432 2234456999999999885 568999999999999999999999998765433211110 00 0
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+.... .....+..+.+++.+||+.||.+||++.|+++
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 11124567889999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=356.88 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=198.5
Q ss_pred CCCccceEeecCceeEEEEEEeC--C--cEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEec-cCCcEEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDD--G--TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD-ENSEMILV 556 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~-~~~~~~lV 556 (832)
.|++.+.||+|+||.||+|...+ + ..||+|.+... .....++|.+|+++|++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46778999999999999997642 2 46899988654 3455678999999999999999999999875 45688999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999996543 468899999999999999999999 99999999999999999999999999999865322
Q ss_pred CC---ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 637 QG---HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 637 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.. .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+.... ...+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-------~~~~~----- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------LLQGR----- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-------HHTTC-----
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-------HHcCC-----
Confidence 11 11233457889999999999999999999999999999999 6788866543322111 01110
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....+..++..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 314 ----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 314 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011223456789999999999999999999999999997754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.69 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=195.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHH-HHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQM-LSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~-L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|+.+ +++.||||++.+.. ......+.+|..+ ++.++||||+++++++.+.+.+++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999876 58899999876542 2334556777776 567899999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||++||+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999996543 68899999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
. ........||+.|+|||++.+..++.++|||||||++|||++|++||......+... . ++...
T Consensus 192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~---------i~~~~ 255 (373)
T 2r5t_A 192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------N---------ILNKP 255 (373)
T ss_dssp C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH------H---------HHHSC
T ss_pred C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH------H---------HHhcc
Confidence 2 223345679999999999999999999999999999999999999997654332211 1 11111
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDV 749 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 749 (832)
+ .+++..+..+.+++.+||+.||.+||++.+.
T Consensus 256 ~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 256 L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 1 1234456789999999999999999998643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=347.16 Aligned_cols=271 Identities=23% Similarity=0.378 Sum_probs=213.4
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHh--CCCcceeeEEEEecc
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSK--LRHRHLVSLIGYCDE 549 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~--l~HpnIv~l~~~~~~ 549 (832)
.++..-....++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 44555566678999999999999999999987 5899999998643 34678889999988 689999999999987
Q ss_pred CC----cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeeccCCCCceeeC
Q 047569 550 NS----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH--------TGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 550 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH--------~~~~~~ivHrDlkp~NILl~ 617 (832)
.. ..++||||+++|+|.+++... .+++.+++.++.|++.||+||| + ++++||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEEC
Confidence 65 899999999999999999653 5899999999999999999999 6 8999999999999999
Q ss_pred CCCceEEecccccccCCCCCCc---eeeccccCccccChhccccC------CCCccccEEechhHHHHHhhC--------
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGH---VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLLEVLCA-------- 680 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~SlGvvl~elltG-------- 680 (832)
.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999765433322 12345699999999999765 334789999999999999999
Q ss_pred --CCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC-CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 681 --RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT-INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 681 --~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
+.||........ ....+.... ......+.+... ...+.+..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 262 ~~~~p~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP-SVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCTTTTTSCSSC-CHHHHHHHH-----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCccccCcCcc-cHHHHHHHH-----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 677765432111 111111111 111112222111 12356788999999999999999999999999999875
Q ss_pred H
Q 047569 758 Q 758 (832)
Q Consensus 758 ~ 758 (832)
+
T Consensus 336 ~ 336 (342)
T 1b6c_B 336 Q 336 (342)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=365.72 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=207.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57889999999999999999876 79999999876432 234567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 999999999999654 369999999999999999999999 99999999999999999999999999999876432
Q ss_pred CceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... .+.+...
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---------------~i~~~~~ 233 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK---------------KICDGIF 233 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH---------------HHHTTCC
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH---------------HHhcCCc
Confidence 23345579999999999988765 789999999999999999999998654332111 1111111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 234 --~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 --YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1223345679999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.50 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=180.3
Q ss_pred cceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 487 SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
.+.||+|+||.||+|... +++.||||++.. .....+.+|++++++++ ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999875 689999999753 34567889999999997 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC---ceEEecccccccCCCCCCcee
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY---VAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 641 (832)
|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++ .+||+|||+++...... ...
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 999997653 69999999999999999999999 9999999999999997665 89999999998654322 223
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 721 (832)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....................+. ........
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~------~~~~~~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD------FSFEGEAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC------CCCCSHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC------CCCCcccc
Confidence 445689999999999999999999999999999999999999976433211110111111111110 00111111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 047569 722 PESLKKFAEAAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 722 ~~~~~~l~~li~~cl~~dP~~RPt~~evl 750 (832)
...+.++.+++.+||+.||.+||++.|++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 23567899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=353.45 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=203.0
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+++|++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45689999999999999999986 478999999876442 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+. |+|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 68888775332 368999999999999999999999 8999999999999999999999999999976532
Q ss_pred CCceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.....||+.|+|||++. ...++.++|||||||++|||++|++||.......... ..... . .
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------~~~~~-~-----~ 270 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQN-E-----S 270 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS-C-----C
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhc-C-----C
Confidence 23456999999999984 5678999999999999999999999997654332211 11111 0 1
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+. ......+..+.+++.+||+.+|.+|||+.++++.
T Consensus 271 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 1123455678999999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=368.54 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=197.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+++|++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999765 6899999987643 334456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++|+|.+++.... .+++.++..++.|+++||+|||+ .++|+||||||+||||+.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999996543 68999999999999999999995 268999999999999999999999999999864322
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........||+.|+|||++.+..++.++|||||||++|||++|+.||............ ... ..
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~-------~~-- 366 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME-------EI-- 366 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC-------CC--
T ss_pred -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhC-------CC--
Confidence 22334567999999999999999999999999999999999999999776543322111 010 01
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
.++...+..+.+++.+||+.||.+|| ++.|+++
T Consensus 367 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 --RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 12334567899999999999999999 9988864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=351.29 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=195.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 468999999999999999999765 78999999987543 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee-----CCCCceEEeccccccc
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL-----DDNYVAKVSDFGLSKD 632 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl-----~~~~~~kl~DFGla~~ 632 (832)
||++ ++|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 59999996554 58999999999999999999999 999999999999999 4555699999999986
Q ss_pred CCCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|++||......+....................
T Consensus 187 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 187 FGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 54222 223345689999999999874 5899999999999999999999999876554432211110000000000000
Q ss_pred c-C-------CCCCCC-----CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 I-D-------PHLVGT-----INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 ~-d-------~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. . +..... +....+.++.+++.+||+.||.+|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0 000000 01114578899999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=351.11 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=199.4
Q ss_pred cCCCcc-ceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSS-AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
+.|++. +.||+|+||.||+|... +++.||||++........+++.+|+++|.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 78999999999999754 7899999998776666678899999999995 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc---eEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV---AKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~ 635 (832)
|+++++|.+++.... .+++.++..++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999996543 68999999999999999999999 89999999999999998776 99999999876532
Q ss_pred CCC------ceeeccccCccccChhcccc-----CCCCccccEEechhHHHHHhhCCCCCCCCChhhhh--------hHH
Q 047569 636 GQG------HVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV--------NLA 696 (832)
Q Consensus 636 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~--------~l~ 696 (832)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.. ...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111 11223459999999999875 56889999999999999999999999765432100 000
Q ss_pred HHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 697 EWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 697 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.........+.. .+........+..+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000011111100 0000000124567999999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.31 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=202.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC----cccHHHHHHHHHHHHhCCCcceeeEEEEe--ccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS----EQGITEFQTEIQMLSKLRHRHLVSLIGYC--DENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~--~~~~~~ 553 (832)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999864 68999999886532 34467899999999999999999999998 456789
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||++++ |.+++.......+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7777766555679999999999999999999999 99999999999999999999999999999875
Q ss_pred CCC-CCceeeccccCccccChhccccCC--CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 634 PIG-QGHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 634 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
... .........||+.|+|||++.+.. .+.++||||||+++|||++|+.||......+.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------i~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN-------IGKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH-------HhcCC---
Confidence 422 222334556999999999997654 37899999999999999999999986543322111 11111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..++...+..+.+++.+||+.||.+||++.|+++.
T Consensus 230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11233456789999999999999999999999754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.87 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=191.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEe--------ccC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYC--------DEN 550 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~--------~~~ 550 (832)
..+|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999865 68999999887666666788999999999996 99999999998 344
Q ss_pred CcEEEEEEecCCCChhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCceeeCCCCceEEecc
Q 047569 551 SEMILVYEYMSNGPFRDHLYG-KNLPPLSWKQRLEISIGSARGLHYLHTGTAQG--IIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
...++||||+. |+|.+++.. .....+++.+++.++.|++.||+|||+ ++ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 56899999995 799888854 223469999999999999999999999 78 999999999999999999999999
Q ss_pred cccccCCCCCCc-----------eeeccccCccccChhcc---ccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh
Q 047569 628 GLSKDAPIGQGH-----------VSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693 (832)
Q Consensus 628 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~ 693 (832)
|+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 999865432211 11134589999999998 56778999999999999999999999996432211
Q ss_pred hHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 694 NLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 694 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
+.............+..+.+++.+||+.||.+||++.|+++.|+.+.+.
T Consensus 261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0111111111222344588999999999999999999999999887653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.27 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=206.7
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
..++|++.+.||+|+||.||++... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567999999999999999999875 689999999876655455678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee---CCCCceEEecccccccCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 635 (832)
|+++++|.+++.... .+++.++..++.|++.||+|||+ ++++||||||+|||+ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999986543 68999999999999999999999 999999999999999 7889999999999875432
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...+.. .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------i~~~~~------~ 225 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK-------IKEGYY------E 225 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHCCC------C
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHcCCC------C
Confidence 1 22345689999999999999999999999999999999999999976544322111 111110 1
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.........+..+.+++.+||+.||.+||++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112234456789999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.31 Aligned_cols=249 Identities=21% Similarity=0.350 Sum_probs=208.3
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467899999999999999999875 5789999987543 334567799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999886543 68999999999999999999999 99999999999999999999999999999875432
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... ..
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~-------~~-- 258 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKN-------EY-- 258 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHT-------CC--
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHhcC-------CC--
Confidence 2 22344569999999999999999999999999999999999999997654332211 11110 01
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.++...+..+.+++.+||+.||.+||++.|+++.
T Consensus 259 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223445678999999999999999999999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=345.44 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=206.8
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc---------
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--------- 549 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--------- 549 (832)
..++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999876 79999999986554 357789999999999999999998754
Q ss_pred -------CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 550 -------NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 550 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
....++||||+++++|.+++.......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 4558999999999999999976555579999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 702 (832)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+... . .....
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~---~~~~~- 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S---KFFTD- 230 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H---HHHHH-
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H---HHHHH-
Confidence 999999998765332 223456899999999999999999999999999999999999876311 0 11111
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+.... ++...+..+.+++.+||+.||.+||++.|+++.|+...+
T Consensus 231 --------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 231 --------LRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp --------HHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred --------hhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 11111 123345678999999999999999999999999887643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=358.92 Aligned_cols=253 Identities=19% Similarity=0.304 Sum_probs=195.3
Q ss_pred cCCCcc-ceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHh-CCCcceeeEEEEecc----CCcEE
Q 047569 482 KNFDSS-AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSK-LRHRHLVSLIGYCDE----NSEMI 554 (832)
Q Consensus 482 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~-l~HpnIv~l~~~~~~----~~~~~ 554 (832)
++|.+. +.||+|+||.||++... +++.||||++... ..+.+|++++.+ ++||||+++++++.. ...++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 78999999999999765 6899999998532 467789998755 489999999998865 56789
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEecccccc
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLSK 631 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~ 631 (832)
|||||+++|+|.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999987655679999999999999999999999 99999999999999997 7899999999998
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh-hHHHHHHHHhhhccccc
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV-NLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~~~~ 710 (832)
..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......... ..... ...+..
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~-- 284 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY-- 284 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC--
T ss_pred ccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc--
Confidence 65422 2234567899999999999999999999999999999999999999765432210 01110 011110
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.+........+.++.+++.+||+.||.+|||+.|+++.-.
T Consensus 285 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 285 ----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 1111111345678999999999999999999999986544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.15 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=206.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 6899999987643 23445789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC-
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ- 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 637 (832)
|+++++|.+++... ..+++.+++.++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999644 368999999999999999999999 999999999999999999999999999987653211
Q ss_pred CceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+ ... ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~---------~~ 226 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEK---------KT 226 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH----HTT---------CT
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh----hhc---------cc
Confidence 112234568999999999987765 7899999999999999999999976543221 11111 110 00
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00112345678899999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=348.61 Aligned_cols=259 Identities=27% Similarity=0.343 Sum_probs=205.3
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEec----cCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD----ENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~----~~~~~~l 555 (832)
.++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999987 578999999887666677788999999999999999999999986 3457899
Q ss_pred EEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 556 VYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
||||+++++|.+++... ....+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988642 34579999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCCCc--------eeeccccCccccChhccccCC---CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHH
Q 047569 634 PIGQGH--------VSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 634 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 702 (832)
...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence 311100 012235799999999987554 68999999999999999999999843111000 0000 0
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.. ........+..+..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 260 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 260 VQ---------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HH---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hh---------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 00 0111112244567899999999999999999999999888754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.83 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=186.3
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999986 478999999875431 23357899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999996542 468999999999999999999999 99999999999999999999999999999875432
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+.....
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~ 229 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc
Confidence 21 223456899999999999999999999999999999999999999765432211 11111111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 230 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 --EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 223345678999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=356.14 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=205.4
Q ss_pred cCCCccceEeecCceeEEEEEE----eCCcEEEEEecCCCC----cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI----DDGTKVAVKRGNPQS----EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+++|+++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6799999999999999999987 368999999876532 23345678899999999 69999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++||||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999996543 68999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCceeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
.............||+.|+|||++.+ ..++.++|||||||+||||++|+.||......... ..........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~----- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS----- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-----
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc-----
Confidence 65433334445679999999999985 35789999999999999999999999754322211 1111111100
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLWNL 753 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 753 (832)
...++...+..+.+++.+||+.||.+|| ++.|+++..
T Consensus 282 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1123345567899999999999999999 888887543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.27 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=208.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367889999999999999999876 5889999987543 334567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999886543 68999999999999999999999 99999999999999999999999999999875432
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .... + .
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~-~--------~- 231 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKK-N--------E- 231 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHT-T--------C-
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhh-c--------c-
Confidence 2 22334568999999999999999999999999999999999999997654332211 1111 0 0
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...+...+..+.+++.+||+.||++||++.++++.
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11233455679999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=349.01 Aligned_cols=268 Identities=22% Similarity=0.266 Sum_probs=200.1
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcc-----cHHHHHHHHHHHHhCCCcceeeEEEEeccCCc
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQ-----GITEFQTEIQMLSKLRHRHLVSLIGYCDENSE 552 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~ 552 (832)
...++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 5899999998653221 12468899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999975 8888886443 468889999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+....................
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 54322 223445689999999999764 5899999999999999999999999876544332211100000000000000
Q ss_pred c---CC---CCCCCC-----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 712 I---DP---HLVGTI-----NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 712 ~---d~---~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
. +. ...... ....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00 000001 13345789999999999999999999998743
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.26 Aligned_cols=253 Identities=17% Similarity=0.183 Sum_probs=207.7
Q ss_pred HhcCCCccceEeecCceeEEEEE------EeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC---CcceeeEEEEeccC
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGE------IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR---HRHLVSLIGYCDEN 550 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~ 550 (832)
..++|++.+.||+|+||.||+|. ..+++.||||++.... ..++..|++++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35779999999999999999993 4568999999987543 457888888888887 99999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---------
Q 047569 551 SEMILVYEYMSNGPFRDHLYGK---NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD--------- 618 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--------- 618 (832)
+..+|||||+++|+|.+++... ....+++.+++.++.|+++||+|||+ ++|+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999642 23469999999999999999999999 99999999999999998
Q ss_pred --CCceEEecccccccCC-CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhH
Q 047569 619 --NYVAKVSDFGLSKDAP-IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695 (832)
Q Consensus 619 --~~~~kl~DFGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l 695 (832)
++.+||+|||+++... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 8999999999997543 222334455679999999999999999999999999999999999999985432110
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDR-PTMGDVLWNLEYALQL 759 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~ 759 (832)
......+... .....+.+++.+||+.+|.+| |++.++.+.|+..++.
T Consensus 293 --------------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 --------------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0011111111 235678899999999999999 7788888888877653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.48 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=200.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------C
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------S 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------~ 551 (832)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+++|++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999874 6999999998653 334467789999999999999999999998765 3
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 88999998653 58999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc--
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL-- 708 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~-- 708 (832)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+................+
T Consensus 177 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 177 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 7542 2334568999999999887 68999999999999999999999999877654433222111000000000
Q ss_pred ----------ccc--cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 ----------EKI--IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ----------~~i--~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+ ..........+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0000111222345678999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=363.91 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=187.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEec-----cCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD-----ENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~-----~~~~ 552 (832)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++|++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999765 6899999988654 3445678999999999999999999999983 3467
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
+++||||+ +++|.+++... ..+++..+..++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999998 57999998654 369999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC--------------------------ceeeccccCccccChhcc-ccCCCCccccEEechhHHHHHhh------
Q 047569 633 APIGQG--------------------------HVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLLEVLC------ 679 (832)
Q Consensus 633 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~SlGvvl~ellt------ 679 (832)
...... .......||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 542211 122445789999999976 56679999999999999999999
Q ss_pred -----CCCCCCCCChhh-----------------hhhHHHHHHHHhhhc---ccc-----------cccCCCC---CCCC
Q 047569 680 -----ARPAINPQLPRE-----------------QVNLAEWAMQWKRKG---LLE-----------KIIDPHL---VGTI 720 (832)
Q Consensus 680 -----G~~pf~~~~~~~-----------------~~~l~~~~~~~~~~~---~~~-----------~i~d~~l---~~~~ 720 (832)
|+++|.+..... ..+............ .+. ..+.... ....
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 667775543100 001111111100000 000 0000000 0011
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1334678999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.76 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=206.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 5789999987543 1233567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999996543 68999999999999999999999 99999999999999999999999999998765422
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......|++.|+|||++.+..++.++||||||+++|||++|+.||......+... . +....
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~---------~~~~~-- 228 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------R---------IVNVD-- 228 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H---------HHTTC--
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------H---------Hhccc--
Confidence 2234568999999999999999999999999999999999999997654332211 1 01111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+++..+..+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 12334456789999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.88 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=204.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC------cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999876 68999999865432 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC----ceEEecccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY----VAKVSDFGL 629 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGl 629 (832)
++||||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999996543 68999999999999999999999 9999999999999998877 899999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... . ..
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~-~~--- 226 (283)
T 3bhy_A 159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------S-AV--- 226 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H-TT---
T ss_pred ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh------H-hc---
Confidence 98754322 223456899999999999999999999999999999999999999876543221110 0 00
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
............+..+.+++.+||+.||.+||++.++++.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 ---NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000001112345679999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=352.29 Aligned_cols=264 Identities=21% Similarity=0.328 Sum_probs=198.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcc-cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQ-GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999876 6899999988654322 122456799999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
++ ++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 97 58988886543 368999999999999999999999 999999999999999999999999999998654222 2
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC-----
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID----- 713 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d----- 713 (832)
......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+................+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2234568999999999876 5789999999999999999999999988765544332211110000000010000
Q ss_pred ----CCCCC----CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 714 ----PHLVG----TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 714 ----~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+.... ...+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 011234567899999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=352.52 Aligned_cols=243 Identities=19% Similarity=0.292 Sum_probs=203.7
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--------cccHHHHHHHHHHHHhCCCcceeeEEEEeccC
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN 550 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~ 550 (832)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++|++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999764 68999999876542 11334678899999999999999999999999
Q ss_pred CcEEEEEEecCCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 551 SEMILVYEYMSNG-PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 551 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
+..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999996543 69999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 177 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------- 235 (335)
T 3dls_A 177 AAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------- 235 (335)
T ss_dssp CEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------
T ss_pred ceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------
Confidence 98765332 2344569999999999988876 8899999999999999999999964211
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...... ..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 236 --~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 --TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111 1122345679999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=341.26 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=205.4
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEe--ccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYC--DENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~--~~~~~~~l 555 (832)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367899999999999999999875 6899999987654 344567899999999999999999999987 45678999
Q ss_pred EEEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeeccCCCCceeeCCCCceEEeccc
Q 047569 556 VYEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGTAQG-----IIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~-----ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
||||+++++|.+++... ....+++.+++.++.|++.||+|||+ .+ ++||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998642 23458999999999999999999999 77 9999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. . ....+..
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~----~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---G----KIREGKF 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHTCC
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH---H----HHhhccc
Confidence 998654321 1223456899999999999999999999999999999999999999866432211 1 1111111
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
..++...+..+.+++.+||+.+|.+||++.|+++.+
T Consensus 234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 122344567899999999999999999999998644
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=354.82 Aligned_cols=266 Identities=23% Similarity=0.327 Sum_probs=208.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999876 6899999987755 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|+++++|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999996543 68999999999999999999998 6 899999999999999999999999999865421
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHH---------------
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW--------------- 702 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~--------------- 702 (832)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1223456899999999999999999999999999999999999999876543321111000000
Q ss_pred --------hh----hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 703 --------KR----KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 703 --------~~----~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
.. ......+.............+..+.+++.+||+.||.+|||+.|+++.-.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00 00000111111111122235668999999999999999999999986543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.54 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=200.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe--CCc--EEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID--DGT--KVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|.+. +++ .||||++... .....+++.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999764 233 6899988754 3345678999999999999999999999998765 8
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999986542 358999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 634 PIGQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 634 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~------ 239 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDK------ 239 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHT------
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHHc------
Confidence 533222 1233457889999999999899999999999999999999 999997664432211 1111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.......+...+..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 240 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 240 ---EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11111223456678999999999999999999999999888664
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.31 Aligned_cols=245 Identities=21% Similarity=0.330 Sum_probs=201.0
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~l 555 (832)
..++|++.+.||+|+||.||+|... +++.||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999876 7999999987653 334467788999999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC--------------
Q 047569 556 VYEYMSNGPFRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-------------- 619 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-------------- 619 (832)
||||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999996532 2468999999999999999999999 999999999999999844
Q ss_pred -----CceEEecccccccCCCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhh
Q 047569 620 -----YVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693 (832)
Q Consensus 620 -----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~ 693 (832)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|||++|.+++.......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-- 238 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-- 238 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH--
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH--
Confidence 47999999999876432 223589999999999776 66789999999999999999998764331100
Q ss_pred hHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 694 NLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 694 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+. ...++...+..+.+++.+||+.||.+||++.|+++
T Consensus 239 --------~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 --------EIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 011111 11233445678999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.03 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=197.8
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHH--HhCCCcceeeEEEEe-----ccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQML--SKLRHRHLVSLIGYC-----DENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L--~~l~HpnIv~l~~~~-----~~~~~~ 553 (832)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++ ..++||||+++++.+ ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36789999999999999999976 6899999997643 234555555554 457999999999854 234467
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeeeccCCCCceeeCCCCceEE
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ---------GIIHRDVKSTNILLDDNYVAKV 624 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~---------~ivHrDlkp~NILl~~~~~~kl 624 (832)
++||||+++|+|.+++.... .++..++.++.|+++||+|||+ . +|+||||||+|||++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 89999999999999996543 5889999999999999999998 6 9999999999999999999999
Q ss_pred ecccccccCCCCC-------CceeeccccCccccChhcccc-------CCCCccccEEechhHHHHHhhCCCCCCCCChh
Q 047569 625 SDFGLSKDAPIGQ-------GHVSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPR 690 (832)
Q Consensus 625 ~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~ 690 (832)
+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998654221 112234569999999999976 45678999999999999999997665432211
Q ss_pred hhh-hH----------HHHHHHHhhhcccccccCCCCCCC--CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 691 EQV-NL----------AEWAMQWKRKGLLEKIIDPHLVGT--INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 691 ~~~-~l----------~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
... .. ......... .....+.+... .....+..+.+++.+||+.||.+|||+.|+++.|+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVS----REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHT----TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhc----ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 100 00 000000000 01111111111 12346778999999999999999999999999999876
Q ss_pred HH
Q 047569 758 QL 759 (832)
Q Consensus 758 ~~ 759 (832)
..
T Consensus 318 ~~ 319 (336)
T 3g2f_A 318 MI 319 (336)
T ss_dssp HC
T ss_pred HH
Confidence 53
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.21 Aligned_cols=263 Identities=17% Similarity=0.177 Sum_probs=198.6
Q ss_pred cCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCCCcc-----------cHHHHHHHHHHHHhCCCcceeeEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQSEQ-----------GITEFQTEIQMLSKLRHRHLVSLIGY 546 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~f~~Ei~~L~~l~HpnIv~l~~~ 546 (832)
++|++.+.||+|+||.||+|... ++..+|+|+....... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 67899999999999999999875 5789999987655322 12346678899999999999999999
Q ss_pred ecc----CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC--
Q 047569 547 CDE----NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-- 620 (832)
Q Consensus 547 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-- 620 (832)
+.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence 877 78899999999 999999996554 79999999999999999999999 8999999999999998877
Q ss_pred ceEEecccccccCCCCCC------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhh
Q 047569 621 VAKVSDFGLSKDAPIGQG------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVN 694 (832)
Q Consensus 621 ~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~ 694 (832)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA- 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence 999999999976542211 1123456999999999999999999999999999999999999999643221111
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
........ .... ........ .....+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 270 ~~~~~~~~-~~~~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 VQTAKTNL-LDEL-PQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHH-HHTT-THHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHhh-cccc-cHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11111110 0000 00000000 0113556899999999999999999999999887743
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=373.23 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=202.3
Q ss_pred ceEeecCceeEEEEEEe---CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEID---DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||.||+|.+. .++.||||++... .....++|.+|+++|++++|||||++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 4678999998754 33446889999999999999999999999965 568999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC--ce
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG--HV 640 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~ 640 (832)
|+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999996543 68999999999999999999999 9999999999999999999999999999987643322 12
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+..... ..+ ....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~---------~~~~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKG---------ERMG 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTT---------CCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC---------CCCC
Confidence 233457889999999999999999999999999999998 99999876543322111 111 1112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.+..++..+.+++.+||+.||++||++.++++.|+...
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 33456678999999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=350.85 Aligned_cols=266 Identities=22% Similarity=0.362 Sum_probs=205.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367899999999999999999875 58999999875443 334566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988875443 68999999999999999999999 999999999999999999999999999997654322
Q ss_pred CceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH---------HHHhhhcc
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA---------MQWKRKGL 707 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~---------~~~~~~~~ 707 (832)
.......||+.|+|||++.+. .++.++|||||||++|||++|++||......+........ ..+.....
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 223345689999999999875 7899999999999999999999999877654432211110 00011111
Q ss_pred cccccCCCCCCCC-----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 708 LEKIIDPHLVGTI-----NPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 708 ~~~i~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
......+...... .+..+..+.+++.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111 12456789999999999999999999999854
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.11 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=199.4
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc----CCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE----NSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~----~~~~~l 555 (832)
.|++.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+++|++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677889999999999999765 6889999987643 44556789999999999999999999998754 456899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCceeeC-CCCceEEeccccccc
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG--IIHRDVKSTNILLD-DNYVAKVSDFGLSKD 632 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 632 (832)
||||+++++|.+++... ..+++..++.++.|++.||+|||+ ++ ++||||||+|||++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999654 368999999999999999999999 77 99999999999998 789999999999976
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.... ......||+.|+|||++. +.++.++|||||||++|||++|+.||.......... .. ...+.
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-----~~-~~~~~----- 246 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----RR-VTSGV----- 246 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-----HH-HTTTC-----
T ss_pred cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-----HH-HhccC-----
Confidence 5422 233456999999999886 458999999999999999999999997654332211 11 11110
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 ---KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111122233467999999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=338.88 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=209.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356889999999999999999764 68999999876543 4457889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++.. ..+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999854 368999999999999999999999 999999999999999999999999999997654322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ...+. . .
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~-----~----~ 237 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------IPKNN-----P----P 237 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSC-----C----C
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------hhcCC-----C----C
Confidence 122345689999999999999999999999999999999999999976544322111 11110 1 1
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
......+..+.+++.+||+.+|.+||++.++++...
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 223345567999999999999999999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=365.57 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=205.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|+++|++++||||+++++++.+.+.+++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67999999999999999999875 6999999987643 2234577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 558 EYMSNGPFRDHLYGKN--LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||++||+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986543 4579999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
... ......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+..... ....
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i---------~~~~ 409 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRV---------LEQA 409 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHH---------HHCC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHH---------hhcc
Confidence 322 233457999999999999999999999999999999999999999765321110 1111111 1111
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMG 747 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 747 (832)
..++...+..+.+++.+||+.||.+||++.
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 123345667899999999999999999763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=348.14 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=202.1
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEecc--------C
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--------N 550 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--------~ 550 (832)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6789999999999999999987 478999999876543 3335678899999999999999999999876 4
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
+..++||||+++ +|.+.+.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 568999999974 7777775433 369999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCC---CceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 631 KDAPIGQ---GHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 631 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||......................
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8654221 122244568999999999876 468999999999999999999999998776554433222111100000
Q ss_pred ccccccCCCC------CCC--CC-hh------HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 707 LLEKIIDPHL------VGT--IN-PE------SLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 707 ~~~~i~d~~l------~~~--~~-~~------~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+..... ... .. .. ....+.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000000 000 00 00 1356889999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.14 Aligned_cols=273 Identities=21% Similarity=0.237 Sum_probs=204.1
Q ss_pred cCHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCc-----------ccHHHHHHHHHHHHhCCCcce
Q 047569 472 FSFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE-----------QGITEFQTEIQMLSKLRHRHL 540 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~f~~Ei~~L~~l~HpnI 540 (832)
....++....++|++.+.||+|+||.||+|...+|+.||||++..... ...+++.+|+++|++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 346788888999999999999999999999888899999998754321 124789999999999999999
Q ss_pred eeEEEEec-----cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCcee
Q 047569 541 VSLIGYCD-----ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNIL 615 (832)
Q Consensus 541 v~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 615 (832)
+++++++. .....++||||++ |+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 99999983 3456899999997 6888888644 3469999999999999999999999 89999999999999
Q ss_pred eCCCCceEEecccccccCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhh
Q 047569 616 LDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVN 694 (832)
Q Consensus 616 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~ 694 (832)
++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999754322 22344568999999999877 678999999999999999999999998765444322
Q ss_pred HHHHHHH------H--hh----hcccccccCCCC---CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 695 LAEWAMQ------W--KR----KGLLEKIIDPHL---VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 695 l~~~~~~------~--~~----~~~~~~i~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....... . .. ...+........ .....+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1110000 0 00 000000000000 00112334567999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.07 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=203.2
Q ss_pred CHHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEecc-
Q 047569 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE- 549 (832)
Q Consensus 473 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~- 549 (832)
++.++....++|++.+.||+|+||.||+|... +++.||||++.... ...+++.+|+++++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33444456788999999999999999999874 78999999876543 3346889999999999 79999999999866
Q ss_pred -----CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEE
Q 047569 550 -----NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKV 624 (832)
Q Consensus 550 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 624 (832)
.+..++||||+++++|.+++.......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEE
Confidence 5688999999999999999976555579999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCCceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHH
Q 047569 625 SDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA 699 (832)
Q Consensus 625 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~ 699 (832)
+|||++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||...........
T Consensus 171 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---- 245 (326)
T 2x7f_A 171 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---- 245 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----
T ss_pred eeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----
Confidence 9999987654221 1223456899999999987 56789999999999999999999999976544322111
Q ss_pred HHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 700 MQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 700 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. .... .+. ......+..+.+++.+||+.||.+||++.++++
T Consensus 246 --~-~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 --I-PRNP-----APR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --H-HHSC-----CCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --h-hcCc-----ccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0110 111 112344578999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=349.22 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=208.5
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc--------ccHHHHHHHHHHHHhC-CCcceeeE
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE--------QGITEFQTEIQMLSKL-RHRHLVSL 543 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~f~~Ei~~L~~l-~HpnIv~l 543 (832)
........++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556788999999999999999999875 799999998765431 1245688999999999 79999999
Q ss_pred EEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceE
Q 047569 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623 (832)
Q Consensus 544 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 623 (832)
++++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999654 368999999999999999999999 8999999999999999999999
Q ss_pred EecccccccCCCCCCceeeccccCccccChhcccc------CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHH
Q 047569 624 VSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAE 697 (832)
Q Consensus 624 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~ 697 (832)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-- 316 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-- 316 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH--
Confidence 99999988764322 2344679999999999864 3588999999999999999999999976543322111
Q ss_pred HHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 698 WAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 698 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+... .........+..+.+++.+||+.||.+||++.++++
T Consensus 317 -----i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 -----IMEGQYQ------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -----HHHTCCC------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----HHhCCCC------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111100 000000123567999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=336.71 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=200.8
Q ss_pred CCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 484 FDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 484 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
|....+||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 445669999999999999864 6889999998776666678899999999999999999999999999999999999999
Q ss_pred CChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEecccccccCCCCCCce
Q 047569 563 GPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 563 gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++|.+++.... ...+++..+..++.|+++||+|||+ ++++||||||+|||++. ++.+||+|||++....... ..
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~ 179 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PC 179 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cc
Confidence 99999997543 3357789999999999999999999 99999999999999987 8999999999998654321 22
Q ss_pred eeccccCccccChhccccCC--CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~--~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.....||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... ... .. .. ....
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~~--~~---------~~~~ 245 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--VG--MF---------KVHP 245 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--HH--HH---------CCCC
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--hc--cc---------cccc
Confidence 33456899999999997653 889999999999999999999999643322111 000 00 00 0111
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.++...+..+.+++.+||+.||++||++.++++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 233455678999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.86 Aligned_cols=247 Identities=28% Similarity=0.398 Sum_probs=198.5
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57899999999999999999876 7899999987543 2234568899999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 9999999999996543 68999999999999999999999 89999999999999999999999999999875432
Q ss_pred CceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... . ...+.
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~-~~~~~--------- 227 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK------K-IRGGV--------- 227 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHCC---------
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------H-hhcCc---------
Confidence 22234568999999999988765 689999999999999999999997654322111 1 11110
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...+...+..+.+++.+||+.||.+||++.++++.
T Consensus 228 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01223445679999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=359.58 Aligned_cols=197 Identities=25% Similarity=0.372 Sum_probs=166.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----Cc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN-----SE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~-----~~ 552 (832)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999765 6889999998754 344567899999999999999999999998765 67
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++||||++ ++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999996 6999999654 369999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC---------------------ceeeccccCccccChhcc-ccCCCCccccEEechhHHHHHhhCCCC
Q 047569 633 APIGQG---------------------HVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLLEVLCARPA 683 (832)
Q Consensus 633 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~SlGvvl~elltG~~p 683 (832)
...... .......||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 643221 123456799999999986 566799999999999999999984433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=357.81 Aligned_cols=262 Identities=20% Similarity=0.213 Sum_probs=206.5
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhC------CCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKL------RHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l------~HpnIv~l~~~~~~~~~~ 553 (832)
..+|++.+.||+|+||.||+|... +++.||||++... ....+++.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999765 5899999998753 33456788899988887 577999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc--eEEecccccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV--AKVSDFGLSK 631 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~ 631 (832)
++||||+. ++|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999995 799999987766679999999999999999999999 89999999999999999887 9999999997
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH-----Hhhh-
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ-----WKRK- 705 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~-----~~~~- 705 (832)
.... ......||+.|+|||++.+..++.++|||||||+||||++|++||......+.......... +...
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred ecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 6432 22345789999999999999999999999999999999999999987765543322211100 0000
Q ss_pred cccccccCC--------------------------------CCCCC----CChhHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 047569 706 GLLEKIIDP--------------------------------HLVGT----INPESLKKFAEAAEKCLADHGVDRPTMGDV 749 (832)
Q Consensus 706 ~~~~~i~d~--------------------------------~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 749 (832)
......++. ..... +.......+.+++.+||+.||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 000000000 00000 011124678999999999999999999999
Q ss_pred HH
Q 047569 750 LW 751 (832)
Q Consensus 750 l~ 751 (832)
++
T Consensus 407 L~ 408 (429)
T 3kvw_A 407 LR 408 (429)
T ss_dssp HT
T ss_pred hC
Confidence 74
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=358.38 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=193.5
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--------cccHHHHHHHHHHHHhCCCcceeeEEEEecc
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~ 549 (832)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35688999999999999999999765 68999999875421 1223358899999999999999999999854
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC---CceEEec
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN---YVAKVSD 626 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~D 626 (832)
+..++||||+++++|.+++... ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.+ +.+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence 4589999999999999998654 369999999999999999999999 899999999999999754 4599999
Q ss_pred ccccccCCCCCCceeeccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh
Q 047569 627 FGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 627 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||........ +... .
T Consensus 286 FG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~----i 357 (419)
T 3i6u_A 286 FGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----I 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH----H
T ss_pred cccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH----H
Confidence 999987542 223345679999999999853 6788999999999999999999999976433211 1110 0
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+... .........+..+.+++.+||+.||.+||++.|+++.
T Consensus 358 ~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111000 0000012345789999999999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.37 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=202.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|... +++.||+|++........+++.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467999999999999999999876 5899999998877777788999999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 99999999886432 368999999999999999999999 89999999999999999999999999987532110 11
Q ss_pred eeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 640 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
......||+.|+|||++. +..++.++|||||||++|||++|+.||......... ...... . .+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-~-----~~ 240 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKS-D-----PP 240 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-C-----CC
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhcc-C-----Cc
Confidence 123346899999999983 667899999999999999999999999765443221 111111 0 00
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 241 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 --TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01123445678999999999999999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=341.91 Aligned_cols=262 Identities=20% Similarity=0.295 Sum_probs=208.7
Q ss_pred hcCCCccceEeecCceeEEEEEE--eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc------eeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI--DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH------LVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn------Iv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36799999999999999999976 36889999998643 344577899999999997654 9999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC--------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-------------- 618 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-------------- 618 (832)
.++||||+ +++|.+++......++++.+++.++.|+++||+|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 8999999987766679999999999999999999999 99999999999999987
Q ss_pred -----CCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh
Q 047569 619 -----NYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693 (832)
Q Consensus 619 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~ 693 (832)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 66899999999986432 223456899999999999999999999999999999999999999877654433
Q ss_pred hHHHHHHHHhhhcccc-----c---------------------ccCCC-CCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 694 NLAEWAMQWKRKGLLE-----K---------------------IIDPH-LVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 694 ~l~~~~~~~~~~~~~~-----~---------------------i~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
................ . ...+. .........+..+.+++.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 3222111000000000 0 00000 0011234567889999999999999999999
Q ss_pred HHHHH
Q 047569 747 GDVLW 751 (832)
Q Consensus 747 ~evl~ 751 (832)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=362.15 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=205.6
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
..++|++.+.||+|+||+||+|... +++.||||++... .......+.+|+++|++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999875 7899999987543 234467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccccccC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDA 633 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~ 633 (832)
|||+++++|.+.+.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999886543 68999999999999999999999 9999999999999995 5568999999999865
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|++||......+..... ..+..
T Consensus 175 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~----- 239 (486)
T 3mwu_A 175 QQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------ETGKY----- 239 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC-----
T ss_pred CCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCC-----
Confidence 432 22344569999999999875 5899999999999999999999999876543322111 11110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..........+..+.+++.+||+.+|.+|||+.++++.
T Consensus 240 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001113456789999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=363.30 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=208.3
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999876 7899999987543 234577899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee---CCCCceEEecccccccC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~ 633 (832)
|||+.+++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999986544 69999999999999999999999 999999999999999 56789999999999876
Q ss_pred CCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||......+..... ..+...
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~---- 245 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------EKGKYT---- 245 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCC----
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCC----
Confidence 4332 2344569999999999876 6899999999999999999999999876543322111 111100
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.........+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0001113456789999999999999999999999854
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.07 Aligned_cols=261 Identities=26% Similarity=0.354 Sum_probs=189.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 478999999999999999999754 68999999886543 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 559 YMSNGPFRDHLYG------KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 559 ~~~~gsL~~~l~~------~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
|+++++|.+++.. .....+++..++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999998853 123468999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCC----CceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 633 APIGQ----GHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 633 ~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... . . .+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~-~-~~~ 243 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----T-L-QND 243 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----H-H-TSS
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----H-h-ccC
Confidence 54221 112234568999999999876 5689999999999999999999999987654332111 0 0 111
Q ss_pred cccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 ~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.................+..+.+++.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111111111222345567999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=362.31 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=201.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++|++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999875 68999999876542 334578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 634 (832)
||+++|+|.+++.... .+++.++..++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999886543 68999999999999999999999 99999999999999976 4559999999998764
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.. .......||+.|+|||++. ..++.++|||||||++|||++|++||......+..... ..+...
T Consensus 191 ~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~----- 255 (494)
T 3lij_A 191 NQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------EKGKYT----- 255 (494)
T ss_dssp TT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCC-----
T ss_pred CC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCC-----
Confidence 32 2234456999999999986 56899999999999999999999999876544322111 111100
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.........+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 256 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 -FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000112345679999999999999999999999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=360.40 Aligned_cols=242 Identities=16% Similarity=0.173 Sum_probs=192.5
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCC---CCcccHHHHHHHHH---HHHhCCCcceeeEE-------EE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNP---QSEQGITEFQTEIQ---MLSKLRHRHLVSLI-------GY 546 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~f~~Ei~---~L~~l~HpnIv~l~-------~~ 546 (832)
.++|++.+.||+|+||.||+|.. .+|+.||||++.. ......+.|.+|++ +|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999986 4699999999763 34455688999995 55555899999998 66
Q ss_pred eccCC-----------------cEEEEEEecCCCChhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 047569 547 CDENS-----------------EMILVYEYMSNGPFRDHLYGKN-----LPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604 (832)
Q Consensus 547 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~i 604 (832)
+.+.+ ..+|||||+ +|+|.+++.... ...+++..++.++.|+++||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 65553 288999999 689999996432 1234468888999999999999999 999
Q ss_pred eeccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCccccChhccccC-----------CCCccccEEechhH
Q 047569 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVV 673 (832)
Q Consensus 605 vHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV~SlGvv 673 (832)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999998642 23345567 999999999887 89999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 674 LLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 674 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+|||++|+.||....... ....+... ....+..+.+++.+||+.||.+||++.|+++.
T Consensus 303 l~elltg~~Pf~~~~~~~---------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------C---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCccccccc---------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999996543211 11111111 12345679999999999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.23 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=203.2
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 58999999886543 34678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999998632 2368999999999999999999999 999999999999999999999999999997654322
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ..... .+. .
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~-----~~~--~ 245 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------IPTNP-----PPT--F 245 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSC-----CCC--C
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------HhcCC-----Ccc--c
Confidence 223345689999999999999999999999999999999999999976544322111 00100 111 1
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223456789999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.59 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=205.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---------cccHHHHHHHHHHHHhCC-CcceeeEEEEecc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---------EQGITEFQTEIQMLSKLR-HRHLVSLIGYCDE 549 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~ 549 (832)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999875 68999999876542 123467889999999996 9999999999999
Q ss_pred CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccc
Q 047569 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGL 629 (832)
Q Consensus 550 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 629 (832)
.+..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999654 368999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccCccccChhccc------cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
+....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........... .
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~- 241 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM------I- 241 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H-
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH------H-
Confidence 98754322 234456899999999985 45688999999999999999999999976543322111 1
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+. ...........+..+.+++.+||+.||.+||++.|+++
T Consensus 242 ~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCC------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 01111112346678999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=370.59 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=210.9
Q ss_pred HhcCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
..++|++.+.||+|+||.||+|.+. .+..||+|++... .....++|.+|+.+|++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 3577999999999999999999764 2467999997754 34445789999999999999999999999854 5689
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999997543 368999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
...........+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+..... ..+.
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-------~~~~------ 609 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGE------ 609 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HHTC------
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcCC------
Confidence 433333334557889999999999999999999999999999997 99999876543322111 1110
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
....++.++..+.+++.+||+.||.+||++.++++.|+.+++.+
T Consensus 610 ---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11233456678999999999999999999999999999887643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=350.62 Aligned_cols=262 Identities=21% Similarity=0.222 Sum_probs=205.3
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC--------CcceeeEEEEec---
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR--------HRHLVSLIGYCD--- 548 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~--------HpnIv~l~~~~~--- 548 (832)
.++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999764 6899999998643 344677899999999985 888999999987
Q ss_pred -cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeCCCC------
Q 047569 549 -ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLDDNY------ 620 (832)
Q Consensus 549 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~------ 620 (832)
+....++||||+ +++|.+.+.......+++.+++.++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 567899999999 6777777766555679999999999999999999999 7 999999999999999775
Q ss_pred -------------------------------------------ceEEecccccccCCCCCCceeeccccCccccChhccc
Q 047569 621 -------------------------------------------VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657 (832)
Q Consensus 621 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 657 (832)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999875422 23456899999999999
Q ss_pred cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh---hHHHHHHHHhhh--------cc-cccccCC----------C
Q 047569 658 RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV---NLAEWAMQWKRK--------GL-LEKIIDP----------H 715 (832)
Q Consensus 658 ~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~---~l~~~~~~~~~~--------~~-~~~i~d~----------~ 715 (832)
+..++.++|||||||+||||++|+.||......... ............ +. ....... .
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999765432211 111111111000 00 0000000 0
Q ss_pred C---------CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 716 L---------VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 716 l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01234567788999999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.37 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=189.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-ccc-HHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQG-ITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~-~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ... .+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999999999999874 78999999987542 222 333455555678889999999999999999999999
Q ss_pred EecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
||++ ++|.+++.. .....+++..++.++.|++.||+|||+ + +++||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777743 233579999999999999999999999 7 99999999999999999999999999997654
Q ss_pred CCCCceeeccccCccccChhcc----ccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.||......... +. .....
T Consensus 162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~----~~~~~----- 229 (290)
T 3fme_A 162 DD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LK----QVVEE----- 229 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HH----HHHHS-----
T ss_pred cc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HH----HHhcc-----
Confidence 32 222334699999999996 5667899999999999999999999999754322111 11 11111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
..........+..+.+++.+||+.||.+|||+.|+++.-
T Consensus 230 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 230 ----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp ----CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred ----CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 111112234567899999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=351.25 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=187.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccC------C
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN------S 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~------~ 551 (832)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+++|++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999754 6899999998654 334567889999999999999999999998653 6
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 7899998854 369999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+................+..
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 6432 2334579999999999877 6889999999999999999999999987765444332211100000000000
Q ss_pred cc--------C--CCCCC----CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 711 II--------D--PHLVG----TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 711 i~--------d--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+. . +.... ...+..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 0 00000 001234567899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=343.30 Aligned_cols=263 Identities=20% Similarity=0.250 Sum_probs=195.4
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC------
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS------ 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~------ 551 (832)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999765 6899999987653 3445677899999999999999999999987654
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
..++||||++ ++|.+.+.. .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999997 578888742 48899999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH-------------
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW------------- 698 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~------------- 698 (832)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......
T Consensus 176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 65422 223445799999999999999999999999999999999999999987654432211100
Q ss_pred ---HHHHhhhc------ccccccCCCCCCC---CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 699 ---AMQWKRKG------LLEKIIDPHLVGT---INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 699 ---~~~~~~~~------~~~~i~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
........ ............. .....+..+.+++.+||+.||.+|||+.|+++.-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00000000 0000000000000 0112367899999999999999999999997543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=360.93 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=203.9
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-------------cccHHHHHHHHHHHHhCCCcceeeEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-------------EQGITEFQTEIQMLSKLRHRHLVSLIG 545 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-------------~~~~~~f~~Ei~~L~~l~HpnIv~l~~ 545 (832)
..++|++.+.||+|+||+||+|... +++.||+|++.... ....+++.+|+++|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999875 58899999876432 134578999999999999999999999
Q ss_pred EeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC---ce
Q 047569 546 YCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY---VA 622 (832)
Q Consensus 546 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~ 622 (832)
++.+....++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999886543 69999999999999999999999 9999999999999998775 69
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~ 702 (832)
||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|+|++|++||......+......
T Consensus 189 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----- 260 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE----- 260 (504)
T ss_dssp EECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred EEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 99999999876432 2234456999999999986 468999999999999999999999998765443222111
Q ss_pred hhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 703 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.+... .........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 261 --~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 --KGKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp --HCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --cCCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11100 0000002345679999999999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=346.80 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=204.3
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----CcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN-----SEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~-----~~~ 553 (832)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+++|++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467999999999999999999765 68899999987543 34457899999999999999999999998654 478
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||++ ++|.+++... .+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 5999988653 58999999999999999999999 99999999999999999999999999999866
Q ss_pred CCCCCce--eeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc----
Q 047569 634 PIGQGHV--STAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG---- 706 (832)
Q Consensus 634 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---- 706 (832)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||......+...............
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 4322111 234579999999998754 558999999999999999999999998776554432221100000000
Q ss_pred --------ccccccCCCC--CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 707 --------LLEKIIDPHL--VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 707 --------~~~~i~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+.. .....+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 00011334567999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=343.86 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=198.3
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC--------cccHHHHHHHHHHHHhCCCcceeeEEEEeccC
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS--------EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN 550 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~ 550 (832)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999765 58999999876532 12234588999999999999999999998765
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc---eEEecc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV---AKVSDF 627 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DF 627 (832)
. .++||||+++++|.+++... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 89999999999999998644 478999999999999999999999 99999999999999987654 999999
Q ss_pred cccccCCCCCCceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
|+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +.... .
T Consensus 162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~ 233 (322)
T 2ycf_A 162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----T 233 (322)
T ss_dssp TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH----H
T ss_pred ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH----H
Confidence 999875422 2233456999999999974 56789999999999999999999999976433211 11111 1
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+... .........+..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11100 000011234568999999999999999999999984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=351.21 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=199.6
Q ss_pred HHHhcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc-------
Q 047569 478 QEATKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE------- 549 (832)
Q Consensus 478 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~------- 549 (832)
....++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999976 4799999998764432 23479999999999999999999833
Q ss_pred -------------------------------CCcEEEEEEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 047569 550 -------------------------------NSEMILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYL 596 (832)
Q Consensus 550 -------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yL 596 (832)
....++||||++ ++|.+.+.. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 587777643 2334799999999999999999999
Q ss_pred hcCCCCCeeeccCCCCceeeC-CCCceEEecccccccCCCCCCceeeccccCccccChhccccC-CCCccccEEechhHH
Q 047569 597 HTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVL 674 (832)
Q Consensus 597 H~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl 674 (832)
|+ ++|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99 9999999999999998 68899999999998764322 23445689999999998765 589999999999999
Q ss_pred HHHhhCCCCCCCCChhhhhhHHHHHHH------Hhhh-cccccccCCCC-----CCCCChhHHHHHHHHHHHhhhcCCCC
Q 047569 675 LEVLCARPAINPQLPREQVNLAEWAMQ------WKRK-GLLEKIIDPHL-----VGTINPESLKKFAEAAEKCLADHGVD 742 (832)
Q Consensus 675 ~elltG~~pf~~~~~~~~~~l~~~~~~------~~~~-~~~~~i~d~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~ 742 (832)
|||++|++||......+.......... +... ....+..-+.. ...++...+..+.+++.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999987765543322111000 0000 00000000111 01123345677999999999999999
Q ss_pred CCCHHHHHHH
Q 047569 743 RPTMGDVLWN 752 (832)
Q Consensus 743 RPt~~evl~~ 752 (832)
|||+.|+++.
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999843
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=372.78 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=205.9
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~ 554 (832)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|.++|..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999865 6889999987643 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
|||||+++|+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999997543 69999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.. ........||+.|+|||++.+..++.++|||||||+||||++|++||......+... .++..
T Consensus 494 ~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~---------------~i~~~ 557 (674)
T 3pfq_A 494 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---------------SIMEH 557 (674)
T ss_dssp CT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHSS
T ss_pred cC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHhC
Confidence 22 223455679999999999999999999999999999999999999998765432211 11111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
.+ .++...+.++.+++.+||+.||.+||++
T Consensus 558 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 558 NV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CC--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11 2344567789999999999999999997
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=340.52 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=204.8
Q ss_pred HhcCCCccceEeecCceeEEEEEE--eCCcEEEEEecCCCC--cccHHHHHHHHHHHHhC---CCcceeeEEEEec----
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEI--DDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKL---RHRHLVSLIGYCD---- 548 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l---~HpnIv~l~~~~~---- 548 (832)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 368899999875321 22223566777777766 8999999999986
Q ss_pred -cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecc
Q 047569 549 -ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDF 627 (832)
Q Consensus 549 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 627 (832)
.....++||||++ ++|.+++.......+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678899999997 699999977665679999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc
Q 047569 628 GLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707 (832)
Q Consensus 628 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 707 (832)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+................
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 998765421 223445689999999999999999999999999999999999999987654433221110000000000
Q ss_pred ccc-------cc---CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 LEK-------II---DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 ~~~-------i~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
+.. .. .......+.+..+..+.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00 000011223445678999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=335.21 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=201.6
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEecc--CCcEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDE--NSEMILV 556 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~--~~~~~lV 556 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .+.+.+|+++|++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999976 478999999987433 467899999999997 9999999999987 6778999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccccccCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAPI 635 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 635 (832)
|||+++++|.+++. .+++.++..++.|+++||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999884 38899999999999999999999 9999999999999999776 899999999986543
Q ss_pred CCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc-------
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL------- 707 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~------- 707 (832)
.. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .+............
T Consensus 184 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHT
T ss_pred CC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHh
Confidence 22 2334568999999999877 6789999999999999999999999955433211 11111110000000
Q ss_pred -------ccccc--------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 -------LEKII--------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 -------~~~i~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+. ............+..+.+++.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000111112335678999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=344.11 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=206.0
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCc-----------------ccHHHHHHHHHHHHhCCCcceeeE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE-----------------QGITEFQTEIQMLSKLRHRHLVSL 543 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------------~~~~~f~~Ei~~L~~l~HpnIv~l 543 (832)
.++|++.+.||+|+||.||+|.. +++.||||++..... ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999988 899999998654311 112789999999999999999999
Q ss_pred EEEeccCCcEEEEEEecCCCChhhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 544 IGYCDENSEMILVYEYMSNGPFRDH------LYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 544 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ .++++||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999999 655445689999999999999999999996 37899999999999999
Q ss_pred CCCceEEecccccccCCCCCCceeeccccCccccChhccccC-CCCc-cccEEechhHHHHHhhCCCCCCCCChhhhhhH
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTE-KSDVYSFGVVLLEVLCARPAINPQLPREQVNL 695 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l 695 (832)
.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||........ .
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE--L 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--H
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--H
Confidence 9999999999999875322 33456799999999999877 6666 99999999999999999999986544211 1
Q ss_pred HHHHHHHhhhcccccccC------C---CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIID------P---HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d------~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.. . ...+......+ + ..........+..+.+++.+||+.||.+||++.|+++
T Consensus 262 ~~---~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FN---N-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH---H-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH---H-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 1 11111100000 0 0000011345678999999999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.77 Aligned_cols=261 Identities=25% Similarity=0.297 Sum_probs=196.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc------CCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE------NSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~------~~~~~ 554 (832)
.+|++.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+++|++++||||+++++++.. ...++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999875 689999998764432 23579999999999999999998843 22367
Q ss_pred EEEEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-CceEEecccccc
Q 047569 555 LVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-YVAKVSDFGLSK 631 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~ 631 (832)
+||||+++ +|.+.+.. .....+++..+..++.||++||+|||+ ++|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 66665532 233479999999999999999999999 999999999999999955 678999999998
Q ss_pred cCCCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH------HHhh
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM------QWKR 704 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~------~~~~ 704 (832)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|++||......+......... .+..
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 754322 23345689999999998764 79999999999999999999999998765544322211110 0000
Q ss_pred -hcccccccCCCCCC-----CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 705 -KGLLEKIIDPHLVG-----TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 705 -~~~~~~i~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.....+..-+.+.. .+.+..+.++.+|+.+||+.||.+||++.|+++.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00001111111110 1223456789999999999999999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=340.59 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=198.7
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEec-----------
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD----------- 548 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~----------- 548 (832)
.++|++.+.||+|+||.||+|... +++.||+|++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367899999999999999999876 58999999988777777888999999999999999999999873
Q ss_pred ---cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCceEE
Q 047569 549 ---ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKV 624 (832)
Q Consensus 549 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl 624 (832)
+....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+ ++++||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 699999853 368999999999999999999999 9999999999999997 5679999
Q ss_pred ecccccccCCCCCC--ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 625 SDFGLSKDAPIGQG--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 625 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
+|||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+..........
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999986542211 12234457999999998865 6789999999999999999999999987654332221110000
Q ss_pred Hhhhccccc------------ccCCCC-CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 702 WKRKGLLEK------------IIDPHL-VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 702 ~~~~~~~~~------------i~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
........+ ...+.. .....+..+..+.+++.+||+.||.+||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000000 000000 001113356789999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=349.78 Aligned_cols=254 Identities=11% Similarity=0.055 Sum_probs=185.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc---ccHHHHHHHHHHHHhC--CCcceeeEE-------EEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE---QGITEFQTEIQMLSKL--RHRHLVSLI-------GYCD 548 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~f~~Ei~~L~~l--~HpnIv~l~-------~~~~ 548 (832)
.+|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+++++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999865 789999999876542 3456678886555555 699988865 4443
Q ss_pred cC-----------------CcEEEEEEecCCCChhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCee
Q 047569 549 EN-----------------SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQR------LEISIGSARGLHYLHTGTAQGII 605 (832)
Q Consensus 549 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------l~i~~~ia~~L~yLH~~~~~~iv 605 (832)
.. ...+|||||++ ++|.+++...+. .+.+..+ +.++.|+++||+|||+ ++|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence 22 33899999998 899999965321 2344555 7888999999999999 9999
Q ss_pred eccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCC
Q 047569 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPA 683 (832)
Q Consensus 606 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~p 683 (832)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986532 2224557799999999987 7899999999999999999999999
Q ss_pred CCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 684 INPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 684 f~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
|....+...... ..................+..+..+.+++.+||+.||++|||+.++++.
T Consensus 293 f~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 293 FGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 976643211100 0000011111111112223567889999999999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=336.45 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=203.8
Q ss_pred CHHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCC--CcceeeEEEEec
Q 047569 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLR--HRHLVSLIGYCD 548 (832)
Q Consensus 473 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~--HpnIv~l~~~~~ 548 (832)
.++.+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ ||||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 333444456789999999999999999999888999999987543 3455678999999999997 599999999999
Q ss_pred cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 549 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
+.+..++||| +.+++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+|||+++ +.+||+|||
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecc
Confidence 9999999999 56899999997553 68999999999999999999999 89999999999999975 799999999
Q ss_pred ccccCCCCCC-ceeeccccCccccChhcccc-----------CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHH
Q 047569 629 LSKDAPIGQG-HVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLA 696 (832)
Q Consensus 629 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~ 696 (832)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--- 248 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--- 248 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH---
Confidence 9986543221 12234568999999999875 47888999999999999999999999754322110
Q ss_pred HHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 697 EWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 697 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
+..+.++.....++...+..+.+++.+||+.||.+||++.|+++..
T Consensus 249 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 249 -----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp -----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 0111222222233334456899999999999999999999998643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.69 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=200.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc-----
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE----- 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~----- 552 (832)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+|++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357889999999999999999865 6899999998654 33445778999999999999999999999977654
Q ss_pred -EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 553 -MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 553 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
.++||||++ ++|.+++.. .+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688888732 48999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc----
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG---- 706 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---- 706 (832)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...............
T Consensus 175 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 6432 2234568999999999877 678999999999999999999999998765443322111000000000
Q ss_pred --------ccccccC--CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 707 --------LLEKIID--PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 707 --------~~~~i~d--~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+..+.. ........+..+..+.+++.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 00011223456788999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=341.86 Aligned_cols=206 Identities=25% Similarity=0.284 Sum_probs=177.1
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-Cc-----ceeeEEEEeccCCc
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HR-----HLVSLIGYCDENSE 552 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-Hp-----nIv~l~~~~~~~~~ 552 (832)
..++|++.+.||+|+||.||+|... +++.||||++... .....++..|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999765 6889999998743 344567888999998885 44 59999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC--CCCceEEeccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD--DNYVAKVSDFGLS 630 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla 630 (832)
.++||||++ ++|.+++.......+++..+..++.|++.||+|||.. ..+|+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5999999876656799999999999999999999941 27899999999999995 5788999999999
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhh
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ 692 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~ 692 (832)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+.
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 876422 2345689999999999999999999999999999999999999987765443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.43 Aligned_cols=270 Identities=20% Similarity=0.266 Sum_probs=193.6
Q ss_pred HHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc-
Q 047569 475 QELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE- 552 (832)
Q Consensus 475 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~- 552 (832)
.+.....++|++.+.||+|+||.||+|... +|+.||||++.... ....++.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999875 68999999875432 223466788889999999999999999855333
Q ss_pred ------EEEEEEecCCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeeccCCCCceeeCC-CCc
Q 047569 553 ------MILVYEYMSNGPFRDHLYG--KNLPPLSWKQRLEISIGSARGLHYLH--TGTAQGIIHRDVKSTNILLDD-NYV 621 (832)
Q Consensus 553 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~~L~yLH--~~~~~~ivHrDlkp~NILl~~-~~~ 621 (832)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence 7899999976 55444321 33447899999999999999999999 7 89999999999999996 899
Q ss_pred eEEecccccccCCCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH
Q 047569 622 AKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM 700 (832)
Q Consensus 622 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~ 700 (832)
+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||................
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999998765322 23445689999999998665 48999999999999999999999998766544332211110
Q ss_pred HHhhhcccccc---------cCC------CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 701 QWKRKGLLEKI---------IDP------HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 701 ~~~~~~~~~~i---------~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+..+ .+. ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000 000 0011122335778999999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=342.15 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=202.1
Q ss_pred HhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
..++|++.+.||+|+||.||+|.... .+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35788999999999999999998753 5999987654 2334466889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC-
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG- 636 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~- 636 (832)
||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999996543 468999999999999999999999 9999999999999998 679999999997754311
Q ss_pred ---CCceeeccccCccccChhcccc---------CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 637 ---QGHVSTAVKGSFGYLDPEYFRR---------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 637 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... . ..
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~-~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW------Q-MG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH------H-HH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-hc
Confidence 1112233458999999999874 457899999999999999999999997665432211 1 11
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.+. .+.. .....+..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 257 ~~~-----~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 257 TGM-----KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TTC-----CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred cCC-----CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1111 1123445689999999999999999999999998876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.28 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=196.2
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC------cEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS------EMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~------~~~l 555 (832)
.+|++.+.||+|+||.||+|+...+..+|+|++...... ..+|+++|+.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 568999999999999999999877777999976543321 247999999999999999999985433 3789
Q ss_pred EEEecCCCChhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCceEEecccccccC
Q 047569 556 VYEYMSNGPFRDHLY-GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDA 633 (832)
Q Consensus 556 V~E~~~~gsL~~~l~-~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~ 633 (832)
||||++++.+..... ......+++..+..++.|+++||+|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998654443332 1223478999999999999999999999 9999999999999999 7999999999999876
Q ss_pred CCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc----cc
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG----LL 708 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~----~~ 708 (832)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||.+....+............... ..
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 4332 23345689999999998764 58999999999999999999999998776544332211110000000 00
Q ss_pred ccccCCCC--------CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKIIDPHL--------VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+ ...+.+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00001000 01122335678999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.99 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=199.7
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE----
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM---- 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~---- 553 (832)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999765 6899999998754 334467889999999999999999999999877655
Q ss_pred --EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 554 --ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 554 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
++||||+. ++|.+++. ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 68888873 248999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc----
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG---- 706 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---- 706 (832)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...............
T Consensus 193 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 193 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 6532 2334568999999999987 789999999999999999999999998765443322111000000000
Q ss_pred --------ccccccCCCCCC---CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 707 --------LLEKIIDPHLVG---TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 707 --------~~~~i~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+. ..... ...+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLP-QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSC-CCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccC-CCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000 00000 011234678999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=337.60 Aligned_cols=262 Identities=20% Similarity=0.269 Sum_probs=205.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CC-cEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc------eeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DG-TKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH------LVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn------Iv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999864 34 78999998643 344577889999999997766 9999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee----------------
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL---------------- 616 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl---------------- 616 (832)
.++||||+ +++|.+++.......+++.+++.++.||++||+|||+ ++|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 6778787766655679999999999999999999999 899999999999999
Q ss_pred ---CCCCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh
Q 047569 617 ---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693 (832)
Q Consensus 617 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~ 693 (832)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5678999999999986432 223456999999999999999999999999999999999999999876654433
Q ss_pred hHHHHHHH-----Hhhhcccccc---------------------cCC-CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCH
Q 047569 694 NLAEWAMQ-----WKRKGLLEKI---------------------IDP-HLVGTINPESLKKFAEAAEKCLADHGVDRPTM 746 (832)
Q Consensus 694 ~l~~~~~~-----~~~~~~~~~i---------------------~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 746 (832)
........ +......... ..+ ..........+..+.+++.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 22221110 0000000000 000 00001223456789999999999999999999
Q ss_pred HHHHH
Q 047569 747 GDVLW 751 (832)
Q Consensus 747 ~evl~ 751 (832)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=328.09 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=205.5
Q ss_pred HHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 479 EATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 479 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
...++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999876 6899999987543 33456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC---CceEEeccccccc
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN---YVAKVSDFGLSKD 632 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~ 632 (832)
||||+++++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+||+++.+ +.+||+|||++..
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999999886543 68999999999999999999999 999999999999999754 4799999999986
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
..... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+... . ...+...
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~--- 240 (287)
T 2wei_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------R-VETGKYA--- 240 (287)
T ss_dssp BCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHCCCC---
T ss_pred ecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHcCCCC---
Confidence 54322 2234458999999999875 48999999999999999999999998764432211 1 1111100
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
... ......+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 241 -~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 -FDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -CCS--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -CCc--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000 0012345679999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=339.78 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=202.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccC-----CcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDEN-----SEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~-----~~~ 553 (832)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....++.+|+++|++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999875 68999999987543 34456788999999999999999999988654 778
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccC
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
++||||+. ++|.+++... .+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6899988653 58999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCc---------eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHh
Q 047569 634 PIGQGH---------VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 634 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||............. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF---GII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---HHh
Confidence 422111 1123468999999998764 778999999999999999999999998765443322111 100
Q ss_pred hhcc----cc--------cccC--CCCC----CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 704 RKGL----LE--------KIID--PHLV----GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 704 ~~~~----~~--------~i~d--~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.... .. +... +... ....+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 00 0000 0000 0011245678899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=331.00 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=195.8
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc---------
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--------- 549 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--------- 549 (832)
..++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999865 789999998853 33456789999999999999999999998754
Q ss_pred ----CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 550 ----NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 550 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
.+..++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++++||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 457899999999999999997543 367889999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCC-------------CceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhh
Q 047569 626 DFGLSKDAPIGQ-------------GHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPRE 691 (832)
Q Consensus 626 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~ 691 (832)
|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh
Confidence 999987654211 1122345689999999999764 78999999999999999998 44321 11
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..... .... . ....+...+....+..+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~---~~~~-~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNIL---KKLR-S------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHH---HHHH-S------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHH---Hhcc-c------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111 1111 0 1122223345566678999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=339.75 Aligned_cols=261 Identities=19% Similarity=0.274 Sum_probs=201.2
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-----------CcceeeEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-----------HRHLVSLIGYCD 548 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-----------HpnIv~l~~~~~ 548 (832)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999986 47899999998743 334567889999999886 899999999987
Q ss_pred cCC----cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeC------
Q 047569 549 ENS----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLD------ 617 (832)
Q Consensus 549 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~------ 617 (832)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||+|||+ + +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 543 789999999 8999999977655679999999999999999999999 7 999999999999994
Q ss_pred CCCceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhh----
Q 047569 618 DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV---- 693 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~---- 693 (832)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999865422 23446899999999999999999999999999999999999999765422111
Q ss_pred hHHHHHHHHhh-------------------hcccccccCCCC---------CCCCChhHHHHHHHHHHHhhhcCCCCCCC
Q 047569 694 NLAEWAMQWKR-------------------KGLLEKIIDPHL---------VGTINPESLKKFAEAAEKCLADHGVDRPT 745 (832)
Q Consensus 694 ~l~~~~~~~~~-------------------~~~~~~i~d~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt 745 (832)
.+.... .... .+....+..... ...++...+..+.+++.+||+.||.+|||
T Consensus 249 ~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 249 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111 0000 000000000000 11245677889999999999999999999
Q ss_pred HHHHHH
Q 047569 746 MGDVLW 751 (832)
Q Consensus 746 ~~evl~ 751 (832)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.99 Aligned_cols=265 Identities=20% Similarity=0.270 Sum_probs=183.2
Q ss_pred cCCCc-cceEeecCceeEEEEEEe---CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEe--ccCCcEEE
Q 047569 482 KNFDS-SAIIGVGGFGNVYLGEID---DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC--DENSEMIL 555 (832)
Q Consensus 482 ~~f~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~--~~~~~~~l 555 (832)
+.|++ .++||+|+||.||+|... +++.||||++..... ...+.+|+++|++++||||+++++++ ......++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44665 558999999999999865 578999999875432 35788999999999999999999999 45778999
Q ss_pred EEEecCCCChhhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee----CCCCceEE
Q 047569 556 VYEYMSNGPFRDHLYG-------KNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL----DDNYVAKV 624 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~-------~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl 624 (832)
||||++ ++|.+++.. .....+++..++.++.||+.||+|||+ ++|+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 578777742 122358999999999999999999999 999999999999999 67889999
Q ss_pred ecccccccCCCCCC--ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhh------hhH
Q 047569 625 SDFGLSKDAPIGQG--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ------VNL 695 (832)
Q Consensus 625 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~------~~l 695 (832)
+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||........ ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999986543211 22344679999999999987 4589999999999999999999999976543210 011
Q ss_pred HHHHHHHhh---hccccccc------------CCCCCCC---------CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 696 AEWAMQWKR---KGLLEKII------------DPHLVGT---------INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 696 ~~~~~~~~~---~~~~~~i~------------d~~l~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
......... ...+..+. ....... ........+.+|+.+||+.||.+|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111101000 00000000 0000000 00111456889999999999999999999874
Q ss_pred H
Q 047569 752 N 752 (832)
Q Consensus 752 ~ 752 (832)
.
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=335.09 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=176.5
Q ss_pred hcCCCccc-eEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc----CCcEE
Q 047569 481 TKNFDSSA-IIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE----NSEMI 554 (832)
Q Consensus 481 ~~~f~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~----~~~~~ 554 (832)
.++|.+.+ +||+|+||.||+|... +++.||||++.... ....+....++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 56788854 6999999999999876 68999999985431 222223334566799999999999865 45589
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEecccccc
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLSK 631 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~ 631 (832)
+||||+++|+|.+++.......+++.+++.++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999987666679999999999999999999999 89999999999999976 4559999999998
Q ss_pred cCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ......
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~------ 247 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRL------ 247 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhc------
Confidence 65422 223456899999999999889999999999999999999999999655332210000 000000
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
.............+..+.+++.+||+.||.+|||+.|+++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000111111234567899999999999999999999998643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.73 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=190.4
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++|+++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998877778999999987542 345688999999986 8999999999999999999999999
Q ss_pred CCCChhhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCC-------------Cce
Q 047569 561 SNGPFRDHLYGKNLPP-----LSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDN-------------YVA 622 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~-----l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~-------------~~~ 622 (832)
. |+|.+++....... ..+..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997554221 1233467899999999999999 999999999999999754 489
Q ss_pred EEecccccccCCCCCCc---eeeccccCccccChhcccc-------CCCCccccEEechhHHHHHhh-CCCCCCCCChhh
Q 047569 623 KVSDFGLSKDAPIGQGH---VSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPRE 691 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~ 691 (832)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 1234579999999999975 678999999999999999999 999997654322
Q ss_pred hhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 692 QVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 692 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ... .+. ...+..........+.++.+++.+||+.||.+||++.++++
T Consensus 248 ~-~i~--------~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S-NII--------RGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H-HHH--------HTC---CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHh--------cCC---CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 110 010 00111112234567789999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.02 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=181.6
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHH-HHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQ-MLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~-~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||.||+|... +|+.||||++.... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999875 68999999886543 334456666666 6777899999999999999999999999
Q ss_pred ecCCCChhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 559 YMSNGPFRDHLYG---KNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 559 ~~~~gsL~~~l~~---~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
|+++ +|.+++.. .....+++..+..++.|+++||.|||+ . +++||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 78777642 234578999999999999999999999 7 99999999999999999999999999997654
Q ss_pred CCCCceeeccccCccccChhcc----ccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........ .+..
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~~ 241 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------------QLTQ 241 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CC
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------------HHHH
Confidence 321 22334689999999998 466789999999999999999999999975422110 0111
Q ss_pred cc---CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 711 II---DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 711 i~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+. .+.+........+..+.+++.+||+.||.+||++.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11 1122222223466789999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=331.63 Aligned_cols=245 Identities=23% Similarity=0.373 Sum_probs=192.9
Q ss_pred HHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc------ccHHHHHHHHHHHHhC----CCcceeeEE
Q 047569 476 ELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE------QGITEFQTEIQMLSKL----RHRHLVSLI 544 (832)
Q Consensus 476 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~f~~Ei~~L~~l----~HpnIv~l~ 544 (832)
+.....++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455688999999999999999999764 689999999865432 1233466799999998 899999999
Q ss_pred EEeccCCcEEEEEEe-cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCce
Q 047569 545 GYCDENSEMILVYEY-MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVA 622 (832)
Q Consensus 545 ~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~ 622 (832)
+++.+.+..++|||+ +.+++|.+++.... .+++.+++.++.|+++||+|||+ ++++||||||+|||++ .++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 78999999996543 68999999999999999999999 8999999999999999 88999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCCC-ccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
||+|||+++..... ......||..|+|||++.+..+. .++|||||||++|||++|+.||..... .
T Consensus 180 kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~------ 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I------ 245 (312)
T ss_dssp EECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------
T ss_pred EEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H------
Confidence 99999999876432 22345689999999999877664 589999999999999999999964210 0
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... ...++...+..+.+++.+||+.+|++||++.|+++
T Consensus 246 -~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 -LEA-----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHT-----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hhh-----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01123445677999999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=339.80 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=190.0
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
..+|++.++||+|+||+||.....+++.||||++...... .+.+|+++|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568889999999999977666668999999998765433 356899999999 799999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-----CCceEEecccccccCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-----NYVAKVSDFGLSKDAP 634 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~ 634 (832)
+. |+|.+++..... .+.+.+++.++.||++||+|||+ ++|+||||||+|||++. ...+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 699999975543 34455677899999999999999 99999999999999953 3368899999998764
Q ss_pred CCCC--ceeeccccCccccChhccc---cCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 635 IGQG--HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 635 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
.... .......||+.|+|||++. ...++.++|||||||++|||++ |++||.......... ....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~--- 244 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGA--- 244 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTC---
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------Hhcc---
Confidence 3221 2234467999999999997 4567889999999999999999 899996543322110 0000
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. .... ..........+.+++.+||+.||.+||++.++++
T Consensus 245 --~-~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 --C-SLDC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --C-CCTT-SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --C-Cccc-cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0000 0112345667899999999999999999999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.89 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=200.3
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc------ccHHHHHHHHHHHHhCC--CcceeeEE
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE------QGITEFQTEIQMLSKLR--HRHLVSLI 544 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~f~~Ei~~L~~l~--HpnIv~l~ 544 (832)
.++.....++|++.+.||+|+||.||+|... +++.||||++..... ...+++.+|++++++++ ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3444555688999999999999999999764 689999998754321 12245778999999996 59999999
Q ss_pred EEeccCCcEEEEEEecCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC-CCCce
Q 047569 545 GYCDENSEMILVYEYMSN-GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVA 622 (832)
Q Consensus 545 ~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~ 622 (832)
+++.+.+..++|||++.+ ++|.+++.... .+++..++.++.|+++||+|||+ ++|+||||||+|||++ +++.+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999999986 89999986543 68999999999999999999999 9999999999999999 78999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~ 701 (832)
||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 190 kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~------ 255 (320)
T 3a99_A 190 KLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I------ 255 (320)
T ss_dssp EECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------
T ss_pred EEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h------
Confidence 99999999876432 2234569999999999987766 6889999999999999999999964210 0
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... . ...+...+..+.+++.+||+.||.+||++.|+++
T Consensus 256 -~~~----~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 -IRG----Q-------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HHC----C-------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hcc----c-------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 0122345567999999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=326.36 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=181.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc-cc-HHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE-QG-ITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~-~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.++|++.+.||+|+||.||+|... +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467889999999999999999875 689999998865432 22 334455556788889999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ-GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
||+ ++.+..++.. ....+++..++.++.|+++||+|||+ + +++||||||+|||++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 4555554432 23468999999999999999999998 6 8999999999999999999999999998765432
Q ss_pred CCceeeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 637 QGHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .. ...... .
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~---~~~~~~-~---- 246 (318)
T 2dyl_A 179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VL---TKVLQE-E---- 246 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HH---HHHHHS-C----
T ss_pred --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HH---HHHhcc-C----
Confidence 2223456899999999984 56788999999999999999999999976432211 11 111111 0
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.+.+ ......+..+.+++.+||+.||.+||++.++++.
T Consensus 247 -~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 -PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111 1112345679999999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.86 Aligned_cols=229 Identities=12% Similarity=0.085 Sum_probs=186.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|... +++.||||++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999875 58999999987653 334578999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||++|++|.+++... ....++.+++.|+++||+|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999432 3566789999999999999999 999999999999999999999998543
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC-
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL- 716 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l- 716 (832)
|++ .++.++|||||||++|||++|+.||.......... ..........
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~~~ 223 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQPI 223 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSCBC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccCCC
Confidence 333 36899999999999999999999998754322110 0000001100
Q ss_pred -CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 717 -VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 717 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.....+..+..+.+++.+||+.||.+| |+.|+++.|+.+..
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 011223456789999999999999999 99999999987754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=355.57 Aligned_cols=241 Identities=20% Similarity=0.298 Sum_probs=196.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe--CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCc-----
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID--DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSE----- 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~----- 552 (832)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+++|++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999875 5899999988654 34456678999999999999999999999987655
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+|||||++|++|.+++.. .+++.+++.++.||++||+|||+ ++|+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987743 68999999999999999999999 999999999999999986 899999999987
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
.... ....||+.|+|||++.+.. +.++|||||||+||||++|.+||...... .+
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------~~- 284 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------GL- 284 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------SC-
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------------cc-
Confidence 5432 3456999999999997654 89999999999999999999887542110 00
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPT-MGDVLWNLEYALQ 758 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~~~~ 758 (832)
.........+..+.+++.+||+.||.+||+ ++++.+.|...+.
T Consensus 285 ---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 285 ---PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000011223467899999999999999995 6666666666543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=341.25 Aligned_cols=241 Identities=16% Similarity=0.161 Sum_probs=183.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCC-ccee---------------
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRH-RHLV--------------- 541 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~H-pnIv--------------- 541 (832)
.+|...+.||+|+||+||+|.+. +|+.||||++.... ....+.|.+|+.+++.++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778899999999999999854 79999999887432 2346789999999999976 2211
Q ss_pred ------eEEEEecc-----CCcEEEEEEecCCCChhhhhc-----cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 047569 542 ------SLIGYCDE-----NSEMILVYEYMSNGPFRDHLY-----GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605 (832)
Q Consensus 542 ------~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~iv 605 (832)
.+..++.. ....+++|+++ +++|.+++. ......+++..++.++.|+++||+|||+ ++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 11111111 23467777766 689998884 2333467888999999999999999999 9999
Q ss_pred eccCCCCceeeCCCCceEEecccccccCCCCCCceeeccccCccccChhcc----------ccCCCCccccEEechhHHH
Q 047569 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYF----------RRQQLTEKSDVYSFGVVLL 675 (832)
Q Consensus 606 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDV~SlGvvl~ 675 (832)
||||||+||||+.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999999886432 2344567 999999999 5566889999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 676 EVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 676 elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
||++|+.||....... ....++.. ....+..+.+++.+||+.||.+||++.++++.
T Consensus 309 elltg~~Pf~~~~~~~---------------~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGS---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhh---------------hHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999997653221 11122111 11345679999999999999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=349.50 Aligned_cols=267 Identities=26% Similarity=0.342 Sum_probs=206.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEecc------CCcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE------NSEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~------~~~~ 553 (832)
++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+++|++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999764 6899999988764 44556789999999999999999999999765 6788
Q ss_pred EEEEEecCCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCc---eEEecccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKN-LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYV---AKVSDFGL 629 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGl 629 (832)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997543 3368899999999999999999999 99999999999999997664 99999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc---
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG--- 706 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~--- 706 (832)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ |........
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC------
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhcccchh
Confidence 98764322 23445799999999999999999999999999999999999999976532211 100000000
Q ss_pred -ccccccC--------CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHH-----HHHHHHHHH
Q 047569 707 -LLEKIID--------PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDV-----LWNLEYALQ 758 (832)
Q Consensus 707 -~~~~i~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev-----l~~L~~~~~ 758 (832)
....... ......+....+..+.+++.+||+.||.+|||+.++ .+.++.++.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000 011223456688999999999999999999999884 455555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=308.10 Aligned_cols=229 Identities=20% Similarity=0.346 Sum_probs=182.4
Q ss_pred hcCCCcc-ceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHH-HhCCCcceeeEEEEecc----CCcE
Q 047569 481 TKNFDSS-AIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQML-SKLRHRHLVSLIGYCDE----NSEM 553 (832)
Q Consensus 481 ~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L-~~l~HpnIv~l~~~~~~----~~~~ 553 (832)
.++|.+. +.||+|+||.||++... +++.||+|++.. ...+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999764 689999999753 24678899988 55689999999999876 6788
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEeccccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLS 630 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla 630 (832)
++||||+++++|.+++.......+++.+++.++.|++.||+|||+ ++++||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999987666679999999999999999999999 99999999999999997 789999999998
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
.... +..++.++|||||||++|||++|+.||........ .......
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~ 213 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTR 213 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHH
Confidence 6532 24467899999999999999999999975432211 0001111
Q ss_pred ccCCCCCCCCC----hhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 047569 711 IIDPHLVGTIN----PESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753 (832)
Q Consensus 711 i~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 753 (832)
+..... ..+ ...+..+.+++.+||+.||.+||++.|+++.-
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 214 IRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp SCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Hhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 111111 111 23567899999999999999999999998543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.44 Aligned_cols=241 Identities=18% Similarity=0.177 Sum_probs=185.0
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--------CcccHHHHHHHHHHHHhCC---------CcceeeE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--------SEQGITEFQTEIQMLSKLR---------HRHLVSL 543 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--------~~~~~~~f~~Ei~~L~~l~---------HpnIv~l 543 (832)
.++|++.+.||+|+||+||+|.. +|+.||||++... .....+.+.+|+++|++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999987 6899999987654 2334578999999999886 6666666
Q ss_pred EEEe-----------------cc-------------CCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 047569 544 IGYC-----------------DE-------------NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGL 593 (832)
Q Consensus 544 ~~~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L 593 (832)
.+.+ .+ .+..+|||||+++|++.+.+.+ ..+++.+++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6643 32 7889999999999987777743 3589999999999999999
Q ss_pred HHHh-cCCCCCeeeccCCCCceeeCCCC--------------------ceEEecccccccCCCCCCceeeccccCccccC
Q 047569 594 HYLH-TGTAQGIIHRDVKSTNILLDDNY--------------------VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652 (832)
Q Consensus 594 ~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 652 (832)
+||| + ++|+||||||+||||+.++ .+||+|||+++.... ....||+.|+|
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTC
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccC
Confidence 9999 8 8999999999999999887 899999999986542 23469999999
Q ss_pred hhccccCCCCccccEEechhH-HHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc-ccCCCCCCCCChhHHHHHHH
Q 047569 653 PEYFRRQQLTEKSDVYSFGVV-LLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK-IIDPHLVGTINPESLKKFAE 730 (832)
Q Consensus 653 PE~~~~~~~~~~sDV~SlGvv-l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~-i~d~~l~~~~~~~~~~~l~~ 730 (832)
||++.+.. +.++|||||+++ .+++++|..||... .|..... ...... ...........+..+.++.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLT-DKMLKQMTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHH-HHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHH-HhhhhhhccCcccchhhhhhcCHHHHH
Confidence 99998776 899999998777 78889999887321 1100000 000100 01111111223467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHH
Q 047569 731 AAEKCLADHGVDRPTMGDVL 750 (832)
Q Consensus 731 li~~cl~~dP~~RPt~~evl 750 (832)
++.+||+.| |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999966 888876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=302.48 Aligned_cols=185 Identities=19% Similarity=0.118 Sum_probs=132.0
Q ss_pred eEeecCceeEEEEE-EeCCcEEEEEecCCC----------CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 489 IIGVGGFGNVYLGE-IDDGTKVAVKRGNPQ----------SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 489 ~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~----------~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
.++.|++|.+..++ .-.|+.+++|.+... .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35677777766654 336899999987543 123456799999999999 699999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||++|++|.++|...+ +++.. +|+.||++||+|||+ +|||||||||+||||+++|.+||+|||+++.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997554 56654 588999999999999 99999999999999999999999999999876432
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPA 683 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~p 683 (832)
.......+||++|||||++.+. +..++|+||+|+++++|.++..+
T Consensus 393 -~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2334556799999999999764 67789999999999988776543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=231.73 Aligned_cols=156 Identities=19% Similarity=0.231 Sum_probs=121.8
Q ss_pred hheeeeecCCCCCCCCCCCCccccccCCCceeccCCCcceeccCCeeecCCCCCCcccchhhHHhhhccCCCCCCCCCcc
Q 047569 196 QYVYRLNMGGPSITPQNDSLGRTWVPDSNFLKEKNLATTASVESNAVQYPDGVTPLIAPATVYSSASMMADSHTVQPNFN 275 (832)
Q Consensus 196 ~~~~r~n~Gg~~~~~~~D~~~R~W~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~ta~~~~~~~~~~~~~~ 275 (832)
++++|+||||..++ |..+|.|.+|..+......... ...+.+ ...+++|+.||||||.+.. +
T Consensus 5 ~~~~~INcGg~~~~---d~~gr~w~~D~~~~~~g~~~~~----~~~~~~---~~~~~~~~~lY~TaR~~~~--------~ 66 (174)
T 2jwp_A 5 KVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRASDY----GMKLPI---LRSNPEDQVLYQTERYNED--------S 66 (174)
T ss_dssp HEEEEEEETSSSEE---ETTTEEECSSCSSTTCCCCCCC----CTTSCC---SSSCHHHHHTTTCCCCCCS--------C
T ss_pred cEEEEEECCCCCcc---CCCCCEEcCCcCcccCCccccc----ccceEe---cccCCCCchhhhhhccCCC--------C
Confidence 56899999999875 6789999999876311111111 011111 1236779999999999664 3
Q ss_pred eeEEeccCCCCceEEEEEeeeeeecccCcEEEEEEEcCeeecccCchhhhhcCcCcceEEEEEEEecc----------cc
Q 047569 276 VTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASL----------MH 345 (832)
Q Consensus 276 ~t~~~~~~~~~~Y~v~LhFae~~~~~~~~R~Fdi~in~~~~~~~~di~~~~~~~~~~~~~d~~~~~~~----------~~ 345 (832)
|+|.+|++++|+|+|||||||+.+.+.++|+|||||||++++++|||+.++++ ..++++++.+.+.. ..
T Consensus 67 ~tY~f~v~~~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~~~~ 145 (174)
T 2jwp_A 67 FGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTF 145 (174)
T ss_dssp EEEEEECCSCEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEEEEC
T ss_pred eEEEEEeCCCeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeeeccc
Confidence 99999999999999999999999888999999999999999999999999976 78999999887521 13
Q ss_pred Cc-eEEEEccCCCCCCCcccccccceeecc
Q 047569 346 NG-LNVQIGPNKENTGTRNAILNGLEVIKM 374 (832)
Q Consensus 346 ~g-l~~s~~~~~~~~~~~~~~lng~ei~~l 374 (832)
+| |+|+|.|.. ...|+||||||++-
T Consensus 146 ~g~L~I~f~p~~----~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 146 TGKLSVEFVKGY----YDNPKVCALFIMKG 171 (174)
T ss_dssp CSEEEEEEECSS----SCSSSEEEEEEESS
T ss_pred CCeEEEEEeccC----CCCcEEEEEEEEeC
Confidence 34 999998641 34899999999974
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=261.34 Aligned_cols=184 Identities=16% Similarity=0.197 Sum_probs=144.7
Q ss_pred CccceEeecCceeEEEEEEeCCcEEEEEecCCCCc--------ccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 485 DSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE--------QGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
...+.||+|+||.||+|.. .++.+++|+...... ...++|.+|+++|++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999944 578899987544321 1245689999999999999999555555566778999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
|||+++++|.+++.. ++.++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999954 56899999999999999 99999999999999999 9999999999976532
Q ss_pred CCce------eeccccCccccChhcccc--CCCCccccEEechhHHHHHhhCCCCC
Q 047569 637 QGHV------STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLLEVLCARPAI 684 (832)
Q Consensus 637 ~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDV~SlGvvl~elltG~~pf 684 (832)
.... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2111 235679999999999987 67888999999999888888887665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.8e-23 Score=217.32 Aligned_cols=154 Identities=16% Similarity=0.102 Sum_probs=123.2
Q ss_pred HHHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCc------------------ccHHHHHHHHHHHHhC
Q 047569 474 FQELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE------------------QGITEFQTEIQMLSKL 535 (832)
Q Consensus 474 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~f~~Ei~~L~~l 535 (832)
+..+......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+++|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444455567778899999999999999887799999999864321 1356789999999999
Q ss_pred CCcceeeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCcee
Q 047569 536 RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNIL 615 (832)
Q Consensus 536 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NIL 615 (832)
+| +++.+++.. +..++||||++|++|.+ +.. .+...++.|+++||+|||+ ++|+||||||+|||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NIL 225 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL 225 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEE
Confidence 94 555554433 56699999999999998 521 2345799999999999999 99999999999999
Q ss_pred eCCCCceEEecccccccCCCCCCceeeccccCccccChhcccc
Q 047569 616 LDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658 (832)
Q Consensus 616 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 658 (832)
++ ++.+||+|||+++. +..++|||++.+
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99 99999999999864 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=182.05 Aligned_cols=137 Identities=18% Similarity=0.176 Sum_probs=107.4
Q ss_pred CCCccceEeecCceeEEEEEE-eCCcE--EEEEecCCCCcc------------------------cHHHHHHHHHHHHhC
Q 047569 483 NFDSSAIIGVGGFGNVYLGEI-DDGTK--VAVKRGNPQSEQ------------------------GITEFQTEIQMLSKL 535 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~f~~Ei~~L~~l 535 (832)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367789999999999999987 68989 999986543111 113688999999999
Q ss_pred CCcce--eeEEEEeccCCcEEEEEEecCC-C----ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeec
Q 047569 536 RHRHL--VSLIGYCDENSEMILVYEYMSN-G----PFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH-TGTAQGIIHR 607 (832)
Q Consensus 536 ~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH-~~~~~~ivHr 607 (832)
+|+++ ..++++ +..+|||||+.+ | +|.++... .++.++..++.|++.+|.||| + .+|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence 88753 445543 356899999942 4 66665432 224467789999999999999 8 899999
Q ss_pred cCCCCceeeCCCCceEEecccccccC
Q 047569 608 DVKSTNILLDDNYVAKVSDFGLSKDA 633 (832)
Q Consensus 608 Dlkp~NILl~~~~~~kl~DFGla~~~ 633 (832)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.8e-16 Score=172.12 Aligned_cols=136 Identities=15% Similarity=0.179 Sum_probs=100.2
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCc--------------ccHHH--------HHHHHHHHHhCCCcc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE--------------QGITE--------FQTEIQMLSKLRHRH 539 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~~--------f~~Ei~~L~~l~Hpn 539 (832)
.-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.+|.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999988999999997653210 01111 234666666664433
Q ss_pred e--eeEEEEeccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 540 L--VSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 540 I--v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
+ ...+++. ..+|||||++|++|.++... .....++.|++.+|.+||+ .+||||||||.|||++
T Consensus 175 v~vp~p~~~~----~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS----RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE----TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred CCCCeeeecc----CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEe
Confidence 3 2233322 23799999999998776521 1235678999999999999 8999999999999998
Q ss_pred CCC----------ceEEeccccccc
Q 047569 618 DNY----------VAKVSDFGLSKD 632 (832)
Q Consensus 618 ~~~----------~~kl~DFGla~~ 632 (832)
+++ .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 776 389999997654
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=135.81 Aligned_cols=130 Identities=14% Similarity=0.184 Sum_probs=81.9
Q ss_pred CcEEEccCCCCCCCCCCCCceeccCCCCccccccCcc----ccccCCCC-CCCCcccccccccCCCeEEEeeccCCceEE
Q 047569 34 DNFLIDCGGKSSNPLPDGRTFKSDKEALPFLQTKEDI----QVSVPSAD-VPSPIYLSARVFKEESTYTFQLNQPGWHWV 108 (832)
Q Consensus 34 ~~~~i~CG~~~~~~~~~~~~~~~~~~~~~~~~~g~~~----~~~~~~~~-~~~~~~~t~R~f~~~~~~cy~l~~~g~~~v 108 (832)
..|+||||++.. ++.++|+|.+|. .|...|... .+...... .++++|+|+|+||...+|.+++...|.|+|
T Consensus 6 ~~~~INcGg~~~-~d~~gr~w~~D~---~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~V 81 (174)
T 2jwp_A 6 VIWAVNAGGESH-VDVHGIHYRKDP---LEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVL 81 (174)
T ss_dssp EEEEEEETSSSE-EETTTEEECSSC---SSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEE
T ss_pred EEEEEECCCCCc-cCCCCCEEcCCc---CcccCCcccccccceEecccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEE
Confidence 479999998654 357899999993 332122111 11111111 123479999999987777777643465559
Q ss_pred EEEeecCCCCcccccceeeeee------------------cCceEEEEEEee-------------cCCeEEEEEEeCCCC
Q 047569 109 RLHFFALPAKEADLQKASFHVA------------------TDNCCEEFMLNL-------------TESTFSIKFTPMKNS 157 (832)
Q Consensus 109 R~~ff~~~~~~~~~~~~~~~~~------------------~~~~~~E~i~~~-------------~~~~~~vc~~~~~~~ 157 (832)
||||.++.+.. .....|.+. ...+.+|+.+.+ .++.+.|+|.|....
T Consensus 82 rLhF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~ 159 (174)
T 2jwp_A 82 VLKFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYD 159 (174)
T ss_dssp EEEEECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSC
T ss_pred EEEEeccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCC
Confidence 99995444332 111112211 114567887763 567899999987678
Q ss_pred ceeeeeeEEEec
Q 047569 158 VAFINAIEVVSA 169 (832)
Q Consensus 158 ~pFi~~iEl~~~ 169 (832)
.||||||||++.
T Consensus 160 ~a~inaIEI~~~ 171 (174)
T 2jwp_A 160 NPKVCALFIMKG 171 (174)
T ss_dssp SSSEEEEEEESS
T ss_pred CcEEEEEEEEeC
Confidence 999999999986
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=8.4e-12 Score=130.88 Aligned_cols=147 Identities=14% Similarity=0.090 Sum_probs=115.2
Q ss_pred HHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEE
Q 047569 477 LQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 477 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~l 555 (832)
+......|++...++.|+.+.||+.... ++.+++|+..........++.+|+++|+.|. |..+.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4455567888888998999999999754 6899999876421122346889999999995 6778899999988889999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT----------------------------------- 600 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~----------------------------------- 600 (832)
||||++|.+|.+.+.. ..+...++.+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999876421 1223477889999999999811
Q ss_pred ---------------------CCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 601 ---------------------AQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 601 ---------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876566799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=5.4e-11 Score=124.11 Aligned_cols=137 Identities=18% Similarity=0.094 Sum_probs=100.6
Q ss_pred CCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc--eeeEEEEeccCCcEEEEEEec
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH--LVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~ 560 (832)
++.+..+.+.|..+.||+....+|+.+++|..... ....+.+|+++|+.+++.+ +.++++++...+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333345569999998777889999986644 2245788999999986444 556888888888899999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT---------------------------------------- 600 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~---------------------------------------- 600 (832)
+|.+|. ... .. ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 999884 211 11 2356778888888888632
Q ss_pred ---------------CCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 601 ---------------AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 601 ---------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
...++|+|++|.|||+++++.+.|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999997653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.7e-09 Score=118.81 Aligned_cols=142 Identities=18% Similarity=0.240 Sum_probs=108.4
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecC--CCC-cccHHHHHHHHHHHHhCC--CcceeeEEEEeccC---CcEEEEE
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGN--PQS-EQGITEFQTEIQMLSKLR--HRHLVSLIGYCDEN---SEMILVY 557 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~f~~Ei~~L~~l~--HpnIv~l~~~~~~~---~~~~lV~ 557 (832)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++|+.|. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4677899999999999875 4678888865 322 122456889999999997 45688999998776 4589999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT------------------------------------- 600 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~------------------------------------- 600 (832)
||++|.++.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998875422 234778888999999999999999721
Q ss_pred ------------------CCCeeeccCCCCceeeCCCCc--eEEeccccccc
Q 047569 601 ------------------AQGIIHRDVKSTNILLDDNYV--AKVSDFGLSKD 632 (832)
Q Consensus 601 ------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 632 (832)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=7.8e-10 Score=118.61 Aligned_cols=186 Identities=18% Similarity=0.199 Sum_probs=123.7
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-Ccc--eeeEEEEeccCC---cEEEEEEec
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRH--LVSLIGYCDENS---EMILVYEYM 560 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~~ 560 (832)
.+.++.|....||+.. ..+++|+... ......+.+|.++|+.+. +.. +.+++..+...+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 5679999999999873 5688998542 234567899999999883 322 455666554433 348899999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT---------------------------------------- 600 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~---------------------------------------- 600 (832)
+|.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9998875432 24677788888888888888888611
Q ss_pred ---------------CCCeeeccCCCCceeeCC--CCceEEecccccccCCCCCCceee-------------ccccCccc
Q 047569 601 ---------------AQGIIHRDVKSTNILLDD--NYVAKVSDFGLSKDAPIGQGHVST-------------AVKGSFGY 650 (832)
Q Consensus 601 ---------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~-------------~~~gt~~y 650 (832)
...++|+|+++.||++++ +..+.|+||+.+............ ......+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 135899999999999998 556789999987653211000000 00000011
Q ss_pred cC-hhccccCCCCccccEEechhHHHHHhhCCCCC
Q 047569 651 LD-PEYFRRQQLTEKSDVYSFGVVLLEVLCARPAI 684 (832)
Q Consensus 651 ~a-PE~~~~~~~~~~sDV~SlGvvl~elltG~~pf 684 (832)
.. |+..... ....+.|+++.++|++.+|.++|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 12 2222111 22368999999999999998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.7e-06 Score=92.62 Aligned_cols=136 Identities=17% Similarity=0.155 Sum_probs=97.2
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc---ceeeEEEEec-cCCcEEEEEEecCC
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR---HLVSLIGYCD-ENSEMILVYEYMSN 562 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~~ 562 (832)
.+.++.|....||+. |+.+++|+.. .......+.+|.++|+.|.+. .+.+++.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 566888888899988 6778888842 233456789999999999642 3567777764 45668899999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG------------------------------------------- 599 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~------------------------------------------- 599 (832)
.+|.+.... .++..+...++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763211 234555556666666666666642
Q ss_pred --------------CCCCeeeccCCCCceeeCC---CCc-eEEeccccccc
Q 047569 600 --------------TAQGIIHRDVKSTNILLDD---NYV-AKVSDFGLSKD 632 (832)
Q Consensus 600 --------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DFGla~~ 632 (832)
....++|+|+++.|||++. ++. ..|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.4e-06 Score=91.26 Aligned_cols=136 Identities=18% Similarity=0.125 Sum_probs=97.1
Q ss_pred ceEeecCce-eEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEEEecCCCC
Q 047569 488 AIIGVGGFG-NVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 488 ~~LG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
+.+..|..+ .||+.... ++..+++|+... ....++.+|...|+.|. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556655 68988665 467899998542 23467889999999885 3346788999988899999999999988
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 047569 565 FRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG--------------------------------------------- 599 (832)
Q Consensus 565 L~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~--------------------------------------------- 599 (832)
+.+..... ......++.++++.|..||..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87655321 122334556666666666641
Q ss_pred ----------CCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 600 ----------TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 600 ----------~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
....++|+|+++.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 011379999999999999877777999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.4e-06 Score=95.37 Aligned_cols=81 Identities=5% Similarity=-0.006 Sum_probs=57.5
Q ss_pred cceE-eecCceeEEEEEEe-------CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCC-C--cceeeEEEEeccC--
Q 047569 487 SAII-GVGGFGNVYLGEID-------DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLR-H--RHLVSLIGYCDEN-- 550 (832)
Q Consensus 487 ~~~L-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~-H--pnIv~l~~~~~~~-- 550 (832)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+++|+.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 77888999998764 26789999865432 101245788999998884 3 3567888887665
Q ss_pred -CcEEEEEEecCCCChhh
Q 047569 551 -SEMILVYEYMSNGPFRD 567 (832)
Q Consensus 551 -~~~~lV~E~~~~gsL~~ 567 (832)
+..++|||+++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 45789999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.3e-05 Score=86.90 Aligned_cols=75 Identities=16% Similarity=0.114 Sum_probs=50.8
Q ss_pred cceEeecCceeEEEEEEe-CCcEEEEEecCCCCc-------ccHHHHHHHHHHHHhCCC--c-ceeeEEEEeccCCcEEE
Q 047569 487 SAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE-------QGITEFQTEIQMLSKLRH--R-HLVSLIGYCDENSEMIL 555 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~f~~Ei~~L~~l~H--p-nIv~l~~~~~~~~~~~l 555 (832)
.+.||.|.++.||++... +++.++||...+... ....++..|.++|+.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 567899999999999754 468899997543211 223567889999988742 3 345666553 345689
Q ss_pred EEEecCCC
Q 047569 556 VYEYMSNG 563 (832)
Q Consensus 556 V~E~~~~g 563 (832)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00011 Score=77.60 Aligned_cols=79 Identities=22% Similarity=0.186 Sum_probs=60.1
Q ss_pred CCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-C--cceeeEEEEeccCCcEEEEEEe
Q 047569 483 NFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-H--RHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-H--pnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.....+.+|.|..+.||+.+..+|+.+++|+...........|..|++.|+.|. . --+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 445577899999999999999999999999876554444567889999999884 2 2345666653 23789999
Q ss_pred cCCCCh
Q 047569 560 MSNGPF 565 (832)
Q Consensus 560 ~~~gsL 565 (832)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00011 Score=78.44 Aligned_cols=138 Identities=16% Similarity=0.159 Sum_probs=93.0
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC---CcceeeEEEEeccCCcEEEEEEecCC
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR---HRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
..+.|+.|....+|+... +++.+++|+... .....|..|.+.|+.|. ...+.+++.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356789999999999976 467888998543 23567899999999884 36788899988888889999999998
Q ss_pred CChhh-----------hhccCCC-C-------------------CCCHHHHH---HHHH----------------HHHHH
Q 047569 563 GPFRD-----------HLYGKNL-P-------------------PLSWKQRL---EISI----------------GSARG 592 (832)
Q Consensus 563 gsL~~-----------~l~~~~~-~-------------------~l~~~~~l---~i~~----------------~ia~~ 592 (832)
.++.. .|+.... . .-+|.... ++.. .+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86521 1122111 0 12454322 1111 11111
Q ss_pred H-HHHhc-CCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 593 L-HYLHT-GTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 593 L-~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
+ ..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 23421 1236799999999999999887 8899974
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0001 Score=79.52 Aligned_cols=140 Identities=20% Similarity=0.237 Sum_probs=80.1
Q ss_pred ceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-----CcceeeEE-E--EeccCCcEEEEEEe
Q 047569 488 AIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-----HRHLVSLI-G--YCDENSEMILVYEY 559 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-----HpnIv~l~-~--~~~~~~~~~lV~E~ 559 (832)
+.|+.|..+.||+....+| .+++|+.... ..++..|.++++.|. .|.++... + +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4465567889999987654 5899987652 234445666666553 34444311 0 11235678999999
Q ss_pred cCCCChh-----------h---hhcc--CCC--C--------CCCHHHHH------------------------------
Q 047569 560 MSNGPFR-----------D---HLYG--KNL--P--------PLSWKQRL------------------------------ 583 (832)
Q Consensus 560 ~~~gsL~-----------~---~l~~--~~~--~--------~l~~~~~l------------------------------ 583 (832)
++|.++. + .++. ... + ...|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 1111 100 0 11232210
Q ss_pred -HHHHHHHHHHHHHhc----------CCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 584 -EISIGSARGLHYLHT----------GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 584 -~i~~~ia~~L~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+..++.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123345666652 1247899999999999998888899999997643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00025 Score=79.22 Aligned_cols=74 Identities=14% Similarity=0.198 Sum_probs=47.3
Q ss_pred ccceEeecCceeEEEEEEeCCcEEEEEecCCC------C-c--ccHHHHHHHHHHHHh-CCCcceeeEEEEeccCCcEEE
Q 047569 486 SSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ------S-E--QGITEFQTEIQMLSK-LRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~------~-~--~~~~~f~~Ei~~L~~-l~HpnIv~l~~~~~~~~~~~l 555 (832)
..+.||.|..+.||+... +++.++||...+. . . .....+..|+..+.. ..+..+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356789999999999964 4678999943211 1 1 123344444443322 2345677777776 456799
Q ss_pred EEEec-CC
Q 047569 556 VYEYM-SN 562 (832)
Q Consensus 556 V~E~~-~~ 562 (832)
|||++ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0003 Score=75.34 Aligned_cols=157 Identities=13% Similarity=0.166 Sum_probs=88.8
Q ss_pred cCHHHHHHHhcCCCc-----cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc--eeeEE
Q 047569 472 FSFQELQEATKNFDS-----SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH--LVSLI 544 (832)
Q Consensus 472 ~~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn--Iv~l~ 544 (832)
++.+++.....+|.+ .+.|+.|....+|+....+| .+++|+..... ...++..|+++++.|.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 556777777777765 23456677789999987655 68899876521 1234566777777774212 23333
Q ss_pred EE------eccCCcEEEEEEecCCCChhh--------------hhcc--CC--CC---CC---CHHHHHHH---------
Q 047569 545 GY------CDENSEMILVYEYMSNGPFRD--------------HLYG--KN--LP---PL---SWKQRLEI--------- 585 (832)
Q Consensus 545 ~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~--~~--~~---~l---~~~~~l~i--------- 585 (832)
.. ....+..+++++|++|..+.. .++. .. .. .. .|...+.-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112356789999999865421 0111 01 00 01 12221110
Q ss_pred ---HHHHHHHHHHHhc----CCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 586 ---SIGSARGLHYLHT----GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 586 ---~~~ia~~L~yLH~----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
...+.+.++.++. ..+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0113444555543 124579999999999999987656899998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0011 Score=71.20 Aligned_cols=142 Identities=14% Similarity=0.094 Sum_probs=75.3
Q ss_pred cceEeecCcee-EEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-C-cceeeEEEEeccCCcEEEEEEecCCC
Q 047569 487 SAIIGVGGFGN-VYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-H-RHLVSLIGYCDENSEMILVYEYMSNG 563 (832)
Q Consensus 487 ~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-H-pnIv~l~~~~~~~~~~~lV~E~~~~g 563 (832)
.+.|+.|+... +|+....+++.+++|....... .++..|+++++.|. + -.+.+++.+..+.+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34565555444 6677654467788887554321 23455677777663 2 23566777655444 7899999776
Q ss_pred Chhhhhcc---------------------C---CCCCCCHHHHH-------H-------------HHHHHHHHHHHHh--
Q 047569 564 PFRDHLYG---------------------K---NLPPLSWKQRL-------E-------------ISIGSARGLHYLH-- 597 (832)
Q Consensus 564 sL~~~l~~---------------------~---~~~~l~~~~~l-------~-------------i~~~ia~~L~yLH-- 597 (832)
.+.+++.. . ..+.++..... . ....+.+.++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66543321 1 01112211100 0 0001111222221
Q ss_pred -cCCCCCeeeccCCCCceeeCCC----CceEEecccccccC
Q 047569 598 -TGTAQGIIHRDVKSTNILLDDN----YVAKVSDFGLSKDA 633 (832)
Q Consensus 598 -~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~ 633 (832)
......++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224679999999999999874 68999999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00081 Score=75.22 Aligned_cols=73 Identities=19% Similarity=0.210 Sum_probs=51.0
Q ss_pred cceEeecCceeEEEEEEeC--------CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc-eeeEEEEeccCCcEEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDD--------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH-LVSLIGYCDENSEMILVY 557 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 557 (832)
.+.|+.|-...+|+....+ ++.+++|+..... ....+.+|..+++.|...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567778889999998753 5789999874321 1245668999998885333 3677776653 3899
Q ss_pred EecCCCCh
Q 047569 558 EYMSNGPF 565 (832)
Q Consensus 558 E~~~~gsL 565 (832)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0029 Score=67.65 Aligned_cols=157 Identities=13% Similarity=0.120 Sum_probs=89.3
Q ss_pred cCHHHHHHHhcCCCc-----cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCc--ceeeEE
Q 047569 472 FSFQELQEATKNFDS-----SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR--HLVSLI 544 (832)
Q Consensus 472 ~~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hp--nIv~l~ 544 (832)
++.+++..+...|.+ ...|+ |....||+....+|+.+++|...... ....++..|..+++.|... .+.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344555544444432 34566 78889999877778889999976432 2345677788888887421 234444
Q ss_pred EE-----eccCCcEEEEEEecCCCChhh-----------h---hcc----CC---CCCCCHHHH----------------
Q 047569 545 GY-----CDENSEMILVYEYMSNGPFRD-----------H---LYG----KN---LPPLSWKQR---------------- 582 (832)
Q Consensus 545 ~~-----~~~~~~~~lV~E~~~~gsL~~-----------~---l~~----~~---~~~l~~~~~---------------- 582 (832)
.. ....+..+++||+++|.++.. . ++. .. ....++...
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 112456688999998865421 0 110 00 112222211
Q ss_pred ------HHHHHHHHHHHHHHhc-CCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 583 ------LEISIGSARGLHYLHT-GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 583 ------l~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
...+..+++.++-+.. ..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0111112222222211 1246789999999999999 4 899999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0015 Score=73.54 Aligned_cols=74 Identities=14% Similarity=0.111 Sum_probs=49.1
Q ss_pred cceEeecCceeEEEEEEeC-CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcce-eeEEEEeccCCcEEEEEEecCCCC
Q 047569 487 SAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL-VSLIGYCDENSEMILVYEYMSNGP 564 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gs 564 (832)
.+.|+.|-...+|+....+ ++.+++|+......... .-.+|..+|+.|...++ .++++.+.. .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4568878889999998764 57889998654332211 12578999998864444 577777742 35999999865
Q ss_pred h
Q 047569 565 F 565 (832)
Q Consensus 565 L 565 (832)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00076 Score=71.50 Aligned_cols=71 Identities=8% Similarity=0.015 Sum_probs=45.6
Q ss_pred cceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcce-eeEEEEeccCCcEEEEEEec-CCCC
Q 047569 487 SAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL-VSLIGYCDENSEMILVYEYM-SNGP 564 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~~gs 564 (832)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+...++ .++++++.+ .-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 678988999999998 668888866532221 123568888877742222 466665433 347899999 6655
Q ss_pred h
Q 047569 565 F 565 (832)
Q Consensus 565 L 565 (832)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0026 Score=69.64 Aligned_cols=141 Identities=16% Similarity=0.148 Sum_probs=85.3
Q ss_pred cceEeecCceeEEEEEEe--------CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEE
Q 047569 487 SAIIGVGGFGNVYLGEID--------DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.+.|..|-...+|+.... +++.+++|+.... ........+|.++++.|. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345666777889998764 2578999986432 234566778999998884 3334677777764 2999
Q ss_pred EecCCCChhhh-----------------hccCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 047569 558 EYMSNGPFRDH-----------------LYGKN---LPPLS--WKQRLEISIGSAR-------------------GLHYL 596 (832)
Q Consensus 558 E~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~l~i~~~ia~-------------------~L~yL 596 (832)
||++|.+|..- |+... ..... +.++.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665321 11111 11122 4455555444321 22333
Q ss_pred h----c-CCCCCeeeccCCCCceeeCCC----CceEEeccccccc
Q 047569 597 H----T-GTAQGIIHRDVKSTNILLDDN----YVAKVSDFGLSKD 632 (832)
Q Consensus 597 H----~-~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 632 (832)
. . ..+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 223569999999999999876 7899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0019 Score=70.60 Aligned_cols=74 Identities=11% Similarity=0.145 Sum_probs=45.6
Q ss_pred cceEeecCceeEEEEEEeC---------CcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc-eeeEEEEeccCCcEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDD---------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH-LVSLIGYCDENSEMILV 556 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV 556 (832)
.+.|+.|....+|+....+ ++.+++|+....... ......|.++++.|...+ ..++++... -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 4567777788999997654 268889986543222 122467888888875223 446665542 2789
Q ss_pred EEecCCCCh
Q 047569 557 YEYMSNGPF 565 (832)
Q Consensus 557 ~E~~~~gsL 565 (832)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0038 Score=61.85 Aligned_cols=101 Identities=14% Similarity=0.082 Sum_probs=65.8
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCceee
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 642 (832)
-+|.+.|...+ .++++.+++.++.|.++.|.-+-.. ..-..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 37888886544 4899999999999999998776211 1111333457999999999998774 2111
Q ss_pred ccccCccccChhccccCCCCccccEEechhHHHHHhhCC
Q 047569 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR 681 (832)
Q Consensus 643 ~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~ 681 (832)
.....+.+||... ...+.+.=|||||++||.-+--.
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0122356788663 45578889999999999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.01 Score=63.98 Aligned_cols=64 Identities=9% Similarity=0.113 Sum_probs=42.1
Q ss_pred ceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC---CcceeeEEEE------eccCCcEEEEEEecCCCCh
Q 047569 495 FGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR---HRHLVSLIGY------CDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 495 fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~---HpnIv~l~~~------~~~~~~~~lV~E~~~~gsL 565 (832)
...||+....+| .+++|+...... ..|+.+++.|. -|++.+.+.. ....+..+++|+|++|..+
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 578999987777 899998654331 35666666553 2224444432 2235678999999998766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.48 E-value=0.069 Score=59.20 Aligned_cols=74 Identities=11% Similarity=0.102 Sum_probs=49.0
Q ss_pred cceEeecCceeEEEEEEeC--------CcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDD--------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~ 557 (832)
.+.|..|-...+|+....+ ++.+++|+......... .-.+|.++++.|. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567667778899997653 58899998655432221 2357888888874 333456665443 27899
Q ss_pred EecCCCCh
Q 047569 558 EYMSNGPF 565 (832)
Q Consensus 558 E~~~~gsL 565 (832)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.74 E-value=0.012 Score=42.20 Aligned_cols=29 Identities=7% Similarity=-0.032 Sum_probs=13.7
Q ss_pred CEEEeehhHHHHHHHHHHheeeeeeeccc
Q 047569 399 PVVAVGFAVMFGAFVGLGAMVIKWHKRPQ 427 (832)
Q Consensus 399 ~vii~~~~~~~~~~v~l~~~~~~~~~r~~ 427 (832)
.|++++++++++++++++++++++|||++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 34444444444444444444555555443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.22 E-value=0.39 Score=52.69 Aligned_cols=30 Identities=30% Similarity=0.361 Sum_probs=24.9
Q ss_pred CeeeccCCCCceee------CCCCceEEeccccccc
Q 047569 603 GIIHRDVKSTNILL------DDNYVAKVSDFGLSKD 632 (832)
Q Consensus 603 ~ivHrDlkp~NILl------~~~~~~kl~DFGla~~ 632 (832)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999987754
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.82 E-value=0.012 Score=41.96 Aligned_cols=28 Identities=7% Similarity=-0.026 Sum_probs=12.4
Q ss_pred EEEeehhHHHHHHHHHHheeeeeeeccc
Q 047569 400 VVAVGFAVMFGAFVGLGAMVIKWHKRPQ 427 (832)
Q Consensus 400 vii~~~~~~~~~~v~l~~~~~~~~~r~~ 427 (832)
+++++++++++++++++.+++++|||++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3333444344444444444455554433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 832 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 5e-73
Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 20/269 (7%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
IG G FG VY G+ V + + Q + F+ E+ +L K RH +++ +GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
++ +V ++ HL+ + ++I+ +A+G+ YLH + IIHRD+
Sbjct: 76 P-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDL 130
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQ---LTEKS 665
KS NI L ++ K+ DFGL+ G H + GS ++ PE R Q + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 666 DVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESL 725
DVY+FG+VL E++ + P +N + + +G L + +
Sbjct: 191 DVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLSK-----VRSNCP 239
Query: 726 KKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
K +CL +RP +L ++E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 3e-68
Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 20/265 (7%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
+G G FG V++G + TKVAVK Q F E ++ +L+H+ LV L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 550 NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDV 609
+ ++ EYM NG D L + L+ + L+++ A G+ ++ + IHRD+
Sbjct: 80 E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 610 KSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 669
++ NIL+ D K++DFGL++ + K + PE T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 670 FGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFA 729
FG++L E++ P + +V +Q +G +++ P PE L +
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEV------IQNLERGY--RMVRPDNC----PEELYQL- 242
Query: 730 EAAEKCLADHGVDRPTMGDVLWNLE 754
C + DRPT + LE
Sbjct: 243 --MRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 4e-67
Identities = 69/288 (23%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE 549
IG G FG V+ G+ G +VAVK + + E+ + EI LRH +++ I ++
Sbjct: 11 IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNK 68
Query: 550 N----SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH-----TGT 600
+ +++ LV +Y +G D+L ++ + +++++ +A GL +LH T
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTA---VKGSFGYLDPEYFR 657
I HRD+KS NIL+ N ++D GL+ + A G+ Y+ PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 658 RQ------QLTEKSDVYSFGVVLLEVLCARPAINP----QLPREQVNLAEWAMQWKRKGL 707
+ +++D+Y+ G+V E+ QLP + ++ +++ RK +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 708 LEKIIDPHLVGTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
E+ + P++ + E+L+ A+ +C +G R T + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-66
Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 20/273 (7%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
K+ +G G FG V G+ VA+K S EF E +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L G C + + ++ EYM+NG ++L +Q LE+ + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+ +HRD+ + N L++D V KVSDFGLS+ + S K + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 662 TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721
+ KSD+++FGV++ E+ ++P E+ +E A + ++ PHL
Sbjct: 179 SSKSDIWAFGVLMWEIYSLG-----KMPYERFTNSETAEHIAQG---LRLYRPHLA---- 226
Query: 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
E + C + +RPT +L N+
Sbjct: 227 SEKVYTI---MYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (558), Expect = 9e-66
Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 20/287 (6%)
Query: 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQM 531
++ + + + +G G +G VY G VAVK + + + EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 532 LSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR 591
+ +++H +LV L+G C ++ E+M+ G D+L N +S L ++ +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
+ YL + IHRD+ + N L+ +N++ KV+DFGLS+ K +
Sbjct: 127 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
PE + + KSDV++FGV+L E+ + P + Q + ++
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYEL 228
Query: 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
++ +K E C + DRP+ ++ E Q
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-65
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 23/281 (8%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
IG G FG V+LG + KVA+K +F E +++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L G C E + + LV+E+M +G D+ + + L + + G+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+IHRD+ + N L+ +N V KVSDFG+++ Q ST K + PE F +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 662 TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721
+ KSDV+SFGV++ EV +V ++ G ++ P L
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTGF--RLYKPRLA---- 227
Query: 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEA 762
+ + C + DRP +L L ++ E+
Sbjct: 228 STHVYQI---MNHCWKERPEDRPAFSRLLRQLA---EIAES 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 7e-65
Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 26/275 (9%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
K IG G FG+V LG+ G KVAVK + F E ++++LRH +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 542 SLIGYC-DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
L+G +E + +V EYM+ G D+L + L L+ S+ + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQ 660
+HRD+ + N+L+ ++ VAKVSDFGL+K+A K + PE R ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKK 176
Query: 661 LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720
+ KSDV+SFG++L E+ ++P ++ L + + ++ ++
Sbjct: 177 FSTKSDVWSFGILLWEIYSFG-----RVPYPRIPLKDVVPRVEKGYKMD--APDGC---- 225
Query: 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEY 755
P ++ + + C RP+ + LE+
Sbjct: 226 -PPAVYEV---MKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 8e-65
Identities = 68/305 (22%), Positives = 125/305 (40%), Gaps = 37/305 (12%)
Query: 472 FSFQELQEATKNFDSSA---------IIGVGGFGNVYLGEI----DDGTKVAVKRGNPQ- 517
F+F++ EA + F +IG G FG V G + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 518 SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPL 577
+E+ +F +E ++ + H +++ L G +++ ++++ E+M NG D +N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 578 SWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637
+ Q + + G A G+ YL +HRD+ + NIL++ N V KVSDFGLS+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 638 GHV----STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV 693
+ K + PE + ++ T SDV+S+G+V+ EV+ + P +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237
Query: 694 NLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNL 753
+ I+ + + C RP G ++ L
Sbjct: 238 TNQDVINA----------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 754 EYALQ 758
+ ++
Sbjct: 288 DKMIR 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-63
Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 20/273 (7%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
++ +G G FG V++G + T+VA+K P F E Q++ KLRH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
L E + +V EYMS G D L G+ L Q ++++ A G+ Y+
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 602 QGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL 661
+HRD+++ NIL+ +N V KV+DFGL++ + K + PE +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 662 TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTIN 721
T KSDV+SFG++L E+ P + +V ++
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPCP 236
Query: 722 PESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
PE + + +C +RPT + LE
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-62
Identities = 61/303 (20%), Positives = 121/303 (39%), Gaps = 36/303 (11%)
Query: 477 LQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGI-TEFQTEIQMLSK 534
++ +F+ + +G G G V+ G +A K + + + I + E+Q+L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 535 LRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLH 594
++V G + E+ + E+M G L + + ++SI +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPE 654
YL I+HRDVK +NIL++ K+ DFG+S ++ + G+ Y+ PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 173
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ---------------------- 692
+ + +SD++S G+ L+E+ R I P +E
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 693 -VNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAA----EKCLADHGVDRPTMG 747
L+ + M + + +++D + F+ KCL + +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 748 DVL 750
++
Sbjct: 294 QLM 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 9e-62
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 27/287 (9%)
Query: 475 QELQEATKNFDSSAI-IGVGGFGNVYLGEI---DDGTKVAVKRGNPQSEQGITE-FQTEI 529
++L N + I +G G FG+V G VA+K +E+ TE E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 530 QMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGS 589
Q++ +L + ++V LIG C + ++LV E GP L GK + E+
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQV 118
Query: 590 ARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH--VSTAVKGS 647
+ G+ YL + +HRD+ + N+LL + + AK+SDFGLSK + +A K
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 648 FGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL 707
+ PE ++ + +SDV+S+GV + E L Q P +++ E ++
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG-----QKPYKKMKGPEVMAFIEQGKR 230
Query: 708 LEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
+E PE + C DRP V +
Sbjct: 231 ME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 27/287 (9%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDDGT-----KVAVKRGNPQ-SEQGITEFQTEIQMLSKLR 536
+IG G FG VY G + + VA+K +E+ +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
H +++ L G + M+++ EYM NG L K+ S Q + + G A G+ YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL 126
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG--HVSTAVKGSFGYLDPE 654
+HRD+ + NIL++ N V KVSDFGLS+ + ++ K + PE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 655 YFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714
++ T SDV+SFG+V+ EV+ +L +V K I+
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAIND 228
Query: 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQE 761
+ + +C RP D++ L+ ++ +
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 7e-61
Identities = 70/316 (22%), Positives = 124/316 (39%), Gaps = 48/316 (15%)
Query: 473 SFQELQEATKNFDSSAIIGVGGFGNVYLGE------IDDGTKVAVKRGNPQ-SEQGITEF 525
L+ N + IG G FG V+ + T VAVK + S +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 526 QTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNL----------- 574
Q E ++++ + ++V L+G C M L++EYM+ G + L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 575 -----------PPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAK 623
PPLS ++L I+ A G+ YL + +HRD+ + N L+ +N V K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 624 VSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP 682
++DFGLS++ ++ PE + T +SDV+++GVVL E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 683 AINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVD 742
+ E+V + + D +++ + C + D
Sbjct: 241 QPYYGMAHEEV--------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPAD 285
Query: 743 RPTMGDVLWNLEYALQ 758
RP+ + L+ +
Sbjct: 286 RPSFCSIHRILQRMCE 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 9e-61
Identities = 72/285 (25%), Positives = 132/285 (46%), Gaps = 30/285 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQSEQG-ITEFQTEIQMLSKLRH 537
+F+ +IG G FG VY G + D AVK N ++ G +++F TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 538 RHLVSLIGYC-DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
+++SL+G C ++V YM +G R+ + + P + K + + A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL 146
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG---HVSTAVKGSFGYLDP 653
+ + +HRD+ + N +LD+ + KV+DFGL++D + H T K ++
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 654 EYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713
E + Q+ T KSDV+SFGV+L E++ P VN + + + +++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQG---RRLLQ 255
Query: 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
P P+ L + KC RP+ +++ +
Sbjct: 256 PEYC----PDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-60
Identities = 64/290 (22%), Positives = 118/290 (40%), Gaps = 41/290 (14%)
Query: 469 GRYFSFQELQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQ--SEQGITEF 525
GR+ F IG G F VY G + +VA + ++ F
Sbjct: 8 GRFLKFDI------------EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 55
Query: 526 QTEIQMLSKLRHRHLVSLIGYC----DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQ 581
+ E +ML L+H ++V ++LV E M++G + +L K + K
Sbjct: 56 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKV 113
Query: 582 RLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLSKDAPIGQGHV 640
+GL +LHT T IIHRD+K NI + K+ D GL+ + +
Sbjct: 114 LRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASF 169
Query: 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM 700
+ AV G+ ++ PE + ++ E DVY+FG+ +LE+ + ++
Sbjct: 170 AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP--------------YSE 214
Query: 701 QWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ ++ + + ++ + E E C+ + +R ++ D+L
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 60/267 (22%), Positives = 111/267 (41%), Gaps = 25/267 (9%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG VY + + A K + +SE+ + ++ EI +L+ H ++V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
+ + ++ E+ + G + PL+ Q + + L+YLH IIHRD
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRD 135
Query: 609 VKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYF-----RRQQLTE 663
+K+ NIL + K++DFG+S + G+ ++ PE + +
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194
Query: 664 KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723
K+DV+S G+ L+E+ P P ++N ++ +
Sbjct: 195 KADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRW-----SS 243
Query: 724 SLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ K F +KCL + R T +L
Sbjct: 244 NFKDF---LKKCLEKNVDARWTTSQLL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 25/279 (8%)
Query: 489 IIGVGGFGNVYLGEI----DDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRHLVSL 543
IG G FG+V+ G + VA+K + + E F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 544 IGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG 603
IG EN + ++ E + G R L + + + L YL + +
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTE 663
+HRD+ + N+L+ N K+ DFGLS+ + ++ K ++ PE ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 664 KSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPE 723
SDV+ FGV + E+L + P + V + + + L + P+ P
Sbjct: 189 ASDVWMFGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGERLP--MPPNC-----PP 236
Query: 724 SLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEA 762
+L KC A RP ++ L L+ ++A
Sbjct: 237 TLYSL---MTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-59
Identities = 79/313 (25%), Positives = 134/313 (42%), Gaps = 39/313 (12%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTK--VAVKRGNPQ-SEQGITEFQTEIQMLSKL-R 536
+ +IG G FG V I DG + A+KR S+ +F E+++L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLP--------------PLSWKQR 582
H ++++L+G C+ + L EY +G D L + LS +Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
L + ARG+ YL + IHRD+ + NIL+ +NYVAK++DFGLS+ T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKT 184
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702
+ ++ E T SDV+S+GV+L E++ P + AE +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELYEKL 239
Query: 703 KRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEA 762
+ LEK ++ + + +C + +RP+ +L +L L+ ++
Sbjct: 240 PQGYRLEKPLNC-------DDEVYDL---MRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 763 FTQGKAEEESQSA 775
+ E+ A
Sbjct: 290 YVNTTLYEKFTYA 302
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 9e-59
Identities = 64/272 (23%), Positives = 105/272 (38%), Gaps = 28/272 (10%)
Query: 490 IGVGGFGNVYLGEIDD---GTKVAVKRGNPQSEQG--ITEFQTEIQMLSKLRHRHLVSLI 544
+G G FG V G VAVK ++ E E ++ +L + ++V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 545 GYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGI 604
G C E +LV E GP +L + K +E+ + G+ YL
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 605 IHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST--AVKGSFGYLDPEYFRRQQLT 662
+HRD+ + N+LL + AK+SDFGLSK + + K + PE + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 663 EKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINP 722
KSDV+SFGV++ E Q P + +E + +++
Sbjct: 189 SKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSE----------VTAMLEKGERMGCPA 233
Query: 723 ESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754
++ + C +RP V L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-58
Identities = 65/295 (22%), Positives = 114/295 (38%), Gaps = 42/295 (14%)
Query: 489 IIGVGGFGNVYLGEI------DDGTKVAVKRGNPQSEQG-ITEFQTEIQMLSKL-RHRHL 540
+G G FG V D VAVK P + +E+++LS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 541 VSLIGYCDENSEMILVYEYMSNGPFRDHLYGK----------------NLPPLSWKQRLE 584
V+L+G C +++ EY G + L K + L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH-VSTA 643
S A+G+ +L + + IHRD+ + NILL + K+ DFGL++D + V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 644 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703
+ ++ PE T +SDV+S+G+ L E+ + P +P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS----------- 255
Query: 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
K+I + + + + C + RPT ++ +E +
Sbjct: 256 ---KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 2e-58
Identities = 72/277 (25%), Positives = 109/277 (39%), Gaps = 32/277 (11%)
Query: 481 TKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKR---GNPQSEQGITEFQTEIQMLSKLR 536
K F IG G FG VY + + VA+K+ QS + + E++ L KLR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 537 HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYL 596
H + + G LV EY K PL + ++ G+ +GL YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131
Query: 597 HTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYF 656
H + +IHRDVK+ NILL + + K+ DFG + + + G+ ++ PE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVI 183
Query: 657 R---RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713
Q K DV+S G+ +E+ +P P +N +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP------PLFNMNAMSALYHIAQNE------S 231
Query: 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
P L E + F + CL DRPT +L
Sbjct: 232 PALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 29/273 (10%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRH 537
++F+ +G G FGNVYL +A+K + + + + E+++ S LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
+++ L GY + + + L+ EY G L + L ++ A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
+ + +IHRD+K N+LL K++DFG S AP + + G+ YL PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIE 177
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717
+ EK D++S GV+ E L +P +E ++ + P V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----------KRISRVEFTFPDFV 227
Query: 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
E + + L + RP + +VL
Sbjct: 228 ----TEGARDL---ISRLLKHNPSQRPMLREVL 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-58
Identities = 63/302 (20%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 483 NFDSSAIIGVGGFGNVYLG------EIDDGTKVAVKRGNPQSEQG-ITEFQTEIQMLSKL 535
N + ++G G FG V + +VAVK +++ +E++M+++L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 536 -RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKN--------------------- 573
H ++V+L+G C + + L++EY G ++L K
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 574 LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDA 633
L L+++ L + A+G+ +L + +HRD+ + N+L+ V K+ DFGL++D
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 634 PIGQGHVS-TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQ 692
+V + ++ PE T KSDV+S+G++L E+ P +P +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 693 VNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752
K+I + ++ + C A RP+ ++
Sbjct: 275 N--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 753 LE 754
L
Sbjct: 321 LG 322
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-57
Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 26/277 (9%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRH 539
+++ IG G +G DG + K + S E +E+ +L +L+H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 540 LVSLIGYC--DENSEMILVYEYMSNGPFRDHL--YGKNLPPLSWKQRLEISIGSARGLHY 595
+V N+ + +V EY G + K L + L + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 596 LH--TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDP 653
H + ++HRD+K N+ LD K+ DFGL++ + A G+ Y+ P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMSP 183
Query: 654 EYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713
E R EKSD++S G +L E+ P P + E A + + I
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP------PFTAFSQKELAGKIREGKFRR--IP 235
Query: 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ L + + L RP++ ++L
Sbjct: 236 YRY-----SDELNEI---ITRMLNLKDYHRPSVEEIL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-57
Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 22/279 (7%)
Query: 473 SFQELQEATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQM 531
S + + K + IG G G VY ++ G +VA+++ N Q + EI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 532 LSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR 591
+ + ++ ++V+ + E+ +V EY++ G D + + Q + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 127
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
L +LH + +IHRD+KS NILL + K++DFG Q ST V G+ ++
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 183
Query: 652 DPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711
PE R+ K D++S G++ +E++ P P N G E
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQ 237
Query: 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
L + F +CL R + ++L
Sbjct: 238 NPEKL-----SAIFRDF---LNRCLDMDVEKRGSAKELL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 71/288 (24%), Positives = 110/288 (38%), Gaps = 31/288 (10%)
Query: 482 KNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSK 534
K+ +G G FG V GE D VAVK P + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 535 LRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLH 594
L HR+L+ L G M +V E G D L ++ A G+
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 125
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH--VSTAVKGSFGYLD 652
YL ++ IHRD+ + N+LL + K+ DFGL + P H + K F +
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712
PE + + + SD + FGV L E+ Q P +N ++ +L KI
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQ---------ILHKID 228
Query: 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760
+ + +C A DRPT + ++ L+ Q
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLEAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-56
Identities = 66/273 (24%), Positives = 104/273 (38%), Gaps = 23/273 (8%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLRHRH 539
+++D +G G +G V L VAVK + + E + EI + L H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V G+ E + L EY S G D + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG-QGHVSTAVKGSFGYLDPEYFRR 658
GI HRD+K N+LLD+ K+SDFGL+ + + + G+ Y+ PE +R
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 659 QQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717
++ E DV+S G+VL +L + Q WK K
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYLNPWKKI-- 232
Query: 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ K L ++ R T+ D+
Sbjct: 233 ----DSAPLAL---LHKILVENPSARITIPDIK 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 58/295 (19%), Positives = 117/295 (39%), Gaps = 27/295 (9%)
Query: 484 FDSSAIIGVGGFGNVYLGE-IDDGT----KVAVKRGNP-QSEQGITEFQTEIQMLSKLRH 537
F ++G G FG VY G I +G VA+K S + E E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
H+ L+G C ++ L+ + M G D++ + + L + A+G++YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE 128
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYF 656
+ ++HRD+ + N+L+ K++DFGL+K + + + K ++ E
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 657 RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716
+ T +SDV+S+GV + E++ +P + + I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGE 230
Query: 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQEAFTQGKAEEE 771
P KC RP +++ + + + + +E
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 185 bits (471), Expect = 8e-53
Identities = 60/271 (22%), Positives = 107/271 (39%), Gaps = 22/271 (8%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
++D +G G FG V+ E G A K E + EIQ +S LRH LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 542 SLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTA 601
+L ++++EM+++YE+MS G + + ++ +S + +E +GL ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE--- 142
Query: 602 QGIIHRDVKSTNILL--DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
+H D+K NI+ + K+ DFGL+ + G+ + PE +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 660 QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719
+ +D++S GV+ +L + E + ++ +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWNMDDSAFSGI--- 252
Query: 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
E K F K L R T+ L
Sbjct: 253 --SEDGKDF---IRKLLLADPNTRMTIHQAL 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-52
Identities = 72/296 (24%), Positives = 133/296 (44%), Gaps = 43/296 (14%)
Query: 489 IIGVGGFGNVYLGE--------IDDGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHR 538
+G G FG V L E + TKVAVK +E+ +++ +E++M+ + +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPP--------------LSWKQRLE 584
++++L+G C ++ + ++ EY S G R++L + P LS K +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
+ ARG+ YL ++ IHRD+ + N+L+ ++ V K++DFGL++D + T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 645 K-GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703
++ PE + T +SDV+SFGV+L E+ + P +P E+
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----------- 245
Query: 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759
L K++ + C RPT ++ +L+ + L
Sbjct: 246 ----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-52
Identities = 65/293 (22%), Positives = 121/293 (41%), Gaps = 34/293 (11%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE------IDDGTKVAVKRGNP-QSEQGITEFQTEIQMLSK 534
+ S +G G FG VY G + T+VA+K N S + EF E ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 535 LRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLY--------GKNLPPLSWKQRLEIS 586
H+V L+G + +++ E M+ G + +L L P S + ++++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 587 IGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-HVSTAVK 645
A G+ YL+ A +HRD+ + N ++ +++ K+ DFG+++D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 646 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705
++ PE + T SDV+SFGVVL E+ L EQV
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------ 244
Query: 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
L +++ L+ E C + RP+ +++ +++ ++
Sbjct: 245 --LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-51
Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 41/294 (13%)
Query: 489 IIGVGGFGNVYLG------EIDDGTKVAVKRGNPQSEQG-ITEFQTEIQMLSKLRHRH-L 540
+G G FG V + VAVK + +E+++L + H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 541 VSLIGYC-DENSEMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEI 585
V+L+G C ++++ E+ G +L K L+ + +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 586 SIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-STAV 644
S A+G+ +L + + IHRD+ + NILL + V K+ DFGL++D +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704
+ ++ PE + T +SDV+SFGV+L E+ P V + E + +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDEEFCRRLK 251
Query: 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
+G + D + + C RPT +++ +L LQ
Sbjct: 252 EGTRMRAPD------YTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (454), Expect = 2e-50
Identities = 58/264 (21%), Positives = 107/264 (40%), Gaps = 22/264 (8%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG V+ E G K N + EI ++++L H L++L +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
+ EM+L+ E++S G D + ++ +S + + + GL ++H I+H D
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 609 VKSTNILLD--DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
+K NI+ + K+ DFGL+ + + + + PE R+ + +D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLK 726
+++ GV+ +L P + E KR + D +++PE K
Sbjct: 211 MWAIGVLGYVLLSGLS------PFAGEDDLETLQNVKRC---DWEFDEDAFSSVSPE-AK 260
Query: 727 KFAEAAEKCLADHGVDRPTMGDVL 750
F + L R T+ D L
Sbjct: 261 DF---IKNLLQKEPRKRLTVHDAL 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 4e-50
Identities = 58/273 (21%), Positives = 108/273 (39%), Gaps = 27/273 (9%)
Query: 483 NFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRHR 538
+F I+G G F V L E+ + A+K + + E + E ++S+L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
V L ++ ++ Y NG ++ + + L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH- 125
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK-DAPIGQGHVSTAVKGSFGYLDPEYFR 657
+GIIHRD+K NILL+++ +++DFG +K +P + + + G+ Y+ PE
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717
+ + SD+++ G ++ +++ P P N + +KII
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP------PFRAGNEYL---------IFQKIIKLEY- 227
Query: 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ K + EK L R ++
Sbjct: 228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (438), Expect = 3e-49
Identities = 73/277 (26%), Positives = 114/277 (41%), Gaps = 29/277 (10%)
Query: 489 IIGVGGFGNVYLGE-IDDGTKVAVKRGNP---QSEQGITEFQTEIQMLSKLRHRHLVSLI 544
I+G GG V+L + VAVK + F+ E Q + L H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 545 GYCDENSE----MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT 600
+ + +V EY+ RD + P++ K+ +E+ + + L++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH--- 128
Query: 601 AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV--STAVKGSFGYLDPEYFRR 658
GIIHRDVK NI++ KV DFG+++ V + AV G+ YL PE R
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 659 QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718
+ +SDVYS G VL EVL P P + A Q R+ + +
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVREDPIPPSARHEGL- 241
Query: 719 TINPESLKKFAEAAEKCLADHGVDRP-TMGDVLWNLE 754
L K LA + +R T ++ +L
Sbjct: 242 ---SADLDAV---VLKALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-49
Identities = 54/331 (16%), Positives = 124/331 (37%), Gaps = 39/331 (11%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCD 548
+G G FG V+ E K + + + EI +L+ RHR+++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFE 71
Query: 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRD 608
E+++++E++S + + + L+ ++ + L +LH + I H D
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 609 VKSTNILLD--DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSD 666
++ NI+ + K+ +FG ++ + G + + Y PE + ++ +D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 667 VYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLK 726
++S G ++ +L + ++ ++E I++ T + E+ K
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQ---------------IIENIMNAEY--TFDEEAFK 228
Query: 727 KFAEAA----EKCLADHGVDRPTMGDVL---W---NLEYALQ--LQEAFTQGKAEEESQS 774
+ + A ++ L R T + L W +E ++ + +
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 775 AATAAASPAAVAAPAATSASDDRPVSAPKEN 805
S A ++ A + V+ K
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGVSVAKVKVA 319
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 2e-47
Identities = 63/282 (22%), Positives = 116/282 (41%), Gaps = 25/282 (8%)
Query: 474 FQELQEATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITE-FQTEIQM 531
+++ ++ +D ++G G F V L E VA+K ++ +G + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 532 LSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR 591
L K++H ++V+L + + L+ + +S G D + K + + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILL---DDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSF 648
+ YLH GI+HRD+K N+L D++ +SDFGLSK G V + G+
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTP 173
Query: 649 GYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708
GY+ PE ++ ++ D +S GV+ +LC P + + + K +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-----FEQILKAEYEF 228
Query: 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ + +S K F + R T L
Sbjct: 229 DSPYWDDI-----SDSAKDF---IRHLMEKDPEKRFTCEQAL 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (423), Expect = 4e-47
Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 37/285 (12%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNP---------QSEQGITEFQTEIQML 532
N++ I+G G V + AVK + + ++ E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 533 SKLR-HRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSAR 591
K+ H +++ L + N+ LV++ M G D+L K LS K+ +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 121
Query: 592 GLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYL 651
+ LH I+HRD+K NILLDD+ K++DFG S + G V G+ YL
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPSYL 176
Query: 652 DPEYFR------RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK 705
PE ++ D++S GV++ +L P P R+Q+ + M +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSGNYQ 233
Query: 706 GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+++K + L R T + L
Sbjct: 234 --FGSPEWDDY-----SDTVKDL---VSRFLVVQPQKRYTAEEAL 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 65/296 (21%), Positives = 115/296 (38%), Gaps = 28/296 (9%)
Query: 477 LQEATKNFDSSAIIGVGGFGNVYLGE--IDDGTKVAVKRGNPQS--EQGITEFQTEIQML 532
L A + ++ A IG G +G V+ + G VA+KR Q+ E E+ +L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 533 SKL---RHRHLVSLIGYC-----DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLE 584
L H ++V L C D +++ LV+E++ +L P + + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKD 120
Query: 585 ISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAV 644
+ RGL +LH+ ++HRD+K NIL+ + K++DFGL++ T+V
Sbjct: 121 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSV 175
Query: 645 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM---- 700
+ Y PE + D++S G + E+ +P +Q+ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 701 --QWKRKGLLEKIIDPHLVGTINPESLKKFAEAA----EKCLADHGVDRPTMGDVL 750
W R L + + + E KCL + R + L
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 3e-45
Identities = 52/280 (18%), Positives = 97/280 (34%), Gaps = 27/280 (9%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC- 547
IG G FG++YLG I G +VA+K +++ + E ++ ++ + I +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E ++V E + + S K L ++ + Y+H ++ IHR
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIHR 127
Query: 608 DVKSTNIL---LDDNYVAKVSDFGLSKDAPIGQGHV------STAVKGSFGYLDPEYFRR 658
DVK N L + + DFGL+K + H + + G+ Y
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 659 QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718
+ + + D+ S G VL+ + E + K +E + +
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY--- 244
Query: 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
P + C + D+P +
Sbjct: 245 ---PSEFATY---LNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 53/283 (18%), Positives = 102/283 (36%), Gaps = 19/283 (6%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRH 539
NF IG G +G VY G VA+K R + ++E + EI +L +L H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
+V L+ +++ LV+E++ + + L + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 600 TAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
+ ++HRD+K N+L++ K++DFGL++ + + V + +
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 660 QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL--------AEWAMQWKRKGLLEKI 711
+ D++S G + E++ R +Q+ E K
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 712 IDPHLVGTINPESLKKFAEAA----EKCLADHGVDRPTMGDVL 750
P + + E + L R + L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-44
Identities = 60/295 (20%), Positives = 112/295 (37%), Gaps = 29/295 (9%)
Query: 479 EATKNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVKRGNPQSEQGITE-FQTEIQMLSKLR 536
+ + + + IG G +G V + + +VA+K+ +P Q + EI++L + R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 537 HRHLVSLIGYCDENS----EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARG 592
H +++ + + + + + ++ L + LS RG
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRG 121
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS--TAVKGSFGY 650
L Y+H+ ++HRD+K +N+LL+ K+ DFGL++ A H T + Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 651 LDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL----------AEWA 699
PE + T+ D++S G +L E+L RP + +Q+N +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 700 MQWKRKGLLEKIIDPHLVGTINPESLKKFAEAA----EKCLADHGVDRPTMGDVL 750
K + PH A +K L + R + L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 2e-44
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 13/217 (5%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRH 537
++F +G G FG V+L +G A+K + + + E MLS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
++ + G + ++ ++ +Y+ G L P + + L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
+ + II+RD+K NILLD N K++DFG +K P V+ + G+ Y+ PE
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVS 174
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVN 694
+ + D +SFG+++ E+L +
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 2e-44
Identities = 59/273 (21%), Positives = 105/273 (38%), Gaps = 30/273 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQ---SEQGITEFQTE---IQMLSKL 535
+F IIG GGFG VY D G A+K + + +QG T E + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 536 RHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHY 595
+V + ++ + + M+ G HL S + GL +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 122
Query: 596 LHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEY 655
+H + +++RD+K NILLD++ ++SD GL+ D + A G+ GY+ PE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 176
Query: 656 FRRQQ-LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714
++ +D +S G +L ++L +++ + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----------V 226
Query: 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMG 747
L + +PE L+ E L R
Sbjct: 227 ELPDSFSPE-LRSL---LEGLLQRDVNRRLGCL 255
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-44
Identities = 50/271 (18%), Positives = 104/271 (38%), Gaps = 28/271 (10%)
Query: 489 IIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGY 546
++G+G G V K A+K + + E+++ + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 547 CD----ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
+ +++V E + G + + + ++ EI + YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 603 GIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQ 659
I HRDVK N+L N + K++DFG +K+ + + Y+ PE +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 660 QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719
+ + D++S GV++ +LC P P + + K + + + P+ +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
E +K L R T+ + +
Sbjct: 243 EVSEEVKML---IRNLLKTEPTQRMTITEFM 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (401), Expect = 4e-44
Identities = 56/275 (20%), Positives = 102/275 (37%), Gaps = 19/275 (6%)
Query: 490 IGVGGFGNVYLGEIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYC 547
IG G +G VY + + G A+K R + E + EI +L +L+H ++V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
++LV+E++ + + L + G+ Y H + ++HR
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 608 DVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 667
D+K N+L++ K++DFGL++ I + + + ++ + D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 668 YSFGVVLLEVLCARPAINPQLPREQVNLAEWAM------QWKRKGLLEKIIDPHLVGTIN 721
+S G + E++ P +Q+ + W L K V
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 722 P--ESLKKFAEAA----EKCLADHGVDRPTMGDVL 750
P LK E+ K L R T L
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 28/275 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSK-LRH 537
+F ++G G FG V+L E A+K + + + E ++LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
L + + V EY++ G H+ ++ + + GL +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
+ +GI++RD+K NILLD + K++DFG+ K+ +G +T G+ Y+ PE
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 176
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717
Q+ D +SFGV+L E+L + P + E + +P
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS------PFHGQDEEELFHSIRMD-------NPFYP 223
Query: 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752
+ E + K R + +
Sbjct: 224 RWLEKE----AKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (397), Expect = 2e-43
Identities = 45/282 (15%), Positives = 91/282 (32%), Gaps = 29/282 (10%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHR-HLVSLIGYC 547
IG G FG ++ G + + +VA+K +S+ + + E + L + ++ +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 548 DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHR 607
E +LV + + GP + L S K + + +H + +++R
Sbjct: 71 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125
Query: 608 DVKSTNILLDDNYV-----AKVSDFGLSKDAPIGQGHV------STAVKGSFGYLDPEYF 656
D+K N L+ V DFG+ K + G+ Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 657 RRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716
++ + + D+ + G V + L E + K+ L ++
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF- 244
Query: 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758
PE K+ P + L+
Sbjct: 245 -----PEEFYKY---MHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-42
Identities = 57/279 (20%), Positives = 104/279 (37%), Gaps = 22/279 (7%)
Query: 489 IIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITE-----FQTEIQMLSKLRHRHLVS 542
+G G F VY + VA+K+ + EI++L +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L+ S + LV+++M + + N L+ + + +GL YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 603 GIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLT 662
I+HRD+K N+LLD+N V K++DFGL+K + V + F +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 663 EKSDVYSFGVVLLEVLCARPAINPQLPREQVNL----------AEWAMQWKRKGLLE-KI 711
D+++ G +L E+L P + +Q+ +W + K
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ I + + + + R T L
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 31/272 (11%)
Query: 490 IGVGGFGNVYLG-EIDDGTKVAVKR------GNPQSEQGITEFQTEIQMLSKLRHRHLVS 542
+G G F V E G + A K + + + + E+ +L +++H ++++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 543 LIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQ 602
L + +++IL+ E ++ G D L K L+ ++ E G++YLH+
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---L 132
Query: 603 GIIHRDVKSTNILLDDNYVA----KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
I H D+K NI+L D V K+ DFGL+ I G+ + G+ ++ PE
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 659 QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718
+ L ++D++S GV+ +L +E A E +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNYEFEDEYFSNT-- 243
Query: 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
K F + L R T+ D L
Sbjct: 244 ---SALAKDF---IRRLLVKDPKKRMTIQDSL 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 64/289 (22%), Positives = 108/289 (37%), Gaps = 29/289 (10%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLV 541
++ + +IG G FG VY + D G VA+K+ E+Q++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 542 SLIGYCDENSE------MILVYEYMSNGPFRDHL-YGKNLPPLSWKQRLEISIGSARGLH 594
L + + E + LV +Y+ +R Y + L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 595 YLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDP 653
Y+H + GI HRD+K N+LLD D V K+ DFG +K G+ +VS + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPE 192
Query: 654 EYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713
F T DV+S G VL E+L +P +Q+ + + + ++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 714 PHLVGTINPESLKKFAEAAEKCLADHGVD------------RPTMGDVL 750
+ + + + R T +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-41
Identities = 55/273 (20%), Positives = 100/273 (36%), Gaps = 41/273 (15%)
Query: 489 IIGVGGFGNVYLG-EIDDGTKVAVKR------GNPQSEQGITEFQTEIQMLSKLRHRH-- 539
++G GGFG+VY G + D VA+K + T E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 540 LVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG 599
++ L+ + + +L+ E + L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN- 128
Query: 600 TAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
G++HRD+K NIL+D + K+ DFG + + V T G+ Y PE+ R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 659 QQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717
+ + V+S G++L +++C P E++ + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQV------------FFRQRV- 227
Query: 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVL 750
+ CLA DRPT ++
Sbjct: 228 ----SSECQHL---IRWCLALRPSDRPTFEEIQ 253
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-40
Identities = 54/285 (18%), Positives = 108/285 (37%), Gaps = 21/285 (7%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHR 538
+ ++ IG G +G V+ + + VA+K R + E + EI +L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
++V L + ++ LV+E+ + + +GL + H+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHS 119
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
+ ++HRD+K N+L++ N K+++FGL++ I S V + F
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 659 QQLTEKSDVYSFGVVLLEVLCARPAINP---------QLPREQVNLAEWAMQWKRKGLLE 709
+ + D++S G + E+ A + P ++ R E K
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 710 KIIDPHLVGTINPESLKKFAEAA----EKCLADHGVDRPTMGDVL 750
K + T + K + L + V R + + L
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 6e-39
Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 35/291 (12%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGY 546
IG G FG V+ G KVA+K+ ++ E EI++L L+H ++V+LI
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 547 CDENSE--------MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
C + + LV+++ + LS +R+ + L+ L+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLYY 132
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG---HVSTAVKGSFGYLDPEY 655
I+HRD+K+ N+L+ + V K++DFGL++ + + + T + Y PE
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 656 FRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNL---------AEWAMQWKRK 705
++ D++ G ++ E+ P + + Q+ L E
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 706 GLLEKIIDPHLVGTINPESLKKFAEAAE------KCLADHGVDRPTMGDVL 750
L EK+ + LK + K L R D L
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-39
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 29/302 (9%)
Query: 472 FSFQELQEATKNFDSS----AIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITE 524
F QE+ + + +G G +G V + G KVA+K QSE
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 525 FQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNL--PPLSWKQR 582
E+++L +RH +++ L+ + + ++ PF GK + L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVST 642
+ +GL Y+H A GIIHRD+K N+ ++++ K+ DFGL++ A ++
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 643 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQW 702
V + + T+ D++S G ++ E++ + +Q+
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 703 KRKGLLEKIID----------PHLVGTINPESLKKFAEAA----EKCLADHGVDRPTMGD 748
++++ P L L + A EK L R T G+
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 749 VL 750
L
Sbjct: 298 AL 299
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 10/205 (4%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK---RGNPQSEQGITEFQTEIQMLSKLRH 537
+FD ++G G FG V L G A+K + ++ + TE ++L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 538 RHLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLH 597
L +L + + V EY + G HL + ++ L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLH 122
Query: 598 TGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFR 657
+ + +++RD+K N++LD + K++DFGL K+ G G+ YL PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLE 178
Query: 658 RQQLTEKSDVYSFGVVLLEVLCARP 682
D + GVV+ E++C R
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 2e-37
Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 16/225 (7%)
Query: 483 NFDSSAIIGVGGFGNVYLGE-IDDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHR 538
FD +G G FG V L + + G A+K + Q + I E ++L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 539 HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHT 598
LV L +NS + +V EY++ G HL S + YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH- 158
Query: 599 GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRR 658
+ +I+RD+K N+L+D +V+DFG +K + + G+ L PE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEIILS 212
Query: 659 QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWK 703
+ + D ++ GV++ E+ P P + + + E + K
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGK 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (332), Expect = 2e-34
Identities = 55/311 (17%), Positives = 117/311 (37%), Gaps = 43/311 (13%)
Query: 470 RYFSFQELQEATKNFDSSAI---IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEF 525
Y+ ++ N D + +G G + V+ I + KV VK P ++ +
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KI 76
Query: 526 QTEIQMLSKLR-HRHLVSLIGYCDENSE--MILVYEYMSNGPFRDHLYGKNLPPLSWKQR 582
+ EI++L LR ++++L + LV+E+++N F+ L+
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDI 131
Query: 583 LEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVS 641
+ L Y H+ GI+HRDVK N+++D ++ ++ D+GL++ G
Sbjct: 132 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEY 186
Query: 642 TAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARP-----------------A 683
S + PE Q+ D++S G +L ++ +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 684 INPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAA----EKCLADH 739
+ + + ++ + + +L + ++ E+ + A +K L
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
Query: 740 GVDRPTMGDVL 750
R T + +
Sbjct: 307 HQSRLTAREAM 317
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 66/277 (23%), Positives = 108/277 (38%), Gaps = 29/277 (10%)
Query: 482 KNFDSSAIIGVGGFGNVYLGE----IDDGTKVAVKRGNP----QSEQGITEFQTEIQMLS 533
+NF+ ++G G +G V+L D G A+K Q + +TE Q+L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 534 KLRHR-HLVSLIGYCDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARG 592
+R LV+L +++ L+ +Y++ G HL + Q I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI--VLA 141
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
L +LH GII+RD+K NILLD N ++DFGLSK+ + + G+ Y+
Sbjct: 142 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 653 PEYFRRQQ--LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710
P+ R + D +S GV++ E+L P + R+ L +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS------PFTVDGEKNSQAEISRRILKSE 252
Query: 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMG 747
P + K ++ L R G
Sbjct: 253 PPYPQEM----SALAKDL---IQRLLMKDPKKRLGCG 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-32
Identities = 62/303 (20%), Positives = 111/303 (36%), Gaps = 44/303 (14%)
Query: 482 KNFDSSAIIGVGGFGNVYLG-EIDDGTKVAVK--RGNPQSEQGITEFQTEIQMLSKLRHR 538
K + + IG G G V + VA+K Q++ E+ ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 539 HLVSLIGYC------DENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARG 592
+++SL+ +E ++ LV E M + L ++ + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCG 131
Query: 593 LHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLD 652
+ +LH + GIIHRD+K +NI++ + K+ DFGL++ G + T + Y
Sbjct: 132 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 186
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARP----------------AINPQLPREQVNLA 696
PE E D++S G ++ E++ + + P L
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 697 EWAMQW-----KRKGLLEKIIDPHLVGTINPESLKKFAEAA----EKCLADHGVDRPTMG 747
+ K GL + P + + E K A A K L R ++
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 748 DVL 750
D L
Sbjct: 307 DAL 309
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-31
Identities = 60/305 (19%), Positives = 109/305 (35%), Gaps = 35/305 (11%)
Query: 472 FSFQELQ----EATKNFDSSAIIGVGGFGNVYLGE-IDDGTKVAVK--RGNPQSEQGITE 524
F QEL E + + + + +G G +G+V G +VAVK QS
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 525 FQTEIQMLSKLRHRHLVSLIGYCDENS-----EMILVYEYMSNGPFRDHLYGKNLPPLSW 579
E+++L ++H +++ L+ + + ++ + + + L+
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTD 120
Query: 580 KQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639
+ RGL Y+H + IIHRD+K +N+ ++++ K+ DFGL A
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTDDE 174
Query: 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWA 699
++ V + + D++S G ++ E+L R +Q+ L
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 700 MQWKRKGLLEKIIDPHLVGTIN----------PESLKKFAEAA----EKCLADHGVDRPT 745
+ LL+KI I A EK L R T
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 746 MGDVL 750
L
Sbjct: 295 AAQAL 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 7e-25
Identities = 37/229 (16%), Positives = 79/229 (34%), Gaps = 20/229 (8%)
Query: 490 IGVGGFGNVYLGE-IDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH----------- 537
+G G F V+L + + + T VA+K + + EI++L ++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 538 RHLVSLIGYCDE---NSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLH 594
H++ L+ + + N +++ + + + +IS GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 595 YLHTGTAQGIIHRDVKSTNILLD-DNYVAKVSDFGLSKDAPIGQGHVSTA-VKGSFGYLD 652
Y+H GIIH D+K N+L++ + + ++ + Y
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 653 PEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQ 701
PE +D++S ++ E++ P + Q
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.6 bits (224), Expect = 2e-21
Identities = 31/208 (14%), Positives = 62/208 (29%), Gaps = 43/208 (20%)
Query: 489 IIGVGGFGNVYLGEIDDGTKVAVK----------RGNPQSEQGITEFQTEIQMLSKLRHR 538
++G G V+ + + VK + + + G F ++ R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 539 HLVSLIGYCD----ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLH 594
L L G ++ E + + E+ +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVA 117
Query: 595 YLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDP- 653
+ +GI+H D+ N+L+ + + + DF S V +G L+
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQS---------VEVGEEGWREILERD 164
Query: 654 -----EYFRRQQLTEKSDVYSFGVVLLE 676
YF R + D+ S +L+
Sbjct: 165 VRNIITYFSRTY-RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 832 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.85 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 96.7 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.42 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.21 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 89.02 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=417.97 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=204.1
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++++|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688899999999999999999888999999987643 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+|+|.+++.... ..+++..++.++.|+|+||+|||+ ++|+||||||+|||+++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999986543 468999999999999999999999 9999999999999999999999999999987654444444
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhC-CCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCA-RPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....||+.|+|||++.+..++.++|||||||++|||+|+ ++||......+.... . ..+. ....
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---i----~~~~---------~~~~ 223 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---I----STGF---------RLYK 223 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---H----HHTC---------CCCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---H----HhcC---------CCCC
Confidence 456799999999999999999999999999999999995 566654433222111 1 1110 1112
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
+..++.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 33456789999999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-49 Score=422.56 Aligned_cols=258 Identities=24% Similarity=0.411 Sum_probs=204.1
Q ss_pred cCCCccceEeecCceeEEEEEEe-CC---cEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DG---TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.++||+|+||+||+|.++ ++ ..||||++... ..+..++|.+|+++|++++|||||+++++|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34667789999999999999875 23 36899987654 455667899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
||||++|+|.+++.... ..+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999886543 469999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCc----eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 637 QGH----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 637 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
... ......||+.|||||.+.++.++.++|||||||+||||+| |++||......+....+ ..+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-------~~~----- 249 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-------EQD----- 249 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTT-----
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC-----
Confidence 221 1122457999999999999999999999999999999998 89999876543322111 111
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.....+.+++..+.+++.+||+.||.+|||+.|+++.|+.+++-
T Consensus 250 ----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 ----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11123455677899999999999999999999999999987653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=418.10 Aligned_cols=260 Identities=28% Similarity=0.502 Sum_probs=208.4
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||+||+|+++ ..||||+++.. +.+..++|.+|+++|++++|||||++++++.+ +.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357888999999999999999764 46999998654 45567889999999999999999999999865 56899999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC-
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ- 637 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 637 (832)
||++|+|.+++.... ..+++.+++.++.||++||+|||+ ++||||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999996543 369999999999999999999999 999999999999999999999999999998764322
Q ss_pred CceeeccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
........||+.|||||++.+ ..++.++|||||||+||||+||+.||............ ...+. ..+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------~~~~~----~~p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------VGRGY----LSP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHHTS----CCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------HhcCC----CCC
Confidence 223345679999999999864 35799999999999999999999999876544322111 11111 111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.+ ...+..+++.+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 12344566789999999999999999999999999987643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-50 Score=427.29 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=218.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ...++|.+|+++|++++|||||+++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467888999999999999999876 58999999987543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
|++|+|.+++.......+++..++.++.|+++||+|||+ ++|+||||||+||||++++.+||+|||+++........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 999999999987766789999999999999999999999 99999999999999999999999999999877655444
Q ss_pred eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 640 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... .+ .... .....
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~--~~----~i~~---------~~~~~ 236 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YE----LLEK---------DYRME 236 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHHT---------TCCCC
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH--HH----HHhc---------CCCCC
Confidence 555567899999999999999999999999999999999977665443332211 11 1111 11223
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.+...+.++.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 34456778999999999999999999999998887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=416.52 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=212.7
Q ss_pred hcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
.++|++.+.||+|+||+||+|.+++++.||||+++... ...++|.+|+++|++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35788899999999999999999888999999987543 345789999999999999999999998865 5679999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++|+|.+++.......+++.++++++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99999998866555569999999999999999999999 999999999999999999999999999999876444444
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCC-CCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARP-AINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~-pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....||+.|+|||++.++.++.++|||||||+||||+||.. |+......+.. .. ...+ ....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~---~~----i~~~---------~~~~ 230 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QN----LERG---------YRMV 230 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HH----HHTT---------CCCC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHhc---------CCCC
Confidence 455679999999999999999999999999999999999654 44443322211 11 1111 1112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.+...+.++.+++.+||+.||++|||+.|+++.|+...
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 23456678999999999999999999999999888653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=416.89 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=205.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||+||+|... +|+.||||++.... .+..+++.+|+++|++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999875 68999999876543 33456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC-C
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-G 638 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 638 (832)
|++|+|.+++... ..+++.++..++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++...... .
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999644 379999999999999999999999 999999999999999999999999999998754222 2
Q ss_pred ceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......||+.|||||++.+..+ +.++|||||||+||||++|++||.......... .. .. .....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~----~~---------~~~~~ 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD----WK---------EKKTY 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH----HH---------TTCTT
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH----Hh---------cCCCC
Confidence 23345679999999999988876 578999999999999999999997654322111 00 00 11111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+.++.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122345678899999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=412.45 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=209.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||+||+|..+ +++.||+|++... .....+++.+|+++|++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999875 6899999987543 2344678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|||++|+|.+++.... .+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999996543 69999999999999999999999 99999999999999999999999999999865432
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......||+.|||||++.+..++.++|||||||+||||++|++||......+..... ....
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---------------~~~~-- 220 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------------SRVE-- 220 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------HTTC--
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH---------------HcCC--
Confidence 234567999999999999999999999999999999999999999776543322111 0111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..++...+.++.+++.+||+.||.+|||+.|+++
T Consensus 221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1233445678999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=416.42 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=211.9
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999976 479999999987665566788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
+||+|.+++.+. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cc
Confidence 999999988653 58999999999999999999999 999999999999999999999999999998764332 23
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
.....||+.|+|||++.++.++.++|||||||++|||++|++||......+..... ...+ .+. ...
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~------~~~--~~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNG------TPE--LQN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHC------SCC--CSS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC------CCC--CCC
Confidence 34567999999999999999999999999999999999999999776543322111 1111 011 122
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
++..+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3456778999999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=403.30 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=215.0
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++++|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998888999999876443 45789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+|+|.+++.... ..+++..+++++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999875443 368899999999999999999999 9999999999999999999999999999987654444444
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.... ...+ .....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-------i~~~---------~~~~~ 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------IAQG---------LRLYR 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-------HHTT---------CCCCC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-------HHhC---------CCCCC
Confidence 45679999999999999999999999999999999998 8999987654332211 1111 11122
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
+...+.++.+++.+||+.||++|||+.|+++.|.
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 3445678999999999999999999999998875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=410.47 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=197.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc--CCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--NSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--~~~~~lV 556 (832)
++|++.+.||+|+||+||+|+.. +|+.||||++... ++...+.|.+|+++|++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999765 6899999988655 34456779999999999999999999998854 4678999
Q ss_pred EEecCCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 557 YEYMSNGPFRDHLYGK--NLPPLSWKQRLEISIGSARGLHYLHTGT--AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
||||++|+|.+++... ....+++.+++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 3457999999999999999999999821 13499999999999999999999999999987
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII 712 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 712 (832)
..... .......||+.|||||++.+..++.++|||||||++|||++|++||......+.... ...+.
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~-------i~~~~----- 230 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-------IREGK----- 230 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHTC-----
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH-------HHcCC-----
Confidence 65322 233456799999999999999999999999999999999999999986544322111 11111
Q ss_pred CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 713 DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 713 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ..++...+.++.+++.+||+.||.+|||+.|+++
T Consensus 231 ---~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 ---F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1233455678999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=413.32 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=209.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
+.|++.+.||+|+||+||+|... +|+.||||++.....+..++|.+|+++|++++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46889999999999999999865 68999999988777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++|+|.+++.+.. ..+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 9999999876433 369999999999999999999999 99999999999999999999999999998754321 112
Q ss_pred eeccccCccccChhccc-----cCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCC
Q 047569 641 STAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPH 715 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 715 (832)
.....||+.|+|||++. +..++.++|||||||++|||++|++||......+..... . .+. .
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~-~~~-------~ 232 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------A-KSE-------P 232 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------H-HSC-------C
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------H-cCC-------C
Confidence 23467999999999984 456899999999999999999999999876544322111 0 110 0
Q ss_pred CCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 716 LVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 716 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....+...+.++.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223456778999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=406.87 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=204.9
Q ss_pred cCCCccceEeecCceeEEEEEEeCC-----cEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDG-----TKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
..|+..++||+|+||+||+|.++.. ..||||++... ......+|.+|+++|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987632 47999998654 34456679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+.+++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998876543 479999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCC--ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQG--HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
... .......||+.|||||++.++.++.++|||||||++|||++|..|+........ +.. ....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~----~i~~-------- 228 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK----AIND-------- 228 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHHT--------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHH----HHhc--------
Confidence 221 222345689999999999999999999999999999999996655543332221 111 1111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
......+..++..+.+++.+||+.+|++|||+.|+++.|+.+.+.
T Consensus 229 -~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 -GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 112233445677899999999999999999999999999887654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=405.85 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=211.0
Q ss_pred cCCCccce-EeecCceeEEEEEEe---CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAI-IGVGGFGNVYLGEID---DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~-LG~G~fg~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|.+.+. ||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++++|.+ +.++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666774 999999999999654 3567999998765 34556889999999999999999999999965 468999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
||||++|+|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999885433 479999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 637 QGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 637 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
... ......||+.|+|||++.++.++.++|||||||++|||+| |++||......+.... ...+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-------i~~~~------ 229 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGK------ 229 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTC------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC------
Confidence 222 2234568999999999999999999999999999999998 8999986654332111 11111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....++.++.++.+++.+||+.+|++|||+.++++.|+....
T Consensus 230 ---~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 230 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112345567789999999999999999999999998886643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=415.31 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=208.2
Q ss_pred cCCCccceEeecCceeEEEEEEeC-C-----cEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD-G-----TKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~ 553 (832)
++|++.+.||+|+||+||+|++.. + ..||+|.+... .......|.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999997653 2 36999987654 344556799999999998 899999999999999999
Q ss_pred EEEEEecCCCChhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCC
Q 047569 554 ILVYEYMSNGPFRDHLYGKN---------------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKST 612 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~---------------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 612 (832)
++|||||++|+|.++|..+. ...+++.+++.++.|+++||+|||+ ++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 99999999999999996542 2358999999999999999999999 99999999999
Q ss_pred ceeeCCCCceEEecccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChh
Q 047569 613 NILLDDNYVAKVSDFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPR 690 (832)
Q Consensus 613 NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~ 690 (832)
|||++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||+||||++ |++||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999865433322 3345668999999999999999999999999999999997 89999765433
Q ss_pred hhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 047569 691 EQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLE 754 (832)
Q Consensus 691 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 754 (832)
... .. .... ......+..++.++.+++.+||+.||++|||++||++.|.
T Consensus 274 ~~~--~~----~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANF--YK----LIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH--HH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HH----HHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 11 1111 1112234456678999999999999999999999998885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=403.90 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=198.4
Q ss_pred CccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc----CCcEEEEE
Q 047569 485 DSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE----NSEMILVY 557 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~----~~~~~lV~ 557 (832)
+..+.||+|+||+||+|.+. +++.||+|++... .....++|.+|+++|++++|||||++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999865 6889999987643 44556789999999999999999999999854 45689999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeccCCCCceeeC-CCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQG--IIHRDVKSTNILLD-DNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 634 (832)
||+++|+|.+++.+.. .+++.+++.++.||++||+|||+ ++ |+||||||+||||+ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999996543 68999999999999999999998 66 99999999999997 57899999999998653
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
. .......||+.|||||++.+ .++.++|||||||++|||++|+.||......... .. . ...+
T Consensus 167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~---~-i~~~-------- 228 (270)
T d1t4ha_ 167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR---R-VTSG-------- 228 (270)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH---H-HTTT--------
T ss_pred C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HH---H-HHcC--------
Confidence 2 23345679999999999865 5999999999999999999999999765433221 11 1 1111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.....++...++++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111122334567899999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=411.05 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=207.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999874 7899999987642 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|||+||+|.+++...+ .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999986554 69999999999999999999999 999999999999999999999999999998765322
Q ss_pred -CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 638 -GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 638 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
........||+.|+|||++.+..++.++|||||||+||||++|+.||......+.... +....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~---------------i~~~~- 226 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK---------------IIKLE- 226 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHTTC-
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH---------------HHcCC-
Confidence 2233456799999999999999999999999999999999999999987654332111 11111
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..++...+.++.+++.+||+.||.+|||++|++.
T Consensus 227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1233445678999999999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=401.00 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=202.6
Q ss_pred ceEeecCceeEEEEEEeC---CcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecCC
Q 047569 488 AIIGVGGFGNVYLGEIDD---GTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMSN 562 (832)
Q Consensus 488 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 562 (832)
+.||+|+||+||+|.+++ ++.||||++... +....++|.+|+++|++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999997653 568999998654 33446789999999999999999999999965 467899999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce--
Q 047569 563 GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV-- 640 (832)
Q Consensus 563 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 640 (832)
|+|.+++.... .+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999997544 69999999999999999999999 999999999999999999999999999998765433222
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....||+.|||||++.+..++.++|||||||++|||++ |++||......+.... ...+ ....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-------i~~~---------~~~~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKG---------ERMG 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTT---------CCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-------HHcC---------CCCC
Confidence 234568999999999999999999999999999999998 8999987654332111 1111 1112
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
.+..++.++.+++.+||+.||++|||+.++++.|+...
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 34456678999999999999999999999988887543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=405.39 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=205.0
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEecC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYMS 561 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 561 (832)
++|++.+.||+|+||.||+|.+++++.||||++.... ...++|.+|+.+|++++|||||+++++|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5789999999999999999999888899999987543 445789999999999999999999999965 56899999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCcee
Q 047569 562 NGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHVS 641 (832)
Q Consensus 562 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 641 (832)
+|+|.+++.......++|.+++.++.||++||+|||+ ++|+||||||+||||+.++++||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999999876555579999999999999999999999 8999999999999999999999999999987654444444
Q ss_pred eccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCC-CCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCC
Q 047569 642 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAI-NPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTI 720 (832)
Q Consensus 642 ~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf-~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 720 (832)
....||+.|+|||++.++.++.++|||||||+||||++|..|+ ......+..... ..+ .....
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-------~~~---------~~~~~ 235 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERG---------YRMPC 235 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTT---------CCCCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-------Hhc---------CCCCC
Confidence 5567999999999999999999999999999999999966554 433322221111 111 11223
Q ss_pred ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 721 NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 721 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
++.++.++.+++.+||+.||++||++++|++.|+..
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 455677899999999999999999999998777643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=417.91 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=207.9
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
.++|++.+.||+|+||+||+|... +|+.||+|+++.. .....+++.+|+++|++++|||||++++++.+.+.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999865 6899999988654 34446789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
||+||+|.+++.+.+ .+++..+..++.|+++||+|||+ .++|+||||||+||||+.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 999999999997544 68999999999999999999996 13899999999999999999999999999986532
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHH-HHHHhh----------h--
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEW-AMQWKR----------K-- 705 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~-~~~~~~----------~-- 705 (832)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ...... .
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 223456799999999999999999999999999999999999999976543321110000 000000 0
Q ss_pred --------------cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 706 --------------GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 706 --------------~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
.....+.............+.++.+++.+||+.||.+|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000001111111112245679999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.7e-47 Score=414.09 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=213.2
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++|+|||||++++++.+++.++|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999864 7999999999877777778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC--CCCceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD--DNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 637 (832)
|+||+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999999986443 369999999999999999999999 9999999999999996 4678999999999876532
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+..... ... .....
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~-------~~~~~ 245 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSC-------DWNMD 245 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHT-------CCCSC
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC-------CCCCC
Confidence 3345567999999999999999999999999999999999999999876543322111 110 11111
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222345678999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-47 Score=409.64 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=195.0
Q ss_pred HhcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 480 ATKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 480 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
..+.|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++.++|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999875 68999999876543 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccccccCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 634 (832)
|||+||+|.++|...+ .+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999996543 69999999999999999999999 9999999999999994 57899999999998654
Q ss_pred CCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.. .......||+.|||||++.+..++.++|||||||+||||++|++||......+..... . .+ ..
T Consensus 162 ~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~-~~------~~ 226 (307)
T d1a06a_ 162 PG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI------L-KA------EY 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------H-TT------CC
T ss_pred CC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------h-cc------CC
Confidence 22 2334567999999999999999999999999999999999999999876543321110 0 10 11
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.......+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1222233456678999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-46 Score=411.90 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=213.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++|+|||||++++++.+++.++||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999864 79999999988776666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC--CCCceEEecccccccCCCCCC
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD--DNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~~ 638 (832)
+||+|.+++.... .++++.+++.++.||+.||+|||+ ++|+||||||+||||+ .++.+||+|||+++.....
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999998875443 369999999999999999999999 9999999999999998 6789999999999876533
Q ss_pred ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVG 718 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 718 (832)
.......||+.|+|||++.+..++.++|||||||+||||++|++||.+....+..... ..+ +..+..
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-------~~~------~~~~~~ 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRC------DWEFDE 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HHC------CCCCCS
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhC------CCCCCc
Confidence 3345567999999999999999999999999999999999999999876544322111 011 112222
Q ss_pred CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 719 TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 719 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
...+..+.++.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233456678999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=398.86 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=204.1
Q ss_pred hcCCCccceEeecCceeEEEEEEeC----CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.++|++.+.||+|+||.||+|.+.. +..||||.+... .....+.|.+|+++|++++|||||++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3578999999999999999997642 457899988654 34446779999999999999999999999964 67899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
||||+++|+|.+++.... ..+++.+++.++.||++||+|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999876543 468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 636 GQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 636 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
..........||+.|+|||++.+..++.++|||||||++|||++ |++||......+..... ..+.
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~~------- 226 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGE------- 226 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTC-------
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC-------
Confidence 44444555678999999999999999999999999999999998 89999876554322111 1111
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQLQ 760 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 760 (832)
....++.++..+.+++.+||+.||++|||+.|+++.|+.+++.+
T Consensus 227 --~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 227 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11234566778999999999999999999999999999886653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-47 Score=408.82 Aligned_cols=245 Identities=27% Similarity=0.373 Sum_probs=204.1
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
+.|+..+.||+|+||+||+|... +|+.||||++.... ....++|.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35889999999999999999764 68999999876543 334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|||++|+|..++..+ .++++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999998776544 369999999999999999999999 9999999999999999999999999999986532
Q ss_pred CceeeccccCccccChhcccc---CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 714 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 714 (832)
.....||+.|||||++.+ ..++.++|||||||++|||++|++||......+.... ... +. .+
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~------i~~-~~-----~~ 232 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQ-NE-----SP 232 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHH-SC-----CC
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHh-CC-----CC
Confidence 234579999999999864 4689999999999999999999999976654332111 000 10 11
Q ss_pred CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 715 HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 715 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 122345678999999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=403.98 Aligned_cols=264 Identities=26% Similarity=0.411 Sum_probs=215.7
Q ss_pred HHHHHHhcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEe
Q 047569 475 QELQEATKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYC 547 (832)
Q Consensus 475 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~ 547 (832)
.+++...++|++.+.||+|+||+||+|+.. +++.||||++.... .+..++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344445678999999999999999999864 35789999987653 34467899999999999999999999999
Q ss_pred ccCCcEEEEEEecCCCChhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 047569 548 DENSEMILVYEYMSNGPFRDHLYGKN----------------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGII 605 (832)
Q Consensus 548 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~iv 605 (832)
.+.+..+++|||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ +++|
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 99999999999999999999985321 2358999999999999999999999 9999
Q ss_pred eccCCCCceeeCCCCceEEecccccccCCCCC-CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCC-CC
Q 047569 606 HRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ-GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR-PA 683 (832)
Q Consensus 606 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~-~p 683 (832)
||||||+||||+.++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998654322 22234456899999999999999999999999999999999995 67
Q ss_pred CCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 684 INPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 684 f~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
|......+.... ..++. ....+..++.++.+++.+||+.+|++||||.||++.|++++
T Consensus 243 ~~~~~~~e~~~~-------v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYY-------VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHH-------HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHH-------HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 766544332211 11111 11233455678999999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=394.61 Aligned_cols=250 Identities=30% Similarity=0.442 Sum_probs=202.3
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc-CCcEEEEEEec
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-NSEMILVYEYM 560 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-~~~~~lV~E~~ 560 (832)
++|++.+.||+|+||.||+|.++ |+.||||+++.. ...++|.+|+++|++++||||++++++|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788999999999999999884 789999998654 345789999999999999999999998854 56789999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCce
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGHV 640 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 640 (832)
++|+|.++|..+....+++..+++++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.... .
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----~ 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----T 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC----C
Confidence 99999999976544468999999999999999999999 9999999999999999999999999999986532 2
Q ss_pred eeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCCCC
Q 047569 641 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLVGT 719 (832)
Q Consensus 641 ~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 719 (832)
.....+|..|+|||++.++.++.++|||||||++|||+| |++||......+. ...+ .. .....
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----~~---------~~~~~ 220 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EK---------GYKMD 220 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TT---------TCCCC
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----Hc---------CCCCC
Confidence 234468899999999999999999999999999999998 6888766543322 1111 11 11223
Q ss_pred CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 047569 720 INPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYAL 757 (832)
Q Consensus 720 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 757 (832)
++...+.++.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 44556678999999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=399.16 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=208.7
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC------CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ------SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||+||+|... +|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999874 7999999987532 223467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC----ceEEecccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY----VAKVSDFGL 629 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGl 629 (832)
+||||||++|+|.+++.... .+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999996543 69999999999999999999999 9999999999999998776 599999999
Q ss_pred cccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 630 SKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 630 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... ..+
T Consensus 164 a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i-------~~~--- 231 (293)
T d1jksa_ 164 AHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-------SAV--- 231 (293)
T ss_dssp CEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HTT---
T ss_pred hhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH-------Hhc---
Confidence 9876432 2334567999999999999999999999999999999999999999876543322111 000
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.........+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 ---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111111335667899999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.3e-46 Score=395.22 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=205.1
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC----c
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS----E 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~----~ 552 (832)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.. +....++|.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999976 47999999998754 3344567999999999999999999999986543 3
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.||||||++|++|.+++...+ .+++.+++.++.||++||+|||+ ++|+||||||+|||++.++..+|+|||++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999999886554 69999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 633 APIGQ--GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 633 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
..... ........||+.|+|||++.+..++.++|||||||++|||++|++||......+... .....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~----- 229 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVRE----- 229 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHC-----
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhc-----
Confidence 54222 223345679999999999999999999999999999999999999998765433211 11111
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRP-TMGDVLWNLEYA 756 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 756 (832)
++.......+..+.++.+++.+||+.||.+|| |++++++.|.++
T Consensus 230 --~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 230 --DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 11111122344567899999999999999998 899998887765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=398.33 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=207.4
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc----EEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT----KVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~l 555 (832)
.+|++.++||+|+||+||+|.+. +|+ +||+|++... +.+..++|.+|+++|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999764 343 6899987654 455678899999999999999999999999865 5778
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCC
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPI 635 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 635 (832)
++||+.+++|.+++.... ..+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999999886543 479999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 636 GQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 636 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.... ......||+.|+|||++.++.++.++|||||||+||||+| |++||......+..... ..+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-------~~~------- 229 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKG------- 229 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-------HHT-------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcC-------
Confidence 3322 2334568999999999999999999999999999999998 78898766543322111 111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
.....++.++..+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11123455677899999999999999999999999998876543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=401.21 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=209.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|+.+ +|+.||||++.+. .....+++.+|+++|++++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999864 7999999987643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|||+||+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 9999999999997654 68999999999999999999999 99999999999999999999999999999865432
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......+||+.|+|||++.+..++.++|||||||++|||++|++||......+.... ...+ ..
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-------i~~~------~~--- 222 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-------ILME------EI--- 222 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHC------CC---
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH-------HhcC------CC---
Confidence 2234456799999999999999999999999999999999999999987654332111 1111 11
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPT-----MGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 751 (832)
.++...+.++.+++.+||+.||.+|++ +.|+++
T Consensus 223 -~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 223445667899999999999999995 666653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-45 Score=398.91 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=207.8
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999874 6999999987643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
|||+||+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 9999999999986554 67889999999999999999999 9999999999999999999999999999987643
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
......||+.|||||++.+..++.++|||||||+||||++|+.||......+..... .. ..
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~---------~~-- 217 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LN---------AE-- 217 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HH---------CC--
T ss_pred --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------Hc---------CC--
Confidence 234567999999999999999999999999999999999999999876543322111 01 11
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
..+++..+.++.+++.+||+.||.+|+ +++++++
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 123344567799999999999999996 7888864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=391.74 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=200.7
Q ss_pred cCCCccceEeecCceeEEEEEEeC--C--cEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD--G--TKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
++|++.+.||+|+||.||+|+... + ..||||++... ..+..++|.+|+++|++++||||++++++|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568999999999999999997642 2 37899987654 34456789999999999999999999999976 4678
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+||||+++|+|.+++..+. ..+++..++.++.|+++||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999876543 369999999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCc--eeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhHHHHHHHHhhhcccccc
Q 047569 635 IGQGH--VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNLAEWAMQWKRKGLLEKI 711 (832)
Q Consensus 635 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 711 (832)
..... ......|+..|+|||.+.+..++.++|||||||++|||+| |++||......+... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~------~i~~~------ 230 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKE------ 230 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTS------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH------HHHhC------
Confidence 43222 2234557889999999999999999999999999999998 899997665433221 11111
Q ss_pred cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 712 IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 712 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
......+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 231 ---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ---GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111223345667899999999999999999999999888765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=396.59 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=203.1
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEecc-CC
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE-NS 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~-~~ 551 (832)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|..++.++ +|+||+.+++++.+ +.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999764 2468999998754 344566788899888887 68999999998765 45
Q ss_pred cEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
.+++|||||++|+|.++|.... ...+++.+++.++.||++||+|||+ ++|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 6899999999999999996432 2358999999999999999999999 9999999999999999
Q ss_pred CCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCC-CCCCCCChhhhhhH
Q 047569 618 DNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQVNL 695 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~-~pf~~~~~~~~~~l 695 (832)
+++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||++|. +||......+..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~-- 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 999999999999986543322 2334567999999999999999999999999999999999874 677654332211
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
......+. ....+...+.++.+++.+||+.||.+|||+.|++++|+.+++.
T Consensus 247 ----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 ----CRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp ----HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11111111 1123344567899999999999999999999999999988653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=390.71 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=209.8
Q ss_pred cCCCccceEeecCceeEEEEEEeC--------CcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDD--------GTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENS 551 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~ 551 (832)
++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578889999999999999997532 3479999987654 44567899999999998 7999999999999999
Q ss_pred cEEEEEEecCCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC
Q 047569 552 EMILVYEYMSNGPFRDHLYGKN--------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD 617 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~ 617 (832)
..++||||+++|+|.++|.... ...+++.++++++.||+.||+|||+ ++||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999996543 2458999999999999999999999 9999999999999999
Q ss_pred CCCceEEecccccccCCCCC-CceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhhH
Q 047569 618 DNYVAKVSDFGLSKDAPIGQ-GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVNL 695 (832)
Q Consensus 618 ~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~l 695 (832)
.++.+||+|||+++...... ........||+.|+|||.+.++.++.++|||||||++|||++ |++||..........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~- 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH-
Confidence 99999999999998664322 223344568999999999999999999999999999999998 688887655432211
Q ss_pred HHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 696 AEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 696 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
....+ .....+...+.++.+++.+||+.||.+|||+.|+++.|+.+.++
T Consensus 249 ------~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 249 ------LLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ------HHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11111 11123344567899999999999999999999999999988654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-45 Score=385.83 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=207.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCc---------ccHHHHHHHHHHHHhCC-CcceeeEEEEeccC
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSE---------QGITEFQTEIQMLSKLR-HRHLVSLIGYCDEN 550 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~ 550 (832)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|+++|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999864 789999998765421 12356889999999997 99999999999999
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
+..|||||||++|+|.++|..++ .+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999996544 69999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCceeeccccCccccChhcccc------CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhh
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKR 704 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 704 (832)
+..... .......||+.|+|||.+.+ ..++.++||||+||+||||++|+.||............ .
T Consensus 158 ~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i-------~ 228 (277)
T d1phka_ 158 CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-------M 228 (277)
T ss_dssp EECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------H
T ss_pred eEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH-------H
Confidence 876532 23345679999999999863 35688999999999999999999999876543322111 1
Q ss_pred hcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 705 KGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 705 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.+. ........+..++++.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 11122223456788999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=393.45 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=207.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCc--EEEEEecCCC-CcccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGT--KVAVKRGNPQ-SEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.++||+|+||.||+|.++ +|. .||||++... ..+..++|.+|+++|+++ +|||||+++++|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999775 444 5788887543 444567899999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCce
Q 047569 557 YEYMSNGPFRDHLYGK--------------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVA 622 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 622 (832)
|||+++|+|.++|+.. ....+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999653 23579999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCC-CCCCCCChhhhhhHHHHHHH
Q 047569 623 KVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQVNLAEWAMQ 701 (832)
Q Consensus 623 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~ 701 (832)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|. +||......+.. .
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~---~---- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E---- 237 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH---H----
Confidence 99999999865422 1223446899999999999999999999999999999999975 567654432211 1
Q ss_pred HhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 702 WKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 702 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
....+ .....+..++.++.+++.+||+.||++||||.|+++.|+.+.+
T Consensus 238 ~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 1122344567789999999999999999999999999998765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=392.58 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=214.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCCC-cccHHHHHHHHHHHHhC-CCcceeeEEEEeccCCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQS-EQGITEFQTEIQMLSKL-RHRHLVSLIGYCDENSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~~~~ 552 (832)
.++|++.+.||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888999999999999999753 45789999987653 44566799999999999 69999999999999999
Q ss_pred EEEEEEecCCCChhhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceee
Q 047569 553 MILVYEYMSNGPFRDHLYGKN----------------LPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILL 616 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl 616 (832)
.++|||||++|+|.+++.... ...+++.+++.++.||++||+|||+ ++++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 999999999999999986532 2368999999999999999999999 999999999999999
Q ss_pred CCCCceEEecccccccCCCCCC-ceeeccccCccccChhccccCCCCccccEEechhHHHHHhh-CCCCCCCCChhhhhh
Q 047569 617 DDNYVAKVSDFGLSKDAPIGQG-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLC-ARPAINPQLPREQVN 694 (832)
Q Consensus 617 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~ellt-G~~pf~~~~~~~~~~ 694 (832)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+| |.+||......+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654332 33345679999999999999999999999999999999998 556665543322211
Q ss_pred HHHHHHHHhhhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 695 LAEWAMQWKRKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 695 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.....+ .....+...+..+.+|+.+||+.||.+|||+.++++.|++.+.
T Consensus 259 ------~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 ------KMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ------HHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 111111 1122334456789999999999999999999999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-45 Score=397.83 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=207.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++|++.+.||+|+||.||+|..+ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 7999999987542 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 637 (832)
||+.+|+|.+++...+ .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999996554 69999999999999999999999 99999999999999999999999999999876432
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.....||+.|||||++.+..++.++|||||||+||||++|++||............ ..+ .
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-------~~~--------~-- 254 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-------VSG--------K-- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC--------C--
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH-------hcC--------C--
Confidence 23467999999999999999999999999999999999999999876443321111 111 0
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRP-----TMGDVLW 751 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 751 (832)
...+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112344567899999999999999994 8888864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.6e-45 Score=398.75 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=201.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHH---HHHHHHhCCCcceeeEEEEeccCCcEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQT---EIQMLSKLRHRHLVSLIGYCDENSEMI 554 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~---Ei~~L~~l~HpnIv~l~~~~~~~~~~~ 554 (832)
++|++.++||+|+||.||+|+.. +|+.||||++... .......+.+ |+++++.++|||||++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999875 6999999987532 1222233444 466777788999999999999999999
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
+|||||+||+|.++|.... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999996543 68899999999999999999999 999999999999999999999999999998764
Q ss_pred CCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccC
Q 047569 635 IGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 713 (832)
Q Consensus 635 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 713 (832)
.. ......||+.|+|||++.+ ..++.++|||||||+||||++|++||......+...+.. .+..
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------------~~~~ 223 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------MTLT 223 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH------------HSSS
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------hccc
Confidence 32 2344579999999999975 568999999999999999999999998654433221111 0111
Q ss_pred CCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 047569 714 PHLVGTINPESLKKFAEAAEKCLADHGVDRPT-----MGDVLW 751 (832)
Q Consensus 714 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 751 (832)
....++...+.++.+++.+||+.||.+||| ++|+++
T Consensus 224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 --MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111233445678999999999999999999 566653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=387.52 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=204.2
Q ss_pred cceEeecCceeEEEEEEeC----CcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEecc-CCcEEEEEEec
Q 047569 487 SAIIGVGGFGNVYLGEIDD----GTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-NSEMILVYEYM 560 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-~~~~~lV~E~~ 560 (832)
.++||+|+||+||+|.+.+ ...||||++... +....++|.+|+++|++++||||++++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998643 236899998753 55567889999999999999999999999865 56899999999
Q ss_pred CCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC--
Q 047569 561 SNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG-- 638 (832)
Q Consensus 561 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 638 (832)
++|+|.+++.... ..+++..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999886543 467889999999999999999999 9999999999999999999999999999987653322
Q ss_pred -ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 639 -HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 639 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ++..+ ...+. .
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~---------~ 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGR---------R 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTC---------C
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCC---------C
Confidence 12233568999999999999999999999999999999999887775433211 11111 11111 1
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...++..+..+.+++.+||+.||++||++.||++.|+.+++
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11233456789999999999999999999999999987753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=390.89 Aligned_cols=252 Identities=16% Similarity=0.230 Sum_probs=208.8
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
.++|++.+.||+|+||+||+|... +|+.||||.+..... ....+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999775 689999999876543 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC--CCceEEecccccccCCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD--NYVAKVSDFGLSKDAPIGQ 637 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 637 (832)
|+||+|.+++...+ ..+++.++..++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 99999999996543 369999999999999999999999 99999999999999984 45899999999987643
Q ss_pred CceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCCC
Q 047569 638 GHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLV 717 (832)
Q Consensus 638 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 717 (832)
........||+.|+|||.+.+..++.++|||||||++|||++|++||......+....+ ... . ..+.
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~-~------~~~~ 223 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNA-E------YTFD 223 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHT-C------CCCC
T ss_pred CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC-C------CCCC
Confidence 23345567999999999999999999999999999999999999999876543322111 010 0 0000
Q ss_pred CCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 718 GTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 718 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
....+..+.++.+++.+||+.||.+|||+.|++++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00112345678999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=391.72 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=206.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC---CcccHHHHHHHHHHHH-hCCCcceeeEEEEeccCCcEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ---SEQGITEFQTEIQMLS-KLRHRHLVSLIGYCDENSEMILV 556 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~f~~Ei~~L~-~l~HpnIv~l~~~~~~~~~~~lV 556 (832)
++|++.+.||+|+||+||+|... +|+.||||++.+. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999775 6999999998643 2344566777877765 68999999999999999999999
Q ss_pred EEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCC
Q 047569 557 YEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 557 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 636 (832)
||||++|+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999996544 68899999999999999999999 99999999999999999999999999999865433
Q ss_pred CCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccccCCCC
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHL 716 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 716 (832)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......... ..+ .+
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~------~~-- 220 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------RMD------NP-- 220 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC------CC--
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcC------CC--
Confidence 2 2334567999999999999999999999999999999999999999876544322111 111 11
Q ss_pred CCCCChhHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 047569 717 VGTINPESLKKFAEAAEKCLADHGVDRPTMG-DVL 750 (832)
Q Consensus 717 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 750 (832)
.++...+.++.+++.+||+.||.+||++. +++
T Consensus 221 --~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 22334567799999999999999999985 664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=393.07 Aligned_cols=251 Identities=19% Similarity=0.299 Sum_probs=202.2
Q ss_pred hcCCCccc-eEeecCceeEEEEEE-eCCcEEEEEecCCCCcccHHHHHHHHHHHHhC-CCcceeeEEEEecc----CCcE
Q 047569 481 TKNFDSSA-IIGVGGFGNVYLGEI-DDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL-RHRHLVSLIGYCDE----NSEM 553 (832)
Q Consensus 481 ~~~f~~~~-~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l-~HpnIv~l~~~~~~----~~~~ 553 (832)
.++|++.. .||+|+||.||+|.. .+++.||||+++. ...+.+|++++.++ +|||||++++++++ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788764 699999999999976 4789999999753 25678899987655 89999999999864 4678
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC---CCceEEeccccc
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD---NYVAKVSDFGLS 630 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla 630 (832)
|+|||||+||+|.++|..++...+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 999999999999999987665679999999999999999999999 99999999999999985 567999999999
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
+...... ......||+.|||||++.+..++.++|||||||+||||++|++||.+......... ....
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-----------~~~~ 228 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----------MKTR 228 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------C
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----------HHHH
Confidence 8765332 33456799999999999999999999999999999999999999976543221110 0111
Q ss_pred ccCCCC--CCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 711 IIDPHL--VGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 711 i~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
+..... ........+.++.+++.+||+.||++|||+.|+++.
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 111123466789999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=384.81 Aligned_cols=260 Identities=22% Similarity=0.238 Sum_probs=198.5
Q ss_pred ccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcc-----cHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 486 SSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQ-----GITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 486 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
..++||+|+||+||+|... +|+.||||++...... ..+++.+|+++|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3678999999999999865 6899999998654221 234689999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+.++++..++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-R 155 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-C
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc-c
Confidence 998887766643 3468889999999999999999999 999999999999999999999999999998754332 2
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc---CCC
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII---DPH 715 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~---d~~ 715 (832)
......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+..................... ...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 2334569999999999865 467999999999999999999999998776554432221110000000000000 000
Q ss_pred CCC---CC-----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 716 LVG---TI-----NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 716 l~~---~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... .. .+..+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 00 1234568999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=387.02 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=211.6
Q ss_pred hcCCCccceEeecCceeEEEEEEe------CCcEEEEEecCCC-CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID------DGTKVAVKRGNPQ-SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEM 553 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~ 553 (832)
.++|++.+.||+|+||+||+|.+. +++.||||+++.. ..+....|.+|++++++++|||||+++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888999999999999999753 3578999998754 445556799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEe
Q 047569 554 ILVYEYMSNGPFRDHLYGK--------NLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVS 625 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 625 (832)
++||||+++|+|.+++... ....+++.++++++.|+++||.|||+ ++|+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999988532 23467999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCCc-eeeccccCccccChhccccCCCCccccEEechhHHHHHhhCC-CCCCCCChhhhhhHHHHHHHHh
Q 047569 626 DFGLSKDAPIGQGH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCAR-PAINPQLPREQVNLAEWAMQWK 703 (832)
Q Consensus 626 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~-~pf~~~~~~~~~~l~~~~~~~~ 703 (832)
|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+ +||......+.....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-------
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------
Confidence 99999865432221 223346899999999999999999999999999999999985 777655433322111
Q ss_pred hhcccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 047569 704 RKGLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYA 756 (832)
Q Consensus 704 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 756 (832)
.+... ...+..++..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 249 --------~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 --------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp --------HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --------HhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111 123345567899999999999999999999999888755
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=387.95 Aligned_cols=271 Identities=24% Similarity=0.341 Sum_probs=201.4
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHH--HHHHHHhCCCcceeeEEEEeccCC----cEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQT--EIQMLSKLRHRHLVSLIGYCDENS----EMIL 555 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~--Ei~~L~~l~HpnIv~l~~~~~~~~----~~~l 555 (832)
++|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+++.. |+..+.+++|||||+++++|.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567789999999999999986 5899999998643 2334444 444556789999999999996543 6899
Q ss_pred EEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 556 VYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTG-----TAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 556 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
|||||++|+|.++|.+. .++|.++++++.|++.||+|||+. +.++|+||||||+||||+.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999754 589999999999999999999963 2369999999999999999999999999999
Q ss_pred ccCCCCCCc---eeeccccCccccChhccccCC------CCccccEEechhHHHHHhhCCCCCCCCChhh----hhhHHH
Q 047569 631 KDAPIGQGH---VSTAVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLLEVLCARPAINPQLPRE----QVNLAE 697 (832)
Q Consensus 631 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~SlGvvl~elltG~~pf~~~~~~~----~~~l~~ 697 (832)
+........ ......||+.|+|||++.+.. ++.++|||||||+||||+||.+|+....... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876533322 223467999999999987643 5779999999999999999998875322111 000000
Q ss_pred HHHHHhhhcccccccCCCCCCCC-ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 047569 698 WAMQWKRKGLLEKIIDPHLVGTI-NPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQL 759 (832)
Q Consensus 698 ~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 759 (832)
...............+|.+.... ..+....+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00000011111122223322222 234567899999999999999999999999999877653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=381.79 Aligned_cols=265 Identities=20% Similarity=0.289 Sum_probs=204.3
Q ss_pred cCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||+||+|.. .+|+.||||++.... +...+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 479999999986542 3346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
|+.+ ++.+++.......+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9965 55555555555679999999999999999999999 999999999999999999999999999998764322
Q ss_pred ceeeccccCccccChhccccCC-CCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccccc-CCCC
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKII-DPHL 716 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~-d~~l 716 (832)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+.............+.....+. .+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2334457999999999887665 5789999999999999999999998765544322211100000000000000 0000
Q ss_pred CCC-----------CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 717 VGT-----------INPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 717 ~~~-----------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
... ..+..+.++.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 01234578899999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-43 Score=377.84 Aligned_cols=264 Identities=19% Similarity=0.240 Sum_probs=205.1
Q ss_pred cCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||+||+|++++|+.||||++.... ....+++.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998899999999986543 33467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCCc
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQGH 639 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 639 (832)
+.++.+..+.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 9877776666433 479999999999999999999999 999999999999999999999999999998754322 2
Q ss_pred eeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccccc-------
Q 047569 640 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEKI------- 711 (832)
Q Consensus 640 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~i------- 711 (832)
......|++.|+|||.+.+ ..++.++|||||||++|||++|++||......+....................
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 2334468999999999875 45799999999999999999999999876554432221111000000000000
Q ss_pred -----cCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 712 -----IDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 712 -----~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..+.......+..+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011122345678999999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=378.12 Aligned_cols=239 Identities=23% Similarity=0.369 Sum_probs=196.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCC---c---ccHHHHHHHHHHHHhCC--CcceeeEEEEeccCCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQS---E---QGITEFQTEIQMLSKLR--HRHLVSLIGYCDENSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~---~~~~~f~~Ei~~L~~l~--HpnIv~l~~~~~~~~~ 552 (832)
++|++.+.||+|+||+||+|... +|+.||||++.... . ....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999764 78999999875421 1 12234778999999996 8999999999999999
Q ss_pred EEEEEEecCC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-CCceEEeccccc
Q 047569 553 MILVYEYMSN-GPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-NYVAKVSDFGLS 630 (832)
Q Consensus 553 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla 630 (832)
.++||||+.+ +++.+++.... .+++.++..++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 57777775443 69999999999999999999999 99999999999999985 579999999999
Q ss_pred ccCCCCCCceeeccccCccccChhccccCCC-CccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcccc
Q 047569 631 KDAPIGQGHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLE 709 (832)
Q Consensus 631 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~ 709 (832)
+.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . .. +
T Consensus 159 ~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------~~-~--- 219 (273)
T d1xwsa_ 159 ALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IR-G--- 219 (273)
T ss_dssp EECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HH-C---
T ss_pred eeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------hh-c---
Confidence 86542 23345679999999999987765 5779999999999999999999964210 0 00 0
Q ss_pred cccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 710 KIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 710 ~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ..++...+.++.+++.+||+.||.+|||++|+++
T Consensus 220 ---~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ---Q----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---C----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---c----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0123345677999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=376.56 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=201.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-C-CcEEEEEecCCC--CcccHHHHHHHHHHHHhC---CCcceeeEEEEec-----
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-D-GTKVAVKRGNPQ--SEQGITEFQTEIQMLSKL---RHRHLVSLIGYCD----- 548 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l---~HpnIv~l~~~~~----- 548 (832)
.++|++.+.||+|+||+||+|... + ++.||||++... .......+.+|+++|+.| +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999863 4 667999987532 222233566777777666 7999999999884
Q ss_pred cCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccc
Q 047569 549 ENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFG 628 (832)
Q Consensus 549 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 628 (832)
.....+++|||++++.+..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 3457899999998877654443 344578999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 629 LSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 629 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
+++.... ........||+.|+|||++.+..++.++|||||||++|||++|++||......+.................
T Consensus 162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 9876432 23345567999999999999999999999999999999999999999877655443322111100000000
Q ss_pred c-------ccc---CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 709 E-------KII---DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 709 ~-------~i~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ... .......+....+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000 000011122345677899999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=368.42 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=199.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEecc--------C
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE--------N 550 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~--------~ 550 (832)
++|++.+.||+|+||+||+|... +|+.||||++... .+...+++.+|+++|++++||||+++++.+.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999864 7999999987544 34456789999999999999999999998744 4
Q ss_pred CcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccc
Q 047569 551 SEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLS 630 (832)
Q Consensus 551 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 630 (832)
+..++||||+.++.+..... ....++..++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 56899999998777765543 33468899999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCC---CceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhc
Q 047569 631 KDAPIGQ---GHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKG 706 (832)
Q Consensus 631 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 706 (832)
+...... ........||+.|+|||++.+. .++.++|||||||++|||++|++||......................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 7654322 1122335699999999998765 68999999999999999999999998766544433322211100000
Q ss_pred ccccccCCCCCC--------CCC-h------hHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 707 LLEKIIDPHLVG--------TIN-P------ESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 707 ~~~~i~d~~l~~--------~~~-~------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
............ ... . .....+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000100000000 000 0 11346778999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-41 Score=360.09 Aligned_cols=261 Identities=16% Similarity=0.165 Sum_probs=209.3
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCC-cceeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH-RHLVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H-pnIv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||+||+|.+. +|+.||||++..... ..++.+|++.++.|+| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 67999999999999999999865 689999998754432 2357889999999975 8999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCC-----CCceEEecccccccCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDD-----NYVAKVSDFGLSKDAP 634 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~ 634 (832)
+ +++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 789999886543 368999999999999999999999 99999999999999974 5789999999998754
Q ss_pred CCCC------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccc
Q 047569 635 IGQG------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLL 708 (832)
Q Consensus 635 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~ 708 (832)
.... .......||+.|||||++.+..++.++|||||||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 3221 1233467999999999999999999999999999999999999999765543332222222111111111
Q ss_pred ccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 709 EKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 709 ~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
.+ +.+.+++++.+++..|++.+|++||+++.+.+.|+.+++
T Consensus 238 ~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 238 RE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 11 122345679999999999999999999999888887754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-41 Score=360.47 Aligned_cols=261 Identities=19% Similarity=0.248 Sum_probs=200.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcc-eeeEEEEeccCCcEEEEEEe
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRH-LVSLIGYCDENSEMILVYEY 559 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~ 559 (832)
++|++.+.||+|+||.||+|.+. +|+.||||++...... +++..|++++++++|+| |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999764 6899999986654332 45789999999998665 55556666888899999999
Q ss_pred cCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeC---CCCceEEecccccccCCCC
Q 047569 560 MSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLD---DNYVAKVSDFGLSKDAPIG 636 (832)
Q Consensus 560 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~ 636 (832)
+ +++|.+.+.... ..+++..++.++.|+++||+|||+ ++|+||||||+|||++ .+..+||+|||+++.....
T Consensus 85 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 566666654333 369999999999999999999999 9999999999999986 4557999999999876433
Q ss_pred CC------ceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 637 QG------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 637 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
.. .......||+.|||||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh-
Confidence 22 12345679999999999999999999999999999999999999997765443322221111110000000
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLWNLEYALQ 758 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 758 (832)
...+.++.++.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 239 --------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 --------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred --------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 1122345679999999999999999999999888887654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=371.38 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=198.0
Q ss_pred hcCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCC------
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS------ 551 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~------ 551 (832)
.++|++.+.||+|+||+||+|... +|+.||||++... +....+++.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999864 6999999998754 3445678999999999999999999999997654
Q ss_pred cEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 552 EMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 552 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
.+++||||+ +.+|..++... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 66777776433 59999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhh-----
Q 047569 632 DAPIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRK----- 705 (832)
Q Consensus 632 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~----- 705 (832)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|++||.....................
T Consensus 170 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 7643 2245679999999999876 45789999999999999999999999877654433222111000000
Q ss_pred ----------cccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 ----------GLLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 ----------~~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....+... .......+..+..+.+|+.+||..||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEK-KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSCHHHHHHHHHSCCCCC-CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcchhhhhhhccCCcccc-cchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0011122344567899999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=370.86 Aligned_cols=260 Identities=25% Similarity=0.304 Sum_probs=196.6
Q ss_pred CCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcceeeEEEEecc------CCcEEE
Q 047569 483 NFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDE------NSEMIL 555 (832)
Q Consensus 483 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~------~~~~~l 555 (832)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++||||+++++++.. ...++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999875 699999999865432 23579999999999999999999843 345789
Q ss_pred EEEecCCCChhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccccccC
Q 047569 556 VYEYMSNGPFRDHLY-GKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDA 633 (832)
Q Consensus 556 V~E~~~~gsL~~~l~-~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~ 633 (832)
|||||+++.+..+.. ......+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998664444332 1234479999999999999999999999 9999999999999999765 8999999999876
Q ss_pred CCCCCceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH-----HHhhh--
Q 047569 634 PIGQGHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM-----QWKRK-- 705 (832)
Q Consensus 634 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~-----~~~~~-- 705 (832)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|++||......+......... .....
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4332 2344579999999998765 578999999999999999999999998776544332221110 00000
Q ss_pred -c----ccccccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 706 -G----LLEKIIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 706 -~----~~~~i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
. ...............+..+.++.+|+.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000001111123345678999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=368.94 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=199.5
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC-cccHHHHHHHHHHHHhCCCcceeeEEEEeccCC----cEE
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS-EQGITEFQTEIQMLSKLRHRHLVSLIGYCDENS----EMI 554 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~----~~~ 554 (832)
+.+|++.+.||+|+||+||+|.. .+|+.||||++.... ....+++++|+++|++|+||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999976 479999999987543 445678999999999999999999999986543 234
Q ss_pred EEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCC
Q 047569 555 LVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAP 634 (832)
Q Consensus 555 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 634 (832)
++++++.+|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555667799999999644 58999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCC--ceeeccccCccccChhcccc-CCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc----
Q 047569 635 IGQG--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL---- 707 (832)
Q Consensus 635 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---- 707 (832)
.... .......||+.|+|||++.. ..++.++||||+||++|||++|++||......+................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3221 12344569999999999854 5678999999999999999999999987765443322211110000000
Q ss_pred -----ccccc-CCCCCC----CCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 -----LEKII-DPHLVG----TINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 -----~~~i~-d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
..... .+.... ...+..+.++.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000000 011233467899999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=355.04 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=205.7
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEeccCCcEEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYE 558 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~~~~~~lV~E 558 (832)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999864 7899999987543 34557889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEecccccccCCCCCC
Q 047569 559 YMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKDAPIGQG 638 (832)
Q Consensus 559 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 638 (832)
++.+++|..++... ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999998887544 368899999999999999999999 999999999999999999999999999998765332
Q ss_pred ceeeccccCccccChhccccCC-CCccccEEechhHHHHHhhCCCCCCCCChhh-hhhHHHHHHHHhhhccc---cccc-
Q 047569 639 HVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLLEVLCARPAINPQLPRE-QVNLAEWAMQWKRKGLL---EKII- 712 (832)
Q Consensus 639 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~SlGvvl~elltG~~pf~~~~~~~-~~~l~~~~~~~~~~~~~---~~i~- 712 (832)
.......+++.|+|||.+.... ++.++|||||||++|||++|+.||....... .............+... ....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2233445788999999987654 6899999999999999999998865443322 21111110000000000 0000
Q ss_pred --------CCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 713 --------DPHLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 713 --------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
.........+..+..+.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111223445678999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=366.40 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=204.5
Q ss_pred cCCCccceEeecCceeEEEEEEe----CCcEEEEEecCCC----CcccHHHHHHHHHHHHhCCC-cceeeEEEEeccCCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID----DGTKVAVKRGNPQ----SEQGITEFQTEIQMLSKLRH-RHLVSLIGYCDENSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~f~~Ei~~L~~l~H-pnIv~l~~~~~~~~~ 552 (832)
++|++.+.||+|+||+||+|... +|+.||||++... .....+++.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999752 4789999987643 22345678899999999976 899999999999999
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.+++|||+.+|+|.+++.... .+.+..+..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999996554 56788999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCCceeeccccCccccChhccccC--CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhccccc
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGLLEK 710 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 710 (832)
.............|++.|++||.+.+. .++.++|||||||+||||++|+.||......+...... ....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~------- 249 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRIL------- 249 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHH-------
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhcc-------
Confidence 654444445567799999999999764 47889999999999999999999997764433222111 0000
Q ss_pred ccCCCCCCCCChhHHHHHHHHHHHhhhcCCCCCCC-----HHHHH
Q 047569 711 IIDPHLVGTINPESLKKFAEAAEKCLADHGVDRPT-----MGDVL 750 (832)
Q Consensus 711 i~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl 750 (832)
.. ...++...+.++.+++.+||+.||.+||+ ++|++
T Consensus 250 --~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 250 --KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp --HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred --cC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 00 11233456778999999999999999995 67765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-40 Score=356.90 Aligned_cols=257 Identities=19% Similarity=0.242 Sum_probs=199.0
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEecc--CCcEEEEE
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDE--NSEMILVY 557 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~--~~~~~lV~ 557 (832)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .+++.+|+++|++++ ||||+++++++.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999874 79999999986543 467899999999995 9999999999864 46799999
Q ss_pred EecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC-ceEEecccccccCCCC
Q 047569 558 EYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY-VAKVSDFGLSKDAPIG 636 (832)
Q Consensus 558 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 636 (832)
||+++++|.++. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 258999999999999999999999 9999999999999998654 6999999999876432
Q ss_pred CCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhh-hHHHHH------HHHhhhcc-
Q 047569 637 QGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQV-NLAEWA------MQWKRKGL- 707 (832)
Q Consensus 637 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~-~l~~~~------~~~~~~~~- 707 (832)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ...... ..+.....
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 23455689999999998765 5799999999999999999999999765432221 111000 00000000
Q ss_pred -----cccccCC--------CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 -----LEKIIDP--------HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 -----~~~i~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
....... ..........+.++.+|+.+||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0111112335578999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=362.60 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=193.2
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCC--CcccHHHHHHHHHHHHhCCCcceeeEEEEec------cCCc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQ--SEQGITEFQTEIQMLSKLRHRHLVSLIGYCD------ENSE 552 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~------~~~~ 552 (832)
++|++.++||+|+||+||+|.+. +|+.||||++... +....+++.+|+.+|++++||||+++++++. ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999865 6999999998654 3455677999999999999999999999985 3478
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
+|+||||+.++.+ +.+. ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 8999999976554 4442 258899999999999999999999 9999999999999999999999999999886
Q ss_pred CCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHH------------
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAM------------ 700 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~------------ 700 (832)
... ........||+.|+|||++.+..++.++||||+||++|||++|++||.+..............
T Consensus 169 ~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 543 233455679999999999999999999999999999999999999998765443322211000
Q ss_pred ----HHhhhc-c-----cccccCCCCCCC---CChhHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 047569 701 ----QWKRKG-L-----LEKIIDPHLVGT---INPESLKKFAEAAEKCLADHGVDRPTMGDVLWN 752 (832)
Q Consensus 701 ----~~~~~~-~-----~~~i~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 752 (832)
...... . ............ .....+..+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0 000000000000 112356789999999999999999999999743
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=362.43 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=198.0
Q ss_pred hcCCCccceEeecCceeEEEEEE-eCCcEEEEEecCCCC--cccHHHHHHHHHHHHhCCCcceeeEEEEecc-----CCc
Q 047569 481 TKNFDSSAIIGVGGFGNVYLGEI-DDGTKVAVKRGNPQS--EQGITEFQTEIQMLSKLRHRHLVSLIGYCDE-----NSE 552 (832)
Q Consensus 481 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~f~~Ei~~L~~l~HpnIv~l~~~~~~-----~~~ 552 (832)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++|||||++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999976 479999999987543 3445678999999999999999999999853 334
Q ss_pred EEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 553 MILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 553 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
.++++||+.+|+|.+++..+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 56677888899999998543 59999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceeeccccCccccChhccccC-CCCccccEEechhHHHHHhhCCCCCCCCChhhhhhHHHHHHHHhhhcc----
Q 047569 633 APIGQGHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVNLAEWAMQWKRKGL---- 707 (832)
Q Consensus 633 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---- 707 (832)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|++||.+.....................
T Consensus 171 ~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 43 233455689999999987665 568999999999999999999999987655443322211100000000
Q ss_pred ----cccccCCCC-CCCC-----ChhHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 047569 708 ----LEKIIDPHL-VGTI-----NPESLKKFAEAAEKCLADHGVDRPTMGDVLW 751 (832)
Q Consensus 708 ----~~~i~d~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 751 (832)
......... .... ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000 0000 1234567899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-34 Score=317.81 Aligned_cols=262 Identities=19% Similarity=0.226 Sum_probs=190.9
Q ss_pred cCCCccceEeecCceeEEEEEEe-CCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-----------CcceeeEEEEecc
Q 047569 482 KNFDSSAIIGVGGFGNVYLGEID-DGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-----------HRHLVSLIGYCDE 549 (832)
Q Consensus 482 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-----------HpnIv~l~~~~~~ 549 (832)
.+|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++|++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35899999999999999999864 79999999987543 33467889999998875 5789999988754
Q ss_pred --CCcEEEEEEecCCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCC------
Q 047569 550 --NSEMILVYEYMSNGPF-RDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNY------ 620 (832)
Q Consensus 550 --~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~------ 620 (832)
....+++|+++..+.. ...........+++..+..++.|+++||+|||+ ..+|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 3566777777655543 333344555678999999999999999999996 36899999999999998654
Q ss_pred ceEEecccccccCCCCCCceeeccccCccccChhccccCCCCccccEEechhHHHHHhhCCCCCCCCChhhhhh----HH
Q 047569 621 VAKVSDFGLSKDAPIGQGHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPAINPQLPREQVN----LA 696 (832)
Q Consensus 621 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~SlGvvl~elltG~~pf~~~~~~~~~~----l~ 696 (832)
.+|++|||.+..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||.......... +.
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 499999999876532 2344579999999999999999999999999999999999999997653322111 11
Q ss_pred HHHHH-------Hhhhc-----------ccccccCC---------CCCCCCChhHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 047569 697 EWAMQ-------WKRKG-----------LLEKIIDP---------HLVGTINPESLKKFAEAAEKCLADHGVDRPTMGDV 749 (832)
Q Consensus 697 ~~~~~-------~~~~~-----------~~~~i~d~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 749 (832)
..... ....+ ....+... ..........+..+.+|+.+||..||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11000 00000 00000000 00112345677899999999999999999999998
Q ss_pred H
Q 047569 750 L 750 (832)
Q Consensus 750 l 750 (832)
+
T Consensus 326 L 326 (362)
T d1q8ya_ 326 V 326 (362)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.9e-22 Score=197.61 Aligned_cols=163 Identities=15% Similarity=0.130 Sum_probs=121.3
Q ss_pred CccceEeecCceeEEEEEEeCCcEEEEEecCCCCc------------------ccHHHHHHHHHHHHhCCCcceeeEEEE
Q 047569 485 DSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSE------------------QGITEFQTEIQMLSKLRHRHLVSLIGY 546 (832)
Q Consensus 485 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~f~~Ei~~L~~l~HpnIv~l~~~ 546 (832)
.+.++||+|+||+||+|...+|+.||||+++.... .....+..|...|.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999988899999997653210 012345678899999999999998876
Q ss_pred eccCCcEEEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeccCCCCceeeCCCCceEEec
Q 047569 547 CDENSEMILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGTAQGIIHRDVKSTNILLDDNYVAKVSD 626 (832)
Q Consensus 547 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 626 (832)
.. .+++|||+++..+.++ +......++.|++++|+|||+ ++|+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 43 3799999988766442 233456789999999999999 999999999999999965 589999
Q ss_pred ccccccCCCCCCceeeccccCccccC------hhccccCCCCccccEEechhHH
Q 047569 627 FGLSKDAPIGQGHVSTAVKGSFGYLD------PEYFRRQQLTEKSDVYSFGVVL 674 (832)
Q Consensus 627 FGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDV~SlGvvl 674 (832)
||++......... .|.. .|. -.+.+..++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9998765322110 1111 111 136678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=2e-07 Score=94.76 Aligned_cols=150 Identities=14% Similarity=0.100 Sum_probs=102.7
Q ss_pred HHHHHHhcCCCccceEeecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcE
Q 047569 475 QELQEATKNFDSSAIIGVGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEM 553 (832)
Q Consensus 475 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~ 553 (832)
.|+...-.+|++.+..+-++.+.||+... +++.+++|+...........+.+|...|..|. +--+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667787766544444578998865 46677888866544444456788998888774 43467788888888899
Q ss_pred EEEEEecCCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 047569 554 ILVYEYMSNGPFRDHLYGKNLPPLSWKQRLEISIGSARGLHYLHTGT--------------------------------- 600 (832)
Q Consensus 554 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~~L~yLH~~~--------------------------------- 600 (832)
++||++++|.++.+..... . ....++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886654211 1 12234455555555555310
Q ss_pred -----------------------CCCeeeccCCCCceeeCCCCceEEeccccccc
Q 047569 601 -----------------------AQGIIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 601 -----------------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
...++|+|+.|.|||+++++..-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999876667999997653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=1.5e-05 Score=79.76 Aligned_cols=76 Identities=16% Similarity=0.080 Sum_probs=55.7
Q ss_pred eEeecCc-eeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCC--CcceeeEEEEeccCCcEEEEEEecCCCCh
Q 047569 489 IIGVGGF-GNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLR--HRHLVSLIGYCDENSEMILVYEYMSNGPF 565 (832)
Q Consensus 489 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 565 (832)
.+..|.. +.||+...+++..+++|....... ..+..|.+.|+.|. .-.+.+++.++.+.+..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 678999888888899998655433 34677888887774 33366788888888899999999998776
Q ss_pred hh
Q 047569 566 RD 567 (832)
Q Consensus 566 ~~ 567 (832)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.0002 Score=76.56 Aligned_cols=77 Identities=17% Similarity=0.125 Sum_probs=50.4
Q ss_pred cceEeecCceeEEEEEEeC-CcEEEEEecCCC-------CcccHHHHHHHHHHHHhCC-C--cceeeEEEEeccCCcEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDD-GTKVAVKRGNPQ-------SEQGITEFQTEIQMLSKLR-H--RHLVSLIGYCDENSEMIL 555 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~f~~Ei~~L~~l~-H--pnIv~l~~~~~~~~~~~l 555 (832)
.+.||.|....||+....+ ++.++||.-.+. -.....+...|.+.|+.+. + ..+.+++.+.. ...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence 4568999999999997654 678999964321 1123345567888887763 2 45667776654 45578
Q ss_pred EEEecCCCCh
Q 047569 556 VYEYMSNGPF 565 (832)
Q Consensus 556 V~E~~~~gsL 565 (832)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.85 E-value=0.0013 Score=68.01 Aligned_cols=135 Identities=16% Similarity=0.166 Sum_probs=79.4
Q ss_pred ceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCCcce--eeEEE-----EeccCCcEEEEEEecCCCChhh
Q 047569 495 FGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHL--VSLIG-----YCDENSEMILVYEYMSNGPFRD 567 (832)
Q Consensus 495 fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~HpnI--v~l~~-----~~~~~~~~~lV~E~~~~gsL~~ 567 (832)
--.||+...++|+.+++|+.++.. ...+++..|+..|..|....+ +..+. .....+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 357999999999999999976553 235678889998888742222 11111 2234567889999998754311
Q ss_pred -----------hh-------ccC---CCCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCC
Q 047569 568 -----------HL-------YGK---NLPPLSWK----------------------QRLEISIGSARGLHYL-HTGTAQG 603 (832)
Q Consensus 568 -----------~l-------~~~---~~~~l~~~----------------------~~l~i~~~ia~~L~yL-H~~~~~~ 603 (832)
.+ ... ....+++. .....+.++...+.-+ .+..+.+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 000 01112211 1122222333222222 1223467
Q ss_pred eeeccCCCCceeeCCCCceEEeccccccc
Q 047569 604 IIHRDVKSTNILLDDNYVAKVSDFGLSKD 632 (832)
Q Consensus 604 ivHrDlkp~NILl~~~~~~kl~DFGla~~ 632 (832)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899997653
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=96.70 E-value=0.0047 Score=55.33 Aligned_cols=80 Identities=15% Similarity=0.206 Sum_probs=54.7
Q ss_pred eeEEeccCCCCceEEEEEeeeeeecccCcEEEEEEEcCeeecccCchhhhhcCcCcceEEEEEEEeccccCceEEEEccC
Q 047569 276 VTWTFDVDSTFSYLLRLHFCDIVSKSLNDLYFNVYVNGKTAISALDLSTVAQGLATPYYRDIVVNASLMHNGLNVQIGPN 355 (832)
Q Consensus 276 ~t~~~~~~~~~~Y~v~LhFae~~~~~~~~R~Fdi~in~~~~~~~~di~~~~~~~~~~~~~d~~~~~~~~~~gl~~s~~~~ 355 (832)
..|.++++ ||.|.|.++|.|.. ..++.+.|+.....+ .+....+.+.+++. +..|++.+...
T Consensus 65 ~~f~v~vP-nG~Y~Vtv~~Gd~~-------~~~~~~eg~~~~~~~--------~g~~~~~~~~V~Vt--DG~L~l~ft~~ 126 (146)
T d2o14a1 65 NTFNVDLP-NGLYEVKVTLGNTA-------RASVAAEGVFQVINM--------TGDGAEDTFQIPVT--DGQLNLLVTEG 126 (146)
T ss_dssp CCEEEECC-SEEEEEEEEESSCS-------EEEEEETTEEEEEEE--------ESTTCEEEEEEEEC--SSEEEEEEEES
T ss_pred ceEEEECC-CCeEEEEEEEecCC-------CccEEEeeEEecccc--------CCccEEEEEEEEEE--CCeEEEEEecC
Confidence 67888885 79999999999952 346777887665432 23333556667765 55599987422
Q ss_pred CCCCCCcccccccceeecccC
Q 047569 356 KENTGTRNAILNGLEVIKMSN 376 (832)
Q Consensus 356 ~~~~~~~~~~lng~ei~~ls~ 376 (832)
..+ ..+.||+|||-+++.
T Consensus 127 ~~G---~~~~in~l~I~~~~d 144 (146)
T d2o14a1 127 KAG---TAFTLSALKIKKLSD 144 (146)
T ss_dssp STT---SCCEEEEEEEEEEES
T ss_pred CCC---CccEEEEEEEEeccc
Confidence 211 167899999998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.42 E-value=0.0048 Score=65.44 Aligned_cols=73 Identities=18% Similarity=0.175 Sum_probs=50.5
Q ss_pred cceEeecCceeEEEEEEeC--------CcEEEEEecCCCCcccHHHHHHHHHHHHhCC-CcceeeEEEEeccCCcEEEEE
Q 047569 487 SAIIGVGGFGNVYLGEIDD--------GTKVAVKRGNPQSEQGITEFQTEIQMLSKLR-HRHLVSLIGYCDENSEMILVY 557 (832)
Q Consensus 487 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~-HpnIv~l~~~~~~~~~~~lV~ 557 (832)
++.|+.|-.-.+|+....+ .+.|.+++... .. ......+|.++++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4567777788899997653 34577776552 22 2345568999999885 4434588888764 6899
Q ss_pred EecCCCCh
Q 047569 558 EYMSNGPF 565 (832)
Q Consensus 558 E~~~~gsL 565 (832)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.21 E-value=0.012 Score=59.95 Aligned_cols=157 Identities=13% Similarity=0.100 Sum_probs=85.4
Q ss_pred cCHHHHHHHhcCCCccceEe-----ecCceeEEEEEEeCCcEEEEEecCCCCcccHHHHHHHHHHHHhCCC-----ccee
Q 047569 472 FSFQELQEATKNFDSSAIIG-----VGGFGNVYLGEIDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRH-----RHLV 541 (832)
Q Consensus 472 ~~~~el~~~~~~f~~~~~LG-----~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~L~~l~H-----pnIv 541 (832)
++.+|+.....+|.+.+... .|---+.|+.+.++| .+++|+...... .++...|+++|..|.+ |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 56788999999998765543 444567899987765 589998765322 2344556667776632 2222
Q ss_pred eEEE---EeccCCcEEEEEEecCCCChhhhh--------------c----cCC---CCCCCHH-----------------
Q 047569 542 SLIG---YCDENSEMILVYEYMSNGPFRDHL--------------Y----GKN---LPPLSWK----------------- 580 (832)
Q Consensus 542 ~l~~---~~~~~~~~~lV~E~~~~gsL~~~l--------------~----~~~---~~~l~~~----------------- 580 (832)
...+ ..........++.++.+......- + ... .......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 2111 112234566777777664321100 0 000 0000000
Q ss_pred -HHHHHHHHHHHHHHHHhc-CCCCCeeeccCCCCceeeCCCCceEEecccccc
Q 047569 581 -QRLEISIGSARGLHYLHT-GTAQGIIHRDVKSTNILLDDNYVAKVSDFGLSK 631 (832)
Q Consensus 581 -~~l~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 631 (832)
.....+..+...+...+. ..+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222221 345789999999999999988777899999765
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=89.02 E-value=1 Score=39.44 Aligned_cols=75 Identities=16% Similarity=0.213 Sum_probs=46.5
Q ss_pred EEeeccCCceE-EEEEeecCCCC-cccccceeeee-ecCceEEEEEEeecCCeEEEEEEeCC-CCceeeeeeEEEecCC
Q 047569 97 TFQLNQPGWHW-VRLHFFALPAK-EADLQKASFHV-ATDNCCEEFMLNLTESTFSIKFTPMK-NSVAFINAIEVVSAPD 171 (832)
Q Consensus 97 cy~l~~~g~~~-vR~~ff~~~~~-~~~~~~~~~~~-~~~~~~~E~i~~~~~~~~~vc~~~~~-~~~pFi~~iEl~~~~~ 171 (832)
-|.+..|...| |+++|=|-.-. .+.-....... .-...-+.+.+.+.++.|.|-|.... ...|=||+|||...++
T Consensus 66 ~f~v~vPnG~Y~Vtv~~Gd~~~~~~~~eg~~~~~~~~g~~~~~~~~V~VtDG~L~l~ft~~~~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 66 TFNVDLPNGLYEVKVTLGNTARASVAAEGVFQVINMTGDGAEDTFQIPVTDGQLNLLVTEGKAGTAFTLSALKIKKLSD 144 (146)
T ss_dssp CEEEECCSEEEEEEEEESSCSEEEEEETTEEEEEEEESTTCEEEEEEEECSSEEEEEEEESSTTSCCEEEEEEEEEEES
T ss_pred eEEEECCCCeEEEEEEEecCCCccEEEeeEEeccccCCccEEEEEEEEEECCeEEEEEecCCCCCccEEEEEEEEeccc
Confidence 35554467777 99999541100 00000000111 11234567899999999999997665 5789999999998744
|